Citrus Sinensis ID: 047969
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 625 | 2.2.26 [Sep-21-2011] | |||||||
| P0C5E2 | 654 | Probable serine/threonine | no | no | 0.470 | 0.449 | 0.697 | 1e-118 | |
| Q8RY67 | 708 | Wall-associated receptor | no | no | 0.460 | 0.406 | 0.493 | 6e-77 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.462 | 0.464 | 0.454 | 7e-71 | |
| Q9M342 | 639 | Wall-associated receptor | no | no | 0.465 | 0.455 | 0.448 | 1e-62 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.470 | 0.386 | 0.447 | 7e-62 | |
| Q9LZM4 | 657 | Wall-associated receptor | no | no | 0.457 | 0.435 | 0.446 | 1e-61 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.486 | 0.415 | 0.432 | 5e-61 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.465 | 0.313 | 0.451 | 8e-61 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.486 | 0.411 | 0.426 | 1e-60 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.468 | 0.399 | 0.445 | 1e-60 |
| >sp|P0C5E2|Y1839_ARATH Probable serine/threonine-protein kinase At1g18390 OS=Arabidopsis thaliana GN=At1g18390 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 427 bits (1098), Expect = e-118, Method: Compositional matrix adjust.
Identities = 205/294 (69%), Positives = 241/294 (81%)
Query: 268 GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMN 327
GV IFSY +L EATN+F KELGDGGFGTVYYGKLKDGR VAVKRLYDNN++R EQF N
Sbjct: 328 GVHIFSYEELEEATNNFDPSKELGDGGFGTVYYGKLKDGRSVAVKRLYDNNFKRAEQFRN 387
Query: 328 EVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
EVEILT LRH NLV+LFGC+S+ S+ LLLVYE+VANGT+AD LHG +A L W IR+
Sbjct: 388 EVEILTGLRHPNLVALFGCSSKQSRDLLLVYEYVANGTLADHLHGPQANPSSLPWSIRLK 447
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
IA+ETASAL YLHAS IIHRDVK+NNILLD NF VKVADFGLSRLFP+D THVSTAPQGT
Sbjct: 448 IAVETASALKYLHASKIIHRDVKSNNILLDQNFNVKVADFGLSRLFPMDKTHVSTAPQGT 507
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507
PGYVDP+YH CYQL++KSDVYSF VVL+ELISS+PAVD+ R R EINL+N+A+ KIQ
Sbjct: 508 PGYVDPDYHLCYQLSNKSDVYSFAVVLMELISSLPAVDITRPRQEINLSNMAVVKIQNHE 567
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
+++DP LGF++D V++ +VAELAF CLQ +K+LRP M V L RI++
Sbjct: 568 LRDMVDPSLGFDTDTRVRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTLTRIQN 621
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 146/296 (49%), Positives = 202/296 (68%), Gaps = 8/296 (2%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
V F Y ++ +AT+ FS +++LG G +GTVY GKL++ VA+KRL + ++Q MNE
Sbjct: 333 VAFFPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNE 392
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
+++L+ + H NLV L GC QG +LVYE++ NGT+++ L DR L W +R+
Sbjct: 393 IKLLSSVSHPNLVRLLGCC--IEQGDPVLVYEYMPNGTLSEHLQRDRGSG--LPWTLRLT 448
Query: 388 IAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444
+A +TA A+AYLH+S I HRD+K+ NILLD +F KVADFGLSRL + +H+STAP
Sbjct: 449 VATQTAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAP 508
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504
QGTPGY+DP+YHQC+ L+DKSDVYSFGVVL E+I+ + VD R EINLA LA++KI
Sbjct: 509 QGTPGYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIG 568
Query: 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
DE+IDP L + D +VAELAF CL + ++RP+M EV EL++I+
Sbjct: 569 SGCIDEIIDPILDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQIR 624
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 136/299 (45%), Positives = 204/299 (68%), Gaps = 10/299 (3%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
VP ++Y ++ +AT+ FS + LG G +GTVY G+ + VA+KRL + ++Q +NE
Sbjct: 299 VPFYTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNE 358
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQGL-LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
+++L+ + H NLV L GC ++ G LVYEF+ NGT+ L +R + L +W +R+
Sbjct: 359 IKLLSSVSHPNLVRLLGCC--FADGEPFLVYEFMPNGTLYQHLQHERGQPPL-SWQLRLA 415
Query: 388 IAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRL---FPLDVTHVS 441
IA +TA+A+A+LH+S I HRD+K++NILLD F K++DFGLSRL + +H+S
Sbjct: 416 IACQTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHIS 475
Query: 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501
TAPQGTPGY+DP+YHQ +QL+DKSDVYSFGVVL+E+IS +D R E+NLA+LA++
Sbjct: 476 TAPQGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVD 535
Query: 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
+I + ++IDPCL E + ++ ++AELAF CL ++ +RP+M E+ +L RIK
Sbjct: 536 RIGRGRVVDIIDPCLNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIK 594
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (616), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 134/299 (44%), Positives = 189/299 (63%), Gaps = 8/299 (2%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVE 330
IF+ ++ +AT++F++ LG GGFG V+ G L DG VAVKR N + + Q +NEV+
Sbjct: 341 IFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEVQ 400
Query: 331 ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLT--WPIR--M 386
IL ++ HKNLV L GC +L VYEFV NGT+ + ++G G L P+R +
Sbjct: 401 ILCQVSHKNLVKLLGCCIELEMPVL-VYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRL 459
Query: 387 NIAIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443
IA +TA L YLH+S I HRDVK++NILLD N VKVADFGLSRL DV+HV+T
Sbjct: 460 MIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTTC 519
Query: 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503
QGT GY+DPEY+ +QLTDKSDVYSFGVVL EL++ A+D NR ++NL +
Sbjct: 520 AQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKAL 579
Query: 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562
++ ++IDP +G + E+ ++ LA LC+++ ++ RP+M+ E++ I G
Sbjct: 580 KEGRLMDVIDPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTMQVAAKEIENILHG 638
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 135/302 (44%), Positives = 189/302 (62%), Gaps = 8/302 (2%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVE 330
IFS ++L +AT++F+ + LG GG GTVY G L DGR VAVKR + +VE+F+NEV
Sbjct: 411 IFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVV 470
Query: 331 ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI 390
+L ++ H+N+V L GC ++ +LVYEFV NG + +L D ++TW +R++IAI
Sbjct: 471 VLAQINHRNIVKLLGCCLE-TEVPVLVYEFVPNGDLCKRLR-DECDDYIMTWEVRLHIAI 528
Query: 391 ETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
E A AL+YLH++ I HRD+KT NILLD + VKV+DFG SR +D TH++T GT
Sbjct: 529 EIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGT 588
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507
GYVDPEY Q + TDKSDVYSFGVVL+ELI+ + A + +++
Sbjct: 589 FGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENR 648
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFE 567
F +++D + DE +VA+LA CL + + RP+M EV EL+RI+S K E
Sbjct: 649 FLDIVDERI---KDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSE 705
Query: 568 IH 569
IH
Sbjct: 706 IH 707
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 134/300 (44%), Positives = 189/300 (63%), Gaps = 14/300 (4%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVE 330
IF+ ++ +ATN+FS++ +G GGFG V+ L+DG A+KR NN + +Q +NEV
Sbjct: 350 IFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEVR 409
Query: 331 ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHG--DRAKHGLLTWPIRMNI 388
IL ++ H++LV L GC LL +YEF+ NGT+ + LHG DR L TW R+ I
Sbjct: 410 ILCQVNHRSLVRLLGCCVDLELPLL-IYEFIPNGTLFEHLHGSSDRTWKPL-TWRRRLQI 467
Query: 389 AIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-----HV 440
A +TA LAYLH++ I HRDVK++NILLD KV+DFGLSRL L T H+
Sbjct: 468 AYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNESHI 527
Query: 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500
T QGT GY+DPEY++ +QLTDKSDVYSFGVVL+E+++S A+D R ++NL + I
Sbjct: 528 FTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLV-MYI 586
Query: 501 NKIQ-KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
NK+ + E IDP L +++ + + LA CL + ++ RPSM+EV E++ I
Sbjct: 587 NKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVADEIEYI 646
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 135/312 (43%), Positives = 188/312 (60%), Gaps = 8/312 (2%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
V IF+ + EATN + + LG GG GTVY G L D VA+K+ N +VEQF+NE
Sbjct: 389 VKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINE 448
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
V +L+++ H+N+V + GC ++ LLVYEF+ +GT+ D LHG L TW R+ I
Sbjct: 449 VLVLSQINHRNVVKVLGCCLE-TEVPLLVYEFINSGTLFDHLHGSLYDSSL-TWEHRLRI 506
Query: 389 AIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
A E A +LAYLH+S IIHRD+KT NILLD N KVADFG SRL P+D ++T Q
Sbjct: 507 ATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQ 566
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505
GT GY+DPEY+ L +KSDVYSFGVVL+EL+S A+ R NL + + +
Sbjct: 567 GTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKN 626
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSK 565
F E+ID G +E+ +R A +A C + E RP M+EV AEL+ ++ +K
Sbjct: 627 NRFHEIID---GQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEALRVKTTK 683
Query: 566 FEIHEEKQDDRE 577
++ ++ ++ E
Sbjct: 684 YKWSDQYRETGE 695
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (600), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 140/310 (45%), Positives = 189/310 (60%), Gaps = 19/310 (6%)
Query: 260 LETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY 319
L+ G YF S L EAT++FS K++G G FG+VYYG++KDG+EVAVK D +
Sbjct: 588 LDEGVAYF----ISLPVLEEATDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKITADPSS 641
Query: 320 RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGL 379
QF+ EV +L+R+ H+NLV L G + +LVYE++ NG++ D LHG + +
Sbjct: 642 HLNRQFVTEVALLSRIHHRNLVPLIGYCEEADR-RILVYEYMHNGSLGDHLHGS-SDYKP 699
Query: 380 LTWPIRMNIAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
L W R+ IA + A L YLH IIHRDVK++NILLD N KV+DFGLSR D
Sbjct: 700 LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEED 759
Query: 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA 496
+THVS+ +GT GY+DPEY+ QLT+KSDVYSFGVVL EL+S V E+N+
Sbjct: 760 LTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIV 819
Query: 497 NLAINKIQKCAFDELIDPCLGFESD-EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555
+ A + I+K +IDPC+ E V R VAE+A C++Q RP M+EV+
Sbjct: 820 HWARSLIRKGDVCGIIDPCIASNVKIESVWR----VAEVANQCVEQRGHNRPRMQEVIVA 875
Query: 556 LQ---RIKSG 562
+Q RI+ G
Sbjct: 876 IQDAIRIERG 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 134/314 (42%), Positives = 191/314 (60%), Gaps = 10/314 (3%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
V IF+ + EAT+ + + LG GG GTVY G L D VA+K+ + +VEQF+NE
Sbjct: 395 VKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINE 454
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
V +L+++ H+N+V L GC ++ LLVYEF+++GT+ D LHG L TW R+ +
Sbjct: 455 VLVLSQINHRNVVKLLGCCLE-TEVPLLVYEFISSGTLFDHLHGSMFDSSL-TWEHRLRM 512
Query: 389 AIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
A+E A LAYLH+S IIHRD+KT NILLD N KVADFG SRL P+D ++T Q
Sbjct: 513 AVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQ 572
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505
GT GY+DPEY+ L +KSDVYSFGVVL+EL+S A+ R + ++ + + ++
Sbjct: 573 GTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKE 632
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSK 565
E+ID G +E +R A +A C + E RP M+EV AEL+ ++ K+K
Sbjct: 633 NRLHEIID---GQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKTK 689
Query: 566 FEIHEE--KQDDRE 577
+ +E +Q+D E
Sbjct: 690 HKWSDEYPEQEDTE 703
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 135/303 (44%), Positives = 189/303 (62%), Gaps = 10/303 (3%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
V IF+ + EAT+ ++ + LG GG GTVY G L+D VA+K+ + +VEQF+NE
Sbjct: 393 VKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINE 452
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
V +L+++ H+N+V L GC ++ LLVYEF+++GT+ D LHG L TW R+ I
Sbjct: 453 VLVLSQINHRNVVKLLGCCLE-TEVPLLVYEFISSGTLFDHLHGSMFDSSL-TWEHRLRI 510
Query: 389 AIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
AIE A LAYLH+ IIHRDVKT NILLD N KVADFG SRL P+D ++T Q
Sbjct: 511 AIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQ 570
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505
GT GY+DPEY+ L +KSDVYSFGVVL+EL+S A+ R + +L + ++ +++
Sbjct: 571 GTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKE 630
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ--RIKSGK 563
E+ID G +E +R A +A C + E RPSM+EV AEL+ R+K+ K
Sbjct: 631 NRLHEIID---GQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALRVKTTK 687
Query: 564 SKF 566
++
Sbjct: 688 HQW 690
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 625 | ||||||
| 359472672 | 735 | PREDICTED: probable serine/threonine-pro | 0.944 | 0.802 | 0.558 | 0.0 | |
| 147811712 | 691 | hypothetical protein VITISV_005934 [Viti | 0.985 | 0.891 | 0.536 | 0.0 | |
| 297737780 | 1368 | unnamed protein product [Vitis vinifera] | 0.940 | 0.429 | 0.558 | 0.0 | |
| 359472670 | 750 | PREDICTED: probable serine/threonine-pro | 0.985 | 0.821 | 0.536 | 0.0 | |
| 356574227 | 643 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.948 | 0.513 | 1e-165 | |
| 255572154 | 673 | wall-associated kinase, putative [Ricinu | 0.936 | 0.869 | 0.524 | 1e-165 | |
| 255572152 | 628 | wall-associated kinase, putative [Ricinu | 0.886 | 0.882 | 0.521 | 1e-165 | |
| 147852668 | 874 | hypothetical protein VITISV_002125 [Viti | 0.889 | 0.636 | 0.520 | 1e-162 | |
| 15222572 | 629 | protein kinase-like protein [Arabidopsis | 0.931 | 0.925 | 0.503 | 1e-158 | |
| 356574218 | 624 | PREDICTED: probable serine/threonine-pro | 0.964 | 0.966 | 0.489 | 1e-155 |
| >gi|359472672|ref|XP_002279708.2| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/623 (55%), Positives = 423/623 (67%), Gaps = 33/623 (5%)
Query: 33 CSFPPCGNLSQFTFPFTNLKHPECGLMVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSIT 92
CSF CG L FPF N +PECGL + NC + P+I+L + G + + NI D +I
Sbjct: 116 CSFFQCGKLGWLKFPFNNETNPECGLRTIVNCTEEAPKIQLERGGRHFEVKNIQGD-TII 174
Query: 93 VEDQVFQNHLNQRSCESFKNFSLPSSASLSFYVKSKL--LSLFRCTDKLD-NKFTSFNST 149
++D+ Q HL C+ N + S S+ F L L+LF+C + + T +N T
Sbjct: 175 IQDEQLQEHLKHGRCDFIDNLTSSPSPSVFFTPVPTLTELTLFKCHRSHNIDLITEYNYT 234
Query: 150 CNSSSFIYYNHPDDDLPSILPPNCSLIQLPVN-KTRKSGDLFNMLTSVFSLQVEVHRVCW 208
I+YNH + P+ PP CS+IQ PVN T L ++LT +L+V V CW
Sbjct: 235 RCQDYIIHYNHSNHIPPTPPPPGCSIIQYPVNMSTVGIAKLDSLLTPDITLEVNVFSHCW 294
Query: 209 ECRWRGGQCQNDSKGNFQCAETRECNDCHKKRGYCHIDDKG------------------- 249
C RGGQCQ+D KG FQCA + ++ K I G
Sbjct: 295 NCLNRGGQCQDDEKGKFQCAHVKGNDNRLKLALGSGISAGGITILIICFIIRQRHKRKYA 354
Query: 250 -NFQCENERTD------LETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK 302
F N +D LET YFG+PIF YS+L EAT F ++E+GDGGFGTVY+G+
Sbjct: 355 STFLSRNTSSDPSSQPGLETTGTYFGIPIFPYSELEEATYHFVPDREIGDGGFGTVYHGQ 414
Query: 303 LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362
L+DGREVAVKRLY+NNYRRVEQFMNEV+ILTRLRH+NLVSL+GCTSR+S+ LLLVYEF+
Sbjct: 415 LRDGREVAVKRLYENNYRRVEQFMNEVQILTRLRHRNLVSLYGCTSRHSRELLLVYEFIP 474
Query: 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422
NGTVAD LHG+RA GLLTWPIR++IAIETASAL YLHASD++HRDVKT NILLD++FCV
Sbjct: 475 NGTVADHLHGNRADSGLLTWPIRLSIAIETASALCYLHASDVVHRDVKTKNILLDNSFCV 534
Query: 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
KVADFGLSRLFP DVTHVSTAPQGTPGYVDPEYH C+QLTDKSDVYSFGVVLIELISS+P
Sbjct: 535 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHLCHQLTDKSDVYSFGVVLIELISSLP 594
Query: 483 AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQN 542
AVD +R +HEINL+N AINKIQKCAF ELIDP LGF SD V RMTT VAELAF CLQ +
Sbjct: 595 AVDFSRLKHEINLSNYAINKIQKCAFHELIDPHLGFNSDLAVNRMTTLVAELAFRCLQPD 654
Query: 543 KELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMRL 602
KE+RPSM+EVL L+ I+S + + E + + D G +PPP P CDE LLK+++L
Sbjct: 655 KEMRPSMDEVLEILKEIESNRHELE-NMDAAADSVGSSMREPPPPSPDCDEVGLLKSVQL 713
Query: 603 PSSPISVTEKWVSISSTTPNASG 625
SP S T +W S STTP+AS
Sbjct: 714 MPSPDSTTAQWAS-RSTTPSASA 735
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147811712|emb|CAN65965.1| hypothetical protein VITISV_005934 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/675 (53%), Positives = 453/675 (67%), Gaps = 59/675 (8%)
Query: 1 MACRSYLQFFVISQLLLLSSAEEERELNKTCLCSFPP--CGNLSQFTFPFTNLKHPECGL 58
M S+L F++S +LLSSAEEER+ TC PP C L FPF N +PECG
Sbjct: 26 MGSVSFLVLFLLSHSVLLSSAEEERKQPPTC----PPFHCEKLGWLHFPFNNETNPECGF 81
Query: 59 MVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSITVEDQVFQNHLNQRSCESFKNFSLPSS 118
V C + +PRI+L + G ++ + NI+Q +I ++D+ Q +L + CE N + S
Sbjct: 82 CTVTRCTEGLPRIQLEREGRYFGVKNISQADTIVIQDKRLQENLQRGICEFIDNLTRFRS 141
Query: 119 ASLSFYVKSKL--LSLFRCTDKLDNKFTS-FNSTCNSSSFIYYNHPDD-DLPSILPPN-- 172
S+SF L L+LF+C L+ T+ N T I+YNHP+ +P LP N
Sbjct: 142 PSVSFKPVPPLAELTLFKCHRNLNIDLTTDHNYTDCQDYIIHYNHPNHTSIPPPLPHNQP 201
Query: 173 -------------CSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCWECRWRGGQCQN 219
CS+IQ P+N + +L +LTS +L+V + R C +C GGQC++
Sbjct: 202 NHTPTLPPPAPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRKCHSSGGQCRD 261
Query: 220 DSKGNFQCAETRECND----------------------------CHKKRGYCHIDDKGNF 251
D +G F+CA T ND HK++ +
Sbjct: 262 D-EGKFRCAHTG--NDKRLKLALGLGISAGSITILIICFFIIWQSHKRKYAPTFLSRNTC 318
Query: 252 QCENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAV 311
+ +++LE YFG+PIF Y++L EATN F ++E+GDGGFGTVY+G+L+DGREVAV
Sbjct: 319 SDPSSKSELEITGAYFGIPIFPYTELEEATNYFDPDREIGDGGFGTVYHGQLRDGREVAV 378
Query: 312 KRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371
KRLY+NN+RRVEQFMNEV+ILTRLRH+NLVSL+GCTSR+S+ LLLVYEF+ NGTVAD LH
Sbjct: 379 KRLYENNHRRVEQFMNEVQILTRLRHRNLVSLYGCTSRHSRELLLVYEFIPNGTVADHLH 438
Query: 372 GDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
GDRA GLLTWPIR++IAIETA+AL YLHASD++HRDVKT NILLD +FCVKVADFGLSR
Sbjct: 439 GDRADSGLLTWPIRLSIAIETATALCYLHASDVVHRDVKTKNILLDDSFCVKVADFGLSR 498
Query: 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH 491
LFP DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS+PAVD+NRHRH
Sbjct: 499 LFPTDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSLPAVDINRHRH 558
Query: 492 EINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551
EINL+N AINKIQKCAF ELIDP LGF+SD V RMTT VAELAF CLQ +KE+RPSM+E
Sbjct: 559 EINLSNYAINKIQKCAFHELIDPRLGFDSDLAVNRMTTLVAELAFRCLQPDKEMRPSMDE 618
Query: 552 VLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPP-PSPPYCDEDSLLKNMRLPSSPISVT 610
VL L+ I+S K + E + + D G +PP P P CDE LLK+++L S +VT
Sbjct: 619 VLEILKEIESDKHESE-NMDIATDSVGSSMHEPPLPPSPDCDEVGLLKSVQLMPSLDTVT 677
Query: 611 EKWVSISSTTPNASG 625
+W S STTP+AS
Sbjct: 678 AQWPS-RSTTPSASA 691
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737780|emb|CBI26981.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/621 (55%), Positives = 422/621 (67%), Gaps = 33/621 (5%)
Query: 33 CSFPPCGNLSQFTFPFTNLKHPECGLMVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSIT 92
CSF CG L FPF N +PECGL + NC + P+I+L + G + + NI D +I
Sbjct: 738 CSFFQCGKLGWLKFPFNNETNPECGLRTIVNCTEEAPKIQLERGGRHFEVKNIQGD-TII 796
Query: 93 VEDQVFQNHLNQRSCESFKNFSLPSSASLSFYVKSKL--LSLFRCTDKLD-NKFTSFNST 149
++D+ Q HL C+ N + S S+ F L L+LF+C + + T +N T
Sbjct: 797 IQDEQLQEHLKHGRCDFIDNLTSSPSPSVFFTPVPTLTELTLFKCHRSHNIDLITEYNYT 856
Query: 150 CNSSSFIYYNHPDDDLPSILPPNCSLIQLPVN-KTRKSGDLFNMLTSVFSLQVEVHRVCW 208
I+YNH + P+ PP CS+IQ PVN T L ++LT +L+V V CW
Sbjct: 857 RCQDYIIHYNHSNHIPPTPPPPGCSIIQYPVNMSTVGIAKLDSLLTPDITLEVNVFSHCW 916
Query: 209 ECRWRGGQCQNDSKGNFQCAETRECNDCHKKRGYCHIDDKG------------------- 249
C RGGQCQ+D KG FQCA + ++ K I G
Sbjct: 917 NCLNRGGQCQDDEKGKFQCAHVKGNDNRLKLALGSGISAGGITILIICFIIRQRHKRKYA 976
Query: 250 -NFQCENERTD------LETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK 302
F N +D LET YFG+PIF YS+L EAT F ++E+GDGGFGTVY+G+
Sbjct: 977 STFLSRNTSSDPSSQPGLETTGTYFGIPIFPYSELEEATYHFVPDREIGDGGFGTVYHGQ 1036
Query: 303 LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362
L+DGREVAVKRLY+NNYRRVEQFMNEV+ILTRLRH+NLVSL+GCTSR+S+ LLLVYEF+
Sbjct: 1037 LRDGREVAVKRLYENNYRRVEQFMNEVQILTRLRHRNLVSLYGCTSRHSRELLLVYEFIP 1096
Query: 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422
NGTVAD LHG+RA GLLTWPIR++IAIETASAL YLHASD++HRDVKT NILLD++FCV
Sbjct: 1097 NGTVADHLHGNRADSGLLTWPIRLSIAIETASALCYLHASDVVHRDVKTKNILLDNSFCV 1156
Query: 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
KVADFGLSRLFP DVTHVSTAPQGTPGYVDPEYH C+QLTDKSDVYSFGVVLIELISS+P
Sbjct: 1157 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHLCHQLTDKSDVYSFGVVLIELISSLP 1216
Query: 483 AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQN 542
AVD +R +HEINL+N AINKIQKCAF ELIDP LGF SD V RMTT VAELAF CLQ +
Sbjct: 1217 AVDFSRLKHEINLSNYAINKIQKCAFHELIDPHLGFNSDLAVNRMTTLVAELAFRCLQPD 1276
Query: 543 KELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMRL 602
KE+RPSM+EVL L+ I+S + + E + + D G +PPP P CDE LLK+++L
Sbjct: 1277 KEMRPSMDEVLEILKEIESNRHELE-NMDAAADSVGSSMREPPPPSPDCDEVGLLKSVQL 1335
Query: 603 PSSPISVTEKWVSISSTTPNA 623
SP S T +W S STTP+A
Sbjct: 1336 MPSPDSTTAQWAS-RSTTPSA 1355
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472670|ref|XP_002279726.2| PREDICTED: probable serine/threonine-protein kinase At1g18390 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/675 (53%), Positives = 453/675 (67%), Gaps = 59/675 (8%)
Query: 1 MACRSYLQFFVISQLLLLSSAEEERELNKTCLCSFPP--CGNLSQFTFPFTNLKHPECGL 58
M S+L F++S +LLSSAEEER+ TC PP C L FPF N +PECG
Sbjct: 85 MGSVSFLVLFLLSHSVLLSSAEEERKQPPTC----PPFHCEKLGWLHFPFNNETNPECGF 140
Query: 59 MVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSITVEDQVFQNHLNQRSCESFKNFSLPSS 118
V C + +PRI+L + G ++ + NI+Q +I ++D+ Q +L + CE N + S
Sbjct: 141 CTVTRCTEGLPRIQLEREGRYFGVKNISQADTIVIQDKRLQENLQRGICEFIDNLTRFRS 200
Query: 119 ASLSFYVKSKL--LSLFRCTDKLDNKFTS-FNSTCNSSSFIYYNHPDD-DLPSILPPN-- 172
S+SF L L+LF+C L+ T+ N T I+YNHP+ +P LP N
Sbjct: 201 PSVSFKPVPPLAELTLFKCHRNLNIDLTTDHNYTDCQDYIIHYNHPNHTSIPPPLPHNQP 260
Query: 173 -------------CSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCWECRWRGGQCQN 219
CS+IQ P+N + +L +LTS +L+V + R C +C GGQC++
Sbjct: 261 NHTPTLPPPAPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRKCHSSGGQCRD 320
Query: 220 DSKGNFQCAETRECND----------------------------CHKKRGYCHIDDKGNF 251
D +G F+CA T ND HK++ +
Sbjct: 321 D-EGKFRCAHTG--NDKRLKLALGLGISAGSITILIICFFIIWQSHKRKYAPTFLSRNTC 377
Query: 252 QCENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAV 311
+ +++LE YFG+PIF Y++L EATN F ++E+GDGGFGTVY+G+L+DGREVAV
Sbjct: 378 SDPSSKSELEITGAYFGIPIFPYTELEEATNYFDPDREIGDGGFGTVYHGQLRDGREVAV 437
Query: 312 KRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371
KRLY+NN+RRVEQFMNEV+ILTRLRH+NLVSL+GCTSR+S+ LLLVYEF+ NGTVAD LH
Sbjct: 438 KRLYENNHRRVEQFMNEVQILTRLRHRNLVSLYGCTSRHSRELLLVYEFIPNGTVADHLH 497
Query: 372 GDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
GDRA GLLTWPIR++IAIETA+AL YLHASD++HRDVKT NILLD +FCVKVADFGLSR
Sbjct: 498 GDRADSGLLTWPIRLSIAIETATALCYLHASDVVHRDVKTKNILLDDSFCVKVADFGLSR 557
Query: 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH 491
LFP DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS+PAVD+NRHRH
Sbjct: 558 LFPTDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSLPAVDINRHRH 617
Query: 492 EINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551
EINL+N AINKIQKCAF ELIDP LGF+SD V RMTT VAELAF CLQ +KE+RPSM+E
Sbjct: 618 EINLSNYAINKIQKCAFHELIDPRLGFDSDLAVNRMTTLVAELAFRCLQPDKEMRPSMDE 677
Query: 552 VLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPP-PSPPYCDEDSLLKNMRLPSSPISVT 610
VL L+ I+S K + E + + D G +PP P P CDE LLK+++L S +VT
Sbjct: 678 VLEILKEIESDKHESE-NMDIATDSVGSSMHEPPLPPSPDCDEVGLLKSVQLMPSLDTVT 736
Query: 611 EKWVSISSTTPNASG 625
+W S STTP+AS
Sbjct: 737 AQWPS-RSTTPSASA 750
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574227|ref|XP_003555252.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-165, Method: Compositional matrix adjust.
Identities = 338/658 (51%), Positives = 426/658 (64%), Gaps = 48/658 (7%)
Query: 1 MACRSYLQFFVISQLLLLSSAEEERELNKTCLCSFPPCGNLSQFTFPFTNLKHPECGLMV 60
MA F + L+L+ SA ++ C SF CGNL F +PFT + P+CGL+
Sbjct: 1 MALVDLFCFLLFCHLVLILSAGYGNG-HQDCPHSFT-CGNLGTFHYPFTKAEKPDCGLLA 58
Query: 61 VDNCNKPVPR---IRLGKAGPFYNILNIAQDVSITVEDQVFQNHLNQRSCESFKN-FSLP 116
+ +C+ P I+L K G + +AQ +I++ D+ F L Q C + KN +SLP
Sbjct: 59 IHDCDNPHQHRKMIQLEKNGKGIVLTGVAQQNAISILDEDFHKRLQQNPCGTLKNNYSLP 118
Query: 117 SSASLSFYVKSKL-LSLFRCTDKLDNKFTS--FNSTCNSSSF-IYYNH---PDDDLPSIL 169
S S + + K ++LF+C L K + FN C + IYY+ P+ L
Sbjct: 119 SPFSSLYSIHIKFNVTLFKCKQSLKMKPPTHYFNHPCPEYDYDIYYDSLPTPNSKEAHSL 178
Query: 170 PPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCWEC-RWRGGQCQNDSKGNFQCA 228
+CS+IQ+ + D+ + +++ LQV + C +C RGGQC+ D+ F C
Sbjct: 179 FSSCSVIQISSKDLTDTNDILSFVSAEMVLQVVLSNDCDQCYNHRGGQCRLDANKKFYCK 238
Query: 229 E-----------------TRECNDCHKKRGY--CHIDDKGNFQCENERTDLETGTVYFGV 269
E R+ H + ++D G + D E G YFGV
Sbjct: 239 EGLSVILSAILIIGYIVFRRKYTPSHPQSQSRNTYVDVIG----PSSNPDPENGRFYFGV 294
Query: 270 PIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEV 329
P+FSY +L +AT +F ++LG GGFGTVYYGKL+DGREVA+KRLY++NYRRVEQFMNEV
Sbjct: 295 PLFSYKELQKATYNFHHARQLGSGGFGTVYYGKLQDGREVAIKRLYEHNYRRVEQFMNEV 354
Query: 330 EILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIA 389
+ILTRLRHKNLVSL+GCTS +S+ LLLVYE V NGTVA LHG+ A+ L W RM IA
Sbjct: 355 QILTRLRHKNLVSLYGCTSSHSRELLLVYEHVPNGTVACHLHGELARRDTLPWHTRMKIA 414
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG 449
IETASAL+YLHASDIIHRDVKT NILL+ +F VKVADFGLSRLFP DVTHVSTAP GTPG
Sbjct: 415 IETASALSYLHASDIIHRDVKTKNILLNESFSVKVADFGLSRLFPNDVTHVSTAPLGTPG 474
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
YVDPEYHQCYQLT+KSDVYSFGVVLIEL+SSMPA+DM R R EINL+NLAINKIQ+ AF
Sbjct: 475 YVDPEYHQCYQLTNKSDVYSFGVVLIELLSSMPAIDMTRRRDEINLSNLAINKIQQSAFS 534
Query: 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIH 569
EL+DPCLGF+SD EVKRM SVAELAF CLQ++KELRPSM+EVL L RI++GK
Sbjct: 535 ELVDPCLGFDSDSEVKRMMVSVAELAFQCLQRDKELRPSMDEVLKVLMRIETGKDM---- 590
Query: 570 EEKQDDREGIKCTQPP--PSPPYCDEDSLLKNMRLPSSPISVTEKWVSISSTTPNASG 625
E DD E ++ PP PSP + DE+ L++ M + SP +VT+ W S STTPN SG
Sbjct: 591 GEHPDDVEDLR---PPSLPSPDW-DENGLVRKMMVHPSPKAVTDTWHS-ESTTPNGSG 643
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572154|ref|XP_002527017.1| wall-associated kinase, putative [Ricinus communis] gi|223533652|gb|EEF35389.1| wall-associated kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-165, Method: Compositional matrix adjust.
Identities = 337/642 (52%), Positives = 410/642 (63%), Gaps = 57/642 (8%)
Query: 33 CSFPPCGNLSQFTFPF--TNLKHPECGLMVVD-NCNK---PVPRIRLGKAGPFYNILNIA 86
C+ CG+ TFPF + P CG D +CN P+ ++R + Y I +I+
Sbjct: 38 CNPRTCGDGQNITFPFYIQGQQEPFCGYPGFDLSCNHNGHPILKLRDNE----YVIRHIS 93
Query: 87 QDVSITVEDQVFQNHLNQRSCESFKNFSLPSSASLSFYVKSKLLSLFRCTDKL----DNK 142
F+N SLP ++ L L+ C L +++
Sbjct: 94 YKTQTVRVSNAAVFDTATTCIPPFRNTSLPEDRFKLSSNQTGLFFLYECNSTLLGNRNSE 153
Query: 143 FTSFNSTC------NSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSV 196
+ C + ++ + P S++ N + + V+ + L ML
Sbjct: 154 LNKYKVDCLIETGTGPTLSMFEDDPLLGYASVVCENKVKVAVDVHGGNSTDGLERMLERG 213
Query: 197 FSLQVEVHRVCWECRWRGGQCQ-NDSKGNFQC-----AETRECNDC-------------- 236
F L + C C GG+C +D+ +F+C +CN
Sbjct: 214 FVLNW-IASNCSICENSGGKCGFDDATYHFKCFCPDRPHASDCNPVKFTLIYAGAGIGLI 272
Query: 237 -----------HKKR---GYCHIDDKGNFQCENERTDLETGTVYFGVPIFSYSDLAEATN 282
H KR +I +F + R+DLE G+VYFGV +FSY++L +AT+
Sbjct: 273 ALLLSFYIFRSHYKRRRNASSNILSTNSFS-PSSRSDLEGGSVYFGVSVFSYAELEKATS 331
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+F +KELGDGGFGTVYYGKLKDGREVAVKRLY++NYRRVEQF+NE+EILTRLRHKNLV+
Sbjct: 332 NFDSKKELGDGGFGTVYYGKLKDGREVAVKRLYEHNYRRVEQFINEIEILTRLRHKNLVT 391
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L+GCTSR S+ LLLVYE++ NGTVAD LHGDR+K LTWPIRM+IAIETA+ALAYLHAS
Sbjct: 392 LYGCTSRRSRELLLVYEYIPNGTVADHLHGDRSKSSPLTWPIRMSIAIETATALAYLHAS 451
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
D IHRDVKTNNILLD+NFCVKVADFGLSRLFP DVTHVSTAPQGTPGYVDPEYHQCYQLT
Sbjct: 452 DTIHRDVKTNNILLDNNFCVKVADFGLSRLFPNDVTHVSTAPQGTPGYVDPEYHQCYQLT 511
Query: 463 DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522
DKSDVYSFGVVLIELISSMPAVD+NRHRHEINLANLA+NKIQ CAFDELIDP G+ SDE
Sbjct: 512 DKSDVYSFGVVLIELISSMPAVDINRHRHEINLANLAVNKIQNCAFDELIDPSFGYNSDE 571
Query: 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCT 582
EVKR T SVAELAF CLQQ+KELRPSM+EVL EL+ I+ G E E DD + +
Sbjct: 572 EVKRKTISVAELAFRCLQQDKELRPSMDEVLEELKSIEIGDHN-ENQEVVLDDNKVLTDM 630
Query: 583 QPPPSPPYCDEDSLLKNMRLPSSPISVTEKWVSISSTTPNAS 624
PPPSP YCDE LLKN+RLP SP++VT +W S STTPN S
Sbjct: 631 PPPPSPAYCDEALLLKNIRLPPSPVTVTAQWASSCSTTPNIS 672
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572152|ref|XP_002527016.1| wall-associated kinase, putative [Ricinus communis] gi|223533651|gb|EEF35388.1| wall-associated kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-165, Method: Compositional matrix adjust.
Identities = 324/621 (52%), Positives = 411/621 (66%), Gaps = 67/621 (10%)
Query: 1 MACRSYLQFFVISQLLLLSSAEEERELNKTCLCSFPPCGNLSQFTFPFTNL-KHPECGLM 59
MA S FF + Q +LL E C CG+L + FP+TN+ ++ ECGL
Sbjct: 3 MAAVSLFVFFALFQPVLLQPIEGPN-------CPRFYCGSLGELVFPYTNITENTECGLF 55
Query: 60 VVDNCNKPVPRIRLGK-AGPFYNILNIA----QDVSITVEDQVFQNHLNQRSCESFKNFS 114
VV++C+K +I+L + +G +Y + I SI++ D Q L+ R+C SF N S
Sbjct: 56 VVNDCDKEHRQIQLERGSGKWYTVERIQFQNPSVSSISIIDTELQKSLDSRNCASFNNLS 115
Query: 115 LPSSASLSF-YVKSKLLSLFRC--TDKLDNKFTSFNSTCNSSSFIYYNHPDDDLPSILPP 171
LP ++ V S+L++L +C T K+ + FN T + I+Y ++P I P
Sbjct: 116 LPHVPLVNIQIVPSQLITLLKCDPTAKVTSPLIKFNYTGCPNFNIFYTGITREVP-IPPT 174
Query: 172 NCSLIQLPVNKTRKSGDLFNMLTSVFSLQV----EVHRVCWECRWRGGQCQNDSKGNFQC 227
+CS IQLP N D+F +LT+ F+LQV E H C +C + G+C +S G QC
Sbjct: 175 SCSTIQLPANIDNGYEDIFKLLTADFTLQVTLSFEFH-FCEQCHLQAGECHGNSTGKLQC 233
Query: 228 AET----------RECNDCHKKRG-------------------------YCHIDDK---- 248
+E + HKK+ +C ++
Sbjct: 234 LNANGSEIKINWEKEGPEPHKKKKEELAWELAVGLGCPAFLITLALVIFFCRRHNRKMAS 293
Query: 249 ------GNFQCENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK 302
+ ++DLE +YFGV IFSY++L EATN+F+ E ELGDGGFGTV+YGK
Sbjct: 294 PNLLRVNTYSGAFSKSDLEGANIYFGVSIFSYAELEEATNNFASENELGDGGFGTVFYGK 353
Query: 303 LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362
L+DGREVAVKRLY+ N R+V+QF+NE+EILTRLRH+NLVSL+G TSR S+ LLLVYE++
Sbjct: 354 LQDGREVAVKRLYERNCRKVQQFLNEIEILTRLRHQNLVSLYGFTSRRSRELLLVYEYIP 413
Query: 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422
NGTVAD LHGDR LT PIRM IAIETA+AL YLHAS IIHRDVKTNNILLD+NFCV
Sbjct: 414 NGTVADHLHGDRVNSSPLTLPIRMRIAIETANALVYLHASGIIHRDVKTNNILLDNNFCV 473
Query: 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
KVADFG+SRLFP DVTH+STAPQGTPGYVDPEY+ CYQLT+KSDVYSFGVVL+ELISSMP
Sbjct: 474 KVADFGISRLFPNDVTHISTAPQGTPGYVDPEYYHCYQLTEKSDVYSFGVVLVELISSMP 533
Query: 483 AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQN 542
AVD+ R RHEINLANLAINKIQ+ AFDELIDP LG++SDEEV+RMT VAELAFLCLQ++
Sbjct: 534 AVDITRERHEINLANLAINKIQRSAFDELIDPFLGYQSDEEVQRMTVLVAELAFLCLQKD 593
Query: 543 KELRPSMEEVLAELQRIKSGK 563
KE+RP+M EVL EL+RI+SG+
Sbjct: 594 KEMRPAMHEVLEELKRIESGE 614
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852668|emb|CAN81685.1| hypothetical protein VITISV_002125 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-162, Method: Compositional matrix adjust.
Identities = 324/623 (52%), Positives = 397/623 (63%), Gaps = 67/623 (10%)
Query: 33 CSFPPCGNLSQFTFPFTNLKHPECGLMVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSIT 92
CSF CG L FPF N +PECGL + NC + P+I+L + G + + NI D +I
Sbjct: 289 CSFFQCGKLGWLKFPFNNETNPECGLRTIVNCTEEAPKIQLERGGRHFEVKNIQGD-TII 347
Query: 93 VEDQVFQNHLNQRSCESFKNFSLPSSASLSFYVKSKL--LSLFRCTDKLD-NKFTSFNST 149
++D+ Q HL C+ N + S S+ F L L+LF+C + + T +N T
Sbjct: 348 IQDEQLQEHLKHGRCDFIDNLTSSPSPSVFFTPVPTLTELTLFKCHRSHNIDLITEYNYT 407
Query: 150 CNSSSFIYYNHPDDDLPSILPPNCSLIQLPVN-KTRKSGDLFNMLTSVFSLQVEVHRVCW 208
I+YNH + P+ PP CS+IQ PVN T L ++LT +L+V V CW
Sbjct: 408 RCQDYIIHYNHSNHIPPTPPPPGCSIIQYPVNMSTVGIAKLDSLLTPDITLEVNVFSHCW 467
Query: 209 ECRWRGGQCQNDSKGNFQCAETRECNDCHKKRGYCHIDDKG------------------- 249
C RGGQCQ+D KG FQCA + ++ K I G
Sbjct: 468 NCLNRGGQCQDDEKGKFQCAHVKXNDNRLKLALGSGISAGGITILIICFIIRQRHKRKYA 527
Query: 250 -NFQCENERTD------LETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK 302
F N +D LET YFG+PIF YS+L EAT F ++E+GDGGFGTVY+G+
Sbjct: 528 STFLSRNTSSDPSSQPGLETTGTYFGIPIFPYSELEEATYHFVPDREIGDGGFGTVYHGQ 587
Query: 303 LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362
L+DGREVAVKRLY+NNYRRVEQFMNEV+ILTRLRH+NLVSL+GCTSR+S+ LLLVYEF+
Sbjct: 588 LRDGREVAVKRLYENNYRRVEQFMNEVQILTRLRHRNLVSLYGCTSRHSRELLLVYEFIP 647
Query: 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422
NGTVAD LHG+RA GLLTWPIR++IAIETASAL YLHASD++HRDVKT NILLD++FCV
Sbjct: 648 NGTVADHLHGNRADSGLLTWPIRLSIAIETASALCYLHASDVVHRDVKTKNILLDNSFCV 707
Query: 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
KVADFGLSRLFP DVTHVSTAPQGTPGYVDPEYH C+QLTDKSDVYSFGVVLIELISS+P
Sbjct: 708 KVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHLCHQLTDKSDVYSFGVVLIELISSLP 767
Query: 483 AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQN 542
AVD NLA+N RMTT VAELAF CLQ +
Sbjct: 768 AVDF----------NLAVN------------------------RMTTLVAELAFRCLQPD 793
Query: 543 KELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMRL 602
KE+RPSM+EVL L+ I+S + + E + + D G +PPP P CDE LLK+++L
Sbjct: 794 KEMRPSMDEVLEILKEIESNRHELE-NMDAAADSVGSSMREPPPPSPDCDEVGLLKSVQL 852
Query: 603 PSSPISVTEKWVSISSTTPNASG 625
SP S T +W S STTP+AS
Sbjct: 853 MPSPDSTTAQWAS-RSTTPSASA 874
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15222572|ref|NP_173910.1| protein kinase-like protein [Arabidopsis thaliana] gi|12321510|gb|AAG50813.1|AC079281_15 wall-associated kinase, putative [Arabidopsis thaliana] gi|332192495|gb|AEE30616.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1457), Expect = e-158, Method: Compositional matrix adjust.
Identities = 319/634 (50%), Positives = 411/634 (64%), Gaps = 52/634 (8%)
Query: 21 AEEERELNKTCLCSFPPCGNLSQFTFPFTNLKHP-ECGLMVVDNCNKPVPRIRLGKAGPF 79
A E R +T F CG F FPF P CGL + NC+ +P I+L K G +
Sbjct: 16 AAEARSTKRTGCKDFT-CGE-HDFKFPFFRTDMPSRCGLFKL-NCSANIPEIQLEKDGKW 72
Query: 80 YNILNIAQDVSITVEDQVFQNHLNQRSCESFKNFSLPSSASLSFYVKSKLLSLFRCTDKL 139
Y + +++Q +IT+ D L C +FSLP S L KL +L++C +
Sbjct: 73 YTVKSVSQANTITIIDPRLNQSLTTGGCSDLSSFSLPDSPWL------KLNTLYKCNNSS 126
Query: 140 DNKFTSFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVN-KTRKSGDLFNMLTSVFS 198
S+ + S +YYN DD S CS I+ P + T K+G+L + + + FS
Sbjct: 127 RKNGFSYANCRGEGSSLYYNLGDDHDVS----GCSPIKTPESWVTPKNGNLSD-VNATFS 181
Query: 199 LQVEVHRVCWECRWRGGQCQNDSKGNFQC-AETRECNDCHKK------------------ 239
L +E+ C+ C GG+C K N++C E N+ H +
Sbjct: 182 LHIELPGNCFRCHNNGGEC-TKVKNNYRCVGANTEPNNYHAEMRLGLGIGGSVILIIILV 240
Query: 240 -------RGYCHIDDKGNFQCENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKELGD 292
R Y D +N ++D+E V+F +PIFSY +L AT++FS+++ LGD
Sbjct: 241 ALFAVIHRNY-RRKDGSELSRDNSKSDVEFSQVFFKIPIFSYKELQAATDNFSKDRLLGD 299
Query: 293 GGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352
GGFGTVYYGK++DGREVAVKRLY++NYRR+EQFMNE+EILTRL HKNLVSL+GCTSR S+
Sbjct: 300 GGFGTVYYGKVRDGREVAVKRLYEHNYRRLEQFMNEIEILTRLHHKNLVSLYGCTSRRSR 359
Query: 353 GLLLVYEFVANGTVADQLHGDRAKH-GLLTWPIRMNIAIETASALAYLHASDIIHRDVKT 411
LLLVYEF+ NGTVAD L+G+ H G LTW +R++IAIETASALAYLHASDIIHRDVKT
Sbjct: 360 ELLLVYEFIPNGTVADHLYGENTPHQGFLTWSMRLSIAIETASALAYLHASDIIHRDVKT 419
Query: 412 NNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFG 471
NILLD NF VKVADFGLSRL P DVTHVSTAPQGTPGYVDPEYH+CY LTDKSDVYSFG
Sbjct: 420 TNILLDRNFGVKVADFGLSRLLPSDVTHVSTAPQGTPGYVDPEYHRCYHLTDKSDVYSFG 479
Query: 472 VVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSV 531
VVL+ELISS PAVD++R + EINL++LAINKIQ A ELID LG+ ++E V++MTT V
Sbjct: 480 VVLVELISSKPAVDISRCKSEINLSSLAINKIQNHATHELIDQNLGYATNEGVRKMTTMV 539
Query: 532 AELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYC 591
AELAF CLQQ+ +RP+ME+V+ EL+ I++ + K ++ +++ P PSPP
Sbjct: 540 AELAFQCLQQDNTMRPTMEQVVHELKGIQNEEQKCPTYDYREE------TIIPHPSPPDW 593
Query: 592 DEDSLLKNMRLPSSPISVTEKWVSISSTTPNASG 625
E +LLKNM+ P SP+SVT++W S STTPN S
Sbjct: 594 GEAALLKNMKFPRSPVSVTDQWTS-KSTTPNTSA 626
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574218|ref|XP_003555248.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1426), Expect = e-155, Method: Compositional matrix adjust.
Identities = 316/646 (48%), Positives = 404/646 (62%), Gaps = 43/646 (6%)
Query: 1 MACRSYLQFFVISQL-LLLSSAEEERELNKTCLCSFPPCGNLSQFTFPFTNLKHPECGLM 59
M+ L F + S L +LL S C SF CG++ + FPFT ++ CG++
Sbjct: 1 MSPAYVLWFLLFSSLPVLLLSEGNANGHRDDCPDSFD-CGSIGKIYFPFTTVERHNCGVL 59
Query: 60 VVDNCN----KPVPRIRLGKAGPFYNILNI----AQDVSITVEDQVFQNHLNQRSCESFK 111
+ CN + L K G + + + SI++ DQ F+ L SC++
Sbjct: 60 AIRGCNDSDQTSAKHVLLTKGGKPFQVTQVNCKWGWPCSISIIDQDFRGLLENGSCKALS 119
Query: 112 -NFSLPSSASLSFYVKSKLLSLFRCTDKLD-----NKFTSFNSTCNSSSFIYYNHP--DD 163
N +P S++ ++ +S+F C+ L N F ++ ST SS Y+ P DD
Sbjct: 120 YNIRVPPSSAFGYFDVQNNISIFNCSRHLRKLNHINGFINYTSTRCPSSVYYFAPPSTDD 179
Query: 164 DLPSILPPNCSLIQLP--VNKTRKSGDLFNMLTSVFSLQVEVHRVCWECRWRGGQCQNDS 221
L +CS++QLP ++ GD F LT+ + + C G C
Sbjct: 180 QTLRSLTSSCSMVQLPKRIDSEFFKGDPFGFLTAEITFEFTFSHDCAVV----GPC---- 231
Query: 222 KGNFQCAETRECNDCHKKRGYCHIDDKGNFQCENERTDLETGTVYFGVPIFSYSDLAEAT 281
C +K G +F D ET ++FGVP+FSY +L EAT
Sbjct: 232 ---IIVGLFLTLRRCKRKYGQSSNTCADSF----PNPDTETDRIFFGVPVFSYKELQEAT 284
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
N+F ++LGDGGFGTVYYG L+DGREVA+K L+++NY+RV+QFMNE+EILTRLRH+NLV
Sbjct: 285 NNFDPTRKLGDGGFGTVYYGTLRDGREVAIKHLFEHNYKRVQQFMNEIEILTRLRHRNLV 344
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
SL+GCTSR+ Q LLLVYE+V NGTVA LHGD A+ GLLTWPIRM IAIETA+ALAYLHA
Sbjct: 345 SLYGCTSRHGQELLLVYEYVPNGTVASHLHGDLARVGLLTWPIRMQIAIETATALAYLHA 404
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
S+IIHRDVKTNNILLD +F VKVADFGLSRL P DV+HVSTAPQG+PGYVDPEY +CY+L
Sbjct: 405 SNIIHRDVKTNNILLDISFSVKVADFGLSRLLPNDVSHVSTAPQGSPGYVDPEYFRCYRL 464
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
TDKSDVYSFGVVL+ELISSMPAVD R R E+NLANLA+ KI K EL+DP GFE+D
Sbjct: 465 TDKSDVYSFGVVLMELISSMPAVDTVRERDEVNLANLAMKKIHKGKLSELVDPSFGFETD 524
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGI-- 579
++VKR+ TSVAELAF C+Q + +LRPSM+EVL L+ I GK + E H EK+ D G+
Sbjct: 525 QQVKRVITSVAELAFRCIQADNDLRPSMDEVLEALKNIGGGKFESE-HIEKEGDSGGVIS 583
Query: 580 KCTQPPPSPPYCDEDSLLKNMRLPSSPISVTEKWVSISSTTPNASG 625
+ PP L N +LP+SP S+TEKW S STTPNASG
Sbjct: 584 STSTEQVHPPV----EFLMNEKLPASPKSLTEKWES-ESTTPNASG 624
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 625 | ||||||
| TAIR|locus:2031230 | 629 | AT1G25390 [Arabidopsis thalian | 0.912 | 0.906 | 0.508 | 2.8e-146 | |
| TAIR|locus:2204465 | 1296 | AT1G66880 [Arabidopsis thalian | 0.558 | 0.269 | 0.600 | 9.7e-118 | |
| TAIR|locus:2176667 | 686 | AT5G38210 [Arabidopsis thalian | 0.553 | 0.504 | 0.615 | 1.6e-113 | |
| TAIR|locus:2014154 | 654 | AT1G18390 [Arabidopsis thalian | 0.524 | 0.501 | 0.642 | 4.3e-113 | |
| TAIR|locus:2046728 | 708 | AT2G23450 [Arabidopsis thalian | 0.555 | 0.490 | 0.440 | 1.2e-77 | |
| TAIR|locus:2174994 | 622 | AT5G66790 [Arabidopsis thalian | 0.462 | 0.464 | 0.454 | 6.5e-67 | |
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.457 | 0.435 | 0.446 | 5.4e-61 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.483 | 0.402 | 0.422 | 5.4e-61 | |
| TAIR|locus:2084425 | 639 | AT3G53840 [Arabidopsis thalian | 0.464 | 0.453 | 0.453 | 1.9e-60 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.486 | 0.413 | 0.426 | 9.9e-60 |
| TAIR|locus:2031230 AT1G25390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
Identities = 316/621 (50%), Positives = 402/621 (64%)
Query: 33 CSFPPCGNLSQFTFPFTNLKHPE-CGLMVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSI 91
C CG F FPF P CGL + NC+ +P I+L K G +Y + +++Q +I
Sbjct: 27 CKDFTCGE-HDFKFPFFRTDMPSRCGLFKL-NCSANIPEIQLEKDGKWYTVKSVSQANTI 84
Query: 92 TVEDQVFQNHLNQRSCESFKNFSLPSSASLSFYVKSKLLSLFRCTDKLDNKXXXXXXXXX 151
T+ D L C +FSLP S L KL +L++C +
Sbjct: 85 TIIDPRLNQSLTTGGCSDLSSFSLPDSPWL------KLNTLYKCNNSSRKNGFSYANCRG 138
Query: 152 XXXXIYYNHPDDDLPSILPPNCSLIQLPVN-KTRKSGDLFNMLTSVFSLQVEVHRVCWEC 210
+YYN DD S CS I+ P + T K+G+L ++ + FSL +E+ C+ C
Sbjct: 139 EGSSLYYNLGDDHDVS----GCSPIKTPESWVTPKNGNLSDV-NATFSLHIELPGNCFRC 193
Query: 211 RWRGGQCQNDSKGNFQCAETR-ECNDCHKK-------------------------RGYCH 244
GG+C K N++C E N+ H + R Y
Sbjct: 194 HNNGGECTK-VKNNYRCVGANTEPNNYHAEMRLGLGIGGSVILIIILVALFAVIHRNYRR 252
Query: 245 IDDKGNFQCENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLK 304
D +N ++D+E V+F +PIFSY +L AT++FS+++ LGDGGFGTVYYGK++
Sbjct: 253 -KDGSELSRDNSKSDVEFSQVFFKIPIFSYKELQAATDNFSKDRLLGDGGFGTVYYGKVR 311
Query: 305 DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG 364
DGREVAVKRLY++NYRR+EQFMNE+EILTRL HKNLVSL+GCTSR S+ LLLVYEF+ NG
Sbjct: 312 DGREVAVKRLYEHNYRRLEQFMNEIEILTRLHHKNLVSLYGCTSRRSRELLLVYEFIPNG 371
Query: 365 TVADQLHGDRAKH-GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423
TVAD L+G+ H G LTW +R++IAIETASALAYLHASDIIHRDVKT NILLD NF VK
Sbjct: 372 TVADHLYGENTPHQGFLTWSMRLSIAIETASALAYLHASDIIHRDVKTTNILLDRNFGVK 431
Query: 424 VADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA 483
VADFGLSRL P DVTHVSTAPQGTPGYVDPEYH+CY LTDKSDVYSFGVVL+ELISS PA
Sbjct: 432 VADFGLSRLLPSDVTHVSTAPQGTPGYVDPEYHRCYHLTDKSDVYSFGVVLVELISSKPA 491
Query: 484 VDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNK 543
VD++R + EINL++LAINKIQ A ELID LG+ ++E V++MTT VAELAF CLQQ+
Sbjct: 492 VDISRCKSEINLSSLAINKIQNHATHELIDQNLGYATNEGVRKMTTMVAELAFQCLQQDN 551
Query: 544 ELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMRLP 603
+RP+ME+V+ EL+ I++ + K + D RE + P PSPP E +LLKNM+ P
Sbjct: 552 TMRPTMEQVVHELKGIQNEEQKCPTY----DYRE--ETIIPHPSPPDWGEAALLKNMKFP 605
Query: 604 SSPISVTEKWVSISSTTPNAS 624
SP+SVT++W S STTPN S
Sbjct: 606 RSPVSVTDQWTS-KSTTPNTS 625
|
|
| TAIR|locus:2204465 AT1G66880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1074 (383.1 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 218/363 (60%), Positives = 273/363 (75%)
Query: 258 TDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN 317
++L + Y GV +FSY +L EAT +FSRE LGDGGFGTVYYG LKDGR VAVKRLY+
Sbjct: 943 SNLANRSDYCGVQVFSYEELEEATENFSRE--LGDGGFGTVYYGVLKDGRAVAVKRLYER 1000
Query: 318 NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
+ +RVEQF NE+EIL L+H NLV L+GCTSR+S+ LLLVYE+++NGT+A+ LHG+RA+
Sbjct: 1001 SLKRVEQFKNEIEILKSLKHPNLVILYGCTSRHSRELLLVYEYISNGTLAEHLHGNRAEA 1060
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
L W R+NIAIETASAL++LH IIHRD+KT NILLD N+ VKVADFGLSRLFP+D
Sbjct: 1061 RPLCWSTRLNIAIETASALSFLHIKGIIHRDIKTTNILLDDNYQVKVADFGLSRLFPMDQ 1120
Query: 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497
TH+STAPQGTPGYVDPEY+QCYQL +KSDVYSFGVVL ELISS AVD+ RHRH+INLAN
Sbjct: 1121 THISTAPQGTPGYVDPEYYQCYQLNEKSDVYSFGVVLTELISSKEAVDITRHRHDINLAN 1180
Query: 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
+A++KIQ A EL+D LG+++D EV+R +VAELAF CLQQ +++RP+M+E++ L+
Sbjct: 1181 MAVSKIQNNALHELVDSSLGYDNDPEVRRKMMAVAELAFRCLQQERDVRPAMDEIVEILR 1240
Query: 558 RIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMRLPSSPISV-TEKWVSI 616
IK + K + K D I+C D+ LL+N P PIS T+KW S
Sbjct: 1241 GIKDDEKKRVL--VKSPDVVDIECGGG-------DDVGLLRNSVPP--PISPETDKWTSS 1289
Query: 617 SST 619
S T
Sbjct: 1290 SDT 1292
|
|
| TAIR|locus:2176667 AT5G38210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
Identities = 218/354 (61%), Positives = 270/354 (76%)
Query: 258 TDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN 317
++L G+VY G+ +FSY +L EAT +FS KELGDGGFGTVYYG LKDGR VAVKRL++
Sbjct: 334 SNLGNGSVYSGIQVFSYEELEEATENFS--KELGDGGFGTVYYGTLKDGRAVAVKRLFER 391
Query: 318 NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
+ +RVEQF NE++IL L+H NLV L+GCT+R+S+ LLLVYE+++NGT+A+ LHG++A+
Sbjct: 392 SLKRVEQFKNEIDILKSLKHPNLVILYGCTTRHSRELLLVYEYISNGTLAEHLHGNQAQS 451
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
+ WP R+ IAIETASAL+YLHAS IIHRDVKT NILLDSN+ VKVADFGLSRLFP+D
Sbjct: 452 RPICWPARLQIAIETASALSYLHASGIIHRDVKTTNILLDSNYQVKVADFGLSRLFPMDQ 511
Query: 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497
TH+STAPQGTPGYVDPEY+QCY+L +KSDVYSFGVVL ELISS AVD+ RHRH+INLAN
Sbjct: 512 THISTAPQGTPGYVDPEYYQCYRLNEKSDVYSFGVVLSELISSKEAVDITRHRHDINLAN 571
Query: 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
+AI+KIQ A EL D LGF D VK+M +SVAELAF CLQQ +++RPSM+E++ L+
Sbjct: 572 MAISKIQNDAVHELADLSLGFARDPSVKKMMSSVAELAFRCLQQERDVRPSMDEIVEVLR 631
Query: 558 RI-KSG--KSK---FEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMRLPSS 605
I K G SK EI DD +K PPP P D+ + + SS
Sbjct: 632 VIQKDGISDSKDVVVEIDVNGGDDVGLLKHGVPPPLSPETDKTTASSSNTTASS 685
|
|
| TAIR|locus:2014154 AT1G18390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 4.3e-113, Sum P(2) = 4.3e-113
Identities = 212/330 (64%), Positives = 254/330 (76%)
Query: 259 DLETGT-VYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN 317
D+E + GV IFSY +L EATN+F KELGDGGFGTVYYGKLKDGR VAVKRLYDN
Sbjct: 318 DIEKAEELLVGVHIFSYEELEEATNNFDPSKELGDGGFGTVYYGKLKDGRSVAVKRLYDN 377
Query: 318 NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
N++R EQF NEVEILT LRH NLV+LFGC+S+ S+ LLLVYE+VANGT+AD LHG +A
Sbjct: 378 NFKRAEQFRNEVEILTGLRHPNLVALFGCSSKQSRDLLLVYEYVANGTLADHLHGPQANP 437
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
L W IR+ IA+ETASAL YLHAS IIHRDVK+NNILLD NF VKVADFGLSRLFP+D
Sbjct: 438 SSLPWSIRLKIAVETASALKYLHASKIIHRDVKSNNILLDQNFNVKVADFGLSRLFPMDK 497
Query: 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497
THVSTAPQGTPGYVDP+YH CYQL++KSDVYSF VVL+ELISS+PAVD+ R R EINL+N
Sbjct: 498 THVSTAPQGTPGYVDPDYHLCYQLSNKSDVYSFAVVLMELISSLPAVDITRPRQEINLSN 557
Query: 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
+A+ KIQ +++DP LGF++D V++ +VAELAF CLQ +K+LRP M V L
Sbjct: 558 MAVVKIQNHELRDMVDPSLGFDTDTRVRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTLT 617
Query: 558 RIKSGKSKFEIHEEKQDDREGIKCTQPPPS 587
RI++ E+ + ++ G Q P S
Sbjct: 618 RIQNNGFGSEM-DVVDVNKSGPLVAQSPDS 646
|
|
| TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 1.2e-77, Sum P(3) = 1.2e-77
Identities = 162/368 (44%), Positives = 226/368 (61%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
V F Y ++ +AT+ FS +++LG G +GTVY GKL++ VA+KRL + ++Q MNE
Sbjct: 333 VAFFPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNE 392
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
+++L+ + H NLV L GC QG +LVYE++ NGT+++ L DR GL W +R+
Sbjct: 393 IKLLSSVSHPNLVRLLGCC--IEQGDPVLVYEYMPNGTLSEHLQRDRGS-GL-PWTLRLT 448
Query: 388 IAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444
+A +TA A+AYLH+S I HRD+K+ NILLD +F KVADFGLSRL + +H+STAP
Sbjct: 449 VATQTAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAP 508
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504
QGTPGY+DP+YHQC+ L+DKSDVYSFGVVL E+I+ + VD R EINLA LA++KI
Sbjct: 509 QGTPGYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIG 568
Query: 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK-SG- 562
DE+IDP L + D +VAELAF CL + ++RP+M EV EL++I+ SG
Sbjct: 569 SGCIDEIIDPILDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQIRLSGW 628
Query: 563 -------KSKFEIHEEKQDDREGIKCTQPPPSP---PYCDEDSLLKNMRLP-SSPISVTE 611
+ + +K + P D L + SSPISV +
Sbjct: 629 IPSMSLDSPAGSLRSSDRGSERSVKQSSIGSRRVVIPQKQPDCLASVEEISDSSPISVQD 688
Query: 612 KWVSISST 619
W+S S+
Sbjct: 689 PWLSAQSS 696
|
|
| TAIR|locus:2174994 AT5G66790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
Identities = 136/299 (45%), Positives = 204/299 (68%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
VP ++Y ++ +AT+ FS + LG G +GTVY G+ + VA+KRL + ++Q +NE
Sbjct: 299 VPFYTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNE 358
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQGL-LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
+++L+ + H NLV L GC ++ G LVYEF+ NGT+ L +R + L +W +R+
Sbjct: 359 IKLLSSVSHPNLVRLLGCC--FADGEPFLVYEFMPNGTLYQHLQHERGQPPL-SWQLRLA 415
Query: 388 IAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRL---FPLDVTHVS 441
IA +TA+A+A+LH+S I HRD+K++NILLD F K++DFGLSRL + +H+S
Sbjct: 416 IACQTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHIS 475
Query: 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501
TAPQGTPGY+DP+YHQ +QL+DKSDVYSFGVVL+E+IS +D R E+NLA+LA++
Sbjct: 476 TAPQGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVD 535
Query: 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
+I + ++IDPCL E + ++ ++AELAF CL ++ +RP+M E+ +L RIK
Sbjct: 536 RIGRGRVVDIIDPCLNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIK 594
|
|
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 5.4e-61, Sum P(2) = 5.4e-61
Identities = 134/300 (44%), Positives = 189/300 (63%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVE 330
IF+ ++ +ATN+FS++ +G GGFG V+ L+DG A+KR NN + +Q +NEV
Sbjct: 350 IFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEVR 409
Query: 331 ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHG--DRAKHGLLTWPIRMNI 388
IL ++ H++LV L GC LL +YEF+ NGT+ + LHG DR L TW R+ I
Sbjct: 410 ILCQVNHRSLVRLLGCCVDLELPLL-IYEFIPNGTLFEHLHGSSDRTWKPL-TWRRRLQI 467
Query: 389 AIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-----HV 440
A +TA LAYLH++ I HRDVK++NILLD KV+DFGLSRL L T H+
Sbjct: 468 AYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNESHI 527
Query: 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500
T QGT GY+DPEY++ +QLTDKSDVYSFGVVL+E+++S A+D R ++NL + I
Sbjct: 528 FTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLV-MYI 586
Query: 501 NKIQ-KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
NK+ + E IDP L +++ + + LA CL + ++ RPSM+EV E++ I
Sbjct: 587 NKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVADEIEYI 646
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 5.4e-61, Sum P(2) = 5.4e-61
Identities = 131/310 (42%), Positives = 190/310 (61%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVE 330
IFS +L +AT++F+ + LG GG GTVY G L DGR VAVKR + +VE+F+NEV
Sbjct: 408 IFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVG 467
Query: 331 ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI 390
+L+++ H+N+V L GC ++ +LVYE + NG + +LH D + +TW +R+ I++
Sbjct: 468 VLSQINHRNIVKLMGCCLE-TEVPILVYEHIPNGDLFKRLHHDSDDY-TMTWDVRLRISV 525
Query: 391 ETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
E A ALAYLH++ + HRDVKT NILLD + KV+DFG SR +D TH++T GT
Sbjct: 526 EIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGT 585
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507
GY+DPEY Q Q TDKSDVYSFGVVL+ELI+ + R L + +++
Sbjct: 586 FGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNR 645
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFE 567
+++D + + +VA+LA CL + RP+M EV EL+RI+S E
Sbjct: 646 VLDIVDSRI---KEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLE 702
Query: 568 IHEEKQDDRE 577
+H E++D+ E
Sbjct: 703 LHIEEEDEEE 712
|
|
| TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 136/300 (45%), Positives = 192/300 (64%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVE 330
IF+ ++ +AT++F++ LG GGFG V+ G L DG VAVKR N + + Q +NEV+
Sbjct: 341 IFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEVQ 400
Query: 331 ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLT--WPIR--M 386
IL ++ HKNLV L GC +L VYEFV NGT+ + ++G G L P+R +
Sbjct: 401 ILCQVSHKNLVKLLGCCIELEMPVL-VYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRL 459
Query: 387 NIAIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443
IA +TA L YLH+S I HRDVK++NILLD N VKVADFGLSRL DV+HV+T
Sbjct: 460 MIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTTC 519
Query: 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503
QGT GY+DPEY+ +QLTDKSDVYSFGVVL EL++ A+D NR ++NL +
Sbjct: 520 AQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKAL 579
Query: 504 QKCAFDELIDPCLGFESDE-EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562
++ ++IDP +G + E E++ M ++ LA LC+++ ++ RP+M+ E++ I G
Sbjct: 580 KEGRLMDVIDPVIGIGATEKEIESMK-ALGVLAELCVKETRQCRPTMQVAAKEIENILHG 638
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 9.9e-60, Sum P(2) = 9.9e-60
Identities = 133/312 (42%), Positives = 187/312 (59%)
Query: 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNE 328
V IF+ + +ATN ++ + LG GG GTVY G L D VA+K+ + +VEQF+NE
Sbjct: 394 VKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINE 453
Query: 329 VEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
V +L+++ H+N+V L GC ++ LLVYEF+ NGT+ D LHG L TW R+ I
Sbjct: 454 VLVLSQINHRNVVKLLGCCLE-TEVPLLVYEFITNGTLFDHLHGSMIDSSL-TWEHRLKI 511
Query: 389 AIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
AIE A LAYLH+S IIHRD+KT NILLD N KVADFG SRL P+D + T Q
Sbjct: 512 AIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQ 571
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505
GT GY+DPEY+ L +KSDVYSFGVVL+EL+S A+ R + +L + ++
Sbjct: 572 GTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATKE 631
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSK 565
DE+I G +E+ + A +A C + E RP M+EV A+L+ ++ K+K
Sbjct: 632 NRLDEIIG---GEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTK 688
Query: 566 FEIHEEKQDDRE 577
+ ++ ++ E
Sbjct: 689 HKWSDQYPEENE 700
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 625 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-39 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-32 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-32 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.003 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 8e-50
Identities = 83/273 (30%), Positives = 124/273 (45%), Gaps = 25/273 (9%)
Query: 284 FSREKELGDGGFGTVYYGKLKD-GREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ ++LG+G FG VY + K G+ VA+K + + E+ + E++IL +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ L LV E+ G + D L K G L+ + SAL YLH+
Sbjct: 61 RLYDVF-EDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHS 115
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
I+HRD+K NILLD + VK+ADFGL+R LD T GTP Y+ PE
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
D++S GV+L EL++ P + E+ KI K
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLEL------FKKIGKP----------KPPFP 217
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
++ +L L ++ E R + EE L
Sbjct: 218 PPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-49
Identities = 76/192 (39%), Positives = 112/192 (58%), Gaps = 9/192 (4%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
LG+GGFGTVY + K G++VA+K + +++ +E+ + E+EIL +L H N+V L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59
Query: 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407
L LV E+ G++ D L + G L+ + I ++ L YLH++ IIHR
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 408 DVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ-LTDKS 465
D+K NILLDS N VK+ADFGLS+L + GTP Y+ PE ++KS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 466 DVYSFGVVLIEL 477
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-46
Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 55/293 (18%)
Query: 284 FSREKELGDGGFGTVYYGKLKD-----GREVAVKRLYDNNYRR-VEQFMNEVEILTRLRH 337
K+LG+G FG VY G LK +VAVK L + E+F+ E I+ +L H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 338 KNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
N+V L G CT + L +V E++ G + D L K LT + +A++ A +
Sbjct: 61 PNIVRLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGM 115
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD---- 452
YL + + +HRD+ N L+ N VK++DFGLSR D+ + G +
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWM 171
Query: 453 -PEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE + + T KSDV+SFGV+L E+ + P M+ + ++
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------VLELLEDG--- 220
Query: 510 ELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAEL 556
R+ + EL C + E RP+ E++ +L
Sbjct: 221 ---------------YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-46
Identities = 89/275 (32%), Positives = 128/275 (46%), Gaps = 25/275 (9%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLY--DNNYRRVEQFMNEVEILTRLRHKNL 340
+ ++LG G FGTVY K K G+ VAVK L ++ + E+ IL RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V L L LV E+ G + D L + G L+ IA++ L YLH
Sbjct: 61 VRLID-AFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLH 115
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
++ IIHRD+K NILLD N VK+ADFGL++ + ++T GTP Y+ PE
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGN 174
Query: 461 L-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA-INKIQKCAFDELIDPCLGF 518
K DV+S GV+L EL++ P E L L I +I +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPF-----SGENILDQLQLIRRILGPPLE--------- 220
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + + +L CL ++ RP+ EE+L
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 85/284 (29%), Positives = 138/284 (48%), Gaps = 42/284 (14%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-GREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKN 339
+++R + LG G FG+VY KD G +AVK L ++ +E E+ IL+ L+H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 340 LVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIETASALA 397
+V +G L + E+V+ G+++ L K G L P IR + LA
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIR-KYTRQILEGLA 115
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPGYVDPEYH 456
YLH++ I+HRD+K NIL+DS+ VK+ADFG ++ L ++ + + +GTP ++ PE
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL--AINKIQKCAFDELIDP 514
+ + +D++S G +IE+ + P L N A+ KI
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWS--------ELGNPMAALYKI---GSSGEPPE 224
Query: 515 ---CLGFESDEEVKRMTTSVAELAFL--CLQQNKELRPSMEEVL 553
L EE K FL CL+++ + RP+ +E+L
Sbjct: 225 IPEHL----SEEAK---------DFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 58/291 (19%)
Query: 287 EKELGDGGFGTVYYGKLKD-----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNL 340
K+LG+G FG VY GKLK EVAVK L ++ + +++E+F+ E I+ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 341 VSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
V L G CT + L +V E++ G + L R L+ ++ A++ A + YL
Sbjct: 64 VKLLGVCTE--EEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS---------TAPQGTPGY 450
+ + IHRD+ N L+ N VK++DFGLSR D + AP
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP------ 172
Query: 451 VDPEYHQCYQL---TDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQK 505
+ + T KSDV+SFGV+L E+ + P M+ + ++
Sbjct: 173 ------ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS--------NEEVLEYLKN 218
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
C + +L C ++ E RP+ E++ L
Sbjct: 219 GYRLPQPPNC------------PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 82/291 (28%), Positives = 133/291 (45%), Gaps = 57/291 (19%)
Query: 287 EKELGDGGFGTVYYGKLKDG-----REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNL 340
K+LG+G FG VY G LK EVAVK L ++ + +++E+F+ E I+ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 341 VSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
V L G CT + L++V E++ G + D L + + L+ ++ A++ A + YL
Sbjct: 64 VKLLGVCTE--EEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYL 119
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVS--------TAPQGTPGY 450
+ + IHRD+ N L+ N VK++DFGLSR L+ D V AP
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP------ 173
Query: 451 VDPEYHQCYQL---TDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQK 505
+ + T KSDV+SFGV+L E+ + P M+ + ++K
Sbjct: 174 ------ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS--------NAEVLEYLKK 219
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
C + +L C ++ E RP+ E++ L
Sbjct: 220 GYRLPKPPNC------------PPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 36/278 (12%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
F +++G GGFG VY + + G+EVA+K + + + E+ +NE++IL + +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+G L +V EF + G++ D L ++ + LT + E L YLH+
Sbjct: 61 KYYGSYL-KKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-----GTPGYVDPEYH 456
+ IIHRD+K NILL S+ VK+ DFGLS +S GTP ++ PE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYWMAPEVI 169
Query: 457 QCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
K+D++S G+ IEL P ++ + A+ KI L +P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------ALFKIATNGPPGLRNP- 220
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
++ + + CLQ+N E RP+ E++L
Sbjct: 221 ---------EKWSDEFKDFLKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 288 KELGDGGFGTVYYGKLKDG----REVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLVS 342
K+LG+G FG VY GKLK EVAVK L D + + F+ E ++ +L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGL-----LTWPIRMNIAIETASALA 397
L G + + L LV E++ G + D L R L+ ++ AI+ A +
Sbjct: 61 LLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYH 456
YL + +HRD+ N L+ + VK++DFGLSR D + P ++ PE
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 457 QCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
+ T KSDV+SFGV+L E+ + + P ++ + ++K +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYRLPKPEY 231
Query: 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
C DE + EL C Q + E RP+ E++ L+
Sbjct: 232 C----PDE--------LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 2e-39
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKN 339
+ K++G G FG VY + DG+ +K + +N E +NEV+IL +L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ + L +V E+ G ++ ++ + + ++ ++ AL YL
Sbjct: 61 IIKYYESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ I+HRD+K NI L SN VK+ DFG+S++ V T GTP Y+ PE Q
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNK 178
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
KSD++S G VL EL + + NL L KI K + + P
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEGE------NLLEL-ALKILKGQYPPI--PS---- 225
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ ++ + L LQ++ E RPS+ ++L
Sbjct: 226 ------QYSSELRNLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 74/266 (27%), Positives = 112/266 (42%), Gaps = 50/266 (18%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL---YDNNYRRVEQFMNEVEILTRL-R 336
+DF K +G+G F TV K K +E A+K L ++V+ E E+LTRL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H ++ L+ T + + L V E+ NG + + K+G L A E AL
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLAL 115
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ----------- 445
YLH+ IIHRD+K NILLD + +K+ DFG +++ + + S
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 446 --------GTPGYVDPEYHQCYQLTDK-----SDVYSFGVVLIELIS-SMPAVDMNRHRH 491
GT YV PE L +K SD+++ G ++ ++++ P N
Sbjct: 176 RRRFASFVGTAEYVSPEL-----LNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---- 226
Query: 492 EINLANLAINKIQKCA--FDELIDPC 515
L KI K F P
Sbjct: 227 ----EYLTFQKILKLEYSFPPNFPPD 248
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 73/217 (33%), Positives = 114/217 (52%), Gaps = 22/217 (10%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+F+ E++LG G FG V+ G K+ VA+K L ++ + + F EV+ L RLRHK+L+S
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
LF S + + ++ E + G++ L + +L +++A + A +AYL
Sbjct: 67 LFAVCSV-GEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLEEQ 123
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS--------TAPQGTPGYVDPE 454
+ IHRD+ NIL+ + KVADFGL+RL DV S TAP+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS------ 177
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRH 489
H + KSDV+SFG++L E+ + +P MN H
Sbjct: 178 -HGTFST--KSDVWSFGILLYEMFTYGQVPYPGMNNH 211
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 30/270 (11%)
Query: 290 LGDGGFG-TVYYGKLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
LG G FG Y + +D V K L + + +NE+ IL+ L+H N+++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIA--IETASALAYLHASDI 404
LL+ E+ GT+ D++ + + + M + + SA++Y+H + I
Sbjct: 68 FMD-DNTLLIEMEYANGGTLYDKIVRQKGQL----FEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDK 464
+HRD+KT NI L +K+ DFG+S++ + + T GTP Y+ PE Q + K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFK 181
Query: 465 SDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEV 524
SD+++ G VL EL++ D N NL + KI + + V
Sbjct: 182 SDIWALGCVLYELLTLKRTFDAT------NPLNL-VVKIVQGNY------------TPVV 222
Query: 525 KRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
++ + L LQQ+ E RP+ +EVL
Sbjct: 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (321), Expect = 3e-32
Identities = 87/350 (24%), Positives = 146/350 (41%), Gaps = 23/350 (6%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKNLVSLF 344
++LG+G FG VY + D + VA+K L ++ + VE+F+ E++IL L H +
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
+ L LV E+V G++ D L + G L+ + I + SAL YLH+ I
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSKGI 122
Query: 405 IHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAPQ-----GTPGYVDPEYHQ- 457
IHRD+K NILLD + VK+ DFGL++L P + S GTPGY+ PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 458 --CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ SD++S G+ L EL++ +P + ++ + I ++ + + P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA-ELQRIKSGKSKFEIHEEKQD 574
+ +L L ++ + R S L+ +L K K D
Sbjct: 243 NPELISKAAS-------DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 575 DREGIKCTQPPPSPPYCDEDSLLKNMRLPSSPISVTEKWVSISSTTPNAS 624
D ++ + PP + L + ++
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSP 345
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
E++LG G FG V+ G +VAVK L E F+ E +I+ +LRH LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLV 64
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ S + + +V E+++ G++ D L K L P +++A + A +AYL +
Sbjct: 65 QLYAVCSE-EEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLES 121
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT--P-GYVDPEYHQC 458
+ IHRD+ NIL+ N K+ADFGL+RL D TA +G P + PE
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANY 178
Query: 459 YQLTDKSDVYSFGVVLIELIS 479
+ T KSDV+SFG++L E+++
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 59/190 (31%), Positives = 103/190 (54%), Gaps = 9/190 (4%)
Query: 290 LGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR 349
+G G FG V G + G++VAVK L D++ + F+ E ++T LRH NLV L G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLG-VVL 70
Query: 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDV 409
L +V E++A G++ D L R + ++T ++ A++ + YL + +HRD+
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR-SRGRA-VITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128
Query: 410 KTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYS 469
N+L+ + KV+DFGL++ + + + + + PE + + + KSDV+S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 470 FGVVLIELIS 479
FG++L E+ S
Sbjct: 185 FGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 68/200 (34%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
KELG G FG V+ GK + +VA+K + + + F+ E +++ +L H NLV L+G
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407
++ + +V E++ANG + + L R + G L +++ + A+ YL ++ IHR
Sbjct: 69 TKQRP-IFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124
Query: 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP---GYVDPEYHQCYQLTDK 464
D+ N L+ + VKV+DFGL+R + LD + S+ QGT + PE + + K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSS--QGTKFPVKWAPPEVFDYSRFSSK 181
Query: 465 SDVYSFGVVLIELIS--SMP 482
SDV+SFGV++ E+ S MP
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 87/277 (31%), Positives = 141/277 (50%), Gaps = 27/277 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
++ + +E+G G FG V+ G + R+VA+K + + E F+ E +++ +L H LV
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLV 62
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+G CT R + LV+EF+ +G ++D L RA+ G + + + ++ +AYL
Sbjct: 63 QLYGVCTERSP--ICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYHQCY 459
+S++IHRD+ N L+ N VKV+DFG++R F LD + S+ P + PE
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
+ + KSDV+SFGV++ E+ S NR E+ + I A L P L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV------VETIN--AGFRLYKPRLA-- 226
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
+ SV EL C ++ E RPS +L +L
Sbjct: 227 --------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 289 ELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVSLFG 345
+G G FG VY G L+ G VA+K++ + ++ M E+++L L+H N+V G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDII 405
S L ++ E+ NG++ + K G + + LAYLH +I
Sbjct: 67 SI-ETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 465
HRD+K NIL + VK+ADFG++ DV+ + GTP ++ PE + + S
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGASTAS 180
Query: 466 DVYSFGVVLIELISSMP 482
D++S G +IEL++ P
Sbjct: 181 DIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 8/202 (3%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG-C 346
++LG G FG V+ G + VAVK L + F+ E +I+ +LRH L+ L+ C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
T + + +V E + G++ + L G + L P +++A + AS +AYL A + IH
Sbjct: 71 TL--EEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQNYIH 126
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 466
RD+ N+L+ N KVADFGL+R+ D+ + + PE + + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 467 VYSFGVVLIELIS--SMPAVDM 486
V+SFG++L E+++ MP M
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 288 KELGDGGFGTVYYGKL-----KDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLV 341
K+LG+G FG V + G +VAVK L + + F E+EIL L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQL--HGDRAKHGLLTWPIRMNIAIETASALAY 398
G C + L L+ E++ +G++ D L H D+ L + + + + Y
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDY 124
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPG-YVDPEYH 456
L + IHRD+ NIL++S VK++DFGL+++ P D + P +P + PE
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 457 QCYQLTDKSDVYSFGVVLIELIS 479
+ + + SDV+SFGV L EL +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
D + + +LG G +G VY G K VAVK L ++ VE+F+ E ++ ++H NLV
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 65
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L G +R ++ EF+ G + D L + + + +A + +SA+ YL
Sbjct: 66 QLLGVCTR-EPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP---GYVDPEYHQC 458
+ IHRD+ N L+ N VKVADFGLSRL D TA G + PE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAY 179
Query: 459 YQLTDKSDVYSFGVVLIEL----ISSMPAVDM 486
+ + KSDV++FGV+L E+ +S P +D+
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 65/202 (32%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLY---DNNYRRVEQFMNEVEILTRLRH 337
+D R K LG G G VY + K G+ A+K+++ D +R+ Q + E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKTLRSCES 58
Query: 338 KNLVSLFGCTSRYSQGLL-LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
+V +G + Y +G + +V E++ G++AD L K G + P+ IA + L
Sbjct: 59 PYVVKCYG--AFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGL 112
Query: 397 AYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
YLH IIHRD+K +N+L++S VK+ADFG+S++ + +T GT Y+ PE
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPER 171
Query: 456 HQCYQLTDKSDVYSFGVVLIEL 477
Q + +D++S G+ L+E
Sbjct: 172 IQGESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 288 KELGDGGFGTVYYGKLKDGRE------VAVKRLYDNNYRRVEQ-FMNEVEILTRLRHKNL 340
+ELG+G FG V+ G+ VAVK L + + F E E+LT +H+N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQL--HG--------DRAKHGLLTWPIRMNIAI 390
V +G + ++V+E++ +G + L HG + G LT + IA+
Sbjct: 71 VKFYGVCTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPG 449
+ AS + YL + +HRD+ T N L+ + VK+ DFG+SR ++ D V
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ PE + T +SDV+SFGVVL E+ +
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 48/277 (17%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTS 348
+G+G G VY G+EVA+K++ + E +NE+ I+ +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSY- 84
Query: 349 RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW-PIRMN------IAIETASALAYLHA 401
L +V E++ G++ D ++T +RMN + E L YLH+
Sbjct: 85 LVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
++IHRD+K++NILL + VK+ADFG L++ + V GTP ++ PE +
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-----GTPYWMAPEVIK 189
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPA-VDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
K D++S G++ IE+ P + R + I ++
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK------------ 237
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
++ + + CL ++ E RPS EE+L
Sbjct: 238 ------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 73/221 (33%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 277 LAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL 335
L + T F + +G+G +G VY + K G+ VA+K + D E+ E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKY 59
Query: 336 -RHKNLVSLFGC-TSRYSQG----LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIA 389
H N+ + +G + G L LV E G+V D + G R K L I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ---G 446
ET LAYLH + +IHRD+K NILL N VK+ DFG+S + G
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIG 175
Query: 447 TPGYVDPEYHQCYQLTD-----KSDVYSFGVVLIELISSMP 482
TP ++ PE C + D +SDV+S G+ IEL P
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 28/271 (10%)
Query: 289 ELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
ELGDG FG VY + K+ G A K + + +E FM E++IL+ +H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-A 70
Query: 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407
Y L ++ EF G + + + GL IR + + AL +LH+ +IHR
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRY-VCRQMLEALNFLHSHKVIHR 127
Query: 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD---- 463
D+K NILL + VK+ADFG+S + T GTP ++ PE C D
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYD 186
Query: 464 -KSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522
K+D++S G+ LIEL P HE+N + + KI K L P
Sbjct: 187 YKADIWSLGITLIELAQMEPP------HHELNPMRVLL-KILKSEPPTLDQP-------- 231
Query: 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ ++S + CL ++ + RP+ E+L
Sbjct: 232 --SKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 36/274 (13%)
Query: 290 LGDGGFGTVYYG-KLKDGREVAVKR--LYDNNYRR---VEQFMNEVEILTRLRHKNLVSL 343
LG G FG+VY G L DG AVK L D+ V+Q E+ +L++L+H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
G T R L + E V G++A L K+G P+ + L YLH +
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP--QGTPGYVDPEY-HQCYQ 460
+HRD+K NIL+D+N VK+ADFG+++ V S A +G+P ++ PE Q
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 461 LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520
+D++S G ++E+ + P + E +A A+ KI + I L S
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPW----SQLE-GVA--AVFKIGRSKELPPIPDHL---S 228
Query: 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
DE + CLQ++ LRP+ E+L
Sbjct: 229 DE--------AKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 64/194 (32%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG-C 346
KELG G FG V YGK + +VA+K + + + ++F+ E +++ +L H+ LV L+G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
T + + +V E+++NG + + L + + + + +AYL + IH
Sbjct: 69 TKQRP--IYIVTEYMSNGCLLNYLREHG--KRFQPSQL-LEMCKDVCEGMAYLESKQFIH 123
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYHQCYQLTDKS 465
RD+ N L+D CVKV+DFGLSR + LD + S+ P + PE + + KS
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 466 DVYSFGVVLIELIS 479
DV++FGV++ E+ S
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 70/206 (33%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
K+LG+G FG V+ G +VAVK L E F+ E +I+ +LRH LV L+
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
S + + +V E+++ G++ D L + L P +++A + A+ +AY+ + IH
Sbjct: 70 VSE--EPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP---GYVDPEYHQCYQLTD 463
RD+++ NIL+ K+ADFGL+RL + TA QG + PE + T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 464 KSDVYSFGVVLIELISS--MPAVDMN 487
KSDV+SFG++L EL++ +P MN
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 68/205 (33%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVK-----RLYDNNYRRVEQFMNEVEILTRLRHKNLVSL 343
LG G FG V + KD G+ A+K ++ VE + E IL+R+ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK--EVEHTLTERNILSRINHPFIVKL 58
Query: 344 FGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIETASALAYLH 400
T L LV E+ G + L K G + R A E AL YLH
Sbjct: 59 HYAFQTEEK---LYLVLEYAPGGELFSHLS----KEGRFSEERARFYAA-EIVLALEYLH 110
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ--C 458
+ II+RD+K NILLD++ +K+ DFGL++ + + +T GTP Y+ PE
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 459 YQLTDKS-DVYSFGVVLIELISSMP 482
Y K+ D +S GV+L E+++ P
Sbjct: 170 Y---GKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 288 KELGDGGFGTVYYGKLKD--GR--EVAVKRLYDNNYRR-VEQFMNEVEILTRLRHKNLVS 342
K+LGDG FG V G+ G+ VAVK L + ++ F+ E I+ L H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L+G + L++V E G++ D+L D H L++ + A++ A+ + YL +
Sbjct: 61 LYGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESK 116
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTP-GYVDPEYHQCYQ 460
IHRD+ NILL S+ VK+ DFGL R P + H P + PE +
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 461 LTDKSDVYSFGVVLIELIS 479
+ SDV+ FGV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRL-YDNN----YRRVEQFMNEVEILTRL 335
++ R K LG G FG VY D GRE+AVK++ +D + + V E+++L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 336 RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+H+ +V +GC R + L + E++ G+V DQL +G LT + +
Sbjct: 62 QHERIVQYYGCL-RDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEG 116
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ----GTPGYV 451
+ YLH++ I+HRD+K NIL DS VK+ DFG S+ L S GTP ++
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--RLQTICSSGTGMKSVTGTPYWM 174
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL----AINKIQKCA 507
PE K+DV+S G ++E+++ P A AI KI
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP-----------WAEFEAMAAIFKIAT-- 221
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ +P L + + +N + RPS EE+L
Sbjct: 222 --QPTNPQLPSHVSPDAR-------NFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 69/196 (35%), Positives = 107/196 (54%), Gaps = 11/196 (5%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
E +LG G FG V+ G VA+K L E F+ E +++ +LRH+ LV L+
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
S + + +V E+++ G++ D L G+ K L P +++A + AS +AY+ + +H
Sbjct: 70 VSE--EPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP---GYVDPEYHQCYQLTD 463
RD++ NIL+ N KVADFGL+RL + TA QG + PE + T
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 464 KSDVYSFGVVLIELIS 479
KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 26/274 (9%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKN 339
DF ++G G FG V+ K D R A+K+ L N R E+ ++E +L +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ + L +V E+ NG + L R + L I+ LA+L
Sbjct: 61 IIRYYESFLD-KGKLNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQILLGLAHL 117
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ I+HRD+K+ N+ LD+ VK+ D G+++L D T+ + GTP Y+ PE +
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDK 176
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
+KSDV++ GVVL E +H + N I KI + F +
Sbjct: 177 PYNEKSDVWALGVVLYECC-------TGKHPFDANNQGALILKIIRGVFPPVSQM----- 224
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ +A+L CL ++ RP ++L
Sbjct: 225 -------YSQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
K+LG G FG V+ G +VA+K L + E F+ E ++ +L+H LV L+
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
++ + + ++ E++ NG++ D L LT +++A + A +A++ + IH
Sbjct: 70 VTQ--EPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIH 125
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP---GYVDPEYHQCYQLTD 463
RD++ NIL+ C K+ADFGL+RL + TA +G + PE T
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 182
Query: 464 KSDVYSFGVVLIELIS 479
KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG-C 346
KELG G FG V+ GK + +VA+K + + E F+ E +++ +L H LV L+G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
T + + L +V EF+ NG + L+ R + G L+ + +++ + + YL + IH
Sbjct: 69 TQQ--KPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYHQCYQLTDKS 465
RD+ N L+ S VKV+DFG++R + LD + S++ P + PE + + KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 466 DVYSFGVVLIELISS--MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523
DV+SFGV++ E+ + MP +N + ++ F L P L
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE---------KKSNYEVVEMISRGF-RLYRPKLA------ 226
Query: 524 VKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
+ +V E+ + C + E RP+ E+L +
Sbjct: 227 ----SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
+++G G FG VY G LK EVAVK R + +F+ E EIL + H N+V L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 346 -CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
C + Q + +V E V G++ L R K LT + ++++ A+ + YL + +
Sbjct: 60 VCVQK--QPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYHQCYQLTD 463
IHRD+ N L+ N +K++DFG+SR + VS + P + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 464 KSDVYSFGVVLIELIS--SMPAVDMNRHR 490
+SDV+S+G++L E S P M+ +
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 73/216 (33%), Positives = 113/216 (52%), Gaps = 29/216 (13%)
Query: 288 KELGDGGFGTVYYGKL--KDGRE----VAVKRLYDNNYRRVEQ-FMNEVEILTRLRHKNL 340
+ELG+G FG VY G+L + R VA+K L +N +V+Q F E E+++ L+H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 341 VSLFG-CTSRYSQGLLLVYEFVANGTVADQL------------HGDRAKHGLLTWPIRMN 387
V L G CT Q +++E++A+G + + L GD L ++
Sbjct: 71 VCLLGVCTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL-FPLD---VTHVSTA 443
IAI+ A+ + YL + +HRD+ N L+ VK++DFGLSR + D V S
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
P ++ PE + T +SD++SFGVVL E+ S
Sbjct: 189 PV---RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 68/196 (34%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
+ +LG G FG V+ G +VA+K L E F+ E +I+ +LRH LV L+
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
S + + +V EF+ G++ D L K+ L P +++A + A +AY+ + IH
Sbjct: 70 VSE--EPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP---GYVDPEYHQCYQLTD 463
RD++ NIL+ N K+ADFGL+RL + TA QG + PE + T
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 464 KSDVYSFGVVLIELIS 479
KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKN 339
DF K+LG G +G+VY K L D + A+K L + + E +NE+ IL + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 340 LVS-----LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
++S L G L +V E+ G ++ + + K L+ I I+
Sbjct: 61 IISYKEAFLDGNK------LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
L LH I+HRD+K+ NILL +N VK+ D G+S++ ++ GTP Y+ PE
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPE 171
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDEL 511
+ + KSD++S G +L E+ + P A M R K+Q+ +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR----------YKVQRGKY--- 218
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
P S + + + LQ +LRP+ +++LA
Sbjct: 219 -PPIPPIYSQD----LQNFIRS----MLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 88/279 (31%), Positives = 133/279 (47%), Gaps = 21/279 (7%)
Query: 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
ELGDG FG VY + K+ +A ++ D + +E +M E++IL H N+V L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-A 70
Query: 348 SRYSQGLLLVYEFVANGTV-ADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
Y L ++ EF A G V A L +R LT P + +T AL YLH + IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD--- 463
RD+K NIL + +K+ADFG+S + + GTP ++ PE C D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 464 --KSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA-----NLAINKIQKCAFDELIDPC 515
K+DV+S G+ LIE+ P ++N R + +A LA F + + C
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
L E + + + TT + + F+ + NK +R + E A
Sbjct: 246 L--EKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 90/278 (32%), Positives = 128/278 (46%), Gaps = 42/278 (15%)
Query: 289 ELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
ELGDG FG VY K K+ G A K + + +E +M E+EIL H +V L G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-- 76
Query: 348 SRYSQG-LLLVYEFVANGTV-ADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDII 405
+ Y G L ++ EF G V A L DR LT P I + AL YLH+ II
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKII 132
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-----GTPGYVDPEYHQCYQ 460
HRD+K N+LL + +K+ADFG+S +V T + GTP ++ PE C
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 461 LTD-----KSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ D K+D++S G+ LIE+ P HE+N + + KI K L P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP------HHELNPMRVLL-KIAKSEPPTLSQP- 238
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + + L ++ E RPS ++L
Sbjct: 239 ---------SKWSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 80/284 (28%), Positives = 129/284 (45%), Gaps = 47/284 (16%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRV-----EQFMNEVEILTRLRHKNLV 341
+ +G G FGTV + K DG+ + K + +Y + +Q ++EV IL L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+ R +Q L +V E+ G +A + + + + I + AL H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 401 -----ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV----THVSTAPQGTPGYV 451
+ ++HRD+K NI LD+N VK+ DFGL+++ D T+V GTP Y+
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYM 177
Query: 452 DPEY--HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE H Y +KSD++S G ++ EL + P N LA KI++ F
Sbjct: 178 SPEQLNHMSY--DEKSDIWSLGCLIYELCALSPPF------TARNQLQLAS-KIKEGKF- 227
Query: 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + E+ + S L + + RPS EE+L
Sbjct: 228 ----RRIPYRYSSELNEVIKS-------MLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 286 REKELGDGGFGTVYYG-KLKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
R ++G G FG VY L G +AVK R+ DN+ + +++ +E+++L L+H NLV
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+G + + + E+ + GT+ + L R + ++ LAYLH+
Sbjct: 64 YYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDEHVI----RVYTLQLLEGLAYLHSH 118
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ---GTPGYVDPEYHQCY 459
I+HRD+K NI LD N +K+ DFG + + T + Q GTP Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 460 QLTDK---SDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
+ +D++S G V++E+ + + +I A +K +L
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F CL+ + + RP+ E+L
Sbjct: 239 DFLD----------------RCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 288 KELGDGGFGTV---YYGKLKD--GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
++LG G FG+V Y L+D G VAVK+L + + F E+EIL L+H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 343 LFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
G C S + L LV E++ G++ D L R + L + A + + YL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYLGS 126
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGY-VDPEYHQCY 459
+HRD+ T NIL++S VK+ DFGL+++ P D + P +P + PE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 460 QLTDKSDVYSFGVVLIELI------SSMPAVDMNRHRHE 492
+ + SDV+SFGVVL EL S PA M ++
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 289 ELGDGGFGTVYYGKL------KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
ELG+G FG V+ + +D VAVK L + + + F E E+LT L+H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 343 LFG-CTSRYSQGLLLVYEFVANGTVADQL--HGDRAK---------HGLLTWPIRMNIAI 390
+G CT + LL+V+E++ +G + L HG AK G LT + IA
Sbjct: 72 FYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPG 449
+ AS + YL + +HRD+ T N L+ VK+ DFG+SR ++ D V
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ PE + T +SD++SFGVVL E+ +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGRE---VAVKRL---YDNNYRRVEQFMNEVEILTR 334
+ + EK +G G FG V G+LK G++ VA+K L + R F+ E I+ +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQ 61
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H N++ L G ++ S+ ++++ E++ NG++ L R G T + + AS
Sbjct: 62 FDHPNIIRLEGVVTK-SRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIAS 117
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG----- 449
+ YL + +HRD+ NIL++SN KV+DFGLSR S A T G
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----RLEDSEATYTTKGGKIPI 172
Query: 450 -YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ PE + T SDV+SFG+V+ E++S
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDN-NYRRVEQFMNEVEILTR 334
+ +ELG G FG VY G K VA+K + +N + R +F+NE ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH------GLLTWPIRMNI 388
++V L G S Q L+V E +A G + L R + G T + +
Sbjct: 66 FNCHHVVRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
A E A +AYL A +HRD+ N ++ + VK+ DFG++R D+ +G
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 449 G-----YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
G ++ PE + T KSDV+SFGVVL E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 58/192 (30%), Positives = 102/192 (53%), Gaps = 4/192 (2%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
K+LG G FG V+ G + +VAVK L V+ F+ E ++ L+H LV L+
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407
++ + + ++ E++A G++ D L D LL P ++ + + A +AY+ + IHR
Sbjct: 71 TK-EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKNYIHR 127
Query: 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 467
D++ N+L+ + K+ADFGL+R+ + + + PE T KSDV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 468 YSFGVVLIELIS 479
+SFG++L E+++
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 22/278 (7%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKN 339
+D+ + +G G VY L + +VA+KR+ + V++ EV+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V + + L LV +++ G++ D + G L I + E L YL
Sbjct: 61 VVKYY-TSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDVTH-VSTAPQGTPGYVDPE-Y 455
H++ IHRD+K NILL + VK+ADFG+S D T V GTP ++ PE
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
Q + K+D++SFG+ IEL + + + + +Q DP
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY------SKYPPMKVLMLTLQN-------DPP 225
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
E+ + K+ + S ++ LCLQ++ RP+ EE+L
Sbjct: 226 -SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/217 (32%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 283 DFSREKELGDGGFGTVYYGK------LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR 336
D ++ELG+G FG V+ + KD VAVK L D + F E E+LT L+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQL--HGD----------RAKHGLLTWP 383
H+++V +G C L++V+E++ +G + L HG R G L
Sbjct: 66 HEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 384 IRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVST 442
++IA + AS + YL + +HRD+ T N L+ +N VK+ DFG+SR ++ D V
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ PE + T +SDV+SFGV+L E+ +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 82/286 (28%), Positives = 139/286 (48%), Gaps = 39/286 (13%)
Query: 287 EKELGDGGFGTVYYGKLK-DGRE---VAVKRL---YDNNYRRVEQFMNEVEILTRLRHKN 339
E+ +G G FG V G+LK G+ VA+K L Y RR F++E I+ + H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPN 66
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ L G ++ S+ ++++ EF+ NG + L R G T + + A+ + YL
Sbjct: 67 IIHLEGVVTK-SRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF---PLDVTHVSTAPQGTP-GYVDPEY 455
+ +HRD+ NIL++SN KV+DFGLSR D T+ S+ P + PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 456 HQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
+ T SDV+S+G+V+ E++S P DM+ IN I++ D +
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQ---DYRLP 231
Query: 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
P + T++ +L C Q+++ RP ++++ L ++
Sbjct: 232 PPMD---------CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ + +G G FG V G + G +VAVK + N + F+ E ++T+LRH NLV
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L G GL +V E++A G++ D L R + +L + +++ A+ YL A+
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
+ +HRD+ N+L+ + KV+DFGL++ + + + + PE + + +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 463 DKSDVYSFGVVLIELIS 479
KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNN---YRRVEQFMNEVEILTRLRH 337
+DF K LG G FG V + K + A+K L ++VE +NE IL +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 338 KNLVSLFGCT--SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
LV+L+G L LV E+V G + L K G P+ A + A
Sbjct: 61 PFLVNLYGSFQDDSN---LYLVMEYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLA 113
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
L YLH+ DI++RD+K N+LLDS+ +K+ DFG ++ T+ GTP Y+ PE
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLAPEI 169
Query: 456 HQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ K+ D ++ G+++ E+++ P
Sbjct: 170 ILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 288 KELGDGGFGTVYYG--KLKDGRE--VAVKRLYDNNYRRVEQ-FMNEVEILTRLRHKNLVS 342
KELG G FG+V G +K G+E VAVK L + ++ F+ E ++ +L H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDR--AKHGLLTWPIRMNIAIETASALAYLH 400
L G + L+LV E G + L R L A + A +AYL
Sbjct: 61 LIGVCK--GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE 112
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT-P-GYVDPEYHQC 458
+ +HRD+ N+LL + K++DFG+SR + G P + PE
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 459 YQLTDKSDVYSFGVVLIELIS 479
+ + KSDV+S+GV L E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 283 DFSREKELGDGGFGTVYYG-KLKDGREVAVKRL-YD----NNYRRVEQFMNEVEILTRLR 336
++ R K LG G FG VY + GRE+A K++ +D + V E+++L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 337 HKNLVSLFGCTSRYSQGLLLVY-EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H+ +V +GC ++ L ++ E++ G+V DQL +G LT + +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEG 118
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS-RLFPLDVTHVST-APQGTPGYVDP 453
++YLH++ I+HRD+K NIL DS VK+ DFG S RL + ++ + GTP ++ P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMP 482
E K+DV+S G ++E+++ P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 288 KELGDGGFGTVYYGKLK-DGR----EVAVKRLYDNNYRR-VEQFMNEVEILTRLRHKNLV 341
K LG G FGTVY G +G VA+K L + + ++ ++E ++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHG---LLTWPIRMNIAIETASALA 397
L G C S + L+ + + G + D + + G LL W ++ A ++
Sbjct: 73 RLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMS 123
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYH 456
YL ++HRD+ N+L+ + VK+ DFGL++L +D P ++ E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 457 QCYQLTDKSDVYSFGVVLIELIS-------SMPAVDMNRH 489
T KSDV+S+GV + EL++ +PAV++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 80/289 (27%), Positives = 140/289 (48%), Gaps = 37/289 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGRE---VAVKRL---YDNNYRRVEQFMNEVEILTR 334
+ +++K +G G FG V+ G LK GR+ VA+K L Y R + F++E I+ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQ 62
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H N++ L G +++ + +++ E++ NG + L R G + + + A+
Sbjct: 63 FSHHNIIRLEGVVTKF-KPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAA 118
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD--VTHVSTAPQGTPGYVD 452
+ YL + +HRD+ NIL++SN KV+DFGLSR+ D T+ ++ + +
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
PE + T SDV+SFG+V+ E++S P DM+ H AIN
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKAIND-------- 225
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
GF + ++V +L C QQ++ RP +++ L ++
Sbjct: 226 ------GFRLPAPMD-CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMN--EVEILTRLRHKNLVSLF 344
++G+G +G VY + G VA+K++ E+++L L H N++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
R+ L LV+EF+ D + + L + + + LA+ H+ I
Sbjct: 65 DVF-RHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST----APQ---GTPGYVDP 453
+HRD+K N+L+++ +K+ADFGL+R F V TH V T AP+ G GY
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY--- 176
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMP 482
+ D++S G + EL+S P
Sbjct: 177 --------STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 88/292 (30%), Positives = 129/292 (44%), Gaps = 34/292 (11%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRVEQF---MNEVEILTRLRHKN 339
F+ +E+G G FG VY+ + E VA+K++ + + E++ + EV L +LRH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+ GC R L V E+ G+ +D L + K L I I LAYL
Sbjct: 77 TIEYKGCYLREHTAWL-VMEYCL-GSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYL 131
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ + IHRD+K NILL VK+ADFG + L + V GTP ++ PE
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 460 ---QLTDKSDVYSFGVVLIELISSMPAV-DMNR-----HRHEINLANLAINKIQKCAFDE 510
Q K DV+S G+ IEL P + +MN H + + L+ N F
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY-FRN 245
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL-QRIKS 561
+D CL + R ++ L+ LR V+ +L QR K
Sbjct: 246 FVDSCLQKIPQD---RPSSEE------LLKHRFVLRERPPTVIIDLIQRTKD 288
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 290 LGDGGFGTVYYGKLKDGREVAVKR--LYDNNY----RRVEQFMNEVEILTRLRHKNLVSL 343
LG G +GTVY G G+ +AVK+ L +N + E+ EV++L L+H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
G T + + EFV G+++ L+ + G L P+ + +AYLH +
Sbjct: 68 LG-TCLDDNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSR---LFPLDVTH--VSTAPQGTPGYVDPEYHQC 458
++HRD+K NN++L N +K+ DFG +R L TH + + GTP ++ PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 459 YQLTDKSDVYSFGVVLIELISSMP 482
KSD++S G + E+ + P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 75/263 (28%), Positives = 121/263 (46%), Gaps = 39/263 (14%)
Query: 293 GGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRHKNLVSLFGCTS 348
G +G V+ K K ++ A+K + + R V+Q + E +IL++ + +V L+ +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 349 RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRD 408
+ + L LV E++ G +A L G L + E AL YLH++ IIHRD
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 409 VKTNNILLDSNFCVKVADFGLSR-------LFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+K +NIL+DSN +K+ DFGLS+ + D GTP Y+ PE
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 462 TDKSDVYSFGVVLIELISSMP--------AVDMNRHRHEI------NLANLAINKIQKCA 507
+ D +S G +L E + +P + N +I +++ AI+ I K
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK-- 236
Query: 508 FDELIDPC----LGFESDEEVKR 526
L+ P LG +S EE+K
Sbjct: 237 ---LLVPDPEKRLGAKSIEEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 8e-23
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRL-YDNNYRRVEQFMN----EVEILTRLRHKNLV 341
K LG G FG VY D GRE+AVK++ +D + + + +N E+++L LRH +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 342 SLFGCTSRYSQGLLLVY-EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+GC + L ++ E++ G++ DQL +G LT + + ++YLH
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLH 123
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP---LDVTHVSTAPQGTPGYVDPEYHQ 457
++ I+HRD+K NIL DS VK+ DFG S+ + T + + GTP ++ PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPYWMSPEVIS 182
Query: 458 CYQLTDKSDVYSFGVVLIELISSMP 482
K+DV+S ++E+++ P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 290 LGDGGFGTVYYG-KLKDGREVAVKRL------YDNNYRR---VEQFMNEVEILTRLRHKN 339
+G G FG+VY G G +AVK++ + R+ ++ E+ +L L+H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V G + + L + E+V G+VA L+ +G + N + L YL
Sbjct: 68 IVQYLGSSLD-ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYL 122
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP-----QGTPGYVDPE 454
H IIHRD+K NIL+D+ +K++DFG+S+ + T QG+ ++ PE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNR 488
+ T K+D++S G +++E+++ P D +
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 33/273 (12%)
Query: 290 LGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVE-QFMNEVEILTRLRHKNLVSLFG-CT 347
LG G FG V+ G LKD VAVK ++ + ++ +F++E IL + H N+V L G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407
R Q + +V E V G D L R K L + A++ A+ +AYL + + IHR
Sbjct: 63 QR--QPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 467
D+ N L+ N +K++DFG+SR + S Q + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 468 YSFGVVLIELIS----SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523
+S+G++L E S P + + R ++ ++ QKC ++
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCP--------------DD 222
Query: 524 VKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
V ++ C E RP E+ EL
Sbjct: 223 VYKVMQR-------CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 43/282 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
F ++LG+G +G+VY K+ G+ VA+K + +++ + E+ IL + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA---LA 397
V +G + + L +V E+ G+V+D + + + LT IA L
Sbjct: 61 VKYYGSYFKNTD-LWIVMEYCGAGSVSDIM---KITNKTLT---EEEIAAILYQTLKGLE 113
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-----GTPGYVD 452
YLH++ IHRD+K NILL+ K+ADFG+S T + GTP ++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL------TDTMAKRNTVIGTPFWMA 167
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512
PE Q +K+D++S G+ IE+ P H + AI I
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP---YSDIHPMR----AIFMIPN------- 213
Query: 513 DPCLGFESDEEV-KRMTTSVAELAFLCLQQNKELRPSMEEVL 553
P E+ V CL ++ E RPS ++L
Sbjct: 214 KPPPTLSDPEKWSPEFNDFVK----KCLVKDPEERPSAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 287 EKELGDGGFGTVYYGKLK--DGRE--VAVKRL---YDNNYRRVEQFMNEVEILTRLRHKN 339
EK +G G FG V G+LK RE VA+K L Y RR F++E I+ + H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR--DFLSEASIMGQFDHPN 66
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ L G ++ S+ +++V E++ NG++ L R G T + + AS + YL
Sbjct: 67 IIHLEGVVTK-SKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT-P-GYVDPEYHQ 457
+HRD+ NIL++SN KV+DFGLSR+ D T G P + PE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 458 CYQLTDKSDVYSFGVVLIELIS 479
+ T SDV+S+G+V+ E++S
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMN-----EVEILTRLRH 337
+ + K+LG+G + VY + + GR VA+K++ + + +N E+++L L+H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGD-----RAKHGLLTWPIRMNIAIET 392
N++ L S + LV+EF + D + K +LT + + T
Sbjct: 62 PNIIGLLDVFGHKSN-INLVFEF---------METDLEKVIKDKSIVLTPADIKSYMLMT 111
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-TPGYV 451
L YLH++ I+HRD+K NN+L+ S+ +K+ADFGL+R F ++ Q T Y
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT--HQVVTRWYR 169
Query: 452 DPE-YHQCYQLTDKSDVYSFGVVLIELISSMP 482
PE D++S G + EL+ +P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 286 REKELGDGGFGTVY---YGKLKD--GREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKN 339
+ + LG+G FG V Y D G VAVK L + + + E+ IL L H+N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 340 LVSLFGCTSRY-SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V GC S +GL L+ E+V G++ D L KH L + + A + +AY
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQL-LLFAQQICEGMAY 122
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-TPGY-VDPEYH 456
LH+ IHRD+ N+LLD++ VK+ DFGL++ P + G +P + E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 457 QCYQLTDKSDVYSFGVVLIELIS 479
+ + + SDV+SFGV L EL++
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 60/194 (30%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
EK+LG G FG V+ +VAVK + + VE F+ E ++ L+H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
++ + + ++ EF+A G++ D L D L P ++ + + A +A++ + IH
Sbjct: 70 VTK--EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYHQCYQLTDKS 465
RD++ NIL+ ++ K+ADFGL+R+ D + + P + PE T KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 466 DVYSFGVVLIELIS 479
DV+SFG++L+E+++
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 291 GDGGFGTVYYGKLKDGREV-AVKRLYDNN-----YRRVEQFMNEVEILTRLRHKNLVSLF 344
G G FG V + +D +++ A+K Y N V +NE IL L H LV+L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL- 65
Query: 345 GCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
YS + + LV + + G + + H + + E AL YLH
Sbjct: 66 ----WYSFQDEENMYLVVDLLLGGDL--RYHLSQKVK--FSEEQVKFWICEIVLALEYLH 117
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+ IIHRD+K +NILLD V + DF ++ D ST+ GTPGY+ PE
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQG 175
Query: 461 LTDKSDVYSFGVVLIELI 478
+ D +S GV E +
Sbjct: 176 YSVAVDWWSLGVTAYECL 193
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 60/190 (31%), Positives = 104/190 (54%), Gaps = 11/190 (5%)
Query: 290 LGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR 349
+G+G FG V G+ G++VAVK + + + F+ E ++T+L HKNLV L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVI-- 68
Query: 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDV 409
GL +V E ++ G + + L R + L++ + +++ A + YL + ++HRD+
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLR-TRGR-ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 410 KTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYS 469
NIL+ + KV+DFGL+R+ + V + + T PE + + + KSDV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSSKSDVWS 182
Query: 470 FGVVLIELIS 479
+GV+L E+ S
Sbjct: 183 YGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLY---DNNYRRVEQFMNEVEILTRLRHK 338
D+ + +G G +G VY + + G VA+K + +++ ++Q E+ +L RH
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHP 60
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V+ FG R + L +V E+ G++ D R G L+ + ET LAY
Sbjct: 61 NIVAYFGSYLRRDK-LWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAY 116
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ---GTPGYVDPEY 455
LH + IHRD+K NILL + VK+ADFG+S +T + GTP ++ PE
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTATIAKRKSFIGTPYWMAPEV 172
Query: 456 HQCYQLTD---KSDVYSFGVVLIEL 477
+ K D+++ G+ IEL
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRH---K 338
+ R + +G G +G VY GK + GR VA+K + D V EV +L++LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 339 NLVSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
N+ +G Y +G L ++ E+ G+V + K G + I E AL
Sbjct: 63 NITKYYGS---YLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVAL 114
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
Y+H +IHRD+K NIL+ + VK+ DFG++ L + + ST GTP ++ PE
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVI 173
Query: 457 QCYQLTD-KSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
+ D K+D++S G+ + E+ + + P D++ R A+ I K L
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMMLIPKSKPPRL--- 222
Query: 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
E + K + VA CL + + R S EE L + + IK+
Sbjct: 223 ----EDNGYSKLLREFVA----ACLDEEPKERLSAEE-LLKSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN--EVEILTRL-RHKNLVSL 343
K+LGDG FG+VY + K+ G VA+K++ + E+ MN EV+ L +L H N+V L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
R + L V+E++ G + QL DR K + + +I + LA++H
Sbjct: 64 KE-VFRENDELYFVFEYM-EGNLY-QLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD------PE--- 454
HRD+K N+L+ VK+ADFGL+R + + P T YV PE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTD-YVSTRWYRAPEILL 171
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSMP 482
Y + D+++ G ++ EL + P
Sbjct: 172 RSTSY--SSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRR-----VEQFMNEVEILTRLRHKNL 340
++LG G F + Y + +K G +AVK++ Y N VE E+ ++ RL H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+ + G T S L V E++A G+V+ L K+G + +N + L+YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 401 ASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAPQ---GTPGYVDPEYH 456
+ IIHRDVK N+L+DS +++ADFG + T GT ++ PE
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
+ Q DV+S G V+IE+ ++ P N +H +LA I KI A P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP--WNAEKHSNHLA--LIFKI-ASATTAPSIP-- 233
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ ++ + ++ CL+ E RP E+L
Sbjct: 234 --------EHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 289 ELGDGGFGTVYYGKLKD-GREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKNLVSL- 343
+G+G +G V + K G VA+K+ D+ + + + EV++L +LRH+N+V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-KTALREVKVLRQLRHENIVNLK 66
Query: 344 --FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
F R L LV+E+V T+ + L + + GL +R I + A+AY H+
Sbjct: 67 EAF----RRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYI-WQLLQAIAYCHS 118
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+IIHRD+K NIL+ + +K+ DFG +R T T Y PE
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 462 TDKS-DVYSFGVVLIELISSMP 482
K DV++ G ++ EL+ P
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 76/281 (27%), Positives = 130/281 (46%), Gaps = 30/281 (10%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKR-----LYDNNYRRVEQFMNEVEILTR 334
+F EK++G G F VY L DGR VA+K+ + D R + + E+++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR--QDCLKEIDLLKQ 58
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
L H N++ + + L +V E G ++ + + + L+ ++ S
Sbjct: 59 LDHPNVIKYLA-SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
AL ++H+ I+HRD+K N+ + + VK+ D GL R F T + + GTP Y+ PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE 176
Query: 455 --YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512
+ Y KSD++S G +L E M A+ + ++NL +L KI+KC + L
Sbjct: 177 RIHENGYNF--KSDIWSLGCLLYE----MAALQSPFYGDKMNLYSL-CKKIEKCDYPPL- 228
Query: 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + +L C+ + E RP + VL
Sbjct: 229 ----------PADHYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 283 DFSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
++G+G G V GR+VAVK++ +R E NEV I+ +H N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 342 SLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ S Y G L +V EF+ G + D + H + + + AL++L
Sbjct: 80 EMY---SSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFL 131
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-----GTPGYVDPE 454
HA +IHRD+K+++ILL S+ VK++DFG +V P+ GTP ++ PE
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPE 185
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSMP 482
+ D++S G+++IE++ P
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 75/280 (26%), Positives = 114/280 (40%), Gaps = 39/280 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKN 339
F+ + +G G FG VY K + VA+K + + +E E++ L++ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 340 LVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+ +G L ++ E+ G+ D L K G L I E L Y
Sbjct: 61 ITKYYGSFLKGSK--LWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEY 113
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPE 454
LH IHRD+K NILL VK+ADFG L+ T V GTP ++ PE
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPE 168
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
+ +K+D++S G+ IEL P D++ R + I K L
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNNPPSLEG 220
Query: 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F + + LCL ++ + RPS +E+L
Sbjct: 221 N--KF---------SKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 287 EKELGDGGFGTVYYGKL------KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
++ELG+G FG V+ + +D VAVK L D + + F E E+LT L+H+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQL--HGDRA-------KHGLLTWPIRMNIAIE 391
V +G L++V+E++ +G + L HG A + LT ++IA +
Sbjct: 70 VKFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPGY 450
A+ + YL + +HRD+ T N L+ N VK+ DFG+SR ++ D V +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 451 VDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ PE + T +SDV+S GVVL E+ +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVE-----QFMNEVEILTRLRHKNLVSL 343
+G+G G V+ K + G VA+K++ RR+E Q + E++ L +H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
+ G +LV E++ +++ L + L + +AY+HA+
Sbjct: 65 LD-VFPHGSGFVLVMEYMP-SDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHANG 119
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-YHQCYQLT 462
I+HRD+K N+L+ ++ +K+ADFGL+RLF + + + T Y PE + +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 463 DKSDVYSFGVVLIELISSMP 482
D+++ G + EL++ P
Sbjct: 180 PGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 3e-21
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 46/221 (20%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQF----MNEVEILTRLR 336
+ + ++LG+G +G VY + K G VA+K RL + E + E+ +L L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELK 56
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHG--DRAKHGLLTWPIRMNIAIETA 393
H N+V L + L LV+E+ D L D+ L I+ +I +
Sbjct: 57 HPNIVKLLDVIHTERK--LYLVFEYCDM----D-LKKYLDKRPGPLSPNLIK-SIMYQLL 108
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST----APQ 445
LAY H+ I+HRD+K NIL++ + +K+ADFGL+R F + + TH V T AP+
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168
Query: 446 ---GTPGYVDPEYHQCYQLTDKS-DVYSFGVVLIELISSMP 482
G+ Y + D++S G + E+I+ P
Sbjct: 169 ILLGSKHY------------STAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 288 KELGDGGFGTVY----YGKLKDGRE--VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNL 340
+ELG G FG VY G +KD E VA+K + + + R +F+NE ++ ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH----GLLTWPIR--MNIAIETAS 394
V L G S+ Q L++ E + G + L R + ++ + +A E A
Sbjct: 72 VRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG----- 449
+AYL+A+ +HRD+ N ++ +F VK+ DFG++R D+ +G G
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
++ PE + T SDV+SFGVVL E +A LA Q + +
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWE------------------IATLAEQPYQGMSNE 228
Query: 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
+++ + ++ + EL +C Q N ++RPS E+++ ++
Sbjct: 229 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLV 341
K LG G FG VY D GRE+AVK++ + + V E+++L L H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 342 SLFGCTSRYSQGLLLVY-EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+GC + L ++ E + G++ DQL +G LT + + ++YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLH 123
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP---LDVTHVSTAPQGTPGYVDPEYHQ 457
++ I+HRD+K NIL DS VK+ DFG S+ L T + + GTP ++ PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVIS 182
Query: 458 CYQLTDKSDVYSFGVVLIELISSMP 482
K+D++S G ++E+++ P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 75/276 (27%), Positives = 134/276 (48%), Gaps = 28/276 (10%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQF--MNEVEILTRLRHKNL 340
+ + + +G G FG V+ + K D + V +K++ + E+ NE ++L L H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+ + + L++V E+ GT+A+ + + LL ++ ++ AL ++H
Sbjct: 62 IEYYE-NFLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVH 118
Query: 401 ASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
I+HRD+KT NILLD + VK+ DFG+S++ L + GTP Y+ PE +
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
KSD+++ G VL EL S + R NL L + KI F + D
Sbjct: 177 PYNQKSDIWALGCVLYELAS------LKRAFEAANLPALVL-KIMSGTFAPISD-----R 224
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555
+++++ L+ L L +K RP + +++A+
Sbjct: 225 YSPDLRQLI-----LSMLNLDPSK--RPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 284 FSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
++R +++G G GTVY + G+EVA+K++ + E +NE+ ++ +H N+V+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+ L +V E++A G++ D + G + R E AL +LH++
Sbjct: 81 YLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN 134
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
+IHRD+K++NILL + VK+ DFG + + ST GTP ++ PE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193
Query: 463 DKSDVYSFGVVLIELISSMP 482
K D++S G++ IE++ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 288 KELGDGGFGTVY----YGKLKDGR--EVAVKRLYDNNYR-RVEQFMNEVEILTRL-RHKN 339
K LG G FG V YG K +VAVK L + E M+E++I++ L H+N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V+L G CT +L++ E+ G + + L R + LT ++ + + A +A+
Sbjct: 101 IVNLLGACT--IGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPE--Y 455
L + + IHRD+ N+LL VK+ DFGL+R D +V P ++ PE +
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 456 HQCYQLTDKSDVYSFGVVLIELIS 479
+ Y T +SDV+S+G++L E+ S
Sbjct: 217 NCVY--TFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 290 LGDGGFGTVYYGKL--KDGREV--AVKRLYD-NNYRRVEQFMNEVEILTRLRHKNLVSLF 344
+G G FG VY+G L DG+++ AVK L + VEQF+ E I+ H N++SL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 345 GCTSRYSQGL-LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
G S+G L+V ++ +G D + R++ T + ++ A + YL +
Sbjct: 63 GICLP-SEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV-------THVSTAPQGTPGYVDPEYH 456
+HRD+ N +LD +F VKVADFGL+R D+ H T + ++ E
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 457 QCYQLTDKSDVYSFGVVLIELIS 479
Q + T KSDV+SFGV+L EL++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 290 LGDGGFGTVYYGKLK-DGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
LG GGFG V K+K R A+K + + + E +E EIL H +V L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLL-TWPIRMNIA--IETASALAYLHAS 402
T + + + ++ E+ G + L GL + R IA + A YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARFYIACVVL---AFEYLHNR 112
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
II+RD+K N+LLDSN VK+ DFG ++ L T GTP YV PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGY 169
Query: 462 TDKSDVYSFGVVLIELISSMP 482
D +S G++L EL++ P
Sbjct: 170 DFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 59/229 (25%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQ--------FMNEVEILTR 334
+ + ++G+G +G VY + K G VA+K++ R+E + E+++L +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQK 54
Query: 335 LRHKNLVSLFG-CTSRYSQGLLLVYEFV--------ANGTVADQLHGDRAKHGLLTWPIR 385
LRH N+V L TS+ + +V+E++ + V + + K
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV--KFTESQIKC-------- 104
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF----PLDVT-HV 440
+ L YLH++ I+HRD+K +NIL++++ +K+ADFGL+R + D T V
Sbjct: 105 --YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 441 ST----APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
T P+ G Y PE D++S G +L EL P
Sbjct: 163 ITLWYRPPELLLGATRY-GPE----------VDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-20
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 16/191 (8%)
Query: 306 GREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362
G EVA+K L + + +F E + RL H N+V+L L V+E+V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSN 419
T+ + L D G L + ++ ALA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAAD----GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 420 FCVKVADFGLSRLFP----LDVTHVSTAPQ--GTPGYVDPEYHQCYQLTDKSDVYSFGVV 473
KV DFG+ L P DV ++ + GTP Y PE + +T SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 474 LIELISSMPAV 484
+E ++ V
Sbjct: 179 FLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 44/224 (19%)
Query: 283 DFSREKE---LGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK 338
++ E LG G +G VY + L +A+K + + + R V+ E+ + + L+H+
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 339 NLVSLFGCTSRYSQGLLLVY-EFVANGTVADQLHGDRAKHGLLTWPIRMN---IAIETAS 394
N+V G S G ++ E V G+++ L R+K G P++ N I T
Sbjct: 66 NIVQYLGSDS--ENGFFKIFMEQVPGGSLSALL---RSKWG----PLKDNEQTIIFYTKQ 116
Query: 395 ---ALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFG----LSRLFPLDVTHVST---- 442
L YLH + I+HRD+K +N+L+++ + VK++DFG L+ + P T T
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYM 176
Query: 443 AP----QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP +G GY P +D++S G ++E+ + P
Sbjct: 177 APEVIDKGPRGYGAP-----------ADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 290 LGDGGFGTVYYG-KLKDGREVAVK------RLYDNNYRR----VEQFMNEVEILTRLRHK 338
+G G +G VY + G +AVK + + R V+ +E+E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V G + L + E+V G++ L +G + + LAY
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAY 123
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSR----LFPLDVTHVSTAPQGTPGYVDPE 454
LH+ I+HRD+K +N+L+D++ K++DFG+S+ ++ D + QG+ ++ PE
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMAPE 180
Query: 455 ----YHQCYQLTDKSDVYSFGVVLIELIS 479
Y Q Y + K D++S G V++E+ +
Sbjct: 181 VIHSYSQGY--SAKVDIWSLGCVVLEMFA 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 288 KELGDGGFGTVYYGKLKD------GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNL 340
+ELG G FG VY G +D VAVK + ++ + R +F+NE ++ ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAK------HGLLTWPIRMNIAIETAS 394
V L G S+ Q L+V E +A+G + L R + T + +A E A
Sbjct: 72 VRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG----- 449
+AYL+A +HRD+ N ++ +F VK+ DFG++R D+ +G G
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
++ PE + T SD++SFGVVL E+ S LA Q + +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS------------------LAEQPYQGLSNE 228
Query: 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
+++ + ++ V +L +C Q N ++RP+ E++ L+
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKNLVSLF 344
K++G+G FG +Y K K D +K L + E EV +L +++H N+V+ F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDR----AKHGLLTWPIRMNIAIETASALAYLH 400
+ L +V E+ G + +++ R ++ +L+W +++++ L ++H
Sbjct: 66 ASFQENGR-LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG------LKHIH 118
Query: 401 ASDIIHRDVKTNNILLDSNFCV-KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
I+HRD+K+ NI L N V K+ DFG++R D ++ GTP Y+ PE Q
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNR 177
Query: 460 QLTDKSDVYSFGVVLIEL 477
+K+D++S G VL EL
Sbjct: 178 PYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 280 ATNDFSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRRVEQF----MNEVEILTR 334
D+ +LG+G FG VY ++K GR VA+K++ +N + + F + E++IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 335 LRHKNLVSLFGCTSRYS---QGLLLVYEFVANGTVAD---QLHGDRAKHGLLTWPIRMNI 388
L+H N+V L + V D L K LT
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCY 120
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
++ + YLH + I+HRD+K NIL+D+ +K+ADFGL+R + P+G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY----DGPPPNPKGGG 176
Query: 449 GYVDPEYHQC-----Y----------QLTDKSDVYSFGVVLIELISSMP 482
G +Y Y + T D++ G V E+ + P
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLY-DNNYRRVEQFMNEVEILTRLRHKN 339
+D ELG G G V + G+ +AVK + + N +Q + E++IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 340 LVSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V +G + Y+ G + + E++ +G D++ + G + I IA+ L Y
Sbjct: 61 IVGFYG--AFYNNGDISICMEYM-DGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTY 115
Query: 399 LHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
LH IIHRDVK +NIL++S +K+ DFG+S V ++ GT Y+ PE Q
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQ 172
Query: 458 CYQLTDKSDVYSFGVVLIEL 477
+ KSD++S G+ LIEL
Sbjct: 173 GNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 77/296 (26%), Positives = 141/296 (47%), Gaps = 22/296 (7%)
Query: 277 LAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL 335
+ + ++R +++G G GTV+ + G+EVA+K++ + E +NE+ ++ L
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 336 RHKNLVSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
++ N+V+ + G L +V E++A G++ D + + R E
Sbjct: 74 KNPNIVNFL---DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECL 125
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
AL +LHA+ +IHRD+K++N+LL + VK+ DFG + + ST GTP ++ P
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAP 184
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMPA-VDMNRHRHEINLANLAINKIQKCA----- 507
E K D++S G++ IE++ P ++ N R +A ++Q
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563
F + ++ CL E D E + + + FL L K L +LA + +KS +
Sbjct: 245 FRDFLNRCL--EMDVEKRGSAKELLQHPFLKLA--KPLSSLTPLILAAKEAMKSNR 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 65/197 (32%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 288 KELGDGGFGTVYYGKLKDGREV-AVKRLYD---NNYRRVEQFMNEVEIL-TRLRHKNLVS 342
K LG G FG V +LK E+ AVK L VE M E +L +H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L C + L V E+V G + + P A E L +LH
Sbjct: 61 LHSCFQTKDR-LFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER 115
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
II+RD+K +N+LLDS +K+ADFG+ + L ST GTP Y+ PE YQ
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILS-YQPY 173
Query: 463 DKS-DVYSFGVVLIELI 478
+ D ++ GV+L E++
Sbjct: 174 GPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 72/232 (31%), Positives = 112/232 (48%), Gaps = 23/232 (9%)
Query: 275 SDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILT 333
S L + F + +G+G +G VY G+ +K G+ A+K + D E+ E+ +L
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLK 67
Query: 334 RL-RHKNLVSLFGCTSRYS-----QGLLLVYEFVANGTVAD---QLHGDRAKHGLLTWPI 384
+ H+N+ + +G + S L LV EF G+V D G+ K + +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-- 125
Query: 385 RMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444
I E LA+LHA +IHRD+K N+LL N VK+ DFG+S V +T
Sbjct: 126 ---ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 445 QGTPGYVDPEYHQCYQLTD-----KSDVYSFGVVLIELISSMPAV-DMNRHR 490
GTP ++ PE C + D +SD++S G+ IE+ P + DM+ R
Sbjct: 183 -GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 4e-19
Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 12/213 (5%)
Query: 273 SYSDLAEATNDFSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRRVEQFMNEVEI 331
S + + ++R +++G G GTVY + G+EVA+K++ + E +NE+ +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 332 LTRLRHKNLVSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIA 389
+ ++ N+V+ Y G L +V E++A G++ D + G + R
Sbjct: 70 MRENKNPNIVNYL---DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 122
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG 449
E AL +LH++ +IHRD+K++NILL + VK+ DFG + + ST GTP
Sbjct: 123 -ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 180
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
++ PE K D++S G++ IE++ P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 288 KELGDGGFGTVYYGKL-----KDGREVAVKRLYD-NNYRRVEQFMNEVEILTRLRHKNLV 341
+ELG+ FG +Y G L + VA+K L D NN ++ +F E ++ L H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQL-----HGD-------------RAKHGLLTWP 383
L G ++ Q + +++E++ G + + L H D HG
Sbjct: 71 CLLGVVTQ-EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF--- 126
Query: 384 IRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVST 442
++IAI+ A+ + YL + +H+D+ NIL+ VK++D GLSR ++ D V
Sbjct: 127 --LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ PE + + SD++SFGVVL E+ S
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRV------EQFMNEVEILTRL 335
D R K +G G FG V+ + + A+K + V + NE +L +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 336 RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H ++ LF T + L ++ E+V G + L R G + + A E A
Sbjct: 59 SHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYL---RNS-GRFSNSTGLFYASEIVCA 113
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
L YLH+ +I++RD+K NILLD +K+ DFG F + + GTP Y+ PE
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDRTWTLCGTPEYLAPEV 169
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMP 482
Q D ++ G+++ E++ P
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 8e-19
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCT 347
+G+G +G VY G+ +K G+ A+K + D E+ E+ +L + H+N+ + +G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 348 SRYS-----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+ + L LV EF G+V D + + W I E L++LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
+IHRD+K N+LL N VK+ DFG+S V +T GTP ++ PE C +
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENP 189
Query: 463 D-----KSDVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
D KSD++S G+ IE+ P + DM+ R A+ I + +P
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR-------NPAP 234
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+S + K+ + + CL +N RP+ E+++
Sbjct: 235 RLKSKKWSKKFQSFIES----CLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 289 ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
++G+G G V + K GR+VAVK + +R E NEV I+ +H+N+V ++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK-S 86
Query: 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407
+ L ++ EF+ G + D + R L + AL YLH+ +IHR
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 467
D+K+++ILL + VK++DFG DV + GTP ++ PE + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRTPYGTEVDI 200
Query: 468 YSFGVVLIELI-------SSMPAVDMNRHRHE 492
+S G+++IE++ S P M R R
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 289 ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
++G+G G V K G++VAVK++ +R E NEV I+ H+N+V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY--- 85
Query: 348 SRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDII 405
+ Y G L +V EF+ G + D + R + + + AL+YLH +I
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQGVI 140
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 465
HRD+K+++ILL S+ +K++DFG +V + GTP ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL-VGTPYWMAPEVISRLPYGTEV 199
Query: 466 DVYSFGVVLIELISSMP 482
D++S G+++IE+I P
Sbjct: 200 DIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 72/216 (33%), Positives = 108/216 (50%), Gaps = 26/216 (12%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF---MNEVEILTRLRHKN 339
FS +E+G G FG VY+ + +++ VA+K++ + + E++ + EV L +LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-MNIAIETASAL-- 396
+ GC R LV E+ G+ +D L + P++ + IA T AL
Sbjct: 77 TIQYRGCYLR-EHTAWLVMEYCL-GSASDLLEVHKK-------PLQEVEIAAVTHGALQG 127
Query: 397 -AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
AYLH+ ++IHRDVK NILL VK+ DFG + + V GTP ++ PE
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 456 HQCY---QLTDKSDVYSFGVVLIELISSMPAV-DMN 487
Q K DV+S G+ IEL P + +MN
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKR-----LYDNNYRRVEQFMNEVEILTRLR 336
+F EK++G G F VY L DG VA+K+ L D R + E+++L +L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR--ADCIKEIDLLKQLN 60
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H N++ + ++ L +V E G ++ + + + L+ ++ SAL
Sbjct: 61 HPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
++H+ ++HRD+K N+ + + VK+ D GL R F T + + GTP Y+ PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERI 178
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
KSD++S G +L E M A+ + ++NL +L KI++C + L
Sbjct: 179 HENGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLYSLC-KKIEQCDYPPL----- 228
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
SD + + +L +C+ + E RP + V +R+
Sbjct: 229 --PSDH----YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 290 LGDGGFGTVY---YGKLKDGR-EVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLVSLF 344
+G+G FG VY Y ++ + VAVK + E+F+ E I+ + H ++V L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 345 GCTSRYSQGLLLVYEFVANGTVAD--QLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
G + + +V E G + Q++ L + + ++ALAYL +
Sbjct: 74 GVIT--ENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALAYLESK 126
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT-P-GYVDPEYHQCYQ 460
+HRD+ N+L+ S CVK+ DFGLSR L+ A +G P ++ PE +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 461 LTDKSDVYSFGVVLIELIS 479
T SDV+ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 36/220 (16%)
Query: 288 KELGDGGFGTVYYGKLK--DGRE----VAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKN 339
K LG+G FG V + D VAVK L D+ + + ++E+E++ + +HKN
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 340 LVSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKH------------GLLTWPIRM 386
+++L G ++ +G L +V E+ A+G + D L R LT +
Sbjct: 78 IINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 387 NIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG 446
+ A + A + +L + IHRD+ N+L+ + +K+ADFGL+R D+ H+ +
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191
Query: 447 TPG-----YVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
T G ++ PE + + Y T +SDV+SFGV+L E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 3e-18
Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 12/213 (5%)
Query: 273 SYSDLAEATNDFSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRRVEQFMNEVEI 331
S + + ++R +++G G GTVY + G+EVA++++ + E +NE+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 332 LTRLRHKNLVSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIA 389
+ ++ N+V+ Y G L +V E++A G++ D + G + R
Sbjct: 71 MRENKNPNIVNYL---DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG 449
E AL +LH++ +IHRD+K++NILL + VK+ DFG + + ST GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 181
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
++ PE K D++S G++ IE+I P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 86/285 (30%), Positives = 137/285 (48%), Gaps = 45/285 (15%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF---MNEVEILTRLRHKN 339
F+ +E+G G FG VY+ + ++ VA+K++ + + E++ + EV+ L R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-MNIAIETASAL-- 396
+ GC R LV E+ G+ +D L + P++ + IA T AL
Sbjct: 87 SIEYKGCYLR-EHTAWLVMEYCL-GSASDLLEVHKK-------PLQEVEIAAITHGALQG 137
Query: 397 -AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
AYLH+ ++IHRD+K NILL VK+ADFG + + + V GTP ++ PE
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 456 HQCY---QLTDKSDVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCAFDEL 511
Q K DV+S G+ IEL P + +MN A++ + A +E
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHIAQNE- 240
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
P L +S+E V CLQ+ + RP+ EE+L +
Sbjct: 241 -SPTL--QSNEWSDYFRNFVDS----CLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 82/276 (29%), Positives = 119/276 (43%), Gaps = 32/276 (11%)
Query: 290 LGDGGFGTVY-YGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGC- 346
+G G +G V+ K+G + AVK L D + E+ E IL L H N+V +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 347 ---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
+ L LV E G+V D + G + + PI I E L +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD 463
IHRDVK NNILL + VK+ DFG+S GTP ++ PE C Q D
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTPFWMAPEVIACEQQLD 203
Query: 464 KS-----DVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+ DV+S G+ IEL P + D++ R A+ KI + L P L
Sbjct: 204 STYDARCDVWSLGITAIELGDGDPPLADLHPMR--------ALFKIPRNPPPTLHQPEL- 254
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + CL ++ E RP++ ++L
Sbjct: 255 ---------WSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 64/204 (31%), Positives = 113/204 (55%), Gaps = 24/204 (11%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLYDN-NYRRVEQF-MNEVEILTRLRHKNLVSLFGC 346
+G+G +G V K K+ G+ VA+K+ ++ + + V++ M E+ +L +LRH+NLV+L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIH 406
R + L LV+EFV + TV D L ++ +GL +R + + + H+ +IIH
Sbjct: 69 FRRKKR-LYLVFEFVDH-TVLDDL--EKYPNGLDESRVR-KYLFQILRGIEFCHSHNIIH 123
Query: 407 RDVKTNNILLDSNFCVKVADFGLSRLF--PLDV--THVST----APQGTPGYVDPEYHQC 458
RD+K NIL+ + VK+ DFG +R P +V +V+T AP+ G D +Y +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYGRA 181
Query: 459 YQLTDKSDVYSFGVVLIELISSMP 482
D+++ G ++ E+++ P
Sbjct: 182 V------DIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 35/210 (16%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVE-QFMNEVEILTRLRHKNL 340
+ R +G G GTVY + GR A+K +Y N+ V Q E+EIL + H N+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 341 VSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDR-AKHGLLTWPIRMNIAIETASALA 397
V C + + ++ EF+ G+ L G A L ++A + S +A
Sbjct: 135 VK---CHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLA-----DVARQILSGIA 182
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDVTHVSTAPQGTPGYVDPEY 455
YLH I+HRD+K +N+L++S VK+ADFG+SR+ +D + S GT Y+ PE
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPER 239
Query: 456 HQCYQLTD---------KSDVYSFGVVLIE 476
TD D++S GV ++E
Sbjct: 240 IN----TDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 28/206 (13%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLY----DNNYRRVEQFMNEVEILTRLRHKNLVSLF 344
+G+G +G V+ + ++ G+ VA+K+ D +++ + E+ +L +L+H NLV+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
R + L LV+E+ + TV ++L ++ G+ I+ I +T A+ + H +
Sbjct: 67 EVFRR-KRKLHLVFEYCDH-TVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHKHNC 121
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLF---PLDVT-HVST----APQGTPGYVDPEYH 456
IHRDVK NIL+ +K+ DFG +R+ D T +V+T AP+ G D +Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG--DTQYG 179
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMP 482
DV++ G V EL++ P
Sbjct: 180 P------PVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 289 ELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347
++G+G G V +K G+ VAVK++ +R E NEV I+ +H+N+V ++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY--- 83
Query: 348 SRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDII 405
+ Y G L +V EF+ G + D + R + + + AL+ LHA +I
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVI 138
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 465
HRD+K+++ILL + VK++DFG +V + GTP ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLPYGPEV 197
Query: 466 DVYSFGVVLIELISSMP 482
D++S G+++IE++ P
Sbjct: 198 DIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 288 KELGDGGFGTVYYGKLK--DGR--EVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLV 341
K LG+G FG+V G+L DG +VAVK + + Y +E+F++E + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 342 SLFGC--TSRYSQGL---LLVYEFVANGTVADQLHGDRAKHGLLTWPIRM--NIAIETAS 394
L G + Q + +++ F+ +G + L R P++ ++ A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDV---THVSTAP---QGT 447
+ YL + IHRD+ N +L + V VADFGLS+ ++ D ++ P
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
D Y T KSDV++FGV + E+ +
Sbjct: 185 ESLADRVY------TSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 76/237 (32%), Positives = 105/237 (44%), Gaps = 14/237 (5%)
Query: 263 GTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVY-YGKLKDGREVAVKRLYDNNYRR 321
G + + L + T+ + + +G G +G VY KDG AVK L D
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDV 61
Query: 322 VEQFMNEVEILTRL-RHKNLVSLFGC---TSRYSQG-LLLVYEFVANGTVADQLHGDRAK 376
E+ E IL L H N+V +G + G L LV E G+V + + G
Sbjct: 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121
Query: 377 HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
L + I L +LH + IIHRDVK NNILL + VK+ DFG+S
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKS-----DVYSFGVVLIELISSMPAV-DMN 487
+T+ GTP ++ PE C Q D S DV+S G+ IEL P + DM+
Sbjct: 182 RLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREV-AVKRL------YDNNYRRVEQFMNEVEILTRL 335
DF+ LG G FG V + K E+ A+K L D++ VE M E +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALP 57
Query: 336 -RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+ L L C + L V E+V G + + + G P + A E A
Sbjct: 58 GKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAI 112
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVD 452
L +LH+ II+RD+K +N++LD+ +K+ADFG+ + +F T GTP Y+
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIA 169
Query: 453 PEYHQCYQLTDKS-DVYSFGVVLIELISSMPAVD 485
PE YQ KS D ++FGV+L E+++ P D
Sbjct: 170 PEI-IAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 21/159 (13%)
Query: 289 ELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFM-NEVEILTRLR---HKNLVS 342
E+G+G +GTVY + L GR VA+K++ + + E+ +L +L H N+V
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 343 LF----GCTSRYSQGLLLVYEFVANGTVADQ-LHGDRAKH---GLLTWPIRMNIAIETAS 394
L G + L LV+E V DQ L +K GL I+ ++ +
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
+ +LH+ I+HRD+K NIL+ S+ VK+ADFGL+R++
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 290 LGDGGFGTVYYGKLKDG-------REVAVKRLYDNNYRR-----VEQFMNEVEILT-RLR 336
LG G FG VY + K+ +E+ V +R + ++EV I+ +LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H N+V + T + L +V + + + + + + K T NI ++ AL
Sbjct: 68 HPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 397 AYLHASD-IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
YLH I+HRD+ NNI+L + V + DFGL++ + S GT Y PE
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILYSCPEI 184
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ +K+DV++FG +L ++ + P + N+ +LA KI + ++ L +
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPF------YSTNMLSLAT-KIVEAVYEPLPEGM 237
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
E+V + TS CL + E RP + +V A
Sbjct: 238 Y----SEDVTDVITS-------CLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREV----AVKRLYDNNYRRVE-QFMNEVEILTRLR 336
+ R K LG G FGTVY G + +G V A+K L + + +FM+E I+ +
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHG---LLTWPIRMNIAIET 392
H +LV L G C S Q LV + + +G + D +H + G LL W ++
Sbjct: 68 HPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQI 118
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYV 451
A + YL ++HRD+ N+L+ S VK+ DFGL+RL D + P ++
Sbjct: 119 AKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELIS 479
E + T +SDV+S+GV + EL++
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 39/223 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNY---RRVEQFMNEVEILTRLRH 337
DF K + +G +G VY + K+ R+ A+K++ N +++Q E +ILT +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKH-GLLTWPI---RMNIAIE 391
+VS+F T R+ L +V E+V G A L K+ G L P+ RM A E
Sbjct: 61 PFVVSMFCSFETKRH---LCMVMEYVEGGDCATLL-----KNIGAL--PVDMARMYFA-E 109
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT------HVSTAPQ 445
T AL YLH I+HRD+K +N+L+ S +K+ DFGLS++ + +T H+ +
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 446 --------GTPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELI 478
GTP Y+ PE Q Y D ++ G++L E +
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGY--GKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 72/209 (34%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR---VEQFMNEVEILTR-LRHKNLVS 342
K +G G FG V K K DG+ AVK L + + M E +L + ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 343 LFGCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
L YS L V ++V G + H R + P A E ASAL Y
Sbjct: 61 L-----HYSFQTADKLYFVLDYVNGGELF--FHLQRERS--FPEPRARFYAAEIASALGY 111
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPE-- 454
LH+ +II+RD+K NILLDS V + DFGL + + H T GTP Y+ PE
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVL 168
Query: 455 YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
Q Y D++ D + G VL E++ +P
Sbjct: 169 RKQPY---DRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 82/302 (27%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKL-KDG--REVAVKRLYD----NNYRRVEQFMNEVEILTR 334
ND + +G+G FG V ++ KDG + A+KR+ + +++R F E+E+L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCK 63
Query: 335 L-RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDR------------AKHGLL 380
L H N+++L G C R L L E+ +G + D L R + L
Sbjct: 64 LGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 381 TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440
+ ++ A + A + YL IHRD+ NIL+ N+ K+ADFGLSR +V
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 179
Query: 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANL 498
T + ++ E T SDV+S+GV+L E++S P M
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------- 228
Query: 499 AINKIQKCAFDELIDPC-LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
CA EL + G+ ++ + V +L C ++ RPS ++L L
Sbjct: 229 -------CA--ELYEKLPQGYRLEKPLN-CDDEVYDLMRQCWREKPYERPSFAQILVSLN 278
Query: 558 RI 559
R+
Sbjct: 279 RM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVE--ILTRLRHKNLVSLF 344
+ +G G +G V + + DG++ +K+L N R E+ E E +L++L+H N+V+
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
L +V F G + +L + K LL + ++ A AL YLH I
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDK 464
+HRD+KT N+ L +KV D G++R+ ST GTP Y+ PE K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYK 182
Query: 465 SDVYSFGVVLIELIS---SMPAVDMN 487
SDV++ G + E+ + + A DMN
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAKDMN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 8/192 (4%)
Query: 290 LGDGGFGTVYYGKLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG-C 346
LG+G G+V +LK+ + + D N +Q + E+EI + +V +G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 347 TSRYSQGLLLVYEFVANGTVADQLHGD-RAKHGLLTWPIRMNIAIETASALAYLHASDII 405
S + + E+ G++ D ++ + + G + + IA L+YLH+ II
Sbjct: 69 LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 465
HRD+K +NILL VK+ DFG+S V ++ GT Y+ PE Q + S
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTSFYMAPERIQGKPYSITS 184
Query: 466 DVYSFGVVLIEL 477
DV+S G+ L+E+
Sbjct: 185 DVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/232 (27%), Positives = 114/232 (49%), Gaps = 43/232 (18%)
Query: 283 DFSRE-----KELGDGGFGTVY----YGKLKDGRE----VAVKRLYDNNYRR-VEQFMNE 328
+F R+ K LG+G FG V YG K + VAVK L DN + + ++E
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 329 VEILTRL-RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLH------------GDR 374
+E++ + +HKN+++L G CT L ++ E+ A G + + L +
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 375 AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434
L++ ++ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--- 182
Query: 435 LDVTHVSTAPQGTPG-----YVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
V + + + G ++ PE + + Y T +SDV+SFG+++ E+ +
Sbjct: 183 -GVHDIDYYKKTSNGRLPVKWMAPEALFDRVY--THQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 56/228 (24%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQ--------FMNEVEILT 333
D+++ +++G+G +G VY G+ K G+ VA+K++ R+E + E+ +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI------RLESEEEGVPSTAIREISLLK 54
Query: 334 RLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
L+H N+V L + S+ L L++EF L D K+ L + P + E
Sbjct: 55 ELQHPNIVCLQDVLMQESR-LYLIFEF---------LSMDLKKY-LDSLPKGQYMDAELV 103
Query: 394 --------SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDV-TH-VS 441
+ + H+ ++HRD+K N+L+D+ +K+ADFGL+R F P+ V TH V
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV 163
Query: 442 T----APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
T AP+ G+P Y P D++S G + E+ + P
Sbjct: 164 TLWYRAPEVLLGSPRYSTP-----------VDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 286 REKELGDGGFGTV---YYGKLKD--GREVAVKRLY-DNNYRRVEQFMNEVEILTRLRHKN 339
R ++LG+G FG V Y D G +VAVK L ++ + E+EIL L H+N
Sbjct: 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V G CT G+ L+ EF+ +G++ + L ++ K L ++ A++ + Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ---QLKYAVQICKGMDY 124
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTPGY-VDPEYH 456
L + +HRD+ N+L++S VK+ DFGL++ D + + +P + PE
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 457 QCYQLTDKSDVYSFGVVLIELIS 479
+ SDV+SFGV L EL++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 54/203 (26%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNL 340
+ + K++G+G FG K K DG++ +K + + + E+ EV +L+ ++H N+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA----KHGLLTWPIRMNIAIETASAL 396
V + + + L +V ++ G + +++ R + +L W +++ +A L
Sbjct: 62 VQ-YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------L 114
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
++H I+HRD+K+ NI L + +K+ DFG++R+ V T GTP Y+ PE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEIC 173
Query: 457 QCYQLTDKSDVYSFGVVLIELIS 479
+ +KSD+++ G VL E+ +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 24/282 (8%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
E + G G Y GK +K+G + VK + N+ + +E+ + +L+H N+V L G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIADMGKLQHPNIVKLIG 750
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH---AS 402
R +G L++E++ +++ L L+W R IAI A AL +LH +
Sbjct: 751 -LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
++ ++ I++D + L L D ++ YV PE + +T
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDIT 856
Query: 463 DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522
+KSD+Y FG++LIEL++ D H ++ A C D IDP + +
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSV 915
Query: 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564
+ V LA C + RP +VL L+ S
Sbjct: 916 N-QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHK 338
DF + LG G FG V K K G A+K L ++V+ E IL L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V++ C+ + + + EFV G + L K G + E A Y
Sbjct: 79 FIVNMM-CSFQDENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEY 133
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
LH+ DII+RD+K N+LLD+ VKV DFG F V + GTP Y+ PE Q
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGTPEYLAPEVIQS 189
Query: 459 YQLTDKSDVYSFGVVLIELISSMP 482
D ++ GV+L E I+ P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 84/277 (30%), Positives = 131/277 (47%), Gaps = 45/277 (16%)
Query: 289 ELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRVEQF---MNEVEILTRLRHKNLVSLF 344
E+G G FG VY+ E VAVK++ + + E++ + EV+ L +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-MNIAIETASAL---AYLH 400
GC + LV E+ G+ +D L + P++ + IA T AL AYLH
Sbjct: 88 GCYLK-EHTAWLVMEYCL-GSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLH 138
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY- 459
+ ++IHRD+K NILL VK+ADFG + + + + GTP ++ PE
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMD 193
Query: 460 --QLTDKSDVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
Q K DV+S G+ IEL P + +MN A++ + A ++ P L
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHIAQND--SPTL 240
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+S+E T S CLQ+ + RP+ E+L
Sbjct: 241 --QSNE----WTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 73/277 (26%), Positives = 129/277 (46%), Gaps = 26/277 (9%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKR-----LYDNNYRRVEQFMNEVEILTRLR 336
+F EK++G G F VY L D + VA+K+ + D R + + E+++L +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLN 60
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H N++ ++ L +V E G ++ + + + L+ ++ SA+
Sbjct: 61 HPNVIKYLDSFIEDNE-LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
++H+ ++HRD+K N+ + + VK+ D GL R F T + + GTP Y+ PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERI 178
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
KSD++S G +L E M A+ + ++NL +L KI++C + P L
Sbjct: 179 HENGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLFSLC-QKIEQCDY-----PPL 228
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
E E R EL +C+ + + RP + V
Sbjct: 229 PTEHYSEKLR------ELVSMCIYPDPDQRPDIGYVH 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGK---LKDGRE---VAVKRLYDNNYRRVE-QFMNEVEILTR 334
N+ +++G G FG V+ + L VAVK L + ++ F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGD--RAKHGL------------- 379
H N+V L G + + + L++E++A G + + L RA+ L
Sbjct: 65 FDHPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 380 ---LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPL 435
L+ ++ IA + A+ +AYL +HRD+ T N L+ N VK+ADFGLSR ++
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
D S ++ PE + T +SDV+++GVVL E+ S
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 272 FSYSDLAEATNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRL-YDNNYRRVEQFMNEV 329
F+ DL + E+G G FGTV K G +AVKR+ + + ++ + ++
Sbjct: 1 FTAEDLKD-------LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 330 EILTRLRH-KNLVSLFG----------CTSRYSQGLLLVYEFV---ANGTVADQLHGDRA 375
+++ R +V +G C L Y++V + +++ G
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG--- 110
Query: 376 KHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434
IA+ T AL YL IIHRDVK +NILLD N +K+ DFG+S
Sbjct: 111 -----------KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159
Query: 435 LDVTHVSTA---PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
+ A P P +DP Y + +SDV+S G+ L E+
Sbjct: 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDV--RSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTR-LRHKNLVS 342
K +G G FG V K K DG+ AVK L N + + M E +L + ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L + + ++ L V +FV G + L +R+ P A E ASAL YLH+
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSI 115
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
+I++RD+K NILLDS V + DFGL + + + +T GTP Y+ PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 463 DKSDVYSFGVVLIELISSMP 482
+ D + G VL E++ +P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDN---NYRRVEQFMNEVEILTRLRH 337
DF ++G GG+G V+ K KD E VA+KR+ + V + E +ILT +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 338 KNLVSLFGCTSRYS----QGLLLVYEFVANG------TVADQLHGDRAKHGLLTWPIRMN 387
+ LV L Y+ + L L E+V G L D A+
Sbjct: 61 EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF---------- 105
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
E A+ LH IHRD+K N L+D++ +K+ DFGLS+ VT+ ++ G+
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSV-VGS 161
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
P Y+ PE + D +S G +L E + P
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 292 DGGFGTVYYGKLKDG-----REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFG 345
+G FG ++YG L D EV VK + D+ + +V + E +L L H+N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 346 CTSRYSQGLLLVYEFVANGTVADQL----HGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ ++Y ++ G + L G+ L+ +++AI+ A ++YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTP-GYVDPEYHQCY 459
+IH+D+ N ++D VK+ D LSR LFP+D H + P ++ E
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNK 194
Query: 460 QLTDKSDVYSFGVVLIELIS--SMPAVDMN 487
+ + SDV+SFGV+L EL++ P V+++
Sbjct: 195 EYSSASDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 18/273 (6%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRV-EQFMNEVEILTRLRHKNL 340
D +LG G G+V K + G +A K ++ V +Q + E++I+ R +
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
VS +G + + EF+ G+ L K G + I IA+ L YL+
Sbjct: 66 VSFYG-AFLNENNICMCMEFMDCGS----LDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 401 -ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
I+HRD+K +NIL++S +K+ DFG+S + ++ GT Y+ PE Q
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTYMSPERIQGG 177
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
+ T KSDV+S G+ +IEL + + + I + + E P L
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPSS 236
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEV 552
E R + CL ++ RP+ +++
Sbjct: 237 DFPEDLR------DFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 67/195 (34%), Positives = 90/195 (46%), Gaps = 11/195 (5%)
Query: 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR---VEQFMNEVEILTRLR-HKNLVSLF 344
LG G FG V +LK GR AVK L + + VE M E IL+ R H L L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
C + L V EFV G + + R A E SAL +LH I
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDKGI 117
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDK 464
I+RD+K +N+LLD K+ADFG+ + + ST GTP Y+ PE Q
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGPS 176
Query: 465 SDVYSFGVVLIELIS 479
D ++ GV+L E++
Sbjct: 177 VDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREV--AVKRL----YDNNYRRVEQFMNEVEILTRL 335
D E +G+G FG V +K DG ++ A+K L +N++R F E+E+L +L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKL 59
Query: 336 -RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRA---------KHGL---LT 381
H N+++L G C +R L + E+ G + D L R +HG LT
Sbjct: 60 GHHPNIINLLGACENRGY--LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 382 WPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441
+ A + A+ + YL IHRD+ N+L+ N K+ADFGLSR +V
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKK 175
Query: 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
T + ++ E T KSDV+SFGV+L E++S
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 290 LGDGGFGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNE---VEILTRLRHKNL 340
LG G FG V + K E+ A+K L + VE M E E RH L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD--EVESLMCEKRIFETANSERHPFL 64
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V+LF C + + V E+ A G + +H D + P + A L YLH
Sbjct: 65 VNLFACF-QTEDHVCFVMEYAAGGDLMMHIHTDV-----FSEPRAVFYAACVVLGLQYLH 118
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVDPEYHQC 458
+ I++RD+K +N+LLD+ VK+ADFGL + + D T ST GTP ++ PE
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFC-GTPEFLAPEV--- 172
Query: 459 YQLTDKS-----DVYSFGVVLIELI 478
LT+ S D + GV++ E++
Sbjct: 173 --LTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 40/296 (13%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGRE----VAVKRLYDNNYRRV-EQFMNEVEILTRLR 336
+ + K LG G FGTVY G + DG VA+K L +N + ++ ++E ++ +
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHG---LLTWPIRMNIAIET 392
+ L G C + Q LV + + G + D + ++ + G LL W ++
Sbjct: 68 SPYVCRLLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQI 118
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYV 451
A ++YL ++HRD+ N+L+ S VK+ DFGL+RL +D T P ++
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
E + T +SDV+S+GV + EL++ D R +L +
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---------KGER 229
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKF 566
L P + T V + C + E RP E++ E R+ S+F
Sbjct: 230 LPQPPI----------CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 28/272 (10%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLV 341
F++ + +G G FG VY G +EV ++ D +E E+ +L++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+G + ++ L ++ E++ G+ D L K G L I E L YLH+
Sbjct: 66 RYYGSYLKGTK-LWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 119
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
IHRD+K N+LL VK+ADFG++ D GTP ++ PE +
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
K+D++S G+ IEL P N H + + L I K + P L +
Sbjct: 179 DFKADIWSLGITAIELAKGEPP---NSDLHPMRVLFL----IPKNS-----PPTLEGQYS 226
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ K + CL ++ RP+ +E+L
Sbjct: 227 KPFKEFVEA-------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 288 KELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLR-HKNLVS 342
K LG G FG V +LK EV A+K L + + V+ M E IL H L +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L C + L V E+V G + Q+ R P A E AL +LH
Sbjct: 61 LH-CCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRH 115
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT 462
+I+RD+K +NILLD+ K+ADFG+ + L+ +T GTP Y+ PE Q +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQELEYG 174
Query: 463 DKSDVYSFGVVLIELISSMP 482
D ++ GV++ E+++ P
Sbjct: 175 PSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 66/232 (28%), Positives = 115/232 (49%), Gaps = 43/232 (18%)
Query: 283 DFSREK-----ELGDGGFGTVYYG--------KLKDGREVAVKRLYDNNYRR-VEQFMNE 328
+FSR+K LG+G FG V K K+ VAVK L D+ + + ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 329 VEILTRL-RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHG------------DR 374
+E++ + +HKN+++L G CT L ++ E+ + G + + L R
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 375 AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434
+T+ ++ + A + YL + IHRD+ N+L+ N +K+ADFGL+R
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--- 185
Query: 435 LDVTHVSTAPQGTPG-----YVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
DV ++ + T G ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 186 -DVNNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 55/242 (22%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRRVEQ---FMNEVEILTRLRH 337
+DF K +G G FG V+ + KD +V A+K L ++ + Q E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI--------- 388
+V L+ + + + L LV E++ G D L+ IR ++
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGG--------D-----LMNLLIRKDVFPEETARFY 106
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS------------------ 430
E AL +H IHRD+K +NIL+D++ +K+ADFGL
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 431 RLFPLDVTHVSTAPQ----------GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS 480
LF +V + GTP Y+ PE + + D +S GV+L E++
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
Query: 481 MP 482
P
Sbjct: 227 FP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 53/172 (30%), Positives = 90/172 (52%), Gaps = 34/172 (19%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKR-LYDNNYRRVEQF----MNEVEILTRL 335
+ + + ++G G FG V+ + K + VA+K+ L +N E F + E++IL L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLL 68
Query: 336 RHKNLVSLFG-C------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMN 387
+H+N+V+L C +RY LV+EF + D A GLL+ ++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH---------DLA--GLLSNKNVKFT 117
Query: 388 IA-IETA-----SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
++ I+ + L Y+H + I+HRD+K NIL+ + +K+ADFGL+R F
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 288 KELGDGGFGTVYYGKLKDGREVA---VKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSL 343
E+G+G FG V G+ G A VK L + F+ EV+ L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 344 FG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIETASALAYLHA 401
G C S LLV EF G + + L +R + + +A E AS L +LH
Sbjct: 61 LGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSR------LFPLDVTHVSTAPQGTPGYVDPEY 455
+D IH D+ N L ++ VK+ D+GL+ + H P V+
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE-IR 177
Query: 456 HQ---CYQLTDKSDVYSFGVVLIEL 477
Q T KS+++S GV + EL
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 286 REKELGDGGFGTVYYGKLKDGRE-----------------VAVKRLY-DNNYRRVEQFMN 327
+EK LG+G FG V+ ++ + ++ VAVK L D N F+
Sbjct: 10 KEK-LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 328 EVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTV-------------ADQLHGD 373
EV+IL+RL+ N++ L G C L ++ E++ NG + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 374 RAKHGLLT--WPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
H L + +++A++ AS + YL + + +HRD+ T N L+ N +K+ADFG+SR
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 432 -LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
L+ D + ++ E + T SDV++FGV L E++
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 28/227 (12%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRVEQ--------FMNEVEILT 333
+F + +G+G +G VY + E VA+K++ R++ + E+ +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLL 61
Query: 334 RLRHKNLVSLFG-CTSRYSQGLLLVYEFVAN--GTVADQLHGDRAKHGLLTWPIRMNIAI 390
LRH N+V L ++ + LV E+ ++ D + + + +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP------FSESQVKCLML 115
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTPG 449
+ L YLH + IIHRD+K +N+LL C+K+ADFGL+R + L ++ P+ T
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT--PKVVTLW 173
Query: 450 YVDPE-YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL 495
Y PE C T D+++ G +L EL++ P + +++L
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 71/206 (34%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQ--FMNEVEILTR-LRHKNLVS 342
K +G G FG V K K DG AVK L ++ EQ M E +L + L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 343 LFGCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
L YS + L V ++V G + L +R P A E ASA+ Y
Sbjct: 61 L-----HYSFQTAEKLYFVLDYVNGGELFFHLQRERC----FLEPRARFYAAEVASAIGY 111
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVDPEYH 456
LH+ +II+RD+K NILLDS V + DFGL + + P + T GTP Y+ PE
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEVL 168
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMP 482
+ D + G VL E++ +P
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 288 KELGDGGFGTV---YYGKLKDGREVAVKRLY--DNNYRRVEQFMNEVEILTRLRHKNLVS 342
ELG G FGTV Y K + VAVK L +N+ ++ + E ++ +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+ G ++ +LV E G L+ K+ +T + + + + YL +
Sbjct: 61 MIGICE--AESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT-P-GYVDPEYHQCYQ 460
+ +HRD+ N+LL + K++DFGLS+ D + G P + PE Y+
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 461 LTDKSDVYSFGVVLIELIS 479
+ KSDV+SFGV++ E S
Sbjct: 175 FSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 68/257 (26%), Positives = 95/257 (36%), Gaps = 28/257 (10%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMN---EVEILTRLRHKNLVSL 343
K + G FG+VY K + G A+K L ++ Q N E I+ V+
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
+ + L LV E++ G A + G L E + LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD 463
IIHRD+K N+L+D +K+ DFGLSR + GTP Y+ PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDK 172
Query: 464 KSDVYSFGVVLIELISSMP--------AVDMNRHRHEINLANLAINKIQKCAFD---ELI 512
SD +S G V+ E + P AV N IN A D L+
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
Query: 513 DPC----LGFESDEEVK 525
LG +E+K
Sbjct: 233 CMDPAKRLGANGYQEIK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 288 KELGDGGFGT--VYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
+ +G+G FG + D + + + VE E +L +++H N+V+ F
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA-FK 64
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAK----HGLLTWPIRMNIAIETASALAYLHA 401
+ L +V E+ G + ++ R K +L W ++M + ++ ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ------HIHE 118
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
++HRD+K+ NI L N VK+ DFG +RL + T GTP YV PE +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPY 177
Query: 462 TDKSDVYSFGVVLIEL 477
+KSD++S G +L EL
Sbjct: 178 NNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRL------YDNNYRRVEQFMNEVEILTRLRHKNL 340
K LG G FG V +LK G AVK L D++ VE M E +L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMVEKRVLALAWENPF 57
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
++ CT + + L V EF+ G + + D+ + L A E L +LH
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATF---YAAEIVCGLQFLH 113
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+ II+RD+K +N++LD + +K+ADFG+ + ST GTP Y+ PE Q +
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172
Query: 461 LTDKSDVYSFGVVLIELI 478
T D +SFGV+L E++
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 286 REKELGDGGFGTVYYGKLKDGRE---------------VAVKRLY-DNNYRRVEQFMNEV 329
+EK LG+G FG V+ + + E VAVK L D F+ E+
Sbjct: 10 KEK-LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 330 EILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI- 388
+I++RL++ N++ L G L ++ E++ NG + +Q R T NI
Sbjct: 69 KIMSRLKNPNIIRLLGVCVS-DDPLCMITEYMENGDL-NQFLSQREIESTFT--HANNIP 124
Query: 389 ----------AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDV 437
A++ AS + YL + + +HRD+ T N L+ +++ +K+ADFG+SR L+ D
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ ++ E + T SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 284 FSREKELGDGGFGTVYYGKLK----DGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRH 337
F+ + LG G FG+V +LK ++VAVK L + +E+F+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 338 KNLVSLFGCT--SRYSQGL---LLVYEFVANGTVADQLHGDRAKHGLLTWPIR--MNIAI 390
N++ L G + SR L +++ F+ +G + L R T P++ + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPG 449
+ AS + YL + + IHRD+ N +L+ N V VADFGLS+ ++ D A +
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ E T SDV++FGV + E+++
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 53/225 (23%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQ--------FMNEVEILTR 334
+ + +++G+G +G VY + G VA+K++ R+E + E+ +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKE 54
Query: 335 LRHKNLVSLFG---CTSRYSQGLLLVYEFVANGTVADQ---LHGDRAKHGLLTWPIRMNI 388
L H N+V L ++ L LV+EF+ D + D + L P+ +
Sbjct: 55 LNHPNIVRLLDVVHSENK----LYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDV-TH-VST-- 442
+ +AY H+ ++HRD+K N+L+D +K+ADFGL+R F P+ TH V T
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW 164
Query: 443 --APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP+ G+ Y P D++S G + E+++ P
Sbjct: 165 YRAPEILLGSRQYSTP-----------VDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 13/210 (6%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVE-QFMNEVEILTRLRHKNLVSLFG 345
+ +G G FG V+ G+L+ D VAVK + ++ +F+ E IL + H N+V L G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 346 -CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA-LAYLHASD 403
CT + Q + +V E V G L + + + I+M +E A+A + YL +
Sbjct: 61 VCTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-IQM---VENAAAGMEYLESKH 114
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEYHQCYQLT 462
IHRD+ N L+ +K++DFG+SR V + + P + PE + +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 463 DKSDVYSFGVVLIELIS--SMPAVDMNRHR 490
+SDV+SFG++L E S ++P +++ +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 288 KELGDGGFGTVYYGKLKDGREV----AVKR---LYDNNYRRVEQFMNEVEILT-RLRHKN 339
K LG G FG V +LK E A+K+ L D++ VE M E +L H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VECTMVERRVLALAWEHPF 57
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
L LF CT + + L V E++ G D + ++ R A E L +L
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARF-YAAEIICGLQFL 112
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H II+RD+K +N+LLD + +K+ADFG+ + ST GTP Y+ PE +
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQ 171
Query: 460 QLTDKSDVYSFGVVLIE-LISSMP 482
+ + D +SFGV+L E LI P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRV-EQFMNEVEILTRLRHKNL 340
F + +++G+G +G VY + G VA+K++ D V + E+ +L L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH------GLLTWPIRMNIAIETAS 394
V L ++ L LV+EF LH D K + P+ + +
Sbjct: 62 VKLLDVIHTENK-LYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---THVSTAPQGTPGYV 451
LA+ H+ ++HRD+K N+L+++ +K+ADFGL+R F + V TH T Y
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYR 167
Query: 452 DPE-YHQCYQLTDKSDVYSFGVVLIELIS 479
PE C + D++S G + E+++
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 46/235 (19%)
Query: 283 DFSRE-----KELGDGGFGTVY----------------YGKLKDG-REVAVKRLYDN-NY 319
+F R+ ++LG+G FG V+ D VAVK L + +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 320 RRVEQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVAD-----QLHGD 373
E F+ EV+IL+RL N+ L G CT L ++ E++ NG +
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 374 RAKHGLLTWPIR--MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
+ + +A + AS + YL + + +HRD+ T N L+ N+ +K+ADFG+SR
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 432 -LFPLDVTHVSTAPQGTPGYVDP------EYHQCYQLTDKSDVYSFGVVLIELIS 479
L+ D V QG P E + T KSDV++FGV L E+++
Sbjct: 179 NLYSSDYYRV----QGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 289 ELGDGGFGTVYYG--KLKDGR-EVAVKRLYDNNYRRV-EQFMNEVEILTRLRHKNLVSLF 344
ELG G FG V G K++ + +VA+K L + N + V ++ M E EI+ +L + +V +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
G ++ L+LV E + G + L G + + +T + + + + + YL +
Sbjct: 62 GVCE--AEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH--VSTAPQGTPGYVDPEYHQCYQLT 462
+HRD+ N+LL + K++DFGLS+ D ++ +A + + PE + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 463 DKSDVYSFGVVLIELIS 479
+SDV+S+G+ + E S
Sbjct: 177 SRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 287 EKELGDGGFGTVYYGK---------LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH 337
++ LG G FGTVY K LK +E+ V L N + Q E ++L++L H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDH 61
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+V F + ++ E+ + +L + L+ I+ +
Sbjct: 62 PAIVK-FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY-- 455
Y+H I+HRD+K NI L +N +K+ DFG+SRL + ++T GTP Y+ PE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALK 178
Query: 456 HQCYQLTDKSDVYSFGVVLIEL 477
HQ Y KSD++S G +L E+
Sbjct: 179 HQGYD--SKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 53/287 (18%)
Query: 283 DFSREKELGDGGFGTVYYG-KLKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNL 340
D ++ LG G GTVY L R +AVK + D +Q M+E+EIL + +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 341 VSLFG----------CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI 390
+ +G CT G L VY + + + G IA+
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLG--------------RIAV 102
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGY 450
L YL + I+HRDVK +N+L+++ VK+ DFG+S V ++ GT Y
Sbjct: 103 AVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAY 159
Query: 451 VDPEYHQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFD 509
+ PE Q SDV+S G+ +EL P + + N +L ++ +C D
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQK-----NQGSLMPLQLLQCIVD 214
Query: 510 ELIDPCL---GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
E DP + G S++ V +T C+++ + RP+ E ++
Sbjct: 215 E--DPPVLPVGQFSEKFVHFITQ--------CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 42/233 (18%)
Query: 288 KELGDGGFGTVYYG------KLKDGR--EVAVKRL-YDNNYRRVEQFMNEVEILTRL-RH 337
K LG+G FG V K K R +VAVK L D + + ++E+E++ + +H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 338 KNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDR------------AKHGLLTWPI 384
KN+++L G CT L ++ E+ + G + + L R L++
Sbjct: 84 KNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 385 RMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444
++ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R D+ H+
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 197
Query: 445 QGTPG-----YVDPE--YHQCYQLTDKSDVYSFGVVLIELI----SSMPAVDM 486
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 285 SREKELGDGGFGTVYYGKLKDGR------EVAVKRLYDNNYRRVEQ-FMNEVEILTRLRH 337
+ + LG G FG VY G + +VAVK L ++ + E F+ E I+++ H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHG---LLTWPIRMNIAIETAS 394
+N+V L G S ++ E +A G + L +R + LT + A + A
Sbjct: 69 QNIVRLIG-VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 395 ALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPG-- 449
YL + IHRD+ N LL K+ADFG++R D+ S +G
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAML 183
Query: 450 ---YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ PE T K+DV+SFGV+L E+ S
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 28/282 (9%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLV 341
F++ + +G G FG V+ G ++V ++ D +E E+ +L++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+G + ++ L ++ E++ G+ D L + ++ E L YLH+
Sbjct: 66 KYYGSYLKGTK-LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHS 119
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
IHRD+K N+LL VK+ADFG++ D GTP ++ PE Q
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
K+D++S G+ IEL P N H + + L I K
Sbjct: 179 DSKADIWSLGITAIELAKGEPP---NSDMHPMRVLFL----IPK------------NNPP 219
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563
+ E CL ++ RP+ +E+L +K+ K
Sbjct: 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 56/248 (22%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGRE------VAVKRLYDNNYRRVEQ 324
F S+L E T LG G FG V+ K K E V VK L + E
Sbjct: 1 AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL---QKTKDEN 50
Query: 325 ----FMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGT-----VADQLHGDR 374
F E+++ +L HKN+V L G C R ++ ++ E+ G A + ++
Sbjct: 51 LQSEFRRELDMFRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEK 108
Query: 375 AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR--- 431
K L+ ++ + + A + +L + +HRD+ N L+ S VKV+ LS+
Sbjct: 109 LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168
Query: 432 ----------LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS- 480
L PL ++ PE Q + KSDV+SFGV++ E+ +
Sbjct: 169 NSEYYKLRNALIPLR-------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 481 -MPAVDMN 487
+P ++
Sbjct: 216 ELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 20/198 (10%)
Query: 289 ELGDGGFGTVYYGKLKDGRE-VAVKRL-YDNNYRRVEQF-MNEVEILTRLRHKNLVSLFG 345
++G+G +GTV+ K ++ E VA+KR+ D++ V + E+ +L L+HKN+V L+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKH-----GLLTWPIRMNIAIETASALAYLH 400
+ L LV+E+ DQ D K+ G + I + + LA+ H
Sbjct: 67 VLHSDKK-LTLVFEY------CDQ---DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+ +++HRD+K N+L++ N +K+ADFGL+R F + V S A T Y P+ +
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS-AEVVTLWYRPPDVLFGAK 175
Query: 461 LTDKS-DVYSFGVVLIEL 477
L S D++S G + EL
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 33/222 (14%)
Query: 288 KELGDGGFGTVYYG---KLKDGR----EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKN 339
K LG+G FG V +LK GR VAVK L +N + + ++E +L ++ H +
Sbjct: 6 KTLGEGEFGKVVKATAFRLK-GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLH-------------GDRAKHGL------ 379
++ L+G C+ LLL+ E+ G++ L G+R L
Sbjct: 65 VIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 380 -LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438
LT ++ A + + + YL ++HRD+ N+L+ +K++DFGLSR + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 439 HVSTAPQGTP-GYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+V + P ++ E + T +SDV+SFGV+L E+++
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 290 LGDGGFGTVYYGKLK-DGREV--AVKRL----YDNNYRRVEQFMNEVEILTRL-RHKNLV 341
+G+G FG V ++K DG + A+KR+ +++R F E+E+L +L H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 59
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRA---------KHGL---LTWPIRMNI 388
+L G C R L L E+ +G + D L R + L+ ++
Sbjct: 60 NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
A + A + YL IHRD+ NIL+ N+ K+ADFGLSR +V T +
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175
Query: 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 287 EKELGDGGFGTVYYG--KLKDGRE--VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLV 341
E+ LG G FG + G KL RE VA+ L + ++ F+ E L + H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L G +R + +++V E+++NG + L R G L M + AS + YL
Sbjct: 70 RLEGVITRGNT-MMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+H+ + + +L++S+ K++ F + + + + + + + PE Q +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 462 TDKSDVYSFGVVLIELIS--SMPAVDM 486
+ SDV+SFG+V+ E++S P DM
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 288 KELGDGGFGTVYYGKLKDG---REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSL 343
KE+G+G FG V G++ G +V VK L + + + +F+ E + L+H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 344 FG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN-IAIETASALAYLHA 401
G CT LLV EF G + L R + P + +A E A L +LH
Sbjct: 61 LGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDPEY----H 456
++ IH D+ N LL ++ VK+ D+GLS + +V+ P ++ PE H
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 457 QCYQLTDK---SDVYSFGVVLIEL 477
+ D+ S+V+S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK---DGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRH 337
+D +ELG G +G V K++ G +AVKR+ N + ++ + +++I R
Sbjct: 1 DDLEVIEELGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD 58
Query: 338 -KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLT-WPIRMNIAIETASA 395
V+ +G + + +G + + V + T D+ + GL I IA+ A
Sbjct: 59 CPYTVTFYG--ALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 396 LAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA---PQGTPGYV 451
L YLH+ +IHRDVK +N+L++ N VK+ DFG+S V A P P +
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIEL 477
+PE +Q KSDV+S G+ +IEL
Sbjct: 176 NPELNQ-KGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 64/286 (22%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF----MNEVEILTRLRHKNLVS 342
K +G G +G V + GR+VA+K++ +N + E+++L LRH+N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 343 L---FGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA----- 393
L S + +V E + D LH + I+ +
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELME----TD-LH--KV--------IKSPQPLTDDHIQYF 108
Query: 394 -----SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
L YLH++++IHRD+K +NIL++SN +K+ DFGL+R V
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG----VDPDEDEKGFLT 164
Query: 449 GYV------DPEYHQCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501
YV PE K+ D++S G + EL++ P + ++N
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN------- 217
Query: 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP 547
LI LG S+E++K +T+ A +L K +P
Sbjct: 218 ---------LIVEVLGTPSEEDLKFITSEKA-RNYLKSLPKKPKKP 253
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRL------YDNNYRRVEQFMNEVEILT-RLRHKN 339
K LG G FG V+ +LK + A+K L D++ VE M E +L+ H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSLAWEHPF 57
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
L L+ CT + + L V E++ G D + ++ H P A E L +L
Sbjct: 58 LTHLY-CTFQTKENLFFVMEYLNGG---DLMFHIQSCHKF-DLPRATFYAAEIICGLQFL 112
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ I++RD+K +NILLD++ +K+ADFG+ + L T GTP Y+ PE
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 460 QLTDKSDVYSFGVVLIELI 478
+ D +SFGV+L E++
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 46/213 (21%)
Query: 293 GGFGTVYYGKLKD-GREVAVKRL-YDNNYRRVEQF----MNEVEILTRLRHKNLVSL--- 343
G +G VY + K G VA+K+L + E F + E+ IL +L+H N+V++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 344 -FGCTSRYSQGLLLVYEFVANGTVADQLHG--DRAKHGLLTWPIRMNIAIETASALAYLH 400
G S + + +V E+V + L + K L ++ + ++ S +A+LH
Sbjct: 73 VVG--SNLDK-IYMVMEYVEH-----DLKSLMETMKQPFLQSEVK-CLMLQLLSGVAHLH 123
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLD------VTHVSTAPQ---GTPG 449
+ I+HRD+KT+N+LL++ +K+ DFGL+R + PL VT AP+ G
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
Y + D++S G + EL++ P
Sbjct: 184 Y-----------STAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 47/286 (16%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
DF + +G G +G VY + + G A+K + E+ ++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAI---ETASALA 397
+ FG R + L + EF G++ D H +T P+ IA ET L
Sbjct: 70 AYFGSYLRRDK-LWICMEFCGGGSLQDIYH--------VTGPLSESQIAYVSRETLQGLY 120
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--- 454
YLH+ +HRD+K NILL N VK+ADFG+S + + GTP ++ PE
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAA 179
Query: 455 ------YHQCYQLTDKSDVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCA 507
Y+Q D+++ G+ IEL P + D++ R A+ + K
Sbjct: 180 VERKGGYNQL------CDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMTKSN 225
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F P L ++ + + S + L +N + RP+ E++L
Sbjct: 226 FQP---PKL-----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 286 REKELGDGGFGTVYY----GKLKDGRE-------------VAVKRLY-DNNYRRVEQFMN 327
+EK LG+G FG V+ G K + VAVK L D N F+
Sbjct: 10 KEK-LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 328 EVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGL------- 379
E++I++RL+ N++ L C + S L ++ E++ NG + L +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 380 LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVT 438
+++ + +A + AS + YL + + +HRD+ T N L+ N+ +K+ADFG+SR L+ D
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ ++ E + T SDV++FGV L E+++
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 73/282 (25%), Positives = 118/282 (41%), Gaps = 44/282 (15%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR---------HKN 339
LG G GTV K + DG AVK + ++ + E+ L H++
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIA----IETASA 395
+ LV ++ G + ++ RAK R + A I+ A
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIK-SRAKTNR---TFREHEAGLLFIQVLLA 155
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPE 454
+ ++H+ +IHRD+K+ NILL SN VK+ DFG S+++ V+ V GTP YV PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS---SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
+ + K+D++S GV+L EL++ +M E+ ++K +D L
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM----EEV------MHKTLAGRYDPL 265
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
M V L L + + RPS ++L
Sbjct: 266 --------PPSISPEMQEIVTAL----LSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLY--DNNYRRVEQFMNEVEILTRLRHK 338
ND E+G G G VY + K V AVK++ N M+ +L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP--IRMNIAIETASAL 396
+V +G S + + E ++ T D+L R + + P I + + AL
Sbjct: 75 YIVKCYGYFITDSD-VFICMELMS--TCLDKLL-KRIQGPI---PEDILGKMTVAIVKAL 127
Query: 397 AYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
YL +IHRDVK +NILLD++ VK+ DFG+S +A G Y+ PE
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPER 185
Query: 455 -----YHQCYQLTDKSDVYSFGVVLIEL 477
+ Y + ++DV+S G+ L+EL
Sbjct: 186 IDPPDPNPKYDI--RADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGRE----VAVKRLYDNNYRRVEQ-FMNEVEILTRLR 336
+F + K LG G FGTVY G + +G + VA+K L + + + ++E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQL--HGDR-AKHGLLTWPIRMNIAIET 392
+ ++ L G C + Q L+ + + G + D + H D LL W ++
Sbjct: 68 NPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQI 118
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYV 451
A + YL ++HRD+ N+L+ + VK+ DFGL++L D P ++
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELIS 479
E T +SDV+S+GV + EL++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 288 KELGDGGFGTVYYGKL------KDGREVAVKRLYDNNYRRV-EQFMNEVEILTRLRHKNL 340
+ELG+ FG VY G L + + VA+K L D + E+F +E + +RL+H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQL------------HGDRAKHGLLTWPIRMNI 388
V L G ++ Q L +++ + ++ + + L D+ L ++I
Sbjct: 71 VCLLGVVTK-EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGT 447
+ A+ + +L + ++H+D+ T N+L+ VK++D GL R ++ D +
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
++ PE + + SD++S+GVVL E+ S
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 9/201 (4%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLV 341
F++ +++G G FG V+ G ++V ++ D +E E+ +L++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+G + ++ L ++ E++ G+ D L + G L I E L YLH+
Sbjct: 66 KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 119
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
IHRD+K N+LL + VK+ADFG++ D GTP ++ PE +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 462 TDKSDVYSFGVVLIELISSMP 482
K+D++S G+ IEL P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGRE----VAVKRLYDNNYRRV-EQFMNEVEILTR 334
+ + K LG G FGTV+ G + +G VA+K + D + R+ ++ + + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
L H +V L G S L LV + G++ D + R L +N ++ A
Sbjct: 66 LDHAYIVRLLGICPGAS--LQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAK 120
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP-GYVDP 453
+ YL ++HR++ NILL S+ V++ADFG++ L D + TP ++
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELIS 479
E + T +SDV+S+GV + E++S
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRHK 338
DF+ LG G FG V + K E+ A+K L + + VE M E +L L K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59
Query: 339 N--LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
L L C + L V E+V G + Q+ + G P + A E A L
Sbjct: 60 PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGL 114
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
+LH+ II+RD+K +N++LDS +K+ADFG+ + D T GTP Y+ PE
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEII 173
Query: 457 QCYQLTDKS-DVYSFGVVLIELISSMPAVD 485
YQ KS D ++FGV+L E+++ +
Sbjct: 174 A-YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRV--EQFMNEVEILTRL 335
E TN + + +G G FG V + G+ VA+K++ V ++ E+++L L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 336 RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW-PIRMNIA----I 390
RH+N++SL + + V E + H LLT P+
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTDL-----------HRLLTSRPLEKQFIQYFLY 115
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPG 449
+ L Y+H++ ++HRD+K +NIL++ N +K+ DFGL+R+ +T +VST
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 450 YVDPEYHQCYQLTD-KSDVYSFGVVLIELISSMP 482
Y PE +Q D + D++S G + E++ P
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 76/288 (26%), Positives = 132/288 (45%), Gaps = 43/288 (14%)
Query: 282 NDFSREKELGDGGFGTVYYG-KLKDGREVAVKRLY---DNNYRRVEQFMNEVEILTRLRH 337
+D+ + +G G +G VY L G AVK + +++ ++Q E+ ++ +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKH 65
Query: 338 KNLVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAI---ET 392
N+V+ FG SR + L + E+ G++ D H +T P+ + IA ET
Sbjct: 66 CNIVAYFGSYLSR--EKLWICMEYCGGGSLQDIYH--------VTGPLSELQIAYVCRET 115
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
LAYLH+ +HRD+K NILL N VK+ADFG++ + + GTP ++
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMA 174
Query: 453 PEYHQCYQ---LTDKSDVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCAF 508
PE + D+++ G+ IEL P + D++ R A+ + K F
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMSKSNF 226
Query: 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
P L ++ + +++ + L +N + RP+ E +L L
Sbjct: 227 QP---PKL-----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 36/225 (16%)
Query: 288 KELGDGGFGTVYYG--------KLKDGREVAVKRLYDNNYRR-VEQFMNEVEILTRL-RH 337
K LG+G FG V K VAVK L D+ + + ++E+E++ + +H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAK------------HGLLTWPIR 385
KN+++L G ++ +LV E+ + G + + L R LT+
Sbjct: 78 KNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
++ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R DV ++ +
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKK 192
Query: 446 GTPG-----YVDPE--YHQCYQLTDKSDVYSFGVVLIELISSMPA 483
T G ++ PE + + Y T +SDV+SFGV+L E+ + +
Sbjct: 193 TTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGS 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSL 343
K LG G FG V + K G+ A+K L V + E +L RH L +L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 344 ---FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
F R L V E+ G + L ++ + + E SAL YLH
Sbjct: 61 KYSFQTHDR----LCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLH 112
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPEYHQC 458
+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE +
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 459 YQLTDKSDVYSFGVVLIELI 478
D + GVV+ E++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTR-LRHKNLVS 342
K +G G FG V + K + + AVK L + + M+E +L + ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 343 L---FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
L F + L V +++ G + L +R P A E ASAL YL
Sbjct: 61 LHFSFQTADK----LYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYL 112
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPE--Y 455
H+ +I++RD+K NILLDS + + DFGL + ++ H T GTP Y+ PE +
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMP 482
Q Y T D + G VL E++ +P
Sbjct: 170 KQPYDRT--VDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRHK 338
DF+ LG G FG V + K E+ A+K L + + VE M E +L L+ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LQDK 59
Query: 339 N--LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
L L C + L V E+V G + + + G P + A E + L
Sbjct: 60 PPFLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGL 114
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
+LH II+RD+K +N++LDS +K+ADFG+ + +D T GTP Y+ PE
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEI- 172
Query: 457 QCYQLTDKS-DVYSFGVVLIELISSMPAVD 485
YQ KS D +++GV+L E+++ P D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 56/187 (29%), Positives = 77/187 (41%), Gaps = 25/187 (13%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-GREVAVKRL------YDNNYRRVEQFMNEVEILTRL 335
F + K LG G G V+ +LK G+ A+K L N +RV E EIL L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL---TEQEILATL 58
Query: 336 RHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHG--DRAKHGLLTW-PIRMNIAI 390
H L +L+ T Y L LV ++ G +L R L+ R A
Sbjct: 59 DHPFLPTLYASFQTETY---LCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAA- 110
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGY 450
E AL YLH I++RD+K NILL + + ++DF LS DV + G
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS--KQSDVEPPPVSKALRKGS 168
Query: 451 VDPEYHQ 457
+
Sbjct: 169 RRSSVNS 175
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 53/233 (22%)
Query: 288 KELGDGGFGTVY-YGKLKDGREVAVKRL----YDNNYRRVEQF----------MNEVEIL 332
LG+G +G V G+ VA+K++ N+ + Q + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 333 TRLRHKNLVSLFGCTSRYSQGLLLVY---EFVANGTVADQLHGDRAK----HGLLTWPIR 385
++H+N++ GL+ VY +F+ V D + D K LT
Sbjct: 75 NEIKHENIM-----------GLVDVYVEGDFI--NLVMDIMASDLKKVVDRKIRLTESQV 121
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
I ++ + L LH +HRD+ NI ++S K+ADFGL+R + + +
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 446 GTPG-------------YVDPEY---HQCYQLTDKSDVYSFGVVLIELISSMP 482
T Y PE + Y D++S G + EL++ P
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKY--HFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 290 LGDGGFGTVYYGKLKD----GRE---VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLV 341
LG G FG VY G D G VAVK L + ++F+ E +++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHG---LLTWPIRMNIAIETASALA 397
L G C Q +++ E + G + L R + LLT ++I ++ A
Sbjct: 63 KLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 398 YLHASDIIHRDVKTNNILL-----DSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPGYV 451
YL IHRD+ N L+ D++ VK+ DFGL+R ++ D ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELIS 479
PE + T +SDV+SFGV++ E+++
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 39/289 (13%)
Query: 288 KELGDGGFGTVYYGKLKDGR---EVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVS 342
K LG+G FG+V G+L +VAVK + R +E F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 343 LFGCTSRYSQ-----GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET--ASA 395
L G + + +++ F+ +G + L R P +M + T AS
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS-RLFPLDVTHVSTAPQGTPGYVDPE 454
+ YL + IHRD+ N +L+ N V VADFGLS +++ D + ++ E
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISS----MPAVDMNRHRHEINLANLAINKIQKCAFDE 510
T KSDV+SFGV + E+ + P V+ EI N++++
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----NSEIYDYLRQGNRLKQPP--- 237
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
CL + L C N + RPS E + EL++
Sbjct: 238 ---DCL------------DGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 53/229 (23%), Positives = 104/229 (45%), Gaps = 15/229 (6%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV----S 342
+ LG G G V+ D + VAVK++ + + V+ + E++I+ RL H N+V
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAK---HGLLTWPIRMNIAIETASALAYL 399
L S ++ + + E + V + + D A G L+ + L Y+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 400 HASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQG--TPGYVDPE-Y 455
H+++++HRD+K N+ +++ + +K+ DFGL+R+ +H +G T Y P
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504
T D+++ G + E+++ P + HE+ L + +
Sbjct: 191 LSPNNYTKAIDMWAAGCIFAEMLTGKP---LFAGAHELEQMQLILESVP 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 29/219 (13%)
Query: 289 ELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQF----MNEVEILTRLRHKNLVSL 343
++G+G +G VY + KD G VA+K++ +N + E F + E++IL +L H+N+V+L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNL 71
Query: 344 FGCTSRYSQGL---------LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI--ET 392
+ L LV+E++ + L G + GL+ + + +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMG-LLESGLVHFSEDHIKSFMKQL 125
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
L Y H + +HRD+K +NILL++ +K+ADFGL+RL+ + + T T Y
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 453 PEY---HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNR 488
PE + Y DV+S G +L EL + P N+
Sbjct: 186 PELLLGEERY--GPAIDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 6/195 (3%)
Query: 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQF---MNEVEILTRLRHKNLVSLFG 345
LG GGFG V +++ G+ A K+L ++ + + M E IL ++ + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDII 405
+ L LV + G + ++ ++ P + S L +LH II
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 465
+RD+K N+LLD++ V+++D GL+ D + GTPG++ PE Q +
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 466 DVYSFGVVLIELISS 480
D ++ GV L E+I++
Sbjct: 179 DYFALGVTLYEMIAA 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRV--EQFMNEVEILTRLRHKN 339
+DF R ELG G G V + K + ++L + Q + E+++L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V +G + YS G + + +G DQ+ + + + I ++I LAYL
Sbjct: 65 IVGFYG--AFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYL 119
Query: 400 HAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
I+HRDVK +NIL++S +K+ DFG+S + ++ + GT Y+ PE Q
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 176
Query: 459 YQLTDKSDVYSFGVVLIEL 477
+ +SD++S G+ L+EL
Sbjct: 177 THYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGRE-VAVKRLY-DNNYRRVEQFMNEVEILTRLRHKNLV 341
F + ++LG+G + TVY G+ + E VA+K ++ D + E+ ++ L+H+N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVAD-----QLHGDRAKHGLLTWPIRMNIAIETASAL 396
L ++ L+LV+E++ D HG R G L + + +
Sbjct: 62 RLHDVIHTENK-LMLVFEYMDK----DLKKYMDTHGVR---GALDPNTVKSFTYQLLKGI 113
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
A+ H + ++HRD+K N+L++ +K+ADFGL+R F + V S T Y P+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172
Query: 457 QCYQLTDKS-DVYSFGVVLIELISSMP 482
+ S D++S G ++ E+I+ P
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 9e-13
Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 38/239 (15%)
Query: 274 YSDLAEATNDFSREKELGDGGFGTVYYGKLKDGRE------VAVKRLYDNNYRRVEQFMN 327
Y D N++ K++G+G FG V+ K K +E ++ + L + R Q +
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE---REKSQLVI 61
Query: 328 EVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRM 386
EV ++ L+HKN+V ++ +Q L ++ EF G ++ + G + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 387 NIAIETASALAYLH-------ASDIIHRDVKTNNILLDSNF-----------------CV 422
+I + ALAY H ++HRD+K NI L +
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
K+ DFGLS+ + + ++ + GTP Y PE H+ DKSD+++ G ++ EL S
Sbjct: 182 KIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
|
Length = 1021 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQ------FMNEVEILTRLRHKNLVS 342
LG GGFG V ++K G+ A K+L + +R+++ +NE +IL ++ + +VS
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL---DKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI--AIETASALAYLH 400
L L LV + G L G +P I A + L +LH
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGG----DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
I++RD+K N+LLD + V+++D GL+ GTPGY+ PE Q
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEV 170
Query: 461 LTDKSDVYSFGVVLIELIS 479
D ++ G L E+I+
Sbjct: 171 YDFSVDWFALGCTLYEMIA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 54/226 (23%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRVEQ--------FMNEVEILTR 334
+ + +++G+G +G VY + + E +A+K++ R+EQ + E+ +L
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKE 57
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI---- 390
++H N+V L + L LV+E+ L D KH + N +
Sbjct: 58 MQHGNIVRLQDVVHS-EKRLYLVFEY---------LDLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 391 --ETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVADFGLSRLFPLDV---TH-VST- 442
+ +AY H+ ++HRD+K N+L+D +K+ADFGL+R F + V TH V T
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
Query: 443 ---APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP+ G+ Y P D++S G + E+++ P
Sbjct: 168 WYRAPEILLGSRHYSTP-----------VDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 41/213 (19%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLY---------DNNYRRVEQFMNEVEILTRLRHKN 339
+G G +G V GR+VA+K+L YR E+ +L + H+N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-------ELRLLKHMDHEN 75
Query: 340 LVSLFGC-----TSRYSQGLLLVYEFVA---NGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
++ L + Q + LV + N V Q D L+ +R
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR------ 129
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGY 450
L Y+H++ IIHRD+K +NI ++ + +K+ DFGL+R ++T +V T Y
Sbjct: 130 ---GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWY 181
Query: 451 VDPEYHQCY-QLTDKSDVYSFGVVLIELISSMP 482
PE + D++S G ++ EL++
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 25/158 (15%)
Query: 288 KELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRVEQFMN---------EVEILTRLR- 336
++LG G +G V+ + +E VA+K+++D F N E+ L L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFD-------AFRNATDAQRTFREIMFLQELGD 65
Query: 337 HKNLVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H N+V L + + + LV+E++ D LH + +L + I + A
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYME----TD-LHA-VIRANILEDVHKRYIMYQLLKA 119
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
L Y+H+ ++IHRD+K +NILL+S+ VK+ADFGL+R
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 289 ELGDGGFGTVYYGK-LKDG-REVAVKRLYDNNYRRVEQFM-----NEVEILTRLR---HK 338
E+G+G +G V+ + LK+G R VA+KR+ + E+ M EV +L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 339 NLVSLFG-CT-SRYSQ--GLLLVYEFVANGTVADQLHGDRAKH-GLLTWPIRMNIAIETA 393
N+V LF CT SR + L LV+E V + D+ G+ T I+ ++ +
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIK-DMMFQLL 120
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
L +LH+ ++HRD+K NIL+ S+ +K+ADFGL+R++ + T+ T Y P
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAP 178
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMP 482
E D++S G + E+ P
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGR--EVAVKRLYDNNY---RRVEQFMNEVEILTRLRH 337
DF+ + LG G FG V K+ VA+KR + ++V+ +E +IL + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP--IRMNIAIETASA 395
V+L+G S L LV EFV G L ++ +P + A +
Sbjct: 91 PFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLI 143
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
YL + +I++RD+K N+LLD + +K+ DFG +++ V + GTP Y+ PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYTLCGTPEYIAPEI 199
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMP 482
+D ++ G+ + E++ P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKN 339
D ++ +G G FG V+ +DG+ VA+K++ + N ++ E+++L +H N
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN------IAIETA 393
++S + +E + V + + D H ++ P ++ +
Sbjct: 61 VLSALDILQ---PPHIDPFEEIY--VVTELMQSDL--HKIIVSPQPLSSDHVKVFLYQIL 113
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
L YLH++ I+HRD+K N+L++SN +K+ DFGL+R+ D + T T Y P
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 454 E-YHQCYQLTDKSDVYSFGVVLIELIS 479
E T D++S G + EL+
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 283 DFSREKELGDGGFGTVYY----GKLKDGREVAVKRLYD----NNYRRVEQFMNEVEILTR 334
+F + LG G +G V+ G G+ A+K L + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 335 LRHKN-LVSLFGCTSRYSQGLLLVYEFVANGTVADQL----HGDRAKHGLLTWPIRMNIA 389
+R LV+L ++ L L+ ++V G + L H ++ +R+ IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESE-------VRVYIA 112
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG 449
E AL +LH II+RD+K NILLDS V + DFGLS+ F + + + GT
Sbjct: 113 -EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171
Query: 450 YVDPEY-------HQCYQLTDKSDVYSFGVVLIELIS 479
Y+ PE H D +S GV+ EL++
Sbjct: 172 YMAPEVIRGGSGGH-----DKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 289 ELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLR---HKNLVS 342
E+G G +GTVY + G VA+K R+ N + EV +L RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 343 LFG--CTSRYSQ--GLLLVYEFVANGTVADQ---LHGDRAKH-GLLTWPIRMNIAIETAS 394
L TSR + + LV+E V DQ + D+ GL I+ ++ +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV------DQDLRTYLDKVPPPGLPAETIK-DLMRQFLR 119
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP-QGTPGYVDP 453
L +LHA+ I+HRD+K NIL+ S VK+ADFGL+R++ ++ P T Y P
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAP 176
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMP 482
E D++S G + E+ P
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRV--EQFMNEVEILTRLRHKN 339
+DF + ELG G G V+ K + ++L + Q + E+++L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V +G + YS G + + +G DQ+ K G + I ++I L YL
Sbjct: 65 IVGFYG--AFYSDGEISICMEHMDGGSLDQV---LKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 400 HAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
I+HRDVK +NIL++S +K+ DFG+S + ++ + GT Y+ PE Q
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 176
Query: 459 YQLTDKSDVYSFGVVLIEL 477
+ +SD++S G+ L+E+
Sbjct: 177 THYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 288 KELGDGGFGTV---YYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLR-HKNLV 341
KELG G +G V + + VA+K++ + + ++ + E+++L R HKN+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 342 SLFGCTSRYSQGL--LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
L+ + L +YE + + + + LT + + L Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP----LTDAHFQSFIYQILCGLKYI 121
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF---PLDVTHVSTAPQGTPGYVDPEYH 456
H+++++HRD+K N+L++++ +K+ DFGL+R F P + T T Y PE
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 457 QCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHEINL 495
+Q K+ DV+S G +L EL+ P + ++N
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 54/243 (22%), Positives = 104/243 (42%), Gaps = 57/243 (23%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQF---------MNEVEIL 332
+ +G+G +G V K G +VA+K+ + F + E++IL
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKIL 57
Query: 333 TRLRHKNLVSLFGC----TSRYSQGLLLVYEFVANG---TVADQ-LHGDRAKHGLLTWPI 384
R +H+N++ + + + +V E + + Q L D ++ L
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY---- 113
Query: 385 RMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444
+ L Y+H+++++HRD+K +N+LL++N +K+ DFGL+R P
Sbjct: 114 ------QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR---------IADP 158
Query: 445 QGTPG-----------YVDPEYHQCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHE 492
+ Y PE + K+ D++S G +L E++S+ P + H+
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ 218
Query: 493 INL 495
+NL
Sbjct: 219 LNL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHK 338
+ + + ++LG+G + TVY GK K +G+ VA+K RL + + E +L L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V L + L LV+E+V + D+ GL +++ + + L+Y
Sbjct: 64 NIVLLHDII-HTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFL-FQLLRGLSY 118
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP----- 453
+H I+HRD+K N+L+ +K+ADFGL+R + +H + T Y P
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLG 177
Query: 454 --EYHQCYQLTDKSDVYSFGVVLIELISSMPA 483
EY C D++ G + +E+I + A
Sbjct: 178 STEYSTCL------DMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSL 343
K LG G FG V + K G+ A+K L V + E +L RH L SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 344 FGCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+YS L V E+V G + L +R + + E SAL YL
Sbjct: 61 -----KYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYL 111
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ I++RD+K N++LD + +K+ DFGL + D + T GTP Y+ PE +
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDN 170
Query: 460 QLTDKSDVYSFGVVLIELI 478
D + GVV+ E++
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 283 DFSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHK 338
+F K + G FG VY G K + + AVK + N V Q E + L +
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 339 NLVSLFGCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+V L+ YS + LV E++ G V LH +G + + E A
Sbjct: 65 FIVHLY-----YSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVAL 115
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432
AL YLH IIHRD+K +N+L+ + +K+ DFGLS++
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC-- 346
+G GGFG VY + D G+ A+K L + +R++ E L +LVS C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 347 ------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L + + + G LH ++HG+ + A E L ++H
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGG----DLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+++RD+K NILLD + V+++D GL+ F H S GT GY+ PE Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 461 LTDKS-DVYSFGVVLIELISSMPAVDMN--RHRHEINLANLAIN 501
D S D +S G +L +L+ + + +HEI+ L +N
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE-VAVKRLYDN--NYRRVEQFMNEVEILTRLRHK 338
N F +G+G +G V + K+ +E VA+K+ D+ N E + E+++L L+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V L R + L LV+E+V + + +G+ +R I + A+ +
Sbjct: 61 NIVELKEAFRRRGK-LYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYI-YQLIKAIHW 115
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
H +DI+HRD+K N+L+ N +K+ DFG +R T T Y PE
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 459 YQLTDKSDVYSFGVVLIELISSMP 482
D++S G +L EL P
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQ--FMNEVEILTRLRHK 338
DF K +G G FG V KLK+ +V ++ + +R E F E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTV-------ADQLHGDRAKHGLLTWPIRMNIAIE 391
+ +L + L LV ++ G + D+L D A+ L M IAI+
Sbjct: 62 WITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL----AEMVIAID 116
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
+ L Y +HRD+K +NIL+D N +++ADFG D T S+ GTP Y+
Sbjct: 117 SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 452 DPEYHQCYQ-----LTDKSDVYSFGVVLIELI 478
PE Q + + D +S GV + E++
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 58/235 (24%)
Query: 284 FSREKELGDGGFGTVYYGKLK---DGREVAVKRLYDNNYRRVEQFMN---EVEILTRLRH 337
+ E +G G +G VY K K DG+E A+K+ + + + E+ +L L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 338 KNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLL---TW---------PI 384
+N+VSL + + L++++ A+H L + P
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDY--------------AEHDLWQIIKFHRQAKRVSIPP 107
Query: 385 RM--NIAIETASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGLSRLF----- 433
M ++ + + + YLH++ ++HRD+K NIL+ VK+ D GL+RLF
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 434 -PLDVTHVSTAPQGTPGYVDPEY-----HQCYQLTDKSDVYSFGVVLIELISSMP 482
D+ V T Y PE H Y T D+++ G + EL++ P
Sbjct: 168 PLADLDPVVV----TIWYRAPELLLGARH--Y--TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 52/245 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN---EVEILTRLRH 337
+DF K +G G FG V + KD G A+K+L + EQ + E +IL +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAIETASAL 396
+V L+ + + L L+ E++ G + L K T R IA ET A+
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLL----MKKDTFTEEETRFYIA-ETILAI 114
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ----------- 445
+H IHRD+K +N+LLD+ +K++DFGL L +H + +
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFL 172
Query: 446 ----------------------------GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
GTP Y+ PE + D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 478 ISSMP 482
+ P
Sbjct: 233 LVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREV-AVKRLY-DNNYRRVEQ--FMNEVEILTRLRHK 338
DF K +G G FG V + K ++V A+K L +R + F E +I+ +
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLT-------WPIRMNIAIE 391
+V L + + L +V E++ G + + L++ W R A E
Sbjct: 104 WIVQLH-YAFQDDKYLYMVMEYMPGGDLVN----------LMSNYDIPEKWA-RFYTA-E 150
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS-RLFPLDVTHVSTAPQGTPGY 450
AL +H+ IHRDVK +N+LLD + +K+ADFG ++ + TA GTP Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDY 209
Query: 451 VDPEYHQCY----QLTDKSDVYSFGVVLIELI 478
+ PE + + D +S GV L E++
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 290 LGDGGFGTVYYGKLKDGREV----AVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSL-F 344
+G G FG V + +D + + +++ + + V + E +L ++ +V L F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLL-TWPIRMNIAIETASALAYLHASD 403
S + L LV F+ G + L + G R A E AL LH +
Sbjct: 61 SFQSP--EKLYLVLAFINGGELFHHLQ----REGRFDLSRARFYTA-ELLCALENLHKFN 113
Query: 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD 463
+I+RD+K NILLD + + DFGL +L D +T GTP Y+ PE + T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTK 172
Query: 464 KSDVYSFGVVLIELISSMP 482
D ++ GV+L E+++ +P
Sbjct: 173 AVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 288 KELGDGGFGTVYYGKLKDGREV----AVKRLYDNNYR---RVEQFMNEVEILTRLRHKNL 340
K LG G FG V+ + G + A+K L + RV M E +IL + H +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFI 60
Query: 341 VSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIETASALAY 398
V L + ++G L L+ +F+ G + +L +K + T ++ +A E A AL +
Sbjct: 61 VKLH--YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLA-ELALALDH 113
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
LH+ II+RD+K NILLD +K+ DFGLS+ +D + + GT Y+ PE
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 459 YQLTDKSDVYSFGVVLIELIS-SMP 482
T +D +SFGV++ E+++ S+P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 290 LGDGGFGTVYYGKLKDGREV----AVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLF 344
+G G + V +LK + VK+ N+ ++ E + + H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHA 401
C S+ L V E+V G + + R +H + E + AL YLH
Sbjct: 63 SCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNYLHE 114
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
II+RD+K +N+LLDS +K+ D+G+ + L P D T GTP Y+ PE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGE 171
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDM 486
D ++ GV++ E+++ D+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 307 REVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTV 366
+V K + N+ R+ +E+ L H +V F + LLL+ E+ + G +
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-DFKSDDKLLLIMEYGSGGDL 152
Query: 367 ADQLHGDRAKH--------GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418
Q+ +H GLL + I + AL +H+ ++HRD+K+ NI L
Sbjct: 153 NKQIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHSRKMMHRDLKSANIFLMP 204
Query: 419 NFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
+K+ DFG S+ + V+ V+++ GTP Y+ PE + + + K+D++S GV+L EL
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
Query: 478 IS 479
++
Sbjct: 265 LT 266
|
Length = 478 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSL 343
K LG G FG V + K GR A+K L V + E +L RH L +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 344 ---FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
F R L V E+ G + L +R + T E SAL YLH
Sbjct: 61 KYAFQTHDR----LCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH 112
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+ D+++RD+K N++LD + +K+ DFGL + D + T GTP Y+ PE +
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 171
Query: 461 LTDKSDVYSFGVVLIELI 478
D + GVV+ E++
Sbjct: 172 YGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMN--EVEILTRLR-HKNLVSLFG 345
+G+G F V + K G+ A+K + +++ +EQ N E++ L RL H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 346 CT-SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
R + L LV+E + + + + + G + L ++ + + +L ++H + I
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRK--RPLPEKRVK-SYMYQLLKSLDHMHRNGI 121
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD- 463
HRD+K NIL+ + +K+ADFG R + T T Y PE C LTD
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPE---CL-LTDG 174
Query: 464 ----KSDVYSFGVVLIELISSMP 482
K D+++ G V E++S P
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRV--EQFMNEVEILTRLRHKNL 340
DF + ELG G G V + + ++L + Q + E+++L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 341 VSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
V +G + YS G + + E + G++ DQ+ K G + I I+I L YL
Sbjct: 62 VGFYG--AFYSDGEISICMEHMDGGSL-DQV---LKKAGRIPENILGKISIAVLRGLTYL 115
Query: 400 HAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPEYH 456
I+HRDVK +NIL++S +K+ DFG+S S A GT Y+ PE
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL 170
Query: 457 QCYQLTDKSDVYSFGVVLIEL 477
Q T +SD++S G+ L+E+
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVE---QFMNEVEILTRLRHKN 339
F + + LG GGFG V +++ G+ A K+L ++ + +NE +IL ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+VSL L LV + G + + H + A E L L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDL--KFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H I++RD+K NILLD + ++++D GL+ P T GT GY+ PE +
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNE 176
Query: 460 QLTDKSDVYSFGVVLIELIS 479
+ T D ++ G +L E+I+
Sbjct: 177 RYTFSPDWWALGCLLYEMIA 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVE-QFMNEVEILTRLRHKNLVSLFG 345
++LG+G + TVY G + +G+ VA+K + V + E +L L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKH------GLLTWPIRMNIAIETASALAYL 399
+ L V+E++ H D A++ GL + +R+ + LAY+
Sbjct: 71 II-HTKETLTFVFEYM---------HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYI 119
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H I+HRD+K N+L+ +K+ADFGL+R + + ++ T Y P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDV--LL 176
Query: 460 QLTDKS---DVYSFGVVLIELISSMPA 483
TD S D++ G + IE++ PA
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 66/302 (21%), Positives = 102/302 (33%), Gaps = 50/302 (16%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
K D + K VAVK+ L + ++ E+ +L+H N++
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDII 405
L +V +A G+ + L GL I I + +AL Y+H+ I
Sbjct: 67 SFI-VDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIA-FILKDVLNALDYIHSKGFI 123
Query: 406 HRDVKTNNILLDSNFCVKVADFGLSR-------------LFPLDVTHVS--TAP----QG 446
HR VK ++ILL + V ++ S FP +P Q
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183
Query: 447 TPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL------ISSMPAVDMNRHRHEINLANL-- 498
GY +KSD+YS G+ EL MPA M + + L
Sbjct: 184 LQGY-----------NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232
Query: 499 -----AINKIQKCAFDELIDPCLGFESDEEVKRM-TTSVAELAFLCLQQNKELRPSMEEV 552
+ P D R + + LCLQ++ E RPS ++
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292
Query: 553 LA 554
L
Sbjct: 293 LN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 383 PIRMNIAIETA--SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440
PI + IE L YLHA IIHRDVKT NI ++ V + D G ++ FP+ V
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV----V 209
Query: 441 STAPQGTPGYVD---PEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ A G G V+ PE + K+D++S G+VL E+++
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 289 ELGDGGFGTVY------YGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
ELG G +G+VY G +E+ ++ L ++ + Q + E++IL + +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFN---QIIMELDILHKAVSPYIVD 63
Query: 343 LFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+G + + +G + + E++ G++ D+L+ + + I L +L
Sbjct: 64 FYG--AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 402 S-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY----- 455
+IIHRDVK N+L++ N VK+ DFG+S V ++ G Y+ PE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGG 177
Query: 456 -HQCYQLTDKSDVYSFGVVLIEL 477
+Q T +SDV+S G+ ++E+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 290 LGDGGFGTVYYG-KLKDGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFG 345
+G GG G VY R VA+K++ ++ N ++F+ E +I L H +V ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY- 68
Query: 346 CTSRYSQGLLLVYE--FVANGTVADQLHGDRAKHGL-------LTWPIRMNIAIETASAL 396
S S G + Y ++ T+ L K L + ++I + + +
Sbjct: 69 --SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR--------LFPLDVT------HVST 442
Y+H+ ++HRD+K +NILL V + D+G + L +DV T
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 443 APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
P GTP Y+ PE ++ +D+Y+ GV+L ++++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 45/165 (27%), Positives = 64/165 (38%), Gaps = 38/165 (23%)
Query: 283 DFSREKELGDGGFGTVYYG-----KLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH 337
DF K+LG+G FG VY + K + +K+ Y VE +MNE R+R
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEYGAVEIWMNE-----RVRR 185
Query: 338 ------KNLVSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDR------------AKH 377
+ V F + LV+ + T+AD L +
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLAD-LMQSKEFPYNVEPYLLGKVQ 244
Query: 378 GLLTWPIRMNIAIETA-----SALAYLHASDIIHRDVKTNNILLD 417
L R N I+T AL LH++ I+HRDVK NI+
Sbjct: 245 DLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289
|
Length = 566 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC-- 346
+G GGFG VY + D G+ A+K L + +R++ E L +LVS C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 347 ------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L + + + G LH ++HG+ + A E L ++H
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGG----DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+++RD+K NILLD + V+++D GL+ F H S GT GY+ PE Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 461 LTDKS-DVYSFGVVLIELI 478
D S D +S G +L +L+
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASAL 396
LV L C S+ L LV E+V G + + R +H A E AL
Sbjct: 58 LVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQRQRKLPEEHARF-------YAAEICIAL 109
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVDPE 454
+LH II+RD+K +N+LLD++ +K+ D+G+ + L P D T GTP Y+ PE
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPE 166
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN 494
+ + D ++ GV++ E+++ D+ ++N
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 48/282 (17%)
Query: 306 GREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLVSLFGC-----TSRYSQGLLLVY 358
G VAVK+L N ++ E+ +L + HKN++SL + Q + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 359 EFV-ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD 417
E + AN + D + L + + I +LH++ IIHRD+K +NI++
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLCGIK--------HLHSAGIIHRDLKPSNIVVK 157
Query: 418 SNFCVKVADFGLSR-------LFPLDVTHVSTAPQGTPGY-----VDPEYHQC------- 458
S+ +K+ DFGL+R + P VT AP+ G VD C
Sbjct: 158 SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 459 ----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ--KCAFDELI 512
+Q TD D ++ +IE + + A MNR + + N N+ Q +F+EL
Sbjct: 218 GSVIFQGTDHIDQWN---KVIEQLGTPSAEFMNRLQPTVR--NYVENRPQYPGISFEELF 272
Query: 513 DPCLGFESDEEVKRMTTSVA-ELAFLCLQQNKELRPSMEEVL 553
P F S+ E ++ TS A +L L + + R S++E L
Sbjct: 273 -PDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 290 LGDGGFGTVYYGKLKDGREV----AVKRLYDNNYRRVEQFMNEVEIL-TRLRHKNLVSLF 344
+G G + V +LK R + +K+ N+ ++ E + T H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDR---AKHGLLTWPIRMNIAIETASALAYLHA 401
C S+ L V EFV+ G + + R +H + E + AL +LH
Sbjct: 63 SCFQTESR-LFFVIEFVSGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNFLHE 114
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
II+RD+K +N+LLD+ +K+ D+G+ + + P D T GTP Y+ PE +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPEILRGE 171
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDM 486
D ++ GV++ E+++ D+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 47/225 (20%)
Query: 288 KELGDGGFGTVYYG-KLKDGREVAVKRLY---------DNNYRRVEQFMNEVEILTRLRH 337
K++G G +GTV + G +VA+K+LY YR E+ +L ++H
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-------ELRLLKHMKH 73
Query: 338 KNLVSLFGCTS------RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
+N++ L + R+ LV F+ GT +L KH L+ + +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHD-FYLVMPFM--GTDLGKL----MKHEKLSEDRIQFLVYQ 126
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
L Y+HA+ IIHRD+K N+ ++ + +K+ DFGL+R ++T GYV
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT----------GYV 176
Query: 452 DPEYHQCYQL-------TDKSDVYSFGVVLIELISSMPAVDMNRH 489
+++ ++ T D++S G ++ E+++ P + H
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 37/260 (14%)
Query: 290 LGDGGFGTVYYGKLKD---------GREVAVKR-LYDNNYRRVEQFMNEVEILTRLRHKN 339
LG G F +Y G L+ G+EV+V + +++R F ++++L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGL-LTWPIRMNIAIETASALAY 398
LV L+G R ++V E+V G + LH R K+ + L W ++++A + ASAL Y
Sbjct: 63 LVKLYGVCVR--DENIMVEEYVKFGPLDVFLH--REKNNVSLHW--KLDVAKQLASALHY 116
Query: 399 LHASDIIHRDVKTNNILL-------DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
L ++H +V NIL+ +K++D G+ V P ++
Sbjct: 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-----WI 171
Query: 452 DPEYHQCYQ--LTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCA 507
PE + Q LT +D +SFG L+E+ S P ++ E + + CA
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCA 231
Query: 508 -FDELIDPCLGFESDEEVKR 526
LI+ C + + KR
Sbjct: 232 ELANLINQCW---TYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 282 NDFSREKELGDGGFGTV-YYGKLKDGREVAVKRLYDNNYRRVEQFMN---EVEILTRLRH 337
DF K +G G FG V K G+ A+K L + + +Q + E ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAIETASAL 396
+VSL+ + + +Q L L+ EF+ G + L K+ + + R +A E A+
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRFYMA-ECVLAI 114
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
+H IHRD+K +NIL+D +K++DFGLS F
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 288 KELGDGGFGTVYYGKLKD---------GREVAVK---RLYDNNYRRVE-QFMNEVEILTR 334
+ LG G +Y G L E +K ++ D ++R + F ++ +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+ HK++V L+G R + ++ V EFV G + +H K +LT P + +A + AS
Sbjct: 61 VSHKHIVLLYGVCVRDVENIM-VEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLAS 116
Query: 395 ALAYLHASDIIHRDVKTNNILL-------DSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
AL+YL D++H +V T NILL + +K++D G+ P+ V +
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQECVERI 172
Query: 448 PGYVDPE-YHQCYQLTDKSDVYSFGVVLIEL 477
P ++ PE L+ +D +SFG L E+
Sbjct: 173 P-WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDN---NYRRVEQFMNEVEILTRLRH 337
DF + +G G FG V + K ++ A+K + + V F E +IL+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 338 KNLVSLFGCTSRY----SQGLLLVYEFVANGTVADQL--HGDRAKHGLLTWPIRMNIAIE 391
+ L +Y L LV E+ G + L + D+ + + +A E
Sbjct: 61 PWIPQL-----QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLA-E 110
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
A+ +H +HRD+K N+L+D +K+ADFG + + S P GTP Y+
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 452 DPEYHQCYQLTDKS------DVYSFGVVLIELI 478
PE K D +S GV+ E+I
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREV----AVKRLYD----NNYRRVEQFMNEVEILTR 334
+F K LG G +G V+ + G + A+K L + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQL-HGDRAKHGLLTWPIRMNIAIETA 393
+R + + L L+ +++ G + L +R K + E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIV 115
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
AL +LH II+RD+K NILLDSN V + DFGLS+ F D + + GT Y+ P
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 454 EYHQCYQLT-DKS-DVYSFGVVLIELIS 479
+ + DK+ D +S GV++ EL++
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSL 343
K LG G FG V K K GR A+K L V + E +L RH L +L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 344 FGCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+YS L V E+ G + L +R + + E SAL YL
Sbjct: 61 -----KYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYL 111
Query: 400 HAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
H+ ++++RD+K N++LD + +K+ DFGL + D + T GTP Y+ PE +
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 170
Query: 459 YQLTDKSDVYSFGVVLIELI 478
D + GVV+ E++
Sbjct: 171 NDYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQ-----FMNEVEILTRLRH 337
D+ K +G G FG V + K ++V +L + + +++ F E +I+
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+V LF C + + L +V E++ G + + + + E AL
Sbjct: 103 PWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-----YTAEVVLALD 156
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLS-RLFPLDVTHVSTAPQGTPGYVDPEYH 456
+H+ +IHRDVK +N+LLD + +K+ADFG ++ + TA GTP Y+ PE
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVL 215
Query: 457 QCYQLTD-----KSDVYSFGVVLIELI 478
+ Q D + D +S GV L E++
Sbjct: 216 KS-QGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 65/238 (27%), Positives = 95/238 (39%), Gaps = 43/238 (18%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN---EVEILTRLRHK 338
DF K +G G FG V + KD G A+K L + EQ + E +IL
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V +F + + L L+ EF+ G + L K LT ET A+
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDS 116
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFG----------------LSRLFPLDVT---- 438
+H IHRD+K +N+LLDS VK++DFG L+ P D T
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 439 --------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
++ + GTP Y+ PE D +S GV++ E++ P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 43/239 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN---EVEILTRLRH 337
+DF K +G G FG V + KD G A+K L + EQ + E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+V +F + + + L L+ EF+ G + L K L + IA ET A+
Sbjct: 61 AWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIA-ETVLAID 115
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGL--------SRLFPLDVTH---------- 439
+H IHRD+K +N+LLD+ VK++DFGL F ++TH
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 440 ----------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
++ + GTP Y+ PE D +S GV++ E++ P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 51/216 (23%)
Query: 288 KELGDGGFGTV---YYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLVS 342
K +G G G V Y G+ VA+K+L N ++ E+ ++ + HKN++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 343 LFGC-TSRYS----QGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
L T + S Q + LV E + AN L I+M++ E S L
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDAN----------------LCQVIQMDLDHERMSYL 123
Query: 397 AY--------LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
Y LH++ IIHRD+K +NI++ S+ +K+ DFGL+R T+ TP
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTP 176
Query: 449 GYVDPEYHQCYQL------TDKSDVYSFGVVLIELI 478
YV Y++ ++ + D++S G ++ E+I
Sbjct: 177 -YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTR-----LR 336
+DF K +G G FG EVAV ++ + +N+ E+L R R
Sbjct: 1 DDFEIIKVIGRGAFG-----------EVAVVKMKHTERIYAMKILNKWEMLKRAETACFR 49
Query: 337 HKNLVSLFG-----CTSRYS----QGLLLVYEFVANGTV-------ADQLHGDRAKHGLL 380
+ V + G T Y+ L LV ++ G + D+L D A+
Sbjct: 50 EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF--- 106
Query: 381 TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440
+ M +AI + L Y +HRD+K +N+LLD N +++ADFG D T
Sbjct: 107 -YIAEMVLAIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159
Query: 441 STAPQGTPGYVDPEYHQCYQ-----LTDKSDVYSFGVVLIELI 478
S+ GTP Y+ PE Q + + D +S GV + E++
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 26/93 (27%), Positives = 50/93 (53%), Gaps = 16/93 (17%)
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL---FPLDVT-----HVSTAPQGT 447
L Y+H++++IHRD+K +N+L++ + +++ DFG++R P + +V+T
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 448 PG--YVDPEYHQCYQLTDKSDVYSFGVVLIELI 478
P PEY T D++S G + E++
Sbjct: 180 PELLLSLPEY------TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
+ + A + +L + IHRD+ NILL N VK+ DFGL+R D +V P
Sbjct: 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 449 -GYVDPE--YHQCYQLTDKSDVYSFGVVLIELI----SSMPAVDMN 487
++ PE + + Y T +SDV+SFGV+L E+ S P V +N
Sbjct: 240 LKWMAPESIFDKVY--TTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
+ + A + +L + IHRD+ NILL N VK+ DFGL+R D +V P
Sbjct: 179 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 449 -GYVDPE--YHQCYQLTDKSDVYSFGVVLIELI----SSMPAVDMN 487
++ PE + + Y T +SDV+SFGV+L E+ S P V ++
Sbjct: 239 LKWMAPESIFDKVY--TTQSDVWSFGVLLWEIFSLGASPYPGVQID 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 288 KELGDGGFGTV--YYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLVSL 343
K +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN++SL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 344 FGC-----TSRYSQGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+ Q + LV E + AN Q+ D + L + + +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY--------QMLCGIK 133
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
+LH++ IIHRD+K +NI++ S+ +K+ DFGL+R T+ TP YV Y++
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTP-YVVTRYYR 185
Query: 458 CYQL------TDKSDVYSFGVVLIELI 478
++ + D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTR-----LR 336
+DF K +G G FG EVAV ++ + + +N+ E+L R R
Sbjct: 1 DDFEILKVIGRGAFG-----------EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR 49
Query: 337 HKNLVSLFG-----CTSRYS----QGLLLVYEFVANGTV-------ADQLHGDRAKHGLL 380
+ V + G Y+ L LV ++ G + D+L D A+ L
Sbjct: 50 EERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL- 108
Query: 381 TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440
M +AI++ L Y +HRD+K +N+LLD N +++ADFG D T
Sbjct: 109 ---AEMVLAIDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159
Query: 441 STAPQGTPGYVDPEYHQCYQ-----LTDKSDVYSFGVVLIELI 478
S GTP Y+ PE Q + + D +S GV + E++
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 35/158 (22%)
Query: 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQ-------FMNEVEILTRLRHKNLV 341
LG+G + TVY G+ K G+ VA+K + R+E + E +L L+H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA----KHGLLTWPIRM-NIAI---ETA 393
+L + L LV+E++ D G + M N+ + +
Sbjct: 67 TLHD-IIHTKKTLTLVFEYL---------DTDLKQYMDDCGGG---LSMHNVRLFLFQLL 113
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
LAY H ++HRD+K N+L+ +K+ADFGL+R
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 288 KELGDGGFGTVYYGKLKDGREVA---VKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSL 343
+E+G+G FG V ++ VA VK L N + + +F+ + + L+H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 344 FG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
G C LLV+E+ G + L ++ + +A E A+ + ++H
Sbjct: 61 LGQCVEAIP--YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGL--------------SRLFPLDVTHVSTAPQGTP 448
+ +H D+ N L S+ VKV D+G+ + PL +
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
G + E T S+V++ GV L EL
Sbjct: 179 GLITAEQ------TKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFG 345
+G G FG VY + KD R A+K L + V + E IL R + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 346 CTSRY--SQGLLLVYEFVANGTVADQLHGD------RAKHGLLTWPIRMNIAIETASALA 397
+ L LV ++++ G + L + RAK IA E AL
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAK---------FYIA-ELVLALE 110
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPEY 455
+LH DI++RD+K NILLD+ + + DFGLS+ ++T T GT Y+ PE
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 456 ---HQCYQLTDKSDVYSFGVVLIEL 477
+ Y T D +S GV++ E+
Sbjct: 168 LLDEKGY--TKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 50/234 (21%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRL---YDN--NYRRVEQFMNEVEILTRLRHKNLV 341
K +G G +G V K + +VA+K++ +DN + +R + E+++L L H+N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT---LREIKLLRHLDHENVI 67
Query: 342 SLFGC---TSRYS-QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI------- 390
++ R + + +VYE + D H + IR + +
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELM-----------DTDLHQI----IRSSQTLSDDHCQY 112
Query: 391 ---ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
+ L Y+H+++++HRD+K +N+LL++N +K+ DFGL+R T T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR------TTSEKGDFMT 166
Query: 448 PGYVDPEYH------QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL 495
V Y C + T DV+S G + EL+ P + H++ L
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 31/219 (14%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKN- 339
+ + +++G+G +G VY + G+ VA+K RL + + E+ +L L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 340 LVSLFGCTSRYSQG----LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+V L + L LV+E++ + R L + +
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 396 LAYLHASDIIHRDVKTNNILLD-SNFCVKVADFGLSRLFPLDV---TH-VST----APQ- 445
+A+ H ++HRD+K N+L+D +K+AD GL R F + V TH + T AP+
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182
Query: 446 --GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
G+ Y P D++S G + E+ P
Sbjct: 183 LLGSTHYSTP-----------VDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 18/179 (10%)
Query: 308 EVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVA 367
E + D +R+ + ++ + R L S+ S S G FV +++
Sbjct: 109 EFVPYKTKDARFRQGKSGYGDISEDLKRR---LDSITSSQSSASSG------FVEEKSLS 159
Query: 368 DQLHGDRAKHGLLTWPIRMNIAI----ETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423
D + + L + + I + A + +L + IHRD+ NILL N VK
Sbjct: 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVK 219
Query: 424 VADFGLSRLFPLDVTHVSTAPQGTP-GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
+ DFGL+R D +V P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 220 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 51/226 (22%)
Query: 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVE------QFMNEVEILTRLRHKNL 340
++G G +G VY K KDG++ D +Y +++E E+ +L L+H N+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 341 VSLFGC-TSRYSQGLLLVYEFVANGTVADQLH------GDRAKHGLLTWPIRM--NIAIE 391
+SL S + + L++++ + D H +A + P M ++ +
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 392 TASALAYLHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLF-----------PLD 436
+ YLHA+ ++HRD+K NIL+ VK+AD G +RLF P+
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
VT AP+ G T D+++ G + EL++S P
Sbjct: 177 VTFWYRAPELLLG--------ARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREV----AVKRLYD----NNYRRVEQFMNEVEILTR 334
+F K LG G +G V+ + G + A+K L + VE E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+R + + L L+ ++V+ G + L+ + +R E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSG-EIIL 116
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
AL +LH I++RD+K NILLDS V + DFGLS+ F + + + GT Y+ PE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 455 YHQCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
+ K+ D +S G+++ EL++ + R N + +I KC D
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER---NTQSEVSRRILKC--DPPFP 231
Query: 514 PCLGFESDEEVKRM 527
+G E+ + + ++
Sbjct: 232 SFIGPEAQDLLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 41/221 (18%)
Query: 289 ELGDGGFGTVYYGKLKDGR---EVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
++G G +G VY K KDG+ E A+K++ E+ +L L+H N+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISM--SACREIALLRELKHPNVIALQK 65
Query: 346 C-TSRYSQGLLLVYEFVANGTVADQLH------GDRAKHGLLTWPIRM--NIAIETASAL 396
S + + L++++ + D H +A + P M ++ + +
Sbjct: 66 VFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 397 AYLHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLF-----------PLDVTHVS 441
YLHA+ ++HRD+K NIL+ VK+AD G +RLF P+ VT
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP+ G T D+++ G + EL++S P
Sbjct: 182 RAPELLLG--------ARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLVS---- 342
+G G +G V G +VA+K++ D + + + E+++L LRH ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+ + R + + +V+E + + LH + LT + AL Y+H +
Sbjct: 68 MLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV--THVSTAPQGTPGYVDPEYHQCY- 459
++ HRD+K NIL +++ +K+ DFGL+R+ D T T Y PE +
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182
Query: 460 -QLTDKSDVYSFGVVLIELISSMP 482
+ T D++S G + E+++ P
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 273 SYSDLAEATNDFSREKELG--DGGFGTVYYGKLKDGREVAVKRLYDN-NYRRVEQFMNEV 329
S S+L + + K+L DG FG V K K +++ V+++ N+ +E M V
Sbjct: 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIE-PM--V 61
Query: 330 EILTRLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
L + + N + L+ T + G +L+ +++ +G + D L K G L+
Sbjct: 62 HQLMK-DNPNFIKLYYSVTTLK---GHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKK 113
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVADFGLSRLFPLDVTHVSTAPQG 446
I + AL LH +IIH D+K N+L D + + + D+GL + + + G
Sbjct: 114 IIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDG 168
Query: 447 TPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
T Y PE Y ++ D ++ GV+ EL++
Sbjct: 169 TLDYFSPEKIKGHNYDVS--FDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 51/266 (19%)
Query: 290 LGDGGFGTVYYGKLKDGRE-VAVKR-LYDNNYRRVEQFMNEVEILTRLRHKNLVSL---- 343
+G+G FG VY D E VA+K+ L D Y+ E+ I+ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNLNHINIIFLKDYY 128
Query: 344 -FGCTSRYSQGLLL--VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
C + + + L V EF+ H R H L + +++ + + ALAY+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYIH 187
Query: 401 ASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
+ I HRD+K N+L+D N +K+ DFG ++ A Q + Y+ +++
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSRFYRAP 239
Query: 460 QL-------TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL- 511
+L T D++S G ++ E+I P + + D+L
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS------------------GQSSVDQLV 281
Query: 512 -IDPCLGFESDEEVKRMTTSVAELAF 536
I LG +++++K M + A++ F
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYADIKF 307
|
Length = 440 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVE---QFMNEVEILTRLRHKN 339
F + + LG GGFG V +++ G+ A KRL ++ + +NE +IL ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLH-----GDRAKHGLLTWPIRMNIAIETAS 394
+V+L L LV + G + ++ G + L A E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-------YAAEILC 113
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
L LH + ++RD+K NILLD ++++D GL+ P GT GY+ PE
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRVGTVGYMAPE 171
Query: 455 YHQCYQLTDKSDVYSFGVVLIELI 478
+ T D + G ++ E+I
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 276 DLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQ-----FMNEVE 330
DL D+ K +G G FG V + K R+V +L + + +++ F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERD 95
Query: 331 ILTRLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
I+ +V LF RY L +V E++ G + + + W R
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRY---LYMVMEYMPGGDLVNLMSNYDVPE---KWA-RFYT 148
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
A E AL +H+ IHRDVK +N+LLD + +K+ADFG + GTP
Sbjct: 149 A-EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 449 GYVDPEYHQCYQLTD-----KSDVYSFGVVLIELI 478
Y+ PE + Q D + D +S GV L E++
Sbjct: 208 DYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 36/115 (31%), Positives = 58/115 (50%), Gaps = 6/115 (5%)
Query: 368 DQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427
L D GL T + ++ + A + +L + + +HRD+ N+LL VK+ DF
Sbjct: 223 KNLLSDDGSEGLTTLDL-LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDF 281
Query: 428 GLSRLFPLDVTHVSTAPQGTP-GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
GL+R D +VS P ++ PE + Y T SDV+S+G++L E+ S
Sbjct: 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY--TTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 33/253 (13%)
Query: 288 KELGDGGFGTVYYGKLKDGRE----VAVKRLYD----NNYRRVEQFMNEVEILTRLRHKN 339
K LG GG+G V+ + G + A+K L N + E IL ++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 340 LVSLFGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+V L + G L L+ E+++ G + L + G+ E + AL
Sbjct: 62 IVDLI---YAFQTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALE 114
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR--LFPLDVTHVSTAPQGTPGYVDPEY 455
+LH II+RD+K NILLD+ VK+ DFGL + + VTH GT Y+ PE
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEI 171
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDM-NRHRHEINLANLAINKIQKCAFDELIDP 514
D +S G ++ ++++ P NR + I+KI K + + P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--------TIDKILKGKLN--LPP 221
Query: 515 CLGFESDEEVKRM 527
L E+ + +K++
Sbjct: 222 YLTPEARDLLKKL 234
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 9/105 (8%)
Query: 382 WPIRM----NIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
WP+ + + + A + +L + + IHRDV N+LL K+ DFGL+R D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 438 THVSTAPQGTP-GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
+V P ++ PE + Y T +SDV+S+G++L E+ S
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSL- 343
S E+ G + GK K R +A KR+ R Q NE+ L RL H+N++ +
Sbjct: 172 STEEAEARRGVNSTNQGKPKCERLIA-KRV-KAGSRAAIQLENEILALGRLNHENILKIE 229
Query: 344 ---------FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+ T +Y L Y F+ + K L R I +
Sbjct: 230 EILRSEANTYMITQKYDFDL---YSFMYDEAF-------DWKDRPLLKQTR-AIMKQLLC 278
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF-----PLDVTHVSTAPQGTPG 449
A+ Y+H +IHRD+K NI L+ + + + DFG + F D V T +P
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPE 338
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ + + + +D++S G++L++++S
Sbjct: 339 ILAGDGY-----CEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 19/151 (12%)
Query: 289 ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQ-------FMNEVEILTRLRHKNL 340
+LG+G + TV+ G+ K VA+K + R+E + EV +L L+H N+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEI------RLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V+L + L LV+E++ + + + D + + +++ + L+Y H
Sbjct: 66 VTLHDII-HTERCLTLVFEYLDSDL---KQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH 120
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
I+HRD+K N+L++ +K+ADFGL+R
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 9/199 (4%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVE---QFMNEVEILTRLRHKN 339
F + LG GGFG V +++ G+ A K+L ++ + +NE IL ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+VSL L LV + G + + H + + A E L L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
I++RD+K NILLD ++++D GL+ P T GT GY+ PE
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE 176
Query: 460 QLTDKSDVYSFGVVLIELI 478
+ T D + G ++ E+I
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 288 KELGDGGFGTV---YYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLVS 342
K +G G G V Y L+ R VA+K+L N ++ E+ ++ + HKN++
Sbjct: 30 KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 343 LFGC-TSRYS----QGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
L T + S Q + +V E + AN Q+ D + L + + +
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY--------QMLCGI 139
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
+LH++ IIHRD+K +NI++ S+ +K+ DFGL+R + + T T Y PE
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 457 QCYQLTDKSDVYSFGVVLIELI 478
+ D++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 33/116 (28%), Positives = 61/116 (52%), Gaps = 9/116 (7%)
Query: 379 LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438
L++ + + + A+ + +L + + +HRD+ N+L+ VK+ DFGL+R D
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN 294
Query: 439 HVSTAPQGTP-GYVDPE--YHQCYQLTDKSDVYSFGVVLIELI----SSMPAVDMN 487
++S P ++ PE ++ Y T SDV+SFG++L E+ + P + MN
Sbjct: 295 YISKGSTFLPLKWMAPESIFNNLY--TTLSDVWSFGILLWEIFTLGGTPYPELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
++ + + A +++L + + IHRD+ NILL K+ DFGL+R D +V
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 446 GTP-GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
P ++ PE ++ Y T +SDV+S+G++L E+ S
Sbjct: 277 RLPVKWMAPESIFNCVY--TFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 62/261 (23%), Positives = 113/261 (43%), Gaps = 49/261 (18%)
Query: 290 LGDGGFGTVYYGK---LKDGREV----AVKRLYDNNYRR-VEQFMNEVEILTRLRHKNLV 341
LG G F ++ G + D E+ + ++ D ++R E F ++++L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+G + ++ V E+V G++ L + L+ ++ +A + A AL +L
Sbjct: 63 LNYGVCVCGDESIM-VQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 402 SDIIHRDVKTNNILL--------DSNFCVKVADFGLS-RLFPLDVTHVSTAPQGTPGYVD 452
+ H +V N+LL + +K++D G+S + P ++ + P +V
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-LERIP-----WVP 172
Query: 453 PE-YHQCYQLTDKSDVYSFGVVLIELIS--SMP--AVDMNRH------RHE------INL 495
PE L+ +D +SFG L E+ S P A+D + RH+ L
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTEL 232
Query: 496 ANLAINKIQKC-AFDELIDPC 515
ANL I +C ++ P
Sbjct: 233 ANL----INQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 33/164 (20%)
Query: 328 EVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW----- 382
E++IL + H+ +++L ++ + TV + + K L T+
Sbjct: 136 EIDILKTISHRAIINL-------------IHAYRWKSTVCMVMP--KYKCDLFTYVDRSG 180
Query: 383 --PIRMNIAIETA--SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438
P+ I I+ ALAYLH IIHRDVKT NI LD + DFG + +
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA----CKLD 236
Query: 439 HVSTAPQ-----GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
PQ GT PE K+D++S G+VL E+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 29/157 (18%)
Query: 288 KELGDGGFGTVYYGKLKDGRE-VAVKRLYDNNYRRVEQ-------FMNEVEILTRLRHKN 339
++LG+G + TV+ G+ K VA+K + R+E + EV +L L+H N
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANG--TVADQLHGDRAKHGLLTWPIRMNIAI---ETAS 394
+V+L + L LV+E++ D + H N+ I +
Sbjct: 66 IVTLHDIV-HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH---------NVKIFLYQILR 115
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
LAY H ++HRD+K N+L++ +K+ADFGL+R
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 289 ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQ-------FMNEVEILTRLRHKNL 340
+LG+G + TVY G+ K VA+K + R+E + EV +L L+H N+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V+L + L LV+E++ + + D + + +++ + + L Y H
Sbjct: 67 VTLHDII-HTEKSLTLVFEYLDKDL---KQYLDDCGNSINMHNVKLFL-FQLLRGLNYCH 121
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
++HRD+K N+L++ +K+ADFGL+R
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 77/317 (24%), Positives = 123/317 (38%), Gaps = 65/317 (20%)
Query: 289 ELGDG--GFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKNLVSL 343
E+G G +VY + G V V+ L + ++ NEV + RH N+++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 344 FGCTSRYSQG--LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ + ++ G L ++ F+A G+ A+ L G+ I NI L YLH
Sbjct: 65 W---TVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQ 119
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL-----------DVTHVSTAPQGTPGY 450
+ IHR++K ++IL+ + V ++ GLS L+ L D ST+ +
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVL---PW 174
Query: 451 VDPEY--HQCYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINKIQKCA 507
+ PE Y KSD+YS G+ EL + +P DM R ++ L L
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM--LRTQMLLQKL--KGPPYSP 230
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAE------------------------------LAFL 537
D PC + + + E L L
Sbjct: 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290
Query: 538 CLQQNKELRPSMEEVLA 554
CLQQ+ E RPS +L+
Sbjct: 291 CLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQF-MNEVEILTRLRHKN 339
F + LG GGFG V +++ G+ A K+L R+ E +NE +IL ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLH-----GDRAKHGLLTWPIRMNIAIETAS 394
+VSL L LV + G + ++ G + + A E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-------YAAEITC 113
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
L LH I++RD+K NILLD ++++D GL+ P T GT GY+ PE
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPE 171
Query: 455 YHQCYQLTDKSDVYSFGVVLIELI 478
+ + T D + G ++ E+I
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 290 LGDGGFGTVYYG-KLKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
+G G +G+V K G VAVK+L + ++ E+ +L ++H+N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 347 TS------RYSQGLLLVYEFVA--NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+ ++ L+ + A N V Q D L+ +R L Y
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 135
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
+H++DIIHRD+K +N+ ++ + +K+ DFGL+R T + T GYV +++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTDDEMT-GYVATRWYRA 185
Query: 459 YQL-------TDKSDVYSFGVVLIELIS 479
++ D++S G ++ EL++
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 60/258 (23%), Positives = 94/258 (36%), Gaps = 77/258 (29%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRRVEQFMN---EVEILTRLRHKN 339
F + K +G G FG V + D + A+K L + Q + E +IL ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 340 LVSLFGCTSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI------- 388
+V L+ YS L V +++ G +++ IR+ I
Sbjct: 63 VVKLY-----YSFQDKDNLYFVMDYIPGGD-------------MMSLLIRLGIFEEDLAR 104
Query: 389 --AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL----------------- 429
E A+ +H IHRD+K +NIL+D + +K+ DFGL
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 430 ------------------SRLFPLDVTHVSTAPQ-------GTPGYVDPEYHQCYQLTDK 464
RL PL+ + GTP Y+ PE T
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224
Query: 465 SDVYSFGVVLIELISSMP 482
D +S GV+L E++ P
Sbjct: 225 CDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 290 LGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRV---EQFMNEVEILTRLRHKNLVSL-F 344
LG GGFG V ++K+ G+ A K+L ++ + + E EIL ++ +V+L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 345 GCTSRYSQGLLLVYEFVANGTVADQLH--GDRAKHGLLTWPIRMNIAI----ETASALAY 398
S+ L LV + G + ++ G+R + M I + + +
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILH 110
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
LH+ DI++RD+K N+LLD +++D GL+ T T GT GY+ PE +
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKE 168
Query: 459 YQLTDKSDVYSFGVVLIELIS 479
+ D ++ G + E+++
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 47/214 (21%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 284 FSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDNNYRRV--EQFMNEVEILTRLRHKNL 340
++ K++G G +G+V + G +VA+K+L + ++ E+ +L ++H+N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 341 VSLFGC-TSRYS----QGLLLVYEFVA---NGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
+ L TS S Q LV ++ + L D+ ++ + +
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY----------LVYQM 126
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
L Y+H++ IIHRD+K N+ ++ + +K+ DFGL+R ++T GYV
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVV 176
Query: 453 PEYHQCYQL-------TDKSDVYSFGVVLIELIS 479
+++ ++ D++S G ++ E+++
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 58/249 (23%), Positives = 94/249 (37%), Gaps = 55/249 (22%)
Query: 284 FSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNY---RRVEQFMNEVEILTRLRHKN 339
F + K LG G FG V + D + + A+K L + +V E +IL ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V L+ + + L V +++ G + L + G+ + E A+ +
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFPEDLARFYIAELTCAVESV 117
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGL------------------------------ 429
H IHRD+K +NIL+D + +K+ DFGL
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 430 ---------SRLFPLDVTHVSTAPQ-------GTPGYVDPEYHQCYQLTDKSDVYSFGVV 473
RL PL+ + GTP Y+ PE T D +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 474 LIELISSMP 482
L E++ P
Sbjct: 238 LYEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 49/220 (22%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 279 EATNDFSREKELGDGGFGTV---YYGKLKDGREVAVKRLYD--NNYRRVEQFMNEVEILT 333
E + +G G +G+V Y +L+ ++VAVK+L + + E+ +L
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 334 RLRHKNLVSLFGCTSRYSQG-----LLLVYEFVA---NGTVADQLHGDRAKHGLLTWPIR 385
++H+N++ L + + + LV + N V Q D L+ +R
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
L Y+H++ IIHRD+K +N+ ++ + +++ DFGL+R ++T
Sbjct: 130 ---------GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT------- 173
Query: 446 GTPGYVDPEYHQCYQL-------TDKSDVYSFGVVLIELI 478
GYV +++ ++ D++S G ++ EL+
Sbjct: 174 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 383 PIRMNIAIETA--SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-H 439
I +AIE + A+ YLH + IIHRD+K NI ++ V + DFG + FP+D+ +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINAN 238
Query: 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
GT PE D++S G+VL E+
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 52/275 (18%), Positives = 114/275 (41%), Gaps = 40/275 (14%)
Query: 298 VYYGKLKDGREVAVKRL--YDNNYRR-VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354
+Y G + +EV ++ + ++ ++ NE++ L R+ N++ ++G L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 355 ---LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-IIHRDVK 410
L+ E+ G + + L ++ L++ ++++AI+ L L+ ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 411 TNNILLDSNFCVKVADFGLSRLFPL----DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 466
+ + L+ N+ +K+ GL ++ +V + + EY T K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY------TIKDD 204
Query: 467 VYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKR 526
+YS GVVL E+ + +I NL +I +D +I+ + +
Sbjct: 205 IYSLGVVLWEIFTG-----------KIPFENLTTKEI----YDLIINKNNSLKLPLDCPL 249
Query: 527 MTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
+ E C + RP+++E+L L K
Sbjct: 250 EIKCIVE---ACTSHDSIKRPNIKEILYNLSLYKF 281
|
Length = 283 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 25/186 (13%)
Query: 305 DGREV-AVKRLYDNNYRRVE-QFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362
+GRE+ V ++ D ++R + F +++++ H +L + G R S+ ++ V EFV
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIM-VEEFVE 99
Query: 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL------ 416
+G + L ++ + W ++ +A + ASAL+YL +++H +V NILL
Sbjct: 100 HGPLDVCLRKEKG-RVPVAW--KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156
Query: 417 -DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVYSFG 471
++ +K++D G+S V P ++ PE C L+ +D +SFG
Sbjct: 157 EGTSPFIKLSDPGVSFTALSREERVERIP-----WIAPE---CVPGGNSLSTAADKWSFG 208
Query: 472 VVLIEL 477
L+E+
Sbjct: 209 TTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 45/216 (20%), Positives = 88/216 (40%), Gaps = 33/216 (15%)
Query: 287 EKELGDGGFGTVYYGK-----------------LKDGREVAVKRLYDNNYR--RVEQFMN 327
+K +G GGFG VY + L++ V +Y+N Y ++ + N
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 328 EVEILTRLRHKNLVSLFGCTS-RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRM 386
+ + H + +GC S + + + Y F+ + + + +
Sbjct: 77 ----IHNIDHLGIPKYYGCGSFKRCR---MYYRFILLEKLVENTKEIFKRIKCKNKKLIK 129
Query: 387 NIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ- 445
NI + + L Y+H I H D+K NI++D N + D+G++ F + H+ + +
Sbjct: 130 NIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 446 -----GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIE 476
GT Y + H +T + D+ S G +++
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD- 452
SA+ Y+H IIHRD+KT N+L++ + + DFG + + + G G VD
Sbjct: 271 SAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF--ARGSWSTPFHYGIAGTVDT 328
Query: 453 --PEYHQCYQLTDKSDVYSFGVVLIE 476
PE T D++S G+V+ E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 62/258 (24%), Positives = 93/258 (36%), Gaps = 73/258 (28%)
Query: 284 FSREKELGDGGFGTVYYG-KLKDGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKN 339
F + K LG G FG V K+ A+K L N +V E +IL ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI---------AI 390
+V L+ + + L V +++ G + L IRM +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLL-------------IRMEVFPEVLARFYIA 108
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF----------------- 433
E A+ +H IHRD+K +NIL+D + +K+ DFGL F
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 434 ----PLDV----------THVSTAPQ---------------GTPGYVDPEYHQCYQLTDK 464
P D+ + T Q GTP Y+ PE T
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 465 SDVYSFGVVLIELISSMP 482
D +S GV+L E++ P
Sbjct: 229 CDWWSVGVILFEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 30/106 (28%), Positives = 44/106 (41%), Gaps = 9/106 (8%)
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
A E AL LH I+ RD+ NNILLD +++ F +V
Sbjct: 91 AAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDGEAVEN 146
Query: 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVD-----MNRH 489
Y PE + T+ D +S G +L EL++ V+ +N H
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTH 192
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 36/155 (23%), Positives = 54/155 (34%), Gaps = 20/155 (12%)
Query: 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS-- 342
S K L G VY KD +K + + EV IL L K L
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDED-YVLKIN--PSREKGADREREVAILQLLARKGLPVPK 57
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+ LL E++ G D++ + +IA + A LA LH
Sbjct: 58 VLASGESDGWSYLL-MEWIE-GETLDEVSEE-------EKE---DIAEQLAELLAKLHQL 105
Query: 403 DI---IHRDVKTNNILLDSNFCVKVADFGLSRLFP 434
+ H D+ NIL+D + + D+ + P
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 31/136 (22%), Positives = 53/136 (38%), Gaps = 23/136 (16%)
Query: 305 DGREVAVKRLYDNNYR--------RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356
G + +K +YR R E+ NE +L+R R G + +
Sbjct: 16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR------KAGVNTPV---VYD 66
Query: 357 VYEFVANGT-VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415
V N T V + + G K + + E + LH + I+H D+ T+NI+
Sbjct: 67 VDPD--NKTIVMEYIEGKPLKD--VIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNII 122
Query: 416 LDSNFCVKVADFGLSR 431
+ + + DFGL +
Sbjct: 123 VRDDKLY-LIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 15/52 (28%), Positives = 24/52 (46%), Gaps = 1/52 (1%)
Query: 380 LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
R ++ E + LH + I+H D+ T+NI+L + DFGL
Sbjct: 89 ALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 29/136 (21%), Positives = 51/136 (37%), Gaps = 26/136 (19%)
Query: 306 GREVAVKRLYDNNYR--------RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357
GR+ +K YR R E+ E +L+ R G + +
Sbjct: 356 GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR------RAGVPTPV------I 403
Query: 358 YEF-VANGT-VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415
Y+ T V + + G K L + + +A LH + I+H D+ T+N +
Sbjct: 404 YDVDPEEKTIVMEYIGGKDLKDVLEG---NPELVRKVGEIVAKLHKAGIVHGDLTTSNFI 460
Query: 416 LDSNFCVKVADFGLSR 431
+ + + DFGL +
Sbjct: 461 VRDDRLY-LIDFGLGK 475
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 625 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.01 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.42 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.39 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.84 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.81 | |
| PLN02236 | 344 | choline kinase | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.43 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.2 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.06 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.85 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.82 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.45 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.29 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.11 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=424.07 Aligned_cols=289 Identities=48% Similarity=0.760 Sum_probs=246.9
Q ss_pred CccccChHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeee
Q 047969 268 GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347 (625)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 347 (625)
....|+|.++.++|++|...+.||+|+||.||+|...+|+.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999988665433134599999999999999999999998
Q ss_pred eeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCCCEEECCCCeEEE
Q 047969 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD---IIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 348 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---ivHrDikp~NIll~~~~~~kl 424 (625)
.+.++..+||||||++|+|.++|+..... .|+|..+++|+.++|+||+|||... ||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 87554589999999999999999864322 7899999999999999999999864 999999999999999999999
Q ss_pred cccccccccCC-CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 425 ADFGLSRLFPL-DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 425 ~DFgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
+|||+|+..+. ....... ..||.+|+|||++..+.++.|+|||||||+|+||++|+++.+......+..+..|....+
T Consensus 219 sDFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999977654 2221111 179999999999998899999999999999999999999998776556666888888888
Q ss_pred hhcccccccCCcCC-CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 504 QKCAFDELIDPCLG-FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 504 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.+..+.+++|+.+. ...... .....+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88899999999876 232211 223357889999999999999999999999966554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=388.07 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=213.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++.+.++.||+|..|+||+++++ +++.+|+|.+... +....+++.+|+++++..+||+||++||++......+.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35566789999999999999988 7888999999544 345568899999999999999999999977764446999999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||++|+|++.+. ..+.+++....+|+.+|++||.|||. ++||||||||+||||+..|.+||+|||.++.....
T Consensus 159 YMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999996 34679999999999999999999995 89999999999999999999999999999876433
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
...+.+||..|||||.+++..|+.++||||||++++|+++|+.|+....... ... -.....|..+..+.
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~-~~Ll~~Iv~~ppP~-------- 301 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDI-FELLCAIVDEPPPR-------- 301 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCH-HHHHHHHhcCCCCC--------
Confidence 4567789999999999999999999999999999999999999997652111 111 11112222211111
Q ss_pred CChHHHH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 519 ESDEEVK-RMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 519 ~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
... .+++++++|+..||++||.+|||++|+++|-.-.+..
T Consensus 302 ----lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 302 ----LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ----CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 111 4778999999999999999999999999986554433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=383.49 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=209.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH-------HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR-------RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
.+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+.... ......+|+++|++|+|||||++++++.. ..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CC
Confidence 356888999999999999999866 8999999999654211 12335799999999999999999996665 66
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC---CeEEEccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN---FCVKVADFGL 429 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~---~~~kl~DFgl 429 (625)
..||||||++||.|.+.+- .++.+.+..-..++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 6799999999999999985 55668888889999999999999999999999999999999765 7899999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCC--C-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ--L-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
|+... ......+.+||+.|.|||++.+.. + ..+.|+||+||+||-+++|.+||....... .....+.++
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~G 397 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILKG 397 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhcC
Confidence 99864 344456789999999999997653 3 347899999999999999999997554321 122333444
Q ss_pred ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+. .....+.+++.+..++|.+||..||++|||+.|+++|-+
T Consensus 398 ~y~---------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 398 RYA---------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ccc---------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 332 123456788999999999999999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=378.67 Aligned_cols=202 Identities=34% Similarity=0.608 Sum_probs=181.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
..+|...++||+|+||+||+|+++ ++..||||.+... +....+.+..|+.+|+.++|||||+++++... .+.++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence 468999999999999999999987 7899999999665 56677888999999999999999999996555 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC------CeEEEccccccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN------FCVKVADFGLSR 431 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~------~~~kl~DFgla~ 431 (625)
||||+||+|.++++ +.+.+++..+..++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999996 44579999999999999999999999999999999999999764 568999999999
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRH 489 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~ 489 (625)
... ......+.+|++.|||||++...+|+.|+|+||+|+++|++++|++||+....
T Consensus 164 ~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 164 FLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 875 33344567899999999999999999999999999999999999999986544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=395.73 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=213.1
Q ss_pred cCCCccceecccCcEEEEEEEE-cCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKL-KDGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.+|...+.||+|||+.||.++. ..|..||+|++.+. .....+.+.+|++|.++|+|||||++++++.+ .+.+|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence 4799999999999999999998 68999999998653 33456788999999999999999999996655 7889999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
.|+|..++|..+++ +.+.+++.+++.++.||+.||.|||+++|+|||||..|+|++++.++||+|||||.....+.
T Consensus 97 LELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999996 55679999999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
....+.+|||.|+|||++.....+..+||||+|||||-||.|+|||+...-. .....+....+.
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------ety~~Ik~~~Y~-------- 236 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------ETYNKIKLNEYS-------- 236 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------HHHHHHHhcCcc--------
Confidence 3346778999999999999889999999999999999999999999765322 222333222111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+..++.+.++||.++|+.+|.+|||+++|+.+=
T Consensus 237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1124566889999999999999999999999873
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=365.50 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=217.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeee-eeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~~~~l 356 (625)
..+|+++++||+|.||+||++... +|..||.|.+.-. +..+.+....|+.+|++|+|||||++++ .+.+..+.++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 457999999999999999999855 8999999998533 4456678899999999999999999999 34444555899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA--SD--IIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--~~--ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
||||+.+|+|.+.++..+.....++++.+|+++.|+++||..+|. .+ |+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999998887788899999999999999999999999 45 99999999999999999999999999998
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
+..+. ......+|||.||+||.+.+.+|+.||||||+||++|||+.=++||.+.+ ......+|..+.+..+-
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcCCCCCCc
Confidence 76543 23455789999999999999999999999999999999999999997652 12234555555443221
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..-++..+.++|..|+..||+.||+.-.++..+.
T Consensus 250 -----------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 -----------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 2357889999999999999999998655554443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=384.64 Aligned_cols=261 Identities=34% Similarity=0.523 Sum_probs=210.5
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+..+.+.||+|+||+||+|.+.....||||++..... ...+.|.+|+.+|++++|||||+++|++.+......|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 4445566999999999999997444499999865432 22678999999999999999999999887754468999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCCCEEECCCC-eEEEcccccccccCCCcc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-IIHRDVKTNNILLDSNF-CVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-ivHrDikp~NIll~~~~-~~kl~DFgla~~~~~~~~ 438 (625)
+++|+|.++++.. ....+++..++.|+.|||+||+|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999999753 4567999999999999999999999999 99999999999999997 99999999998754322
Q ss_pred ccccCCCCCCCccCccccc--cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 439 HVSTAPQGTPGYVDPEYHQ--CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
...+...||+.|||||+++ ...|+.|+||||||+++|||+||+.||...... ..... ....... +.+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~---v~~~~~R-----p~~ 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASA---VVVGGLR-----PPI 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhcCCC-----CCC
Confidence 2233467999999999999 568999999999999999999999999765431 11111 1111111 111
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
. ...+..+..++.+||..||+.||++.+++..|+.+.....
T Consensus 268 p-------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 268 P-------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred C-------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1 1145578889999999999999999999999998876443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=353.57 Aligned_cols=268 Identities=23% Similarity=0.358 Sum_probs=215.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
+.|+.+.++|+|+||+||+++++ +|+.||||++.+. +....+-.++|+++|++|+|+|+|.+++++.. .+.++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence 57888999999999999999988 6999999999654 33344567899999999999999999997666 67899999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||++.--| +.|.. ....++.+.+.+++.|+++|+.|+|++++|||||||+||||+.+|.+||+|||+|+.... ..
T Consensus 81 E~~dhTvL-~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 81 EYCDHTVL-HELER---YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred eecchHHH-HHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99987444 44432 333488999999999999999999999999999999999999999999999999998764 34
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---------ccc
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---------CAF 508 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~ 508 (625)
...+..+.|.+|+|||.+.+ .+|+...||||+||++.||++|.+.|.+..+-.+.+.+......+.. ..|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 45577889999999999877 68999999999999999999999999987776666655554433221 111
Q ss_pred ccccCCcC--CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 DELIDPCL--GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+.-|.. ....+.....++..+.+|+..||+.||++|++-+|++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 21111111 111222344566788999999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=371.63 Aligned_cols=271 Identities=24% Similarity=0.337 Sum_probs=219.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~l 356 (625)
.+.|+.+++||+|.||.||+|+.. +|+.||+|++..++ .....-..+||.||++|+||||+++.+..... ...+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 457888899999999999999865 89999999986554 33445567999999999999999999966654 568999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
|+|||+. +|..++.. ..-.+++.++..++.||+.||+|+|.+||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 78888753 3345999999999999999999999999999999999999999999999999999998877
Q ss_pred ccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc--cc--
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD--EL-- 511 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 511 (625)
.....+..+-|.+|+|||++.+. .|+.+.|+||.||||.||+.|++.|.+.....+++.+-.....-.+..+. .+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 77777888899999999998775 79999999999999999999999998876555444333333222222111 11
Q ss_pred ---cCCcCC--CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 ---IDPCLG--FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ---~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+... ....+..+.++....+|+..+|..||++|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111 11234466778888999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=375.87 Aligned_cols=257 Identities=30% Similarity=0.509 Sum_probs=215.5
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
+.++.++.||+|-||.||.|++.....||+|.+..... ..+.|.+|+++|++|+|+|||++++++.. .+.++||||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEec-CCceEEEEEec
Confidence 45667789999999999999998777999999976533 34789999999999999999999998876 34799999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
+.|+|.++|.. ..+..+...+.+.++.|||+||+||+++++|||||...||||+++..+||+|||||+....+.....
T Consensus 284 ~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 284 PKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred ccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999999974 2456799999999999999999999999999999999999999999999999999996655555555
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....-...|.|||.+....++.|||||||||+||||+| |+.|+....... ....+.++.-
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~GyR------------ 422 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGYR------------ 422 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccCc------------
Confidence 55667889999999999999999999999999999999 888886543322 1222222210
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
-+.+..+++++.+++..||+.+|++|||++.+...|+.+..
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 01122467789999999999999999999999999988765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=359.24 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=202.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++++.||+|+||.||+++.+ +++.+|+|++.+... ...+..++|..+|.+++||.||+++..+. ..+.+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-t~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-TEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-cCCeEEE
Confidence 468999999999999999999876 688999999976532 34677889999999999999999997554 4788999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
|+||+.||.|...|. +++.+++..+.-++.+|+.||.|||++|||||||||+|||||.+|+++|+||||++..-..
T Consensus 103 Vld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999996 5677999999999999999999999999999999999999999999999999999864332
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+... ....+.++....
T Consensus 179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~~~------ 244 (357)
T KOG0598|consen 179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKLPL------ 244 (357)
T ss_pred -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcCCC------
Confidence 223345789999999999999999999999999999999999999997654322 122222222110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP 547 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 547 (625)
...-++.+.++++.++|+.+|++|.
T Consensus 245 ------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 ------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 0112455788999999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=367.94 Aligned_cols=270 Identities=25% Similarity=0.351 Sum_probs=214.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHH--HHHHHHHHHhcC-CCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQ--FMNEVEILTRLR-HKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 355 (625)
..++|.++++||.|.||.||+|+.+ +|..||||++++.-.. .++ -++|+..|++|+ |||||++.+++.+....++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4579999999999999999999866 7899999998655322 233 368999999998 9999999998887666899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+|||||+. +|.++++. ++..+++..+..|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||||+....
T Consensus 87 fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999975 99999964 466899999999999999999999999999999999999999999999999999997643
Q ss_pred CccccccCCCCCCCccCcccc-ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc----
Q 047969 436 DVTHVSTAPQGTPGYVDPEYH-QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE---- 510 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 510 (625)
....+.++.|.+|+|||++ +..-|+.+.|||++|||++|+++=++.|.+...-+++...-.++..-.+....+
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3445778899999999976 567899999999999999999999999987665444433322221111111111
Q ss_pred --ccC----CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 511 --LID----PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 511 --~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+. +..+..........+.+..++|.+|++.||++|||+.|++++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 011 1111222223334677889999999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.18 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=207.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-eEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ-GLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e 359 (625)
.+|...+.||+|+||+||++.+. +|...|||.+...+....+.+.+|+.+|++++|||||+++|....... .++|.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 46888899999999999999977 489999999866544446778999999999999999999995343333 6899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEcccccccccCC--C
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPL--D 436 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgla~~~~~--~ 436 (625)
|+++|+|.+++... ++.|++..+..++.||++||+|||++|||||||||+||||+. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999632 226999999999999999999999999999999999999999 79999999999987653 1
Q ss_pred ccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.........||+.|||||++..+ ....++|||||||++.||+||++||... .....+..........+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P------ 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP------ 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC------
Confidence 12223457899999999999853 3345999999999999999999999753 11111122111111111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.....++.+..+|+.+|++.+|++||||+++++|.-....
T Consensus 243 ------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 ------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1122366788999999999999999999999998765443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.79 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=211.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
..|+...+||+|+.|.||.|+.. +++.||||++........+.+++|+.+|+..+|+|||.+++.+.. ++.+|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEEEee
Confidence 46777789999999999999855 789999999987777777889999999999999999999996554 4779999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
|+||+|.+.+. ...+++.++..|+.++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+......
T Consensus 352 m~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 352 MEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred cCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 99999999984 334899999999999999999999999999999999999999999999999999887655543
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
..+.+||+.|||||+.....|++|.||||||++++||+.|.+||-..+.-..++ .+...-...+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-------LIa~ng~P~l--------- 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPKL--------- 489 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-------HHhhcCCCCc---------
Confidence 456789999999999999999999999999999999999999995433222111 1111111111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....++..+++|+.+||+.|+++|++++|||+|
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1234678899999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=362.26 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=210.7
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.+..++|...+.||+|+|++|++|+.+ .++.+|||++.+.- ....+.+..|-.+|.+| .||.|++||. .+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~-TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF-TFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE-Eeeccc
Confidence 445678999999999999999999866 79999999985442 22345577899999999 7999999997 555678
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.+|+|+||+++|+|.++|+ +.+.+++..++.++.||+.||+|||++|||||||||+|||||.++++||+|||.|+.
T Consensus 148 sLYFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ceEEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 8999999999999999996 567899999999999999999999999999999999999999999999999999998
Q ss_pred cCCCccc----------cc--cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH
Q 047969 433 FPLDVTH----------VS--TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 433 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~ 500 (625)
+...... .. ...+||..|.+||++.....+..+|||+||||||+|+.|++||...+.- ...
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liF 296 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIF 296 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHH
Confidence 7543222 11 3468999999999999999999999999999999999999999765431 122
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+|....+. ....+++.+.+||.++|..||.+|++.+||.+|.
T Consensus 297 qkI~~l~y~-------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 QKIQALDYE-------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHhccc-------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 233322111 0113345788999999999999999999998873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=349.15 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=212.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||.|.-++||+|+.. .+..||||++.-+.. ...+.+.+|+..|+.++||||++++..|.. +..+|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEee
Confidence 468999999999999999999965 679999999965433 336889999999999999999999986555 67899999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
.||.+|++.+.+...-.. .+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+.....
T Consensus 104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999999754433 399999999999999999999999999999999999999999999999997754432211
Q ss_pred ---ccccCCCCCCCccCccccc--cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 439 ---HVSTAPQGTPGYVDPEYHQ--CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 439 ---~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
......+||+.|||||++. ...|+.|+||||||++..||++|..||..... .......++.. .....
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~-pp~~~- 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQND-PPTLL- 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCC-CCCcc-
Confidence 1114568999999999843 35799999999999999999999999964322 22222333222 11111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......+..+.++..+++++..||++||++|||+.+++++
T Consensus 254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 2334556677888899999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=328.89 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=210.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHH--HHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+|..+++||+|.||.||+|++. +|+.||||++...+... ....++|++.|+.++|+||+.+++++.. ...+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence 47888999999999999999865 89999999997554331 2446899999999999999999997665 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|||+. +|...++ .+...++...+..++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.....
T Consensus 81 Efm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred Eeccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99975 8988885 3566799999999999999999999999999999999999999999999999999999865443
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc--
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC-- 515 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 515 (625)
.. +..+-|.+|+|||.+.+ ..|+...|+||.|||+.||+-|.|.|.+..+-+ ....+.+.+.....+++-+-.
T Consensus 157 ~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid---QL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID---QLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH---HHHHHHHHcCCCCcccCcccccc
Confidence 32 33368999999998866 479999999999999999999999998765433 333333333332222221110
Q ss_pred -----CC----CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 -----LG----FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 -----~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+. ..........+....+|+.++|..||.+|.++.|+++|=
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 00 000112234456778999999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.43 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=207.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+++|+.+++++ +||||+++++++.....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999742 35679999986532 33456789999999999 89999999997766566
Q ss_pred eEEEEEEeccCCChHHHhccCccc--------------------------------------------------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAK-------------------------------------------------------- 376 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 376 (625)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 789999999999999998642210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCc
Q 047969 377 --HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDP 453 (625)
Q Consensus 377 --~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aP 453 (625)
...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++........ ......++..|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 235888999999999999999999999999999999999999999999999999865332221 12234567889999
Q ss_pred cccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHH
Q 047969 454 EYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVA 532 (625)
Q Consensus 454 E~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 532 (625)
|++.+..++.++||||||+++|||++ |..||....... .....+....... . ....+..+.
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~-----~-------~~~~~~~l~ 307 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR-----A-------PENATPEIY 307 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC-----C-------CCCCCHHHH
Confidence 99988889999999999999999997 999997543211 1111111111100 0 012345788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 533 ELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 533 ~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
+++.+||+.+|++|||+.++++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=359.45 Aligned_cols=267 Identities=26% Similarity=0.444 Sum_probs=214.2
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
.++....+++.+...||+|.||+||+|++.. .||||++... .....+.|.+|+.++++-+|.||+-++|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-- 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-- 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--
Confidence 4555566778889999999999999999873 5999998644 345788999999999999999999999987763
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.+.||+.+++|-+|..+++..+ ..+.....++|+.||++|+.|||.++|||||||..|||+.++++|||+||||+..
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred ceeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 3499999999999999998543 4588899999999999999999999999999999999999999999999999975
Q ss_pred cCC-CccccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 433 FPL-DVTHVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 433 ~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
-.. ..........|...|||||+++. .+|++.+||||||+++|||++|..|+.....+..+... ..+.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG~- 609 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRGY- 609 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------cccc-
Confidence 322 12222344568899999998863 47999999999999999999999999843322221111 1110
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
+...........++++++|+..||..++++||.+.+|+..|+.+....
T Consensus 610 -------l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 610 -------LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -------cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 111122233456678999999999999999999999999988877643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=347.54 Aligned_cols=263 Identities=27% Similarity=0.380 Sum_probs=206.8
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH--------------HHHHHHHHHHHHHhcCCCCeee
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR--------------RVEQFMNEVEILTRLRHKNLVS 342 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~ 342 (625)
.+..++|++++.||+|.||.|-+|+.. +++.||||++.+.... .++...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345689999999999999999999976 7999999998544221 2467899999999999999999
Q ss_pred eeeeeee-ccceEEEEEEeccCCChHHHhccCcccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 047969 343 LFGCTSR-YSQGLLLVYEFVANGTVADQLHGDRAKHGL-LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF 420 (625)
Q Consensus 343 ~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~ 420 (625)
++++..+ ..+.+|||+|||..|.+..-- .... |++.++++++.+++.||+|||.+|||||||||+|+||+++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9996654 456799999999988754332 2233 99999999999999999999999999999999999999999
Q ss_pred eEEEcccccccccCCCccc----cccCCCCCCCccCccccccCC----CCCchhhhhHHHHHHHHHhCCCCCcccccccc
Q 047969 421 CVKVADFGLSRLFPLDVTH----VSTAPQGTPGYVDPEYHQCYQ----LTDKSDVYSFGVVLIELISSMPAVDMNRHRHE 492 (625)
Q Consensus 421 ~~kl~DFgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwslG~il~elltG~~p~~~~~~~~~ 492 (625)
++||+|||.+..+...... ......||+.|+|||...+.. -+.+.||||+||+||.|+.|+.||-....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 9999999999876322111 112367999999999876532 35678999999999999999999964321
Q ss_pred cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 493 INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
.....+|. +..+.+...+ ++...+++||.++|.+||+.|.+..+|..|.+..+...
T Consensus 325 ----~~l~~KIv--------n~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 325 ----LELFDKIV--------NDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred ----HHHHHHHh--------cCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 11222222 2222222222 34567889999999999999999999999987766533
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=327.04 Aligned_cols=237 Identities=32% Similarity=0.447 Sum_probs=201.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|+.++.||.|+||.|.+++.+ +|..+|+|++.+... ...+...+|..+|+.+.||.++++++-+. +...++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-DNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-cCCeEEE
Confidence 468999999999999999999977 788999999976533 45667889999999999999999998444 4778999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||.|..+++ +.++++++.++-++.||+.||+|||+.+|++|||||+|||||.+|.+||+|||.|+.....
T Consensus 122 vmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999996 5667999999999999999999999999999999999999999999999999999976432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.-+.+|||.|+|||+++...+..++|-|||||++|||+.|.+||-..+. .....+|.++.+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~------- 259 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVK------- 259 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCccc-------
Confidence 3456899999999999999999999999999999999999999976543 2233344333221
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCC
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELR 546 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 546 (625)
+ +.-++.++.+|+..+|+.|-.+|
T Consensus 260 -f-----P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -F-----PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -C-----CcccCHHHHHHHHHHHhhhhHhh
Confidence 0 11245578899999999999988
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.39 Aligned_cols=252 Identities=29% Similarity=0.416 Sum_probs=206.5
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc----cH-HHHHHHHHHHHHHHhcC-CCCeeeeeeeeeecc
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN----NY-RRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYS 351 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 351 (625)
...++|.+.+.||+|+||.|++|++. +++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++.. .
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-P 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-C
Confidence 34578999999999999999999865 7899999976543 11 23455668999999999 9999999997665 4
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLS 430 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla 430 (625)
..+++||||+.||+|.+++. ..+++.+..+..++.|++.|++|+|++||+||||||+|||++.+ +++||+|||++
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 55999999999999999996 35679999999999999999999999999999999999999999 99999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccccCC-CC-CchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ-LT-DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+. ......+..+.+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PNLYRKIRKGEF 240 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HHHHHHHhcCCc
Confidence 9764 2233456778999999999998876 76 689999999999999999999986321 112222333322
Q ss_pred ccccCCcCCCCChHHHHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 509 DELIDPCLGFESDEEVKRM-TTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.- ...+ +.++..++.+||..+|..|+++.+++++=
T Consensus 241 ~~-------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 241 KI-------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred cC-------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 10 0012 56788999999999999999999999543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=351.84 Aligned_cols=247 Identities=30% Similarity=0.435 Sum_probs=209.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+. ...+.+.+.+|++|++.++|||||.+++++.. ..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence 67888999999999999999977 7889999998654 34557789999999999999999999996554 78899999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.| +|..+|. ..+.++++.+..|+.+++.||.|||+.+|+|||+||.|||++.+|.+|++|||+|+.... ..
T Consensus 81 e~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 99987 9999996 556799999999999999999999999999999999999999999999999999997643 34
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
...+...|||-|||||+..+..|+..+|+||+||++|||+.|+|||-... .....+.|.....
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~v---------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDPV---------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCCC----------
Confidence 44566789999999999999999999999999999999999999995321 1111122222111
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+..++..+..|+..+|.+||..|.+-.+++.|
T Consensus 218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122677789999999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=348.80 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=204.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
..++|++++.||+|+||.||+|+.+ +|..+|+|++.+... ..++.++.|-.+|...++|.||++|..+. +.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ-D~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ-DKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec-CCCeeE
Confidence 4679999999999999999999976 799999999977644 34667889999999999999999998554 478899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
|||||++||++..+|. +.+.|++..+..++.+++-|++-||+.|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999995 667899999999999999999999999999999999999999999999999999853311
Q ss_pred -----------------------Cccc-----------------------cccCCCCCCCccCccccccCCCCCchhhhh
Q 047969 436 -----------------------DVTH-----------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYS 469 (625)
Q Consensus 436 -----------------------~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvws 469 (625)
+... .....+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 001124999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC--
Q 047969 470 FGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-- 547 (625)
Q Consensus 470 lG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-- 547 (625)
||||+||||.|.+||........ .+++.... ..+.+.... ..+++..+||.+||. ||++|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr------~~l~fP~~~---~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQET-------YRKIVNWR------ETLKFPEEV---DLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHh------hhccCCCcC---cccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999987654321 12221110 011111111 234688899999999 999995
Q ss_pred -CHHHHHHH
Q 047969 548 -SMEEVLAE 555 (625)
Q Consensus 548 -s~~ell~~ 555 (625)
.++||.+|
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 57777665
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=348.23 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=208.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..|+.++.||+|.||.||+|.+. .++.||+|++... ....++++.+|+.+|.+++++||.++|+.+.. +..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHH
Confidence 46777889999999999999865 7889999998543 44567889999999999999999999996665 677899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+.||++.+.|. ....+.+..+.-|+++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+.........
T Consensus 92 y~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999995 3444588888889999999999999999999999999999999999999999999876554433
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
. .+.+||+.|||||++++..|+.|+||||||++.+||++|.+|+....+...+.+. .+...+
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~PP---------- 229 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSAPP---------- 229 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCCCC----------
Confidence 3 6778999999999999889999999999999999999999999755442222111 111111
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+++.+++|+..||.++|+.||++.+++++
T Consensus 230 --~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 --RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1112567789999999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=334.98 Aligned_cols=272 Identities=24% Similarity=0.326 Sum_probs=213.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEec--cccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee----ccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLY--DNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR----YSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 352 (625)
....|..++.||+|+||.|..|..+ +|+.||||++. -.+....++..+|+++|+.++|+||+.+++++.. .-+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777889999999999999877 78999999986 3455667888999999999999999999986543 345
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.+|+|+|+|+ -+|.+.++ .+..|+.+.+..++.||++||+|+|+.+|+||||||+|+|++.+..+||+|||+|+.
T Consensus 100 DvYiV~elMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 6899999994 58888885 444599999999999999999999999999999999999999999999999999998
Q ss_pred cCCCc-cccccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH--------H
Q 047969 433 FPLDV-THVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN--------K 502 (625)
Q Consensus 433 ~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~ 502 (625)
..... ....+..+-|.+|+|||++. ...|+.+.||||.||||.||++|++-|.+.+.-.++.+...... .
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 75331 12235678899999999874 45799999999999999999999999988776555443332221 1
Q ss_pred hhhcccccccC---CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 503 IQKCAFDELID---PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 503 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+........+. +..............+...+++.+||..||.+|+|++|.++|-
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11111111111 1111222333445667888999999999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.34 Aligned_cols=269 Identities=23% Similarity=0.288 Sum_probs=203.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence 47999999999999999999987 68889999986432 2335678899999999999999999996654 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||++++.+..+.. ....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 80 EYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999887765542 234689999999999999999999999999999999999999999999999999987643322
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh---------hcccc
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ---------KCAFD 509 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 509 (625)
.......|++.|+|||++.+..++.++||||||+++|+|++|++||..................+. ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223345689999999999888899999999999999999999999976443221111111000000 00000
Q ss_pred cccCCcCCCCC---hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ELIDPCLGFES---DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....+...... ......++.++.+|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 11122356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.36 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=214.2
Q ss_pred cCCCccceecccCcEEEEEEEEcCC-cEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeee-eeee----c-cce
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDG-REVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFG-CTSR----Y-SQG 353 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~----~-~~~ 353 (625)
.++++.+.|.+|||+.||+|+...+ ..||+|++.-.+....+.+++|+.+|++|+ |+|||.+++ .... . ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4778899999999999999998755 999999998888889999999999999997 999999999 3221 1 235
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECCCCeEEEccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
++|.||||.||.|.++|.... ...|++.++++|+.|+++|+++||... |||||||-+||||+.+|..||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 789999999999999997433 234999999999999999999999997 9999999999999999999999999987
Q ss_pred ccCCCcccc--------ccCCCCCCCccCcccc---ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH
Q 047969 432 LFPLDVTHV--------STAPQGTPGYVDPEYH---QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 432 ~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~ 500 (625)
..-...... ......|+.|+|||++ .+...++|+|||+|||+||-|+....||+....-.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------- 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------- 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence 532211100 0123479999999976 56789999999999999999999999998653211
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCCccc
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFE 567 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~~~~ 567 (625)
+++-...+.. ...+++.+.+||+.||+.+|++||++-|+++.+.++........
T Consensus 266 ----------Ilng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 266 ----------ILNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ----------EEeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 1111111111 24678899999999999999999999999999999887765443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.42 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=200.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++.. .+..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEE
Confidence 3778899999999999999875 799999999864322 223457899999999999999999986655 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 80 TIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred EecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999999887532 23458999999999999999999999999999999999999999999999999998653222
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......||..|+|||++.+..++.++||||||+++|+|++|+.||......... ......+....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------- 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ----------- 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc-----------
Confidence 123456899999999999889999999999999999999999999754332111 11111111100
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAEL 556 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L 556 (625)
......++..+.+|+.+||+.||++||+ +++++++-
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 0011234567889999999999999997 88888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=339.46 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=200.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD-----------------GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVS 342 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 342 (625)
.++|++.++||+|+||.||+|++.+ +..||+|.+... .......|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3689999999999999999997532 336999998654 2334567999999999999999999
Q ss_pred eeeeeeeccceEEEEEEeccCCChHHHhccCcc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 047969 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA---------------KHGLLTWPIRMNIAIETASALAYLHASDIIHR 407 (625)
Q Consensus 343 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 407 (625)
+++++.. ....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.||+||
T Consensus 84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 84 LLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9997665 4568999999999999998854221 12357889999999999999999999999999
Q ss_pred CCCCCCEEECCCCeEEEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh--CCCCC
Q 047969 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAV 484 (625)
Q Consensus 408 Dikp~NIll~~~~~~kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt--G~~p~ 484 (625)
||||+|||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986533221 11223456789999999988889999999999999999987 45666
Q ss_pred cccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 485 DMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
......... ........... .... ... ....+..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 243 ~~~~~~~~~---~~~~~~~~~~~-~~~~---~~~-----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELTDEQVI---ENAGEFFRDQG-RQVY---LFR-----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCCHHHHH---HHHHHHhhhcc-cccc---ccC-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 543322111 11111111000 0000 000 0123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=334.96 Aligned_cols=247 Identities=18% Similarity=0.274 Sum_probs=199.0
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceEEEEEEec
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGLLLVYEFV 361 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~~ 361 (625)
..||+|++|.||+|++ +|+.||||++..... ...+.|.+|+.+|++++|||||++++++.+ .....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 689999999865432 235778899999999999999999997654 234679999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
++|+|.+++.. .+.+++...+.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 99999999963 34689999999999999999999985 9999999999999999999999999999865322
Q ss_pred ccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 441 STAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.....|+..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+...... ..+.
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~----~~~~- 244 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-------IYDLIINKNNS----LKLP- 244 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcCCC----CCCC-
Confidence 123457899999999876 578999999999999999999999997543211 11111111000 0000
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 245 ------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 245 ------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1235578899999999999999999999999988763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.45 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=214.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+-|++.+.||.|+-|.|-+|++. +|+.+|||++.+. .......+.+|+-||+.+.|||++++|+++.. ..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEE
Confidence 46888999999999999999976 8999999998654 12234557899999999999999999997665 7789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
.||++||.|.++|. ..+.+++.++.++++||+.|+.|+|..+|+||||||+|+|||..+++||+|||+|.+-. .
T Consensus 91 lEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--P 164 (786)
T ss_pred EEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--C
Confidence 99999999999995 66789999999999999999999999999999999999999999999999999998632 2
Q ss_pred cccccCCCCCCCccCccccccCCCC-CchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLT-DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....+.+|++.|.|||++.+..|. .++||||-|||||.||+|+.||+..+ ....+.+++.+.++-
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f~M------ 231 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVFEM------ 231 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcccC------
Confidence 3444677899999999999998875 58999999999999999999998543 334455666665431
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
+..++.+.++|+.+||..||+.|.|++||++|-.-
T Consensus 232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred -------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 13466788999999999999999999999998543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=348.51 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=204.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ....+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence 47899999999999999999987 68899999986542 2345678899999999999999999986654 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 80 MEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999999999995 345689999999999999999999999999999999999999999999999999986432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......||+.|+|||++.+..++.++||||||+++|||++|..||......... ..+.... ..+..+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~-~~~~~~~~- 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-------ENLKYWK-ETLQRPVY- 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-------HHHHhcc-ccccCCCC-
Confidence 223456899999999998889999999999999999999999999754322111 1111100 00000000
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
......++.++.+++.+||+.+|++||++++++++-
T Consensus 223 ---~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 ---DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ---CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 000123566788999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=323.19 Aligned_cols=272 Identities=21% Similarity=0.282 Sum_probs=207.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHH--HHHHHHHHHHHHhcCCCCeeeeeeeee-eccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVSLFGCTS-RYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~~ 355 (625)
..++|+.++.|++|.||.||+|+++ +++.||+|+++...... --.-++|+.+|.+++|||||.+-.+.. ..-+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3567999999999999999999977 78899999996543211 122478999999999999999988543 3445699
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
|||||++. +|..+++. ..+++...++..++.|+++||+|||...|+||||||+|+|+...|.+||+|||||+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999987 88888864 335789999999999999999999999999999999999999999999999999998865
Q ss_pred CccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.. ...+..+-|.+|+|||++.+. .|+...|+||+|||+.||+++++.|.+...-.+++.+-.....-.+..++.+...
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 42 334566789999999988765 6999999999999999999999999876544333322222211111111111110
Q ss_pred ----cCCCC--ChHH----HH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 ----CLGFE--SDEE----VK--RMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ----~~~~~--~~~~----~~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...+. .... .. .++..-.+|+..+|..||.+|.|++|.|++=
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 00011 1000 11 1456778899999999999999999999873
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=342.61 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=201.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence 47899999999999999999976 78999999985432 2345668899999999999999999985554 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 80 MEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 99999999999985 3346899999999999999999999999999999999999999999999999999865322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... +
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~------~- 217 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKLE------F- 217 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcC------C-
Confidence 123468999999999988889999999999999999999999996543211 11111111110 0
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAELQ 557 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L~ 557 (625)
...++..+.+++.+||+.||.+||+ +++++++-.
T Consensus 218 ------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 218 ------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 0123457889999999999999995 888887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.77 Aligned_cols=242 Identities=26% Similarity=0.404 Sum_probs=198.2
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCC
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG 364 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g 364 (625)
..++-||.|+.|.||+|+++ ++.||||++.+-+ ..+|+-|++|+||||+.+.|++.. ...++||||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-sPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-CceeEEeeeccccc
Confidence 33567999999999999996 7899999875432 247888999999999999998887 67789999999999
Q ss_pred ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCC
Q 047969 365 TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444 (625)
Q Consensus 365 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 444 (625)
-|...|+ .+..++......|..+||.||.|||.+.|||||||.-||||..+..|||+|||-++...... .....
T Consensus 198 qL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMSF 271 (904)
T KOG4721|consen 198 QLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMSF 271 (904)
T ss_pred cHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhhh
Confidence 9999996 45568889999999999999999999999999999999999999999999999998754432 23456
Q ss_pred CCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHH
Q 047969 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEV 524 (625)
Q Consensus 445 ~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (625)
.||..|||||+++..+.++|.|||||||+|||||||..|+..-+....+ | +.-...+ .. +..
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-------GVGsNsL----~L---pvP 333 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-------GVGSNSL----HL---PVP 333 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-------eccCCcc----cc---cCc
Confidence 7999999999999999999999999999999999999998643321111 0 0000000 00 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 525 KRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 525 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...++.++-|+++||+..|.+||++++++.||+..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 23456777899999999999999999999987653
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=310.46 Aligned_cols=264 Identities=20% Similarity=0.330 Sum_probs=215.2
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeee----eccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTS----RYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~~ 355 (625)
.++|++.+.||+|||+-||+++. .+++.+|+|++.-.+.+..+..++|++..++++|||+++++++.. +.+...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46899999999999999999984 478999999997777778889999999999999999999988432 2344589
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
|+++|...|+|.+.+.....++..+++.+++.|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.+...
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999999877777778999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccc--------cCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH
Q 047969 434 PLDVTHVS--------TAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 434 ~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+....... .....|..|+|||.+.- ...++++|||||||+||.|+.|..||+..-.+.+. +.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-la------ 252 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-LA------ 252 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-EE------
Confidence 43322211 12347899999998853 45789999999999999999999999754332111 00
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
..+....+.++... .++..+.++|.+||+.||.+||++.+++..++.+.
T Consensus 253 ------LAv~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ------LAVQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EeeeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01112222222222 37778999999999999999999999999988653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.46 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=200.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.++||+|+||+||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.. ....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEE
Confidence 357999999999999999999876 78899999986432 2234567899999999999999999996654 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 83 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 83 EYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred eCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99975 88888852 234578999999999999999999999999999999999999999999999999976432221
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---------c
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA---------F 508 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 508 (625)
......+++.|+|||++.+ ..++.++||||+|+++|+|++|++||..................-.... +
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1233468999999998865 5689999999999999999999999975543222211111000000000 0
Q ss_pred ccccCCcCCC-CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 DELIDPCLGF-ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+.... ........++.+..+++.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0011112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=347.45 Aligned_cols=264 Identities=20% Similarity=0.168 Sum_probs=198.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|+.. .+.+.+|++++++++|||||++++++.. ....++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEe
Confidence 368999999999999999999876 78899999743 2346789999999999999999996654 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
++. ++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 164 ~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 985 68888875 2345899999999999999999999999999999999999999999999999999754322222
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccc-cc---hhHHHHHHhhhc---------
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE-IN---LANLAINKIQKC--------- 506 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~-~~---~~~~~~~~~~~~--------- 506 (625)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+-....... .. ............
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 23345799999999999888899999999999999999999977643221100 00 000000000000
Q ss_pred -cccc----c---cCCcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 -AFDE----L---IDPCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 -~~~~----~---~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.... . ..... ..........++.++.+|+.+||+.||++|||++|++++-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0000 0 00000 0011122335677899999999999999999999999764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.08 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=205.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+++.+ ++..+|+|.+... .....+.+.+|+++|++++||||+++++++.. ....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEe
Confidence 368999999999999999999977 6888999988654 23445679999999999999999999997655 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||+++++|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999985 334589999999999999999999986 6999999999999999999999999998765322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---cc-----
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA---FD----- 509 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~----- 509 (625)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ............. ..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233468999999999998889999999999999999999999996433211 0000000000000 00
Q ss_pred ----------------------cccCCcCCCC-ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 510 ----------------------ELIDPCLGFE-SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 510 ----------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
++.+...... .......++.++.+|+.+||+.||++|||+++++++..--
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 0000000000 0000013566889999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=327.86 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=210.9
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-KDGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
..+|++.+.||+|.||.|-+|+. ..|+.||||.+.++. ..+.-.+.+|++||..|+||||+.+|.+|.. ...+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEE
Confidence 46899999999999999999985 589999999987653 3445567899999999999999999996554 778999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||..+|.|.+|+. ..+.|++.++..+++||..|+.|+|.++++|||||.+|||+|.++++||+||||+-.+...
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999995 5567999999999999999999999999999999999999999999999999999887543
Q ss_pred ccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
....+.+|++.|.+||++.+..| .+..|.||||++||.|+.|..||++.+.. ...+++..+.+.+--
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP~--- 274 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREPE--- 274 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCCC---
Confidence 33467789999999999999877 46799999999999999999999876543 233444444433211
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+....-||+|||..+|++|.|+.+|..|.+
T Consensus 275 -----------~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 275 -----------TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -----------CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1224456899999999999999999998854
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.49 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=196.3
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.||+|+||.||+|+.+ +|+.||||++.... ......+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 46999999999999876 78999999986532 2345678899999999999999999986554 6678999999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccC
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 443 (625)
|+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 80 GELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 99999885 34568999999999999999999999999999999999999999999999999987532211 11234
Q ss_pred CCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHH
Q 047969 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (625)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+..... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~------~~------- 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------RF------- 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC------CC-------
Confidence 569999999999988889999999999999999999999996533211 1111111110 00
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 524 VKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 524 ~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
...++.++.+++.+||+.||++|| ++.++++|
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 113456788999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.37 Aligned_cols=274 Identities=24% Similarity=0.344 Sum_probs=207.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCC-eeeeeeeeeeccc----
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKN-LVSLFGCTSRYSQ---- 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~---- 352 (625)
...|..+++||+|+||+||+|+.+ +|+.||+|++..... ..-....+|+.+|+.|+|+| ||+++++......
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777888999999999999976 889999999865433 12344689999999999999 9999997766443
Q ss_pred -eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 353 -GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 353 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
.+++|+||++. +|..++.........++...+..++.||++||+|||+++|+||||||+||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 78999999975 8999997544322457778999999999999999999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
.+..... ..+..++|.+|+|||++.+. .|+...||||+|||++||+++++-|.+.....+. ..+.+.+.......
T Consensus 169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLGTPNEKD 244 (323)
T ss_pred HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcCCCCccC
Confidence 6543222 24556799999999998765 7999999999999999999999999876542222 22222222211111
Q ss_pred c---c---CCcCCCCC-------hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhch
Q 047969 511 L---I---DPCLGFES-------DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRI 559 (625)
Q Consensus 511 ~---~---~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~--L~~i 559 (625)
+ . +....+.. ............+++.+||+.+|.+|.|++.+++| +..+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1 0 11101111 11112222478899999999999999999999998 5544
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.81 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=198.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----ceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----QGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 355 (625)
+|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|++++++++||||+++++++.... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999976 7899999998642 2234457889999999999999999998654322 3479
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+. ++|.+++. ....+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68888885 334689999999999999999999999999999999999999999999999999986432
Q ss_pred Ccc--ccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH--------HHHHh
Q 047969 436 DVT--HVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL--------AINKI 503 (625)
Q Consensus 436 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~~~ 503 (625)
... .......||+.|+|||++.+ ..++.++||||||+++|+|++|++||.............. ....+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 11234568999999998865 5789999999999999999999999975432211110000 00000
Q ss_pred hhcccccc---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 504 QKCAFDEL---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 504 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
........ +...............+..+.+++.+||+.+|++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000001111112345577899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.54 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=213.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|..++++|+|+||.+++++++ +++.+++|++.-.. ....+..++|+.++++++|||||.+.+.+.+.+..++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999987 78899999985432 334456789999999999999999999888766669999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|+|++||++.+.+... ++..++++.+.+++.|++.|+.|||+++|+|||||+.|||++.++.|||+|||+|+....+.
T Consensus 83 m~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999754 35679999999999999999999999999999999999999999999999999999876544
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......||+.||.||++.+.+|..|+|||||||++|||++=+++|...+-... ..++......
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------i~ki~~~~~~-------- 224 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------ILKINRGLYS-------- 224 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-------HHHHhhccCC--------
Confidence 234556899999999999999999999999999999999999999986653221 1222222111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+....++.++..+|..||+.+|+.||++.+++.+
T Consensus 225 ----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1123467789999999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=310.10 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=211.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|.||.||+|+.+ ++..||+|++.+... ....++.+|++|-..|+||||+++|+++.+ ...+||
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cceeEE
Confidence 468999999999999999999976 677899999865532 224578899999999999999999996655 778999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
++||..+|++...|... ....+++.....++.|+|.||.|+|.++|+||||||+|+|++.++.+||+|||-+...+
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999999643 34568999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....+.+||..|.+||...+...+.+.|+|++|++.||++.|.+||+... ......++.+..+. .
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~~~~---~--- 241 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKVDLK---F--- 241 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHcccc---C---
Confidence 334466789999999999999999999999999999999999999997543 12223333332211 1
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
...++...+++|.+|+.++|.+|.+..|++++-.-
T Consensus 242 -------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 242 -------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred -------CcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 12456688999999999999999999999998653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.35 Aligned_cols=272 Identities=24% Similarity=0.332 Sum_probs=206.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc----eEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ----GLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~lv 357 (625)
.|...+.+|.|+||.||+|... ++..||||++..+..- --+|+.+|+.++|||||++..++....+ ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5677789999999999999976 6789999998665432 2369999999999999999986654322 35689
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccccccCCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLD 436 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~~~~~ 436 (625)
||||+. +|.+.++.....+..++...+.-+++||++||+|||+.||+||||||.|||+|.+ |.+||+|||.|+.....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 999976 8999987654556678888889999999999999999999999999999999976 99999999999987544
Q ss_pred ccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH-----hhhc--cc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK-----IQKC--AF 508 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~~~--~~ 508 (625)
..+ .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.....+....-..... +..- ..
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 433 445678999999988765 7999999999999999999999999876544333222222211 1110 00
Q ss_pred ccccCCcCCCCCh--HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhchhc
Q 047969 509 DELIDPCLGFESD--EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRIKS 561 (625)
Q Consensus 509 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~--L~~i~~ 561 (625)
.+...+.+..... -.....+.+..+|+.++|+.+|.+|.++.|++.| +..++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0111111111111 1334567789999999999999999999999976 444443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.21 Aligned_cols=247 Identities=29% Similarity=0.399 Sum_probs=201.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEE
Confidence 368999999999999999999986 68999999986542 2345678899999999999999999996655 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+.+|+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999986 3456899999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. ....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+...... +
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~------~ 234 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK------F 234 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC------C
Confidence 1 2346899999999999888999999999999999999999999643321 111222222110 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L 556 (625)
. ..++..+.+|+.+||+.||++||+ ++++++|-
T Consensus 235 p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 235 P-------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred C-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 0 013446788999999999999986 68888774
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.74 Aligned_cols=261 Identities=30% Similarity=0.428 Sum_probs=214.3
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.+.+..+.||+|+||.||+|+.. +...||||.+++.... ...+|.+|+++|..++|||||+++|++.+ ++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CCee
Confidence 45566789999999999999853 3457999999876554 77899999999999999999999998877 6778
Q ss_pred EEEEEeccCCChHHHhccCcc------c----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 355 LLVYEFVANGTVADQLHGDRA------K----HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
+||+|||..|+|.++|..... . ..+|+..+.+.||.|||.||+||-++.+|||||-..|+||.++..|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 999999999999999964221 1 334899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHH
Q 047969 425 ADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+||||++..-...... .....-.++|||||.+..++++.+||||||||+|||+++ |+.|+.....++. ...
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------Ie~ 717 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------IEC 717 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------HHH
Confidence 9999998654333322 223446789999999999999999999999999999998 8888876544332 233
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
++.+.+.. ..+..+.++.+|+..||+.+|.+||+++||-..|+..-..
T Consensus 718 i~~g~lL~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQLLS------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHcCCccc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 33333211 1234677899999999999999999999999999876544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=360.33 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=205.6
Q ss_pred CCCccceecccCcEEEEEEEEc-C-CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-D-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++|||||++++++.. .+..+|||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEEC
Confidence 4889999999999999999865 4 67899998766655666778899999999999999999997665 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc-c
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-H 439 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~-~ 439 (625)
+++|+|.+++.........+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....... .
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999999998865444556789999999999999999999999999999999999999999999999999987643322 1
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+........
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~~-------- 291 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVLYGKYDPF-------- 291 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCC--------
Confidence 223456999999999998888999999999999999999999999654321 11111111111110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.++|.+||+.+|++||++.+++++
T Consensus 292 ----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11244578899999999999999999999764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=335.36 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc--CCcEEEEEEecccc--HHHHHHHHHHHHHHHhc---CCCCeeeeeeeeee----c
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK--DGREVAVKRLYDNN--YRRVEQFMNEVEILTRL---RHKNLVSLFGCTSR----Y 350 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----~ 350 (625)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 46889999885432 12234566777777766 69999999996542 2
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
...+++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 445899999996 5898888632 2345899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh---hcc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ---KCA 507 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 507 (625)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|++||......... ........ ...
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEED 232 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChhh
Confidence 865432 2223456899999999998888999999999999999999999999765432211 11111100 000
Q ss_pred ccc-------ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 FDE-------LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+.. ................++..+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000001111223456678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=329.30 Aligned_cols=256 Identities=25% Similarity=0.467 Sum_probs=206.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++.+.. ....+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEec
Confidence 358999999999999999999988888999998865433 45788999999999999999999986554 5668999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999999998642 34468899999999999999999999999999999999999999999999999998764332222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++....++.++||||||+++|+|++ |..||....... ....+...... +.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~----~~---- 225 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRM----PR---- 225 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC----CC----
Confidence 233346778999999988889999999999999999998 999996533211 11111111000 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...++.++.+++.+||..+|++||+++++++.|+.+
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 012345788899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.85 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=201.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence 47899999999999999999976 78999999986542 2345668899999999999999999986654 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999863 23468999999999999999999999999999999999999999999999999998764433
Q ss_pred cccccCCCCCCCccCccccc------cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 438 THVSTAPQGTPGYVDPEYHQ------CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
........||+.|+|||++. ...++.++||||||+++|+|++|+.||....... ....+... ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~--~~~ 227 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNF--QRF 227 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcC--CCc
Confidence 33334457899999999886 4467889999999999999999999996543211 11111111 000
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+.... ...++..+.+++.+||+ +|++||++++++++-
T Consensus 228 ----~~~~~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 228 ----LKFPE---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred ----cCCCC---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 00000 01245578889999998 999999999998763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.37 Aligned_cols=251 Identities=28% Similarity=0.490 Sum_probs=201.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.+.||+|+||.||+|+.+++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcC
Confidence 46888999999999999999998888999998764432 34678899999999999999999996654 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++|+|.+++... .+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999998632 24589999999999999999999999999999999999999999999999999986533222222
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+...... ..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~--~~~------ 223 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGFRL--YRP------ 223 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCC--CCC------
Confidence 23345678999999988889999999999999999999 899996543211 11112111100 001
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...+..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01234688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=341.79 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=199.3
Q ss_pred CCCccceecccCcEEEEEEEEc----CCcEEEEEEecccc----HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 283 DFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNN----YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++++ +|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence 5888999999999999999753 57899999986432 23346678999999999 59999999986554 567
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 80 LHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 899999999999999985 3346899999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
............||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ......+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC------
Confidence 43333333345699999999998764 4788999999999999999999999754322111 1111111111
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
++.+. ..++..+.+++.+||+.||++|| ++++++++-
T Consensus 227 ~~~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 227 DPPFP-------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 01010 12345788899999999999999 788888774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=330.56 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=202.3
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|.++ .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEE
Confidence 57889999999999999999754 35689999986542 3345678999999999999999999996654 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999863 2346899999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+...... +
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~----~- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL----P- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC----C-
Confidence 2111122345678999999988889999999999999999875 999996543221 11111111100 0
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
....++..+.+++.+||+.+|++||+++++++.|.++
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112455788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=340.86 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=196.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+++++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 46999999999999976 7899999998653 22345678899999999999999999986554 6778999999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccC
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 443 (625)
|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 80 GELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 99998885 34468999999999999999999999999999999999999999999999999987532221 12234
Q ss_pred CCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHH
Q 047969 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (625)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+..... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~------~~------- 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDI------KF------- 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCc------cC-------
Confidence 569999999999988889999999999999999999999996543211 1111111100 00
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 524 VKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 524 ~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
...++.++.+++.+||+.||++|+ ++.+++++-
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 112455788999999999999997 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=365.02 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=212.2
Q ss_pred cCCCccceecccCcEEEEEEEEc--CCc----EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK--DGR----EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
...+..+.||+|+||.||.|... +|. .||||.+.+. +.....+|++|+.+|++++|||||+++|++.+ ....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCc
Confidence 34556788999999999999865 343 4999998654 45677899999999999999999999998887 6678
Q ss_pred EEEEEeccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
+|++|||+||+|..+|.+.+. ....|+....+.++.|||+|++||+++++|||||..+|+||+....+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999999976532 24569999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCccccc-cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 432 LFPLDVTHVS-TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 432 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
.......... ....-...|||||.+..+.++.|+|||||||+|||+++ |..|+...+..+... .....++++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ggRL~ 924 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGGRLD 924 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCCccC
Confidence 4433322222 22245679999999999999999999999999999999 999997654332111 111111111
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
.+..+++.+.++|..||+.+|++||++..|++.+..+.+...
T Consensus 925 -------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 925 -------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 112345677899999999999999999999998888776543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.65 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=209.2
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc--CC--cE-EEEEEecc---ccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK--DG--RE-VAVKRLYD---NNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
..+++-.+.++||+|+||.||+|+++ ++ .. ||||.... .......+|++|+++|++++|||||++||+...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~- 232 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL- 232 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-
Confidence 34556666789999999999999876 23 23 89998874 345678899999999999999999999996665
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
...++||||+|.||+|.++|.. ....++..+.+.++.+.|.||+|||+++++||||-.+|+|++.++.+||+|||++
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 6778999999999999999963 2336999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
+...... .......-...|+|||.+....+++++|||||||++||+++ |..|+...... .....+....+.
T Consensus 310 ~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~~~~r 381 (474)
T KOG0194|consen 310 RAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVKNGYR 381 (474)
T ss_pred cCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHhcCcc
Confidence 8643111 11112245689999999999899999999999999999998 88888754322 122222111111
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
- .. ....+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 382 ~------~~-----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 382 M------PI-----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred C------CC-----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0 00 01345678889999999999999999999999998876544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.10 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=194.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|+..++||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.. ...+++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEE
Confidence 346777889999999999999976 78999999986543 3345678999999999999999999996654 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+.. .+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999886532 356778889999999999999999999999999999999999999999999986543211
Q ss_pred ccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
......||..|+|||++.. ...+.++||||||+++|||++|+.||........ ... ...+......
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~-~~~~~~~~~~---- 294 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASL-MCAICMSQPP---- 294 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHH-HHHHhccCCC----
Confidence 1234568999999998743 2345689999999999999999999974322111 111 1111000000
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.....++.++.+||.+||+.+|++|||+.|++++-.
T Consensus 295 --------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 295 --------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred --------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 001134557889999999999999999999999754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=340.33 Aligned_cols=243 Identities=26% Similarity=0.340 Sum_probs=195.7
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++++.++||||+++++++.. ....+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence 46999999999999976 7899999998653 22345667889999999999999999986654 5678999999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccC
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 443 (625)
|+|..++. +...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 80 GELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 99998885 34468999999999999999999999999999999999999999999999999987532221 11233
Q ss_pred CCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHH
Q 047969 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (625)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+..... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~------~~------- 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------RF------- 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC------CC-------
Confidence 568999999999988889999999999999999999999996543211 1111111110 00
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 524 VKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 524 ~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
...++.++.+++.+||+.+|++|| ++.+++++-
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 012456788999999999999998 899998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=348.27 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++++.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.. ....+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence 47899999999999999999876 78999999986432 2345678899999999999999999996655 6679999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999985 33568999999999999999999999999999999999999999999999999996432100
Q ss_pred cc----------------------------------------------cccCCCCCCCccCccccccCCCCCchhhhhHH
Q 047969 438 TH----------------------------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFG 471 (625)
Q Consensus 438 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG 471 (625)
.. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999888899999999999
Q ss_pred HHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCC---CC
Q 047969 472 VVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELR---PS 548 (625)
Q Consensus 472 ~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps 548 (625)
|++|||++|.+||....... ....+.... .. +.... ...++.++.+++.+||+ +|.+| ++
T Consensus 236 vil~elltG~~Pf~~~~~~~-------~~~~i~~~~-~~-----~~~p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE-------TYRKIINWR-ET-----LYFPD---DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH-------HHHHHHccC-Cc-----cCCCC---CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999996543211 111111100 00 00000 01234578889999997 67765 59
Q ss_pred HHHHHHHH
Q 047969 549 MEEVLAEL 556 (625)
Q Consensus 549 ~~ell~~L 556 (625)
+.+++++-
T Consensus 299 ~~~~l~hp 306 (377)
T cd05629 299 AHEIKSHP 306 (377)
T ss_pred HHHHhcCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.95 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=202.1
Q ss_pred hcCCCccceecccCcEEEEEEEE------cCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL------KDGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|+. .++..||||++... .....+.+.+|+.+|+.+ +||||+++++++.. ..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-GG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-CC
Confidence 45799999999999999999963 24568999998643 234456789999999999 89999999996655 56
Q ss_pred eEEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--------------------------------------------------------- 375 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 375 (625)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 68999999999999999864221
Q ss_pred --------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc-
Q 047969 376 --------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV- 440 (625)
Q Consensus 376 --------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~- 440 (625)
....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 11257899999999999999999999999999999999999999999999999998654322211
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++.+..++.++||||||+++|||++ |..||....... .....+....... .+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~--~~----- 339 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML--SP----- 339 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC--CC-----
Confidence 122345678999999988889999999999999999998 888886432211 1111111111000 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
...+.++.+|+.+||+.||++|||+.|++++|++
T Consensus 340 -----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 -----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1124578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.95 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=202.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++++.+ +|+|||++++++.. ..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-GG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-CC
Confidence 458999999999999999998742 3457999998653 334456788999999999 89999999996655 56
Q ss_pred eEEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--------------------------------------------------------- 375 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 375 (625)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 78999999999999998853210
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc-cccCCC
Q 047969 376 ---------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQ 445 (625)
Q Consensus 376 ---------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~ 445 (625)
....+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++........ ......
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 1235788999999999999999999999999999999999999999999999999865332211 112234
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEV 524 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (625)
++..|+|||++....++.++||||||+++|+|++ |+.||........ ....+ ...... ..+
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~-~~~~~~-~~~---------- 337 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMV-KRGYQM-SRP---------- 337 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHH-HcccCc-cCC----------
Confidence 5678999999988889999999999999999997 9999965432111 11111 111000 000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 525 KRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 525 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
...+.++.+++.+||+.+|++|||+.+++++|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 012457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=345.56 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=199.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.. ....+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence 47999999999999999999976 68999999986532 2344667899999999999999999996655 6788999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+.+|+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999986 33468999999999999999999999999999999999999999999999999987543211
Q ss_pred cc-------------------------------------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC
Q 047969 438 TH-------------------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS 480 (625)
Q Consensus 438 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG 480 (625)
.. ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 00123589999999999888899999999999999999999
Q ss_pred CCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 047969 481 MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS---MEEVLAEL 556 (625)
Q Consensus 481 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ell~~L 556 (625)
.+||....... ....+.... ..+..... ..++.++.++|.+|+. +|.+|++ +++++++-
T Consensus 236 ~~Pf~~~~~~~-------~~~~i~~~~------~~~~~~~~---~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 236 YPPFCSDNPQE-------TYRKIINWK------ETLQFPDE---VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCHHH-------HHHHHHcCC------CccCCCCC---CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99997543211 111111110 00000000 1235577889999996 9999997 99998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=358.59 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=207.4
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc---
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS--- 351 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 351 (625)
....++|++.+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334579999999999999999999865 7999999998543 3445667889999999999999999887443211
Q ss_pred ----ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 352 ----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 352 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
..+++||||+++|+|.+++.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 1368999999999999999755445567999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 428 GLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 428 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
|+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+...
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~~~~~~~ 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VMHKTLAG 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhcC
Confidence 99987543222 22234579999999999998889999999999999999999999997543211 11111111
Q ss_pred ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....+ ...++.++.+++.+||+.+|++||++.+++++
T Consensus 261 ~~~~~------------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPL------------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 11245578899999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=345.74 Aligned_cols=245 Identities=28% Similarity=0.383 Sum_probs=203.2
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccc
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 352 (625)
....++|+.+++||+|.||.|++|..+ +++.+|||++++... ++++..+.|.+|+.... ||.++.++.++.. .+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~ 442 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KE 442 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CC
Confidence 345679999999999999999999987 688999999987643 45778899999999885 9999999996655 78
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
+++.||||+.||++..+. ..+.+++..+.-++.+|+.||.|||++|||+||||.+|||+|.+|.+||+|||+++.
T Consensus 443 ~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred eEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999943333 445799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
... ......+.+||+.|||||++.+..|+.+.|.|||||+|||||.|..||.+.+.+... ..|...
T Consensus 518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-------dsI~~d------ 583 (694)
T KOG0694|consen 518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-------DSIVND------ 583 (694)
T ss_pred cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcC------
Confidence 432 233456789999999999999999999999999999999999999999876543211 111110
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSM 549 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 549 (625)
....+.-++.+..++++++|.++|++|.-+
T Consensus 584 -------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111123466788899999999999999754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.30 Aligned_cols=261 Identities=23% Similarity=0.419 Sum_probs=209.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecc---ccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYD---NNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|+.. +++.||||.+.. ........+.+|+++++.++||||+++++++.. .+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence 57999999999999999999976 789999998743 233445678999999999999999999996665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.........+++..++.++.||++||+|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999999999886544445568999999999999999999999999999999999999999999999999988754322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ... ....+.......
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~------- 227 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFS-LCQKIEQCDYPP------- 227 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHH-HHHHHhcCCCCC-------
Confidence 1 112345888999999998888899999999999999999999998543211 111 111111111110
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
......+..+.+++.+||+.+|++||+++++++.|++++
T Consensus 228 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 ----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.08 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=203.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence 47999999999999999999976 78999999986542 1345678899999999999999999986554 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999963 3568999999999999999999999999999999999999999999999999998654332
Q ss_pred ----------------------------cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccc
Q 047969 438 ----------------------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRH 489 (625)
Q Consensus 438 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~ 489 (625)
........||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1112345699999999999988999999999999999999999999975442
Q ss_pred ccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 047969 490 RHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-MEEVLAEL 556 (625)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~ell~~L 556 (625)
.. ....+.... ..+..... ..++..+.++|.+||+ +|++||+ +++++++.
T Consensus 236 ~~-------~~~~i~~~~------~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 236 QE-------TYNKIINWK------ESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HH-------HHHHHhccC------CcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 11 111111100 00000000 0145678899999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.56 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=206.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 358999999999999999999642 35789999986432 33456788999999999 89999999997776667
Q ss_pred eEEEEEEeccCCChHHHhccCccc--------------------------------------------------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAK-------------------------------------------------------- 376 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 376 (625)
.++++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999998542210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc-ccCCCCCCCccCcc
Q 047969 377 -HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPE 454 (625)
Q Consensus 377 -~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE 454 (625)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 2368999999999999999999999999999999999999999999999999998753322211 22345677899999
Q ss_pred ccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHH
Q 047969 455 YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAE 533 (625)
Q Consensus 455 ~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 533 (625)
++.+..++.++||||||+++|||++ |..||....... .....+....... . ....+.++.+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~--~----------~~~~~~~~~~ 307 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMR--A----------PEYATPEIYS 307 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCC--C----------CccCCHHHHH
Confidence 9988899999999999999999998 999996533211 1111111111000 0 0123457889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 534 LAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 534 li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
++.+||+.+|++||++.|++++|+.+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=343.28 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=200.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcC--CcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD--GREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+|+||.||+|+++. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEE
Confidence 4579999999999999999998653 3689999985432 2345678899999999999999999997655 56789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+.+|+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 108 lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999986 344689999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. .....||+.|+|||++.+..++.++||||||+++|||++|.+||...... .....+......
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~------ 246 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGIIY------ 246 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCC------
Confidence 2 12346899999999998888999999999999999999999999754321 111222221110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
.. ..++..+.+++.+||+.+|++|+ ++++++++-
T Consensus 247 ~p-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 247 FP-------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CC-------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 00 11344678899999999999995 899988773
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.36 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=196.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|++++.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||+++++++.. ...+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEE
Confidence 6889999999999999999876 68899999986532 2345678999999999999999999996665 66799999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.||+||||||+||||+.++++||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999986 334689999999999999999999999999999999999999999999999999864321000
Q ss_pred ----------------------------------------------ccccCCCCCCCccCccccccCCCCCchhhhhHHH
Q 047969 439 ----------------------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGV 472 (625)
Q Consensus 439 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~ 472 (625)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012346999999999998888999999999999
Q ss_pred HHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHh--cccCCCCCCCHH
Q 047969 473 VLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLC--LQQNKELRPSME 550 (625)
Q Consensus 473 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~~P~~RPs~~ 550 (625)
++|||++|..||........ ...+..... .+... ....++.++.+++.++ +..++..||++.
T Consensus 237 il~elltG~~Pf~~~~~~~~-------~~~i~~~~~------~~~~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET-------QLKVINWEN------TLHIP---PQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH-------HHHHHcccc------ccCCC---CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999975432111 111110000 00000 0012345777888884 455666699999
Q ss_pred HHHHHH
Q 047969 551 EVLAEL 556 (625)
Q Consensus 551 ell~~L 556 (625)
++++|-
T Consensus 301 ~~l~hp 306 (381)
T cd05626 301 DIKAHP 306 (381)
T ss_pred HHhcCc
Confidence 999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.62 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=193.3
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 799999999999976 6889999998643 23345678899999999999999999986654 677899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......
T Consensus 80 L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 80 LFHHLQ----REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 999986 34468999999999999999999999999999999999999999999999999998542221 2223456
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+..... .. ..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~~~~--------~~-----~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQEPL--------RF-----PD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCC--------CC-----CC
Confidence 999999999999888999999999999999999999999654321 11111111110 00 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRPS---MEEVLAE 555 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs---~~ell~~ 555 (625)
.++..+.+++.+||+.||++||+ +.++++|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 24557889999999999999975 6677665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.19 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=202.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.++||+|+||.||+|++. ++..+|+|++... .....+.+.+|++++++++|+||+++++++.. .+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEE
Confidence 368999999999999999999987 6888999987654 33445678999999999999999999997665 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||+.+++|.+++. ..+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999985 334689999999999999999999985 7999999999999999999999999998764322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc------
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL------ 511 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 511 (625)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ..............
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE----LMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH----HHhcCcccCCccccccCccc
Confidence 123346899999999998888999999999999999999999999654321100 00000000000000
Q ss_pred ---------cCCc--------------CCCCCh-HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 512 ---------IDPC--------------LGFESD-EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 512 ---------~~~~--------------~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..+. ...... .....++.++.+|+.+||+.||++|||+.|++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000 000000 000123457889999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=327.03 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=208.6
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccE
Confidence 57889999999999999999742 345699999876666667789999999999999999999996655 56789
Q ss_pred EEEEeccCCChHHHhccCc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 356 LVYEFVANGTVADQLHGDR---------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
+||||+++++|.+++.... .....+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 9999999999999986432 1223589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhh
Q 047969 427 FGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 427 Fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |.+||....... ....+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECIT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH
Confidence 9999865332211 1123345788999999988889999999999999999998 999986543211 112222
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
........ ...+.++.+++.+||+.+|.+|||++++++.|+.+...
T Consensus 237 ~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QGRVLQRP------------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cCCcCCCC------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22111110 12344788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.83 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=209.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+-|.++.+||+|+||.||+|.++ .|+.||||.+.-. ..++++..|+.+|++++.|++|++||.++. ...+||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEY 109 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhh
Confidence 45778889999999999999877 7999999998554 356789999999999999999999997776 4568999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
|..|+..+.+. .++..|+++++..++...++||+|||...-+|||||..|||++.+|.+||+|||.|..+......
T Consensus 110 CGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 110 CGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred cCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 99999999984 46678999999999999999999999999999999999999999999999999999865433222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
..+..||+.|||||++..-.|..++||||||++..||..|++|+........+... . ..+-..+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------P-------T~PPPTF-- 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------P-------TKPPPTF-- 249 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------c-------CCCCCCC--
Confidence 34568999999999999889999999999999999999999999654332221100 0 0111111
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......++++.+|++.||-++|++|-|+.++++|
T Consensus 250 -~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 -KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2234567899999999999999999999999987
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.93 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=196.4
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||+|+||+||++..+ +++.||+|++..... ...+.+..|+++++.++|+||+++.+++.. ....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 799999999999876 789999999864422 234567889999999999999999986554 567899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|..++.........+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++........ ......
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 158 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYA 158 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccC
Confidence 9988865444556799999999999999999999999999999999999999999999999999976543222 123356
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ......+.... . ....
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~-----~~~~ 222 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS--------V-----TYPD 222 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC--------C-----CCcc
Confidence 899999999999889999999999999999999999999754321110 01111111000 0 0112
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
.++..+.+++.+||+.+|++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3556788999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=345.37 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=202.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence 3568999999999999999999976 68899999986432 2334557899999999999999999986554 67789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999852 3478899999999999999999999999999999999999999999999999986543
Q ss_pred CccccccCCCCCCCccCccccccC----CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCY----QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..........||+.|+|||++.+. .++.++||||||+++|||++|++||....... ....+.....
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~--- 264 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKN--- 264 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCC---
Confidence 322223445799999999988643 47889999999999999999999997543211 1111111100
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAEL 556 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~L 556 (625)
.+.... ...++.++.+++.+||+.+|++ |+++.+++++-
T Consensus 265 ---~~~~~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 ---SLTFPD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ---cCCCCC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 000000 1124567889999999999988 99999999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=326.41 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=209.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
...+|++.++||.|+||.||+|+..+++.+|+|.+........+.+.+|+.+++.++|+||+++++++.. ....++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEe
Confidence 3467999999999999999999998899999999977766567789999999999999999999996654 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999999643 3346899999999999999999999999999999999999999999999999999875432221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.....++..|+|||++....++.++||||||+++|+|++ |+.||....... ....+....... .
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~-- 225 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQITAGYRMP-----C-- 225 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHhCCcCC-----C--
Confidence 123346778999999988889999999999999999998 899996543211 111111110000 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 -----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 012345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=339.18 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=195.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++.+.. ...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence 47899999999999999999876 68899999986532 2334567889999999999999999996654 6678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999986 34568999999999999999999999999999999999999999999999999987543211
Q ss_pred c----------------------------------ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCC
Q 047969 438 T----------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA 483 (625)
Q Consensus 438 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p 483 (625)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234699999999999888899999999999999999999999
Q ss_pred CcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 047969 484 VDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQ--QNKELRPSMEEVLAE 555 (625)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~RPs~~ell~~ 555 (625)
|....... ....+..... .+ ..... ..++.++.+++.+++. .++..||+++|+++|
T Consensus 236 f~~~~~~~-------~~~~i~~~~~-~~-----~~p~~---~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQE-------TYKKVMNWKE-TL-----IFPPE---VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHH-------HHHHHHcCcC-cc-----cCCCc---CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 97543211 1111111000 00 00000 0134466777777554 233356899999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.44 Aligned_cols=268 Identities=22% Similarity=0.313 Sum_probs=198.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|+.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.. ....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEE
Confidence 468999999999999999999987 789999999864322 223457889999999999999999996655 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+. ++|.+++.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9996 577777753 33568999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---ccc-----
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---AFD----- 509 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~----- 509 (625)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ........... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhc
Confidence 12234568999999998865 45788999999999999999999999754321110 00000000000 000
Q ss_pred -cccCCcCCC-CCh---HHHH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 -ELIDPCLGF-ESD---EEVK--RMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 -~~~~~~~~~-~~~---~~~~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
......... ... .... ..+..+.+++.+||+.||++|||++|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 000000000 000 0000 1235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=323.43 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=204.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.. .+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeec
Confidence 357899999999999999999988788999999865432 34678999999999999999999996554 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999998643 23468999999999999999999999999999999999999999999999999998765322211
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......+..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+...... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~-------~~- 225 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYRM-------PC- 225 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC-------CC-
Confidence 122233468999999988889999999999999999999 999996543211 11111111000 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 226 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 ----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.31 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=197.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++++.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|+||+++++.+.. .+.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence 47999999999999999999976 689999999864322 234668899999999999999999996655 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999999985 34568999999999999999999999999999999999999999999999999985331000
Q ss_pred ------------------------------------------cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHH
Q 047969 438 ------------------------------------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLI 475 (625)
Q Consensus 438 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ 475 (625)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246999999999999888999999999999999
Q ss_pred HHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC---CHHHH
Q 047969 476 ELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP---SMEEV 552 (625)
Q Consensus 476 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~el 552 (625)
||++|+.||......... ..+..... ....+ . ...++.++.+++.+|+ .+|.+|+ ++.++
T Consensus 236 ell~G~~Pf~~~~~~~~~-------~~i~~~~~-~~~~~-----~---~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ-------LKVINWET-TLHIP-----S---QAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCHHHHH-------HHHhccCc-cccCC-----C---CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999754422110 11111000 00000 0 0123456777888876 5999999 89999
Q ss_pred HHHH
Q 047969 553 LAEL 556 (625)
Q Consensus 553 l~~L 556 (625)
+++-
T Consensus 299 l~h~ 302 (376)
T cd05598 299 KAHP 302 (376)
T ss_pred hCCC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.34 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=204.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.+|++.+.||+|+||.||+|++. ++. .||+|++.... ....+++.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCce
Confidence 57999999999999999999864 333 48999986442 3456778999999999999999999997665 3468
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999863 234588999999999999999999999999999999999999999999999999987653
Q ss_pred Cccccc-cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTHVS-TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
...... ....++..|+|||++.+..++.++||||||+++|||++ |..||+...... . ...+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~----- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER----- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCCC-----
Confidence 322211 22334678999999988889999999999999999998 999996532211 0 111111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
.... ...+..+.+++.+||+.+|++||++.+++.+|..+.....
T Consensus 230 --~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 230 --LPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --CCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0000 0123467889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=324.10 Aligned_cols=252 Identities=27% Similarity=0.494 Sum_probs=201.5
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.+.||+|+||.||+|+..++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcC
Confidence 46888999999999999999987777899998865433 34678999999999999999999997654 55689999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
.+++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999998632 23689999999999999999999999999999999999999999999999999886543322222
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+........ +
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~--~------ 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRLYR--P------ 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCCCC--C------
Confidence 22346678999999988889999999999999999998 999986443211 1111111110000 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 012457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=328.26 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=205.4
Q ss_pred cCCCccceecccCcEEEEEEEEcC------CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
++|++.+.||+|+||.||+|.... .+.||+|.+.... ....+.|.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCce
Confidence 578899999999999999998642 2579999886443 3345678999999999999999999996654 5668
Q ss_pred EEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeE
Q 047969 355 LLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~ 422 (625)
+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+++++||||||+||+++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999999999999864321 11468899999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHH
Q 047969 423 KVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 423 kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 500 (625)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~~ 236 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------VI 236 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 9999999986532221 12233456889999999988889999999999999999998 999986543221 11
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
..+....... ....++.++.+|+.+||+.+|++||++++|+++|+.+
T Consensus 237 ~~i~~~~~~~------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 EMIRSRQLLP------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCcCC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1222211111 1123567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=324.29 Aligned_cols=255 Identities=31% Similarity=0.462 Sum_probs=204.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.+|++.+.||+|+||.||+|..+ .++.||+|++.... ...+.+.+|++++++++|+||+++++++.. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEe
Confidence 46888899999999999999866 58899999986543 345678999999999999999999996655 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.|+++||+|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999998642 23458999999999999999999999999999999999999999999999999998764332222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+.......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYRME--------- 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCCC---------
Confidence 222334678999999988889999999999999999998 999986533211 111111110000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.....+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0112456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.64 Aligned_cols=244 Identities=27% Similarity=0.370 Sum_probs=195.2
Q ss_pred cceecccCcEEEEEEEEc----CCcEEEEEEecccc----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 287 EKELGDGGFGTVYYGKLK----DGREVAVKRLYDNN----YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++.||+|+||.||+++.. +++.||||++.... ......+.+|+.+|+.++||||+++++++.. ++..++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEE
Confidence 368999999999999853 57889999986432 2234567889999999999999999996655 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++. +.+.+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 80 EYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred eCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999999985 34568899999999999999999999999999999999999999999999999987542221
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+...... +.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~~--~~----- 220 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKLN--LP----- 220 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC--CC-----
Confidence 12234568999999999988888999999999999999999999997543211 11122211110 00
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
..++..+.+++.+||+.+|++|| ++.+++++-
T Consensus 221 ------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 221 ------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 12345788999999999999999 888888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.15 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=193.8
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHH---HhcCCCCeeeeeeeeeeccceEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEIL---TRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++ +.++||||+++++++.. ....++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence 678899999999999999876 68999999986442 22345667776665 46679999999996654 678899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|..++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 v~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 80 VMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999998874 245899999999999999999999999999999999999999999999999998753221
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... .
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~~------~ 220 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEVR------Y 220 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC------C
Confidence 1 22234568999999999988889999999999999999999999997543211 11111111110 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
...++..+.+++.+||+.||++|| ++.+++++
T Consensus 221 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 -------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 012355778899999999999999 57777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.33 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=199.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
...++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEE
Confidence 34578999999999999999999987 68899999985421 2234567899999999999999999996654 6779
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999842 247899999999999999999999999999999999999999999999999998754
Q ss_pred CCccccccCCCCCCCccCccccccC----CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCY----QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
...........||+.|+|||++.+. .++.++||||||+++|+|++|+.||....... ....+.....
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------~~~~i~~~~~-- 264 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------TYSKIMDHKN-- 264 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc--
Confidence 3322222456799999999998653 37889999999999999999999997543211 1111111100
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAEL 556 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~L 556 (625)
.+.... ...++..+.+++.+||+.++.+ |+++.|+++|-
T Consensus 265 ----~~~~p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 265 ----SLNFPE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred ----ccCCCC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 000000 1124557788999999855543 88999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=326.99 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=205.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|.+.+.||+|+||.||+|+..+ ++.||||++...... ..+.+.+|+++|+.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCC
Confidence 3568889999999999999998643 478999998655433 45789999999999999999999997665 567
Q ss_pred EEEEEEeccCCChHHHhccCc----------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEE
Q 047969 354 LLLVYEFVANGTVADQLHGDR----------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~k 423 (625)
.++||||+++++|.+++.... .....+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 899999999999999996432 1234588999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHH
Q 047969 424 VADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAIN 501 (625)
Q Consensus 424 l~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~ 501 (625)
|+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~~ 235 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VIE 235 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence 999999975432211 11223346788999999998889999999999999999998 999986543221 111
Q ss_pred HhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+........ ...++..+.+++.+||+.+|++||+++|+++.|+
T Consensus 236 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQGRLLQR------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcCCcCCC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111110 1134567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=306.30 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=209.3
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--------cHHHHHHHHHHHHHHHhcC-CCCeeeeeeeee
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--------NYRRVEQFMNEVEILTRLR-HKNLVSLFGCTS 348 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 348 (625)
..-+.|...+.||+|..++|-+..++ +|+++|+|++... ...-.+.-.+|+.||+++. ||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888899999999999988766 7899999987422 1233566788999999994 999999999665
Q ss_pred eccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccc
Q 047969 349 RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFG 428 (625)
Q Consensus 349 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFg 428 (625)
. +.-+++|+|.|+.|.|.++|.+ .-.++++...+|+.|+.+|++|||.++||||||||+|||+|++.++||+|||
T Consensus 94 s-~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 S-DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred C-cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 4 5678999999999999999963 3459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccCcccccc------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQC------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+|+..... ......+|||+|+|||.+.. ..|+...|+|+.|||||.|+.|.+||--.. ....++.
T Consensus 169 Fa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ 239 (411)
T KOG0599|consen 169 FACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM 239 (411)
T ss_pred eeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence 99976433 33355689999999998753 358889999999999999999999994211 1223344
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+.++.+. -..+++.+++..++++|.+||+.||.+|.|++|++.|-.
T Consensus 240 ImeGkyq---------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 240 IMEGKYQ---------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred HHhcccc---------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 4444432 123456778889999999999999999999999998743
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=323.16 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=201.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++.+.. ....++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEe
Confidence 357999999999999999999975 788999999865544455678899999999999999999996655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++. ..+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 87 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999999885 334689999999999999999999999999999999999999999999999999986532211
Q ss_pred cccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 440 VSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
......++..|+|||.+. ...++.++||||||+++|+|++|.+||.......... .+....+ ..+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCCC
Confidence 123346889999999874 3457889999999999999999999985432211100 0000000 00000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.....++..+.+++.+||+.+|++||++++++++|
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01123456788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=345.15 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=195.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|+++++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|||++++.+.. ...+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEE
Confidence 6889999999999999999976 68899999986542 2345678899999999999999999996665 66799999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc-
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV- 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~- 437 (625)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999985 33468999999999999999999999999999999999999999999999999975331100
Q ss_pred ---------------------------------------------cccccCCCCCCCccCccccccCCCCCchhhhhHHH
Q 047969 438 ---------------------------------------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGV 472 (625)
Q Consensus 438 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~ 472 (625)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011246899999999998888999999999999
Q ss_pred HHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC---H
Q 047969 473 VLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS---M 549 (625)
Q Consensus 473 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~ 549 (625)
++|||++|++||....... ....+.... ..+... ....++.++.+++.+++ .+|++|++ +
T Consensus 237 il~elltG~~Pf~~~~~~~-------~~~~i~~~~------~~~~~p---~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE-------TQMKVINWQ------TSLHIP---PQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH-------HHHHHHccC------CCcCCC---CcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999997543211 111111100 000000 01123556778888876 59999987 8
Q ss_pred HHHHHH
Q 047969 550 EEVLAE 555 (625)
Q Consensus 550 ~ell~~ 555 (625)
.++++|
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=341.46 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=199.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----ceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----QGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 355 (625)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+++++.++|+||+++++++.... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5788999999999999999975 7899999998543 2334567889999999999999999999665432 2689
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 57777774 345689999999999999999999999999999999999999999999999999986543
Q ss_pred CccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH--------Hhhhc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN--------KIQKC 506 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 506 (625)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||................. .....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333445688999999988764 478999999999999999999999976543221111100000 00000
Q ss_pred ccccccCCcCCCCChH----HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 AFDELIDPCLGFESDE----EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....+........... .....+.++.+|+.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0000000000000000 0012355788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=326.60 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=200.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence 4788899999999999999976 789999999864322 223457889999999999999999986554 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++... ....+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 80 TLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred eccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999999888532 234589999999999999999999999999999999999999999999999999986532221
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.....|+..|+|||++.+..++.++||||+|+++|+|++|..||......... ......+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ----------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc-----------
Confidence 23346899999999998888999999999999999999999999754321111 11111111100
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
......++..+.+|+.+||+.||++|| ++++++++-
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 001123566788999999999999999 888988773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.89 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=203.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEe
Confidence 357899999999999999999988888999999865433 34678999999999999999999986543 457899999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.|++.||+|||+.+|+||||||+||++++++.+||+|||++..........
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 9999999998642 23458999999999999999999999999999999999999999999999999998754332222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||....... ....+...... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGYRM---------P 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------C
Confidence 222345678999999988889999999999999999999 899996533211 11111111000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
.....+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 ---CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011234578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.24 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=193.9
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+.++.++ +||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence 46999999999999976 6889999998653 233456678899998877 79999999996655 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 80 GGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 999998885 33568999999999999999999999999999999999999999999999999987532211 1223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc--ccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH--EINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........+...... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~---- 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I---- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------C----
Confidence 4568999999999998889999999999999999999999996422111 111111222222111110 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPS------MEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs------~~ell~~ 555 (625)
...++..+.+++.+||+.||++||+ +.++++|
T Consensus 225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 ---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0123456788999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=333.38 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=198.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+++.+ +++.||+|++.+.. ....+.+.+|+.+++.++|+||+++++++.. .+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 47999999999999999999976 68899999986432 2334567889999999999999999996654 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||++||+|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999963 23468999999999999999999999999999999999999999999999999998764433
Q ss_pred cccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 438 THVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ....+.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~---- 225 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHEE---- 225 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-------HHHHHHcCCC----
Confidence 322234569999999998865 457889999999999999999999996543211 1111111100
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~L 556 (625)
... .......++.++.+++.+||..++++ |+++++++++-
T Consensus 226 --~~~--~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 226 --RFQ--FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred --ccc--CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000 00111234567888999999866544 46888888773
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=322.76 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=204.1
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.++||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++|+||+++++.+.. ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEc
Confidence 357999999999999999999987777899999865432 34578999999999999999999986543 457999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++|+|.+++... ....+++..+..++.|+++||+|||+.+++||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 9999999999642 23457999999999999999999999999999999999999999999999999998654333222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||+..+..++.++||||||+++|+|++ |..||....... ....+...... +
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~----~----- 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM----P----- 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCCCC----C-----
Confidence 223446778999999988889999999999999999999 888886543211 11111111000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
....++..+.+++.+||+.+|++||++.++++.|+..
T Consensus 224 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0123456788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.54 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=208.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|+.. +++.+|||.+... .....+++.+|+.+++.++|+||+++++++.. ....+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence 47888999999999999999965 8899999987542 23345678999999999999999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.........+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99999999999986443345678999999999999999999999999999999999999999999999999988654332
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......+........
T Consensus 161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~------ 228 (267)
T cd08229 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDYPPL------ 228 (267)
T ss_pred cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhhhhcCCCCCC------
Confidence 21 223458899999999988889999999999999999999999986432210 011111111111100
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.....+..+.+++.+||+.+|++|||+++|++.++++
T Consensus 229 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0123556888999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.23 Aligned_cols=237 Identities=30% Similarity=0.407 Sum_probs=186.8
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHH-HHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVE-ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||+||+|+.. +|+.||||++.... ......+++|.. +++.++||||+++++.+.. ....++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 46999999999999986 78999999986432 122344555554 5678999999999986654 667899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 80 ~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 80 GGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 999999885 3456899999999999999999999999999999999999999999999999998753221 12223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+...... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~--~~--------- 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKPLR--LK--------- 216 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCCC--CC---------
Confidence 4568999999999988889999999999999999999999996543211 11111111110 00
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSME 550 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ 550 (625)
..++..+.+++.+||+.+|++||++.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 --PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12355788899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=334.51 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=195.4
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|..+++.+ +||||+++++++.. ...+++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence 46999999999999976 68899999986532 23456688999999998 79999999996654 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 80 ~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 80 GGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 999998885 3456999999999999999999999999999999999999999999999999998743211 11223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc--ccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH--EINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||+...... ...........+...... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I---- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C----
Confidence 4568999999999998889999999999999999999999997432211 111112222222221110 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPS------MEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs------~~ell~~ 555 (625)
...++..+.+++.+||+.||++|++ ++++++|
T Consensus 225 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 ---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0123457888999999999999997 6777766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=321.42 Aligned_cols=251 Identities=28% Similarity=0.488 Sum_probs=200.4
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.+|++.+.||+|+||.||+|+++++..+|+|++..... ..+.+.+|++++++++|+||+++++++.. ....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecC
Confidence 36888999999999999999988778899998865432 33568899999999999999999996554 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999863 234689999999999999999999999999999999999999999999999999976533222212
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+.... .....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~~--- 223 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGY-----RLYRP--- 223 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCC-----cCCCC---
Confidence 22234568999999988889999999999999999998 899997543221 111111110 00000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...+.++.+++.+||+.+|++|||+.++++.|
T Consensus 224 ----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 ----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12455788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=325.78 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=202.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-----CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-----DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~ 355 (625)
++|++.+.||+|+||.||+|..+ +++.||+|++........+.+.+|++++++++||||+++++++.. .....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57899999999999999999742 578999999877766667889999999999999999999986543 334579
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999998532 34589999999999999999999999999999999999999999999999999987643
Q ss_pred Ccccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccc---------cchhHHHHHHhh
Q 047969 436 DVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE---------INLANLAINKIQ 504 (625)
Q Consensus 436 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~---------~~~~~~~~~~~~ 504 (625)
..... .....++..|+|||++.+..++.++||||||+++|||++|..++........ ..........+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 32211 1122344569999999888899999999999999999998766532211000 000000000000
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.. .... ....++..+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 241 ~~---------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NN---------GRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cC---------CcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 0000 0112345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.11 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=208.7
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceE
Confidence 46888899999999999999742 355699999877666666789999999999999999999996655 56789
Q ss_pred EEEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEE
Q 047969 356 LVYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~k 423 (625)
+||||+++++|.+++.... ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999996432 1234589999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHH
Q 047969 424 VADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAIN 501 (625)
Q Consensus 424 l~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~ 501 (625)
|+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~ 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIE 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 999999976533221 11233456788999999988889999999999999999998 999986543211 111
Q ss_pred HhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.+........ ....+..+.+++.+||+.+|++||++++++++|+.+..
T Consensus 237 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222111110 01234578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=321.11 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=205.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEc
Confidence 467999999999999999999988899999999865543 3467899999999999999999998653 3467999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+.+++|.+++... ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999998642 33468999999999999999999999999999999999999999999999999998764332222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++....++.++||||||+++|+|++ |+.||....... ....+.......
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYRMP--------- 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCCCC---------
Confidence 223346788999999988888999999999999999998 999996543211 111111110000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
.....+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=339.93 Aligned_cols=261 Identities=26% Similarity=0.347 Sum_probs=204.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 352 (625)
.++|++.++||+|+||.||+|.+. .+..||||++.... ....+.+++|+++|+++. ||||+++++++.. ..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CC
Confidence 568999999999999999999853 23479999986542 334567999999999996 9999999997655 56
Q ss_pred eEEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--------------------------------------------------------- 375 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 375 (625)
..+|||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 78999999999999998864211
Q ss_pred -----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 047969 376 -----------------------------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF 420 (625)
Q Consensus 376 -----------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~ 420 (625)
....+++..++.++.||++||+|||+.+|+||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 013478889999999999999999999999999999999999999
Q ss_pred eEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHH
Q 047969 421 CVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANL 498 (625)
Q Consensus 421 ~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~ 498 (625)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~ 348 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------T 348 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------H
Confidence 99999999998654322211 123456788999999988889999999999999999997 888886432211 1
Q ss_pred HHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 499 AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
....+...... . ....++..+.+++.+||+.+|++||++.+|.++|+.+.
T Consensus 349 ~~~~~~~~~~~-------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRM-------A-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCC-------C-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11111111000 0 01134567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.33 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=203.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC----CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|+.+. ...||||.+.... ......|.+|+.++++++||||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEE
Confidence 579999999999999999998752 3579999886542 3345678999999999999999999996654 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.. ..+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999863 2346899999999999999999999999999999999999999999999999999876422
Q ss_pred ccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 437 VTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 437 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+...... +
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~----~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL----P 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC----C
Confidence 211 1122345678999999988889999999999999999998 999985432111 11111111100 0
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
. ....+..+.+++.+||+.+|++||+++|++++|..+
T Consensus 229 ~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 P--------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 012345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.13 Aligned_cols=243 Identities=26% Similarity=0.331 Sum_probs=195.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 46999999999999875 7899999998653 22345677889999999999999999986554 5678999999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
|+|..++. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (325)
T cd05594 80 GELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK 154 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence 99998885 34468999999999999999999997 799999999999999999999999999987532221 1123
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+..... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~------~~------ 215 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------RF------ 215 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCC------CC------
Confidence 3569999999999988889999999999999999999999996543211 1111111110 00
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
...++.++.+++.+||+.||++|+ ++.+++++-
T Consensus 216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 012345788999999999999996 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.88 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=202.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
..++|++.+.||+|+||.||+|... .++.||||++... ......++.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence 4578999999999999999999753 3567999988543 23445678999999999999999999996654 56
Q ss_pred eEEEEEEeccCCChHHHhccCccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAK------HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 789999999999999998643211 23467889999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhh
Q 047969 427 FGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 427 Fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....... ....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~~ 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVM 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHH
Confidence 9998754332221 1122345788999999988889999999999999999998 788886443211 111111
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
........ ...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 236 ~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLDKP------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111100 1234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=334.47 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=212.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 354 (625)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+... ...+.+.+|+++|+++. |||||.+++.+.. ...+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCeE
Confidence 3457888899999999999999987 599999999966533 24568899999999998 9999999996665 6689
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC----CCeEEEcccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS----NFCVKVADFGLS 430 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~----~~~~kl~DFgla 430 (625)
++|||++.||.|.+.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+.. ++.+|++|||++
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999999643 3999999999999999999999999999999999999954 357999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
..... .......+||+.|+|||++....|+...||||+|+++|.|++|.+||......... ..+..+.+.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~~- 256 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDFD- 256 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCCC-
Confidence 98765 34456678999999999999889999999999999999999999999765532211 122332221
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
-..+.+..++..+.++|..+|..||..|+|+.++++|-+
T Consensus 257 --------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 257 --------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred --------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 122334466788999999999999999999999999844
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=326.42 Aligned_cols=270 Identities=27% Similarity=0.422 Sum_probs=202.0
Q ss_pred cCC-CccceecccCcEEEEEEEE-----cCCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cce
Q 047969 282 NDF-SREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQG 353 (625)
Q Consensus 282 ~~~-~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~ 353 (625)
++| ++.+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988653 357889999986543 23456788999999999999999999966543 345
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 7999999999999999852 34899999999999999999999999999999999999999999999999999876
Q ss_pred CCCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
...... ......++..|+|||.+....++.++||||||+++|+|++|..|+......-. ................+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence 432221 11223456779999999888899999999999999999999999854321100 000000000000000011
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
.+...... ....++.++.+++.+||+.+|++|||++++++.|+.+.
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11100000 01124568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=331.86 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=190.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999976 67899999986532 23345566777777654 89999999986554 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|.+++. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 80 GGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 999999885 33468999999999999999999999999999999999999999999999999997543222 2223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+.... +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~------~~~------ 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDR------PHF------ 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------CCC------
Confidence 4568999999999988889999999999999999999999997543211 111111110 000
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSME-EVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~ 555 (625)
...++.++.+++.+||+.+|++||++. +++++
T Consensus 216 -~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 216 -PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 012345678899999999999999875 55553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.14 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=209.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|++++++++|+|++++++.+.. .+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence 58999999999999999999987 8999999987532 23346778999999999999999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.........+++..++.++.|+++||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999999999986544445668999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .... ....+........
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~~~~------ 228 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS-LCKKIEKCDYPPL------ 228 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHH-HHhhhhcCCCCCC------
Confidence 11 2234588899999999888899999999999999999999999854321 1111 1111111111110
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
....++..+.+++.+||..+|++||++.+|+++|+.+.
T Consensus 229 -----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 -----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=309.22 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=207.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|.|+.||+..+. +|+.+|+|++... .....+.+.+|++|-+.|+|||||++..-... ....+||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cceeEEE
Confidence 467888899999999999998765 7999999987432 33456788899999999999999999984443 5667999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEcccccccccC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFP 434 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~~~~ 434 (625)
+|+|+|++|..-+- +....++..+-..+.||++||.|+|.+||||||+||+|+++.. ..-+||+|||+|....
T Consensus 89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999977664 2245788899999999999999999999999999999999953 3469999999999875
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.........|||+|||||+++..+|+-.+|||+-||+||-|+.|.+||-.... ......+..+.++-
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------~rlye~I~~g~yd~---- 231 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYEQIKAGAYDY---- 231 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhccccCC----
Confidence 33334567899999999999999999999999999999999999999975432 22333444433321
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...++..++++.++|+++||..||.+|.|+.|.|+|-+
T Consensus 232 -----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 232 -----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred -----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 12234456778899999999999999999999998744
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.62 Aligned_cols=245 Identities=25% Similarity=0.426 Sum_probs=202.0
Q ss_pred eecccCcEEEEEEEEcC-CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChH
Q 047969 289 ELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVA 367 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~ 367 (625)
+||+|.||+||.|++.+ ...+|||.+...+.+..+.+..|+.+-++|+|.|||+++|.+.+ ++.+-|.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHH
Confidence 69999999999999874 55699999988888888889999999999999999999997666 56788999999999999
Q ss_pred HHhccCcccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCeEEEcccccccccCCCccccccCC
Q 047969 368 DQLHGDRAKHGLL--TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVADFGLSRLFPLDVTHVSTAP 444 (625)
Q Consensus 368 ~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~~ 444 (625)
++|.. +-+++ .+..+-.+..||++||.|||+..|||||||-+|+||+ -.|.+||+|||-++.... .+....+.
T Consensus 661 sLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 661 SLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 99963 55566 7888888999999999999999999999999999996 579999999999987643 23334556
Q ss_pred CCCCCccCccccccC--CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 445 QGTPGYVDPEYHQCY--QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 445 ~gt~~y~aPE~~~~~--~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
-||..|||||++..+ .|+.++|||||||++.||.||+|||-...... .+. ..-+.+ ..-++
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAM--FkVGmy---------KvHP~ 799 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAM--FKVGMY---------KVHPP 799 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhh--hhhcce---------ecCCC
Confidence 799999999999654 68999999999999999999999995432211 110 011111 11123
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+..++.+.+.||.+|+..+|.+||+++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 345788899999999999999999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.47 Aligned_cols=266 Identities=23% Similarity=0.270 Sum_probs=196.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-------cc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-------SQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------~~ 352 (625)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+|+.++|||||++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999876 68899999885442 2235799999999999999998854321 12
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSR 431 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~ 431 (625)
.+++||||+++ +|.+++.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 36789999975 77777754444556799999999999999999999999999999999999998664 79999999998
Q ss_pred ccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc-
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD- 509 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 509 (625)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|.+||........... ....+......
T Consensus 220 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~---i~~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR---IIQVLGTPTEDQ 294 (440)
T ss_pred hccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHH
Confidence 654322 2234568999999998865 4689999999999999999999999976543221111 11100000000
Q ss_pred ------cccCCcCCCCChHH-----HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 ------ELIDPCLGFESDEE-----VKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 ------~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...+..+....... ....+.++.+|+.+||+.+|.+|||+.|+++|-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 00000000000001 112456789999999999999999999999873
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=349.62 Aligned_cols=272 Identities=20% Similarity=0.266 Sum_probs=198.0
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC------CCeeeeeeeee
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH------KNLVSLFGCTS 348 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 348 (625)
++....++|++.++||+|+||+||+|.+. .++.||||++.... .....+..|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44445689999999999999999999876 67889999985432 223445667777777755 45888888776
Q ss_pred eccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCC-------
Q 047969 349 RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNF------- 420 (625)
Q Consensus 349 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~------- 420 (625)
......++|||++ +++|.+++. +.+.+++..+..|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 6667789999988 678888885 34569999999999999999999998 5999999999999998765
Q ss_pred ---------eEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc
Q 047969 421 ---------CVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH 491 (625)
Q Consensus 421 ---------~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~ 491 (625)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|++||+......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999886422 22244679999999999998899999999999999999999999997654322
Q ss_pred ccchhHHHHHHhhhcc--------cccc------cCCcCCCC--------ChHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 047969 492 EINLANLAINKIQKCA--------FDEL------IDPCLGFE--------SDEEVKRMTTSVAELAFLCLQQNKELRPSM 549 (625)
Q Consensus 492 ~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 549 (625)
...........+.... ...+ +.+..... ...........+.+||.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 2221111110000000 0000 00000000 000000113467799999999999999999
Q ss_pred HHHHHHHh
Q 047969 550 EEVLAELQ 557 (625)
Q Consensus 550 ~ell~~L~ 557 (625)
+|+++|-.
T Consensus 433 ~e~L~Hp~ 440 (467)
T PTZ00284 433 RQMTTHPY 440 (467)
T ss_pred HHHhcCcc
Confidence 99998754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.93 Aligned_cols=269 Identities=25% Similarity=0.308 Sum_probs=199.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-----
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----- 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 351 (625)
..++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4579999999999999999999876 6899999998543 2344567889999999999999999999664322
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
...++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 347999999976 5666553 137889999999999999999999999999999999999999999999999997
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchh------------HHH
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA------------NLA 499 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~------------~~~ 499 (625)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+........ ...
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54322 2223456899999999999889999999999999999999999999755322111000 000
Q ss_pred HHHhh---hc--cc-----ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 500 INKIQ---KC--AF-----DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 500 ~~~~~---~~--~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...+. .. .. .+.................+..+.+|+.+||+.||++|||+.|++++-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000 00 00 0000000000000011123457889999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=340.79 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=203.6
Q ss_pred hHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeee
Q 047969 274 YSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSR 349 (625)
Q Consensus 274 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 349 (625)
..++....++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556789999999999999999999987 68899999985422 2234567899999999999999999996654
Q ss_pred ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccc
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL 429 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgl 429 (625)
....++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 -DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 6778999999999999999842 3478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccC----CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCY----QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
++..............||+.|+|||++... .++.++||||||+++|||++|+.||....... ....+..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~ 261 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMN 261 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHc
Confidence 987643332233456799999999998653 37889999999999999999999997543211 1111111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHh
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAELQ 557 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~L~ 557 (625)
... . +... ....++..+.++|.+||..++.+ |+++++++++..
T Consensus 262 ~~~-~-----~~~~---~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 262 HKN-S-----LTFP---DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCC-c-----ccCC---CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 100 0 0000 11234567888999999844433 789999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=332.30 Aligned_cols=243 Identities=27% Similarity=0.388 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|.++++.+ +||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence 46999999999999976 57899999986532 23445678899999876 79999999996655 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+++|..++. +...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 80 GGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 999998885 33468999999999999999999999999999999999999999999999999987543222 1223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~~---~p-------- 216 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDVL---YP-------- 216 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---CC--------
Confidence 4568999999999988889999999999999999999999997554221 11111111100 00
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRP-------SMEEVLAEL 556 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RP-------s~~ell~~L 556 (625)
..++.++.+++.+||+.+|++|| ++++++++-
T Consensus 217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 01345788899999999999999 888888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.33 Aligned_cols=253 Identities=29% Similarity=0.504 Sum_probs=202.7
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.++||+|++|.||+|....+..+|+|++..... ..+.+.+|++++++++|+|++++++++.. ...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcC
Confidence 56889999999999999999988777899998865432 34678899999999999999999986643 4578999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
.+++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999999642 234589999999999999999999999999999999999999999999999999986543322222
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+... ... +
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~-~~~---~------ 223 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERG-YRM---P------ 223 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-CCC---C------
Confidence 23346778999999988889999999999999999999 899986543211 11111111 000 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
.....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 --CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=333.78 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=195.1
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCC-CeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHK-NLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~lv 357 (625)
+|++++.||+|+||.||+|+.+ +++.||||++.... ....+.+..|+++++.++|+ +|+++++++.. .+.+++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence 5888999999999999999876 67899999986532 23456788999999999765 57777775544 6678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 80 MEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999885 33468999999999999999999999999999999999999999999999999987532211
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~~------~- 220 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNVS------Y- 220 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC------C-
Confidence 11234568999999999998889999999999999999999999997543211 11111111100 0
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSM-----EEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~~ 555 (625)
...++.++.+++.+||..+|++|++. ++++++
T Consensus 221 ------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 ------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01234578899999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.08 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=199.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|++++++++||||+++++.+.. .+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEe
Confidence 36888899999999999999865 7889999998544 33445678999999999999999999996665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 99999986553 3688899999999999999999999999999999999999999999999999765322
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||..................+...... .+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-- 221 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-----VLP-- 221 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----CCC--
Confidence 1234568999999999988889999999999999999999999996533221111111111111111000 000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
....+.++.+++.+||+.+|++||++++++++..-
T Consensus 222 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 222 ----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred ----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 01234578899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.07 Aligned_cols=253 Identities=34% Similarity=0.521 Sum_probs=200.1
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHH--HHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRV--EQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
|++.+.||+|+||+||+++.. +++.+|+|++........ ....+|+.++++++||||+++++++.. ....++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence 677899999999999999987 567899999976654332 234569999999999999999997666 6778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+.+++|.+++. +...+++..++.++.||++||++||+.+|+|+||||+||+++.++.++|+|||.+.... .....
T Consensus 80 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 80 CPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp ETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccc----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence 99999999996 44568999999999999999999999999999999999999999999999999997641 22223
Q ss_pred ccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++. +..++.++||||||+++++|++|..||..........................
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ--------- 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc---------
Confidence 34566899999999998 77899999999999999999999999976521111111111111000000000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......+.+++.+||+.+|++||++++++++
T Consensus 226 ----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 ----SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ----cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012588999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.20 Aligned_cols=242 Identities=29% Similarity=0.405 Sum_probs=193.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.+ +++.||||++.+.. ....+.+..|..+++.+ +||||+++++++.. ...+++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999976 68899999986432 23456678899998877 69999999996654 677899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|.+++. +...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 80 GGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred CchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 999999885 33468999999999999999999999999999999999999999999999999987532221 1223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~------~------ 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVV------Y------ 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCCC------C------
Confidence 4568999999999988889999999999999999999999997543211 11122211110 0
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSM------EEVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~------~ell~~ 555 (625)
...++.++.+++.+||+.||++||++ +++++|
T Consensus 216 -~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 -PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 01234578899999999999999998 556554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.12 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=201.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-----YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence 57899999999999999999865 68999999875432 2234678899999999999999999997665 56899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++. ..+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999985 334689999999999999999999999999999999999999999999999999976533
Q ss_pred Cccccc--cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTHVS--TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
...... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .... .......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~---- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFK-IATQPTN---- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHH-HhccCCC----
Confidence 211111 23457889999999988889999999999999999999999986432211 0111 1110000
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. .....++..+.+++.+||..+|++|||+.+++++.
T Consensus 226 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 226 P-------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred C-------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0 00113455788899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.22 Aligned_cols=238 Identities=27% Similarity=0.342 Sum_probs=190.5
Q ss_pred ceecccCcEEEEEEEE----cCCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 288 KELGDGGFGTVYYGKL----KDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence 5799999999999975 2578999999865432 234567789999999999999999996655 66789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++|+|.+++. +...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 81 RGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 9999999985 34568999999999999999999999999999999999999999999999999987643221 122
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+..... ..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~--------~~--- 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL--------GM--- 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC--------CC---
Confidence 34568999999999988888999999999999999999999997543211 1111111111 00
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEE 551 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 551 (625)
...++..+.+++.+||+.||++||++.+
T Consensus 218 --p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 --PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0123457788999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.47 Aligned_cols=237 Identities=29% Similarity=0.389 Sum_probs=185.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHH-HHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVE-ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++.+.. .+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999986 68899999986432 122344555554 6788999999999986554 667899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+++|..++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 80 GGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 999988885 34568899999999999999999999999999999999999999999999999987532211 1223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|||++|..||...... .....+..... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~--------~~~--- 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------QMYDNILHKPL--------QLP--- 216 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-------HHHHHHhcCCC--------CCC---
Confidence 456899999999998888999999999999999999999999654311 11111111110 000
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSME 550 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ 550 (625)
...+..+.+++.+||+.+|.+||++.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 --GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11234678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.82 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=209.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD-----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.++|++.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.......
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688999999999999999999765 678999988644 3445677899999999999999999999776656778
Q ss_pred EEEEEeccCCChHHHhccCccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAK----HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
++++||+.+++|.+++...... ...+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999999998653322 256899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccc
Q 047969 431 RLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 431 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
+.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...+... . ...+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~ 237 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M----AAYLKDGYR 237 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHcCCC
Confidence 865332222 1223346778999999988889999999999999999998 999996543211 1 111111110
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. .. ...++.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 238 ~-------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 L-------AQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C-------CC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00 01234578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=323.98 Aligned_cols=265 Identities=26% Similarity=0.313 Sum_probs=195.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhc---CCCCeeeeeeeeeec----cc
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRL---RHKNLVSLFGCTSRY----SQ 352 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~----~~ 352 (625)
+|++.+.||+|+||+||+|+.+ +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999876 688999998864321 1223455677777665 799999999965431 34
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+.+ +|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 57999999975 888888532 234589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh---hcccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ---KCAFD 509 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 509 (625)
..... ......+|..|+|||++.+..++.++||||||+++|+|++|++||.......... .....+. ...+.
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGLPPEDDWP 232 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCCCChhhCc
Confidence 54221 1233468999999999988889999999999999999999999996543221110 1111000 00000
Q ss_pred c-------ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 E-------LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ...+............++..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000011111223456678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.06 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=204.7
Q ss_pred hcCCCccceecccCcEEEEEEEE------cCCcEEEEEEecccc-HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL------KDGREVAVKRLYDNN-YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.++ +|+||+++++++...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 257889999986542 33456788999999999 68999999997766666
Q ss_pred eEEEEEEeccCCChHHHhccCcc---------------------------------------------------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--------------------------------------------------------- 375 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 375 (625)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 78999999999999999864221
Q ss_pred ------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc-cccCCCCCC
Q 047969 376 ------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTP 448 (625)
Q Consensus 376 ------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~ 448 (625)
....+++..+..++.||++||+|||+++|+||||||+|||++.++.+||+|||++......... ......++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 0124788889999999999999999999999999999999999999999999999865322211 112234567
Q ss_pred CccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHH
Q 047969 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM 527 (625)
Q Consensus 449 ~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (625)
.|+|||++.+..++.++||||||+++|+|++ |..||........ ....+....... .. ...
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~-----~~-------~~~ 307 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR-----AP-------DYT 307 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCC-----CC-------CCC
Confidence 8999999988889999999999999999997 9999865322111 111111111000 00 012
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 528 TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 528 ~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
+..+.+++.+||+.+|++|||+.+|+++|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3467889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.41 Aligned_cols=270 Identities=22% Similarity=0.322 Sum_probs=200.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.++||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEe
Confidence 67999999999999999999876 688899999864322 233467889999999999999999996655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9975 78887743 234588999999999999999999999999999999999999999999999999976432221
Q ss_pred cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc------c
Q 047969 440 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL------I 512 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 512 (625)
......+++.|+|||++.+ ..++.++||||||+++|+|++|++||..........................+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223457899999998864 46889999999999999999999999755432221111111000000000000 0
Q ss_pred C---CcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 513 D---PCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 513 ~---~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+ +.. ..........++.++.+++.+||+.||++|||+.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 0 000 00001112235667889999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.79 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=197.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.++||+|+||.||+++.+ +++.+|+|++.+.. ....+.+.+|+.++..++|+||+++++++.. ....++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence 47899999999999999999977 57889999985432 2234557889999999999999999986654 5778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999963 23468999999999999999999999999999999999999999999999999997653333
Q ss_pred cccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 438 THVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
........||+.|+|||++. ...++.++||||||+++|||++|+.||....... ....+.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~---- 225 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHKE---- 225 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCc----
Confidence 32233457999999999885 3457889999999999999999999996543211 1111111100
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAE 555 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~ 555 (625)
.. ........++.++.+++.+||..+++. |++++++++|
T Consensus 226 --~~--~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 --RF--QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cc--cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 001111234567888999988665444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=353.53 Aligned_cols=265 Identities=21% Similarity=0.350 Sum_probs=206.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.++||+|+||.||+|++. +|+.||||++... .....+++.+|++++++++||||+++++++.. .+..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence 68999999999999999999976 6899999998643 23345679999999999999999999996655 5678999
Q ss_pred EEeccCCChHHHhccCcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 358 YEFVANGTVADQLHGDRA-------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
|||++|++|.+++..... ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999999864211 1234667788999999999999999999999999999999999999999999999
Q ss_pred cccCCCcc-----------------ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccccc
Q 047969 431 RLFPLDVT-----------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI 493 (625)
Q Consensus 431 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~ 493 (625)
+....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 86521110 0112246999999999999888999999999999999999999999653221110
Q ss_pred chhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhchhcCCC
Q 047969 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKSGKS 564 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~i~~~~~ 564 (625)
.. ..+ ..+. .......++..+.+++.+||+.+|++|| +++++++.|+.......
T Consensus 241 -~~----~~i--------~~P~----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 241 -YR----DVI--------LSPI----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred -hh----hhc--------cChh----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 00 000 0000 0001124556788999999999999995 77888888888765443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.86 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=195.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.. ...+++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence 46999999999999976 67899999986542 23456688999999888 69999999996654 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|..++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 80 GGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 999998885 33469999999999999999999999999999999999999999999999999987532211 1223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|..||..................+...... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~------ 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------I------ 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC------C------
Confidence 4568999999999988889999999999999999999999997543322222222222222211110 0
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSM------EEVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~------~ell~~ 555 (625)
...++..+.+++.+||+.||++|+++ +++++|
T Consensus 223 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 -PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 01234567889999999999999985 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=332.17 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=195.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 357 (625)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..++..+ +|++|+++++++.. .+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence 5888999999999999999877 67899999986542 22345567788888887 58889989886554 6678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 80 MEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999885 33468999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+......
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~~-------- 219 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVA-------- 219 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------
Confidence 12234568999999999998889999999999999999999999997543211 11112111110
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSM-----EEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~~ 555 (625)
. ...++.++.+++.+||+.+|++|++. ++++++
T Consensus 220 ~-----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred C-----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 01245578899999999999999974 565544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.60 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=201.3
Q ss_pred cCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.+|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceE
Confidence 4788889999999999999984 24678999998643 33445778999999999999999999996554 56789
Q ss_pred EEEEeccCCChHHHhccCc-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeE
Q 047969 356 LVYEFVANGTVADQLHGDR-------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~ 422 (625)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 9999999999999985321 112358899999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHH
Q 047969 423 KVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 423 kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 500 (625)
||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~~~ 236 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVI 236 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999986533221 11223345778999999988889999999999999999998 99998643221 111
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
..+........ ...++..+.+++.+||+.+|++||++.+++++|..
T Consensus 237 ~~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLLPC------------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCCC------------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111100 01234578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.93 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=201.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|++.+.||+|+||+||+|+.. +++ .+++|.+.... .....++..|+.++++++||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccE
Confidence 57888999999999999999865 444 47888775432 234467888999999999999999999654 34568
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+++||+++|+|.+++.. ..+.+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999963 334689999999999999999999999999999999999999999999999999986543
Q ss_pred Cccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+.++.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--Q 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--C
Confidence 2221 1233457789999999988889999999999999999998 999996543211 111111111110 0
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
+. ..+..+.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus 233 ~~----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 233 PQ----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00 1223567799999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.63 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=203.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|+++++.++||||+++++++.. ....++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence 4778899999999999999876 7899999987543 34456788999999999999999999996655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 80 YAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred eCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999999743 235689999999999999999999999999999999999999999999999999886543221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......|++.|+|||++.+..++.++|+||||+++++|++|+.||...... .....+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-------- 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPPV-------- 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCCC--------
Confidence 123346889999999998888999999999999999999999999754321 11112222111110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++||++.+++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=322.94 Aligned_cols=249 Identities=36% Similarity=0.543 Sum_probs=192.1
Q ss_pred ccceecccCcEEEEEEEEc-----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 286 REKELGDGGFGTVYYGKLK-----DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+.+.||.|.||.||+|.+. .+..|+||.+... .....+.|.+|++.+++++||||++++|++.. .+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccc
Confidence 4578999999999999876 2567999999553 34457889999999999999999999997774 556899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC-cc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD-VT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~-~~ 438 (625)
|+++|+|.++|... ....+++..++.|+.||++||.|||+++++|+||+++||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999743 2456899999999999999999999999999999999999999999999999999876222 11
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
...........|+|||.+....++.++||||||+++|||++ |+.|+...... .....+.+.......
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~----- 227 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-------EIIEKLKQGQRLPIP----- 227 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-------HHHHHHHTTEETTSB-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccceec-----
Confidence 22233457789999999988889999999999999999999 77887544221 111222222111100
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..++..+.+++.+||..+|++|||+.++++.|
T Consensus 228 -------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 -------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12345788899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.46 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=194.6
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
+.||+|+||.||+|+.+ +++.||+|.+... .......+.+|++++++++||||+++++++.. ....++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence 36999999999999876 7899999987543 23445678999999999999999999996655 567899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc-cCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS-TAP 444 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~-~~~ 444 (625)
|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999853 234689999999999999999999999999999999999999999999999999875432111111 112
Q ss_pred CCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHH
Q 047969 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523 (625)
Q Consensus 445 ~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (625)
..+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+....... .
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~~------------~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRLP------------C 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCC------------C
Confidence 23467999999988889999999999999999997 888886432211 111111110000 0
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 524 VKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 524 ~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1123557889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.09 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=202.0
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.+|++.+.||+|+||.||+|... |+.||+|.+.... ..+.+.+|+.++++++|+|++++++++.......++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57899999999999999999875 7889999886543 34678999999999999999999997666566789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++... ....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999999998632 23358899999999999999999999999999999999999999999999999987543221
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+........
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~--------- 220 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKMDA--------- 220 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCCCCC---------
Confidence 22345678999999988889999999999999999997 99998643211 11111111111100
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...++..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112455788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.58 Aligned_cols=256 Identities=24% Similarity=0.314 Sum_probs=197.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence 47999999999999999999976 6899999998642 22334668899999999999999999996655 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999853 23468999999999999999999999999999999999999999999999999987654333
Q ss_pred cccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 438 THVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
........||+.|+|||++.. ..++.++||||||+++|+|++|+.||....... ....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-------~~~~i~~~~----- 224 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHK----- 224 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC-----
Confidence 222233468999999998863 357889999999999999999999996543211 111111100
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKE--LRPSMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~--~RPs~~ell~~L 556 (625)
..... ......++..+.+++.+||..+++ .|+++++++++-
T Consensus 225 -~~~~~--~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 225 -EHFQF--PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred -CcccC--CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 00000 001112456778899998865443 378999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.98 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=201.0
Q ss_pred CCccceecccCcEEEEEEEEc-C---CcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-----
Q 047969 284 FSREKELGDGGFGTVYYGKLK-D---GREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ----- 352 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 352 (625)
|++.+.||+|+||.||+|... + +..||+|++... .....+.+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999865 2 367999998643 33456789999999999999999999996544222
Q ss_pred eEEEEEEeccCCChHHHhccCcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
..+++|||+++++|..++...+. ....+++..++.++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 36899999999999999854321 2346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccc
Q 047969 431 RLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 431 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
+......... .....++..|+|||.+.+..++.++||||||+++|||++ |.+||....... ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRHGNR 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 8654332221 122335678999999988889999999999999999999 889986533211 1111111111
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.. .....+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 234 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0112455788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=322.77 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=199.1
Q ss_pred cCCCccceecccCcEEEEEEEEcC---------------CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeee
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD---------------GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFG 345 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~ 345 (625)
++|++.+.||+|+||.||+++... ...||+|.+... .....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999987642 235899998654 3344567999999999999999999999
Q ss_pred eeeeccceEEEEEEeccCCChHHHhccCcc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 047969 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRA--------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD 417 (625)
Q Consensus 346 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~ 417 (625)
++.. ....++||||+.+++|.+++..... ....+++..++.++.|++.||.|||+++++||||||+||+++
T Consensus 85 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 85 VCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 6654 5678999999999999999853211 112478899999999999999999999999999999999999
Q ss_pred CCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh--CCCCCcccccccccc
Q 047969 418 SNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEIN 494 (625)
Q Consensus 418 ~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt--G~~p~~~~~~~~~~~ 494 (625)
.++.+||+|||++......... ......++..|+|||++....++.++||||||+++|+|++ |..||........+.
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 9999999999999765332211 1122345778999999988889999999999999999998 566776433221111
Q ss_pred hhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 495 LANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
............... .. ....+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~-------~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 244 NTGEFFRNQGRQIYL-------SQ-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHhhhhccccccC-------CC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000000000000000 00 0013457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=331.08 Aligned_cols=242 Identities=26% Similarity=0.389 Sum_probs=191.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+..|..++..+ +||||+++++++.. .+..++||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 46999999999999987 68899999986542 12345667788888765 89999999996655 668899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 80 ~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 80 GGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 999999885 3356899999999999999999999999999999999999999999999999998743211 11223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+.... +...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~------~~~~----- 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDT------PHYP----- 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CCCC-----
Confidence 4568999999999998889999999999999999999999997543211 111111110 0000
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSME-EVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~ 555 (625)
..++.++.+++.+||+.||++||++. ++++|
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 --RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11345778899999999999999984 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.15 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=198.7
Q ss_pred CCccceecccCcEEEEEEEEcC-Cc--EEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cce
Q 047969 284 FSREKELGDGGFGTVYYGKLKD-GR--EVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQG 353 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 353 (625)
|.+.+.||+|+||.||+|+..+ +. .||+|.+... .....+.+.+|+.+++.++|+||+++++.+... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999998763 33 5899987543 344567889999999999999999999865331 124
Q ss_pred EEEEEEeccCCChHHHhccCc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDR--AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
.+++|||+.+|+|.+++...+ .....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 689999999999999874322 123458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 432 LFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 432 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... ....+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~ 233 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNRL 233 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence 754322111 122346778999999988889999999999999999999 889986532211 11112211110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
. .. ...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 234 ~-------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 K-------QP-----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C-------CC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 12345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.29 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=206.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++++.||.|.-|+||+++++ ++..+|+|++.+... ....+...|-+||+.++||-++.+|..+.. ++..++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEE
Confidence 357888999999999999999987 458899999966533 334567789999999999999999996554 678899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC-
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL- 435 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~- 435 (625)
|||||+||+|..+++. ...+.+++..+.-++.+|+-||+|||..|||.|||||+||||.++|++.|+||.|+.....
T Consensus 155 ~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999998864 3556799999999999999999999999999999999999999999999999998753310
Q ss_pred --------------------------------Ccc----------------------ccccCCCCCCCccCccccccCCC
Q 047969 436 --------------------------------DVT----------------------HVSTAPQGTPGYVDPEYHQCYQL 461 (625)
Q Consensus 436 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 461 (625)
... ..+...+||-.|+|||++++...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01122469999999999999999
Q ss_pred CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhccc
Q 047969 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQ 541 (625)
Q Consensus 462 s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 541 (625)
+.++|.|+|||++|||+.|..||.+.+.+... ..++-+.+.+.... ..+...++||+++|.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEP---EVSSAAKDLIRKLLVK 374 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCC---cchhHHHHHHHHHhcc
Confidence 99999999999999999999999876643321 11222222222222 4566889999999999
Q ss_pred CCCCCCC----HHHHHHH
Q 047969 542 NKELRPS----MEEVLAE 555 (625)
Q Consensus 542 ~P~~RPs----~~ell~~ 555 (625)
||.+|.. +.||.+|
T Consensus 375 dP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ChhhhhccccchHHhhcC
Confidence 9999987 7777765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=344.88 Aligned_cols=274 Identities=28% Similarity=0.486 Sum_probs=220.0
Q ss_pred ccccChHHHHHHhcCC---------CccceecccCcEEEEEEEEc-CC---cEEEEEEeccc-cHHHHHHHHHHHHHHHh
Q 047969 269 VPIFSYSDLAEATNDF---------SREKELGDGGFGTVYYGKLK-DG---REVAVKRLYDN-NYRRVEQFMNEVEILTR 334 (625)
Q Consensus 269 ~~~~~~~~~~~~~~~~---------~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~ 334 (625)
+..++|+|--++...| ++.+.||.|.||.|++|+++ .| ..||||.++.. ..+...+|+.|+.||-+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3456777766655444 46889999999999999987 33 45999999765 34556789999999999
Q ss_pred cCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 047969 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNI 414 (625)
Q Consensus 335 l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NI 414 (625)
++||||++|.|+... .+.+.||+|||++|+|+.+|.. +.+.+++.++..+++.|+.||+||.+.++|||||...||
T Consensus 687 FdHPNIIrLEGVVTk-s~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTK-SKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNI 762 (996)
T ss_pred CCCCcEEEEEEEEec-CceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhe
Confidence 999999999996665 6778999999999999999963 456799999999999999999999999999999999999
Q ss_pred EECCCCeEEEcccccccccCCCccccccCC--CCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCC-Ccccccc
Q 047969 415 LLDSNFCVKVADFGLSRLFPLDVTHVSTAP--QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPA-VDMNRHR 490 (625)
Q Consensus 415 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p-~~~~~~~ 490 (625)
||+.+...|++||||++....+.....+.. .-..+|.|||.+.-.+++.+|||||||++|||.++ |..| |++.+++
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 999999999999999998755543333332 34578999999998999999999999999999887 6555 4554321
Q ss_pred cccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCCcc
Q 047969 491 HEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKF 566 (625)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~~~ 566 (625)
.++.+.++. ++ +.+-+++..|.+|+++||++|-.+||.+.||+.+|.++..+...+
T Consensus 843 --------VIkaIe~gy-------RL-----PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 843 --------VIKAIEQGY-------RL-----PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred --------HHHHHHhcc-------CC-----CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 122222221 11 111245678999999999999999999999999999988765543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.49 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=199.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY----- 350 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 350 (625)
...++|++.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45679999999999999999999875 6889999998643 334456788999999999999999999965432
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
....++||||+++ +|.+.+. ..+++..+..++.|+++||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 2357999999976 5666663 13788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHH
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INK 502 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 502 (625)
+..... .......||..|+|||++.+..++.++||||||+++|+|++|+.||............... ...
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 864322 1223456899999999998888999999999999999999999999754322111000000 000
Q ss_pred h-------hhc--ccccc-----cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 503 I-------QKC--AFDEL-----IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 503 ~-------~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+ ... ....+ ................+..+.+|+.+||+.||++|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0 000 00000 000000000011122345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.38 Aligned_cols=242 Identities=27% Similarity=0.391 Sum_probs=194.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||+||+|+.+ +++.||||++.+.. ....+.+.+|..+++.+ +||||+++++++.. .+.+++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999876 67899999986542 23456678899999888 69999999996654 667999999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|..++. +...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 80 GGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 999998885 33468999999999999999999999999999999999999999999999999987532211 1123
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+...... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~~~------~------ 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDEVR------Y------ 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCC------C------
Confidence 346899999999999889999999999999999999999999754321 111111111100 0
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSM-----EEVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~~ 555 (625)
...++..+.+++.+||+.||++||++ .+++++
T Consensus 216 -~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 -PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 01245578899999999999999999 888766
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=321.50 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=202.7
Q ss_pred CCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
+|++.+.||+|+||.||+|... ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence 4788899999999999999853 23578999876543 3445779999999999999999999996654 56689
Q ss_pred EEEEeccCCChHHHhccCcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 047969 356 LVYEFVANGTVADQLHGDRA--------------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIl 415 (625)
++|||+.+++|.+++...+. ....+++..++.++.|++.||+|||+.+|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 99999999999999864221 1235889999999999999999999999999999999999
Q ss_pred ECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCccccccccc
Q 047969 416 LDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEI 493 (625)
Q Consensus 416 l~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~ 493 (625)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-- 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 999999999999999865332221 1122345778999999888889999999999999999998 999996543221
Q ss_pred chhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+.... . . . ....++.++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 238 -----~~~~~~~~~-~----~----~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -----LFNLLKTGY-R----M----E---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHhCCC-C----C----C---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111110 0 0 0 011234578899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=320.72 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=199.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-----------------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeee
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-----------------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSL 343 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~ 343 (625)
++|++.+.||+|+||.||+++.. ++..||+|++... .....+.+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998643 2346899998654 33445789999999999999999999
Q ss_pred eeeeeeccceEEEEEEeccCCChHHHhccCcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 047969 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRA-------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL 416 (625)
Q Consensus 344 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll 416 (625)
++++.. ....++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.|++||||||+|||+
T Consensus 85 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 85 LAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 996655 5668999999999999999865321 12357889999999999999999999999999999999999
Q ss_pred CCCCeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh--CCCCCccccccccc
Q 047969 417 DSNFCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEI 493 (625)
Q Consensus 417 ~~~~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt--G~~p~~~~~~~~~~ 493 (625)
+.++.+||+|||+++......... .....++..|+|||...+..++.++||||||+++|||++ |..||........+
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 999999999999998653322111 122334678999998887889999999999999999998 67777543322111
Q ss_pred chhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. .......... .....+. ....+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 244 ~---~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 244 E---NTGEFFRDQG-RQVYLPK--------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHhhcc-ccccCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 0000000000 0000000 0123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.00 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=203.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++.+.. ....++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeec
Confidence 358999999999999999999865 789999999876655566788999999999999999999996655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999999999842 3478999999999999999999999999999999999999999999999999876433221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......+++.|+|||.+.+..++.++||||||+++|+|++|++||......... .. +.......+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~-~~~~~~~~~-------- 236 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YL-IATNGTPEL-------- 236 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HH-HhcCCCCCC--------
Confidence 122346889999999998888899999999999999999999999654321111 00 000000000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....++..+.+++.+||..+|++||++.+++++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112345678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=320.48 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=204.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCc----EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.++|++.++||+|+||+||+|++. +|+ .||+|++... .....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCc
Confidence 357899999999999999999854 454 4899988643 33445778899999999999999999996654 346
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
+++|||+++|+|.+++.. ..+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 899999999999999863 23468999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 435 LDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 435 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 232 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLPQ- 232 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC-
Confidence 332221 122345678999999988889999999999999999998 999986533211 1111111110000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
....+..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 233 -----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 -----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0123457888999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=328.37 Aligned_cols=246 Identities=30% Similarity=0.431 Sum_probs=200.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|.-++.||+|+||.||.|++. +...||||++.-. ......+++.|++.|++++|||+|.+-||+.. ....||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHH
Confidence 4667788999999999999966 7788999998543 33456789999999999999999999998876 55679999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|||-| +..|++.. ...++-+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.....
T Consensus 106 EYClG-SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHhc-cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99964 78888753 345688999999999999999999999999999999999999999999999999976432
Q ss_pred ccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 439 HVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
....+|||.|||||++. .+.|+-|+||||||++..||...+||.-..+. ...+-.|.....+-+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNesPtL---- 245 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPTL---- 245 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcCCCCC----
Confidence 34567999999999864 56899999999999999999999998743221 112222222221111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. ....++.+..|+..||++-|.+|||.++++.|-
T Consensus 246 -q------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 -Q------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -C------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1 124577899999999999999999999999763
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=329.03 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=212.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC---Cc--EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD---GR--EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
+..+..++||.|-||.||+|.+.+ |. .||||.-+.+ .....+.|+.|+.+|++++|||||+++|++.+ ...|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--ccee
Confidence 344556789999999999998653 32 4899988663 45667899999999999999999999998876 5679
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
||||+++.|.|..+|+. +...|+......++.||..||+|||++++|||||...|||+...-.+||+||||++....
T Consensus 467 ivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999974 344688899999999999999999999999999999999999999999999999998876
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
+.........-...|||||.++-..++.+||||.|||.+||++. |..||.+-.....+ ..+.++
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnG-------- 608 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENG-------- 608 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCC--------
Confidence 65554455556789999999988899999999999999999986 99999765433222 111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
+..+.+..+++.+..++.+||..+|.+||.++|+...|..+...+.
T Consensus 609 ----eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 609 ----ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred ----CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 1112223456677889999999999999999999999998877544
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.90 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=193.1
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||+|+||.||+++.+ +|+.||+|++..... .....+..|++++++++||||+++++++.. ....++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 799999999999876 689999999854321 123445679999999999999999986554 667899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|.+++... ....+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++....... ......
T Consensus 80 L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 80 LKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 99888532 23358899999999999999999999999999999999999999999999999998654322 223346
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
|+..|+|||++.+..++.++||||||+++|+|++|+.||........ .. ........... .. ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~-~~~~~~~~~~~--------~~----~~~ 220 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KE-ELKRRTLEDEV--------KF----EHQ 220 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HH-HHHHHhhcccc--------cc----ccc
Confidence 89999999999888899999999999999999999999965332111 01 11111111100 00 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 526 RMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.++.++.+++.+||+.||++||+++|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 34567889999999999999999987765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.58 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=190.7
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..+++.+ +||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 46999999999999976 57899999986542 23345567788888765 89999999996655 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 80 GGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 999999985 33468999999999999999999999999999999999999999999999999987532211 1123
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+.... +...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~------~~~~----- 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDN------PCYP----- 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CCCC-----
Confidence 3468999999999988889999999999999999999999997543211 111111110 0000
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSME-EVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~ 555 (625)
..++.++.+++.+||+.+|++||++. +++++
T Consensus 217 --~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 --RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred --ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 11345678899999999999999997 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=322.33 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=204.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
..++|++.+.||+|+||.||+|.... ...+|+|.+... .......+.+|+.+++++ +|+||+++++++.. .
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-E 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-C
Confidence 34689999999999999999998642 367999988653 334456788999999999 79999999996655 5
Q ss_pred ceEEEEEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 047969 352 QGLLLVYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN 419 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~ 419 (625)
...+++|||+.+|+|.+++.... .....+++..++.++.|++.||+|||+.+|+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 67899999999999999986421 234568999999999999999999999999999999999999999
Q ss_pred CeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhH
Q 047969 420 FCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 420 ~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~ 497 (625)
+.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 242 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH------
Confidence 999999999998754322211 122345678999999988889999999999999999997 888886433211
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
....+....... . ....+..+.+|+.+||+.+|++|||+.++++.|+.+.
T Consensus 243 -~~~~~~~~~~~~-------~-----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFKLLKEGYRME-------K-----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHcCCcCC-------C-----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111111000 0 0122447888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=315.52 Aligned_cols=254 Identities=25% Similarity=0.443 Sum_probs=204.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.++||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEe
Confidence 4689999999999999999999877888999988654 3345778999999999999999999996655 567999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 9999999999642 23458899999999999999999999999999999999999999999999999998654322222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++....++.++|+||||+++|+|++ |+.||....... ....+.......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMP--------- 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCC---------
Confidence 223345678999999988888999999999999999998 999996433211 111111110000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
.....+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011345578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.04 Aligned_cols=256 Identities=29% Similarity=0.426 Sum_probs=202.9
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.+|+..++||+|+||.||+++.. ++..+|+|.+........+.+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceE
Confidence 46788899999999999999642 356799999877766677889999999999999999999996654 56689
Q ss_pred EEEEeccCCChHHHhccCcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 356 LVYEFVANGTVADQLHGDRA-----------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
++|||+++++|.+++..... ....+++..++.++.||+.||+|||+.|++||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 99999999999999864321 1135899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHH
Q 047969 425 ADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 425 ~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |.+||........ ...
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~ 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------IEC 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------HHH
Confidence 99999976532221 11122345788999999988889999999999999999998 9999864332211 111
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+....... ....++..+.+++.+||+.+|++||++++|++.|+
T Consensus 237 ~~~~~~~~------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRELE------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccCC------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11110000 00123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=314.96 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=204.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|...+++.||||.+..... ..+.+.+|+.++++++|+||+++++++.. ....++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEec
Confidence 468999999999999999999988888999999875433 34678999999999999999999996554 5668999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999999642 23468999999999999999999999999999999999999999999999999998764322222
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||.+.+..++.++|+||||+++++|++ |+.||....... ....+....... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~--- 225 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGYRMP-----R--- 225 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----C---
Confidence 222335678999999988889999999999999999998 999986433211 111111110000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01124578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.76 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=202.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCc--EEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGR--EVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+|+||.||+|+++ ++. .+|+|.+... .....+.+.+|+.++.++ +|+||+++++++.. ....+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCce
Confidence 357889999999999999999875 454 4688876543 234456788999999999 89999999996655 56789
Q ss_pred EEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEE
Q 047969 356 LVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~k 423 (625)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 99999999999999964321 123689999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHH
Q 047969 424 VADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 424 l~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
|+|||++...... .......++..|+|||++.+..++.++||||||+++|||++ |..||....... ....
T Consensus 165 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~ 235 (303)
T cd05088 165 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK 235 (303)
T ss_pred eCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHHH
Confidence 9999998643211 11122234678999999988888999999999999999998 999986433211 1111
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
+...... .. ....+..+.+++.+||+.+|++||++.+++++|..+.....
T Consensus 236 ~~~~~~~-------~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 236 LPQGYRL-------EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HhcCCcC-------CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1111000 00 01134567889999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=311.76 Aligned_cols=247 Identities=29% Similarity=0.414 Sum_probs=196.7
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCCh
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTV 366 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL 366 (625)
+.||+|+||.||+|...+++.+|+|++.... ......+.+|+++++.++||||+++++++.. ....++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcH
Confidence 3699999999999998888999999986543 2334578899999999999999999997655 5578999999999999
Q ss_pred HHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCC
Q 047969 367 ADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG 446 (625)
Q Consensus 367 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~g 446 (625)
.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...............+
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 999853 23458899999999999999999999999999999999999999999999999987543322222222345
Q ss_pred CCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 447 TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 447 t~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
+..|+|||++....++.++||||||+++|+|++ |..||....... ....+....... .. .
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~~-------~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMS-----CP-------Q 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCCC-----CC-------C
Confidence 678999999988889999999999999999998 999986443211 111111111000 00 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 526 RMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.++..+.+++.+||+.+|++||++.+++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 13457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.32 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=199.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----c
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----S 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 351 (625)
..++|++.+.||+|+||.||+|+.. .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4579999999999999999999876 6889999998643 233456788999999999999999999865432 2
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999975 6777663 137889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh------
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK------ 505 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 505 (625)
..... .......+|..|+|||++.+..++.++||||||+++|+|++|+.||......... ......+..
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~ 249 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCPEFM 249 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHH
Confidence 64322 1223456899999999999888999999999999999999999999755432111 111000000
Q ss_pred ------------cc-------cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 506 ------------CA-------FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 506 ------------~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.. +..+...................+.+++.+||+.||++|||+.++++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 0000000000000001112245778999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=336.84 Aligned_cols=264 Identities=22% Similarity=0.250 Sum_probs=196.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..+|.+.+.||+|+||.||+|++. .++.||||.... ..+.+|+++|++++|+|||++++++.. ....++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 458999999999999999999977 578899996422 345689999999999999999996655 566899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
++. ++|.+++.. ....+++..++.|+.||++||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 241 ~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 995 688888753 2346999999999999999999999999999999999999999999999999999865432221
Q ss_pred -cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCC-cccccccccchhHHHHHHhhhccc--ccc----
Q 047969 440 -VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAV-DMNRHRHEINLANLAINKIQKCAF--DEL---- 511 (625)
Q Consensus 440 -~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 511 (625)
......||..|+|||++.+..++.++|||||||+||||++|..++ ..................+..... ..+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 122356999999999999888999999999999999999987554 222111111111111111111110 000
Q ss_pred ---------------cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 ---------------IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+............+...+.+||.+||+.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000111122345578899999999999999999999987
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=317.58 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=200.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++.+.. ....++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEe
Confidence 357889999999999999999875 688999999876555555678899999999999999999996655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++. ..+.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++....... .
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 87 FCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred ccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 999999999985 34568999999999999999999999999999999999999999999999999987653221 1
Q ss_pred cccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 440 VSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
......|+..|+|||++. ...++.++|+||||+++|+|++|..||......... ......... .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-------~~~~~~~~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMTKSNFQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-------HhhhccCCC---CCcc
Confidence 223446899999999874 445888999999999999999999998543221110 000011100 0000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....++..+.+++.+||+.+|++||++++++++
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 -----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0001234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=328.30 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=187.3
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHH-HHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEV-EILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence 46999999999999977 678899999864321 2223444444 45678899999999986654 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+++|.+++. ....+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 80 GGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 999999985 34458888999999999999999999999999999999999999999999999997532211 1223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|.+||....... ....+...... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~~--~~--------- 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPLQ--LK--------- 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCcC--CC---------
Confidence 4569999999999998889999999999999999999999996543211 11111111100 00
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 554 (625)
..++..+.+++.+||+.+|.+||++.+.+.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 --PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 123457888999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.75 Aligned_cols=267 Identities=21% Similarity=0.286 Sum_probs=198.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY----- 350 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 350 (625)
+..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45679999999999999999999865 78899999986532 22345678999999999999999999865422
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
....+++||++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 23468999988 778988773 345899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH--------HHH
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL--------AIN 501 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~ 501 (625)
+..... .....||..|+|||++.+ ..++.++||||||+++|+|++|+.||.............. ...
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865322 234468999999999876 4688999999999999999999999965432111100000 000
Q ss_pred HhhhcccccccCCcCCCCCh----HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 502 KIQKCAFDELIDPCLGFESD----EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+.......... .+..... .........+.+|+.+||+.||++|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 242 KISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred hcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000000000 0000000 11112344678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.47 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=196.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.++..++|+||+++++.+.. .+.+++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 47889999999999999999876 68999999986432 2345678889999999999999999996554 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. +.+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999985 34568999999999999999999999999999999999999999999999999987542211
Q ss_pred c----------------------------------ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCC
Q 047969 438 T----------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA 483 (625)
Q Consensus 438 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p 483 (625)
. .......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001134699999999999888899999999999999999999999
Q ss_pred CcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 047969 484 VDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS---MEEVLAE 555 (625)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ell~~ 555 (625)
|....... ....+..... . +..... ..++.++.++|.+++. +|++|++ +.++++|
T Consensus 236 f~~~~~~~-------~~~~i~~~~~-~-----~~~p~~---~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQE-------TYRKVMNWKE-T-----LVFPPE---VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHH-------HHHHHHcCCC-c-----eecCCC---CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 97543221 1111111000 0 000000 0134467778888764 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.90 Aligned_cols=266 Identities=22% Similarity=0.252 Sum_probs=199.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc---CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK---DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
..+|++++.||+|+||.||++... .++.||+|.+... ..+.+|+++|++++|||||++++++.. ....++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEE
Confidence 357999999999999999999754 3578999987543 234689999999999999999996654 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||++. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99996 58888873 34569999999999999999999999999999999999999999999999999997654332
Q ss_pred cc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc-------
Q 047969 438 TH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD------- 509 (625)
Q Consensus 438 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 509 (625)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..................+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 22 1234569999999999998889999999999999999999999996544322111111111111100000
Q ss_pred -------cccC-CcCCCCChHH--HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 510 -------ELID-PCLGFESDEE--VKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 510 -------~~~~-~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.... .......... ...++.++.++|.+||+.+|++|||+.|++.+-.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 0000 0000000111 1134557888999999999999999999999843
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=319.20 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=198.7
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|++++++++.+.. ....++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEE
Confidence 677889999999999999876 78999999885432 2223567889999999999999999986654 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999988532 223589999999999999999999999999999999999999999999999999876432221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||.....................
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-------------- 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--------------
Confidence 22346899999999998888999999999999999999999999754321110000000000000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAEL 556 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L 556 (625)
.....++..+.+|+.+||+.||++||| ++|++++-
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 001123457889999999999999999 88999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=318.38 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=203.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcC------CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCC
Confidence 4689999999999999999998652 3679999986442 3445678899999999999999999996655 567
Q ss_pred EEEEEEeccCCChHHHhccCcc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRA------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 8999999999999999864321 2235789999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||....... ....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHhc
Confidence 99976543221 12233456789999999988889999999999999999998 999986433221 1111111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...... . ...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~~-----~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDL-----P-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCC-----C-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111110 0 012457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.01 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=201.3
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.+|++.++||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCce
Confidence 35778899999999999999864 247899999865432 335678899999999999999999996655 4568
Q ss_pred EEEEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeE
Q 047969 355 LLVYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~ 422 (625)
++++||+.+++|.+++.... .....+++..++.++.|++.||.|||++||+||||||+|||+++++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 99999999999999985211 123458899999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHH
Q 047969 423 KVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 423 kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 500 (625)
||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||...... ...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~ 236 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVI 236 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999886532221 11233456789999999988889999999999999999998 88888653321 112
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
..+........ ...++..+.+++.+||+.+|++||++++++..|+.
T Consensus 237 ~~i~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLPC------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCCC------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222111110 11245578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.07 Aligned_cols=241 Identities=29% Similarity=0.404 Sum_probs=188.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHH-HHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVE-ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|.. +++.++||||+++++.+.. .+..++||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 46999999999999876 78999999986432 223345556655 5677999999999986654 677899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|..++. +...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 80 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 80 GGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 999998885 3456899999999999999999999999999999999999999999999999998753221 11223
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...||+.|+|||++.+..++.++||||||+++|+|++|.+||....... ....+...... ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~~--~~~-------- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPLV--LRP-------- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCcc--CCC--------
Confidence 4568999999999998889999999999999999999999996543211 11111111100 000
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 554 (625)
..+..+.+++.+||+.+|++||++++.++
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 13446778999999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=315.97 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=204.6
Q ss_pred cCCCccceecccCcEEEEEEEEcC----CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence 468889999999999999998653 2468999886544 4556789999999999999999999996654 45689
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999632 335899999999999999999999999999999999999999999999999999865443
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.........++..|+|||.+....++.++||||||+++|+|++ |..||........ ...+.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~~----- 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGERLP----- 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCcCC-----
Confidence 2222223345678999999888889999999999999999996 9999965432211 11111111000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
. ....+..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus 229 --~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 --M-----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 112345788899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=313.24 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=202.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|++|.||+++.+ +++.||+|++... .....+.+.+|++++++++|+|++++++.+......+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999976 6789999998543 234456788999999999999999999865544556799999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++... ....+++.+++.++.|++.||++||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-D 157 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-C
Confidence 99999999998642 33468999999999999999999999999999999999999999999999999998664322 2
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......+++.|+|||++.+..++.++||||||+++++|++|+.||....... . ...+........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~-~~~~~~~~~~~~-------- 222 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------L-VYRIIEGKLPPM-------- 222 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------H-HHHHHhcCCCCC--------
Confidence 2234568899999999988889999999999999999999999986433211 1 111111111110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++||++.+++++
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.12 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=201.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD-----------------GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVS 342 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 342 (625)
.++|++.+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3689999999999999999997642 2468999986543 345678999999999999999999
Q ss_pred eeeeeeeccceEEEEEEeccCCChHHHhccCcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 047969 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA-------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415 (625)
Q Consensus 343 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIl 415 (625)
+++++.. +...++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9997665 4678999999999999999864321 1236899999999999999999999999999999999999
Q ss_pred ECCCCeEEEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh--CCCCCcccccccc
Q 047969 416 LDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHE 492 (625)
Q Consensus 416 l~~~~~~kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt--G~~p~~~~~~~~~ 492 (625)
++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ- 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence 99999999999999876432221 12233456789999999988889999999999999999998 667775432211
Q ss_pred cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 493 INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
......... .. ........ .....+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 242 ------~~~~~~~~~-~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ------VIENAGHFF-RD-DGRQIYLP---RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ------HHHHHHhcc-cc-ccccccCC---CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111100 00 00000000 01123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=318.52 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=198.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|+..+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|+++|+.++|+||+++++.+.. ++..++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEE
Confidence 3677789999999999999876 789999999854422 223457889999999999999999886554 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.+++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 80 TIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred EeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999999888632 23469999999999999999999999999999999999999999999999999987643221
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||......... ......+.....
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~---------- 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEE---------- 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcccc----------
Confidence 123446899999999998888999999999999999999999999754321111 111111111100
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAE 555 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~ 555 (625)
.....++..+.+|+..||+.+|++||+ +.+++++
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 ---VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 001134557788999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=313.39 Aligned_cols=252 Identities=30% Similarity=0.534 Sum_probs=201.0
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.+|++.+.||+|+||.||+|...+++.+|+|++..... ..+.+.+|++++++++|||++++++++.. ....++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcC
Confidence 47888899999999999999887788999998865432 34578899999999999999999996554 55789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++.. ..+.++++.++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999853 234688999999999999999999999999999999999999999999999999876543322222
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||++.+..++.++||||||+++|||++ |..||....... ....+.+.. ....+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~~------ 223 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYKP------ 223 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCCC------
Confidence 23335678999999988889999999999999999998 999986433211 111111110 00011
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...+..+.+|+.+||+.+|++||++.+++++|.
T Consensus 224 ----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 012457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=313.67 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=195.8
Q ss_pred eecccCcEEEEEEEEc---CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 289 ELGDGGFGTVYYGKLK---DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+||+|+||.||+|.++ +++.+|+|++... +....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 6999999999999653 5788999988543 2345678899999999999999999999654 3467899999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc--c
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV--S 441 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~--~ 441 (625)
++|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999985 33468999999999999999999999999999999999999999999999999998764332211 1
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....++..|+|||.+....++.++|+||||+++|||++ |.+||....... ....+.+......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~~~--------- 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERMEC--------- 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCCC---------
Confidence 22334678999999987788999999999999999998 999997543211 1122222111110
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...++.++.++|.+||+.+|++||++.+|.+.|+..
T Consensus 220 ---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 012455788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.72 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=204.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 357999999999999999999753 2356999998654 234456788999999999 79999999997655
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
....++||||+.+|+|.+++..... ....+++..++.++.|++.||+|||+.|++||||||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 5578999999999999999965321 1235899999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------ 249 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 249 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------
Confidence 9999999999987653221111 122234578999999988889999999999999999998 88888643221
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.....+....... .....+.++.+++.+||+.+|++||++.+++++|..+...
T Consensus 250 -~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 -ELFKLLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHHHHHcCCCCC------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111100 0112345788899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=318.09 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=200.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC------CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|++|.||+|.+.+ +..||+|.+.... ......|.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCC
Confidence 4679999999999999999998753 5679999875443 3344678999999999999999999996655 456
Q ss_pred EEEEEEeccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---eEEEccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF---CVKVADF 427 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~---~~kl~DF 427 (625)
.++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 7899999999999999865431 123589999999999999999999999999999999999998654 6999999
Q ss_pred ccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+++......... ......+..|+|||++.+..++.++||||||+++|+|++ |..||........ ...+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------MEFVTG 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHc
Confidence 9998653222111 112234568999999988889999999999999999997 9999975433211 111111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..... ....++..+.+++.+||+.+|++||++.+|+++|.
T Consensus 237 ~~~~~------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGRLD------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCcCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10000 01123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.17 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=204.7
Q ss_pred hHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeee--
Q 047969 274 YSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSR-- 349 (625)
Q Consensus 274 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-- 349 (625)
++.+..+.++|++.+.||+|+||.||+|+.. +++.+|+|++.... ...+.+.+|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455567789999999999999999999876 68899999875432 2235678899999999 69999999996532
Q ss_pred --ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 350 --YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 350 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
.+...++||||+++++|.+++.........+++..+..++.|+++||.|||+.+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 345689999999999999988644334567899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH
Q 047969 428 GLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 428 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
|+++...... .......|+..|+|||++.. ..++.++||||||+++|+|++|+.|+......... ..
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-------~~ 240 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-------FK 240 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-------hh
Confidence 9988653321 12233468999999998753 34788999999999999999999998654321110 01
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+..........+ ...+..+.+++.+||+.+|++|||+.|+++++
T Consensus 241 ~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPRNPPPTLHQP----------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccccCCCcccCC----------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111100000000 11234688899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.85 Aligned_cols=251 Identities=26% Similarity=0.471 Sum_probs=203.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.. ....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEe
Confidence 457899999999999999999875 88999999876544 56789999999999999999999997665 6678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999998632 22368999999999999999999999999999999999999999999999999998653221
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+..|+|||++....++.++||||||+++++|++ |..||....... ....+.......
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 219 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRME--------- 219 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC---------
Confidence 12335678999999988889999999999999999997 999986543211 111111110000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.....+..+.+++.+||..+|++||++.+++++|+.+
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 ---APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112356788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.69 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=201.1
Q ss_pred CCCccceecccCcEEEEEEEEc-----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-----DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 355 (625)
-|++++.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++... ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4788999999999999999742 5788999998644 234457799999999999999999999976554 35679
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 99999999999999853 223589999999999999999999999999999999999999999999999999986543
Q ss_pred Cccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccc---------cccchhHHHHHHhh
Q 047969 436 DVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHR---------HEINLANLAINKIQ 504 (625)
Q Consensus 436 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~---------~~~~~~~~~~~~~~ 504 (625)
.... ......++..|+|||++.+..++.++||||||+++|+|++++.|....... ...... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHHHHHH
Confidence 2221 112345677899999988888999999999999999999987654321100 000000 0111111
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.... .. ....++..+.+|+.+||+.+|++||+++++++.|+.+
T Consensus 241 ~~~~-------~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKR-------LP-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCcc-------CC-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1100 00 0112456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=351.49 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=201.2
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGL 354 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 354 (625)
...++|++++.||+|+||+||+|+.. +++.||+|++... .......|..|+.+|++|+|||||++++++.. ....+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34579999999999999999999976 6778999988543 33456778999999999999999999996643 34568
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCcccCCCCCCEEECC---------
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-------DIIHRDVKTNNILLDS--------- 418 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-------~ivHrDikp~NIll~~--------- 418 (625)
+|||||+++|+|.++|.......+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999975444456799999999999999999999984 4999999999999964
Q ss_pred --------CCeEEEcccccccccCCCccccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccc
Q 047969 419 --------NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNR 488 (625)
Q Consensus 419 --------~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~ 488 (625)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999998653321 2234568999999998854 458899999999999999999999996433
Q ss_pred cccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 489 HRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... .....+.... . +. ....+..+.+||..||+.+|++||++.|++.+
T Consensus 248 ~~~------qli~~lk~~p--~-----lp------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFS------QLISELKRGP--D-----LP------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHH------HHHHHHhcCC--C-----CC------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 211 1111111110 0 00 01234578899999999999999999999964
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.35 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=201.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|++|.||+|+.+ +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++.. ....++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence 47889999999999999999987 68999999885432 2233567899999999999999999996655 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|..++. ....+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 80 EYCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred eccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999988887764 334589999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---------ccc
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---------CAF 508 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~ 508 (625)
......++..|+|||++.+ ..++.++||||||+++|+|++|.+||..................+.. ...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999998865 45788999999999999999999999754432211111111000000 000
Q ss_pred ccccCCcC--CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 DELIDPCL--GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+.. ..........++..+.+|+.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 000111223456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.30 Aligned_cols=268 Identities=29% Similarity=0.390 Sum_probs=209.0
Q ss_pred ccccChHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeee
Q 047969 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGC 346 (625)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 346 (625)
...+++.++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+.+++++ +|||+++++++
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hhhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 334566677778899999999999999999999875 78899999986542 2345678899999999 79999999997
Q ss_pred eeecc----ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeE
Q 047969 347 TSRYS----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422 (625)
Q Consensus 347 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~ 422 (625)
+.... ...++||||+++++|.++++........+++..++.++.|++.||+|||+.+++||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE
Confidence 65422 35899999999999999886544445678999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCccccccCCCCCCCccCccccccC-----CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH
Q 047969 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-----QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 423 kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~ 497 (625)
||+|||++........ ......|+..|+|||.+... .++.++||||||+++|+|++|++||........
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----- 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----- 241 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence 9999999886532221 12334688999999987543 368899999999999999999999965432111
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+.......+.+ .......+.++|.+||+.+|++||++.|++++
T Consensus 242 --~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 --LFKIPRNPPPTLLH----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHHhcCCCCCCCc----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111111111 11234578899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.11 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=201.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc--EEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR--EVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|..+ ++. .+++|.+... .....+.+.+|+.+++++ +||||+++++++.. ....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceE
Confidence 57899999999999999999876 343 4788887642 333456789999999999 79999999996654 556899
Q ss_pred EEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 357 VYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 9999999999999964321 1235889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHh
Q 047969 425 ADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||....... ....+
T Consensus 161 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~~~ 231 (297)
T cd05089 161 ADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYEKL 231 (297)
T ss_pred CCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence 999998643211 11112233567999999988889999999999999999997 999996543211 11111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
....... . ...++..+.+|+.+||+.+|.+||++.++++.|..+....
T Consensus 232 ~~~~~~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRME-----K-------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCCC-----C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1110000 0 0124457889999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=320.84 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=204.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++.. ....++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeec
Confidence 468999999999999999999975 799999999876555556778999999999999999999996655 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 9999999999842 3578999999999999999999999999999999999999999999999999876533221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... +..... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~~~----------~ 233 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGT----------P 233 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccCCC----------C
Confidence 12334588999999999888889999999999999999999999965432211100 000000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......++..+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.92 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=203.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|+||.||+|++. ++..+|+|.+... .....+++.+|++++++++||||+++++++.. .+..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence 47899999999999999999876 6788999988644 33345678899999999999999999997665 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|+++++|.+++. +.+.+++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 80 y~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 80 HMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred ccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999996 33568999999999999999999998 59999999999999999999999999998754322
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc---------
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD--------- 509 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 509 (625)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ..............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCC
Confidence 12334688999999999888899999999999999999999999864432110 00000000000000
Q ss_pred -----------cccCCcCCCC-ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 510 -----------ELIDPCLGFE-SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 510 -----------~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
++.+...... .......++.++.+++.+||+.+|++||++++++++..-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0000000000 0000012456789999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=321.65 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=205.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|++.+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 468899999999999999999742 3457999988643 234457789999999999 89999999996655
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
....++||||+.+|+|.+++..... ....+++..++.++.||++||.|||++||+||||||+||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 5678999999999999999965321 1245888999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------ 246 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ 246 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------
Confidence 9999999999998764322221 223346778999999988889999999999999999998 78887543211
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.....+....... . ....+..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 247 -~~~~~~~~~~~~~-------~-----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 -ELFKLLKEGHRMD-------K-----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHHcCCcCC-------C-----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111000 0 012345788899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=326.98 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=191.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv 357 (625)
+|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+..|+.+++.+. |++|+++++++.. .+..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence 4778899999999999999876 78999999986532 233456788999999886 5667778875544 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 80 MEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999885 34569999999999999999999999999999999999999999999999999987542221
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+......
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~~~-------- 219 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHNVS-------- 219 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC--------
Confidence 1123346899999999998888999999999999999999999999754321 111112111110
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSM 549 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 549 (625)
. ...++.++.+++.+||+.+|.+|++.
T Consensus 220 ~-----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 Y-----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C-----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 01234577889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.99 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=202.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCc---EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGR---EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|+..+.||+|+||.||+|+.+ +++ .+|+|.+... .....+.+.+|++++++++|+|++++++++.. ....+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcE
Confidence 357888899999999999999875 333 6999988654 33446778999999999999999999996655 56789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ..+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999853 335689999999999999999999999999999999999999999999999999986543
Q ss_pred Ccccccc--CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 436 DVTHVST--APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 436 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
....... ....+..|+|||++....++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~~~---- 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGFR---- 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcCCC----
Confidence 2221111 1223467999999988889999999999999999997 99998643321 11111111100
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.+ . ....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 ~~-----~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LP-----A---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-----C---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0 012345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.79 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=196.4
Q ss_pred ceecccCcEEEEEEEEc--C--CcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK--D--GREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
++||+|+||.||+|++. + +..+|+|.+..... ...+.+.+|+++++.++|+||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence 47999999999999754 2 26899999865543 34567899999999999999999999654 346799999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc-
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS- 441 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~- 441 (625)
+++|.+++.. ...+++..++.++.|++.||+|||..+++||||||+|||++.++.+||+|||+++..........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 79 LGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 9999999963 33689999999999999999999999999999999999999999999999999986643322211
Q ss_pred -cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 442 -TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 442 -~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
....++..|+|||.+.+..++.++||||||+++|+|++ |.+||....... ....+.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGERLP--------- 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCcCC---------
Confidence 12234568999999988889999999999999999998 999996543211 111111111000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
....++..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.61 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=204.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
++|++.+.||.|+||.||+|+.. +++.+|+|.+........+.+.+|+.++++++||||+++++.+.. ...++++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeC
Confidence 57999999999999999999876 678899999876655567889999999999999999999996655 6678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+.+++|.+++.. ....+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 999999998863 22468999999999999999999999999999999999999999999999999987654321 11
Q ss_pred ccCCCCCCCccCccccccC---CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 441 STAPQGTPGYVDPEYHQCY---QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....++..|+|||.+... .++.++|+||||+++|+|++|.+||......... ..+....+. ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-------~~~~~~~~~---~~--- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-------FLISKSNFP---PP--- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccCC---Cc---
Confidence 2334678899999998766 7889999999999999999999999654321111 011111000 00
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......++.++.+++.+||+.+|++|||+.+++.+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001123456688999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.18 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=202.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.. ...+++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence 5788999999999999999876 7889999988532 34456778899999999999999999996654 6788999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 9999999988532 33458999999999999999999999999999999999999999999999999997654322 12
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||....... ....+.......+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHhcCCCCCC---------
Confidence 233468899999999988889999999999999999999999997533211 1111112111110
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++||++.+++..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.74 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=194.7
Q ss_pred eecccCcEEEEEEEEc---CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCC
Q 047969 289 ELGDGGFGTVYYGKLK---DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG 364 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g 364 (625)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence 4899999999999764 35579999986553 334567899999999999999999999654 34679999999999
Q ss_pred ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc--cc
Q 047969 365 TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV--ST 442 (625)
Q Consensus 365 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~--~~ 442 (625)
+|.+++.. ....+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......... ..
T Consensus 80 ~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999853 23468999999999999999999999999999999999999999999999999998654332211 12
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
...++..|+|||.+....++.++||||||+++|+|++ |..||....... ....+....... .+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~-------- 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD-CP-------- 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC-CC--------
Confidence 2234578999999988889999999999999999996 999996543211 111111111100 00
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...+.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ---~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 ---AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12345788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.06 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=199.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec-----c
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY-----S 351 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~ 351 (625)
.+.+.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++++ +|+||+++++.+... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999876 68889999985443 3345688999999999 699999999966542 2
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
...++||||+.+++|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4579999999999999998642 33468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
...... .......|+..|+|||++. ...++.++||||||+++|||++|..||......... ......
T Consensus 160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-------~~~~~~ 231 (272)
T cd06637 160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FLIPRN 231 (272)
T ss_pred eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HHHhcC
Confidence 653222 1223456899999999875 335788999999999999999999999643221100 011110
Q ss_pred ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...... ...++..+.+|+.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLK-----------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCC-----------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 01234578899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.48 Aligned_cols=253 Identities=30% Similarity=0.406 Sum_probs=201.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.|++.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+++++.++|+||+++++.+.. ....++||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEec
Confidence 3678889999999999999976 578899999876666667889999999999999999999996655 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|..++.. ....+++..+..++.|+++||.|||+.|++||||||+|||++.++.+||+|||++....... ...
T Consensus 85 ~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 85 AGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 99999888753 23468999999999999999999999999999999999999999999999999987643221 122
Q ss_pred cCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 442 TAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
....++..|+|||++. +..++.++||||||+++|+|++|.+||....... . ...+.........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~---- 229 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------V-LLKIAKSEPPTLA---- 229 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------H-HHHHhhcCCCCCC----
Confidence 3346899999999873 3457789999999999999999999986543211 0 1111111111000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....++.++.+++.+||+.+|++||++.+++++-.
T Consensus 230 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 230 ------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 01134567889999999999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.72 Aligned_cols=251 Identities=26% Similarity=0.469 Sum_probs=199.9
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEecccc------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNN------YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.. ....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEE
Confidence 588899999999999999998889999999875331 2334668899999999999999999997665 577899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++. +...+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 80 FMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999985 3345889999999999999999999999999999999999999999999999998764321
Q ss_pred c-----cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 437 V-----THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 437 ~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
. ........++..|+|||++.+..++.++||||||+++|+|++|..||......... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~- 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRGLMPR- 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccCCCCC-
Confidence 1 11122345889999999998888999999999999999999999999643321111 000000000010
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+ ...++.++.+++.+||+.+|++||++.+++++
T Consensus 230 ----~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 ----L-------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----C-------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 11245578899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.29 Aligned_cols=269 Identities=22% Similarity=0.338 Sum_probs=198.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|++|.||+|+.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.. +...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence 5788899999999999999976 68999999885432 2234668899999999999999999997665 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+. ++|.+++.... ....+++..++.++.||++||+|||+++|+||||||+||+++.++.+||+|||++....... .
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred cCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 997 58888875432 33568999999999999999999999999999999999999999999999999997653221 1
Q ss_pred cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---------cc
Q 047969 440 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA---------FD 509 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 509 (625)
......+++.|+|||++.+. .++.++||||||+++|+|++|++||....................... +.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 12334578999999987653 578899999999999999999999975432111100000000000000 00
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.................++.++.++|.+||+.||++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000111122356688899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.43 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=203.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.+|++.+.||.|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+.. ....++||||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEe
Confidence 46999999999999999999865 789999999866555556778999999999999999999996654 6678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 98 LAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred cCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 99999999884 235899999999999999999999999999999999999999999999999998765432221
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ..+.......+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-------~~~~~~~~~~~~-------- 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGTPELQ-------- 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCCcccC--------
Confidence 22346889999999998888999999999999999999999999754332111 011111000000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....++..+.++|.+||..+|++||++.+++++=
T Consensus 237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0123455788899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.10 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=195.0
Q ss_pred ceecccCcEEEEEEEEc----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK----DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|.+. +...||+|++... .....+.+.+|+.+++.++||||+++++++...+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999854 2457999988543 345567889999999999999999999966554566789999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc---
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH--- 439 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~--- 439 (625)
+++|.+++.. ....+++..+..++.||++||+|||+.+++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999999863 2334678888999999999999999999999999999999999999999999999754322111
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||.+....++.++||||||+++|||++ |.+||...... . ....+....... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~-~~~~~~~~~~~~-------~ 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------D-ITVYLLQGRRLL-------Q 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhcCCCCC-------C
Confidence 1122346778999999988889999999999999999999 56666533211 1 111111111000 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 224 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 -----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01234578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.44 Aligned_cols=271 Identities=21% Similarity=0.296 Sum_probs=200.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ....++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEE
Confidence 357999999999999999999876 68899999986432 2233467789999999999999999996654 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+. ++|.+++.. ....+++..+..++.||++||+|||+.||+|+||||+|||++.++.+||+|||++........
T Consensus 84 e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred eccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 9997 588888753 234588999999999999999999999999999999999999999999999999976432221
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC----
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID---- 513 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 513 (625)
......+++.|+|||++.+ ..++.++||||||+++|+|++|++||..........................+..
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1223457899999998765 3578899999999999999999999975543221111110000000000000000
Q ss_pred --CcCCCCC----hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 --PCLGFES----DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 --~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....... ......++..+.++|.+||+.||++|||++|++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000000 0111234667889999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=312.55 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=203.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++.. ....++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEE
Confidence 47888999999999999999976 68899999986543 3455678899999999999999999996665 577899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ..+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999999853 2689999999999999999999999999999999999999999999999999987653321
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......++..|+|||++.+..++.++||||||+++|+|++|++||....... ....+.......+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~------ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPPSLEG------ 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCCCCCcc------
Confidence 2233468889999999988889999999999999999999999996543211 111111111111000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..++..+.+++.+||..+|++||++++++++-
T Consensus 221 -----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 221 -----NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred -----cccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 01455788999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.20 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=198.4
Q ss_pred ceecccCcEEEEEEEEcC--Cc--EEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLKD--GR--EVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|++|.||+|.+.+ ++ .||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999998653 33 699999877655 567789999999999999999999996665 67899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc--c
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH--V 440 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~--~ 440 (625)
+++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999964321 46899999999999999999999999999999999999999999999999999876432221 1
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.... ... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~-~~~-----~~- 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILKKIDKEG-ERL-----ER- 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcC-CcC-----CC-
Confidence 123457789999999988889999999999999999998 999986433211 111111100 000 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ----PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0123557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.66 Aligned_cols=198 Identities=26% Similarity=0.392 Sum_probs=160.7
Q ss_pred cceecccCcEEEEEEEEc---CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEEEEEecc
Q 047969 287 EKELGDGGFGTVYYGKLK---DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLLVYEFVA 362 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~ 362 (625)
.++||+|+||+||+|+.+ +++.||+|.+..... ...+.+|+++|++++||||+++++++.. .....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999865 467899999865432 2456789999999999999999996643 3456899999986
Q ss_pred CCChHHHhccCc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE----CCCCeEEEccccccccc
Q 047969 363 NGTVADQLHGDR-----AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLF 433 (625)
Q Consensus 363 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll----~~~~~~kl~DFgla~~~ 433 (625)
+ +|.+++.... .+...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 4 7877764321 122358999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCccc--cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCccc
Q 047969 434 PLDVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMN 487 (625)
Q Consensus 434 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~ 487 (625)
...... ......||+.|+|||++.+ ..++.++||||+|+++|+|++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 432221 1234568999999998876 45889999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.55 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=203.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
++|++.+.||+|+||.||+|+.. +++.+|+|.+..... .+++.+|++++++++|+||+++++.+.. ....++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEec
Confidence 68999999999999999999987 488999999865432 6789999999999999999999996665 5778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+.+++|.+++.. ....+++..++.++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999999853 335689999999999999999999999999999999999999999999999999987543221 2
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....++..|+|||++.+..++.++||||||+++|+|++|++||......... ..+..... ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~----------~~ 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP----------PT 218 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC----------CC
Confidence 23345789999999998888999999999999999999999999754322111 00000000 00
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......++..+.+++.+||+.+|++|||++|++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11122355678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.79 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=203.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeecc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYS 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 351 (625)
..++|.+.++||+|+||.||+|++. .++.||||++.... ....+.+++|+++|.++. |||||++++++.. .
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-~ 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-G 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-C
Confidence 3457888999999999999999864 34679999996542 333457899999999997 9999999997665 4
Q ss_pred ceEEEEEEeccCCChHHHhccCcc--------------------------------------------------------
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRA-------------------------------------------------------- 375 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 375 (625)
...++||||+.+|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 578999999999999999964321
Q ss_pred --------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 047969 376 --------------------------------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD 417 (625)
Q Consensus 376 --------------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~ 417 (625)
....+++..++.++.||+.||+|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 112477888999999999999999999999999999999999
Q ss_pred CCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccch
Q 047969 418 SNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINL 495 (625)
Q Consensus 418 ~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~ 495 (625)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---- 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---- 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence 9999999999999865322211 1123356789999999988889999999999999999998 888886432211
Q ss_pred hHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 496 ANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
.....+..... ... ....+.++.+++.+||+.+|++||++++|++.|+.+.
T Consensus 350 --~~~~~~~~~~~-----~~~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QFYNAIKRGYR-----MAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHHHHHcCCC-----CCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111100 000 0123457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.94 Aligned_cols=261 Identities=27% Similarity=0.410 Sum_probs=202.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence 3568999999999999999999754 24579999875443 3344568899999999999999999996655 45
Q ss_pred eEEEEEEeccCCChHHHhccCcc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
..++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 78999999999999999964221 123467788899999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhh
Q 047969 427 FGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 427 Fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~ 235 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVM 235 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH
Confidence 99998653322111 122345678999999988889999999999999999998 788886432211 111111
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
....... ....+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 236 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYLDQ------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111100 0122457889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.37 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=201.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-C---CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-D---GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|+.. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEE
Confidence 57889999999999999999864 2 3379999886432 3345678999999999999999999996654 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.. ..+.+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999963 2346899999999999999999999999999999999999999999999999999876433
Q ss_pred ccccc--cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 437 VTHVS--TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 437 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... ....++..|+|||++.+..++.++|+||||+++|++++ |..||....... ....+.+....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~---- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYRL---- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCcC----
Confidence 22211 11223568999999988889999999999999999886 999986543211 11111111000
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
+. ....+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 229 ~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PA--------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC--------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 012345778999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=307.36 Aligned_cols=250 Identities=31% Similarity=0.480 Sum_probs=201.7
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLKD----GREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 469999999999998763 788999998665433 36788999999999999999999996665 677899999999
Q ss_pred CCChHHHhccCccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 363 NGTVADQLHGDRAK-----HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 363 ~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
+++|.+++...... ...+++..++.++.|+++||+|||+++++||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999753211 3679999999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 438 T-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 438 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. .......++..|+|||.+....++.++||||||+++|+|++ |..||...... .....+.......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~----- 227 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKGYRLP----- 227 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCC-----
Confidence 1 11233457889999999988789999999999999999999 69999755221 1111111111000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....++.++.+++.+||+.+|++|||+.+++++|+
T Consensus 228 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 -------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01123568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=313.91 Aligned_cols=252 Identities=30% Similarity=0.394 Sum_probs=201.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+.|+++++||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++.+.. ....++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEec
Confidence 57999999999999999999976 588999999977766777889999999999999999999996654 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|..++.. ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++...... ...
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 999999888753 2345899999999999999999999999999999999999999999999999998753221 111
Q ss_pred ccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 441 STAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.....++..|+|||++. ...++.++||||||+++|+|++|.+||...... .....+.........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~--- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLS--- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCCCccCC---
Confidence 23345788999999874 334678999999999999999999998643321 111111111110000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++..+.+++.+||+.+|++||++++++++
T Consensus 237 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 -------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011234567889999999999999999999876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=311.73 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=201.8
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcc
Confidence 57889999999999999999864 3467999988654433 46789999999999999999999996654 5668
Q ss_pred EEEEEeccCCChHHHhccCccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAK-----HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL 429 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgl 429 (625)
++||||+++++|.+++...... ...+++..++.++.||+.||+|||+.+|+||||||+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999999999644321 12689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
+...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~ 236 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKL 236 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCCc
Confidence 87543222222233456778999999888888999999999999999998 788885432211 1111111111
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.... ...++..+.+++.+||+.+|++||++.+++++|.
T Consensus 237 ~~~~-----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPV-----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCC-----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1000 0123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=305.79 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=204.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|+..+.||.|+||.||.++.. +++.+++|++... ......++.+|++++++++|+||+++++++.. ....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence 5888999999999999999865 6889999987543 34556778999999999999999999997765 677899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++... ....+++..+..++.|+++||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 80 YANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred ecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999998643 235689999999999999999999999999999999999999999999999999987643332
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......++..|+|||++.+..++.++||||||+++|+|++|..||...... .....+........
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKIVQGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCCC--------
Confidence 223456899999999998878899999999999999999999999653321 11111111111110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...++..+.+++.+||+.+|++||+++++++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 123455788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.28 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=202.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|.+.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+.+++++ +|+||+++++++.. .+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CC
Confidence 357999999999999999999742 34579999886542 34456789999999999 79999999996654 56
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+.+|+|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+|||++.++.+||+|||+++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 789999999999999998642 223489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 433 FPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 433 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....+.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~ 264 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA 264 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC
Confidence 5433221 1122346788999999988889999999999999999998 999986543211 1111111110000
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
. ....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 265 -----~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 -----Q-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----C-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 011245788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.44 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=203.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|.+.+.||+|+||.||+|+.. ....+|+|.+... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 368899999999999999999742 2456999988644 234466789999999999 69999999996654
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
....++||||+.+|+|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 5668999999999999999964321 2345899999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----- 244 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----- 244 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 9999999999998654322111 122234567999999988889999999999999999999 888885432211
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+........ ....+.++.+++.+||+.+|++|||+.++++.|..+..
T Consensus 245 --~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 --LFKLLREGHRMDK------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred --HHHHHHcCCCCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111110000 01234477889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=320.88 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=204.4
Q ss_pred cCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
.+|++.+.||+|+||.||+|+.. .+..||+|.+... .....+.+.+|+++++++ +||||+++++++.. .
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-D 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-C
Confidence 47899999999999999999743 1236899987643 234467889999999999 79999999997665 5
Q ss_pred ceEEEEEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 047969 352 QGLLLVYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN 419 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~ 419 (625)
...+++|||+.+|+|.+++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 57899999999999999986432 123458899999999999999999999999999999999999999
Q ss_pred CeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhH
Q 047969 420 FCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 420 ~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~ 497 (625)
+.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 244 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 244 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 999999999998654322111 122334578999999988889999999999999999998 888886432211
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
....+........ ...++.++.+++.+||+.+|++||++.|++++|+.+....
T Consensus 245 -~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -LFKLLKEGHRMDK------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHcCCCCCC------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111111110000 0123457889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=321.61 Aligned_cols=261 Identities=29% Similarity=0.444 Sum_probs=216.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.+..+..+||-|.||.||.|.++ -.-.||||.++++. -.+++|+.|+.+|+.++|||+|+++|+|.. ...+|||+||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEf 344 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEF 344 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEec
Confidence 45667789999999999999987 35679999997664 467899999999999999999999998876 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
|..|+|.+||.+. ....++.-.++.++.||..||+||..+++|||||...|.||.++..+||+||||++++..+....
T Consensus 345 M~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999999754 33457778889999999999999999999999999999999999999999999999987776655
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....-.+.|.|||-+.-..++.|+|||+|||+|||+.| |..|+.+.+... ....+.++. ..
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkgy---------RM- 485 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKGY---------RM- 485 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhccc---------cc-
Confidence 545556789999999988889999999999999999998 999987543221 111111111 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCCc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSK 565 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~~ 565 (625)
+..+.++..+.+|++.||+..|.+||++.|+-+.++.+-...+-
T Consensus 486 --~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 486 --DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred --cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 11235667888999999999999999999999999988766553
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.38 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=199.4
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
+..++.+.....||+|+||.||+|++. +++.||+|.+........+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEE
Confidence 344556666678999999999999866 678899999877766677889999999999999999999996655 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEccccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLL--TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLF 433 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgla~~~ 433 (625)
||||+++++|.+++... ...+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999998632 2334 78888999999999999999999999999999999976 679999999998765
Q ss_pred CCCccccccCCCCCCCccCccccccC--CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... ......++..|+|||++... .++.++||||||+++|+|++|++||.......... .... .. ..
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~-~~-~~---- 229 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVG-MF-KI---- 229 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhh-hh-cc----
Confidence 32221 12234578999999988653 37889999999999999999999986432211100 0000 00 00
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+. ....++.++.+++.+||+.+|++|||+.|++++
T Consensus 230 -~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 -HPE-------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -CCC-------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 011244578889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.58 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=200.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CC---cEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DG---REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|+.. ++ ..||||.+... .....+.|.+|+.++++++||||+++++++.. +...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEE
Confidence 46888999999999999999875 33 36999998654 34456789999999999999999999996654 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.. ..+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999863 2346899999999999999999999999999999999999999999999999998765432
Q ss_pred ccccc-c-CC--CCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 437 VTHVS-T-AP--QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 437 ~~~~~-~-~~--~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... . .. ..+..|+|||++.+..++.++||||||+++|||++ |..||....... ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~~---- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQDY---- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC----
Confidence 21111 1 11 12457999999988889999999999999999886 999986443211 111111110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
. .. . ...++..+.+++.+||+.+|++||++++++.+|+.+
T Consensus 229 -~--~~--~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -R--LP--P---PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -c--CC--C---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 0 012345778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.74 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=196.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 354 (625)
.+|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++... ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999875 6899999987532 223456788999999999999999999966542 4567
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
+++|||+++++|.+++. ..+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999985 33458999999999999999999999999999999999999999999999999987653
Q ss_pred CCcc--ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 435 LDVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 435 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~-~~~~~~----~ 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIF-KIATQP----T 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHH-HHhcCC----C
Confidence 2111 11123458899999999988889999999999999999999999996432211 111 111000 0
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+. ....+...+.+++ .||..+|++||+++|++++
T Consensus 227 ~~~-------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQ-------LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCC-------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 110 0122344666777 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=326.88 Aligned_cols=241 Identities=26% Similarity=0.314 Sum_probs=187.1
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhc---CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRL---RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
||+|+||+||+|+.+ +++.||||++..... .....+..|..++..+ +||||+++++.+.. ....++||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence 799999999999976 689999999854321 2334456677777766 69999999986554 667899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+|+|.+++. +.+.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 80 GGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred CChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 999998885 34568999999999999999999999999999999999999999999999999987532221 1223
Q ss_pred CCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 443 APQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
...||..|+|||++.+. .++.++||||||+++|+|++|+.||....... ....+...... +. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~------~~--~- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVR------FP--K- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCCC------CC--C-
Confidence 45699999999988654 47899999999999999999999996543211 11122111110 00 0
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRP----SMEEVLAE 555 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RP----s~~ell~~ 555 (625)
..++.++.+++.+||+.+|++|| ++.+++++
T Consensus 219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 12345778899999999999998 56777665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.62 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=205.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~ 358 (625)
+|++.+.||.|+||.||+|... +++.||+|++... .....+++.+|++++++++|+||+++++.+.. .....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5788899999999999999865 7889999988543 33456778899999999999999999985543 345679999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH-----ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
||+++++|.+++.........+++..++.++.||+.||+||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765445667999999999999999999999 889999999999999999999999999999876
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
...... .....++..|+|||++.+..++.++|+||||+++++|++|+.||...... .....+.......+
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-- 230 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGKFRRI-- 230 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCCCCCC--
Confidence 433221 23346899999999998888899999999999999999999999754311 11122222211111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++||++++|+++
T Consensus 231 ----------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 ----------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=309.59 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=199.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN------YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.. .+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence 4788899999999999999864 78999999885432 2245778999999999999999999996654 56789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccccccC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSRLFP 434 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~~~ 434 (625)
+||||+++++|.+++. +.+.+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus 80 ~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 80 LFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999999985 334689999999999999999999999999999999999998775 69999999998764
Q ss_pred CCccc---cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 435 LDVTH---VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 435 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... ......++..|+|||.+.+..++.++||||+|+++++|++|..||......... .... .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~-~~~~~~~--- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIF-KIASATT--- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHH-HHhccCC---
Confidence 33211 112345789999999998888899999999999999999999999644322111 1110 1000000
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......++..+.+++.+||+.+|++||++.+++++
T Consensus 229 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 --------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 001112355678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=310.38 Aligned_cols=249 Identities=26% Similarity=0.445 Sum_probs=198.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---------HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---------RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence 4778889999999999999875 688999998754321 123568899999999999999999996655 56
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+++++|.+++. ..+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 7899999999999999995 335688999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccc-----cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 433 FPLDVTH-----VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 433 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~ 228 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------IFKIGENA 228 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------HHHHhccC
Confidence 6422111 11123578999999999888889999999999999999999999975322111 11111111
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... + ...++..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPE-----I-------PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCc-----C-------CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 110 0 11245578889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.05 Aligned_cols=258 Identities=28% Similarity=0.396 Sum_probs=201.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCc
Confidence 367999999999999999999863 46789999986543 3345678999999999999999999996654 567
Q ss_pred EEEEEEeccCCChHHHhccCcc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 047969 354 LLLVYEFVANGTVADQLHGDRA------------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIl 415 (625)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 8999999999999999863211 1234788999999999999999999999999999999999
Q ss_pred ECCCCeEEEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCccccccccc
Q 047969 416 LDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEI 493 (625)
Q Consensus 416 l~~~~~~kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~ 493 (625)
++.++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-- 240 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-- 240 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999876432221 11122335678999999988889999999999999999997 888875432211
Q ss_pred chhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
....+........ ....+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 -----~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -----VIYYVRDGNVLSC------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112222111100 01234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=312.51 Aligned_cols=254 Identities=30% Similarity=0.407 Sum_probs=204.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||.|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++|+||+++++.+.. ....++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEee
Confidence 467999999999999999999875 688999999877666677889999999999999999999996654 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 83 FCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred ccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 9999999999853 23468999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 440 VSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
......++..|+|||++. ...++.++|+||||+++|+|++|++||....... ....+.......+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~-- 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-------VLLKILKSEPPTLD-- 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-------HHHHHhcCCCCCcC--
Confidence 123345889999999874 3346789999999999999999999996543211 11111111111000
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....++.++.+++.+||+.+|++||++.+++++-
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 230 --------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred --------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 0113455788999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.82 Aligned_cols=265 Identities=23% Similarity=0.273 Sum_probs=204.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-C-----CCeeeeeeeeeeccceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-H-----KNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 355 (625)
+|.+++.||+|.||.|.+|.+. +++.||||+++.. .....+-..|+.+|..|+ | -|+|++++++.. .++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-cccee
Confidence 8899999999999999999865 7999999998654 556677788999999997 4 389999996554 78999
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC--CeEEEccccccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN--FCVKVADFGLSRLF 433 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~--~~~kl~DFgla~~~ 433 (625)
||+|.+. -+|.++++.++ ...++...++.|+.||+.||..||+.||||.||||+||||.+- ..+||+|||.++..
T Consensus 265 iVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999995 49999998654 3459999999999999999999999999999999999999653 36999999999875
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc-------
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC------- 506 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------- 506 (625)
..... ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+....+..+...+......
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 43222 4567889999999999999999999999999999999999998766544443333222110000
Q ss_pred ---cccc------c----------------------cCCc-CC---CCChHHHH-HHHHHHHHHHHHhcccCCCCCCCHH
Q 047969 507 ---AFDE------L----------------------IDPC-LG---FESDEEVK-RMTTSVAELAFLCLQQNKELRPSME 550 (625)
Q Consensus 507 ---~~~~------~----------------------~~~~-~~---~~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~ 550 (625)
.+.. . .+.. .. ........ .-...+.+|+++||..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0000 0 0000 00 00000111 2234788999999999999999999
Q ss_pred HHHHHH
Q 047969 551 EVLAEL 556 (625)
Q Consensus 551 ell~~L 556 (625)
|.++|-
T Consensus 498 qal~Hp 503 (586)
T KOG0667|consen 498 QALNHP 503 (586)
T ss_pred HHhcCc
Confidence 999984
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.80 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=191.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
...+|++++.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.. ....++||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEE
Confidence 3468999999999999999999976 5778999975332 23569999999999999999997665 56689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|++. ++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9995 588888753 3456899999999999999999999999999999999999999999999999999753221
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCC-CCCcccccccccchh---HHHHHHhhh-----cccc
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLA---NLAINKIQK-----CAFD 509 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~-~p~~~~~~~~~~~~~---~~~~~~~~~-----~~~~ 509 (625)
.......||..|+|||++.+..++.++||||||+++|||+++. ++|............ ......+.. ..+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 1123346899999999998888999999999999999999854 444432211000000 000000000 0000
Q ss_pred ---------cccC----CcCCCCCh--HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ---------ELID----PCLGFESD--EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ---------~~~~----~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+.+ ........ .....++..+.++|.+||+.||++|||++|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 00000000 0011234566779999999999999999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.39 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=207.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.+.|.++..||.|+||.||+|..++ +-..|.|++.......+++++-|++||..++||+||++++.+.. .+.++|+.|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliE 109 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIE 109 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEe
Confidence 3568889999999999999999884 44567888877777889999999999999999999999995544 467899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
||.||..+..+.. -+..|++.++.-++.|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... ...
T Consensus 110 FC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred ecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 9999999888753 345699999999999999999999999999999999999999999999999998764321 122
Q ss_pred cccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 440 VSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
......|||.|||||++. ..+|+.++||||||++|.||..+.||-..-+ ....+-++.+...+.++.|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhcCCCcccCc
Confidence 234568999999999864 4579999999999999999999999875332 2233344444444444332
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+..+.+|+.+||.+||+.||++.++++|
T Consensus 259 ----------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 ----------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 3456788999999999999999999999976
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.92 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=186.5
Q ss_pred ceecccCcEEEEEEEEcC-------------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 288 KELGDGGFGTVYYGKLKD-------------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++.. ....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence 368999999999998532 23589998766555556678899999999999999999997665 4567
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe-------EEEccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC-------VKVADF 427 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~-------~kl~DF 427 (625)
++||||+++++|..++.. ....+++..++.++.||++||+|||+++|+||||||+|||++.++. +|++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 899999999999888753 3356899999999999999999999999999999999999986654 899999
Q ss_pred ccccccCCCccccccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHH-hCCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELI-SSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+........ .....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~~ 223 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFYE 223 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHHh
Confidence 998754221 2345788999999886 456889999999999999998 58888754321110 01111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.... ... ....++.+|+.+||+.+|++||++++|+++|
T Consensus 224 ~~~~-~~~------------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCM-LVT------------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCcc-CCC------------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1000 000 1134678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.19 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=205.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~ 358 (625)
++|+..+.||.|++|.||++.+. +++.+|+|.+.... ....+++.+|++++++++||||+++++++.. ....+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999986 68889999886442 2445778999999999999999999996643 344689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++.........+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 9999999999876544455678999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||+........ ... ....+.......+ ..
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~-~~---- 230 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIE-LLSYIVNMPNPEL-KD---- 230 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHH-HHHHHhcCCchhh-cc----
Confidence 12335788999999998888999999999999999999999999765321111 011 1111111111110 00
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
.. ......+..+.+++.+||+.+|++|||+.|++++-.-
T Consensus 231 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 231 EP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred CC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 00 0001245678899999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.51 Aligned_cols=261 Identities=26% Similarity=0.344 Sum_probs=205.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++.+.. ....++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEEEe
Confidence 57889999999999999999876 68899999875442 3345778999999999999999999997665 467899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|+++++|.+++. +.+.+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 84 FMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred cCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999885 33568999999999999999999997 599999999999999999999999999986542211
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchh-HH---HHHHhhhcccccccCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA-NL---AINKIQKCAFDELIDP 514 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~ 514 (625)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||.......+.... .. ....+..... +
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 231 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-----P 231 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-----C
Confidence 12346899999999988778999999999999999999999999754432111000 00 0111111100 0
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.+. ...++..+.+++.+||+.+|++|||+.|++++..-++.
T Consensus 232 ~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 RLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000 01245578899999999999999999999998665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=310.38 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=203.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..|+..+.||.|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEe
Confidence 46778889999999999999976 68899999886442 3456788999999999999999999997665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999998842 3588999999999999999999999999999999999999999999999999976543221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......++..|+|||++.+..++.++|+||||+++|+|++|..||......... ..+....
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~------------ 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNN------------ 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcCC------------
Confidence 122345788999999998888999999999999999999999998654321111 0000000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
.......++..+.+++.+||+.+|++||++.+++++-.-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 011122456678899999999999999999999988543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.74 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=203.7
Q ss_pred ChHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeee-
Q 047969 273 SYSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSR- 349 (625)
Q Consensus 273 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 349 (625)
+..++....+.|++.+.||.|+||.||+|++. +++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455566789999999999999999999975 68899999885543 3446688999999999 69999999996642
Q ss_pred ----ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEc
Q 047969 350 ----YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVA 425 (625)
Q Consensus 350 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~ 425 (625)
.....+++|||+.+|+|.+++... ....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 245689999999999999998642 23458899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH
Q 047969 426 DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 426 DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~ 500 (625)
|||++........ ......|+..|+|||.+. ...++.++||||||+++|+|++|..||..........
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------ 236 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------ 236 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------
Confidence 9999876432211 123356889999999875 3457889999999999999999999996433211110
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+...... ......++..+.++|.+||+.+|.+||++.|++++
T Consensus 237 -~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 -LIPRNPPP-----------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -hHhhCCCC-----------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 01110000 00112355688999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.02 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=202.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|++|.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence 5888999999999999999976 78999999986543 2345678999999999999999999996655 677899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+ +++|.+++... ...+++..++.++.||++||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 99999998632 256899999999999999999999999999999999999999999999999999876543322
Q ss_pred cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc------ccccc
Q 047969 440 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA------FDELI 512 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 512 (625)
......++..|+|||++.+. .++.++||||+|+++++|++|.++|........ .......+.... +.++.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcc
Confidence 23345689999999988654 468899999999999999999888865432211 111111110000 00000
Q ss_pred C---CcCCCC----ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 513 D---PCLGFE----SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 513 ~---~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+ ...... ........+..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000 011112345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=320.51 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+...+.++||+|-||.|.++....+..||||+++..... ...+|..|+++|.+|+|||||+++|++.. ++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHHHH
Confidence 456778999999999999999987899999999876443 45889999999999999999999998877 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC-Cccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL-DVTH 439 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~-~~~~ 439 (625)
|++|+|.+++...... .+.-....+|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-. +...
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999999754322 245566678999999999999999999999999999999999999999999985433 3233
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh--CCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....+-..+|||+|.+..++++.+||||+||+++||+++ ...|+....++..+..... ...... .+..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~---~~~~~~-~~~~----- 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE---FFRDQG-RQVV----- 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh---hcCCCC-ccee-----
Confidence 3344566789999999988899999999999999999875 6677754333222111111 111000 0000
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...+.-++..+.+++.+||..+.++||+++++...|+..
T Consensus 766 ---l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ---LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 011123455778899999999999999999999998753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=310.69 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=194.1
Q ss_pred ceecccCcEEEEEEEEc-CCc--EEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGR--EVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|+.+ ++. .+|+|.+... .....+.+.+|+++++++ +||||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence 36899999999999976 444 4788887643 234456789999999999 79999999996655 456899999999
Q ss_pred CCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 363 NGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 363 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
+|+|.+++..... ....+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 9999999864321 1235889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
...... ........+..|+|||++....++.++||||||+++|||++ |..||....... ....+......
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~ 230 (270)
T cd05047 160 RGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRL 230 (270)
T ss_pred cccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCCCCC
Confidence 642211 11122234667999999988889999999999999999997 999986432211 11111111000
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
. . ....+.++.+++.+||+.+|.+|||+.++++.|..+.
T Consensus 231 ~-----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 E-----K-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-----C-------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0 0123446889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=308.22 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=197.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 354 (625)
++|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999876 6899999987432 123456788999999999999999999966543 3467
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+++|+|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999985 33458899999999999999999999999999999999999999999999999987653
Q ss_pred CCcc--ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 435 LDVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 435 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... .......++..|+|||++.+..++.++||||||+++|+|++|+.||....... .. ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~~---- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AI-FKIATQPT---- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HH-HHHhcCCC----
Confidence 2111 11223458899999999988888999999999999999999999996432111 11 11110000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+ ......+..+.+++.+|+. +|++||++++++++
T Consensus 227 ~~-------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NP-------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CC-------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 0112345577889999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.90 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=199.1
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++.+.. .+..++||||+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~ 101 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFL 101 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCC
Confidence 3444467999999999999875 688999999876555666789999999999999999999996554 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++. .+.+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 102 ~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 102 EGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 9999999884 23589999999999999999999999999999999999999999999999999876533221 12
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
....|+..|+|||.+.+..++.++||||||+++|||++|..||........ ...+... .. +...
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~-~~----~~~~---- 239 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRDN-LP----PRVK---- 239 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-CC----Cccc----
Confidence 334588999999999888899999999999999999999999965432111 1111110 00 0000
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++..+.+++.+||..+|.+|||+++++++
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011245577889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.95 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=203.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.+|++.+.||+|+||.||+|..+ +|+ .+|+|.+.... ....+.+.+|+.++++++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence 57888999999999999999865 333 58999876553 3455778999999999999999999997665 5689
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999863 234589999999999999999999999999999999999999999999999999987643
Q ss_pred Cccccc-cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTHVS-TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
...... ....++..|+|||.+....++.++|+||||+++|||++ |+.||....... ....+...... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~ 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL--PQ 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC--CC
Confidence 322211 12224578999999988889999999999999999998 999997543211 11111111100 00
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
+ ...+..+.+++.+||..+|++||++.++++.|..+....
T Consensus 233 ~----------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 233 P----------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred C----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0 012236778999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.02 Aligned_cols=254 Identities=27% Similarity=0.344 Sum_probs=189.5
Q ss_pred ceecccCcEEEEEEEEcC---CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLKD---GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence 369999999999998653 4579999886543 2334578899999999999999999996655 4567999999999
Q ss_pred CChHHHhccCcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc-cc
Q 047969 364 GTVADQLHGDRA-KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VS 441 (625)
Q Consensus 364 gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~~ 441 (625)
|+|.+++..... ....+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++........ ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 999999965332 2234677888899999999999999999999999999999999999999999999754322211 12
Q ss_pred cCCCCCCCccCccccccC-------CCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 442 TAPQGTPGYVDPEYHQCY-------QLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~-------~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
....++..|+|||++.+. .++.++||||||+++|||++ |..||.......... ..+.. .......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~-~~~~~~~ 232 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT------YTVRE-QQLKLPK 232 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH------HHhhc-ccCCCCC
Confidence 234578889999987532 35789999999999999996 999996543221110 01110 0011111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+.+. ...+..+.+++..|| .+|++|||+++|+..|+
T Consensus 233 ~~~~-------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK-------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC-------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 112346778999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=305.20 Aligned_cols=247 Identities=30% Similarity=0.450 Sum_probs=196.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCCh
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTV 366 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL 366 (625)
++||+|+||.||+|...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.. ....++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcH
Confidence 469999999999999877999999988654333 55789999999999999999999996655 5678999999999999
Q ss_pred HHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc-cCCC
Q 047969 367 ADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS-TAPQ 445 (625)
Q Consensus 367 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~-~~~~ 445 (625)
.+++.. ....+++..++.++.+++.||.|||+++++||||||+|||++.++.+||+|||++........... ....
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999853 234588999999999999999999999999999999999999999999999999986532211111 1223
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEV 524 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (625)
++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ....+.... .. . ..
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~--~~-------~---~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY--RM-------P---AP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC--CC-------C---CC
Confidence 4667999999988889999999999999999998 888885443211 111111100 00 0 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 525 KRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 525 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 124557889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=312.01 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=201.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++.+.. ....++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence 46889999999999999999976 7899999988643 33445789999999999999999999996555 577899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|+++++|..++.... ....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999998886421 23468999999999999999999997 59999999999999999999999999998765322
Q ss_pred ccccCCCCCCCccCccccccC------CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 439 HVSTAPQGTPGYVDPEYHQCY------QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||......... .....+.......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~-- 229 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF----AQLSAIVDGDPPT-- 229 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH----HHHHHHhhcCCCC--
Confidence 12334578899999988543 3478999999999999999999999643221111 1111111111110
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....++.++.+++.+||+.+|++||++++++++-.
T Consensus 230 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 230 ----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 11135667889999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.50 Aligned_cols=197 Identities=26% Similarity=0.394 Sum_probs=159.9
Q ss_pred ceecccCcEEEEEEEEc---CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLK---DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~~ 363 (625)
++||+|+||.||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. .....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999865 357899998865432 2457889999999999999999996643 35568999999875
Q ss_pred CChHHHhccCc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE----CCCCeEEEcccccccccC
Q 047969 364 GTVADQLHGDR-----AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 364 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll----~~~~~~kl~DFgla~~~~ 434 (625)
+|.+++.... .....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 7777764221 123358999999999999999999999999999999999999 566799999999998764
Q ss_pred CCccc--cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCccc
Q 047969 435 LDVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMN 487 (625)
Q Consensus 435 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~ 487 (625)
..... ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 33221 1233568999999998866 45789999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.58 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=206.6
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH--HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR--RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++..-|.+.+.||+|.|++|-+|++- +|..||||++.+.... ....+.+|++.|+.++|||||++|++... ...+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEE
Confidence 34567888899999999999999976 8999999999765433 34568899999999999999999996554 56799
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE-CCCCeEEEcccccccccC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL-DSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll-~~~~~~kl~DFgla~~~~ 434 (625)
||+|+-++|+|.+|+.. ....+.+..+.+++.||+.|+.|+|+..+|||||||+|+++ ..-|-+||+|||++-.+.
T Consensus 94 LiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999999964 33458999999999999999999999999999999999866 567899999999997764
Q ss_pred CCccccccCCCCCCCccCccccccCCCC-CchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLT-DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
. ....++.+|+..|.|||++.+..|+ ++.||||||||||.|++|++||+..++.+.+. .|..+.+
T Consensus 171 P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-------mImDCKY----- 236 (864)
T KOG4717|consen 171 P--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-------MIMDCKY----- 236 (864)
T ss_pred C--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-------hhhcccc-----
Confidence 3 2334667899999999999988776 47899999999999999999998665433221 1121111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+..++++.++||..||..||.+|.+.+||...
T Consensus 237 --------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 --------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1123467789999999999999999999998753
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=310.79 Aligned_cols=239 Identities=24% Similarity=0.353 Sum_probs=185.7
Q ss_pred eecccCcEEEEEEEEcC-------------------------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeee
Q 047969 289 ELGDGGFGTVYYGKLKD-------------------------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSL 343 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 343 (625)
.||+|+||.||+|.... ...||+|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589998866555555678899999999999999999
Q ss_pred eeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---
Q 047969 344 FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF--- 420 (625)
Q Consensus 344 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~--- 420 (625)
++++.. ....++||||+++|+|..++.. ..+.+++..++.++.||++||+|||+++|+||||||+|||++..+
T Consensus 82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVR-GSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEe-CCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 997765 4567899999999999998853 345689999999999999999999999999999999999997543
Q ss_pred ----eEEEcccccccccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHH-hCCCCCcccccccccc
Q 047969 421 ----CVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELI-SSMPAVDMNRHRHEIN 494 (625)
Q Consensus 421 ----~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~ell-tG~~p~~~~~~~~~~~ 494 (625)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 4899999988643211 22346788999998865 56899999999999999985 69999865432111
Q ss_pred hhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 495 LANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.. .... .... .. .....+.+++.+||+.+|++|||++++++.|.
T Consensus 231 -~~-~~~~--~~~~--------~~-------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 -ER-FYEK--KHRL--------PE-------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HH-HHHh--ccCC--------CC-------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 0000 0000 00 11236788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=310.12 Aligned_cols=257 Identities=32% Similarity=0.459 Sum_probs=203.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec-----cc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY-----SQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~ 352 (625)
..++|++.+.||+|++|.||+|+.+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999986 678999998865543 346789999999999 699999999976542 33
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+++++|.+++.........+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 57999999999999999865443456799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
..... .......++..|+|||++.. ..++.++||||||+++|+|++|++||....... ....+....
T Consensus 163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~ 234 (275)
T cd06608 163 LDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFKIPRNP 234 (275)
T ss_pred cccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHHhhccC
Confidence 53222 22234568899999998743 346789999999999999999999996432211 111111111
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+ .....++..+.+++.+||..||++|||+.+++++
T Consensus 235 ~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 PPTL----------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCC----------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0112355678899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.83 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=199.1
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-----YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence 4778889999999999999977 78999999875432 3355778999999999999999999996554 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
+|||+++++|.+++. +...+++..+..++.||++||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999985 3345889999999999999999999999999999999999999999999999998865332
Q ss_pred ccccccCCCCCCCccCccccccCC-CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh-cccccccCC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK-CAFDELIDP 514 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 514 (625)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... .. ..+.. .....
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~-~~~~~~~~~~~---- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AV-FKIGRSKELPP---- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HH-HHHHhcccCCC----
Confidence 2 223456889999999887665 8999999999999999999999996543111 01 11111 00000
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++..+.+++.+||+.+|++||++.+++.+
T Consensus 223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011234577889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=315.33 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=200.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|+..+.||+|+||.||+|... +|. .||+|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCce
Confidence 57888899999999999999864 444 47899876543 2334578899999999999999999997654 3457
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999999863 234589999999999999999999999999999999999999999999999999987643
Q ss_pred Ccccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... .....++..|+|||++.+..++.++||||||+++|||++ |..||....... .. ..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~----- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEKGER----- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCC-----
Confidence 32221 122345778999999988889999999999999999997 888986432211 01 11111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.... ...+..+.+++.+||..+|++||++.++++.|..+...
T Consensus 230 --~~~~-----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 --LPQP-----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 01234678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.43 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=202.1
Q ss_pred CCCccceecccCcEEEEEEEEcC--CcEEEEEEeccc----------cHHHHHHHHHHHHHHHh-cCCCCeeeeeeeeee
Q 047969 283 DFSREKELGDGGFGTVYYGKLKD--GREVAVKRLYDN----------NYRRVEQFMNEVEILTR-LRHKNLVSLFGCTSR 349 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 349 (625)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... ......++.+|+.++++ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 678999987422 22345667889998875 799999999996655
Q ss_pred ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccc
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFG 428 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFg 428 (625)
....++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 667899999999999999886544455679999999999999999999996 689999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|++||....... ....+.....
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhccC
Confidence 998754332 2234568899999999988889999999999999999999999986443211 1111111111
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.... ...++..+.+++.+||+.||++||++.|+.++++
T Consensus 231 ~~~~-----------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLP-----------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCC-----------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1000 0123457889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.18 Aligned_cols=261 Identities=21% Similarity=0.231 Sum_probs=194.3
Q ss_pred ccceeccc--CcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 286 REKELGDG--GFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 286 ~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
++++||+| +|++||+++.+ +|+.||+|++... .....+.+.+|+++++.++||||+++++++.. .+..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence 45789999 78999999876 7899999998643 22344667789999999999999999997665 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc--
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-- 438 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~-- 438 (625)
+++|+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+++.||+.+........
T Consensus 81 ~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 81 MAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred cCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999998532 223589999999999999999999999999999999999999999999999986543321110
Q ss_pred ----ccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 439 ----HVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 439 ----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... . .. .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~----~~-~~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--L----EK-LNGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--H----HH-hcCCccccc
Confidence 01122346788999999865 45889999999999999999999999643221100 0 00 000000000
Q ss_pred C-------------------C--------------cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 513 D-------------------P--------------CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 513 ~-------------------~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+ . .......+....++..+.+|+.+||+.||++|||++|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0 0 000000112234567889999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=313.91 Aligned_cols=269 Identities=23% Similarity=0.360 Sum_probs=202.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++|+||+++++++.. .+..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence 47899999999999999999977 6889999987543 23345778999999999999999999997765 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||++++.+..++. +...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 80 EYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999877766553 334589999999999999999999999999999999999999999999999999987654433
Q ss_pred ccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc-cCC--
Q 047969 439 HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL-IDP-- 514 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 514 (625)
.......++..|+|||++.+. .++.++||||||+++|+|++|++||..........................+ .+.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233445678999999999877 7899999999999999999999999754322111100000000000000000 000
Q ss_pred ---cC-CCC-ChHH----HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 515 ---CL-GFE-SDEE----VKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 515 ---~~-~~~-~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.. ... .... ...++.++.+||.+||..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 000 0000 11236789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.47 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=199.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEc
Confidence 4667788999999999999865 67889999886432 3455678999999999999999999996654 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++. ...+++..+..++.|+++||.|||+++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999999884 24589999999999999999999999999999999999999999999999999976543221 1
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+........ ...+..... +.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~-----~~~---- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKNSP-----PTL---- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcCCC-----CCC----
Confidence 2234578999999999888899999999999999999999999864322110 001111100 000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....+..+.+++.+||+.+|++||++.+++++-.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 1124557889999999999999999999998743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.16 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=203.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-----CCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-----DGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 354 (625)
.+|++.+.||+|+||.||+|+.. +++.+|||++...... ..+.|.+|+++++.++|+||+++++++.. .....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999854 3678999998755443 46789999999999999999999986543 24468
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999642 2358999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccccc--------chhHHHHHHhh
Q 047969 435 LDVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI--------NLANLAINKIQ 504 (625)
Q Consensus 435 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~ 504 (625)
...... .....++..|+|||.+....++.++||||||++++||++|..|+......... .........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 222211 12234566799999998888999999999999999999999887543221100 00000111111
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
... .... ...++.++.+++.+||+.+|++||++.||+++|+.+
T Consensus 241 ~~~---------~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE---------RLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC---------cCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 100 0000 112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.46 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=196.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEec--cccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLY--DNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv 357 (625)
...|+++++||.||.+.||++...+.+.+|+|++. ..+...+.-|.+|+..|.+|+ |.+||++|++-.. ++.+|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 45799999999999999999999888888888764 345566788999999999995 9999999995444 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||+=+ .+|..+|... ...++.-.++.+..|++.|+.++|+.||||.||||.|+|+- .|.+||+|||+|..+..+.
T Consensus 439 mE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 99864 4899999632 22333237888999999999999999999999999999994 5699999999999887766
Q ss_pred cccc-cCCCCCCCccCccccccC-----------CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 438 THVS-TAPQGTPGYVDPEYHQCY-----------QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 438 ~~~~-~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
.... ...+||+.||+||.+... +.++++||||||||||+|+.|++||..... ... +
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~a----K--- 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIA----K--- 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHH----H---
Confidence 5544 456899999999987532 267899999999999999999999963221 111 1
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+..+.++....+...... ..++.++++.||+.||.+||+..|||++
T Consensus 582 --l~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 --LHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112223322111111111 1137889999999999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.71 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=188.1
Q ss_pred eecccCcEEEEEEEEcCC---cEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCC
Q 047969 289 ELGDGGFGTVYYGKLKDG---REVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG 364 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g 364 (625)
+||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence 699999999999975533 346677665432 3456789999999999999999999996665 56689999999999
Q ss_pred ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc-cccccC
Q 047969 365 TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV-THVSTA 443 (625)
Q Consensus 365 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~-~~~~~~ 443 (625)
+|.+++.........+++..++.++.||++||+|||+.+++||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997543334457778888999999999999999999999999999999999999999999986432111 111223
Q ss_pred CCCCCCccCcccccc-------CCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 444 PQGTPGYVDPEYHQC-------YQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~-------~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
..++..|+|||++.. ..++.++||||||+++|||++ |..||....... ....+.......+.++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhhcccccCCCc
Confidence 457889999998743 245789999999999999997 577875433211 11111111111222222
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+.. .++..+.+++..|| .+|++||+++++++.|.
T Consensus 234 ~~~-------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LEL-------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCC-------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 211 13456778899999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.85 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=204.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+.. .+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence 47899999999999999999865 68899999986432 2356788999999999999999999996654 677899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
++++++|.+++.... ....+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 80 YLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred ccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999986422 1246899999999999999999999999999999999999999999999999998866443222
Q ss_pred ---cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 440 ---VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 440 ---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
......|+..|+|||++... .++.++|+||||+++|+|++|+.||........ .......... .
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-----~ 226 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-------LMLTLQNDPP-----S 226 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-------HHHHhcCCCC-----C
Confidence 12334588999999988766 788999999999999999999999965432210 1111111000 0
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+ ........++..+.+++.+||+.+|++||++++++++
T Consensus 227 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 L--ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred c--CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 1111123456788899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.20 Aligned_cols=268 Identities=25% Similarity=0.369 Sum_probs=199.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++.. ....++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 47889999999999999999986 589999998754322 235678899999999999999999997654 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|..+.. ....+++..++.++.||++||+|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 80 EFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred ecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 9999998888764 23358999999999999999999999999999999999999999999999999998654332
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---------cc
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---------AF 508 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 508 (625)
.......++..|+|||++.+ ..++.++||||||+++|+|++|++||...................... ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233457899999998865 357889999999999999999999996543211100000000000000 00
Q ss_pred ccccCCcCCCC--ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 DELIDPCLGFE--SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+..... .......++..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 001122456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=308.92 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=195.3
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 288 KELGDGGFGTVYYGKLKD-------GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+.||+|+||.||+|+..+ ++.+|||.+.... ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence 369999999999998652 2579999875442 2445678999999999999999999996654 566899999
Q ss_pred eccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-----eEEEccccccc
Q 047969 360 FVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-----CVKVADFGLSR 431 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-----~~kl~DFgla~ 431 (625)
|+++++|.+++..... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9999999999964321 224588999999999999999999999999999999999999877 89999999997
Q ss_pred ccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 432 LFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 432 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~ 232 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGGRL 232 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-------HHHHHhcCCcc
Confidence 65332211 1123346788999999988889999999999999999998 999986443211 11111110000
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.....++..+.+++.+||+.+|++||++.+++++|+
T Consensus 233 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 ------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001234567889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.17 Aligned_cols=251 Identities=30% Similarity=0.485 Sum_probs=199.4
Q ss_pred CCccceecccCcEEEEEEEEcC-----CcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLKD-----GREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+++.+.||.|+||.||+++..+ +..||+|++...... ..+.+.+|+.+++.++|+||+++++++.. .+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEE
Confidence 4567899999999999998763 378999998655433 56789999999999999999999996665 4678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999986422 1128999999999999999999999999999999999999999999999999998764432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
........++..|+|||.+....++.++||||||+++++|++ |.+||...... .....+........
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~----- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-------EVLEYLKKGYRLPK----- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCCCCC-----
Confidence 222222347789999999988889999999999999999998 88888653211 11111111111100
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...++.++.+++.+||..+|++|||+.++++.|
T Consensus 226 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 012456788999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.32 Aligned_cols=252 Identities=25% Similarity=0.455 Sum_probs=200.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|+||++++++... ....++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence 5888899999999999999865 789999999865543 367789999999999999999999996544 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++. ....+++..+..++.|+++||+|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999986 3345889999999999999999999999999999999999999999999999999876543332
Q ss_pred ccc---CCCCCCCccCccccccCC---CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 440 VST---APQGTPGYVDPEYHQCYQ---LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 440 ~~~---~~~gt~~y~aPE~~~~~~---~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
... ...++..|+|||++.+.. .+.++||||||+++++|++|+.||......... . ..+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~-~~~~~~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----M-FHVGAGH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----H-HHHhcCC-----C
Confidence 211 346789999999987665 888999999999999999999999643211110 0 0011100 0
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+.+. .....+..+.+++.+||+.+|++||++.+++.+
T Consensus 225 ~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIP-----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCC-----cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 111234567889999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.56 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=188.3
Q ss_pred ceecccCcEEEEEEEEcC---CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 288 KELGDGGFGTVYYGKLKD---GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.||+|+||.||+|...+ ...+|+|.+... .......+.+|+.+++.++|+||+++++.+.. ....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence 369999999999997543 346888887543 23345678899999999999999999996654 5678999999999
Q ss_pred CChHHHhccCccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc-cc
Q 047969 364 GTVADQLHGDRAK-HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VS 441 (625)
Q Consensus 364 gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~~ 441 (625)
|+|.+++...... ....++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 9999999754322 234568888999999999999999999999999999999999999999999998754322111 11
Q ss_pred cCCCCCCCccCcccccc-------CCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 442 TAPQGTPGYVDPEYHQC-------YQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
....++..|+|||++.. ..++.++||||||+++|||++ |..||....... .....+... ...+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~~~ 232 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKLPK 232 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccCCC
Confidence 23346778999998642 356789999999999999999 788886443211 111111111 111111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+. ....++..+.+++..|| .+|++|||+++|++.|.
T Consensus 233 ~~-------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 PQ-------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Cc-------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 11234456677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=306.45 Aligned_cols=250 Identities=24% Similarity=0.442 Sum_probs=201.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.++++++|+||+++++++.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence 5888999999999999999876 7899999998543 23455678999999999999999999996654 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+.+++|.+++... ....+++..++.++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 80 YCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred cCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999988632 223578999999999999999999999999999999999999999999999999986543221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......|+..|+|||++.+..++.++|+||||+++++|++|+.||....... ....+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~--------- 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------LVLKIIRGSYPP--------- 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-------HHHHHhcCCCCC---------
Confidence 1223457889999999988888999999999999999999999986432211 111111111110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++..+.+++.+||+.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 012345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.04 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=199.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
|+....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~ 101 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQ 101 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCC
Confidence 444557999999999999876 789999999865544556778899999999999999999996655 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+++|..++. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........ ...
T Consensus 102 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 102 GGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 999998773 24589999999999999999999999999999999999999999999999999876543221 123
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...++..|+|||++.+..++.++||||||+++|||++|+.||........ ...+........ .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~----------~ 238 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPKL----------K 238 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccCCCCc----------c
Confidence 35688999999999888899999999999999999999999964332111 111111110000 0
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....++..+.+++.+||+.+|++||++++++++-.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 01123456788999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.94 Aligned_cols=245 Identities=29% Similarity=0.451 Sum_probs=199.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. +...++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence 47899999999999999999876 68999999986432 2345678899999999999999999996654 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++. ....+++..+..++.||+.||+|||+.||+||||+|+|||++.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 80 MEYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 99999999999985 3356899999999999999999999999999999999999999999999999999875433
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... .....+...... +
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------~- 217 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKVR------F- 217 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCcc------C-
Confidence 23345889999999998878899999999999999999999999654311 111111111100 0
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
...++..+.+++.+||..+|.+|+ ++++++++
T Consensus 218 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 ------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 012245778899999999999998 77787765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.08 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|++|+||+|... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+.. ....++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence 47889999999999999999976 589999999865432 245678999999999999999999996654 6678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+.+++|.+++... ....+++..+..++.||++||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 80 MDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999998632 33568999999999999999999999999999999999999999999999999987543211
Q ss_pred cc----------------------------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccc
Q 047969 438 TH----------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRH 489 (625)
Q Consensus 438 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~ 489 (625)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01123578999999999888899999999999999999999999965432
Q ss_pred ccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 047969 490 RHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS----MEEVLAE 555 (625)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~ell~~ 555 (625)
... ...+..... .... ...++..+.+++.+||+.+|++||+ ++|++++
T Consensus 238 ~~~-------~~~~~~~~~--------~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DET-------FSNILKKEV--------TFPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHH-------HHHHhcCCc--------cCCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 111111100 0000 0115668899999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.82 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+++.. .++.||+|.+.... ....+.+.+|+++++.++||||+++++.+.. ....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence 47889999999999999999977 67899999986543 2345678899999999999999999986554 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||++|++|.+++. ..+.+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999999995 33468999999999999999999999999999999999999999999999999987421110
Q ss_pred c--------------ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 438 T--------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 438 ~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
. .......++..|+|||.+....++.++|+||||+++|+|++|..||...... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH
Confidence 0 0111235788999999998888999999999999999999999999643221 111111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...... .+. . ...++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 229 ~~~~~~---~~~-----~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 ISDDIE---WPE-----G--DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HhcccC---CCC-----c--cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111110 000 0 0124557889999999999999999655555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.07 Aligned_cols=238 Identities=26% Similarity=0.392 Sum_probs=187.1
Q ss_pred ceecccCcEEEEEEEEcC-C----------cEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 288 KELGDGGFGTVYYGKLKD-G----------REVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
+.||+|+||.||+|.+.+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence 469999999999999763 3 25788877554333 6788999999999999999999997665 45689
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-------eEEEccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-------CVKVADFGL 429 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-------~~kl~DFgl 429 (625)
||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999998632 22689999999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccC--CCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
+..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..|+......... .. ....
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~----~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RF----YQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HH----HhcC
Confidence 986432 1233467789999998766 78999999999999999999 57777544321100 00 0000
Q ss_pred ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ...... ...+.+++.+||..+|++|||+.++++.|+
T Consensus 223 ~-------~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H-------RLPMPD-------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CCCCCC-------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000000 147788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.26 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=195.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++.. ....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence 5788899999999999999976 78999999985432 1223567889999999999999999996654 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+.+ +|.+++.. ....+++..++.++.||++||.|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 80 YCDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred cCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9974 78777753 234689999999999999999999999999999999999999999999999999986533221
Q ss_pred cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc------ccccc
Q 047969 440 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA------FDELI 512 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 512 (625)
......++..|+|||++.+. .++.++||||||+++|+|++|..|+........ ............. .....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcc
Confidence 12334578999999988664 478899999999999999998877533221110 0000100000000 00000
Q ss_pred C-----CcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 513 D-----PCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 513 ~-----~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+ ... ..........++.++.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 000 000011223456788899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.85 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=199.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH-----HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR-----RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
+|++.+.||+|++|.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 4788899999999999999976 6899999998654322 23456789999999999999999997665 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+ +++|.+++... ...+++..++.++.||++||.|||++||+|+||||+|||++.++.+||+|||+++.....
T Consensus 80 v~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99999 88999998632 136999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---c-----
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---A----- 507 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~----- 507 (625)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|.++|......... .......... .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhcc
Confidence 22 1223356788999998754 45788999999999999999998888654322111 1111110000 0
Q ss_pred -cccccC--CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 -FDELID--PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 -~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...... ..............+..+.+++.+||+.+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 000011111223346788899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.15 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=203.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+.. .+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEe
Confidence 368999999999999999999865 688999999865545556778999999999999999999996655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999999999842 3478999999999999999999999999999999999999999999999999876543222
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......+++.|+|||.+....++.++|+||||+++|+|++|+.||............ ..... .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~----------~ 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT----------P 233 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCC----------C
Confidence 122345888999999998888899999999999999999999999754322111100 00000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.......++..+.+++.+||..+|++||++.+++.+-
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0011223455788999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.68 Aligned_cols=247 Identities=26% Similarity=0.465 Sum_probs=198.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++.. +..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECC
Confidence 5789999999999999999975 58889999986543 34678899999999999999999997654 3469999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
.+++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~ 154 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V 154 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence 999999999643 2345899999999999999999999999999999999999999999999999998754321 1
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |++||....... ....+...... . .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---~------~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRM---E------P 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCC---C------C
Confidence 12234578999999988889999999999999999997 999986543211 11111111100 0 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
...++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.11 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=195.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHH-HHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEI-LTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+..|+.+ ++.++||||+++++++.. ....++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence 47889999999999999999976 79999999986542 2223445566665 666789999999997665 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||++ ++|.+++.........+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 588888765433446799999999999999999999998 99999999999999999999999999998653221
Q ss_pred cccccCCCCCCCccCcccccc----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 438 THVSTAPQGTPGYVDPEYHQC----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .. . ...........+
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~-~-~~~~~~~~~~~~-- 228 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQ-Q-LKQVVEEPSPQL-- 228 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HH-H-HHHHHhcCCCCC--
Confidence 1223457899999998754 34688999999999999999999998642211 00 0 111111111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....++.++.+++.+||+.+|++||++.+++++-.
T Consensus 229 ---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 229 ---------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred ---------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 01124567889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=307.71 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=186.8
Q ss_pred ceecccCcEEEEEEEEcC--------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 288 KELGDGGFGTVYYGKLKD--------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+.||+|+||.||+|..+. ...+|+|.+........+.+.+|+.+++.++||||+++++++.. +...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence 369999999999998642 23488888866555566788999999999999999999997665 456799999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe--------EEEccccccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC--------VKVADFGLSR 431 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~--------~kl~DFgla~ 431 (625)
|+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++.
T Consensus 80 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999632 336899999999999999999999999999999999999987664 6999999886
Q ss_pred ccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCC-CCCcccccccccchhHHHHHHhhhcccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
.... .....++..|+|||++.+ ..++.++||||||+++|+|++|. +|+......... ...... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--------~~~~~~-~ 222 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--------QFYEDR-H 222 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--------HHHHcc-c
Confidence 5422 122457889999999876 45789999999999999999984 665433221100 000000 0
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. +. . ....++.+++.+||+.+|++|||++++++.|.
T Consensus 223 ~-----~~--~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 Q-----LP--A-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-----CC--C-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0 11246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=319.10 Aligned_cols=269 Identities=23% Similarity=0.330 Sum_probs=198.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec----cceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY----SQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~ 354 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++|+||++++++.... ....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 78999999986432 23456688999999999999999999854432 2357
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+.+ +|.+++. ...+++..+..++.|+++||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999975 7777763 3458999999999999999999999999999999999999999999999999998653
Q ss_pred CCcccc--ccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHh
Q 047969 435 LDVTHV--STAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKI 503 (625)
Q Consensus 435 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~ 503 (625)
...... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|++||............... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 322111 123468899999998654 46889999999999999999999999654321111000000 0000
Q ss_pred hhccccccc---CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 504 QKCAFDELI---DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 504 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......... ...............+.++.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000000011122346678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.10 Aligned_cols=270 Identities=23% Similarity=0.281 Sum_probs=195.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++.. ....++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence 3578999999999999999999875 688999999854422 223457789999999999999999996654 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+. ++|.+++.. ....+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||+++......
T Consensus 82 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 99996 677766642 23457888899999999999999999999999999999999999999999999997543221
Q ss_pred cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH---------Hhh--h
Q 047969 438 THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN---------KIQ--K 505 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~---------~~~--~ 505 (625)
. ......++..|+|||++.+. .++.++||||||+++|+|++|..||+......+.....+... .+. .
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1 12234578999999988653 578899999999999999999999975432211100000000 000 0
Q ss_pred cccccccCCcCCCCChHHHH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 506 CAFDELIDPCLGFESDEEVK--RMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+.............. ..+..+.+++.+|++.||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000000 113477889999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.86 Aligned_cols=256 Identities=29% Similarity=0.407 Sum_probs=193.1
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee------
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR------ 349 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 349 (625)
.+-.++|+.++.||+||||.||+++++ ||+.+|||++... .......+.+|+..|.+|+|||||++|..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456788999999999999999999998 9999999998544 33345668899999999999999999863000
Q ss_pred -----------------------------------------------------------------------c--------
Q 047969 350 -----------------------------------------------------------------------Y-------- 350 (625)
Q Consensus 350 -----------------------------------------------------------------------~-------- 350 (625)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred -------------------------c--------ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHH
Q 047969 351 -------------------------S--------QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397 (625)
Q Consensus 351 -------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~ 397 (625)
+ ..+||-||||+..++.+++..+.... .....|+++.||++||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence 0 13688999999988888886432111 46788999999999999
Q ss_pred HHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC-----------------CCccccccCCCCCCCccCccccccC-
Q 047969 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP-----------------LDVTHVSTAPQGTPGYVDPEYHQCY- 459 (625)
Q Consensus 398 yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~- 459 (625)
|+|++|||||||||.|||+|+++.|||+|||+|+... .......+..+||..|+|||++.+.
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999999998721 0111123456899999999998764
Q ss_pred --CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHH
Q 047969 460 --QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFL 537 (625)
Q Consensus 460 --~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 537 (625)
.|+.|+|+|||||+|+||+. ||...-. ....+..++++.++. ...-...+++ .-+.+|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR~g~iP~--------~~~f~~~~~~-~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTNLRKGSIPE--------PADFFDPEHP-EEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHhcccCCCCC--------Ccccccccch-HHHHHHHH
Confidence 49999999999999999996 3543211 112233333333322 1011112222 34568999
Q ss_pred hcccCCCCCCCHHHHHH
Q 047969 538 CLQQNKELRPSMEEVLA 554 (625)
Q Consensus 538 cl~~~P~~RPs~~ell~ 554 (625)
+++.||.+|||+.|+|+
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999986
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=308.66 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=202.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|+..+.||+|++|.||+|.++ +++.||+|++.... ....+++.+|++++++++||||+++++.+.. ....++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEE
Confidence 36888899999999999999987 68999999886543 3455678999999999999999999996655 477899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|+.+++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999999986422 568999999999999999999999 9999999999999999999999999999876532211
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ... ....+...... .+
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~-----~~-- 224 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFE-LLQYIVNEPPP-----RL-- 224 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHH-HHHHHhcCCCC-----CC--
Confidence 1256889999999998888999999999999999999999999654321111 111 11111111000 00
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ...++..+.++|.+||..+|++|||+.+++.+
T Consensus 225 -~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 -P---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -C---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 01156678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=301.07 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=204.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++|+|++++++++.. ....++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence 47888999999999999999987 589999999866543 456789999999999999999999996665 577899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|+++++|.+++.. ...+++..++.++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999963 2568999999999999999999999 9999999999999999999999999999987643322
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
. .....++..|+|||.+....++.++|+||||+++|+|++|+.||......... . ....+.......+
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---~-~~~~~~~~~~~~~------- 223 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF---E-LMQAICDGPPPSL------- 223 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH---H-HHHHHhcCCCCCC-------
Confidence 2 12345789999999998888999999999999999999999999765421111 1 1111111111100
Q ss_pred CChHHHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 519 ESDEEVKR-MTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 519 ~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... ++..+.+++.+||..+|++||++.+++++
T Consensus 224 -----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 45678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.34 Aligned_cols=273 Identities=20% Similarity=0.265 Sum_probs=189.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc--CCcEEEEE------------------EeccccHHHHHHHHHHHHHHHhcCCCC
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK--DGREVAVK------------------RLYDNNYRRVEQFMNEVEILTRLRHKN 339 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 339 (625)
..++|+++++||+|+||+||++..+ .+..+++| .+ .........+.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCCC
Confidence 4579999999999999999998754 22222222 11 112234466889999999999999
Q ss_pred eeeeeeeeeeccceEEEEEEeccCCChHHHhccCcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA-KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 340 iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
||++++++.. ....++|+|++. ++|.+++..... .........+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 225 Iv~l~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 225 ILKIEEILRS-EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cCcEeEEEEE-CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 9999997655 566899999985 467776643221 1223456677889999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCC-CCcccccccccchhH
Q 047969 419 NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP-AVDMNRHRHEINLAN 497 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~-p~~~~~~~~~~~~~~ 497 (625)
++.+||+|||+++.+............||..|+|||++.+..++.++||||||+++|||++|.. |+..........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999998765433333334579999999999998889999999999999999999864 443222111111111
Q ss_pred HHHHHhh--hccccc-------ccC-CcCC---CCChHHH--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 498 LAINKIQ--KCAFDE-------LID-PCLG---FESDEEV--KRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 498 ~~~~~~~--~~~~~~-------~~~-~~~~---~~~~~~~--~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. ...+. ...+.+ .++ .... ....... ..++..+.+++.+||+.||.+|||+.|++++-
T Consensus 383 ~-~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 383 I-IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred H-HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 1 00000 000000 000 0000 0000111 12345677889999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.22 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=194.3
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEec----cccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEEEEEe
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLY----DNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLLVYEF 360 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~ 360 (625)
..+||+|+|-+||+|.+. +|.+||=-.++ .......++|..|+.+|+.|+|||||++|..|.. ..+.+.+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999876 67777643332 1234567899999999999999999999996654 44568899999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCCEEECC-CCeEEEcccccccccCCCc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS--DIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--~ivHrDikp~NIll~~-~~~~kl~DFgla~~~~~~~ 437 (625)
+..|+|..|+. +.+.++.+.+..|++||++||.|||++ -|+|||||-+||||+. .|.|||+|+|||.......
T Consensus 125 ~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999996 556689999999999999999999998 5999999999999985 5899999999999865433
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....|||.|||||+.. ..|.+..|||||||.++||+|+..|+..=... ..+.......+....+..+.|
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~kV~d---- 270 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALSKVKD---- 270 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhhccCC----
Confidence 23468999999999887 67999999999999999999999998532221 122222222222223333322
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+++++||.+||.. .++|||+.|+|++
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3788999999999 8999999999975
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=301.23 Aligned_cols=249 Identities=28% Similarity=0.461 Sum_probs=199.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|+..+.||+|+||.||+|... +++.+|||.+... .....+.+.+|++++++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence 5888999999999999999875 7888999998543 23446778999999999999999999985544 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~~~~~~~ 438 (625)
|+++++|.+++... ....+++..++.++.|+++||+|||++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 80 YAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred cCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999999642 23458999999999999999999999999999999999999854 568999999998754322
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||.+.+..++.++||||||+++|+|++|..||....... . ...+.......+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~-~~~~~~~~~~~~------- 221 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------L-VLKIMSGTFAPI------- 221 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------H-HHHHHhcCCCCC-------
Confidence 1223468899999999988888999999999999999999999986543211 1 111111111111
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++|||+.|++++
T Consensus 222 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01245578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.60 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=197.7
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc----------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN----------YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS 351 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 351 (625)
+|.+.+.||.|+||.||+|... +|+.+|+|.+.... ....+.+.+|+.+++.++|+|++++++++.. .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence 5778899999999999999865 78999999874321 1123567889999999999999999996554 5
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
...++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+||+++.++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 678999999999999999863 3568999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCccc-cccCCCCCCCccCccccccCC--CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 432 LFPLDVTH-VSTAPQGTPGYVDPEYHQCYQ--LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 432 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
........ ......++..|+|||.+.... ++.++|+||||+++|+|++|..||....... .. ..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~~~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AM-FKLGNKRS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HH-HHhhcccc
Confidence 64322111 123345889999999887644 7899999999999999999999985432110 00 01000000
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.... .......++..+.+++.+||+.+|++||++++++++
T Consensus 230 ----~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 ----APPI---PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----CCcC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000 011112356788999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.38 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=198.5
Q ss_pred CCccceecccCcEEEEEEEEc----CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-----
Q 047969 284 FSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ----- 352 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 352 (625)
|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999854 3688999988643 33456778999999999999999999996543221
Q ss_pred eEEEEEEeccCCChHHHhccCc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDR--AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
..++++||+.+|+|.+++...+ .....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478899999999998875322 12235889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccc
Q 047969 431 RLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 431 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
+........ ......++..|++||.+....++.++||||||+++|+|++ |++||....... ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKGNR 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-------HHHHHHcCCc
Confidence 865432211 1123345678999999988888999999999999999999 889986443211 1111111110
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
.. .. ...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 234 ~~-------~~-----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK-------QP-----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC-------CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 12345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.57 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=197.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++++.||.|++|.||+|+.+ +++.||||++.... ....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence 4888999999999999999876 78999999885432 2233578899999999999999999996654 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+. ++|..++... ....+++..++.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 996 5888888542 335689999999999999999999999999999999999999999999999999876533221
Q ss_pred cccCCCCCCCccCccccccCC-CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh--------------
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQ-LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ-------------- 504 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------------- 504 (625)
......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.......... .......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF---RIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHhCCCChhhhhhhhHHH
Confidence 122335688999999886543 6889999999999999999999996543221110 0000000
Q ss_pred --hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 505 --KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 505 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+..... .........++.++.++|.+||+.||++||++++++++
T Consensus 233 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWAR----QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccc----cCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000 00011122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.93 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=196.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|++++++++|+||+++++++.. ....++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEE
Confidence 368999999999999999999976 789999999864322 223456789999999999999999996654 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.+ +|.+++.. ....+++..+..++.|+++||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 83 EYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred ecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 99985 89888853 234689999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---cccccc---
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---CAFDEL--- 511 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 511 (625)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.......+. .......+.. ......
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhhc
Confidence 1122346889999998865 45789999999999999999999999654311100 0000000000 000000
Q ss_pred ---cCCcCCCCCh----HHHHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 ---IDPCLGFESD----EEVKRMT--TSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ---~~~~~~~~~~----~~~~~~~--~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......... .....+. ..+.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 0011122 577889999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.09 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=198.9
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLR---HKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv 357 (625)
.|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++ |||++++++++.. +...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence 5778889999999999999975 7899999988543 3345567889999999997 9999999996655 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 81 MEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998842 368999999999999999999999999999999999999999999999999998764433
Q ss_pred cccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ..+..... +.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~-----~~~ 222 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKP-----PRL 222 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCC-----CCC
Confidence 2 2233468899999998865 45788999999999999999999999754322111 00000000 001
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.. ...+.++.+++.+||+.+|++||++.+++++-
T Consensus 223 ~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 223 ED------NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred Cc------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 00 01455788999999999999999999999853
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.53 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=199.0
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
-|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.. +...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEe
Confidence 4777889999999999999865 78899999875432 3345678899999999999999999997665 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 99999999984 2358999999999999999999999999999999999999999999999999987653321 11
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||....... ....+....... +
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~---- 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNPPT-----L---- 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCCCC-----C----
Confidence 223457889999999988888999999999999999999999986432211 111111111110 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++.++.+++.+||+.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11234578889999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.81 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=200.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----ce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----QG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 353 (625)
.++|++.+.||+|+||+||+|+.. +++.||||.+... .......+.+|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999876 7899999998643 2233456788999999999999999998654322 34
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+. ++|.+++. ..+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 68888875 3456999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH--------hh
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK--------IQ 504 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~ 504 (625)
.... .......++..|+|||.+.. ..++.++||||||+++|+|++|++||.................. +.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4322 22233457889999998754 46889999999999999999999999754321111111000000 00
Q ss_pred hccccccc---CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 505 KCAFDELI---DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 505 ~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
........ ..............++.++.+++.+||+.+|++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 0000000011123456788999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=291.81 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=210.6
Q ss_pred hHHHHHHhcCCCccceecccCcEEEEEEE-EcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeecc
Q 047969 274 YSDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYS 351 (625)
Q Consensus 274 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 351 (625)
+.|+-+.++ +.||+|+|+.|-.+. ..+|.++|||++.+.......++.+|++++.+.+ |+||+.+++++.+ +
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d 148 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-D 148 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-c
Confidence 456655554 579999999999887 5589999999998776667788999999999996 9999999996655 6
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe---EEEcccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC---VKVADFG 428 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~---~kl~DFg 428 (625)
..+|||||-|.||+|...++ +...+++.++.++..+|+.||.+||.+||.||||||+|||...... +||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccc
Confidence 78999999999999999996 4456999999999999999999999999999999999999976544 7999999
Q ss_pred cccccCCC------ccccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCccccccc------
Q 047969 429 LSRLFPLD------VTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH------ 491 (625)
Q Consensus 429 la~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~------ 491 (625)
|+...... ......+++|+..|||||+..- ..|+.+.|.||||||+|-||+|.+||.+.-...
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 88643211 1122345789999999997632 358889999999999999999999996543210
Q ss_pred c--cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 492 E--INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 492 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+ -.-.+.....|+++.+. -++.++..++.+..+++..+|..++.+|.++.+++++
T Consensus 305 e~Cr~CQ~~LFesIQEGkYe---------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYE---------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CccHHHHHHHHHHHhccCCc---------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1 01222333444444332 2456778899999999999999999999999999985
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.81 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=199.7
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceEEEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLLLVYE 359 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e 359 (625)
|++.+.||.|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... ....++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999977 58899999987652 33446788999999999999999999976653 267899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++ +|.+++... ...+++..++.++.||++||+|||+.|++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888887532 246899999999999999999999999999999999999999999999999999876544322
Q ss_pred cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---ccccccc---
Q 047969 440 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---CAFDELI--- 512 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 512 (625)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... ........ .....+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccch
Confidence 2333457889999997764 457899999999999999999999997554321111 11110000 0000000
Q ss_pred -----CCcCC--CCChHHHHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 513 -----DPCLG--FESDEEVKR-MTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 513 -----~~~~~--~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+... ....+.... ++..+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 000111222 26788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=306.30 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=199.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.|...+.||+|++|.||+|... +++.+|+|++........+.+.+|+.+++.++|+||+++++++.. ....++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEecc
Confidence 3455578999999999999865 788999999865555556778999999999999999999996554 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 99999999853 4589999999999999999999999999999999999999999999999998875533222 12
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+........ .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~-----~---- 236 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNLPPKL-----K---- 236 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHhcCCCCC-----c----
Confidence 33458899999999988889999999999999999999999986432211 1111111111000 0
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++..+.+++.+||+.+|++||++.+++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 011244578899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.82 Aligned_cols=265 Identities=24% Similarity=0.327 Sum_probs=199.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----c
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----S 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 351 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999976 7899999998542 334456778999999999999999999965432 2
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999964 88887742 18899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh------
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK------ 505 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 505 (625)
...... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+..... ......+..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~ 241 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW---NKIIEQLGTPSDEFM 241 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCCHHHH
Confidence 653322 123345789999999998888999999999999999999999999654321110 000000000
Q ss_pred --------c-----------ccccccCCcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 506 --------C-----------AFDELIDPCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 506 --------~-----------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. .+.++..... ...........+..+.+++.+||+.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0 0000000000 0000000123456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.76 Aligned_cols=269 Identities=25% Similarity=0.345 Sum_probs=199.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-ceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-QGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~l 356 (625)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++.... ...++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 568999999999999999999976 689999999854322 12234678999999999999999999765432 46899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+.+ +|.+++... ...+++..++.++.||++||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 788887532 256899999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---cccc--
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---AFDE-- 510 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 510 (625)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.......... ......... ....
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhchhhh
Confidence 21 1223346788999998865 457899999999999999999999997543322111 111100000 0000
Q ss_pred ------cc--CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 511 ------LI--DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 511 ------~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.. ...............+..+.++|.+||+.||++|||+++++++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 000000000111224667889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.11 Aligned_cols=269 Identities=20% Similarity=0.290 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccc----e
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQ----G 353 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----~ 353 (625)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++ |+||+++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999976 789999998754322 23356888999999995 6999999996654322 2
Q ss_pred EEEEEEeccCCChHHHhccCccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAK-HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSR 431 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgla~ 431 (625)
.++||||+++ +|.+++...... ...+++..++.++.||++||.|||++||+||||||+||+++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999986 788887643322 356899999999999999999999999999999999999998 8999999999998
Q ss_pred ccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA--- 507 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 507 (625)
.+..... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||......... ......+....
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (295)
T cd07837 160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LHIFKLLGTPTEQV 235 (295)
T ss_pred ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHhCCCChhh
Confidence 6533211 1223356889999998754 45789999999999999999999999754321111 00111000000
Q ss_pred cccccC-------Cc-CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 FDELID-------PC-LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ~~~~~~-------~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+..... +. ...........++.++.++|.+||+.+|++||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00 0000011112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=290.37 Aligned_cols=258 Identities=25% Similarity=0.314 Sum_probs=207.0
Q ss_pred HhcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeee---eccce
Q 047969 280 ATNDFSRE-KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTS---RYSQG 353 (625)
Q Consensus 280 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~---~~~~~ 353 (625)
++++|++. ++||-|-.|.|-.+.++ +++.+|+|++... ...++|+++--.. .|||||.+++++. ...+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56777764 56999999999999876 7899999998544 2345788876666 5999999999653 34567
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEcccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLS 430 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla 430 (625)
+.+|||.|+||.|...+.+. ..+.+++.++..|+.||..|+.|||+.+|.||||||+|+|... +..+||+|||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999743 3456999999999999999999999999999999999999964 457999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
+.-.. .....+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-..... .+.--...+|..+.+.
T Consensus 212 K~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy~- 285 (400)
T KOG0604|consen 212 KETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQYE- 285 (400)
T ss_pred cccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCcc-
Confidence 86432 23346678899999999999889999999999999999999999999644321 1111222333333221
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
-+.+++..++.+.+++|+.+|+.+|.+|.|+++++++-+-
T Consensus 286 --------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 286 --------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred --------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 2456778899999999999999999999999999987543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.67 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=197.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~l 356 (625)
.++|++.+.||.|+||.||+|..+ +++.+|+|.+..... .....+.+|+.++++++||||+++++++... ....++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999976 688999999864322 2234567899999999999999999966542 267899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+.+ +|.+++... ...+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999975 898888532 236899999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---------
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC--------- 506 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 506 (625)
.. ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||......... ..........
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHhh
Confidence 21 12334578899999988654 4688999999999999999999999754322111 1000000000
Q ss_pred ccccccCCcCCCCC----hHHHHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 AFDELIDPCLGFES----DEEVKR--MTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~~~~~~~~~~~~~~----~~~~~~--~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+............ ...... ++..+.++|.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000 000111 35678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.38 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=200.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
+|++.+.||.|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 5888999999999999999976 68999999986542 2456789999999999999999999986554 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.+++|.+++.. ...+++..+..++.||++||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred eCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999853 2578999999999999999999999999999999999999999999999999988654332
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......|+..|+|||.+....++.++|+||||+++|+|++|..||....... ........... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~--~--------- 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETA--D--------- 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccc--c---------
Confidence 2234568899999999988888999999999999999999999997654321 11111111100 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSM--EEVLA 554 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~ell~ 554 (625)
.......+..+.+++.+||+.+|.+||++ +|+++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 --VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred --ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 00011244678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.70 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=204.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+++++.++|+||+++++++.. ....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence 5788999999999999999865 7889999998643 23445678899999999999999999986655 477899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.........+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999998654434567899999999999999999999999999999999999999999999999999876443
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....+....+..+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-------- 221 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYPPI-------- 221 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCCCC--------
Confidence 2223457899999999988889999999999999999999999996543211 1111111111111
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++.++.+++.+||+.+|++||++.+++++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=304.48 Aligned_cols=266 Identities=23% Similarity=0.366 Sum_probs=199.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+|++.+.||.|++|.||+|+.. +|+.||||++..... ...+.+.+|+.++++++|+||+++++++.. .+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence 5888999999999999999986 688999999865432 234567889999999999999999997665 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++ +|.+++.... ....+++..+..++.||+.||.|||+.|++||||||+||++++++.+||+|||++........ .
T Consensus 80 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred CCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 985 8888875432 234689999999999999999999999999999999999999999999999999976533221 1
Q ss_pred ccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHhhhcccccc
Q 047969 441 STAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKIQKCAFDEL 511 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 511 (625)
.....++..|++||++.+. .++.++||||||+++|+|++|++||............... ...+. ....+
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLPEY 234 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCchh
Confidence 2234578899999987653 5788999999999999999999999755432211100000 00000 00000
Q ss_pred cCCcCCCCC----hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFES----DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ....... .......+..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 K-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred c-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000000 11122346788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.65 Aligned_cols=272 Identities=19% Similarity=0.303 Sum_probs=202.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~ 354 (625)
.++|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+.+|++++||||+++++++.. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999876 68999999986532 2345677889999999999999999885542 23468
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+. ++|.+++. ....+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 58888885 33458999999999999999999999999999999999999999999999999997653
Q ss_pred CCccc---cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHH
Q 047969 435 LDVTH---VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INK 502 (625)
Q Consensus 435 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 502 (625)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||........+...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 1123468899999998755 45889999999999999999999999654322111100000 000
Q ss_pred hhhcccccc---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 503 IQKCAFDEL---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 503 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
......... ................+..+.+++.+||+.+|++||++.+++.+-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 000000000 0000011111222345678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.36 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=205.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++|+|++++++.+.. ....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence 5888899999999999999976 68899999986543 3556778999999999999999999996655 477899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.........+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 999999999997544345779999999999999999999999999999999999999999999999999998764432 1
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......|++.|+|||.+....++.++|+||+|+++++|++|..||...... .............+ .
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-----~-- 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------ELALKILKGQYPPI-----P-- 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------HHHHHHhcCCCCCC-----C--
Confidence 223346889999999988888999999999999999999999998654311 11111111111111 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..++..+.+++.+||..+|++||++.+++++
T Consensus 225 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 -----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=293.63 Aligned_cols=250 Identities=32% Similarity=0.498 Sum_probs=203.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++.. ....++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecC
Confidence 4778899999999999999986 788999999876655566789999999999999999999996655 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++... ...+++..+..++.|++.||.+||..|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 80 SGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998632 25689999999999999999999999999999999999999999999999999987644322 2
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
....++..|+|||.+.+..++.++|+||||+++++|++|+.||......... . .........+..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~-~~~~~~~~~~~~-------- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------F-KIATNGPPGLRN-------- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------H-HHHhcCCCCcCc--------
Confidence 3456889999999998888899999999999999999999998654311111 0 011111111100
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++|||+.+++++
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01135578899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=309.07 Aligned_cols=272 Identities=23% Similarity=0.344 Sum_probs=198.1
Q ss_pred CCCccceecccCcEEEEEEEEc---CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK---DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 355 (625)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 47899999987632 23346678899999999999999999976553 26789
Q ss_pred EEEEeccCCChHHHhccCccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC----CCeEEEcccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAK-HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS----NFCVKVADFGLS 430 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~----~~~~kl~DFgla 430 (625)
+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 676766533322 237899999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCccc--cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCccccccccc--chhHHHHHHhhh
Q 047969 431 RLFPLDVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI--NLANLAINKIQK 505 (625)
Q Consensus 431 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~ 505 (625)
......... ......++..|+|||++.+ ..++.++||||||+++++|++|++||......... .........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 875433221 1233467899999998765 35789999999999999999999999755432200 000000000000
Q ss_pred c----------------cccccc--CCcCCCCChHHHH------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 506 C----------------AFDELI--DPCLGFESDEEVK------RMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 506 ~----------------~~~~~~--~~~~~~~~~~~~~------~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. .+.... ............. ..+..+.+++.+||+.+|++|||+.|++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000000 0000001001111 234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.23 Aligned_cols=273 Identities=25% Similarity=0.344 Sum_probs=199.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---- 351 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 351 (625)
...++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999986 688999999864322 23356778999999999999999998654422
Q ss_pred -----ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 352 -----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 352 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
...++|+||+++ ++...+.. ....+++..++.++.||+.||+|||+.||+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 368999999986 67676643 234689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 427 FGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 427 Fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
||++...............++..|+|||.+.+ ..++.++||||||+++++|++|++||..................-..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998764433222223346788999998754 35788999999999999999999999754322111100000000000
Q ss_pred ccccccc--------CCc--CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 506 CAFDELI--------DPC--LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 506 ~~~~~~~--------~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+..+. +.. ...........++..+.+++.+||+.+|++||++++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 000 0000111222356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.45 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=204.7
Q ss_pred CCCccceecccCcEEEEEEEEc--CCc--EEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK--DGR--EVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+.+..++||+|.||+|++|.++ +|+ .||||.+...... ....|++|+.+|.+|+|+|+|++||++.+ ....||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHH
Confidence 4455678999999999999876 455 4899999766544 67899999999999999999999997665 567899
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||+++.|+|.+.|+. .....|.......++.|||.||.||..+++|||||...|+||-....+||+||||.+.+....
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999975 456678899999999999999999999999999999999999999999999999999775443
Q ss_pred ccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
... .....-...|.|||.++...++.+||||+|||++|||++ |..||.+-.... ++..+.++
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------IL~~iD~~-------- 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------ILKNIDAG-------- 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-------HHHhcccc--------
Confidence 322 223345678999999999999999999999999999998 889997544221 12222111
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+..+..+.++..+.++++.||..+|++|||+..|.+.+
T Consensus 332 ----erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ----ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ----ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11112234567889999999999999999999997544
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=300.62 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=198.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 354 (625)
.+|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|++++++++|+||+++++++... ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999876 6899999987422 234556789999999999999999999976543 3457
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
+++|||+++++|.+++. ..+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999985 33458899999999999999999999999999999999999999999999999998653
Q ss_pred CCcc--ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 435 LDVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 435 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... .......++..|+|||++.+..++.++|+||||+++++|++|+.||....... ... .+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~-- 228 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIF-KIATQPTKP-- 228 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHH-HHHcCCCCC--
Confidence 2111 11123458899999999988888999999999999999999999996432211 111 111100000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+++.+.+++.+||+ +|..||++.+++.|
T Consensus 229 ---------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 ---------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0112355678899999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.87 Aligned_cols=270 Identities=26% Similarity=0.359 Sum_probs=200.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeee-ccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSR-YSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~ 354 (625)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++.. .....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999976 6889999988542 233445677899999999 99999999996644 34468
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 489888842 268899999999999999999999999999999999999999999999999998664
Q ss_pred CCccc----cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HH
Q 047969 435 LDVTH----VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------IN 501 (625)
Q Consensus 435 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~ 501 (625)
..... ......|+..|+|||++.+ ..++.++||||||+++|+|++|++||............... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 1233468999999998754 45788999999999999999999999654322111000000 00
Q ss_pred HhhhcccccccCC---cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 502 KIQKCAFDELIDP---CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 502 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+.......+++. ............++.++.+++.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000001100 00001111222356788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.42 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=205.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..+.|+..+.||.|++|.||+|.+. +++.||+|++..... ..+.+.+|+++++.++|+|++++++.+.. ....++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEEE
Confidence 4567888999999999999999987 788999999876544 55778899999999999999999996655 57789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++.... ..+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999996422 3699999999999999999999999999999999999999999999999999875533221
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||........ ...+.......
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~-------- 235 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LFLITTKGIPP-------- 235 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCCC--------
Confidence 12234578899999999888899999999999999999999999864322110 01111111110
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
......++..+.+++.+||+.+|.+||++.+++++..
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 0111224567889999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.92 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=198.9
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.. ....++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 5788899999999999999976 68899999985432 2345678899999999999999999996554 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~~~~~~~ 438 (625)
|+++++|.+++... ....+++..+..++.|+++||.|||+.+++|+||||+||++++++ .+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 80 YCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred cCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999998632 233579999999999999999999999999999999999998875 57999999998654322
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.......|+..|+|||++.+..++.++|+||||+++++|++|..||...... .... .+........
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~------- 222 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL-KICQGYFAPI------- 222 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH-HHhcccCCCC-------
Confidence 1223345889999999998888999999999999999999999998643321 1111 1111111110
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....+..+.+++.+||+.+|++|||+++++++
T Consensus 223 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01234578889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.30 Aligned_cols=265 Identities=21% Similarity=0.255 Sum_probs=193.9
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeec-cceEEEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRY-SQGLLLVYE 359 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~e 359 (625)
|++.+.||+|+||.||+|... +++.||+|++.... ........+|+.+++++. |+|++++++++... .+..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999876 78899999986532 122234467999999995 99999999976552 267899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+.+ +|.+.+.. ....+++..++.++.||+.||+|||+.|++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9974 77777753 2346899999999999999999999999999999999999999 9999999999986543221
Q ss_pred cccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHhhhccccc
Q 047969 440 VSTAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKIQKCAFDE 510 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 510 (625)
.....++..|+|||++. +..++.++||||||+++|||++|.+||........+...... ...........
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 12345789999999764 345788999999999999999999999754432111100000 00000000000
Q ss_pred ccC-CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 511 LID-PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 511 ~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... .............++..+.++|.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 000001111223457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.32 Aligned_cols=272 Identities=24% Similarity=0.319 Sum_probs=196.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-----
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----- 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 351 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3468999999999999999999976 78999999885432 122345678999999999999999999654422
Q ss_pred --ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccc
Q 047969 352 --QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL 429 (625)
Q Consensus 352 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgl 429 (625)
...++||||+.+ +|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 346999999965 78777742 234689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccc---cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 430 SRLFPLDVTH---VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 430 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
+......... ......++..|+|||.+.+. .++.++||||||+++|+|++|++||..................+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9865432211 11234578899999987654 4788999999999999999999999765432221111111111111
Q ss_pred cccccccC------CcCCCCCh-HHHH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 506 CAFDELID------PCLGFESD-EEVK-----RMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 506 ~~~~~~~~------~~~~~~~~-~~~~-----~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+....+ ........ .... ..+..+.++|.+||+.+|++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 10000000 00000000 0000 013456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=310.40 Aligned_cols=269 Identities=24% Similarity=0.327 Sum_probs=201.4
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 277 LAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 277 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
+..++++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999866 7899999987542 222346788999999999999999999977665667
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+ +++|.+++. ...+++..+..++.||++||+|||+++|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 89999998 568888874 235788889999999999999999999999999999999999999999999998754
Q ss_pred CCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHhh
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKIQ 504 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~ 504 (625)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||............... ...+.
T Consensus 159 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 159 DPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 221 123457889999998765 56899999999999999999999999654322111110000 00000
Q ss_pred hccccccc---CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 505 KCAFDELI---DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 505 ~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....++. ..............++..+.++|.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000011111222345688999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.62 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=206.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
...|.+.+.||+|.|+.|.+|++. ++..||||.+.+. +......+.+|+++|+.|+|||||+++.+... ...+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEE
Confidence 468999999999999999999976 7999999998664 34445668899999999999999999996554 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||..+|.+.+++. +.+.+.+..+..++.|+.+|++|||+++|||||||++||||+.+.++||+|||++..+. .
T Consensus 134 ~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--c
Confidence 99999999999996 55667789999999999999999999999999999999999999999999999999875 3
Q ss_pred cccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....+..|++.|.|||++.+..| .+..|+||+|+++|-|+.|..||++......- .+. ..+.+ ++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------~rv-l~gk~------rI 274 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------PRV-LRGKY------RI 274 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------chh-eeeee------cc
Confidence 344567789999999999988764 56899999999999999999999865422100 000 00000 00
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..-++.+..++|+++|-.+|.+|++++++.++-
T Consensus 275 -------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 275 -------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -------cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 112455677899999999999999999998763
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.96 Aligned_cols=266 Identities=21% Similarity=0.336 Sum_probs=196.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|++|+||+|+.+ +|+.||+|++..... ...+.+.+|++++++++|+||+++++++.. ....++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence 57999999999999999999976 789999998854322 234668899999999999999999996654 56889999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgla~~~~~~~ 437 (625)
||++ ++|.+++... ....+++..+..++.||+.||+|||+++++||||||+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred eccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9996 4787777432 2234678889999999999999999999999999999999985 5679999999997653321
Q ss_pred cccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---cccc---
Q 047969 438 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---AFDE--- 510 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 510 (625)
. ......+++.|+|||++.+ ..++.++||||||+++|+|++|++||........... ....+... .+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWPGVTS 233 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcccccc
Confidence 1 1233457889999998865 3578899999999999999999999975433211110 00000000 0000
Q ss_pred ccC-----Cc-CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 511 LID-----PC-LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 511 ~~~-----~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+.+ +. ...........++.++.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 0000011122345678899999999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.18 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=201.1
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
|++.+.||.|++|.||+|... +++.+|+|++..... .....+.+|++++++++|+||+++++++.. +...++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence 567789999999999999876 788999999865432 245678899999999999999999996654 5778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++ +|.+++.. ....+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 975 88887753 23578999999999999999999999999999999999999999999999999998765433 12
Q ss_pred ccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---ccccccC---
Q 047969 441 STAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---AFDELID--- 513 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 513 (625)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........+. .....+... ....+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCchHhcccchhhhh
Confidence 2334578899999988766 78899999999999999999999996554322111 111111000 0000000
Q ss_pred ------C-cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 ------P-CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ------~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+ ............++.++.++|.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00011122234567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.43 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=196.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
|++.+.||.|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.. ....+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence 677889999999999999876 79999999986432 2233568899999999999999999996655 5778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
++ ++|.+++.... ...+++..++.++.|+++||+|||+++++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 80 LD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 95 68999886322 236899999999999999999999999999999999999999999999999999765322111
Q ss_pred ccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---------cccc
Q 047969 441 STAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---------AFDE 510 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 510 (625)
.....++..|+|||++.+. .++.++||||||+++|+|++|++||........... ........ ...+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR---IFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhhhhhchh
Confidence 1223568899999987654 578899999999999999999999975432211100 00000000 0000
Q ss_pred ccCC--cC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 511 LIDP--CL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 511 ~~~~--~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.... .. ..........++..+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00 000011122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.71 Aligned_cols=250 Identities=30% Similarity=0.416 Sum_probs=197.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+.|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEE
Confidence 56889999999999999999876 6899999988533 23345678899999999999999999997665 5668999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+. |++.+++.. ....+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 577776642 2345899999999999999999999999999999999999999999999999998764322
Q ss_pred cccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
....++..|+|||++. ...++.++||||||+++|+|++|++||........ ...+.......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~---- 233 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNDSPT---- 233 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-------HHHHhcCCCCC----
Confidence 2345788999999874 35688899999999999999999999864332110 01111110000
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
......+..+.+++.+||+.+|++||++.+++.+..-.
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 234 -------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred -------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 00123456789999999999999999999999876433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=291.97 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=203.1
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-ceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-QGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~ 358 (625)
+|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+.++++++|+||+++++...... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999987 78999999986543 245678999999999999999999999665531 6789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 99999999999863 23789999999999999999999999999999999999999999999999999987654332
Q ss_pred c-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh-cccccccCCcC
Q 047969 439 H-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK-CAFDELIDPCL 516 (625)
Q Consensus 439 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 516 (625)
. ......++..|+|||.+.....+.++||||||+++++|++|..||...... .... ..+.. .....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~-~~~~~~~~~~~------ 224 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAAL-YKIGSSGEPPE------ 224 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHH-HhccccCCCcC------
Confidence 1 123456889999999998888999999999999999999999999755411 1111 11110 00000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.....+..+.+++.+||+.+|++||++.+++++
T Consensus 225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111235688999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.82 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=185.5
Q ss_pred eecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHh---cCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 289 ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTR---LRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.||+|+||.||+++.. +++.+|+|.+..... .....+.+|..+++. .+||||+.+++.+.. .+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence 4899999999999976 688999998854321 122334455544443 479999999886554 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++. ..+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus 80 ~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 80 NGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 9999999885 34569999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....|+..|+|||.+. +..++.++||||+|+++|+|++|..||.......... ....... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~------ 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNV------ 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCc------
Confidence 2346899999999886 4568899999999999999999999997543221111 0000000 000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
.....++.++.+++.+||+.||++|| +++|+++|.
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 00123456788999999999999999 699999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.16 Aligned_cols=258 Identities=18% Similarity=0.263 Sum_probs=184.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeccccHHH-----------HHHHHHHHHHHHhcCCCCeeeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDNNYRR-----------VEQFMNEVEILTRLRHKNLVSLFG 345 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~ 345 (625)
.++|++.+.||+|+||.||+|+..+ +..+|+|+........ ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999999764 4556777542221110 011233445566778999999998
Q ss_pred eeeeccc---eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeE
Q 047969 346 CTSRYSQ---GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422 (625)
Q Consensus 346 ~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~ 422 (625)
+...... ..++++|++.. ++.+.+. .....++..+..++.|+++||+|||+++|+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 6543222 23677777643 5655553 22235788899999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccc-cch
Q 047969 423 KVADFGLSRLFPLDVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE-INL 495 (625)
Q Consensus 423 kl~DFgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~-~~~ 495 (625)
||+|||+|+.+...... ......||+.|+|||++.+..++.++||||||+++|||++|..||........ +..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 11234699999999999988999999999999999999999999976532211 111
Q ss_pred hHH-HHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 496 ANL-AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 496 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
... ....+.+... .....+..+.+++..|++.+|++||+++++++.|+
T Consensus 246 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRLHEGKI--------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHhhhhhh--------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 110 1111111100 01123567889999999999999999999998763
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.02 Aligned_cols=245 Identities=25% Similarity=0.337 Sum_probs=191.2
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||+|+||+||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++.+.. .+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence 699999999999865 789999999864321 234567889999999999999999986554 567899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|.+++... ....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... .......
T Consensus 80 L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 80 LKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99998632 2236899999999999999999999999999999999999999999999999998765331 1223345
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
++..|+|||.+.+..++.++||||||+++++|++|+.||......... .......... ......
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~-------------~~~~~~ 219 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEM-------------AVEYPD 219 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccc-------------cccCCc
Confidence 788999999998878899999999999999999999999654331110 0010110000 000011
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
.++..+.+++.+||+.+|++|| ++.+++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 2356788999999999999999 66667664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=311.28 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=202.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----ceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----QGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 355 (625)
+|++.+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999976 58999999986543 344567899999999999999999999665533 3689
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+.+ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999974 7888885 333799999999999999999999999999999999999999999999999999987644
Q ss_pred Ccc--ccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc-----
Q 047969 436 DVT--HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA----- 507 (625)
Q Consensus 436 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 507 (625)
... .......++..|+|||++.+. .++.++|+||||+++|+|++|++||......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHhh
Confidence 321 112334578899999999877 7899999999999999999999999765432111 11111000000
Q ss_pred ------ccccc---CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 ------FDELI---DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ------~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....+ ..............++..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 0000000111122356788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.64 Aligned_cols=275 Identities=27% Similarity=0.357 Sum_probs=201.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~ 355 (625)
-|...+.||+||||.||+|+++ +|+.||||.+.+. ..+..+...+|+++|++++|+|||+++++-... .....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556678999999999999976 8999999998653 345678889999999999999999999843332 23468
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC--CCC--eEEEccccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD--SNF--CVKVADFGLSR 431 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~--~~~--~~kl~DFgla~ 431 (625)
+|||||.||+|...|.+.. +...|++.+.+.++.++..||.|||++||+||||||.||++- ++| ..||+|||.|+
T Consensus 94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999999997654 344599999999999999999999999999999999999983 333 47999999999
Q ss_pred ccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH-Hhhhcccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN-KIQKCAFD 509 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 509 (625)
...... .....+||..|++||+... ..|+..+|.||||+++|+.+||..||.............+... +-..+...
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 765433 4566789999999999874 7889999999999999999999999975543321111111111 10111000
Q ss_pred cc----cCC-----cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhchhc
Q 047969 510 EL----IDP-----CLGFESDEEVKRMTTSVAELAFLCLQQNKELRP--SMEEVLAELQRIKS 561 (625)
Q Consensus 510 ~~----~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~ell~~L~~i~~ 561 (625)
.. -++ .+.. +..........+..++..+|..+|++|- ...+....+..|..
T Consensus 251 ~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 000 0111 1112233344555677778888899997 66666666655543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=307.68 Aligned_cols=271 Identities=23% Similarity=0.307 Sum_probs=196.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS------ 351 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 351 (625)
.++|++.+.||+|+||.||+|... +++.+|||++..... .....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999976 689999998854322 12345678999999999999999998654322
Q ss_pred -ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 352 -QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 352 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
..+++||||+.+ +|...+.. ....+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 347999999975 67666643 2346999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccc----------cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH
Q 047969 431 RLFPLDVTH----------VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA 499 (625)
Q Consensus 431 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~ 499 (625)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865332211 1122356888999998765 35789999999999999999999999754432211110000
Q ss_pred HHHhhhcc------cccc----cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 500 INKIQKCA------FDEL----IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 500 ~~~~~~~~------~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
........ .... ...............+...+.+++.+||+.+|++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 0000 00000001111122344678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.63 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=196.0
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
..+||+|+||.||+|..+ +++.||||++........+.+.+|+.+++.++|+|++++++.+.. .+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCc
Confidence 357999999999999875 789999999865555556778999999999999999999996655 567899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|.+++. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .......
T Consensus 104 L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 104 LTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 999874 2357999999999999999999999999999999999999999999999999987654322 1123345
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ..+... .. ..+. ...
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-------~~~~~~-~~----~~~~-----~~~ 240 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDN-LP----PKLK-----NLH 240 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhh-CC----cccC-----Ccc
Confidence 889999999998878899999999999999999999998643221110 111110 00 0000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.++..+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=345.07 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=204.6
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
..+-+|....+||.|.||.||.|.+. +|...|+|.+.-. .........+|..++..++|||+|++||+-.+ .+..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHH
Confidence 34567888889999999999999865 7888999987432 23345667899999999999999999995544 66789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
|.||||++|+|.+.+. .++.+++.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.|.....
T Consensus 1311 IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999999995 444567777888999999999999999999999999999999999999999999987654
Q ss_pred Cccc---cccCCCCCCCccCccccccC---CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 436 DVTH---VSTAPQGTPGYVDPEYHQCY---QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 436 ~~~~---~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
.... ......||+.|||||++.+. .-..+.|||||||+++||+||+.||...+....+.+... .+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~------~gh-- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA------AGH-- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh------ccC--
Confidence 3211 12346799999999998653 456689999999999999999999976554433322211 111
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+..+.+++.+-.+|+..||+.||++|.++.|++++=
T Consensus 1459 ----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 ----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1122334888999999999999999999999888763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=295.42 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=192.0
Q ss_pred HHHHHhcCCCcccee--cccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 276 DLAEATNDFSREKEL--GDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 276 ~~~~~~~~~~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
+.....++|++.+.+ |.|+||.||+++.+ +++.+|+|++........ |+.....+ +|+||+++++.+.. .
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-~ 81 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-L 81 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-C
Confidence 444555778887777 99999999999876 788899998864422211 22222222 79999999996665 4
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLS 430 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla 430 (625)
...++||||+++++|.+++.. ...+++..+..++.||++||.|||+.|++||||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 578999999999999999953 23789999999999999999999999999999999999999988 9999999998
Q ss_pred cccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
...... ....++..|+|||++.+..++.++||||||+++|+|++|..||...... ......+.... ..
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~---- 225 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QK---- 225 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cc----
Confidence 765322 2335889999999998888999999999999999999999999743321 11111111111 00
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-MEEVLAE 555 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~ell~~ 555 (625)
.....+.++..+.+++.+||+.+|.+||+ +++++++
T Consensus 226 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111245668899999999999999995 6999865
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=295.21 Aligned_cols=243 Identities=28% Similarity=0.381 Sum_probs=193.2
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||.|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.. +...++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 799999999999976 58999999986432 2345678999999999999999999996554 667899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|.+++.. ...+++..+..++.||++||+|||+.+++|+||||+||+++.++.+||+|||++....... ......
T Consensus 80 L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 80 LWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999963 3458999999999999999999999999999999999999999999999999998764332 123346
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
++..|+|||.+....++.++|+||||+++|+|++|..||....... . .....+..... . .... .
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~-~~~~~~~~~~~----~--~~~~-----~ 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----M-EIYNDILKGNG----K--LEFP-----N 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----H-HHHHHHhccCC----C--CCCC-----c
Confidence 7899999999888888999999999999999999999997543210 1 11111110000 0 0000 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRPS-----MEEVLAE 555 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~ 555 (625)
..+..+.+++.+||+.+|++||+ ++|++++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 12457889999999999999999 7777774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=293.89 Aligned_cols=248 Identities=27% Similarity=0.472 Sum_probs=201.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|++.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.. ....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence 5788899999999999999876 688999999866543 456789999999999999999999996655 577899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999853 256899999999999999999999999999999999999999999999999999876433221
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||...+..++.++|||++|+++++|++|..||....... ............+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-------- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-------ALFRIVQDDHPPL-------- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHhccCCCCC--------
Confidence 233458899999999887778999999999999999999999986433110 0001111111100
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||..+|++||++.+++.+
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11234578899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.07 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=193.8
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++.. ....+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEe
Confidence 5566788999999999999876 68999999986432 344567889999999996 9999999996655 566789999
Q ss_pred eccCCChHHHhcc-CcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHG-DRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|+.. ++.++... .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9864 55444321 111335699999999999999999999985 99999999999999999999999999997653322
Q ss_pred cccccCCCCCCCccCccccccC---CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCY---QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
. .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||..... ..... ..+..... +
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~-~~~~~~~~-----~ 229 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQL-TQVVKGDP-----P 229 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHH-hhhcCCCC-----C
Confidence 1 1233588999999998765 688999999999999999999999964321 11111 11111110 0
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+.. .....++.++.+|+.+||+.+|++|||+++++++-
T Consensus 230 ~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 230 ILSN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred cCCC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1100 01123566889999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.33 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=204.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR---RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.+.|+.-+.||+||||.||-++.+ +|+.+|.|++.+.... .....++|-.||.+++.+.||.+-..+.. .+.+++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEE
Confidence 467888999999999999999876 7999999988543221 12346799999999999999988764444 778999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||..|+||+|.-+|... .++.++++.+.-++.+|+-||++||+.+||.|||||+|||+|+.|+++|+|+|||..++..
T Consensus 263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999888743 3357999999999999999999999999999999999999999999999999999987544
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.. ....+||.+|||||++.+..|+...|.|||||++|||+.|+.||......... .+ +|.+.
T Consensus 341 ~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------eE---------vdrr~ 402 (591)
T KOG0986|consen 341 KP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------EE---------VDRRT 402 (591)
T ss_pred Cc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------HH---------HHHHH
Confidence 33 34458999999999999999999999999999999999999999644321100 01 11122
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~ 555 (625)
.....+...+++++.+++.+.+|++||++|.. ++++.+|
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 22333444678889999999999999999964 4455544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.58 Aligned_cols=269 Identities=20% Similarity=0.314 Sum_probs=196.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc--------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-------- 351 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 351 (625)
..+|++.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999876 68999999986665556677899999999999999999998544322
Q ss_pred -----ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCeEEEc
Q 047969 352 -----QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVA 425 (625)
Q Consensus 352 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-~~~~~kl~ 425 (625)
...++||||+. ++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 24689999997 58888774 23589999999999999999999999999999999999997 45679999
Q ss_pred ccccccccCCCccc--cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH---
Q 047969 426 DFGLSRLFPLDVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--- 499 (625)
Q Consensus 426 DFgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--- 499 (625)
|||+++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...............
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999765322111 1122357889999997644 46788999999999999999999999654321111000000
Q ss_pred -----HHHhhhccccccc-CC-cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 500 -----INKIQKCAFDELI-DP-CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 500 -----~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
............. .. ............++.++.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000000 00 00000011122355678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.51 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=203.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
..++|..++.||+|.||.|.+++.+ +|+.+|+|++++.- ...+..-+.|-++|+..+||.+..+-..+. ...+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-t~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-TQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-cCceEE
Confidence 3578999999999999999999977 89999999987652 344556678999999999999888765444 467899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
.||||..||.|.-+|. +...++++...-+-.+|+.||.|||+++||.||||.+|+|+|.+|++||+||||++.--.
T Consensus 245 FVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999988885 455689999999999999999999999999999999999999999999999999985322
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. .....+.+|||.|+|||++....|..+.|.|.+||++|||++|+.||-..+......++- . .+-.+
T Consensus 321 ~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~---ed~kF------- 387 (516)
T KOG0690|consen 321 Y-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--M---EDLKF------- 387 (516)
T ss_pred c-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--h---hhccC-------
Confidence 2 233456789999999999999999999999999999999999999996544332211110 0 01111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
+..++++...|+..+|.+||.+|. .++||.++
T Consensus 388 --------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 388 --------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 224566788899999999999994 46666654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=347.99 Aligned_cols=265 Identities=26% Similarity=0.433 Sum_probs=204.5
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.....|+..+.||+|+||.||+|+.. +++.||||++...... ..+|++++++++|||||++++++.. ....++|
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv 761 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLI 761 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEE
Confidence 34456888889999999999999975 7899999998644321 2356889999999999999997765 4568999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH---ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
|||+++|+|.++++ .++|..+.+|+.||++||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 762 ~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 762 HEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999994 2789999999999999999999 6699999999999999998888775 66554322
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
. .....+|..|+|||++.+..++.++|||||||++|||++|+.||+..... ......+............+.++
T Consensus 834 ~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 834 T-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred c-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCc
Confidence 1 12236789999999999889999999999999999999999999643322 12233333322222333344454
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
.+....... .....++.+++.+||+.+|++||+|+|++++|+.+....
T Consensus 908 ~~~~~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 908 SIRGDVSVN-QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cccCCCCcc-HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 443222211 223446788999999999999999999999999886543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=297.44 Aligned_cols=264 Identities=25% Similarity=0.311 Sum_probs=196.6
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhc---CCCCeeeeeeeeeeccc----e
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRL---RHKNLVSLFGCTSRYSQ----G 353 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----~ 353 (625)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++++ +|+|++++++++..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999987 589999999864321 2234566788877766 59999999997655322 3
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.+++|||+.+ +|.+++... ....+++..++.++.|+++||.|||+.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 8999999975 788888532 2235899999999999999999999999999999999999999999999999999876
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---cccc-
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---CAFD- 509 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~- 509 (625)
..... .....++..|+|||++.+..++.++|+||||+++|+|++|.+||......... ......... ....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HHHHHHcCCCChHhcCC
Confidence 43322 12234788999999998888999999999999999999999999754432111 111110000 0000
Q ss_pred ------cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ------ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.................++..+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000111122334566788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.20 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=197.9
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.|+..+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|++++++++|+|++++++++.. ....++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEE
Confidence 4778889999999999999975 6889999998533 23345678899999999999999999997665 56689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 105 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred eCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 99975 77777642 234589999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 439 HVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.....++..|+|||++. ...++.++||||||+++|+|++|.+||........ ...+........
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~---- 244 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNESPTL---- 244 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhccCCCC----
Confidence 12345788999999873 35688899999999999999999999864321111 111111111000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
....++..+.+++.+||+.+|.+||++.++++++..+...
T Consensus 245 -------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 245 -------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0112445788999999999999999999999987765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=299.68 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=195.4
Q ss_pred CCCccceecccCcEEEEEEEEc----CCcEEEEEEeccccH----HHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 283 DFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNNY----RRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
+|++.+.||.|+||.||+|+.. +|+.||+|++..... ...+.+.+|+++++++ +|+||+++++++.. +..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence 4788899999999999999863 688999999864322 2346678999999999 59999999986554 567
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+++++|.+++. ....+++..+..++.||++||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 80 LHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 899999999999999985 3346889999999999999999999999999999999999999999999999999865
Q ss_pred CCCccccccCCCCCCCccCccccccC--CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
............|+..|+|||.+... .++.++||||||+++|+|++|..||......... .. ....+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~-~~~~~~~~~---- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AE-ISRRILKSE---- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HH-HHHHhhccC----
Confidence 43322222345688999999988643 4678999999999999999999999643321111 11 111111100
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
+ +....++..+.+++.+||+.+|++|| ++++++++
T Consensus 229 --~-------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --P-------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --C-------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 00112445788999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.06 Aligned_cols=273 Identities=21% Similarity=0.284 Sum_probs=200.3
Q ss_pred hHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 274 YSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 274 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
..++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456667899999999999999999999865 78899999986432 23346788999999999999999999865432
Q ss_pred -----cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEc
Q 047969 351 -----SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVA 425 (625)
Q Consensus 351 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~ 425 (625)
....+++++++ +++|.+++. ...+++..++.++.||++||+|||++||+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence 23467888887 778988874 2358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH------
Q 047969 426 DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL------ 498 (625)
Q Consensus 426 DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~------ 498 (625)
|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||..............
T Consensus 163 dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 163 DFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred cccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999875422 1233467899999998765 4688899999999999999999999965432211100000
Q ss_pred --HHHHhhhcccccc---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 499 --AINKIQKCAFDEL---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 499 --~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....+........ +...............+..+.++|.+||+.+|++||++.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000000000 000000000001112355788999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=295.07 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=186.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHH-HhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEIL-TRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.||+|+||.||+|... +++.||+|++..... .....+..|..++ ...+|+|++++++++.. ....++||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 57999999999999875 689999999865432 2223345555544 44589999999996654 667899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccccc
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVST 442 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 442 (625)
+++|.+++. ..+.+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||+++.... ..
T Consensus 81 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 81 GGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 999999985 334689999999999999999999999999999999999999999999999999875432 22
Q ss_pred CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChH
Q 047969 443 APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDE 522 (625)
Q Consensus 443 ~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (625)
...++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+...... ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN---------WPEE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC---------CCCc
Confidence 3457889999999988778999999999999999999999996543211 11111111100 0001
Q ss_pred HHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 523 EVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 523 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++..+.+++.+||+.+|++||++.++.+.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 111345678899999999999999976544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.69 Aligned_cols=268 Identities=20% Similarity=0.304 Sum_probs=195.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-----c
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-----Q 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 352 (625)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++|+||+++++++.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999875 78999999986432 223456889999999999999999999664322 3
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999964 6666542 2488999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHh
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKI 503 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~ 503 (625)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ...+
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 4321 123457889999998865 46888999999999999999999999754321111000000 0000
Q ss_pred hhccccccc---CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhch
Q 047969 504 QKCAFDELI---DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRI 559 (625)
Q Consensus 504 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~--L~~i 559 (625)
......... ...............+..+.+++.+||+.||++||++.+++.+ ++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000 0000000011112345578899999999999999999999987 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=298.20 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=197.0
Q ss_pred CCCccceecccCcEEEEEEEEc----CCcEEEEEEecccc----HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 283 DFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNN----YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
+|++.+.||+|++|.||+++.. +++.||||.+.... ....+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence 4788899999999999999743 57889999886432 22345688999999999 59999999986544 567
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+.+++|.+++. ....+++..+..++.|+++||.|||+.+++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 80 LHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 899999999999999985 2346899999999999999999999999999999999999999999999999998865
Q ss_pred CCCccccccCCCCCCCccCccccccCC--CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQ--LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
............|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ .......+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~---- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRILKSK---- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHHccC----
Confidence 433222223345889999999886654 78899999999999999999999864322111 011111111110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
+ .....++..+.+++.+||+.+|++|||+.++.+.|..
T Consensus 229 --~-------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --P-------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --C-------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 0011244578899999999999999998887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.30 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=192.9
Q ss_pred ceeccc--CcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDG--GFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
..||+| +||+||+|++. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence 456766 99999999976 7999999998643 33445788999999999999999999997665 567899999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc--
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV-- 440 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~-- 440 (625)
+++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+|++||+.+..........
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999986432 2358999999999999999999999999999999999999999999999998654322111110
Q ss_pred ----ccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc-----
Q 047969 441 ----STAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD----- 509 (625)
Q Consensus 441 ----~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 509 (625)
.....++..|+|||++.+ ..++.++||||||+++|+|++|++||........ ....+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCcccc
Confidence 011234667999999865 3578999999999999999999999965432111 00000000000
Q ss_pred ----------------------cccC----CcC--CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 510 ----------------------ELID----PCL--GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 510 ----------------------~~~~----~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.... ... ..........++..+.+|+.+||+.||++|||+.|++++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000 000 00011223456778999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.66 Aligned_cols=268 Identities=21% Similarity=0.255 Sum_probs=197.1
Q ss_pred hcCCCc-cceecccCcEEEEEEEEc-CCcEEEEEEeccccHHH--------------HHHHHHHHHHHHhcCCCCeeeee
Q 047969 281 TNDFSR-EKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR--------------VEQFMNEVEILTRLRHKNLVSLF 344 (625)
Q Consensus 281 ~~~~~~-~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 344 (625)
.++|.. .+.||.|+||+||+|+.. +++.||||++....... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356764 467999999999999976 78999999885432211 12477899999999999999999
Q ss_pred eeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 345 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
+++.. ....++||||+. ++|.+++. ....+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||
T Consensus 87 ~~~~~-~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVE-GDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEec-CCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 96654 567899999997 58888885 3345899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc-------------cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccc
Q 047969 425 ADFGLSRLFPLDV-------------THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHR 490 (625)
Q Consensus 425 ~DFgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~ 490 (625)
+|||++....... ........++..|+|||.+.+. .++.++||||||+++|+|++|.+||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 1111223468889999988654 4688999999999999999999999765432
Q ss_pred cccchhHHHHHHhhhcc---ccccc--------CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 491 HEINLANLAINKIQKCA---FDELI--------DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 491 ~~~~~~~~~~~~~~~~~---~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
... ........... +.... ...............+..+.+++.+||+.+|++||++++++.+-.
T Consensus 241 ~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 241 DQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 211 11111110000 00000 000000011112234567889999999999999999999998644
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.09 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=199.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~l 356 (625)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++ |+||+++++++.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence 47899999999999999999976 7899999998642 2233467889999999998 9999999996554 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++. +.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 80 VLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 999999999999985 3346999999999999999999999999999999999999999999999999999865433
Q ss_pred cc-------------------ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH
Q 047969 437 VT-------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 437 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~ 497 (625)
.. .......++..|+|||.+....++.++||||||+++++|++|..||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------ 229 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------ 229 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------
Confidence 21 11123457899999999888888999999999999999999999997543211
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSM----EEVLAE 555 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~ell~~ 555 (625)
....+..... .+ ...++..+.+++.+||+.+|++||++ ++++++
T Consensus 230 -~~~~~~~~~~------~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 -TFQKILKLEY------SF-------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -HHHHHHhcCC------CC-------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111111000 00 01225578899999999999999999 777764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=282.32 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=197.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYD-NNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++.+.+..||.|.-|.|++++++ .|...|||.+.. .+.++.++++..+.++.+.+ .|.||+.+|++.. +..++|.|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHHH
Confidence 45566778999999999999987 689999999865 46677888999999888775 8999999997776 45578999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|.|.- -++.++. .-.+++++..+-++...+++||.||..+ +|+|||+||+|||+|+.|++||+|||++..+-...
T Consensus 171 elMs~-C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99853 3444443 2345689999999999999999999986 89999999999999999999999999998764433
Q ss_pred cccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.+ +...|.+.|||||.+.. ..|+-++||||||++++||+||+.||..-+.+-+ . +.++.... + +
T Consensus 247 Ah--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~----ltkvln~e-P----P 313 (391)
T KOG0983|consen 247 AH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--V----LTKVLNEE-P----P 313 (391)
T ss_pred cc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--H----HHHHHhcC-C----C
Confidence 32 44568999999998854 3688899999999999999999999976433211 1 11111111 1 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
++.. ..+++..+.+|+..||++|+.+||...++++|-
T Consensus 314 ~L~~-----~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 314 LLPG-----HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCCc-----ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 1111 123677899999999999999999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=306.28 Aligned_cols=267 Identities=23% Similarity=0.348 Sum_probs=197.5
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---- 351 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 351 (625)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999865 7899999998543 2233456889999999999999999999665432
Q ss_pred -ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 352 -QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 352 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
...++||||+ +++|.+++. ...+++..++.++.||++||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 2468999998 678988874 245899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH--------HHHH
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN--------LAIN 501 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~--------~~~~ 501 (625)
...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||............. ....
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 764321 123457889999998865 458889999999999999999999997543211100000 0000
Q ss_pred HhhhcccccccC--CcCCC-CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 502 KIQKCAFDELID--PCLGF-ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 502 ~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+.......... +.... ........++..+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00000 0001112345578899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.19 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=195.3
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEEe
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
|++.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ |+|++++++++.. ....++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence 667889999999999999986 578899999854422 22234567999999999 9999999996655 6778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 9 789988886322 3468999999999999999999999999999999999999999999999999998653321 1
Q ss_pred ccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH----------HHHHhhhcccc
Q 047969 441 STAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL----------AINKIQKCAFD 509 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~ 509 (625)
.....++..|+|||++. ...++.++|+||||+++++|++|++||.............. ...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23345788999999874 44578999999999999999999999965533221110000 00000000000
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..................+..+.+++.+||+.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000011111224678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.68 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=199.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---- 351 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 351 (625)
...++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999986 6889999988543 2334466788999999999999999988554322
Q ss_pred -ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 352 -QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 352 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
...++|+||+ +++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 2479999998 5699998852 45899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH--------HHH
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL--------AIN 501 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~ 501 (625)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............. ...
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 865322 233457889999998754 3678899999999999999999999975433211100000 000
Q ss_pred HhhhcccccccC---CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 502 KIQKCAFDELID---PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 502 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+.......+.. ..............+..+.+++.+||+.+|++|||+.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 000000111222346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=284.72 Aligned_cols=278 Identities=22% Similarity=0.294 Sum_probs=202.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc---C--CcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK---D--GREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS 351 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 351 (625)
+....|+.+..||+|.||.||+|.-+ + .+.+|||+++.... .......+|+.+++.++|||++.+..++...+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34568999999999999999999533 2 33799999865421 12244678999999999999999999887778
Q ss_pred ceEEEEEEeccCCChHHHhccCc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC----CeEEEcc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDR-AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN----FCVKVAD 426 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~----~~~kl~D 426 (625)
..++|++||.+. +|.+.++-.+ .+...++...+..|++||+.|+.|||+.-|+||||||.||||..+ |++||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 889999999987 7888776433 234579999999999999999999999999999999999999877 9999999
Q ss_pred cccccccCCCccccc--cCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCccccccccc--chh----H
Q 047969 427 FGLSRLFPLDVTHVS--TAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI--NLA----N 497 (625)
Q Consensus 427 Fgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~--~~~----~ 497 (625)
||+++.+........ ...+-|.+|+|||++.+. .|+.+.|||+.|||+.||++-.+-|......... .+. .
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999999865443332 345679999999998775 6999999999999999999998888654321111 111 1
Q ss_pred HHHHHhhhcccccccC-------------CcCCCCCh-------HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 498 LAINKIQKCAFDELID-------------PCLGFESD-------EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~-------------~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+.+-+....-..+-+ ........ ...+.-++...+|+.++|..||.+|.|+++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 1111111111111100 00000000 001111223668999999999999999999999853
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=292.45 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=193.0
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||.|+||.||+++.. +|+.+|+|++..... ...+.+.+|++++++++|+||+++++.+.. ....++||||+.+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 689999999999987 599999999865433 456778999999999999999999986554 677899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc-------
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT------- 438 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~------- 438 (625)
|.+++.. .+.+++..+..++.||++||.|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 80 L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999863 23689999999999999999999999999999999999999999999999999876432211
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
.......++..|+|||.......+.++||||||+++|+|++|..||....... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------- 220 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIEW-------- 220 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcCC--------
Confidence 11233457889999999988788999999999999999999999996543211 111111111100
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. ....++..+.+++.+||+.+|++|||+.++.+.|
T Consensus 221 ~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 221 P---EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred C---ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 0001356788999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=327.11 Aligned_cols=259 Identities=26% Similarity=0.327 Sum_probs=209.8
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS 351 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 351 (625)
+++-..++|.+++.||+|+||.|.+++++ +++.||+|++.+. ......-|..|-.+|..-+.+=||.++..+. +.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-D~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-DE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-Cc
Confidence 44445689999999999999999999987 6888999998763 2234566889999999888888998887444 47
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
+++|+|||||+||+|..+|. +...++++++..++.+|+-||.-||+.|+|||||||+|||||..|++||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 88999999999999999995 44479999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccc----c-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQ----C-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
.+..+....+...+|||.|++||+++ + +.|+..+|.||+||++|||+.|..||-..... ....+|...
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KIm~h 296 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKIMNH 296 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHHhch
Confidence 88877777778889999999999885 2 46899999999999999999999999543211 112222221
Q ss_pred ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 047969 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS---MEEVLAEL 556 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ell~~L 556 (625)
...+.++... .++.+..+||.+.+. +|+.|.. ++++..|.
T Consensus 297 ------k~~l~FP~~~---~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 297 ------KESLSFPDET---DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ------hhhcCCCccc---ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 0122333111 267788889988776 7888877 88887764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.10 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=185.5
Q ss_pred eecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHH---HHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 289 ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVE---ILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.||+|+||.||+|+.. +++.||+|.+.+... .....+.+|.. .++...||||+++++.+.. ....++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence 4899999999999875 688999998865321 11222344443 4444579999999985554 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
.|++|.+++. ..+.+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 80 ~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 80 NGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 9999998885 34569999999999999999999999999999999999999999999999999987553221 2
Q ss_pred cCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||............ ...... ...+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~------~~~~---- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------AVEL---- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhcc------CCCC----
Confidence 234689999999998644 6889999999999999999999999754322111110 000000 0000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
...++..+.+++.+||..+|++|| ++.+++++-
T Consensus 219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 112356788999999999999999 999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.10 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred CCCccceecccCcEEEEEEEEc-C--CcEEEEEEeccc--cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeee---ccce
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-D--GREVAVKRLYDN--NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSR---YSQG 353 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---~~~~ 353 (625)
+|++.+.||+|+||.||+++.. . ++.||+|++... .....+.+.+|+++++++ +||||+++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999976 4 778999988542 222356788999999999 59999999985332 2245
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++++||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899886 58888885 3456899999999999999999999999999999999999999999999999999865
Q ss_pred CCCccc---cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH--------HHH
Q 047969 434 PLDVTH---VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL--------AIN 501 (625)
Q Consensus 434 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~ 501 (625)
...... ......|+..|+|||++.+ ..++.++||||||+++|+|++|.+||.............. ...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1123468999999998765 4688999999999999999999999975432111100000 000
Q ss_pred Hhhhcccccc---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 502 KIQKCAFDEL---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 502 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+........ ................+..+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000000001111234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.58 Aligned_cols=259 Identities=22% Similarity=0.231 Sum_probs=190.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.+++.++|+||+++++++.. ....+++|||+++++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCC
Confidence 3344444444444444 6999999998654 34566789999999999999999999996655 567899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc------c
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT------H 439 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~------~ 439 (625)
|.+++... ....+++..+..++.|+++||+|||+++|+||||||+||+++.++.+||+|||.+........ .
T Consensus 86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998643 223588999999999999999999999999999999999999999999999998875432111 1
Q ss_pred cccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc------
Q 047969 440 VSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL------ 511 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 511 (625)
......++..|+|||++.. ..++.++|+||||+++|+|++|..||........ ....+.. ....+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~------~~~~~~~-~~~~~~~~~~~ 236 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM------LLEKVRG-TVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-cCccccccCch
Confidence 1123457788999999865 3588999999999999999999999975332111 1111100 00000
Q ss_pred --------------cCCcCC-CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 512 --------------IDPCLG-FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 512 --------------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+.... .........++.++.+++.+||+.+|++|||+++++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000 0011123355678899999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=292.60 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=195.2
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
+|.+.+.||+|+||.||+++.. .+..+++|.++.. ......++..|+.++++++||||+++++.+.. ....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEE
Confidence 5888899999999999999865 3445666655321 12233457789999999999999999996654 456899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.........+++..++.++.|+++||.|||+.|++|+||||+||+++. +.+||+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999998754445567999999999999999999999999999999999999975 56999999998765332
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.......
T Consensus 159 ~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~------ 224 (260)
T cd08222 159 C-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-------SVVLRIVEGPTPS------ 224 (260)
T ss_pred c-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCCCCC------
Confidence 2 1223345788999999988878899999999999999999999998643211 1111111111110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++.++.+++.+||+.+|++||++.+++++
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112455688899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.88 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=199.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|++++++++.. ....++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence 566788999999999999977 58999999986542 2334677899999999999999999996655 4678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+. ++|.+++... ...+++..++.++.|++.||+|||+.||+||||+|+||+++.++.+||+|||+++....... .
T Consensus 80 ~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 80 CD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 98 5899998632 14689999999999999999999999999999999999999999999999999987543322 1
Q ss_pred ccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHhhhcc-ccc
Q 047969 441 STAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKIQKCA-FDE 510 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~ 510 (625)
.....++..|+|||.+.+. .++.++||||||++++||++|.+||............... ...+.... ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233467889999988665 7899999999999999999999999654422111100000 00000000 000
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.................+..+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000111112223346689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.95 Aligned_cols=252 Identities=29% Similarity=0.428 Sum_probs=197.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++.. ....++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEE
Confidence 45777889999999999999976 6788999988532 23345678899999999999999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+. |++.+.+.. ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99996 577777642 2345899999999999999999999999999999999999999999999999998764321
Q ss_pred cccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
....++..|+|||.+. ...++.++||||||+++|+|++|..||....... ....+........
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~--- 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPAL--- 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhhcCCCCc---
Confidence 2345788999999874 3457889999999999999999999985432111 0111111111100
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.....+..+.++|.+||+.+|++||++.+++++......
T Consensus 235 --------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 011345578899999999999999999999998765554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.87 Aligned_cols=244 Identities=30% Similarity=0.428 Sum_probs=192.0
Q ss_pred CCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++++.++|||++++++++.. ....++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence 666778999999999999875 6889999998532 23445678899999999999999999997665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+. +++.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 996 577777642 334689999999999999999999999999999999999999999999999999864321
Q ss_pred cccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 440 VSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....|+..|+|||++. ...++.++||||||+++|+|++|.+|+......... ..+.........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~---- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQNDSPTLQ---- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHHhcCCCCCC----
Confidence 22346889999999874 356888999999999999999999998654321111 111111111100
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++..+.+++.+||+.+|++||++.+++.+
T Consensus 242 -------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234568889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=292.17 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=194.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|++|.||+|... +++.||||++.... ......+..|+.++.++. |+||+++++++.. ....++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEE
Confidence 367899999999999999999987 48999999986542 234456677887777775 9999999997655 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
|||+.+ ++.+++.. ....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999854 67776642 23478999999999999999999997 59999999999999999999999999998765332
Q ss_pred ccccccCCCCCCCccCccccccCC----CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... .....+.......
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~-- 238 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------EVLTKILQEEPPS-- 238 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------HHHHHHhcCCCCC--
Confidence 22 12335788999999886543 7889999999999999999999996432110 0111111111000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
... ...++.++.+++.+||+.+|++||++++++++..
T Consensus 239 ---~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 ---LPP-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ---CCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000 0123457889999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=256.81 Aligned_cols=268 Identities=24% Similarity=0.347 Sum_probs=203.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+|...++||+|.||+||+|++. +++.||+|++..++ ...-...++|+-+|+.++|.|||+++++.. .++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-sdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-cCceeEEeH
Confidence 35667789999999999999977 57789999986442 223345789999999999999999999544 367789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.. +|..+..+ -++.++.+.+..++.|+++||.+.|++++.|||+||.|+||+.+|.+|++|||+++.+.....
T Consensus 81 e~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 99965 78887753 456799999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccc---cC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL---ID 513 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 513 (625)
. ....+-|.+|++|.++.+. -|+...|+||.||++.|+.. |++.|.+.+-..+....-+......+...+.+ -|
T Consensus 157 c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2 2344679999999998776 48889999999999999996 88888766543333222222222222222111 11
Q ss_pred C--cCCCCC----hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 P--CLGFES----DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~--~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ...+.. ...+.++...-++++.+.|.-+|..|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1 001111 12334555566789999999999999999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.90 Aligned_cols=269 Identities=25% Similarity=0.372 Sum_probs=194.5
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc--CCCCeeeeeeeeeec---cceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL--RHKNLVSLFGCTSRY---SQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~---~~~~~l 356 (625)
...+..+.||+|.||.||+|++. ++.||||++... ..+.|.+|-+|.+.. +|+||+++++.-... ...++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556678999999999999996 699999998543 456788888888765 799999999843221 236899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccCCCCCCEEECCCCeEEEccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS---------DIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
|+||.+.|+|.+||. ...++|....+|+.-+++||+|||+. .|+|||||.+||||..|++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999994 44699999999999999999999974 5999999999999999999999999
Q ss_pred ccccccCCCccccc-cCCCCCCCccCccccccCC-CC-----CchhhhhHHHHHHHHHhCCCCCcc-cccccccchhHHH
Q 047969 428 GLSRLFPLDVTHVS-TAPQGTPGYVDPEYHQCYQ-LT-----DKSDVYSFGVVLIELISSMPAVDM-NRHRHEINLANLA 499 (625)
Q Consensus 428 gla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~-~s-----~~sDvwslG~il~elltG~~p~~~-~~~~~~~~~~~~~ 499 (625)
|||..+........ ...+||.+|||||++.+.. +. .+.||||+|.+||||++....++. .-..-+..+...+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99998764333222 2367999999999987642 22 258999999999999986544321 1111111111000
Q ss_pred -----HHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 500 -----INKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 500 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...++...+.+-.+|.+...... ......+.+.+..||..|++-|.|+.=+.+.+..+..
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK--HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc--CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 01111111111112211111000 1234578889999999999999999998888877653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=321.38 Aligned_cols=146 Identities=32% Similarity=0.504 Sum_probs=129.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.++||+|+||.||+|++. +++.||||++.... ......+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEE
Confidence 468999999999999999999987 78999999986432 3345678899999999999999999986554 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
||||+.+++|.+++. ..+.+++..++.|+.||+.||.|||.++|+||||||+||||+.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999985 33468899999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=280.99 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=195.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+.+.+..||.|+||+|++-.++ .|+..|||++...+. .+.++++.|.+...+- +.||||++||..+. ++..||.||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHH
Confidence 4444568999999999999877 799999999976543 5567788887765554 79999999997776 345799999
Q ss_pred eccCCChHHHhcc-CcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHG-DRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
+|+- +|+.+.+. ...+...+++..+-.|+...+.||.||-.. .||||||||+|||++..|.+||+|||++..+..+
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 9964 66554432 223556799999999999999999999976 8999999999999999999999999998765322
Q ss_pred cccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 438 THVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
...+.-.|...|||||.+.. ..|+-+|||||||++|||+.||+.|+..-.. .-.....+..+..+.+..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l~~-- 292 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPILLF-- 292 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCeecC--
Confidence 22244568999999998853 3589999999999999999999999853221 111122233333332221
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+...-.++..+..+|.-||.+|-++||...+++++
T Consensus 293 -----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 -----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11222466788999999999999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.41 Aligned_cols=243 Identities=26% Similarity=0.344 Sum_probs=198.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
+++|.....+|.|+|+.|-.+... +++..++|++.+.. .+-.+|+.++... +||||+++.+.+.+ ..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-Cceeeeee
Confidence 678888889999999999998866 78899999986552 2234677666666 79999999996655 67899999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE-CCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL-DSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll-~~~~~~kl~DFgla~~~~~~~ 437 (625)
|.+.|+-+.+.+.. .. .....+..|+.+|+.|+.|||++|+|||||||+|||+ +..++++|+|||.++....+
T Consensus 396 e~l~g~ell~ri~~----~~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KP-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHh----cc-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999988887742 22 2226777899999999999999999999999999999 68999999999999876544
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
....+-|..|.|||++....|++++|+||||++||+||+|+.||.....+ ..+...+....+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS-------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------
Confidence 34456789999999999999999999999999999999999999765443 1122222222221
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
..++.+.++|+.+||+.||.+||+|.++..+-..
T Consensus 533 -------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 -------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3567789999999999999999999999987654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.70 Aligned_cols=275 Identities=23% Similarity=0.335 Sum_probs=212.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeee-------cc
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSR-------YS 351 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~ 351 (625)
+.|+...+||+|.||.||+|+.+ .|+.||+|++...+. ..-...++|+++|..|+|+|++.+++.+.. ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45667788999999999999976 688899998643322 223456789999999999999999885422 22
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
..+++||.+++. +|..+|.. ....++...+.+++.++..||.|+|+..|+|||+||.|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 348999999987 78888742 33468899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCc---cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 432 LFPLDV---THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 432 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
.+.... ....+..+-|.+|++||.+.+. .|+++.|||+.||++.||+++.+-+.....+..+.+.......+.+..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 764332 2234556789999999988764 799999999999999999999999998888877777777766655554
Q ss_pred cccccCC----c-----CCCCChHHHHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 508 FDELIDP----C-----LGFESDEEVKRMT------TSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 508 ~~~~~~~----~-----~~~~~~~~~~~~~------~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
.+..... . +.......++... ++..+++.++|..||.+|+.+.+++.+-.-.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 4443211 0 1111111122222 26778999999999999999999998754433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=283.06 Aligned_cols=275 Identities=24% Similarity=0.389 Sum_probs=202.4
Q ss_pred cCccccChHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc--CCCCeeeee
Q 047969 267 FGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL--RHKNLVSLF 344 (625)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~ 344 (625)
.|.|.+-... ...+.++.+.||+|.||.||+|+++ |..||||++...+. +.+.+|.+|.+.. +|+||+.++
T Consensus 199 SGlplLVQRT---iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQRT---IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHHh---hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhh
Confidence 4555544333 3457888999999999999999997 89999999975543 4567788887764 999999999
Q ss_pred eeeeecc---ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCC
Q 047969 345 GCTSRYS---QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS--------DIIHRDVKTNN 413 (625)
Q Consensus 345 ~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~ivHrDikp~N 413 (625)
+...... ..++||++|-+.|||.|+|.. ..++.+..++++..+|.||++||.. .|.|||||..|
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 8443322 248999999999999999953 4689999999999999999999964 49999999999
Q ss_pred EEECCCCeEEEcccccccccCCCcccc---ccCCCCCCCccCccccccC------CCCCchhhhhHHHHHHHHHh-----
Q 047969 414 ILLDSNFCVKVADFGLSRLFPLDVTHV---STAPQGTPGYVDPEYHQCY------QLTDKSDVYSFGVVLIELIS----- 479 (625)
Q Consensus 414 Ill~~~~~~kl~DFgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslG~il~ellt----- 479 (625)
|||..++..-|+|+|||.....+.... ....+||.+|||||++... .--..+||||||.++||++.
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999999999999999998776553322 3557899999999998542 11225899999999999985
Q ss_pred C-----CCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047969 480 S-----MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554 (625)
Q Consensus 480 G-----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 554 (625)
| ++||..--+... . .+++.+-.-.+-+.|.+...... ......+.++++.||..+|.-|.|+-.+.+
T Consensus 427 gi~eey~~Pyyd~Vp~DP-s-----~eeMrkVVCv~~~RP~ipnrW~s--~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDP-S-----FEEMRKVVCVQKLRPNIPNRWKS--DPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CEehhhcCCcccCCCCCC-C-----HHHHhcceeecccCCCCCccccc--CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 2 355532211111 1 11111111112222222211111 123346778999999999999999999999
Q ss_pred HHhchhc
Q 047969 555 ELQRIKS 561 (625)
Q Consensus 555 ~L~~i~~ 561 (625)
.|.++.+
T Consensus 499 tl~~l~~ 505 (513)
T KOG2052|consen 499 TLAKLSN 505 (513)
T ss_pred HHHHHhc
Confidence 9988875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=294.14 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=199.5
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
.+.||.|-||+||-|+++ +|+.||||++.+.. ....+++++|+.||++++||.||.+.- ..+..+++++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~-M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLEC-MFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEE-eecCCceEEEEehhhcc
Confidence 478999999999999876 89999999985432 233477899999999999999999876 44457889999999976
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC---CeEEEcccccccccCCCcccc
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN---FCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~---~~~kl~DFgla~~~~~~~~~~ 440 (625)
.-|.-.|. ...++|++.....++.||+.||.|||.++|+|.||||+|||+... -.+||+|||.|+.++... .
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 44444443 355679999999999999999999999999999999999999653 469999999999876433 3
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....+||+.|+|||+++...|...-|+||.|||+|--++|.-||....+- ..+|+...+. .+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI---------ndQIQNAaFM---------yP 784 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI---------NDQIQNAAFM---------YP 784 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch---------hHHhhccccc---------cC
Confidence 35567999999999999999999999999999999999999999654321 1222222221 22
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+++++.+..+||..+|+..-++|-|.++.+.+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 34567788899999999999999999999998765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.20 Aligned_cols=240 Identities=30% Similarity=0.412 Sum_probs=191.9
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++|+||+++++.+.. +...++||||+.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 699999999999976 589999999865432 245678999999999999999999985544 677899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 445 (625)
|.+++.. ...+++..+..++.|+++||.|||+.+++|+||||+||+++.++.++|+|||++....... .......
T Consensus 80 L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 80 LFSHLSK----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 9999853 3368999999999999999999999999999999999999999999999999998754322 1223456
Q ss_pred CCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 446 gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
++..|+|||.+.+...+.++|+||||+++|+|++|..||..... ......+...... + ..
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~------~-------~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLR------F-------PE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCC------C-------CC
Confidence 88999999999888889999999999999999999999965432 1111111111100 0 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRPSM---EEVLAE 555 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs~---~ell~~ 555 (625)
..+..+.+++.+||..+|++||++ ++++++
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 124578889999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=289.29 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=202.2
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeccc-cH------HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-KDGREVAVKRLYDN-NY------RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
.++|-++..||+|||+.||+|.+ ...+.||||+-..+ +. .-.+...+|.+|-+.|+||.||++|+++.-+..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45788899999999999999974 46889999985322 11 123456899999999999999999998888788
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCCEEECC---CCeEEEccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS--DIIHRDVKTNNILLDS---NFCVKVADF 427 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--~ivHrDikp~NIll~~---~~~~kl~DF 427 (625)
.++-|+||++|.+|+-+|+ ....++++++..|+.||+.||.||... .|||-||||.|||+.. -|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 8999999999999999996 455799999999999999999999987 5999999999999943 478999999
Q ss_pred ccccccCCCccc------cccCCCCCCCccCcccccc----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH
Q 047969 428 GLSRLFPLDVTH------VSTAPQGTPGYVDPEYHQC----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 428 gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~ 497 (625)
||++.+..+... ......||.+|++||.+.- .+.+.|.||||+|||+|..+.|+.||.....+.++-..+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999988654332 1234579999999997642 357889999999999999999999997655444332222
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.++.. . ...+...+ .++.+...||++||+...++|....++..+
T Consensus 698 TIlkA----t-------EVqFP~KP---vVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 698 TILKA----T-------EVQFPPKP---VVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred chhcc----e-------eccCCCCC---ccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 22111 0 11111111 245678889999999999999988887653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.40 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=205.2
Q ss_pred CCccceecccCcEEEEEEEEc-CCc----EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.+..++||.|+||+||+|.+- .|+ +||||++... .....+++++|+-+|.+++|||+++++|++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 445678999999999999753 443 5899988654 3445688999999999999999999999776533 7899
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
++||+.|.|.++++.+ ...+..+..+.|..||++||.|||.+++|||||-..||||..-..+||.|||+|+....+.
T Consensus 776 tq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999753 4468889999999999999999999999999999999999999999999999999887665
Q ss_pred ccccc-CCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 438 THVST-APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 438 ~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
..... ...-.+.|||-|.++...++.++|||||||++|||+| |..|++....++.. ..++++. +
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~ge-------R 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGE-------R 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhccc-------c
Confidence 54432 2345678999999999999999999999999999998 88888754332211 1111111 1
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
+. .....+.++..++.+||..|++.||+++++...+.++.+..
T Consensus 919 Ls-----qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 919 LS-----QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CC-----CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 11 11234457778999999999999999999999887765443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.59 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=208.8
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeee---
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSR--- 349 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--- 349 (625)
+.+...++-|++.+.||.|.+|.||+++.+ +++.+|+|++..... .-+++..|.++|+.+ .|||++.+||++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 344455678999999999999999999865 789999998865532 335677899999998 59999999996643
Q ss_pred -ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccc
Q 047969 350 -YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFG 428 (625)
Q Consensus 350 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFg 428 (625)
.++.+|||||||.+|+..|+++... +..+.|+.+..|++.++.||.+||...++|||||-.|||++.++.+||.|||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 3456999999999999999998654 7789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccCccccccC-----CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-----QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
++...... .....+..||+.|||||++... .|+.++|+||||++..||..|.+|+-...... ++-.+
T Consensus 169 vSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------aLF~I 240 (953)
T KOG0587|consen 169 VSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLI 240 (953)
T ss_pred eeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------hhccC
Confidence 99875432 2334567899999999998543 47779999999999999999999985332211 11111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...... ....++..+.++.+||..||.+|-++||++.++++|
T Consensus 241 pRNPPP----------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 PRNPPP----------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCc----------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111 111245677899999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=277.18 Aligned_cols=219 Identities=20% Similarity=0.191 Sum_probs=174.1
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhc
Q 047969 293 GGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371 (625)
Q Consensus 293 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 371 (625)
|.+|.||++++. +++.||+|++.... .+.+|...+....||||+++++++.. ....++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence 899999999976 78999999986543 23455666666789999999996655 577899999999999999985
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCcc
Q 047969 372 GDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451 (625)
Q Consensus 372 ~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~ 451 (625)
. ...+++..+..++.|+++||+|||++||+||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 3 345899999999999999999999999999999999999999999999999987654321 12234577899
Q ss_pred CccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHH
Q 047969 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSV 531 (625)
Q Consensus 452 aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 531 (625)
|||.+....++.++|+||+|+++|||++|..|+....... ... ....+ ...++..+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~~~-------~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTLNI-------PEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cccCC-------cccCCHHH
Confidence 9999988888999999999999999999998875321100 000 00000 01234578
Q ss_pred HHHHHHhcccCCCCCCCH
Q 047969 532 AELAFLCLQQNKELRPSM 549 (625)
Q Consensus 532 ~~li~~cl~~~P~~RPs~ 549 (625)
.+++.+||+.||++||++
T Consensus 206 ~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 206 RSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHccCCHHHhcCC
Confidence 889999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.69 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=205.1
Q ss_pred cCCCccceecccCcEEEEEEEEc----C----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK----D----GREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
++.++.+.||+|.||.|++|... . ...||||.+... ...+.+.+..|+++|+.+ +|+||+.++|++.. .
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-D 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-C
Confidence 45566679999999999999743 1 346999998654 335678899999999999 69999999998777 6
Q ss_pred ceEEEEEEeccCCChHHHhccCc---c-------cC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 047969 352 QGLLLVYEFVANGTVADQLHGDR---A-------KH--GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN 419 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~ 419 (625)
..+++|+||+..|+|.+++...+ . .. ..|+....+.++.|||.|++||+++++|||||-..||||..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 77899999999999999997655 0 01 238999999999999999999999999999999999999999
Q ss_pred CeEEEcccccccccCCCccccccCCC--CCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 420 FCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 420 ~~~kl~DFgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
..+||+|||+|+.............. -...|||||.+....++.|+||||||++|||+++ |..|+..-.. .
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------~ 528 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP------T 528 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc------H
Confidence 99999999999965444333222222 3456999999999999999999999999999998 8888864211 1
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
......+.++.-.+ .+...+.++.++++.||+.+|++||++.++.+.|....
T Consensus 529 ~~l~~~l~~G~r~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EELLEFLKEGNRME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHhcCCCCC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11122333322111 11123557788999999999999999999999998853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.76 Aligned_cols=270 Identities=22% Similarity=0.306 Sum_probs=183.9
Q ss_pred HhcCCCccceecccCcEEEEEEEE-----------------cCCcEEEEEEeccccHHHHHHH--------------HHH
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKL-----------------KDGREVAVKRLYDNNYRRVEQF--------------MNE 328 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 328 (625)
..++|++.++||+|+||+||+|.. .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999964 2456899999865443333333 346
Q ss_pred HHHHHhcCCCCe-----eeeeeeeee-------ccceEEEEEEeccCCChHHHhccCcc--------------------c
Q 047969 329 VEILTRLRHKNL-----VSLFGCTSR-------YSQGLLLVYEFVANGTVADQLHGDRA--------------------K 376 (625)
Q Consensus 329 ~~~l~~l~h~ni-----v~~~~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 376 (625)
+.++.+++|.++ +++++++.. .....+|||||+.+++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 556664432 12457999999999999999864211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCcccc
Q 047969 377 HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456 (625)
Q Consensus 377 ~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 456 (625)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++...............+++.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12356788999999999999999999999999999999999999999999999976533222212223458899999987
Q ss_pred ccCC----------------------CCCchhhhhHHHHHHHHHhCCC-CCccccccc-ccchhHHHHHHhhhccccccc
Q 047969 457 QCYQ----------------------LTDKSDVYSFGVVLIELISSMP-AVDMNRHRH-EINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 457 ~~~~----------------------~s~~sDvwslG~il~elltG~~-p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... ...+.||||+||++++|++|.. |+....... +............. ..
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-----~~ 457 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-----YK 457 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-----hc
Confidence 4321 1234799999999999999874 664321110 00000000000000 00
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHHh
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNK---ELRPSMEEVLAELQ 557 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~ell~~L~ 557 (625)
.....+ ......+....+++.++|..+| .+|+|++|+++|-.
T Consensus 458 ~~~~~~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 458 GQKYDF---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred ccCCCc---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 000111 1122345678899999999866 68999999998743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=307.25 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=171.4
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-C----CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeee----e-ee
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-D----GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC----T-SR 349 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~----~-~~ 349 (625)
..++|++.+.||+|+||.||+|++. + +..||||++..... .+.+.+| .++...+.+++.++.. . ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999976 4 68999998754322 1222222 1222223333222221 1 13
Q ss_pred ccceEEEEEEeccCCChHHHhccCcc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRA----------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNN 413 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~N 413 (625)
.....+|||||+.+++|.+++..... .........+..++.||+.||+|||+++|+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 34568999999999999999863210 01112234566899999999999999999999999999
Q ss_pred EEECC-CCeEEEcccccccccCCCccccccCCCCCCCccCccccccC----------------------CCCCchhhhhH
Q 047969 414 ILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY----------------------QLTDKSDVYSF 470 (625)
Q Consensus 414 Ill~~-~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDvwsl 470 (625)
||++. ++.+||+|||+|+..............+++.|+|||.+... .+..++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 68999999999986544333334556789999999965321 23456799999
Q ss_pred HHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc--ccc---ccCCcCCCCCh---HHHHHHHHHHHHHHHHhcccC
Q 047969 471 GVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA--FDE---LIDPCLGFESD---EEVKRMTTSVAELAFLCLQQN 542 (625)
Q Consensus 471 G~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~ 542 (625)
||+||||+++..+++... ..+. ..+.... ... ...+....... +..........+|+.+||+.|
T Consensus 366 GviL~el~~~~~~~~~~~----~~~~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNL----IQFN----RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHhCcCCCchHH----HHHH----HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 999999999766543211 0000 0000000 000 00100000000 000011223458999999999
Q ss_pred CCCCCCHHHHHHH
Q 047969 543 KELRPSMEEVLAE 555 (625)
Q Consensus 543 P~~RPs~~ell~~ 555 (625)
|++|||++|+++|
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999998
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=280.97 Aligned_cols=241 Identities=27% Similarity=0.383 Sum_probs=194.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 355 (625)
..+|..+.+||+|+||.|-+|..+ +...+|||+++++-. ..++--+.|-++|.... -|.++.+..++.. -+++|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhhee
Confidence 357888999999999999999876 567799999876522 23444577888888774 5677788775554 67899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
.||||+.||+|...++ +-+.+.+..+.-++.+|+-||-+||++||+.||||.+|||+|.+|++||+|||+++.--.
T Consensus 427 FVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999988886 456688889999999999999999999999999999999999999999999999985321
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
......+.+||+.|+|||++.-.+|+...|.||+||+||||+.|++||++.+.... ...|.+...
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~ehnv------- 567 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIMEHNV------- 567 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHccC-------
Confidence 22334567899999999999988999999999999999999999999987654321 112222111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCC
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRP 547 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 547 (625)
..++.++.+..++....|.+.|.+|.
T Consensus 568 ------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 ------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 12345677888999999999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=282.73 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=206.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCc-EEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGR-EVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
..+++++..||-||||.|=+++.+..+ .+|+|++++. +....+.+..|-+||...+.|.||++|. ...+.+.+|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr-Tfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR-TFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH-Hhccchhhhh
Confidence 356777888999999999999876433 4899988654 3345567889999999999999999998 5555788999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
+||-|-||.|...|. +.+.++...+..++..+++|++|||++|||.|||||+|.|+|.+|-+||.|||+|+.....
T Consensus 498 LmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999995 6677899999999999999999999999999999999999999999999999999987533
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
...-+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||...++.. ..+.+++-+..-
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---tYn~ILkGid~i---------- 638 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---TYNLILKGIDKI---------- 638 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHhhhhhh----------
Confidence 22345789999999999988889999999999999999999999998765432 223333322221
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L~ 557 (625)
+.++.+.....++|+++...+|.+|.. +.++.+|-+
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 123456677888999999999999965 666666643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=273.61 Aligned_cols=266 Identities=21% Similarity=0.255 Sum_probs=197.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-C-C----Ceeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-H-K----NLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~ 353 (625)
+++|++...||+|.||.|-...+. .+..||||+++.- ....+..+-|+++|.++. + | -+|.+.+ +++..++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~-wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRD-WFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh-hhhccCc
Confidence 689999999999999999998755 5788999988544 234466678999999993 2 2 2556656 4556788
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---------------
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS--------------- 418 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~--------------- 418 (625)
.+||+|.+ |.++.++|..+ ...+++...+..|+.|+++++++||+.+++|-||||+|||+..
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 99999998 56999999743 4456888999999999999999999999999999999999931
Q ss_pred -----CCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccccc
Q 047969 419 -----NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI 493 (625)
Q Consensus 419 -----~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~ 493 (625)
+-.++|+|||.|....... ...+.|..|+|||++.+-.++..+||||+||||.||.+|...|......+.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2358999999998743322 4556799999999999999999999999999999999999999876644433
Q ss_pred chhHHHHHHhhhcccccc----------cC---CcCCC------C-ChHH------HHHHHHHHHHHHHHhcccCCCCCC
Q 047969 494 NLANLAINKIQKCAFDEL----------ID---PCLGF------E-SDEE------VKRMTTSVAELAFLCLQQNKELRP 547 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~----------~~---~~~~~------~-~~~~------~~~~~~~l~~li~~cl~~~P~~RP 547 (625)
...+.+...+........ +| ..... + ..+. .......+.+|+++||..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 222222222111111100 00 00000 0 0000 011233688999999999999999
Q ss_pred CHHHHHHH
Q 047969 548 SMEEVLAE 555 (625)
Q Consensus 548 s~~ell~~ 555 (625)
|+.|++.|
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=248.83 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=167.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++...+..||+|++|.|-+-++. +|...|+|++... +.+..++.++|+.+..+. ..|.+|++||...+ ...++|.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEeH
Confidence 34455678999999999988876 8999999998543 334556788898887766 69999999996666 45689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|.|+- +|..+......+++.+++..+-+|+..+.+||.|||++ .++|||+||+||||+.+|++|++|||++..+..+.
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 99964 88877766666888999999999999999999999988 89999999999999999999999999997654332
Q ss_pred cccccCCCCCCCccCcccccc----CCCCCchhhhhHHHHHHHHHhCCCCCcc
Q 047969 438 THVSTAPQGTPGYVDPEYHQC----YQLTDKSDVYSFGVVLIELISSMPAVDM 486 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwslG~il~elltG~~p~~~ 486 (625)
.. +...|...|||||.+.. ..|+-|+||||||+++.||.+++.|++.
T Consensus 204 Ak--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 AK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 22 22458899999998753 3689999999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=261.97 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=195.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 354 (625)
..++|.++++||+|+|+.|.+++++ +.+.+|+|++++. +.+.++-...|-.+..+- +||.+|-+..|+.. ..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceE
Confidence 3578999999999999999999976 6788999998653 223445556677777666 69999999986665 5678
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
+.|.||++||+|.-.+. +...|+++.+..+..+|.-||.|||++||+.||||.+|+|+|..|++||+|+|+++.--
T Consensus 327 ffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999987775 44569999999999999999999999999999999999999999999999999998532
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccc-cccchhHHHHHHhhhcccccccC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHR-HEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
. ......+.+||+.|+|||++++..|....|.|+|||+++||+.|+.||+.-.-+ .+.+-......-+.+..
T Consensus 403 ~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------ 475 (593)
T KOG0695|consen 403 G-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------ 475 (593)
T ss_pred C-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence 2 223345678999999999999999999999999999999999999999854321 22222222222222111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP 547 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 547 (625)
+.. ++.++-....+++.-|++||.+|.
T Consensus 476 --iri-----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 --IRI-----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --ccc-----cceeehhhHHHHHHhhcCCcHHhc
Confidence 111 122344556688899999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=261.85 Aligned_cols=239 Identities=33% Similarity=0.454 Sum_probs=191.0
Q ss_pred CcEEEEEEEEc-CCcEEEEEEeccccHHH-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhc
Q 047969 294 GFGTVYYGKLK-DGREVAVKRLYDNNYRR-VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371 (625)
Q Consensus 294 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 371 (625)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....+++|||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence 68999999987 58999999987654433 6789999999999999999999996665 467899999999999999985
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCcc
Q 047969 372 GDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451 (625)
Q Consensus 372 ~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~ 451 (625)
.. ..+++..++.++.+++++|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 80 ~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 80 KR----GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred hc----cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 32 238999999999999999999999999999999999999999999999999998764432 223455788999
Q ss_pred CccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHH
Q 047969 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSV 531 (625)
Q Consensus 452 aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 531 (625)
+||.+....++.++|||+||+++++|++|..||...... ......+....... ......++.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPF----------PPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCC----------ccccccCCHHH
Confidence 999998878899999999999999999999999653211 11111111111110 00000144578
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 047969 532 AELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 532 ~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+++.+||..+|++||++.+++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhhC
Confidence 899999999999999999999973
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=250.07 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=195.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeee-eccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTS-RYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-~~~~~~~lv 357 (625)
.++|++.+++|+|.++.||.|..- +...++||++++-. .+.+.+|+.||..|. ||||+++++... ..++...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 468999999999999999999854 77889999987553 356789999999997 999999999553 345667899
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccccccCCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLD 436 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~~~~~ 436 (625)
+||+++.+...+.. .|+...+...+.++++||.|+|++||+|||+||+|+|||.. ..++|+|+|||.++...
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999877666552 47788889999999999999999999999999999999964 56999999999987543
Q ss_pred ccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCccc-ccccccchhHHHH------HHhhhcc-
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMN-RHRHEINLANLAI------NKIQKCA- 507 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~-~~~~~~~~~~~~~------~~~~~~~- 507 (625)
. .....+.+..|.-||++... .|+..-|+|||||+|..|+..+.||-.. ....+.-.....+ .-+.+..
T Consensus 187 ~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 K--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred c--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 2 23445667888999988765 4788899999999999999988887432 2222111111111 0111111
Q ss_pred -----cccccCCcCCCC-----ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 -----FDELIDPCLGFE-----SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 -----~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+.+++....... ..+...-.+++..+|+.++|..|-.+|+|++|.+.|
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111111111110 111112235788999999999999999999999886
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=291.16 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=186.7
Q ss_pred CCccceecccCcEE-EEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEec
Q 047969 284 FSREKELGDGGFGT-VYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 284 ~~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
|.-.+.+|.|..|+ ||+|.+ +|+.||||++.... .+...+|+..|+.- +|||||++|+ .....+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc-~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYC-SEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEe-eccCCceEEEEehHh
Confidence 33456789999986 699998 48999999986443 23457899999998 5999999998 555577889999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-----CCeEEEcccccccccCCC
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-----NFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-----~~~~kl~DFgla~~~~~~ 436 (625)
.. +|.+++...........-...+.++.|+++||++||+.+||||||||.||||+. ..+++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 64 999999753111111222455788999999999999999999999999999965 357999999999988655
Q ss_pred ccccc--cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 437 VTHVS--TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 437 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... ....||-+|+|||++....-+.+.|||||||++|+.++| ..||...-.++. .|..+...-.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------NIl~~~~~L~-- 733 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------NILTGNYTLV-- 733 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------hhhcCcccee--
Confidence 44333 456799999999999888778899999999999999885 999975432210 1111111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....... . +..+||.+|+..+|..||++.+|+.|
T Consensus 734 ---~L~~~~d--~---eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 ---HLEPLPD--C---EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---eeccCch--H---HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0011111 1 67789999999999999999999976
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=258.77 Aligned_cols=270 Identities=23% Similarity=0.333 Sum_probs=195.4
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee----ccceEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR----YSQGLL 355 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~ 355 (625)
+.+-.+.||.|+||.||.+.+. +|+.||+|++..- +....+++.+|+++|.-++|.|++..++.... .-+.+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556789999999999999866 8999999998432 33445788999999999999999988774321 123467
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+++|+|.. +|...+. ..+.|+.+.+.-++.||++||+|||+.+|.||||||.|+|++.+-.+||+|||+|+....
T Consensus 134 V~TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 88888753 5655553 556788899999999999999999999999999999999999999999999999998765
Q ss_pred CccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH--------Hhhhc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN--------KIQKC 506 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 506 (625)
+.....+..+-|..|+|||++.+. .|+.+.||||.|||+.||+..+-.|.....-....+...... .-.++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555444555678899999998764 699999999999999999998888865544333322221111 00011
Q ss_pred ccccccCCcCCCCChHH------HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 507 AFDELIDPCLGFESDEE------VKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.-..+++...+...... ...-..+...+..+++..+|++|.+.++.+.++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111000000000 0011224556788999999999999999988753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=271.65 Aligned_cols=202 Identities=27% Similarity=0.414 Sum_probs=170.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
-|..++.||-|+||.|.+++.. +...+|+|.+.+.+. ..+.....|-.||..-+.+=||+||..+. +++.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ-DkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec-cCCceEEEE
Confidence 4778899999999999999754 456799999876543 23455678999999999999999998554 478899999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC--
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD-- 436 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~-- 436 (625)
+|++||++..+|. +.+.+.+..+..++.++..|+++.|..|+|||||||+|||||.+|++||+||||+.-+.-.
T Consensus 709 dYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999885 6678999999999999999999999999999999999999999999999999998644210
Q ss_pred ------ccc---------------------------------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHH
Q 047969 437 ------VTH---------------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477 (625)
Q Consensus 437 ------~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~el 477 (625)
..+ .....+||+.|+|||++....++..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000 00112499999999999988999999999999999999
Q ss_pred HhCCCCCccccc
Q 047969 478 ISSMPAVDMNRH 489 (625)
Q Consensus 478 ltG~~p~~~~~~ 489 (625)
+.|++||.....
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999976654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.53 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=209.8
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeee
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTS 348 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 348 (625)
++.....+++....+-+|.||.||.|.+. +.+.|-+|.++.. +.-....++.|.-.+..+.|||+..+.++..
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444567888888999999999999654 3455778877543 3445678999999999999999999999888
Q ss_pred eccceEEEEEEeccCCChHHHhccCc----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 349 RYSQGLLLVYEFVANGTVADQLHGDR----AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 349 ~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
+.....+++|.++.-|+|..+|..-+ ...+.++..+...++.|++.|++|||.+||||.||...|.+||+..++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 87888899999999999999997322 23345788888999999999999999999999999999999999999999
Q ss_pred ccccccccc-CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHH
Q 047969 425 ADFGLSRLF-PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 425 ~DFgla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+|=.+++.. +.+-............||+||.+....|+.++|||||||+||||+| |+.|+...++.+. ...
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHY 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHH
Confidence 999999864 3332222333446789999999999999999999999999999998 8888864432210 111
Q ss_pred hhhc-ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 503 IQKC-AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 503 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
+.++ ++.+ +-.+++++..++.-||...|++||+++|++.-|.++.
T Consensus 511 lkdGyRlaQ-------------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 511 LKDGYRLAQ-------------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HhccceecC-------------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 1111 1111 1245678899999999999999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.28 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=205.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|+.+..+|.|.||.||+|+++ .++..|+|+++........-+.+|+-+++..+|||||.++|.+.. ...++|.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEE
Confidence 3468999999999999999999976 789999999977666666778899999999999999999996655 56689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.||+|.+..+ ..+++++.++..+.++.++||+|||++|-+|||||-.||++++.|.+|++|||.+..+.....
T Consensus 92 EycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999876 567899999999999999999999999999999999999999999999999999876643322
Q ss_pred ccccCCCCCCCccCcccc---ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 439 HVSTAPQGTPGYVDPEYH---QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
......||+.|||||+. +.+.|..++|||++|++..||..-++|........ ....+.+..+.. +
T Consensus 168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS~~qp---p- 235 (829)
T KOG0576|consen 168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKSGFQP---P- 235 (829)
T ss_pred -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhccCCCC---C-
Confidence 23556799999999975 45679999999999999999988777753222111 111111111111 1
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+..+.+..+.+|++.+|.++|.+||+++.++.|
T Consensus 236 ----~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 236 ----TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ----cccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111122456688999999999999999999988753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=257.11 Aligned_cols=132 Identities=26% Similarity=0.383 Sum_probs=111.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-----C---CCeeeeeeeee---
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-----H---KNLVSLFGCTS--- 348 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~--- 348 (625)
..+|.+.++||.|.|++||+|.+. +.+.||+|+++.. ..-.+..+.||++|++++ | .+||++++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999866 6788999998544 344567789999999994 3 36999999653
Q ss_pred eccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEE
Q 047969 349 RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILL 416 (625)
Q Consensus 349 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll 416 (625)
..+.+++||+|++ |.+|..+|..... +-++...+.+|+.||+.||.|||++ ||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 3567899999998 6689999875433 3489999999999999999999988 99999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=236.06 Aligned_cols=211 Identities=41% Similarity=0.672 Sum_probs=180.8
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChH
Q 047969 290 LGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVA 367 (625)
Q Consensus 290 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~ 367 (625)
||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|+++++++++... ....+++||++.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence 689999999999986 4899999998665432 35678999999999999999999996655 46789999999999999
Q ss_pred HHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEcccccccccCCCccccccCCCC
Q 047969 368 DQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQG 446 (625)
Q Consensus 368 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~g 446 (625)
+++.... ..+++..++.++.+++++|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 9985321 46899999999999999999999999999999999999999 89999999999987643321 1233457
Q ss_pred CCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHH
Q 047969 447 TPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVK 525 (625)
Q Consensus 447 t~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (625)
...|++||..... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999998776 788899999999999998
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 526 RMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 526 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2567799999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=246.97 Aligned_cols=264 Identities=25% Similarity=0.310 Sum_probs=194.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cce
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQG 353 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 353 (625)
.+|..++.+|.|.- .|-.|.+. .++.||+|++... +....++..+|...+..++|+||++++.++... ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888899999999 66666544 7899999987432 233456678999999999999999999965432 234
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.|+|||+|.. +|.+.+.. .++=+.+..|+.|++.|++|||+.||+||||||+||++..+..+||.|||+|+..
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 7999999964 88887751 2566788899999999999999999999999999999999999999999999864
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH--------Hhh-
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN--------KIQ- 504 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~- 504 (625)
..+ -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|.+...-........... ++.
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 333 344667889999999999988899999999999999999999988875443222211111100 000
Q ss_pred ----------h---cccccc-cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 505 ----------K---CAFDEL-IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 505 ----------~---~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+ -.+.+. .|.......+.. +.-.....+++.+||..+|++|-|++++|.|-
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0 000000 010000000000 12234677899999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=259.92 Aligned_cols=196 Identities=23% Similarity=0.364 Sum_probs=163.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH--------HHHHHHHHHHHHHhcC---CCCeeeeeeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR--------RVEQFMNEVEILTRLR---HKNLVSLFGCTS 348 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 348 (625)
..+|+.++.||.|+||.|++|.++ +...|+||.+.+...- ..-.+-.|++||..++ |+||+++++++.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356999999999999999999987 5667999988654321 1122457999999997 999999999665
Q ss_pred eccceEEEEEEec-cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 349 RYSQGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 349 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
+ .+.+||+||-- +|.+|.+++. ....+++.++..|+.||+.|+++||++||||||||-+|+.++.+|-+||+||
T Consensus 640 d-dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 D-DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred c-CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 5 67789999964 4668999996 4557999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccCccccccCCCCC-chhhhhHHHHHHHHHhCCCCC
Q 047969 428 GLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTD-KSDVYSFGVVLIELISSMPAV 484 (625)
Q Consensus 428 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~sDvwslG~il~elltG~~p~ 484 (625)
|.|.... .......+||.+|.|||++.+..|-- .-|||++|++||.++....|+
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9987542 22334568999999999999987755 479999999999988766665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=234.63 Aligned_cols=253 Identities=17% Similarity=0.274 Sum_probs=189.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+.|.+.+.||+|-||.+-+++++ +.+.+++|.+... .....+|.+|..---.| .|.||+.-|++.++..+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 468999999999999999999988 5677999987543 45567899998776666 48999999987777677888999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC--CCCeEEEcccccccccCCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD--SNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~--~~~~~kl~DFgla~~~~~~ 436 (625)
||++.|+|..-+.. ..+.+....+++.|++.||.|+|++++||||||.+||||- +..++||+|||+.+..+..
T Consensus 102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999888742 3478888899999999999999999999999999999993 3458999999998754322
Q ss_pred ccccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
. ....-+..|.+||.... ....+.+|||.||++++..++|.+||.... ..+....++. ...+...
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~--~w~~rk~--- 246 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWE--QWLKRKN--- 246 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHH--HHhcccC---
Confidence 1 11224577999996532 245678999999999999999999997332 2222222222 1111111
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...+...+.++..+..+.++-|..++++|=-..++.++
T Consensus 247 ------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 ------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 12223345566777888999999999999444444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=235.16 Aligned_cols=199 Identities=36% Similarity=0.554 Sum_probs=170.1
Q ss_pred CCccceecccCcEEEEEEEEcC-CcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 284 FSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
|++.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.. ....++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence 5677899999999999999874 889999998765544 56788999999999999999999996554 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++.... ..+++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999986322 1178999999999999999999999999999999999999999999999999987654421122
Q ss_pred cCCCCCCCccCcccc-ccCCCCCchhhhhHHHHHHHHHhCCCCCcc
Q 047969 442 TAPQGTPGYVDPEYH-QCYQLTDKSDVYSFGVVLIELISSMPAVDM 486 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~-~~~~~s~~sDvwslG~il~elltG~~p~~~ 486 (625)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578899999988 666778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=252.90 Aligned_cols=270 Identities=22% Similarity=0.240 Sum_probs=202.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC------CCCeeeeeeeeeeccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR------HKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 352 (625)
.-.+|.+....|+|-|++|..|+.. -|..||||++..+. .-.+.-+.|++||++|+ --|+++++..|. +.+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-hkn 507 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-HKN 507 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh-hcc
Confidence 3468999999999999999999866 58899999996553 33455678999999995 237888887444 478
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSR 431 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~ 431 (625)
++|||+|-+. .+|.+.|+... ++-.|....+..++.|+.-||..|-..||+|.||||.||||++. ..+||||||.|.
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 9999999874 58999987543 33347888999999999999999999999999999999999875 568999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH-----Hhhhc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN-----KIQKC 506 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~-----~~~~~ 506 (625)
...... .+.+.-+..|.|||++.+..|+...|+||.||+||||+||+..|.+......+.+...... .+.++
T Consensus 586 ~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 586 FASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 754332 2334456789999999999999999999999999999999999976654333322222211 11222
Q ss_pred cccc-ccCCcC---------------------------------C-CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047969 507 AFDE-LIDPCL---------------------------------G-FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551 (625)
Q Consensus 507 ~~~~-~~~~~~---------------------------------~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 551 (625)
.|.+ -.|..+ . .....+.......+.+|+.+||..||++|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 2111 000000 0 0011122345568999999999999999999999
Q ss_pred HHHHH
Q 047969 552 VLAEL 556 (625)
Q Consensus 552 ll~~L 556 (625)
.|+|-
T Consensus 743 AL~Hp 747 (752)
T KOG0670|consen 743 ALKHP 747 (752)
T ss_pred HhcCC
Confidence 99863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=242.98 Aligned_cols=270 Identities=26% Similarity=0.401 Sum_probs=195.1
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeec
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRY 350 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 350 (625)
++....+.|..+++||+|.|++||+|.+. ..+.||+|.+.... ...++.+|+++|..+. +.||+++.+++. .
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r-n 106 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR-N 106 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc-c
Confidence 34556678999999999999999999743 46789999986654 3356889999999995 899999999544 4
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGL 429 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgl 429 (625)
++...+|+||++.....+++. .++..++..+++.++.||+++|.+|||||||||+|+|.+. .++-.|+||||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechh
Confidence 677899999999998888874 2678899999999999999999999999999999999974 57789999999
Q ss_pred ccccCCCc-------------cc------------------------------cccCCCCCCCccCcccccc-CCCCCch
Q 047969 430 SRLFPLDV-------------TH------------------------------VSTAPQGTPGYVDPEYHQC-YQLTDKS 465 (625)
Q Consensus 430 a~~~~~~~-------------~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~s~~s 465 (625)
|....... .. ......||++|+|||++.. ..-+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221000 00 0012359999999998854 4578899
Q ss_pred hhhhHHHHHHHHHhCCCCCccccccccc--chhHHH-HHHhhhc-------------c----------cccc-cCCcCC-
Q 047969 466 DVYSFGVVLIELISSMPAVDMNRHRHEI--NLANLA-INKIQKC-------------A----------FDEL-IDPCLG- 517 (625)
Q Consensus 466 DvwslG~il~elltG~~p~~~~~~~~~~--~~~~~~-~~~~~~~-------------~----------~~~~-~~~~~~- 517 (625)
||||.|||++.+++++.||-.....-+. .+.... ...+++. + +..+ ...+.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999998533221111 000000 0111110 0 0000 000000
Q ss_pred ----CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 ----FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..........+..+.+++.+||..||.+|-|+++.|+|
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01111122344478899999999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=228.97 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=193.6
Q ss_pred CCCccceecccCcEEEEEEEEcCC--cEEEEEEeccccHHHHHHHHHHHHHHHhcCC----CCeeeeeeeeeeccceEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDG--REVAVKRLYDNNYRRVEQFMNEVEILTRLRH----KNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~l 356 (625)
+|++.++||+|+||.||++..... ..+|+|............+..|..++..+.. .++..+++.........+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997643 4789998755433222267789999999873 5777887744333556799
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-----CeEEEccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-----FCVKVADFGLSR 431 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-----~~~kl~DFgla~ 431 (625)
||+.+ |.+|.++..... .+.++...++.|+.|++.+|++||+.|++||||||.|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 99988 779999875332 5679999999999999999999999999999999999999754 469999999999
Q ss_pred --ccCCCccc----c---ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH
Q 047969 432 --LFPLDVTH----V---STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 432 --~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
.+...... . ....+||..|.+++.+.+...+.+.|+||++.++.+|+.|..||..................
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 43222211 1 12345999999999999999999999999999999999999999654322211111111110
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
.. ... . ....+.++.++...+-..+..++|....+.+.|+......
T Consensus 256 ---~~----~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 ---LL----TDR-F-------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---hc----ccc-c-------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 000 0 0112335555666666689999999999999987765543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=215.07 Aligned_cols=262 Identities=15% Similarity=0.207 Sum_probs=203.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e 359 (625)
-+|++.++||+|.||+.+.|++- +++.||||.-.. ..+.-++..|.+..+.|. .++|..+|. +...+.+-.||||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYY-FGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYY-FGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceee-eccccchhhhhhh
Confidence 37999999999999999999855 899999996432 234467788999999995 688888887 4455677789999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-----CCeEEEcccccccccC
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-----NFCVKVADFGLSRLFP 434 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-----~~~~kl~DFgla~~~~ 434 (625)
++ |.+|.|++. .-+..++.+.+..+|.|++.-++|+|++.+|.|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 105 LL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 98 779999885 34556999999999999999999999999999999999999964 3468999999999886
Q ss_pred CCccccc------cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 435 LDVTHVS------TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 435 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
...+... ...-||.+||+-..+.+..-+.+.|+-|||-+++++|.|..||.+..........+.+-..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~------ 254 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET------ 254 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc------
Confidence 5544332 3345999999999999999999999999999999999999999865432221111111111
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.-.....+....++.++...+.-.-..+-++-|..+-+...+..+...
T Consensus 255 ------Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 255 ------KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ------cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 111122344456777777777777778888889988887777665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=229.96 Aligned_cols=166 Identities=22% Similarity=0.190 Sum_probs=130.2
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhcCCCCeee-eeeeee
Q 047969 277 LAEATNDFSREKELGDGGFGTVYYGKLK--DGREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLVS-LFGCTS 348 (625)
Q Consensus 277 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~ 348 (625)
.....++|++.+.||+|+||+||+|+++ +++.||||++... .....+.|.+|+++|++++|+|+++ +++ .
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-
Confidence 3445678999999999999999999875 5777899986532 2234567899999999999999985 443 1
Q ss_pred eccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCCEEECCCCeEEEccc
Q 047969 349 RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDV-KTNNILLDSNFCVKVADF 427 (625)
Q Consensus 349 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDi-kp~NIll~~~~~~kl~DF 427 (625)
...+|||||++|++|.. +. ..+ ...++.|+++||.|||++||+|||| ||+|||++.++.+||+||
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 34699999999999963 21 111 1467889999999999999999999 999999999999999999
Q ss_pred ccccccCCCccccc-------cCCCCCCCccCcccccc
Q 047969 428 GLSRLFPLDVTHVS-------TAPQGTPGYVDPEYHQC 458 (625)
Q Consensus 428 gla~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 458 (625)
|+|+.+........ ....+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99997654321111 34568889999998854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=263.86 Aligned_cols=197 Identities=18% Similarity=0.242 Sum_probs=136.6
Q ss_pred cCC-CCeeeeeeeee------eccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 047969 335 LRH-KNLVSLFGCTS------RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407 (625)
Q Consensus 335 l~h-~niv~~~~~~~------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 407 (625)
++| .||+++++.+. ...+.++.+||++ +++|.++|.. ....+++..++.++.||++||+|||++||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 344 45666665331 1124567788987 5699999963 23459999999999999999999999999999
Q ss_pred CCCCCCEEECC-------------------CCeEEEcccccccccCCCc---------------cccccCCCCCCCccCc
Q 047969 408 DVKTNNILLDS-------------------NFCVKVADFGLSRLFPLDV---------------THVSTAPQGTPGYVDP 453 (625)
Q Consensus 408 Dikp~NIll~~-------------------~~~~kl~DFgla~~~~~~~---------------~~~~~~~~gt~~y~aP 453 (625)
||||+||||+. ++.+||+|||+++...... ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 4456677777765421100 0001123588999999
Q ss_pred cccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHH
Q 047969 454 EYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAE 533 (625)
Q Consensus 454 E~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 533 (625)
|++.+..++.++|||||||+||||++|.+|+..... ....+..... .+ ..... .....+
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~~~----~~-------~~~~~-~~~~~~ 243 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHRVL----PP-------QILLN-WPKEAS 243 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHhhc----Ch-------hhhhc-CHHHHH
Confidence 999888999999999999999999999888642210 0111111000 00 00011 123457
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 047969 534 LAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 534 li~~cl~~~P~~RPs~~ell~~L 556 (625)
++.+||+.+|.+||++.|++++-
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhch
Confidence 88999999999999999998763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=208.54 Aligned_cols=169 Identities=22% Similarity=0.297 Sum_probs=127.9
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccC
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 443 (625)
|+|.+++.. .+..+++..++.|+.||++||.|||+++ ||+|||++.++.+|+ ||+++..... .
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~ 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------Q 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------c
Confidence 688898853 2456999999999999999999999998 999999999999999 9999865332 1
Q ss_pred CCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHH
Q 047969 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (625)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............ .+ .....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~------~~----~~~~~ 131 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD------DP----RDRSN 131 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC------Cc----ccccc
Confidence 2588999999999998999999999999999999999999864322110 111111111100 00 00011
Q ss_pred HHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 524 VKRMTT--SVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 524 ~~~~~~--~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...... .+.+++.+||+.+|++||++.|+++++..+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 223333 68999999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=206.13 Aligned_cols=263 Identities=19% Similarity=0.225 Sum_probs=202.9
Q ss_pred hcCCCccceecccCcEEEEEEEE-cCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH-KNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+.|+++++||.|+||.+|.|.. .+|.+||||+-... ....++..|.++.+.|++ ..|..+.. +..+...-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~-y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRH-YGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhh-hccccccceeee
Confidence 46899999999999999999984 58999999985433 223467789999999975 45655555 334466678999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~~~~~ 435 (625)
+++ |.+|.+++.- -...++.++++-++-|++.-++|+|.++++||||||+|+|..- ..++.|+|||||+.+..
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 7799998853 3345889999999999999999999999999999999999963 45799999999998754
Q ss_pred Ccccc------ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 436 DVTHV------STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 436 ~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
..+.. .....||.+|.+-..+.+..-+.+.|+-|+|.+|..+..|..||.+..........+.+.++
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek------- 239 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK------- 239 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-------
Confidence 33322 13346999999999888888899999999999999999999999876544333333322222
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.++...+...+.++.++.-.+.-|-..--++-|...-+.+.+..+...
T Consensus 240 -----K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 240 -----KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred -----hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 122223344556777888889999999999999988888877665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-22 Score=206.42 Aligned_cols=261 Identities=32% Similarity=0.510 Sum_probs=195.8
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeccccHH---HHHHHHHHHHHHHhcCCC-CeeeeeeeeeeccceEEEEEE
Q 047969 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR---RVEQFMNEVEILTRLRHK-NLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e 359 (625)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++.+ ......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-QDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCEEEEEEe
Confidence 677889999999999999986 78999988654322 467899999999999988 799999966 33445799999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~~~~~~~ 438 (625)
++.++++.+++...... ..+.......++.|++.++.|+|+.+++||||||+||+++..+ .++++|||+++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999776432111 3689999999999999999999999999999999999999988 799999999986544332
Q ss_pred c-----cccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 439 H-----VSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 439 ~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
. ......|+..|+|||.+.+ ..++...|+|++|++++++++|..|+...... .........+.......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPS 234 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCcc
Confidence 2 2355679999999999887 57888999999999999999999997544321 00111112211111110
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.... ...... ......+.+++..++..+|..|.+..+....
T Consensus 235 ~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASP-LSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccc-cCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000 000000 2223467789999999999999998887765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-23 Score=196.57 Aligned_cols=173 Identities=13% Similarity=0.140 Sum_probs=133.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH---HHHHH------HHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY---RRVEQ------FMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
..++|++++.||.|+||.||++.. +++.+|||++.+... ...+. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 458999999999999999999766 577899999864422 22222 67999999999999999888754322
Q ss_pred -------cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEE
Q 047969 351 -------SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423 (625)
Q Consensus 351 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~k 423 (625)
....+|||||++|.+|.++.. +++ ....+++.+|..+|+.|++||||||+||+++.+| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 235789999999999988742 232 2456999999999999999999999999999988 99
Q ss_pred EcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh
Q 047969 424 VADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479 (625)
Q Consensus 424 l~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt 479 (625)
|+|||.......+.... .+.....+..++|+|+||+++..+..
T Consensus 175 liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHHH
Confidence 99999886542211110 02333446679999999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=226.58 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=189.1
Q ss_pred CccceecccCcEEEEEEEEc-CCcEEEEEEec----cc-cHHH-HHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 285 SREKELGDGGFGTVYYGKLK-DGREVAVKRLY----DN-NYRR-VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
...+.+|.|++|.|+.+... ..+..+.|... .. .... ...+..|+-+-..++|+|++..+....+... ..-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence 34578999999988877644 33434444332 11 1111 2226678888888999999887764444333 3334
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++ +|..++.. .+.++...+..++.|++.|++|||..||.|||||++|+++..+|.+||+|||.+..+....
T Consensus 400 mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 999999 99999853 3468899999999999999999999999999999999999999999999999998765433
Q ss_pred c---ccccCCCCCCCccCccccccCCCCCc-hhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 438 T---HVSTAPQGTPGYVDPEYHQCYQLTDK-SDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 438 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
. .......|+..|+|||++.+..|.+. .||||.|+++..|++|+.||............... . ..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------~--~~ 543 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------S--DQ 543 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------c--cc
Confidence 3 34456789999999999999888875 69999999999999999999765544332100000 0 00
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.............++.+.+.+|.++|+.+|.+|-|+++|++.
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 011122334456677888899999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=191.68 Aligned_cols=139 Identities=18% Similarity=0.164 Sum_probs=108.3
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHH--H-------H-----------------HHHHHHHHHHHhcCCCCe
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR--R-------V-----------------EQFMNEVEILTRLRHKNL 340 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 340 (625)
...||+|+||.||+|...+|+.||||++...... . . ....+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998644211 0 0 122459999999988776
Q ss_pred eeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCCEEECCC
Q 047969 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL-HASDIIHRDVKTNNILLDSN 419 (625)
Q Consensus 341 v~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~ivHrDikp~NIll~~~ 419 (625)
........ .. .+|||||++|+++...+. ....+++..+..++.|++.+|.+| |+.||+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~-~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KS-HVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cC-CEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C
Confidence 43332111 12 389999999887655432 234688999999999999999999 699999999999999998 4
Q ss_pred CeEEEccccccccc
Q 047969 420 FCVKVADFGLSRLF 433 (625)
Q Consensus 420 ~~~kl~DFgla~~~ 433 (625)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=182.84 Aligned_cols=140 Identities=19% Similarity=0.149 Sum_probs=110.5
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHH--------------------------HHHHHHHHHHHHHhcCCCCe
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR--------------------------RVEQFMNEVEILTRLRHKNL 340 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 340 (625)
.+.||+|++|.||+|++.+|+.||||++...... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999998643210 01234679999999999987
Q ss_pred eeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCC
Q 047969 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSN 419 (625)
Q Consensus 341 v~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~ 419 (625)
.....+... ..+|||||++|+++..... ....++...+..++.|++.+|.+||+ .||+||||||+|||++ +
T Consensus 82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK---KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec---CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 443332222 2389999999886544321 22357888999999999999999999 9999999999999999 8
Q ss_pred CeEEEcccccccccC
Q 047969 420 FCVKVADFGLSRLFP 434 (625)
Q Consensus 420 ~~~kl~DFgla~~~~ 434 (625)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-22 Score=219.53 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=180.2
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEecccc-H---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNN-Y---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++...+.||.+.|=.|.+|+++.|. |+||++.+.+ . +...+.+.|++ .+.++|||++++.-+ ....+..|||=
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHHH
Confidence 6777889999999999999998887 9999985543 2 23334445555 566699999988763 33345567888
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc--CCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLD 436 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~--~~~ 436 (625)
+|+.+ +|.|.+. ..+.|...+...|+.|++.||..+|..||+|||||.+||||+.-+-+.|+||..-+.. +.+
T Consensus 101 qyvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 88865 8888884 5566888888999999999999999999999999999999999999999999877643 222
Q ss_pred ccccc----cCCCCCCCccCccccccC----------C-CCCchhhhhHHHHHHHHHh-CCCCCccccc---c-cccchh
Q 047969 437 VTHVS----TAPQGTPGYVDPEYHQCY----------Q-LTDKSDVYSFGVVLIELIS-SMPAVDMNRH---R-HEINLA 496 (625)
Q Consensus 437 ~~~~~----~~~~gt~~y~aPE~~~~~----------~-~s~~sDvwslG~il~ellt-G~~p~~~~~~---~-~~~~~~ 496 (625)
+.... .+...-..|+|||.+... . .+++.||||+||+++||++ |+++|.-... + ......
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 22211 122344679999976431 1 6778999999999999997 8999963210 0 001111
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
+..++++. ...+++++..|++.||++|.++++.|+.-+++
T Consensus 256 e~~Le~Ie-----------------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 256 EQLLEKIE-----------------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHHHhCc-----------------------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11111111 12567899999999999999999999875443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=176.07 Aligned_cols=185 Identities=15% Similarity=0.121 Sum_probs=138.9
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeccccHH----HHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEE
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR----RVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.+...|++|+||+||.+.. ++.+++.+.+.....- ....+.+|+++|++|. |+++++++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEe
Confidence 3457899999999998776 6888888877554321 1235789999999995 5789998874 23589999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDV-KTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDi-kp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|+.|.+|.+.+. . . ...++.|++++|+++|++||+|||| ||+|||++.++.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~----~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPP----R------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhh----h------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998865431 1 1 1347889999999999999999999 79999999999999999999985443221
Q ss_pred c----c--------ccCCCCCCCccCccccccC-CCC-CchhhhhHHHHHHHHHhCCCCCcc
Q 047969 439 H----V--------STAPQGTPGYVDPEYHQCY-QLT-DKSDVYSFGVVLIELISSMPAVDM 486 (625)
Q Consensus 439 ~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~sDvwslG~il~elltG~~p~~~ 486 (625)
. . ......++.|++|+...-. ..+ .+.+.++-|..+|.++|+..+.-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0112368888988855322 223 467889999999999998877643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=183.61 Aligned_cols=249 Identities=17% Similarity=0.342 Sum_probs=183.2
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
...+.+|.+...|..|+|+++ |..+++|++.-. ..+...+|..|.-.|+-+.||||+.++|.+.. ..++.++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeec
Confidence 344567999999999999996 666777776432 33445679999999999999999999997766 46788999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC-Cccc-CCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-IIHR-DVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-ivHr-Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
+.|+|...|++. ..-.++-.++.+++.+|++|++|||+.. ++-| -|....++||++.+.+|.- +-+++ +-
T Consensus 270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kf-----sf 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SF 341 (448)
T ss_pred cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-cccee-----ee
Confidence 999999999854 2334677788999999999999999984 4444 6899999999998877641 11111 00
Q ss_pred cccCCCCCCCccCccccccCCC---CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQL---TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~---s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
......-.+.||+||.++..+. -.++|+|||++++|||.|...||..-...+ .-.++..+-+ ..
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------cgmkialegl----rv-- 408 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------CGMKIALEGL----RV-- 408 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------hhhhhhhccc----cc--
Confidence 1122234688999999876543 347899999999999999999996432211 0011111100 10
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
..+.+++..+..++.-|+..||.+||.+..++-.|++++
T Consensus 409 -----~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 -----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 112245667888999999999999999999999988764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-21 Score=188.75 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=150.5
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCC----------CC------eee
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRH----------KN------LVS 342 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~n------iv~ 342 (625)
.+...+.||.|+++.||.+.+. +|+++|||++... .....+++.+|.-....+.+ -. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456678999999999999987 6899999987432 22346677777655544322 11 222
Q ss_pred eee---eeeecc--c-----eEEEEEEeccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 047969 343 LFG---CTSRYS--Q-----GLLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHRDV 409 (625)
Q Consensus 343 ~~~---~~~~~~--~-----~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDi 409 (625)
+-+ +..... . ..+++|+-+. ++|.+.+..... ....+....++.+..|+++.+++||..|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 221 111111 1 2366777774 578777542111 1223445566778899999999999999999999
Q ss_pred CCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCcccccc--------CCCCCchhhhhHHHHHHHHHhCC
Q 047969 410 KTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC--------YQLTDKSDVYSFGVVLIELISSM 481 (625)
Q Consensus 410 kp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwslG~il~elltG~ 481 (625)
||+|+|++.+|.++|+||+........... ...+..|.+||.... ..++.+.|.|+||+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999988764332211 234578999997633 24788999999999999999999
Q ss_pred CCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCC
Q 047969 482 PAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELR 546 (625)
Q Consensus 482 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 546 (625)
.||+.......... . ... ...++..++.+|..+|+.+|++|
T Consensus 248 lPf~~~~~~~~~~~-----------~----f~~---------C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW-----------D----FSR---------CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG-----------G----GTT---------SS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc-----------c----chh---------cCCcCHHHHHHHHHHccCCcccC
Confidence 99986644332211 0 011 11567789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=176.55 Aligned_cols=137 Identities=16% Similarity=0.178 Sum_probs=105.5
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc-----CCCCeeeeeeeeeeccc--e-EEE
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-----RHKNLVSLFGCTSRYSQ--G-LLL 356 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~--~-~~l 356 (625)
...+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|++....+ . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999995 443333479988665444557789999999999 57999999997766432 2 337
Q ss_pred EEEe--ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccCCCCCCEEECC----CCeEEEccccc
Q 047969 357 VYEF--VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL-AYLHASDIIHRDVKTNNILLDS----NFCVKVADFGL 429 (625)
Q Consensus 357 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~ivHrDikp~NIll~~----~~~~kl~DFgl 429 (625)
|||| +.+++|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 557999999953 235555 35678888888 9999999999999999999973 34899999554
Q ss_pred c
Q 047969 430 S 430 (625)
Q Consensus 430 a 430 (625)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=203.62 Aligned_cols=197 Identities=22% Similarity=0.292 Sum_probs=152.3
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccceE
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR---HKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 354 (625)
....+.|.|.+.||+|+||.||+|...+|+.||+|+-+..+.-+ |.=-.+++.+|+ -+.|.++..+.. ..+.-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~-~~~~S 769 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV-FQNAS 769 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc-cCCcc
Confidence 33456789999999999999999998889999999876654322 111122333333 223444433222 13445
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-------CCCeEEEccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-------SNFCVKVADF 427 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-------~~~~~kl~DF 427 (625)
+||+||.+.|+|.+++. ..+.++|..++.++.|+++.++.||..+|||+||||+|+||. ...-++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 89999999999999996 556789999999999999999999999999999999999993 2345899999
Q ss_pred ccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCC
Q 047969 428 GLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482 (625)
Q Consensus 428 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~ 482 (625)
|.+-.+..-.. ......++|-.+-.+|+..+..++...|.|.|+.+++-||.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99865432212 23355678999999999999999999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=198.41 Aligned_cols=225 Identities=26% Similarity=0.291 Sum_probs=175.9
Q ss_pred eecccCcEEEEEEE----EcCCcEEEEEEeccccHH--HHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEEec
Q 047969 289 ELGDGGFGTVYYGK----LKDGREVAVKRLYDNNYR--RVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.+|+|.||.|++++ ...|..+|+|++++.... .......|..++...+ ||.+|++...+.. ....++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence 37999999999775 335777999988654221 1224567888888887 9999999875554 56689999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
.||.|...+. +.....+.....+...++-+++++|+.+|+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 80 rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 80 RGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred ccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9999888875 344567777778889999999999999999999999999999999999999999986533221
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
.+||..|||||+++ ....+.|.||||++++||++|..||.. .....|.+. ..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~-------------~~ 204 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA-------------EL 204 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh-------------cc
Confidence 17999999999998 467889999999999999999999965 111111111 11
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSM 549 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~ 549 (625)
...+.++....+++..++..+|.+|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1234567788889999999999999644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=178.72 Aligned_cols=260 Identities=21% Similarity=0.244 Sum_probs=172.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcC-Cc-----------------------------------EEEEEEecccc----
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLKD-GR-----------------------------------EVAVKRLYDNN---- 318 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~-----------------------------------~vavK~~~~~~---- 318 (625)
...++|++.+.||+|-.+.||.|+..+ |. +.|||.+..-+
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 345789999999999999999997652 11 35677653211
Q ss_pred -HHHHHHHHHHH------H--------HHHh--------cCCCCeeeeeeeeee--------------------------
Q 047969 319 -YRRVEQFMNEV------E--------ILTR--------LRHKNLVSLFGCTSR-------------------------- 349 (625)
Q Consensus 319 -~~~~~~~~~E~------~--------~l~~--------l~h~niv~~~~~~~~-------------------------- 349 (625)
....+.+-+|. . ..+. -+|||||++++++.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 11122222221 1 1111 259999999875322
Q ss_pred ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE--CCCC--eEEEc
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL--DSNF--CVKVA 425 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll--~~~~--~~kl~ 425 (625)
....+|+||.-++. +|.+++.. ...+.....-|+.|+++|+.|||++||.|||+|.+|||| |+|+ .++|+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 23458999998865 89999842 235666777799999999999999999999999999999 3333 57899
Q ss_pred ccccccccCCCcc-----ccccCCCCCCCccCccccccCC------CCCchhhhhHHHHHHHHHhCCCCCcccccccccc
Q 047969 426 DFGLSRLFPLDVT-----HVSTAPQGTPGYVDPEYHQCYQ------LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN 494 (625)
Q Consensus 426 DFgla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~ 494 (625)
|||.+-....... .......|...-||||+....+ .-.|+|.|+.|.+.||+++...||-... +..
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~ 464 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EML 464 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hhe
Confidence 9998753221111 1112345788899999875321 2348999999999999999999985411 111
Q ss_pred hhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 495 LANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
+.... .++..++. ....++..+.+++...|+.||.+|++.+-....|.-..-.
T Consensus 465 L~~r~---Yqe~qLPa------------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 465 LDTRT---YQESQLPA------------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred echhh---hhhhhCCC------------CcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 11111 11111111 1234566788999999999999999987777666544433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-19 Score=173.01 Aligned_cols=142 Identities=18% Similarity=0.109 Sum_probs=111.4
Q ss_pred cCCCccceecccCcEEEEEEE--EcCCcEEEEEEeccccHH------------------------HHHHHHHHHHHHHhc
Q 047969 282 NDFSREKELGDGGFGTVYYGK--LKDGREVAVKRLYDNNYR------------------------RVEQFMNEVEILTRL 335 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 335 (625)
..|++.+.||+|++|.||+|. ..+|+.||||++...... ....+.+|+.+++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 458999999998643210 112356899999999
Q ss_pred CCC--CeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCC
Q 047969 336 RHK--NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-IIHRDVKTN 412 (625)
Q Consensus 336 ~h~--niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-ivHrDikp~ 412 (625)
.+. .+.++++. ...++||||++|++|...+. ....+....+..++.||+.+|.+||+.| |+||||||+
T Consensus 108 ~~~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe-----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 753 34444442 12489999999988766542 2234566677899999999999999999 999999999
Q ss_pred CEEECCCCeEEEccccccccc
Q 047969 413 NILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~~ 433 (625)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-18 Score=166.05 Aligned_cols=134 Identities=22% Similarity=0.386 Sum_probs=109.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccccH--------HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--------RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
+.||+|++|.||+|+. +|..+++|+...... .....+.+|++++..+.|+++.....++.. ....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEE
Confidence 5799999999999988 678899997643211 123467899999999999987655543333 345689999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
|++|++|.+++... .. .+..++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998521 12 7788999999999999999999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=164.59 Aligned_cols=142 Identities=18% Similarity=0.074 Sum_probs=111.1
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH----------------------HHHHHHHHHHHHHHhcC
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY----------------------RRVEQFMNEVEILTRLR 336 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 336 (625)
.....|.+.+.||+|+||.||++..++|+.||||++..... .....+..|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33334888899999999999999988899999998653220 01123677899999998
Q ss_pred CCC--eeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 047969 337 HKN--LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNI 414 (625)
Q Consensus 337 h~n--iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NI 414 (625)
|++ +.+.++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||
T Consensus 92 ~~~i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 92 EEGFPVPKPID-----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred HcCCCCCceee-----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 874 444443 1334899999999998765420 23467889999999999999999999999999
Q ss_pred EECCCCeEEEcccccccccCC
Q 047969 415 LLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 415 ll~~~~~~kl~DFgla~~~~~ 435 (625)
+++.++.++|+|||++.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-19 Score=183.76 Aligned_cols=242 Identities=22% Similarity=0.254 Sum_probs=158.9
Q ss_pred CccceecccCcEEEEEEEEcCC----cEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeee------eee----ee
Q 047969 285 SREKELGDGGFGTVYYGKLKDG----REVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLF------GCT----SR 349 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~------~~~----~~ 349 (625)
.+.+..+..+++.++..+...+ ..++.+....++........+++..+.... |++.+..- ... ..
T Consensus 247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~ 326 (516)
T KOG1033|consen 247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVG 326 (516)
T ss_pred cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccc
Confidence 3344566666666665543322 223444333333222333344444444444 44333221 001 11
Q ss_pred ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccc
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL 429 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgl 429 (625)
....++|.|++++..+|.+||...+ .....++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 327 ~~~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 327 KKVYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cccchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhh
Confidence 1235789999999999999996433 34457788899999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc-----cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHh
Q 047969 430 SRLFPLDV-----THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 430 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
........ ....+...||.+||+||.+.+..|+.|+||||||++|+||+. =..+++ .......+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhh
Confidence 88665443 222355679999999999999999999999999999999997 122221 11122223
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEV 552 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~el 552 (625)
+.+.++ .....+++ .-..|+.+++...|.+||++.+.
T Consensus 473 r~g~ip-----------~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIP-----------PEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCC-----------hHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 333222 11222233 23468999999999999954443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=181.03 Aligned_cols=219 Identities=25% Similarity=0.446 Sum_probs=163.7
Q ss_pred HHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCC-cccCCC
Q 047969 332 LTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI-IHRDVK 410 (625)
Q Consensus 332 l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i-vHrDik 410 (625)
|+.+.|.|+.+++|..... ...++|.+|+..|+|.+.+.. ....+++.....++++|+.||+|||...| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 4678999999999977764 778999999999999999964 44568999999999999999999999865 999999
Q ss_pred CCCEEECCCCeEEEcccccccccCCC-ccccccCCCCCCCccCccccccCC-------CCCchhhhhHHHHHHHHHhCCC
Q 047969 411 TNNILLDSNFCVKVADFGLSRLFPLD-VTHVSTAPQGTPGYVDPEYHQCYQ-------LTDKSDVYSFGVVLIELISSMP 482 (625)
Q Consensus 411 p~NIll~~~~~~kl~DFgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDvwslG~il~elltG~~ 482 (625)
..|.++|....+||+|||+....... .........-..-|.|||.++... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998875321 111111122346799999887631 4667999999999999999999
Q ss_pred CCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 483 AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 483 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
||+........ ......+.+ .......|.+.. ......++..++.+||..+|++||+++++-..++.+...
T Consensus 157 ~~~~~~~~~~~---~eii~~~~~-~~~~~~rP~i~~-----~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDP---DEIILRVKK-GGSNPFRPSIEL-----LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCCh---HHHHHHHHh-cCCCCcCcchhh-----hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99865443322 111111222 111111221110 113444788899999999999999999999988887765
Q ss_pred C
Q 047969 563 K 563 (625)
Q Consensus 563 ~ 563 (625)
.
T Consensus 228 ~ 228 (484)
T KOG1023|consen 228 G 228 (484)
T ss_pred c
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=159.39 Aligned_cols=130 Identities=22% Similarity=0.350 Sum_probs=102.9
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDNN--------YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.||+|+||.||+|.. +|+.|++|+..... ....+++.+|+++++.++|+++.....+... ....++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEEE
Confidence 389999999999985 57889999864321 1123667899999999988765433322222 3446899999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
++|++|.+++.... . .++.+++++|.+||+.|++|||++|.||+++ ++.++++|||+++.
T Consensus 79 ~~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998874211 0 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=183.68 Aligned_cols=137 Identities=19% Similarity=0.300 Sum_probs=108.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--------cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--------NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
...|...+.||+|+||+||+|.+.. +.+++|+.... .....+++.+|+++++.++|++++....+... ..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CC
Confidence 4456778899999999999998754 34444432111 11123568899999999999998876654443 34
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||++|++|.+++. ....++.+++++|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 5689999999999999874 346789999999999999999999999999999 677999999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-18 Score=186.02 Aligned_cols=208 Identities=27% Similarity=0.407 Sum_probs=144.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..+|..++.|..|+||.||..+++ ..+.+|+|+ .+.+. |++ ||..+-+ ..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----------ilR-----nilt~a~-------npfvv-- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----------ILR-----NILTFAG-------NPFVV-- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----------hhh-----ccccccC-------Cccee--
Confidence 468999999999999999999988 456788854 33221 111 1222221 11222
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+-...++ ..+.++.+. +.+++|||+.||+|||+||+|.+|+.-|++|++|||+.+..-+....
T Consensus 136 ----gDc~tllk----~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLLK----NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhcc----cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 34344442 223444433 67999999999999999999999999999999999998754221110
Q ss_pred --------------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 440 --------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 440 --------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
.....+||+.|+|||++....|...+|.|++|+|+||.+-|..||.+...+... ..+..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-------g~vis 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-------GQVIS 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-------hhhhh
Confidence 123357999999999998889999999999999999999999999876543211 11110
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP 547 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 547 (625)
.. + ...+....++.+.++++.++|+.+|..|-
T Consensus 273 d~--------i--~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DD--------I--EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh--------c--cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00 0 01111224566889999999999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=4e-16 Score=153.91 Aligned_cols=135 Identities=18% Similarity=0.219 Sum_probs=104.3
Q ss_pred ceec-ccCcEEEEEEEEcCCcEEEEEEecccc-------------HHHHHHHHHHHHHHHhcCCCCe--eeeeeeeeecc
Q 047969 288 KELG-DGGFGTVYYGKLKDGREVAVKRLYDNN-------------YRRVEQFMNEVEILTRLRHKNL--VSLFGCTSRYS 351 (625)
Q Consensus 288 ~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 351 (625)
..|| .||.|+||.+... +..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999885 7789999774321 1223567889999999998775 66666433222
Q ss_pred c---eEEEEEEeccC-CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 352 Q---GLLLVYEFVAN-GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 352 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
. ..++|||+++| .+|.+++.. ..++.. .+.+|+.+|.+||+.||+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 689888742 235543 3578999999999999999999999999999899999999
Q ss_pred ccccc
Q 047969 428 GLSRL 432 (625)
Q Consensus 428 gla~~ 432 (625)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 99875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=150.09 Aligned_cols=135 Identities=21% Similarity=0.228 Sum_probs=98.4
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHH--HHHH----------------------HHHHHHHHHhcCCCC--e
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR--RVEQ----------------------FMNEVEILTRLRHKN--L 340 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 340 (625)
.+.||+|+||.||+|...+|+.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643211 1111 135666666665433 4
Q ss_pred eeeeeeeeeccceEEEEEEeccCCChHH-HhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECC
Q 047969 341 VSLFGCTSRYSQGLLLVYEFVANGTVAD-QLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDS 418 (625)
Q Consensus 341 v~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~ 418 (625)
.+.+++ ...++||||++++.+.. .+... ... ..+..++.+++.++.++|. .+|+||||||+||+++
T Consensus 82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec-----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence 444442 23489999999954321 12110 011 5678899999999999999 9999999999999999
Q ss_pred CCeEEEccccccccc
Q 047969 419 NFCVKVADFGLSRLF 433 (625)
Q Consensus 419 ~~~~kl~DFgla~~~ 433 (625)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=136.43 Aligned_cols=132 Identities=22% Similarity=0.208 Sum_probs=109.1
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC--CCeeeeeeeeeeccceEEEEEEeccC
Q 047969 286 REKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH--KNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
+.+.||+|.++.||++... ++.+++|....... ...+.+|+.+++.++| .+++++++.... .+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCC
Confidence 4578999999999999985 47899998865433 4678899999999976 488888874443 4567999999988
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
+.+..+ +......++.+++++|++||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 765433 4556677899999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.1e-17 Score=177.71 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=191.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcC--CcEEEEEEecccc--HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD--GREVAVKRLYDNN--YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 355 (625)
...|.+.+.||+|+|+.|-.+.... ...+|+|.+.... ....+....|..+-+.+. |.|++++++.... .+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Ccccc
Confidence 4578888899999999998887643 3456777664432 233445556888888887 9999999994443 66778
Q ss_pred EEEEeccCCChHHHh-ccCcccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCCEEECCCC-eEEEcccccccc
Q 047969 356 LVYEFVANGTVADQL-HGDRAKHGLLTWPIRMNIAIETASALAYLH-ASDIIHRDVKTNNILLDSNF-CVKVADFGLSRL 432 (625)
Q Consensus 356 lv~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~ 432 (625)
++++|..|+++.+-+ +.. ....+...+-.++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988877 321 113556667789999999999999 99999999999999999999 999999999998
Q ss_pred cCC-Ccc-ccccCCCC-CCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 433 FPL-DVT-HVSTAPQG-TPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 433 ~~~-~~~-~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
+.. ... .......| ++.|+|||...+. -.....|+||.|+++.-+++|..|++........ +
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~ 240 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------Y 240 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------c
Confidence 766 222 22244668 9999999988774 4466789999999999999999999765433211 1
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
..+.... .......+..+.....+++.+++..+|..|.+.+++...-..
T Consensus 241 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~ 289 (601)
T KOG0590|consen 241 SSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWL 289 (601)
T ss_pred eeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccc
Confidence 1111111 000112234455677788999999999999999988765433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=154.63 Aligned_cols=145 Identities=23% Similarity=0.244 Sum_probs=103.7
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHH----------------------------------------
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRV---------------------------------------- 322 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 322 (625)
.|. .+.||.|++|.||+|++++|+.||||+.++......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 367999999999999999999999999865421110
Q ss_pred HHHHHHHHHHHhcC----CCCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHH-HHH
Q 047969 323 EQFMNEVEILTRLR----HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS-ALA 397 (625)
Q Consensus 323 ~~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~ 397 (625)
-+|.+|++.+.++. |.+-+.+-.++.+.....+|||||++|++|.+...... . .+. ...++.+++. .+.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~-~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--A-GLD---RKALAENLARSFLN 271 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--c-CCC---HHHHHHHHHHHHHH
Confidence 02455666666652 33334444434343445689999999999988764211 1 122 3446666666 478
Q ss_pred HHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 398 yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
.+|..|++|+|+||.||+++.+++++++|||++....
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-13 Score=149.25 Aligned_cols=147 Identities=23% Similarity=0.272 Sum_probs=100.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC-CcEEEEEEeccccHHH------------------------------H------
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR------------------------------V------ 322 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~------------------------------~------ 322 (625)
....|+. +.||.|++|.||+|++++ |+.||||++.+.-... .
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999987 9999999986442110 0
Q ss_pred ----HHHHHHHHHHHhcC----CCCeeeeeeeeeeccceEEEEEEeccCCChHHHh--ccCcccCCCCCHHHHHHHHHHH
Q 047969 323 ----EQFMNEVEILTRLR----HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQL--HGDRAKHGLLTWPIRMNIAIET 392 (625)
Q Consensus 323 ----~~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~qi 392 (625)
-++.+|+..+.+++ +.+.+.+-.++.+.....+|||||++|+.+.+.- .........+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 11455665555553 4555555555555556678999999999997742 111000012333333333333
Q ss_pred HHHHHHHHhCCCcccCCCCCCEEECCCC----eEEEcccccccccC
Q 047969 393 ASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGLSRLFP 434 (625)
Q Consensus 393 ~~~L~yLH~~~ivHrDikp~NIll~~~~----~~kl~DFgla~~~~ 434 (625)
+...|++|+|+||.||+++.++ +++++|||++....
T Consensus 276 ------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4468999999999999999888 99999999998664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.1e-14 Score=148.69 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=181.6
Q ss_pred cCCCccceecc--cCcEEEEEEEE--c-CCcEEEEEEecc--ccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 282 NDFSREKELGD--GGFGTVYYGKL--K-DGREVAVKRLYD--NNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 282 ~~~~~~~~LG~--G~~g~Vy~~~~--~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
+.|.+.+.+|. |.+|.||.++. . ++..+|+|+-+. ........=++|+...+.+ .|+|.++.+..+.. .+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCc
Confidence 45667788999 99999999987 4 788899997422 1112222335677777777 49999997775554 667
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS----ALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFG 428 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFg 428 (625)
.++-+|++. .+|..+.+. ....++...++.+..+..+ ||.++|..+++|-|+||.||++..+ ...+++|||
T Consensus 193 lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 788888885 688887763 3334778888888888888 9999999999999999999999998 889999999
Q ss_pred cccccCCCccc----cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh
Q 047969 429 LSRLFPLDVTH----VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 429 la~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
+...+....-. ......|...|++||..++ -++.++|+|++|.++++..++............. .+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--------~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--------QLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--------ccc
Confidence 99877544311 1123368889999998876 4788999999999999999886655332111000 000
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
-.+...+.....+.++...+..+++.+|..|++.+.+..+
T Consensus 340 -----------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 340 -----------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -----------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0112233333455566678999999999999999888754
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-13 Score=117.19 Aligned_cols=92 Identities=28% Similarity=0.585 Sum_probs=71.4
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCCCC-cccc-cccCC--CcEEEeccCCCeEEEEEee-CCeeEEEEeccccccccCCC
Q 047969 32 LCSFPPCGNLSQFTFPFTNLKHPECGL-MVVD-NCNKP--VPRIRLGKAGPFYNILNIA-QDVSITVEDQVFQNHLNQRS 106 (625)
Q Consensus 32 ~C~~~~CG~~~~IsyPF~~~~~~~CG~-p~f~-~C~~~--~~~l~~~~~~~~y~V~~I~-~~~ti~v~d~~~~~~~~~~~ 106 (625)
.| |.+||| ++|.||||... .||+ |+|+ +|+++ .+.|.+. ++. |+|++|+ .+++|+|.++... .
T Consensus 3 ~C-~~~CGn-v~IpYPFgi~~--~C~~~~~F~L~C~~~~~~~~l~l~-~~~-~~V~~I~~~~~~i~v~~~~~~------~ 70 (106)
T PF13947_consen 3 GC-PSSCGN-VSIPYPFGIGP--GCGRDPGFELTCNNNTSPPKLLLS-SGN-YEVLSISYENGTIRVSDPISS------N 70 (106)
T ss_pred CC-CCccCC-EeecCCCccCC--CCCCCCCcEEECCCCCCCceeEec-CCc-EEEEEEecCCCEEEEEecccc------c
Confidence 69 579999 89999998853 7999 9999 99998 7788886 678 9999999 9999999998855 3
Q ss_pred CCC----CC-CCCCCCCCccceEecc--ceeEEEcCCC
Q 047969 107 CES----FK-NFSLPSSASLSFYVKS--KLLSLFRCTD 137 (625)
Q Consensus 107 C~~----~~-n~~~~~~~~~~f~~~~--~~~~f~~C~~ 137 (625)
|.. .. +.+++.. .||.++. |.+++++|+.
T Consensus 71 ~~~~~~~~~~~~~~~~~--~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 71 CYSSSSSNSSNSNLSLN--GPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred eecCCCCcccccEEeec--CCceEccCCcEEEEECCCC
Confidence 443 11 1222221 2677766 8999999973
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=122.73 Aligned_cols=128 Identities=18% Similarity=0.165 Sum_probs=95.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCee-eeeeeeeeccceEEEEEEeccCCC
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV-SLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
++.|+.|.++.||+++.. ++.+++|+...... ....+.+|+.+++.+.+.+++ +++.+ .. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eC--CCCeEEEEecCCCc
Confidence 357899999999999875 78899998754422 123467899999998765544 44442 22 23479999999987
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----cccCCCCCCEEECCCCeEEEcccccccc
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI-----IHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i-----vHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
+.... . ....++.+++++|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 65431 0 112356789999999999985 9999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.7e-12 Score=119.55 Aligned_cols=135 Identities=19% Similarity=0.177 Sum_probs=98.6
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEeccc-------------cH---------HHHHHH----HHHHHHHHh
Q 047969 288 KELGDGGFGTVYYGKLKD-------GREVAVKRLYDN-------------NY---------RRVEQF----MNEVEILTR 334 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~~---------~~~~~~----~~E~~~l~~ 334 (625)
..||.|.-+.||.|...+ +..+|||+.+.. +. ...+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999997553 479999986311 00 012223 389999999
Q ss_pred cC--CCCeeeeeeeeeeccceEEEEEEeccCCChHH-HhccCcccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCC
Q 047969 335 LR--HKNLVSLFGCTSRYSQGLLLVYEFVANGTVAD-QLHGDRAKHGLLTWPIRMNIAIETASALAYL-HASDIIHRDVK 410 (625)
Q Consensus 335 l~--h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~ivHrDik 410 (625)
+. .-++.+++++ ..-+|||||+.+..+.. .+ +...++.+....+..+++.+|..| |+.||||+||+
T Consensus 83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 95 3566666653 22389999997754322 22 222355566778899999999999 89999999999
Q ss_pred CCCEEECCCCeEEEccccccccc
Q 047969 411 TNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 411 p~NIll~~~~~~kl~DFgla~~~ 433 (625)
+.|||++ ++.++|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.1e-13 Score=110.15 Aligned_cols=80 Identities=28% Similarity=0.518 Sum_probs=61.5
Q ss_pred ccCCC--CCceeeeCCCCCCCCCCCCCCce-EeccccccC------CCCchhhhhcccEEEEEEe-cccccccccCCCcc
Q 047969 148 STCNS--SSFIYYNHPDDDLPSILPPNCSL-IQLPVNKTR------KSGDLFNMLTSVFSLQVEV-HRVCWECRWRGGQC 217 (625)
Q Consensus 148 ~~C~~--~~~~~y~~~~~~~~~~~~~~C~~-v~vPv~~~~------~~~~~~~~l~~GF~l~w~~-~~~C~~C~~sgg~C 217 (625)
|+|.+ ....+|..... ..+...|+. +.|||.... +..+|.++|++||+|+|.. .++|.+|+.|||+|
T Consensus 1 ~~C~~~~~~~~~~~v~~~---~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~C 77 (94)
T PF14380_consen 1 INCSINSGNSVSYFVFRS---SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRC 77 (94)
T ss_pred CccccCCCCceeEEEeCC---cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEe
Confidence 46766 22233333322 237789999 999998753 4788999999999999994 44999999999999
Q ss_pred ccCCCC-cccc--cCC
Q 047969 218 QNDSKG-NFQC--AET 230 (625)
Q Consensus 218 g~~~~~-~f~C--~~~ 230 (625)
||+.++ +|.| +|+
T Consensus 78 gy~~~~~~f~C~C~dg 93 (94)
T PF14380_consen 78 GYDSNSEQFTCFCSDG 93 (94)
T ss_pred CCCCCCceEEEECCCC
Confidence 999998 8888 554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.9e-13 Score=128.51 Aligned_cols=204 Identities=21% Similarity=0.300 Sum_probs=140.3
Q ss_pred HHHHhcCCCCeeeeeeeeeec----cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 047969 330 EILTRLRHKNLVSLFGCTSRY----SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS--D 403 (625)
Q Consensus 330 ~~l~~l~h~niv~~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--~ 403 (625)
.-|-.+.|.|||+++.++.+. ..+...+.|||.-|++..+|+..+.....+......+|+-||+.||.|||+- -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 334556799999998866542 2357889999999999999988777777888888899999999999999987 5
Q ss_pred CcccCCCCCCEEECCCCeEEEcccccccccCCC---ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC
Q 047969 404 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD---VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS 480 (625)
Q Consensus 404 ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG 480 (625)
|+|+++..+.|++..+|-+||.----....... .........+-++|.+||.-...+.+.++|||+||+..++|..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998887521111100000 00111223467899999987666778899999999999999876
Q ss_pred CCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 481 MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 481 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..--... ...........+.+. .+-+ ..-++++.+|++..|..||+|++++-|
T Consensus 279 Eiq~tns--eS~~~~ee~ia~~i~-----~len---------------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNS--ESKVEVEENIANVII-----GLEN---------------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCC--cceeehhhhhhhhee-----eccC---------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 4321110 000000001101000 0000 012347899999999999999998765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.1e-11 Score=126.15 Aligned_cols=165 Identities=21% Similarity=0.199 Sum_probs=126.0
Q ss_pred EcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCH
Q 047969 303 LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW 382 (625)
Q Consensus 303 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 382 (625)
..++.+|.|......+....+...+-++.|+.++||||++++..+.. ..++|||+|-+. .|..++.. ++.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHH-------hHH
Confidence 44788898888866655455667888999999999999999995555 568999999885 56667742 345
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCC
Q 047969 383 PIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461 (625)
Q Consensus 383 ~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 461 (625)
..+...+.||+.||.+||. .+++|++|.-+-|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6677789999999999985 5899999999999999999999999998865432221 111222334566777554322
Q ss_pred CCchhhhhHHHHHHHHHhC
Q 047969 462 TDKSDVYSFGVVLIELISS 480 (625)
Q Consensus 462 s~~sDvwslG~il~elltG 480 (625)
-..|.|.||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 246999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-12 Score=135.46 Aligned_cols=249 Identities=20% Similarity=0.250 Sum_probs=176.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeccccHHHHHH--HHHHHHHHHhc-CCCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK--DGREVAVKRLYDNNYRRVEQ--FMNEVEILTRL-RHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 354 (625)
...+|..+..||.|.|+.|+....+ ++..+++|.+.+.-.....+ -+.|+-+...+ .|.+++.++..+.. .+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccc
Confidence 3568889999999999999987643 67889999886553332222 24566666666 58888887775555 3455
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEccccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLF 433 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~~ 433 (625)
+|--||++++++...+. ....+.+..++++..|++.++.++|++.++|+|+||+||++..+ +.-++.|||.+..+
T Consensus 342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 79999999998877662 33457788889999999999999999999999999999999886 78899999998742
Q ss_pred CCCccccccCCCCCCCcc--CccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVTHVSTAPQGTPGYV--DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
.... ......-+++ +++......+..+.|++|||..+.+.++|.+.-....... .+..+....
T Consensus 418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------~i~~~~~p~- 482 (524)
T KOG0601|consen 418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------TIRSGDTPN- 482 (524)
T ss_pred ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------eeecccccC-
Confidence 2111 1122233344 5556667788899999999999999999865432211110 001110000
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
.......+..+.+.++..++..||.+.++..+.+..+
T Consensus 483 ------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 483 ------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0011235566788889999999999999887765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.8e-11 Score=109.38 Aligned_cols=129 Identities=25% Similarity=0.413 Sum_probs=97.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccccH--------HHHHHHHHHHHHHHhcCCC--CeeeeeeeeeeccceEEEE
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--------RRVEQFMNEVEILTRLRHK--NLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~lv 357 (625)
..+++|+-+.+|.+.+. |..+++|.-.+... -..++..+|++++.+++-- +...++.+. .....|+
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD---~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD---PDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc---CCCCEEE
Confidence 35889999999999875 55577775322211 1245678899999998643 344444422 3344799
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
|||++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999888532 255788888889999999999999999999998765 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.1e-10 Score=114.17 Aligned_cols=140 Identities=23% Similarity=0.276 Sum_probs=105.6
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCC--Ceeeeeeeeeecc--ceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHK--NLVSLFGCTSRYS--QGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~--~~~~lv~e~~~ 362 (625)
+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+.+. ++.+++.+..... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57999999999999987778999998754322 1345688999999999753 4566666443321 24689999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS---------------------------------------- 402 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------------------------------------- 402 (625)
|.++.+.+.. ..+++.....++.+++++|..||+.
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9887665421 2467777777888888888888741
Q ss_pred ----------------CCcccCCCCCCEEECC--CCeEEEcccccccc
Q 047969 403 ----------------DIIHRDVKTNNILLDS--NFCVKVADFGLSRL 432 (625)
Q Consensus 403 ----------------~ivHrDikp~NIll~~--~~~~kl~DFgla~~ 432 (625)
.++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 3599999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-09 Score=113.29 Aligned_cols=218 Identities=17% Similarity=0.220 Sum_probs=150.5
Q ss_pred CcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeee---eccceEEEEEEeccC-CChHH
Q 047969 294 GFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTS---RYSQGLLLVYEFVAN-GTVAD 368 (625)
Q Consensus 294 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---~~~~~~~lv~e~~~~-gsL~~ 368 (625)
.-.+.|++... ||..|++|+++............-+++++++.|+|+|++.+++. -.+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999755 99999999994433222223345688999999999999988543 123458999999986 46766
Q ss_pred HhccCc-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 369 QLHGDR-----------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 369 ~l~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
+..... ..+..+++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|..-|.......+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 543211 123458889999999999999999999999999999999999999999998877766543322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
. |-+.. -.+-|.=.||.+++.|.+|...-...+.. .....
T Consensus 448 ~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-----~~s~~----------------- 487 (655)
T KOG3741|consen 448 T---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST-----QSSHL----------------- 487 (655)
T ss_pred C---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch-----HHHHH-----------------
Confidence 0 11111 22568889999999999996542111100 00000
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......++.++.+++.-....++++ -++++++.+
T Consensus 488 ---~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 488 ---TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1112245667777777777777776 567776654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.6e-10 Score=102.42 Aligned_cols=141 Identities=25% Similarity=0.306 Sum_probs=100.8
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeccccH--------HHHHHHHHHHHHHHhcCCCCe--eeeeeeeeeccceEE
Q 047969 286 REKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--------RRVEQFMNEVEILTRLRHKNL--VSLFGCTSRYSQGLL 355 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~ 355 (625)
.+..|-+|+-+.|+++... |+...||.-..... -...+..+|+++|.++.--.| .+++. ... ..-.
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-IDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-Eec--CCCe
Confidence 5678999999999999985 88888886422211 124567889999999864333 23332 222 2337
Q ss_pred EEEEeccC-CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---eEEEccccccc
Q 047969 356 LVYEFVAN-GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF---CVKVADFGLSR 431 (625)
Q Consensus 356 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~---~~kl~DFgla~ 431 (625)
|+|||++| .++.+++...- ......+....++..|-+.+.-||..+|+|+||..+||++..++ .+.++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99999987 46777775322 11223333478899999999999999999999999999996554 45899999986
Q ss_pred c
Q 047969 432 L 432 (625)
Q Consensus 432 ~ 432 (625)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.6e-09 Score=108.09 Aligned_cols=266 Identities=18% Similarity=0.211 Sum_probs=169.0
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeee--------eeeeeeeccceEEE
Q 047969 286 REKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVS--------LFGCTSRYSQGLLL 356 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------~~~~~~~~~~~~~l 356 (625)
..+.||+|+-+.+|..-.- +.-+.|+..........+ -+..|... .||-+-. ++| .+.+..+-+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G--~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG--GRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC--CCccceeEE
Confidence 3567999999999954321 224556654443322222 23333333 4554332 222 222333667
Q ss_pred EEEeccCCChHHHhccC---cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 357 VYEFVANGTVADQLHGD---RAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.|..+.|..-...+.+. +.......|+.+++++++++.+.+.||..|.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 78888775333333321 223345789999999999999999999999999999999999999999999985544332
Q ss_pred CCCccccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHHHHHHhhhcc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
.+.......+|...|.+||... +..-+...|.|.||+++++|+.| ++||.+....... ..-....|..+.
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a--p~p~E~~Ia~g~ 243 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA--PNPLETDIAHGR 243 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC--CCcchhhhhcce
Confidence 2333345567999999999654 44567789999999999999875 9999654322111 000111222222
Q ss_pred cccccCCcCCCC---ChHHHHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhchhcC
Q 047969 508 FDELIDPCLGFE---SDEEVKRMTTSVAELAFLCLQQN--KELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 508 ~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~--P~~RPs~~ell~~L~~i~~~ 562 (625)
+..-.+...+.. ....+.-++..+..+..+|+... +.-|||++.++..|..+...
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 322222222221 22234566778888899998753 56899999999988777654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.3e-10 Score=104.77 Aligned_cols=125 Identities=26% Similarity=0.288 Sum_probs=82.8
Q ss_pred EEEEEEEcCCcEEEEEEecccc-------------H-------------HHHHHHHHHHHHHHhcCCC--Ceeeeeeeee
Q 047969 297 TVYYGKLKDGREVAVKRLYDNN-------------Y-------------RRVEQFMNEVEILTRLRHK--NLVSLFGCTS 348 (625)
Q Consensus 297 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 348 (625)
.||.|...+|..+|||+..... . .......+|++.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999863210 0 0123467899999999765 566666532
Q ss_pred eccceEEEEEEecc--CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccCCCCCCEEECCCCeEEEc
Q 047969 349 RYSQGLLLVYEFVA--NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY-LHASDIIHRDVKTNNILLDSNFCVKVA 425 (625)
Q Consensus 349 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~ivHrDikp~NIll~~~~~~kl~ 425 (625)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1279999998 65554433211 1133456677888885555 579999999999999999888 89999
Q ss_pred cccccccc
Q 047969 426 DFGLSRLF 433 (625)
Q Consensus 426 DFgla~~~ 433 (625)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.1e-11 Score=134.03 Aligned_cols=251 Identities=21% Similarity=0.245 Sum_probs=173.4
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
+...+++.+.+.+-.|.++.++.++-. .|...++|....... .+.+....+-.++-..++|-++....- ......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP 878 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSP 878 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCC
Confidence 345577888888999999999988744 454555554432211 112223334344434455666655442 122455
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.+|+++|+.+++|...|+. .+..+.+.+......+.++++|||...+.|||++|.|+++..++..+++|||.....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence 7899999999999999873 334666666777888899999999999999999999999999999999999844322
Q ss_pred CCC-------------------------c-----cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCC
Q 047969 434 PLD-------------------------V-----THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA 483 (625)
Q Consensus 434 ~~~-------------------------~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p 483 (625)
..- . ........||+.|.+||...+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0 0011234599999999999998889999999999999999999999
Q ss_pred CcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047969 484 VDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSME 550 (625)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 550 (625)
|.....+... +.+ ...... ...-...++.+.++++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~f-------~ni--------~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF-------ENI--------LNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh-------hcc--------ccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9876554322 111 111111 1111223455778889999999999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.6e-09 Score=102.61 Aligned_cols=141 Identities=15% Similarity=0.116 Sum_probs=98.2
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeccccHHH-HH----------HHHHHHHHHHhcCCCC--eeeeeeeeeec----c
Q 047969 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRR-VE----------QFMNEVEILTRLRHKN--LVSLFGCTSRY----S 351 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~----------~~~~E~~~l~~l~h~n--iv~~~~~~~~~----~ 351 (625)
.+-......|++... +|+.+.||......... .+ .+.+|.+.+.++..-+ ....+++.... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 334334444666655 68899999764433211 11 3678999888884322 33333322211 2
Q ss_pred ceEEEEEEeccCC-ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-------CCeEE
Q 047969 352 QGLLLVYEFVANG-TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-------NFCVK 423 (625)
Q Consensus 352 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-------~~~~k 423 (625)
...+||||++++. +|.+++.... ....+......++.+++..+..||..||+|+|++++|||++. ++.+.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 2468999999986 7888874221 234566778889999999999999999999999999999975 57899
Q ss_pred Ecccccccc
Q 047969 424 VADFGLSRL 432 (625)
Q Consensus 424 l~DFgla~~ 432 (625)
|+||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-09 Score=104.45 Aligned_cols=134 Identities=20% Similarity=0.132 Sum_probs=99.5
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeccccH----------------------HHHHHHHHHHHHHHhcCCC--C
Q 047969 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY----------------------RRVEQFMNEVEILTRLRHK--N 339 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 339 (625)
..+..+||-|.-+.||.|....|.++|||.-..... -......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456678999999999999999999999996321100 0123357899999999754 6
Q ss_pred eeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 047969 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN 419 (625)
Q Consensus 340 iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~ 419 (625)
+.+.+++ ++-.+|||+++|-.|...- ++....-.++..|++-+..+-..||||+|+.+-||+++++
T Consensus 173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW-----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc-----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC
Confidence 7777762 3348999999986554332 1333444566666666666668899999999999999999
Q ss_pred CeEEEccccccc
Q 047969 420 FCVKVADFGLSR 431 (625)
Q Consensus 420 ~~~kl~DFgla~ 431 (625)
|.++++||-.+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999997654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1e-08 Score=110.71 Aligned_cols=146 Identities=23% Similarity=0.249 Sum_probs=98.2
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHH------------------------------HH--------
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRR------------------------------VE-------- 323 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~-------- 323 (625)
..|.. +.|+.++-|.||+|++++|+.||||+.+++-... .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34553 6799999999999999999999999976432111 11
Q ss_pred --HHHHHHHHHHhcC----CCCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHH-H
Q 047969 324 --QFMNEVEILTRLR----HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA-L 396 (625)
Q Consensus 324 --~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~-L 396 (625)
++.+|+.-+.+++ +..-+++-.++.+....-.|+|||++|-.+.+...- +...++.+.+ +..++++ +
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~i---a~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKEL---AELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHH---HHHHHHHHH
Confidence 1455666666652 333333444444445556899999999888777421 1122443333 3333322 3
Q ss_pred HHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 397 ~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
..+=..|++|.|..|.||+++.+|++.+.|||+.....
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 34445799999999999999999999999999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-07 Score=92.05 Aligned_cols=106 Identities=24% Similarity=0.218 Sum_probs=80.6
Q ss_pred HHHHHHHHHHHhcCC--CCeeeeeeeeeec---cceEEEEEEeccCC-ChHHHhccCcccCCCCCHHHHHHHHHHHHHHH
Q 047969 323 EQFMNEVEILTRLRH--KNLVSLFGCTSRY---SQGLLLVYEFVANG-TVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396 (625)
Q Consensus 323 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L 396 (625)
....+|...+..|.. -.+.+.+++.... ....+||+|++++. +|.+++... ..++......++.++++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 356788888877743 2334444433321 12358999999984 788888532 1256677888999999999
Q ss_pred HHHHhCCCcccCCCCCCEEECCCC---eEEEcccccccc
Q 047969 397 AYLHASDIIHRDVKTNNILLDSNF---CVKVADFGLSRL 432 (625)
Q Consensus 397 ~yLH~~~ivHrDikp~NIll~~~~---~~kl~DFgla~~ 432 (625)
.-||+.||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-07 Score=88.53 Aligned_cols=140 Identities=18% Similarity=0.134 Sum_probs=101.6
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEecccc------HHHHHHHHHHHHHHHhcCCC--Ceeeeeeeeeec----cceEEE
Q 047969 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDNN------YRRVEQFMNEVEILTRLRHK--NLVSLFGCTSRY----SQGLLL 356 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~~l 356 (625)
--|+||-+.|+...+. |+.+-+|+-...- +--...|.+|...|.+|..- .+.++.. +... ...-+|
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf-~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF-GEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce-eeeeccCCceEEEE
Confidence 3577999999998775 5578899764111 11235689999999999533 3444432 2211 123589
Q ss_pred EEEeccC-CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe--EEEcccccccc
Q 047969 357 VYEFVAN-GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC--VKVADFGLSRL 432 (625)
Q Consensus 357 v~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~--~kl~DFgla~~ 432 (625)
|+|-+.| -+|.+++... ...+.+......++.++++.+.-||+.|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997764 4888887432 2234677788899999999999999999999999999999986666 99999986653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.5e-07 Score=87.83 Aligned_cols=151 Identities=19% Similarity=0.155 Sum_probs=105.0
Q ss_pred cChHHHHHHhcCCCccce---ecccCcEEEEEEEEcCCcEEEEEEeccccHHH-------------------H-----HH
Q 047969 272 FSYSDLAEATNDFSREKE---LGDGGFGTVYYGKLKDGREVAVKRLYDNNYRR-------------------V-----EQ 324 (625)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~---LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~-----~~ 324 (625)
.+...+....++..+... |..|.-+.||+|...++..+|||+........ . .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 455666677777766555 45677789999998889999999874321100 0 11
Q ss_pred HHHHHHHHHhcC--CCCeeeeeeeeeeccceEEEEEEeccCCC-hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 047969 325 FMNEVEILTRLR--HKNLVSLFGCTSRYSQGLLLVYEFVANGT-VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401 (625)
Q Consensus 325 ~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 401 (625)
...|+.-|+++. +-.+.+-+.+.. ..|||||+.... -.-.| +.-.+...+...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~-----nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN-----NVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC-----CeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 356888888884 455555565322 279999996531 11111 22223444677788899999998887
Q ss_pred -CCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 402 -SDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 402 -~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||+||+.-|||+. ++.+.|+|||.|...
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 7999999999999999 889999999988643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.2e-09 Score=111.06 Aligned_cols=148 Identities=20% Similarity=0.280 Sum_probs=103.1
Q ss_pred HHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCcc--------ccccCCCCCCCccCccccccCCC
Q 047969 391 ETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT--------HVSTAPQGTPGYVDPEYHQCYQL 461 (625)
Q Consensus 391 qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~ 461 (625)
+++.||.|+|+. ++||++|.|++|.++.++..||..|+.+........ ...........|.|||++.....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344899999987 899999999999999999999999998765432111 11112245678999999988888
Q ss_pred CCchhhhhHHHHHHHHH-hCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcc
Q 047969 462 TDKSDVYSFGVVLIELI-SSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQ 540 (625)
Q Consensus 462 s~~sDvwslG~il~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 540 (625)
+.++|+||+|+++|.+. .|+.-+..........+.. ...+. ........++.++.+=+.+++.
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------~~~~~-------~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------NLLNA-------GAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------ccccc-------ccccccccCcHHHHHHHHHHhc
Confidence 89999999999999999 4555554332211100000 00000 0001114566788888999999
Q ss_pred cCCCCCCCHHHHHH
Q 047969 541 QNKELRPSMEEVLA 554 (625)
Q Consensus 541 ~~P~~RPs~~ell~ 554 (625)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998888754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.3e-07 Score=86.37 Aligned_cols=138 Identities=19% Similarity=0.291 Sum_probs=91.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHH---------HHHHHHHHhcCC---CCeeeeeeee
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQF---------MNEVEILTRLRH---KNLVSLFGCT 347 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~~~~~~ 347 (625)
..++|++.+.+-......|.+-.. +|+.+++|..........+.| .+++..+.+++. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 357888888888877777766665 589999998765543322222 233333334432 2222222211
Q ss_pred e----eccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEE
Q 047969 348 S----RYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423 (625)
Q Consensus 348 ~----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~k 423 (625)
. ......+|+|||++|..|.+... +++ .++..+.+++.-||+.|++|+|..|.|++++.++ ++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence 1 11234578999999987766542 222 2456677889999999999999999999998655 99
Q ss_pred Eccccccc
Q 047969 424 VADFGLSR 431 (625)
Q Consensus 424 l~DFgla~ 431 (625)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.4e-06 Score=93.92 Aligned_cols=160 Identities=20% Similarity=0.245 Sum_probs=102.5
Q ss_pred CccccChHHHHHHh------------cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHH--------------
Q 047969 268 GVPIFSYSDLAEAT------------NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRR-------------- 321 (625)
Q Consensus 268 ~~~~~~~~~~~~~~------------~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------- 321 (625)
..|.++++++.+.. ..|. .+.||.-+.|.||+|++++|+.||||+-++.-...
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~ 214 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKV 214 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence 45667776665443 3344 36799999999999999999999999875431110
Q ss_pred -------------HH----------HHHHHHHHHHhc----CCCC---eeeeeeeeeeccceEEEEEEeccCCChHHHhc
Q 047969 322 -------------VE----------QFMNEVEILTRL----RHKN---LVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371 (625)
Q Consensus 322 -------------~~----------~~~~E~~~l~~l----~h~n---iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 371 (625)
.+ +|.+|++-..+. .|-+ -|.+-.++.+......|+||||+|..+.+.-.
T Consensus 215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~ 294 (538)
T KOG1235|consen 215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA 294 (538)
T ss_pred HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH
Confidence 00 145555444433 4555 22233334444455689999999987665532
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHH-HHHHHhCCCcccCCCCCCEEEC----CCCeEEEcccccccccC
Q 047969 372 GDRAKHGLLTWPIRMNIAIETASA-LAYLHASDIIHRDVKTNNILLD----SNFCVKVADFGLSRLFP 434 (625)
Q Consensus 372 ~~~~~~~~l~~~~~~~i~~qi~~~-L~yLH~~~ivHrDikp~NIll~----~~~~~kl~DFgla~~~~ 434 (625)
- ....++...+. ..+.++ ++-|-..|++|.|-.|.||+++ .++.+.+.|||+.....
T Consensus 295 i---~~~gi~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 295 I---DKRGISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred H---HHcCCCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 1 22235555433 333333 2333345899999999999998 46789999999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.4e-06 Score=83.66 Aligned_cols=135 Identities=18% Similarity=0.209 Sum_probs=80.4
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC--eeeeeeeeeeccceEEEEEEeccCCC
Q 047969 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN--LVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-+ +.+.+++.. ..+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE-DGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-cCCeeeeeeeecCCcc
Confidence 47999999999984 25567889875432 2345688999999986433 345555333 3455678999999963
Q ss_pred -hHHHh---------------------ccCcccCCCCCHHHHH-HHHHH----------HHH-HHHHHHh----CCCccc
Q 047969 366 -VADQL---------------------HGDRAKHGLLTWPIRM-NIAIE----------TAS-ALAYLHA----SDIIHR 407 (625)
Q Consensus 366 -L~~~l---------------------~~~~~~~~~l~~~~~~-~i~~q----------i~~-~L~yLH~----~~ivHr 407 (625)
+...+ |...... ....... .+..+ +.+ ..++|.. ..++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 21111 1100011 1111110 01000 111 1222221 147899
Q ss_pred CCCCCCEEECCCCeEEEccccccc
Q 047969 408 DVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 408 Dikp~NIll~~~~~~kl~DFgla~ 431 (625)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-06 Score=79.59 Aligned_cols=131 Identities=20% Similarity=0.233 Sum_probs=94.7
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccC
Q 047969 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
-+..+.|++|.+|.||++.+. |.++|+|+-..++ ....+..|+++|..++-.++.+=+..+.. .++.|||++|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 345678999999999999996 6699999865554 34568899999999987777543332332 2566999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC-CCCEEECCCCeEEEcccccccc
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVK-TNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDik-p~NIll~~~~~~kl~DFgla~~ 432 (625)
-.|.++-... +. +-...+++.---|-..||-|+.|. |..++|-.++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~~-------~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-------DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-------cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887765321 22 234455566556777799999885 5566666666999999999873
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-05 Score=78.17 Aligned_cols=143 Identities=20% Similarity=0.216 Sum_probs=84.0
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC--Ceeeeeeeee--eccceEEEEEEecc
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK--NLVSLFGCTS--RYSQGLLLVYEFVA 362 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~--~~~~~~~lv~e~~~ 362 (625)
++.|+.|..+.||+....+ ..+++|..... .....+.+|+.+++.+... .+.+++.... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999876 69999987544 4456778899999888533 3455555221 12234689999999
Q ss_pred CCChHH----------------Hh---ccCcccCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 047969 363 NGTVAD----------------QL---HGDRAKHGLLTWPI---------RMNI------------AIETAS-ALAYLHA 401 (625)
Q Consensus 363 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~qi~~-~L~yLH~ 401 (625)
|..+.. .+ +............. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 11100111111100 0000 111222 3333332
Q ss_pred -------CCCcccCCCCCCEEEC-CCCeEEEcccccccc
Q 047969 402 -------SDIIHRDVKTNNILLD-SNFCVKVADFGLSRL 432 (625)
Q Consensus 402 -------~~ivHrDikp~NIll~-~~~~~kl~DFgla~~ 432 (625)
..++|+|+.|.|||++ +++++-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3599999999999999 667778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2e-07 Score=99.34 Aligned_cols=188 Identities=19% Similarity=0.151 Sum_probs=135.9
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC-eeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN-LVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv~e~ 360 (625)
.-+....-+++|+++.++|++-...+....+.+... ....-++++|.+++||| .++.++ ..+.+...++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~-d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLE-DYDGEDYLWIPMRI 315 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccc-cCCcccccchhhhh
Confidence 334445568999999999998765566667766443 23446899999999999 666655 23335567899999
Q ss_pred ccCC-ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 361 VANG-TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 361 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
+.++ +....+. ...-.+..-+...+.+.-+++|++||+.--+||| ||+..+ +..|..||+....+....
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9877 2222221 1112234445556777778899999998878999 777765 678999999987664433
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCc
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVD 485 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~ 485 (625)
......+++.++|||+.....+..+.|+|++|+-..++.-|.+|-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2345678999999999998899999999999998888887776653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=5e-05 Score=72.21 Aligned_cols=128 Identities=23% Similarity=0.323 Sum_probs=90.3
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEecccc----------------HHHHHHHHHHHHHHHhcC------CCCeeeee
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNN----------------YRRVEQFMNEVEILTRLR------HKNLVSLF 344 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~ 344 (625)
...||+|+.=.||. +.++....||++.... .....+..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999984 5566678889886654 122456677777776666 78899999
Q ss_pred eeeeeccceEEEEEEeccCC------ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 345 GCTSRYSQGLLLVYEFVANG------TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 345 ~~~~~~~~~~~lv~e~~~~g------sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
|+... +....+|+|.+.+. +|.+++. .+.++. . +...+-+-..||-+.+|+.+|++|+||++..
T Consensus 84 G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVET-NLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEec-CCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 96555 56678999987542 5777773 233555 3 3333445567888899999999999999953
Q ss_pred C---C-eEEEcc
Q 047969 419 N---F-CVKVAD 426 (625)
Q Consensus 419 ~---~-~~kl~D 426 (625)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.4e-05 Score=77.65 Aligned_cols=139 Identities=19% Similarity=0.113 Sum_probs=83.0
Q ss_pred eecccCc-EEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEEeccCCCh
Q 047969 289 ELGDGGF-GTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYEFVANGTV 366 (625)
Q Consensus 289 ~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~gsL 366 (625)
.|-.|.. +.||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++... .+..++|||+++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCccH
Confidence 4566666 789999764 4788888875432 335678999988884 4445566664433 3456899999999877
Q ss_pred HHHh-------------------ccCcccCCCCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 047969 367 ADQL-------------------HGDRAKHGLLTWP--IRMNIAI--------------------ETASALAYLH----- 400 (625)
Q Consensus 367 ~~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~~L~yLH----- 400 (625)
.... +............ ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 1110000011100 0000000 0111122221
Q ss_pred --hCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 401 --ASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 401 --~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999988888999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.6e-06 Score=77.47 Aligned_cols=102 Identities=22% Similarity=0.249 Sum_probs=80.1
Q ss_pred HHHHHHHHhcCC-CCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 047969 326 MNEVEILTRLRH-KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-- 402 (625)
Q Consensus 326 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-- 402 (625)
.+|.-+|+.+++ +++.+++|.+.. ++|.||...+++..... ....-...+|..+.+|+.++++.+++|+..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 468889999976 699999997765 78999998775532100 000112368999999999999999999984
Q ss_pred -CCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 403 -DIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 403 -~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.+.-.|++|+|+-+++++++|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5666799999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=6e-05 Score=71.12 Aligned_cols=126 Identities=28% Similarity=0.326 Sum_probs=90.3
Q ss_pred cCCCccceecccCc-EEEEEEEEcCCcEEEEEEecc---c------------cH------HHHHHHHHHHHHHHhcC---
Q 047969 282 NDFSREKELGDGGF-GTVYYGKLKDGREVAVKRLYD---N------------NY------RRVEQFMNEVEILTRLR--- 336 (625)
Q Consensus 282 ~~~~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~~~~---~------------~~------~~~~~~~~E~~~l~~l~--- 336 (625)
.+++.++.||.|.- |.||+++. +|+.+|+|++.. . .. ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68889999999999 99999999 488999999321 0 00 12345788988888775
Q ss_pred CCCe--eeeeeeeeecc-----------------ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHH
Q 047969 337 HKNL--VSLFGCTSRYS-----------------QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397 (625)
Q Consensus 337 h~ni--v~~~~~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~ 397 (625)
+.++ |+.+|+..-.. ....||.||++... .+. ..-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 4455 89998653211 12467888776532 112 234567788889
Q ss_pred HHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 398 yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
.+|..||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999999987 2368999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.3e-05 Score=87.35 Aligned_cols=79 Identities=10% Similarity=0.259 Sum_probs=54.9
Q ss_pred cceecccCcEEEEEEEEcCC---cEEEEEEecccc-HHHHHHHHHHHHHHHhcC-CCCe--eeeeeeeeec--cceEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKDG---REVAVKRLYDNN-YRRVEQFMNEVEILTRLR-HKNL--VSLFGCTSRY--SQGLLLV 357 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~--~~~~~lv 357 (625)
++.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+. .+..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887654 467788754322 122346789999999995 6654 6666644332 1356899
Q ss_pred EEeccCCC
Q 047969 358 YEFVANGT 365 (625)
Q Consensus 358 ~e~~~~gs 365 (625)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.9e-05 Score=73.19 Aligned_cols=75 Identities=17% Similarity=0.178 Sum_probs=46.0
Q ss_pred cceecccCcEE-EEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC---Ceeeeeeeeeec--cceEEEEEEe
Q 047969 287 EKELGDGGFGT-VYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK---NLVSLFGCTSRY--SQGLLLVYEF 360 (625)
Q Consensus 287 ~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~--~~~~~lv~e~ 360 (625)
++.|+.||... ||+. +..+++|...... ....+.+|+++|+.+... .+.++++..... ....+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 35688787774 8875 2357788654322 235788999999888532 333444322111 1234789999
Q ss_pred ccCCChH
Q 047969 361 VANGTVA 367 (625)
Q Consensus 361 ~~~gsL~ 367 (625)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.6e-05 Score=79.06 Aligned_cols=134 Identities=17% Similarity=0.145 Sum_probs=95.3
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEecccc--H------H--------------HHHHHHHHHHHHHhcCC--C
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNN--Y------R--------------RVEQFMNEVEILTRLRH--K 338 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~--------------~~~~~~~E~~~l~~l~h--~ 338 (625)
-+.+.++||-|.-+.||.+-..+|++.++|.-.... . + ..-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 356788999999999999999999999999532110 0 0 01124679999999853 3
Q ss_pred CeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 339 niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
-+.+.+++ .+.++|||++.|..|.+.-+ ..+...+ ...+..-+.-|..+|+||+|..--||+|++
T Consensus 173 pVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPIDH-----NRHCVVMELVDGYPLRQVRH-------VEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCcccc-----cceeeHHHhhcccceeeeee-------cCChHHH---HHHHHHHHHHHHHcCceecccchheeEEec
Confidence 44555542 33489999999987765432 1233333 334444566788899999999999999999
Q ss_pred CCeEEEccccccc
Q 047969 419 NFCVKVADFGLSR 431 (625)
Q Consensus 419 ~~~~kl~DFgla~ 431 (625)
++.++++||-...
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999997554
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00063 Score=70.47 Aligned_cols=157 Identities=16% Similarity=0.200 Sum_probs=85.6
Q ss_pred cChHHHHHHhcCCCc-----cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC--Ceeeee
Q 047969 272 FSYSDLAEATNDFSR-----EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK--NLVSLF 344 (625)
Q Consensus 272 ~~~~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~ 344 (625)
.+.+++......|.+ .+.|+.|....+|+....+| .+++|+..... .+....|+.+++.|... .+.+++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence 344556555566654 35566777789999887655 68889875222 23344455666665321 233333
Q ss_pred e-----eeeeccceEEEEEEeccCCChH-----------HH---hccCccc-------CCCCCH-HHHHH----------
Q 047969 345 G-----CTSRYSQGLLLVYEFVANGTVA-----------DQ---LHGDRAK-------HGLLTW-PIRMN---------- 387 (625)
Q Consensus 345 ~-----~~~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~~-------~~~l~~-~~~~~---------- 387 (625)
. .+....+..++++||++|..+. +. +|..... ...+.+ .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1122244578999999986431 11 1211100 001111 11111
Q ss_pred --HH-HHHHHHHHHHH-------hCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 388 --IA-IETASALAYLH-------ASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 388 --i~-~qi~~~L~yLH-------~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.+ ..+...++.+. ..+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 11 11112223333 23799999999999999776668999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00026 Score=70.80 Aligned_cols=137 Identities=15% Similarity=0.085 Sum_probs=78.7
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEEEEeccCCChH
Q 047969 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLVYEFVANGTVA 367 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~gsL~ 367 (625)
.+..|-.+.+|+... +++.+++|+.........-...+|.++++.+...++ .+++.. .. .++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~-~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV-NE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE-eC----CEEEEEeccCcccc
Confidence 356677889998874 577888987543322211235679999999864433 233332 21 26899999986653
Q ss_pred HH-----------------hccCcccCCCCCHHHH-HHHHHH---------HHHHHHHHHh--------CCCcccCCCCC
Q 047969 368 DQ-----------------LHGDRAKHGLLTWPIR-MNIAIE---------TASALAYLHA--------SDIIHRDVKTN 412 (625)
Q Consensus 368 ~~-----------------l~~~~~~~~~l~~~~~-~~i~~q---------i~~~L~yLH~--------~~ivHrDikp~ 412 (625)
.. +|........++.... .....+ +...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 2221111112222211 111111 1112222221 15899999999
Q ss_pred CEEECCCCeEEEcccccccc
Q 047969 413 NILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~ 432 (625)
||++++++ +.|+||..|..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00044 Score=70.75 Aligned_cols=79 Identities=13% Similarity=0.075 Sum_probs=55.5
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC---CCeeeeeeeeee--ccceEEEEEE
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH---KNLVSLFGCTSR--YSQGLLLVYE 359 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~--~~~~~~lv~e 359 (625)
...+.||.|..+.||.....+++ +.+|..+.. .....+.+|++.|+.|.. ..+.++++++.. ..+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34567999999999999876564 666764321 123578899999998853 357777774432 2345799999
Q ss_pred eccCCCh
Q 047969 360 FVANGTV 366 (625)
Q Consensus 360 ~~~~gsL 366 (625)
+++|+++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00068 Score=69.80 Aligned_cols=155 Identities=19% Similarity=0.251 Sum_probs=88.9
Q ss_pred hHHHHHHhcCCCc-----cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC--Ceeeeeee
Q 047969 274 YSDLAEATNDFSR-----EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK--NLVSLFGC 346 (625)
Q Consensus 274 ~~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~ 346 (625)
.+++....++|.+ ++.++.|....+|+....+| .+++|+..... ..+....|++++..|... .+.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 3455555555544 45677777789999876555 57788764431 123455677777777422 23444431
Q ss_pred -----eeeccceEEEEEEeccCCChH-----------H---HhccCccc---C-----CCCCHHHHH------------H
Q 047969 347 -----TSRYSQGLLLVYEFVANGTVA-----------D---QLHGDRAK---H-----GLLTWPIRM------------N 387 (625)
Q Consensus 347 -----~~~~~~~~~lv~e~~~~gsL~-----------~---~l~~~~~~---~-----~~l~~~~~~------------~ 387 (625)
.....+..++++||++|..+. . .+|..... . ..-.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 112234568999999885431 0 12211000 0 001111110 0
Q ss_pred HHHHHHHHHHHHHh-------CCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 388 IAIETASALAYLHA-------SDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 388 i~~qi~~~L~yLH~-------~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
....+.+.++++.. .+++|+|+.+.||+++.++...|+||+.+.
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11223345555543 489999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0006 Score=69.76 Aligned_cols=142 Identities=19% Similarity=0.190 Sum_probs=85.2
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC--Ceeeeeee-----eeeccceEEEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK--NLVSLFGC-----TSRYSQGLLLVYE 359 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~~lv~e 359 (625)
.+.|..|....+|+.... +..+++|+.... ..+....|++++..+.+. .+.+++.. .....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777888899998764 457888987542 234566788888888533 24444431 1122345689999
Q ss_pred eccCCChHH--------------HhccCcc--cC-----CCCCHHHHH----------HHHHHHHHHHHHHHh-------
Q 047969 360 FVANGTVAD--------------QLHGDRA--KH-----GLLTWPIRM----------NIAIETASALAYLHA------- 401 (625)
Q Consensus 360 ~~~~gsL~~--------------~l~~~~~--~~-----~~l~~~~~~----------~i~~qi~~~L~yLH~------- 401 (625)
|++|..+.. .+|.... .. ....|.... .....+..++.++.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999866421 1111000 00 011111110 011223344555553
Q ss_pred CCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 402 ~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999987788999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0002 Score=82.11 Aligned_cols=201 Identities=19% Similarity=0.197 Sum_probs=135.0
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeeeeeeeccce---EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHH
Q 047969 322 VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG---LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398 (625)
Q Consensus 322 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~y 398 (625)
+....-|...+.++.|+|++.++.+..+.... ..+..|++..-++...+. .-+.++....+.+..++.+||+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHH
Confidence 33445678888889999999999865442211 233456777777777774 44568889999999999999999
Q ss_pred HHhCCCcccCCCCC---CEEECCCCeEEEc--ccccccccCCCccccccCCCCCCCccCccccccCCC--CCchhhhhHH
Q 047969 399 LHASDIIHRDVKTN---NILLDSNFCVKVA--DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL--TDKSDVYSFG 471 (625)
Q Consensus 399 LH~~~ivHrDikp~---NIll~~~~~~kl~--DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~~sDvwslG 471 (625)
+|+....|.-+..+ +--++..+.+.++ ||+..+........ ....-+..+.++|......+ +...|+|.+|
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 99996666555544 4445666777777 88888765433222 22234566778887654433 4457999999
Q ss_pred HHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047969 472 VVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551 (625)
Q Consensus 472 ~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 551 (625)
..+..+..|..+-...... ..+++. ....++.+...+|+..++++|+++.+
T Consensus 380 ll~~~~~~~~~i~~~~~~~------------------~~~l~~-----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVP------------------VSLLDV-----------LSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHhhhhhcCcccccccch------------------hhhhcc-----------ccchhhhhhhhhhcchhhhhccchhh
Confidence 9999999876543221110 000100 00114566788999999999999999
Q ss_pred HHHHHh
Q 047969 552 VLAELQ 557 (625)
Q Consensus 552 ll~~L~ 557 (625)
++.+.-
T Consensus 431 ll~~~f 436 (1351)
T KOG1035|consen 431 LLTHPF 436 (1351)
T ss_pred hhhchh
Confidence 998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00045 Score=68.05 Aligned_cols=74 Identities=20% Similarity=0.207 Sum_probs=48.6
Q ss_pred cceecccCcEEEEEEEEcC--CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEEEEeccC
Q 047969 287 EKELGDGGFGTVYYGKLKD--GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
++.|..|-...+|+....+ ++.|++|+....... .-...+|+.+++.+...++ .++++. .. . .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~-~~--~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYAT-FQ--N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEE-eC--C--cEEEEeeCC
Confidence 3568888889999998764 678999976543221 1223478889988854333 344432 22 1 489999998
Q ss_pred CCh
Q 047969 364 GTV 366 (625)
Q Consensus 364 gsL 366 (625)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.002 Score=67.96 Aligned_cols=76 Identities=18% Similarity=0.235 Sum_probs=53.9
Q ss_pred cceecccCcEEEEEEEEcCC-cEEEEEEeccc------c-HHHHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccceEE
Q 047969 287 EKELGDGGFGTVYYGKLKDG-REVAVKRLYDN------N-YRRVEQFMNEVEILTRLR---HKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 355 (625)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|+.+. ..++.+++.+ . ....+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-D--~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-D--EELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-C--CCCCE
Confidence 35799999999999998877 58999974311 1 124567778888888873 2456777764 2 23458
Q ss_pred EEEEeccCCC
Q 047969 356 LVYEFVANGT 365 (625)
Q Consensus 356 lv~e~~~~gs 365 (625)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00063 Score=69.86 Aligned_cols=74 Identities=23% Similarity=0.313 Sum_probs=48.7
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCee-eeeeeeeeccceEEEEEE
Q 047969 288 KELGDGGFGTVYYGKLKD-------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV-SLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e 359 (625)
+.|..|--..||+....+ ++.+++|+..... .......+|.++++.+...++. +++++.. + .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N---GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cchhh
Confidence 466777777999988664 5789999865432 2234457888888888543333 4444322 1 36899
Q ss_pred eccCCChH
Q 047969 360 FVANGTVA 367 (625)
Q Consensus 360 ~~~~gsL~ 367 (625)
|++|..+.
T Consensus 78 ~i~G~~l~ 85 (302)
T cd05156 78 FIPSRTLT 85 (302)
T ss_pred eeCCCcCC
Confidence 99987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=7.2e-05 Score=87.31 Aligned_cols=161 Identities=13% Similarity=0.014 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHhcCCCCeeeeee-eeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 047969 323 EQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401 (625)
Q Consensus 323 ~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 401 (625)
+....|...++...|++++..+. .-.......+.+++|+.+|.+...+.....+...+....+.....+...+..-.|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 34456666777789999887765 22223344689999999999999987666666667666666666665777777776
Q ss_pred C-----CCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHH
Q 047969 402 S-----DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIE 476 (625)
Q Consensus 402 ~-----~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~e 476 (625)
. -.+|+++|+.|.+|..+.++|++++|+.+..... ........+++-|++|++.+.-.++.++|+|..|..+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 5 2799999999999999999999999999842221 222244567888999999988888889999999999999
Q ss_pred HHhCCCCC
Q 047969 477 LISSMPAV 484 (625)
Q Consensus 477 lltG~~p~ 484 (625)
+-.|.++|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887776
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0016 Score=66.30 Aligned_cols=139 Identities=19% Similarity=0.191 Sum_probs=95.5
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeccc------------------------cHHHHH--HHHHHHHHHHhcCCCC
Q 047969 286 REKELGDGGFGTVYYGKLKDGREVAVKRLYDN------------------------NYRRVE--QFMNEVEILTRLRHKN 339 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~------------------------~~~~~~--~~~~E~~~l~~l~h~n 339 (625)
+-..|..|.-+.||.|...+|..+|||+.+-. +++..- -...|++-|++++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34568889999999999999999999986311 111111 1246888888887655
Q ss_pred eeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECC
Q 047969 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDS 418 (625)
Q Consensus 340 iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~ 418 (625)
|.-.--... ..-.|||+|+.+.. |- ..+.+.-.++...+..+-.|++.-|.-|-+. ++||.||.--|+|+.
T Consensus 228 IP~PePIlL---k~hVLVM~FlGrdg---w~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPILL---KNHVLVMEFLGRDG---WA-APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCceee---ecceEeeeeccCCC---Cc-CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence 432111111 12379999995322 11 1112444577788888888999888888765 899999999999994
Q ss_pred CCeEEEcccccccc
Q 047969 419 NFCVKVADFGLSRL 432 (625)
Q Consensus 419 ~~~~kl~DFgla~~ 432 (625)
+|.+.|+|-+.+..
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 56899999887653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.004 Score=62.92 Aligned_cols=30 Identities=20% Similarity=0.447 Sum_probs=25.3
Q ss_pred CCcccCCCCCCEEECCCCe-EEEcccccccc
Q 047969 403 DIIHRDVKTNNILLDSNFC-VKVADFGLSRL 432 (625)
Q Consensus 403 ~ivHrDikp~NIll~~~~~-~kl~DFgla~~ 432 (625)
.++|+|++|.|||++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0071 Score=62.59 Aligned_cols=72 Identities=21% Similarity=0.214 Sum_probs=47.6
Q ss_pred eecccCcEEEEEEEEcCC-cEEEEEEecc-------ccHHHHHHHHHHHHHHHhcC--CC-CeeeeeeeeeeccceEEEE
Q 047969 289 ELGDGGFGTVYYGKLKDG-REVAVKRLYD-------NNYRRVEQFMNEVEILTRLR--HK-NLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~lv 357 (625)
.||.|....||++...+| +.|+||.-.. .-.-..++..-|.+.|+... -| .+.++|. +.. ....+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~--e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDT--EMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-Ecc--ccceeh
Confidence 589999999999998754 6899996321 11223455567888887763 34 4555665 332 334799
Q ss_pred EEeccC
Q 047969 358 YEFVAN 363 (625)
Q Consensus 358 ~e~~~~ 363 (625)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.014 Score=60.08 Aligned_cols=29 Identities=34% Similarity=0.416 Sum_probs=25.3
Q ss_pred CCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 402 ~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 578899998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.014 Score=61.03 Aligned_cols=140 Identities=19% Similarity=0.220 Sum_probs=80.6
Q ss_pred cceecccCcEEEEEEEEcC-----CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCee-eeeeeeeeccceEEEEEEe
Q 047969 287 EKELGDGGFGTVYYGKLKD-----GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV-SLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~ 360 (625)
++.|-.|-...+|+....+ ++.|++|+........++ ..+|..+++.+..-++. ++++.+ . . ..|+||
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~-~---g~v~ef 114 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRF-P-N---GRVEEF 114 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEE-C-C---ceEEEe
Confidence 3456567788999987542 367999987554322222 36789999888644443 444533 2 1 258999
Q ss_pred ccCCChHHH-----------------hccCcccCC--CCCHHHHHHHHHHH-----------------HHHHHHH----H
Q 047969 361 VANGTVADQ-----------------LHGDRAKHG--LLTWPIRMNIAIET-----------------ASALAYL----H 400 (625)
Q Consensus 361 ~~~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~~L~yL----H 400 (625)
+++.++... +|....... ...+..+..+..++ ...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 987665421 121111111 11223332332111 1112222 1
Q ss_pred ----hCCCcccCCCCCCEEECC-CCeEEEcccccccc
Q 047969 401 ----ASDIIHRDVKTNNILLDS-NFCVKVADFGLSRL 432 (625)
Q Consensus 401 ----~~~ivHrDikp~NIll~~-~~~~kl~DFgla~~ 432 (625)
...++|+|+++.|||+++ ++.++|+||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 125899999999999986 47899999988753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.022 Score=58.60 Aligned_cols=30 Identities=13% Similarity=0.218 Sum_probs=27.8
Q ss_pred CCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 403 ~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
+++|+|+.++|||+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.032 Score=58.83 Aligned_cols=73 Identities=16% Similarity=0.185 Sum_probs=48.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccc----cH---HHHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccceEEE
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDN----NY---RRVEQFMNEVEILTRLR---HKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~l 356 (625)
.+.||.|....||+.... ++.++||.-... .. ...++-..|++.|+.+. ..++.+++.+..+ ..++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CCEE
Confidence 568999999999998874 567999974311 00 13344455677776664 2467778775442 3478
Q ss_pred EEEeccC
Q 047969 357 VYEFVAN 363 (625)
Q Consensus 357 v~e~~~~ 363 (625)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.027 Score=57.57 Aligned_cols=148 Identities=16% Similarity=0.191 Sum_probs=80.1
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEec-cccHHHHHHHHHHHHHHHhcCC--CCeeeeeeeeeecc-ceEEEEEEe
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLY-DNNYRRVEQFMNEVEILTRLRH--KNLVSLFGCTSRYS-QGLLLVYEF 360 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~-~~~~lv~e~ 360 (625)
.+.+.+..|-.-.+|..... ++.+++++-. ...........+|..+|+.+.- .-+.+.++.+.... ...+.||+|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 33444433433445555443 7888888321 1223344556778888888853 23334455444433 457999999
Q ss_pred ccCCChHHHhccCc---------------------c------------cCCC-CCHHHHHHH--------HHHHHHHHHH
Q 047969 361 VANGTVADQLHGDR---------------------A------------KHGL-LTWPIRMNI--------AIETASALAY 398 (625)
Q Consensus 361 ~~~gsL~~~l~~~~---------------------~------------~~~~-l~~~~~~~i--------~~qi~~~L~y 398 (625)
++|..+...+.... . .... -.|...+.. .-....-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 99843222221000 0 0000 001011100 0011222344
Q ss_pred HHhC--------CCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 399 LHAS--------DIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 399 LH~~--------~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
|+++ .++|+|+.+.||+++.++-+=|.||+++..-
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4433 3799999999999999888999999998753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.019 Score=58.15 Aligned_cols=75 Identities=20% Similarity=0.254 Sum_probs=45.5
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccceEEEEEEec
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR---HKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
+..+.|+-|....+|+.. .+++.+.||.-.. .....|..|++-|+.|. --.+.+++++... ....+|||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEEee
Confidence 345678989999999987 5788999998652 23356788998888884 3346677774433 34458999999
Q ss_pred cCC
Q 047969 362 ANG 364 (625)
Q Consensus 362 ~~g 364 (625)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.011 Score=62.65 Aligned_cols=70 Identities=19% Similarity=0.289 Sum_probs=46.7
Q ss_pred EEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhc
Q 047969 298 VYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371 (625)
Q Consensus 298 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 371 (625)
.+.|..++|... .--+.-. ....+++-...+++.+.|+|.-.++.+......+..+|||++. .+|.+.+.
T Consensus 5 ~~~a~~~~~~~c-~nglplt--~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~ 74 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLT--PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILK 74 (725)
T ss_pred EEehhcCCCccc-cCCCcCC--CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHH
Confidence 455665555544 2222111 1224566778899999999999999865555556889999984 58888874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.022 Score=59.28 Aligned_cols=139 Identities=15% Similarity=0.196 Sum_probs=78.3
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCee-eeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLKD----GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV-SLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~ 362 (625)
+.|..|--..+|+....+ +..|++|+...... ..-.-.+|..+++.+..-++- ++++++ . .+ +|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-C-Cc---Eeehhhc
Confidence 456557777889887543 24789998755432 222235789999988655543 445433 2 22 5899998
Q ss_pred CCChHH-----------------HhccCcccCC--CCCHHHHHHHHHHH----------------------HHHHHH---
Q 047969 363 NGTVAD-----------------QLHGDRAKHG--LLTWPIRMNIAIET----------------------ASALAY--- 398 (625)
Q Consensus 363 ~gsL~~-----------------~l~~~~~~~~--~l~~~~~~~i~~qi----------------------~~~L~y--- 398 (625)
+.++.. .+|....... .-.+..+.++..++ .+-+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765521 1121111111 11233322222221 111111
Q ss_pred HH-hC----CCcccCCCCCCEEECC-CCeEEEcccccccc
Q 047969 399 LH-AS----DIIHRDVKTNNILLDS-NFCVKVADFGLSRL 432 (625)
Q Consensus 399 LH-~~----~ivHrDikp~NIll~~-~~~~kl~DFgla~~ 432 (625)
+. .. -++|.|+.+.|||+++ ++.++++||..|..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 21 11 2799999999999974 57899999998753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.011 Score=57.22 Aligned_cols=30 Identities=30% Similarity=0.452 Sum_probs=21.5
Q ss_pred CCcccCCCCCCEEE-CCCCeEEEcccccccc
Q 047969 403 DIIHRDVKTNNILL-DSNFCVKVADFGLSRL 432 (625)
Q Consensus 403 ~ivHrDikp~NIll-~~~~~~kl~DFgla~~ 432 (625)
.++|.|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.13 Score=53.43 Aligned_cols=96 Identities=14% Similarity=0.074 Sum_probs=56.0
Q ss_pred ccccChHHHHHHhcCCCcc---c-eecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC--Ceee
Q 047969 269 VPIFSYSDLAEATNDFSRE---K-ELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK--NLVS 342 (625)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~---~-~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~ 342 (625)
.+.++.+.+..+...+-+. + .+-.+.-..||+....+|+.+++|+..... .....+..|++.+..|... .++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3445556666666555331 1 222355678999988888889999864332 2345566788888777421 2222
Q ss_pred ee---e-eeeeccceEEEEEEeccCCC
Q 047969 343 LF---G-CTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 343 ~~---~-~~~~~~~~~~lv~e~~~~gs 365 (625)
.. | .....++..+.++++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 2 11122345678999998754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.028 Score=58.99 Aligned_cols=74 Identities=19% Similarity=0.113 Sum_probs=49.6
Q ss_pred cceecccCcEEEEEEEEcC-CcEEEEEEec------cccHHHHHHHHHHHHHHHhcC--CC-CeeeeeeeeeeccceEEE
Q 047969 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLY------DNNYRRVEQFMNEVEILTRLR--HK-NLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~------~~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~l 356 (625)
.+.||.|....||++...+ ++.|+||.-. ..-.-..++..-|.++|+.+. -| .+.++|. +.. ....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~D~--e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-FDS--VMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-ECc--HHhhH
Confidence 4689999999999999853 6789999631 111223566677888888773 34 4556665 332 33478
Q ss_pred EEEeccC
Q 047969 357 VYEFVAN 363 (625)
Q Consensus 357 v~e~~~~ 363 (625)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999854
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.026 Score=58.40 Aligned_cols=60 Identities=18% Similarity=0.212 Sum_probs=43.2
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCCEEECC
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH-ASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ivHrDikp~NIll~~ 418 (625)
..|+-+|+.|.++..++. ....+++...+++.-.++||-.+- -.+.+|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 467778888989888884 223455566666666666654443 458999999999999953
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.06 Score=55.53 Aligned_cols=139 Identities=23% Similarity=0.288 Sum_probs=84.8
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC------eeeeeee-eeecc--ceEEEEEE
Q 047969 289 ELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN------LVSLFGC-TSRYS--QGLLLVYE 359 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~-~~~~~--~~~~lv~e 359 (625)
.|.. .-..||+....+|+. ++|+.... ...+++..|...|..|.-.+ +..+-|- ..... ...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 567799998887777 88877654 34456677888888884211 2222221 11112 36788999
Q ss_pred eccCCChHH---------------HhccC--------cccCCCCCHHH-------------HHHHHHHHHHHHHHHHhC-
Q 047969 360 FVANGTVAD---------------QLHGD--------RAKHGLLTWPI-------------RMNIAIETASALAYLHAS- 402 (625)
Q Consensus 360 ~~~~gsL~~---------------~l~~~--------~~~~~~l~~~~-------------~~~i~~qi~~~L~yLH~~- 402 (625)
|++|..+.. .|+.. ........|.. -.....++...++.+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999987762 11110 01111233431 012344455555555543
Q ss_pred -------C--CcccCCCCCCEEECCCCe-EEEccccccc
Q 047969 403 -------D--IIHRDVKTNNILLDSNFC-VKVADFGLSR 431 (625)
Q Consensus 403 -------~--ivHrDikp~NIll~~~~~-~kl~DFgla~ 431 (625)
+ +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999999875 8899999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.07 Score=50.88 Aligned_cols=148 Identities=20% Similarity=0.226 Sum_probs=89.6
Q ss_pred cCcEEEEEEEEcCCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhc
Q 047969 293 GGFGTVYYGKLKDGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLH 371 (625)
Q Consensus 293 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 371 (625)
||.++.-+++.+=| ...+|++...... ....|.++.+++.+++ .|+++.. +..-..-++.|+|....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~------ 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIK------ 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCcc------
Confidence 45555555544333 3455555433222 3456788999998886 4777764 23445678889884321
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCC
Q 047969 372 GDRAKHGLLTWPIRMNIAIETASALAYLHAS--DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPG 449 (625)
Q Consensus 372 ~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~ 449 (625)
... ..++..=+++|.-.|+. +.+|+|-.|+|||-|..|.+||.|=+..-. .+..
T Consensus 141 -------i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~ 196 (308)
T PF07387_consen 141 -------INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVN 196 (308)
T ss_pred -------cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh-------------heee
Confidence 011 11222224678888954 799999999999999999999999764321 1122
Q ss_pred ccCccccccCCCCCchhhhhHHHHHHHHHh
Q 047969 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479 (625)
Q Consensus 450 y~aPE~~~~~~~s~~sDvwslG~il~ellt 479 (625)
|.--|+ ...+.++.+=+|=.-++++..
T Consensus 197 ~vN~~Y---~~lT~~aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 197 MVNIEY---ESLTQEAEVKVFVKSCLKLVE 223 (308)
T ss_pred EEeeec---cccChHHHHHHHHHHHHHHHH
Confidence 222111 235667777777777777765
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.13 Score=54.30 Aligned_cols=75 Identities=23% Similarity=0.284 Sum_probs=44.7
Q ss_pred cceecccCcEEEEEEEEcCC--cE-----EEEEEeccccHHHHHHHHHHHHHHHhcCCCCee-eeeeeeeeccceEEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKDG--RE-----VAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV-SLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~ 358 (625)
++.|..|-...+|++...++ .. |.++.. .......-.-.+|+++++.+...++- ++++.+.. .+|+
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-----g~l~ 128 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-----FTIQ 128 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC-----EEEE
Confidence 34566688889999976533 22 444432 12111112235789999999765554 44543321 6999
Q ss_pred EeccCCChH
Q 047969 359 EFVANGTVA 367 (625)
Q Consensus 359 e~~~~gsL~ 367 (625)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.053 Score=55.50 Aligned_cols=52 Identities=31% Similarity=0.349 Sum_probs=47.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 380 LTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 380 l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++++..++++.+..|.-+..+ ..-|||+.-.||||+ +|++.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 46888999999999888888876 799999999999999 99999999999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 625 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-47 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-28 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-22 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-22 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-07 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 6e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-134
Identities = 116/288 (40%), Positives = 171/288 (59%), Gaps = 7/288 (2%)
Query: 272 FSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI 331
DL EATN+F + +G G FG VY G L+DG +VA+KR + + +E+F E+E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 332 LTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
L+ RH +LVSL G ++ ++L+Y+++ NG + L+G ++W R+ I I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNE-MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP-LDVTHVSTAPQGTPGY 450
A L YLH IIHRDVK+ NILLD NF K+ DFG+S+ LD TH+ST +GT GY
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 451 VDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
+DPEY +LT+KSDVYSFGVVL E++ + A+ + R +NLA A+ ++
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 511 LIDPCLGFE-SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
++DP L + E +++ + A CL + E RPSM +VL +L+
Sbjct: 268 IVDPNLADKIRPESLRKF----GDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-120
Identities = 120/300 (40%), Positives = 173/300 (57%), Gaps = 13/300 (4%)
Query: 265 VYFGVP-IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVE 323
V+ G FS +L A+++FS + LG GGFG VY G+L DG VAVKRL + + E
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 324 -QFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW 382
QF EVE+++ H+NL+ L G ++ LLVY ++ANG+VA L L W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 383 PIRMNIAIETASALAYLH-ASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439
P R IA+ +A LAYLH D IIHRDVK NILLD F V DFGL++L TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE--INLAN 497
V+TA +GT G++ PEY + ++K+DV+ +GV+L+ELI+ A D+ R ++ + L +
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 498 LAINKIQKCAFDELIDPCLGFE-SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
+++ + L+D L DEEV+++ ++A LC Q + RP M EV+ L
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQL----IQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-115
Identities = 102/323 (31%), Positives = 163/323 (50%), Gaps = 32/323 (9%)
Query: 254 ENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKE------LGDGGFGTVYYGKLKDGR 307
EN+ ++ FS+ +L TN+F +G+GGFG VY G + +
Sbjct: 1 ENKSLEVSDT----RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNT 55
Query: 308 EVAVKRLYDNNYRRVEQ----FMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363
VAVK+L E+ F E++++ + +H+NLV L G +S L LVY ++ N
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPN 114
Query: 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423
G++ D+L L+W +R IA A+ + +LH + IHRD+K+ NILLD F K
Sbjct: 115 GSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK 173
Query: 424 VADFGLSRLFPL-DVTHVSTAPQGTPGYVDPEY---HQCYQLTDKSDVYSFGVVLIELIS 479
++DFGL+R T +++ GT Y+ PE +T KSD+YSFGVVL+E+I+
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE----ITPKSDIYSFGVVLLEIIT 229
Query: 480 SMPAVDMNRHRHEINLANLAINKIQ-KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLC 538
+PAVD + R L ++ + ++ ID + V+ M +A C
Sbjct: 230 GLPAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM----YSVASQC 283
Query: 539 LQQNKELRPSMEEVLAELQRIKS 561
L + K RP +++V LQ + +
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-78
Identities = 73/316 (23%), Positives = 124/316 (39%), Gaps = 37/316 (11%)
Query: 272 FSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI 331
+L + + G FG V+ +L VAVK + + Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 332 LTRLRHKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
L ++H+N++ G + L L+ F G+++D L + +++W +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHI 126
Query: 389 AIETASALAYLHASD----------IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438
A A LAYLH I HRD+K+ N+LL +N +ADFGL+ F +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 439 HVSTAPQ-GTPGYVDPEY-----HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE 492
T Q GT Y+ PE + + D+Y+ G+VL EL S A D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 493 INLANL-----AINKIQKCAFDELIDPCLG--FESDEEVKRMTTSVAELAFLCLQQNKEL 545
+ ++ +Q+ + P L ++ + + E C + E
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML----CETIEECWDHDAEA 302
Query: 546 RPSMEEVLAELQRIKS 561
R S V + +++
Sbjct: 303 RLSAGCVGERITQMQR 318
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-64
Identities = 74/303 (24%), Positives = 130/303 (42%), Gaps = 59/303 (19%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR-------RVEQFMNEVEILT 333
N+ EK++G GGFG V+ G+L D VA+K L + + ++F EV I++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 334 RLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
L H N+V L+G +V EFV G + +L K + W +++ + ++
Sbjct: 79 NLNHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDI 131
Query: 393 ASALAYLHASD--IIHRDVKTNNILLDS-----NFCVKVADFGLSRLFPLDVTHVSTAPQ 445
A + Y+ + I+HRD+++ NI L S C KVADFGLS+ H +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLL 187
Query: 446 GTPGYVDPE----YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAI 500
G ++ PE + Y T+K+D YSF ++L +++ P + + I
Sbjct: 188 GNFQWMAPETIGAEEESY--TEKADTYSFAMILYTILTGEGPFDEYS---------YGKI 236
Query: 501 NKIQKCAFD----ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
I + + + C ++ + C + + RP ++ EL
Sbjct: 237 KFINMIREEGLRPTIPEDC-----PPRLRNVIEL-------CWSGDPKKRPHFSYIVKEL 284
Query: 557 QRI 559
+
Sbjct: 285 SEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-64
Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 46/326 (14%)
Query: 272 FSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI 331
+ S+ + ++ + +G G +G VY G L D R VAVK N + F+NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 332 --LTRLRHKNLVSLFGCTSRYSQG----LLLVYEFVANGTVADQLHGDRAKHGLLTWPIR 385
+ + H N+ R + LLV E+ NG++ L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113
Query: 386 MNIAIETASALAYLHASD---------IIHRDVKTNNILLDSNFCVKVADFGLSRLF--- 433
+A LAYLH I HRD+ + N+L+ ++ ++DFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 434 ----PLDVTHVSTAPQGTPGYVDPEY-------HQCYQLTDKSDVYSFGVVLIELISSMP 482
P + + + + GT Y+ PE + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 483 AVDMNRHRHEINLA-------NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELA 535
+ E +A + +Q E P E+ +E S+ E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVRSLKETI 292
Query: 536 FLCLQQNKELRPSMEEVLAELQRIKS 561
C Q+ E R + + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMM 318
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 6e-64
Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 33/287 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKN 339
+ + +G G FGTVY GK +VAVK L ++++ F NEV +L + RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ G ++ L +V ++ ++ LH K ++IA +TA + YL
Sbjct: 82 ILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYL 136
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF-PLDVTHVSTAPQGTPGYVDPE---Y 455
HA IIHRD+K+NNI L + VK+ DFGL+ +H G+ ++ PE
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 456 HQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL--I 512
+ +SDVY+FG+VL EL++ +P ++N +R +I I+ L
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQI---------IEMVGRGSLSPD 246
Query: 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
+ + +KR+ CL++ ++ RPS +LAE++ +
Sbjct: 247 LSKVRSNCPKRMKRLMAE-------CLKKKRDERPSFPRILAEIEEL 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-63
Identities = 86/290 (29%), Positives = 140/290 (48%), Gaps = 38/290 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKN 339
D + ++++G G FGTV+ + G +VAVK L + ++ RV +F+ EV I+ RLRH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V G T L +V E+++ G++ LH A+ L R+++A + A + Y
Sbjct: 96 IVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNY 152
Query: 399 LHASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
LH + I+HR++K+ N+L+D + VKV DFGLSRL S + GTP ++ PE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVL 211
Query: 457 QCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD----EL 511
+ +KSDVYSFGV+L EL + P ++N + + F E+
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLN---------PAQV--VAAVGFKCKRLEI 260
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
+ +V + C RPS ++ L+ +
Sbjct: 261 PRNL-----NPQVAAIIEG-------CWTNEPWKRPSFATIMDLLRPLIK 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-63
Identities = 71/286 (24%), Positives = 134/286 (46%), Gaps = 36/286 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ E+ +G G FG V K + ++VA+K++ + R + F+ E+ L+R+ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+G C + LV E+ G++ + LHG T M+ ++ + +AYLH
Sbjct: 65 KLYGACLNPVC----LVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 401 ASD---IIHRDVKTNNILLDSNF-CVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
+ +IHRD+K N+LL + +K+ DFG + D+ T +G+ ++ PE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVF 175
Query: 457 QCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ ++K DV+S+G++L E+I+ P ++ A + + LI
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNGTRPPLIKNL 229
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
+ ++ + T C ++ RPSMEE++ + +
Sbjct: 230 -----PKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-63
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 55/304 (18%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
+D + LG G FG ++ G + +K L + F+ EV+++ L H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 341 VSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+ G + L + E++ GT+ + W R++ A + AS +AYL
Sbjct: 70 LKFIGVLYK--DKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYL 124
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-------------VSTAPQG 446
H+ +IIHRD+ ++N L+ N V VADFGL+RL + T G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 447 TPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKI 503
P ++ PE + Y +K DV+SFG+VL E+I D + L
Sbjct: 185 NPYWMAPEMINGRSY--DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------ 236
Query: 504 QKCAFDELIDPCLGFESDEEVKRMT------TSVAELAFLCLQQNKELRPSMEEVLAELQ 557
S + C + E RPS ++ L+
Sbjct: 237 ------------------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
Query: 558 RIKS 561
++
Sbjct: 279 TLRM 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-62
Identities = 54/291 (18%), Positives = 122/291 (41%), Gaps = 43/291 (14%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKN 339
+ +L + G ++ G+ + G ++ VK L ++ R+ F E L H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
++ + G C S + L+ ++ G++ + LH + ++ + A++ A +A+
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAF 126
Query: 399 LHASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-- 454
LH + I + + ++++D + +++ + F S P +V PE
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL 180
Query: 455 YHQCYQL-TDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL- 511
+ +D++SF V+L EL++ +P D++ N+ I K A + L
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------NMEI--GMKVALEGLR 229
Query: 512 --IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
I P + V ++ C+ ++ RP + ++ L++++
Sbjct: 230 PTIPPGI----SPHVSKLMKI-------CMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 9e-61
Identities = 61/300 (20%), Positives = 108/300 (36%), Gaps = 52/300 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKN 339
+ +G G FG VY+G+ EVA++ + +++ F EV + RH+N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V G C S L ++ T+ + + L IA E + Y
Sbjct: 91 VVLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGY 145
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL----FPLDVTHVSTAPQGTPGYVDPE 454
LHA I+H+D+K+ N+ D N V + DFGL + G ++ PE
Sbjct: 146 LHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 455 -----------YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502
+ + SDV++ G + EL + P AI
Sbjct: 205 IIRQLSPDTEEDKLPF--SKHSDVFALGTIWYELHAREWPFKTQP---------AEAI-- 251
Query: 503 IQKCAFDE--LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
I + + +E+ + C +E RP+ +++ L+++
Sbjct: 252 IWQMGTGMKPNLSQI---GMGKEISDILLF-------CWAFEQEERPTFTKLMDMLEKLP 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-57
Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 63/303 (20%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRL----YDNNYRRVEQFMNEVEILTRLRH 337
+ + E+ +G GGFG VY G EVAVK ++ + +E E ++ L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 338 KNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
N+++L G C L LV EF G + L G R + I +N A++ A +
Sbjct: 66 PNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGM 118
Query: 397 AYLHAS---DIIHRDVKTNNILLD--------SNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
YLH IIHRD+K++NIL+ SN +K+ DFGL+R T +A
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA- 175
Query: 446 GTPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502
G ++ PE + + SDV+S+GV+L EL++ +P ++ LA+
Sbjct: 176 GAYAWMAPEVIRASMF--SKGSDVWSYGVLLWELLTGEVPFRGID---------GLAV-- 222
Query: 503 IQKCAFDELIDPCLGFESDEEVKRMT------TSVAELAFLCLQQNKELRPSMEEVLAEL 556
A ++L + A+L C + RPS +L +L
Sbjct: 223 AYGVAMNKL--------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
Query: 557 QRI 559
I
Sbjct: 269 TTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 37/301 (12%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI--LTRLRHKNLVSLF 344
K++G G +G V+ GK + G +VAVK + + E EI +RH+N++
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI 97
Query: 345 G-CT--SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ L L+ ++ NG++ D L L + +A + S L +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 402 SD--------IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV---STAPQGTPGY 450
I HRD+K+ NIL+ N +AD GL+ F D V GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 451 VDPE------YHQCYQLTDKSDVYSFGVVLIELIS----SMPAVDMNRHRHEINLANLAI 500
+ PE +Q +D+YSFG++L E+ + H++ ++ +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
+++ + + P F + + +L C N R + V L ++
Sbjct: 273 EDMREIVCIKKLRP--SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 561 S 561
Sbjct: 331 E 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-54
Identities = 67/301 (22%), Positives = 120/301 (39%), Gaps = 41/301 (13%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI--LTRLRHKNLVSLF 344
+ +G G +G V+ G + G VAVK + + + E E+ LRH+N++
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFI 68
Query: 345 GCTSRYSQG---LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L L+ + G++ D L L + I + AS LA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 402 SD--------IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV---STAPQGTPGY 450
I HRD+K+ NIL+ N +AD GL+ + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 451 VDPE------YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHR----HEINLANLAI 500
+ PE C+ + D+++FG+VL E+ M + + +++ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 501 NKIQKCAFDELIDPCL--GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
++K + P + + SD + + A+L C QN R + + L +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSL----AKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 559 I 559
I
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 69/303 (22%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI--LTRLRHKNLVSLF 344
++ +G G FG V+ GK + G EVAVK R + E EI LRH+N++
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFI 102
Query: 345 GCTSRYSQG---LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
++ + L LV ++ +G++ D L+ +T + +A+ TAS LA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 402 S--------DIIHRDVKTNNILLDSNFCVKVADFGLSRLF---PLDVTHVSTAPQGTPGY 450
I HRD+K+ NIL+ N +AD GL+ + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 451 VDPE------YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHR----HEINLANLAI 500
+ PE + ++ ++D+Y+ G+V E+ ++ +++ ++ ++
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 501 NKIQKCAFDELIDPCL--GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
+++K ++ + P + ++S E ++ M A++ C N R + + L +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 559 IKS 561
+
Sbjct: 334 LSQ 336
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 72/294 (24%), Positives = 133/294 (45%), Gaps = 22/294 (7%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVK--RLYDN-NYRRVEQFMNEVEILTRLRH 337
+F EK++G G F VY L DG VA+K +++D + + + E+++L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
N++ + L +V E G ++ + + + L+ ++ SAL
Sbjct: 92 PNVIKYYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
++H+ ++HRD+K N+ + + VK+ D GL R F T + GTP Y+ PE
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH 209
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
KSD++S G +L E+ + + ++NL +L KI++C + L
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSL-CKKIEQCDYPPLPSDHY- 263
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEE 571
S+E + +L +C+ + E RP + V +R+ + + H
Sbjct: 264 --SEE--------LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-47
Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 32/294 (10%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ ++LG+GGF V + L DG A+KR+ + + E+ E ++ H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 342 SLFGCTSRYSQG---LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
L R L+ F GT+ +++ + K LT + + + L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--------GTPGY 450
+HA HRD+K NILL + D G + V A T Y
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 451 VDPEYHQCYQ---LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507
PE + +++DV+S G VL ++ DM ++ +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV------FQKGDSVALAVQNQ 263
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
P R ++++ +L + + RP + +L++L+ ++
Sbjct: 264 LSIPQSP-----------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 73/306 (23%), Positives = 120/306 (39%), Gaps = 52/306 (16%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
DF + +G GGFG V+ K DG+ +KR+ Y E+ EV+ L +L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNN-EKAEREVKALAKLDHVNI 66
Query: 341 VSLFGC---------------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR 385
V GC + ++ L + EF GT+ + + + L +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
+ + + + Y+H+ +I+RD+K +NI L VK+ DFGL D +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 446 GTPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503
GT Y+ PE Q Y + D+Y+ G++L EL+ + E + +
Sbjct: 183 GTLRYMSPEQISSQDY--GKEVDLYALGLILAELLH------VCDTAFETS--KF-FTDL 231
Query: 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563
+ ++ D L L + E RP+ E+L L K
Sbjct: 232 RDGIISDIFDKKE---------------KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
Query: 564 SKFEIH 569
K E H
Sbjct: 277 EKNERH 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 74/334 (22%), Positives = 138/334 (41%), Gaps = 28/334 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHK 338
+ R +++G+G FG K +DGR+ +K + + + E+ EV +L ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V + L +V ++ G + +++ K L ++ ++ AL +
Sbjct: 84 NIVQYRESFEE-NGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKH 140
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
+H I+HRD+K+ NI L + V++ DFG++R+ V GTP Y+ PE +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICEN 199
Query: 459 YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+KSD+++ G VL EL + A + ++ NL + KI +F +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNL-VLKIISGSFPPV--S---- 246
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREG 578
+ + L ++N RPS+ +L E I KF + + +
Sbjct: 247 ------LHYSYDLRSLVSQLFKRNPRDRPSVNSIL-EKGFIAKRIEKF-LSPQLIAEEFC 298
Query: 579 IKCTQPPPSPPYCDEDSLLKNMRLPSSPISVTEK 612
+K S P + + P K
Sbjct: 299 LKTFSKFGSQPIPAKRPASGQNSISVMPAQKITK 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-45
Identities = 74/283 (26%), Positives = 130/283 (45%), Gaps = 46/283 (16%)
Query: 286 REKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVS 342
+ E+G G F TVY G + EVA L D + ++F E E+L L+H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 343 LFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+ T + + ++LV E + +GT+ L + ++ + + + L +L
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 145
Query: 400 HASD--IIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-Y 455
H IIHRD+K +NI + VK+ D GL+ L + GTP ++ PE Y
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAV-IGTPEFMAPEMY 202
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL---AINKIQKCAFDELI 512
+ Y + DVY+FG+ ++E+ +S + N A + + ++ +FD++
Sbjct: 203 EEKY--DESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 513 DPCLGFESDEEVKRMTTSVAELAFL--CLQQNKELRPSMEEVL 553
P EVK + C++QNK+ R S++++L
Sbjct: 256 IP--------EVKE---------IIEGCIRQNKDERYSIKDLL 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 29/282 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHK 338
D+ +G G +G + DG+ + K + ++EV +L L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 339 NLVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
N+V + R + L +V E+ G +A + + L + + + AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 398 YLH-----ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
H ++HRD+K N+ LD VK+ DFGL+R+ D + T GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMS 184
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512
PE +KSD++S G +L EL + MP + L KI++ F +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKEL-AGKIREGKFRRI- 236
Query: 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
P R + + E+ L RPS+EE+L
Sbjct: 237 -P----------YRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 53/296 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR-VEQFMNEVEILTRLRHKN 339
D +++G G FG V+ G+L+ D VAVK + +F+ E IL + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V L G CT + Q + +V E V G L R + L + + + A+ + Y
Sbjct: 174 IVRLIGVCTQK--QPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TPGYVD 452
L + IHRD+ N L+ +K++DFG+SR D + ++ T
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTA---- 283
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
PE + + +SDV+SFG++L E S + P +++ + ++K
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--------TREFVEK----- 330
Query: 511 LIDPCLGFESDEEVKRMT------TSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
G R+ +V L C RPS + ELQ I+
Sbjct: 331 ------GG-------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 70/301 (23%), Positives = 112/301 (37%), Gaps = 54/301 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKN 339
DF + LG GGFG V+ K K D A+KR+ N E+ M EV+ L +L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 340 LVSLFGC-----------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
+V F S L + + + D ++ R + ++I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHI 123
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--- 445
++ A A+ +LH+ ++HRD+K +NI + VKV DFGL D +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 446 --------GTPGYVDPEYHQC----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI 493
GT Y+ PE Q Y + K D++S G++L EL+ M R
Sbjct: 184 YARHTGQVGTKLYMSPE--QIHGNSY--SHKVDIFSLGLILFELLYPFST-QMER----- 233
Query: 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ ++ F L + E + L + RP ++
Sbjct: 234 ---VRTLTDVRNLKFPPLFTQ----KYPCE--------YVMVQDMLSPSPMERPEAINII 278
Query: 554 A 554
Sbjct: 279 E 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-44
Identities = 68/320 (21%), Positives = 117/320 (36%), Gaps = 56/320 (17%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
+DF LG G FG V + D R A+K++ + ++ ++EV +L L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 340 LVSLFGC------------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-M 386
+V + + L + E+ NGT+ D +H L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYW 119
Query: 387 NIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ- 445
+ + AL+Y+H+ IIHRD+K NI +D + VK+ DFGL++ + + Q
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 446 ------------GTPGYVDPEYHQCYQLTD---KSDVYSFGVVLIELISSMPAVDMNRHR 490
GT YV E K D+YS G++ E+I + M R
Sbjct: 180 LPGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYP-FSTGMER-- 234
Query: 491 HEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSME 550
+ K++ + + P + K++ + + RP
Sbjct: 235 ------VNILKKLRSVSIE--FPPDFDDNKMKVEKKIIRL-------LIDHDPNKRPGAR 279
Query: 551 EVLAELQRIKSGKSKFEIHE 570
+L + I E
Sbjct: 280 TLL-NSGWLPVKHQDEVIKE 298
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 39/286 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
E +LG G FG V+ G VA+K L E F+ E +++ +LRH+ LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ S + + +V E+++ G++ D L G+ K+ L P +++A + AS +AY+
Sbjct: 243 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER 298
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+ +HRD++ NIL+ N KVADFGL+RL + + + PE +
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 462 TDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
T KSDV+SFG++L EL + +P M ++++++ G+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVER-----------GY- 398
Query: 520 SDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
RM S+ +L C ++ E RP+ E + A L+
Sbjct: 399 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-42
Identities = 81/306 (26%), Positives = 132/306 (43%), Gaps = 40/306 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
D + + +LG G +G VY G K VAVK L ++ E+F+ E ++ ++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 278
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V L G +R ++ EF+ G + D L + ++ + + +A + +SA+ YL
Sbjct: 279 VQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE 335
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+ IHR++ N L+ N VKVADFGLSRL D + + PE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 461 LTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+ KSDV++FGV+L E+ + P ++ + ++K +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEK-----------DY 436
Query: 519 ESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEK 572
RM V EL C Q N RPS E+ + + +S EK
Sbjct: 437 -------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-ESSISDEVEK 488
Query: 573 QDDREG 578
+ + G
Sbjct: 489 ELGKRG 494
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 55/294 (18%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
++ + +E+G G FG V+ G + +VA+K + + E F+ E E++ +L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 66
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+G C + LV EF+ +G ++D L R + GL + + ++ +AYL
Sbjct: 67 QLYGVCLE--QAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TPGYVDP 453
+ +IHRD+ N L+ N +KV+DFG++R D T+ G P
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWAS----P 174
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
E + + KSDV+SFGV++ E+ S +P + + + I
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDIST------ 220
Query: 512 IDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
GF R+ +T V ++ C ++ E RP+ +L +L I
Sbjct: 221 -----GF-------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-42
Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 39/286 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
E +LG G FG V+ G VA+K L E F+ E +++ +LRH+ LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ S + + +V E+++ G++ D L G+ K+ L P +++A + AS +AY+
Sbjct: 326 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER 381
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+ +HRD++ NIL+ N KVADFGL+RL + + + PE +
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 462 TDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
T KSDV+SFG++L EL + +P M ++++++ G+
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVER-----------GY- 481
Query: 520 SDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
RM S+ +L C ++ E RP+ E + A L+
Sbjct: 482 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 70/309 (22%), Positives = 116/309 (37%), Gaps = 59/309 (19%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK----DGREVAVKRL---YDNNYRRVEQFMNEVEILTR 334
D ++LGDG FG V G+ VAVK L + ++ F+ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 335 LRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
L H+NL+ L+G + + +V E G++ D+L + A++ A
Sbjct: 78 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVA 131
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------T 447
+ YL + IHRD+ N+LL + VK+ DFGL R P + H
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQK 505
PE + + SD + FGV L E+ + P + +N +I ++KI K
Sbjct: 192 A----PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQI------LHKIDK 239
Query: 506 CAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
R+ + + C E RP+ + L
Sbjct: 240 EGE-----------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
Query: 560 K--SGKSKF 566
+ +++F
Sbjct: 283 QPTDMRAEF 291
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-42
Identities = 69/294 (23%), Positives = 128/294 (43%), Gaps = 57/294 (19%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ + +G G FG V G + G +VAVK + ++ + F+ E ++T+LRH NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L G GL +V E++A G++ D L L + +++ A+ YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG 307
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TPGYVDPE 454
++ +HRD+ N+L+ + KV+DFGL++ S+ T PE
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----PE 356
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512
+ + + KSDV+SFG++L E+ S +P + + +++K
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEK------- 401
Query: 513 DPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
G+ +M +V ++ C + RP+ ++ +L+ I+
Sbjct: 402 ----GY-------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 72/299 (24%), Positives = 120/299 (40%), Gaps = 36/299 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-----DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR 336
++LG G FG+V + G VAVK+L + + F E+EIL L+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H N+V G C S + L L+ E++ G++ D L + + + + +
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKG 126
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TP 448
+ YL IHRD+ T NIL+++ VK+ DFGL+++ P D +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKEPGESPIFWYA 185
Query: 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508
PE + + SDV+SFGVVL EL + + + I
Sbjct: 186 ----PESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGNDKQ 233
Query: 509 DELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
++I L E + R+ + + C N RPS ++ + +I+
Sbjct: 234 GQMIVFHL-IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ + KELG G FG V GK K +VAVK + + ++F E + + +L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLV 66
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+G C+ + +V E+++NG + + L R+ L + + + +A+L
Sbjct: 67 KFYGVCSK--EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TPGYVDP 453
+ IHRD+ N L+D + CVKV+DFG++R D + G + P
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSA----P 174
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELIS 479
E ++ + KSDV++FG+++ E+ S
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 84/308 (27%), Positives = 126/308 (40%), Gaps = 35/308 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-----DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR 336
+LG G FG+V + G VAVK+L + + F E++IL L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+V G Q L LV E++ +G + D L RA+ L + + +
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKG 139
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVD-- 452
+ YL + +HRD+ NIL++S VK+ADFGL++L PLD + V P +P +
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IFWY 197
Query: 453 -PEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE + +SDV+SFGVVL EL + +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL------S 251
Query: 510 ELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563
L+ E EE +R+ V EL LC + + RPS + +L + SG
Sbjct: 252 RLL------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
Query: 564 SKFEIHEE 571
E H
Sbjct: 306 RGCETHAF 313
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-41
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
EK+LG G FG V+ +VAVK + + E F+ E ++ L+H LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLV 246
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L ++ + + ++ EF+A G++ D L D P ++ + + A +A++
Sbjct: 247 KLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQ 302
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD---PEYHQC 458
+ IHRD++ NIL+ ++ K+ADFGL+R+ + TA +G + PE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINF 359
Query: 459 YQLTDKSDVYSFGVVLIELIS 479
T KSDV+SFG++L+E+++
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ LG G FG V+ G +VAVK L + F+ E ++ +L+H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ ++ + + ++ E++ NG++ D L LT +++A + A +A++
Sbjct: 72 RLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE 127
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TPGYVDPE 454
+ IHRD++ NIL+ K+ADFGL+RL + TA +G T PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTA----PE 180
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS 479
T KSDV+SFG++L E+++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 73/298 (24%), Positives = 121/298 (40%), Gaps = 34/298 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR 336
++LG G FG+V + G VAVK+L + + F E+EIL L+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H N+V G C S + L L+ E++ G++ D L + + + + +
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKG 157
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TPG 449
+ YL IHRD+ T NIL+++ VK+ DFGL+++ P D + G
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA- 216
Query: 450 YVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE + + SDV+SFGVVL EL + + + I
Sbjct: 217 ---PESLTESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGNDKQG 265
Query: 510 ELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
++I L E + R+ + + C N RPS ++ + +I+
Sbjct: 266 QMIVFHL-IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
D + KELG G FG V YGK + +VA+K + + ++F+ E +++ L H+ LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 82
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+G CT + + ++ E++ANG + + L R + + + A+ YL
Sbjct: 83 QLYGVCTK--QRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TPGYVDP 453
+ +HRD+ N L++ VKV+DFGLSR D T+ G +P P
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSP----P 190
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELIS 479
E + + KSD+++FGV++ E+ S
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 85/315 (26%), Positives = 132/315 (41%), Gaps = 58/315 (18%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGR-EVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
D + + +LG G +G VY G K VAVK L ++ VE+F+ E ++ ++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V L G +R ++ EF+ G + D L + ++ + + +A + +SA+ YL
Sbjct: 72 VQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE 128
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS---------TAPQGTPGYV 451
+ IHRD+ N L+ N VKVADFGLSRL D TA
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA-------- 180
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE + + KSDV++FGV+L E+ + P ++ + ++K
Sbjct: 181 -PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEK---- 227
Query: 510 ELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563
+ RM V EL C Q N RPS E+ + +
Sbjct: 228 -------DY-------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
Query: 564 SKFEIHEEKQDDREG 578
S EK+ + G
Sbjct: 274 S-ISDEVEKELGKRG 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 69/297 (23%), Positives = 125/297 (42%), Gaps = 36/297 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-----DGREVAVKRL-YDNNYRRVEQFMNEVEILTRL 335
R ++LG+G FG V + G +VAVK L ++ + E+EIL L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 336 RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H+N+V G CT G+ L+ EF+ +G++ + L ++ K + ++ A++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICK 137
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TP 448
+ YL + +HRD+ N+L++S VK+ DFGL++ D + +
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508
PE + SDV+SFGV L EL++ + + K+
Sbjct: 198 ----PECLMQSKFYIASDVWSFGVTLHELLT---------YCDSDSSPMALFLKMIGPTH 244
Query: 509 DELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
++ L + +E KR+ V +L C + R S + ++ + +
Sbjct: 245 GQMTVTRL-VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ + +G G FG V G + G +VAVK + ++ + F+ E ++T+LRH NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L G GL +V E++A G++ D L L + +++ A+ YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG 135
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG-------TPGYVDPE 454
++ +HRD+ N+L+ + KV+DFGL++ S+ T PE
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----PE 184
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS 479
+ + + KSDV+SFG++L E+ S
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 38/300 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-----GREVAVKRL-YDNNYRRVEQFMNEVEILTRL 335
+ ++LG+G FG V G VAVK L D + + E++IL L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 336 RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H++++ G C + L LV E+V G++ D L L + A +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICE 145
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TP 448
+AYLHA IHRD+ N+LLD++ VK+ DFGL++ P + G
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 449 GYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508
PE + Y+ SDV+SFGV L EL++ H ++ A
Sbjct: 206 ----PECLKEYKFYYASDVWSFGVTLYELLT---------HCDSSQSPPTKFLELIGIAQ 252
Query: 509 DELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562
++ L E E +R+ V L C + RP+ E ++ L+ +
Sbjct: 253 GQMTVLRL-TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 61/294 (20%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKN 339
+S K++G GG V+ + + A+K L + + + ++ + NE+ L +L+ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 340 L--VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+ L+ T +Y + +V E N + L K + R + A
Sbjct: 88 DKIIRLYDYEITDQY---IYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEA 139
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTPGYVDPE 454
+ +H I+H D+K N L+ +K+ DFG++ D T V Q GT Y+ PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 455 -----------YHQCYQLTDKSDVYSFGVVLIELISSMP----AVDMNRHRHEINLANLA 499
+++ KSDV+S G +L + ++ H I N
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 500 INKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
I F ++ + + ++ CL+++ + R S+ E+L
Sbjct: 259 IE------FPDIPEK---------------DLQDVLKCCLKRDPKQRISIPELL 291
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-40
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 27/306 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR-VEQFMNEVEILTRLRHKN 339
+ + LG G V+ G+ K G A+K + ++ R V+ M E E+L +L HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 340 LVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V LF ++ +L+ EF G++ L + + L + + + + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 399 LHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
L + I+HR++K NI+ D K+ DFG +R D VS GT Y+ P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185
Query: 455 YHQCYQLTD--------KSDVYSFGVVLIELIS-SMPAVDMNRHRHEINL--------AN 497
++ L D++S GV + S+P R + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
AI+ +QK + S + + + + L+ ++E ++ AE
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 558 RIKSGK 563
I
Sbjct: 306 DILHRG 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 44/290 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKN 339
+S K++G GG V+ + + A+K L + + + ++ + NE+ L +L+ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 340 L--VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+ L+ T +Y + +V E N + L K + R + A
Sbjct: 69 DKIIRLYDYEITDQY---IYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEA 120
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTPGYVDPE 454
+ +H I+H D+K N L+ +K+ DFG++ D T V Q GT Y+ PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 455 -----------YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503
+++ KSDV+S G +L + ++ ++ I
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAI 233
Query: 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + + +K CL+++ + R S+ E+L
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKC-----------CLKRDPKQRISIPELL 272
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 74/328 (22%), Positives = 119/328 (36%), Gaps = 49/328 (14%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLF 344
+ L +GGF VY + + GRE A+KRL N + + EV + +L H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 345 GCT------SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
S Q L+ + G + + L G L+ + I +T A+ +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 399 LHASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ----------- 445
+H IIHRD+K N+LL + +K+ DFG + + +A +
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 446 GTPGYVDPEYHQCYQ---LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502
TP Y PE Y + +K D+++ G +L L + A +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-----------AKLR 260
Query: 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562
I + T L LQ N E R S+ EV+ +LQ I +
Sbjct: 261 IVNGKYSIPPHD-----------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
Query: 563 KSKF--EIHEEKQDDREGIKCTQPPPSP 588
++ E + G P
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 66/303 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE-----VAVKRLYDNNYRRVEQ-FMNEVEILTRL 335
+F + K LG G FGTVY G E VA+K L + + + ++E ++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 336 RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+ ++ L G C + + L+ + + G + D + R + +N ++ A
Sbjct: 75 DNPHVCRLLGICLT---STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAK 128
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS----------TAP 444
+ YL ++HRD+ N+L+ + VK+ DFGL++L + A
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA- 187
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINK 502
E T +SDV+S+GV + EL++ S P + EI +
Sbjct: 188 --------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI------SSI 231
Query: 503 IQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAEL 556
++K G R+ T V + C + + RP E++ E
Sbjct: 232 LEK-----------GE-------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273
Query: 557 QRI 559
++
Sbjct: 274 SKM 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-39
Identities = 58/290 (20%), Positives = 118/290 (40%), Gaps = 44/290 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRLRHKN 339
+S K++G GG V+ + + A+K L + + + ++ + NE+ L +L+ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 340 L--VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+ L+ T +Y + +V E N + L K + R + A
Sbjct: 116 DKIIRLYDYEITDQY---IYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEA 167
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTPGYVDPE 454
+ +H I+H D+K N L+ +K+ DFG++ D T V Q G Y+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 455 -----------YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503
+++ KSDV+S G +L + + ++I+ + I+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPN 284
Query: 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ F ++ + + ++ CL+++ + R S+ E+L
Sbjct: 285 HEIEFPDIPEK---------------DLQDVLKCCLKRDPKQRISIPELL 319
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 287 EKELGDGGFGTVYYGKLKDGRE---VAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ ELG G FG+V G + ++ VA+K L E+ M E +I+ +L + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 343 LFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L G C + + L+LV E G + L K + + + + + YL
Sbjct: 75 LIGVCQA---EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TPGYVDPEY 455
+ +HRD+ N+LL + K++DFGLS+ D ++ + G PE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PEC 184
Query: 456 HQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
+ + +SDV+S+GV + E +S P M E+ + I++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV------MAFIEQ-------- 228
Query: 514 PCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRI-KSGKSKF 566
G RM + L C E RP V ++ S SK
Sbjct: 229 ---GK-------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
Query: 567 EIHEEKQ 573
E H
Sbjct: 279 EGHHHHH 285
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 83/361 (22%), Positives = 146/361 (40%), Gaps = 65/361 (18%)
Query: 272 FSYSDLAEATNDFSRE---------KELGDGGFGTVYYGKLKDGRE----VAVKRL-YDN 317
++ D + ++F++E K +G G FG V G+LK + VA+K L
Sbjct: 26 HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 318 NYRRVEQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAK 376
++ F+ E I+ + H N++ L G T S+ +++V E++ NG++ L R
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFL---RKH 140
Query: 377 HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
T + + AS + YL +HRD+ NIL++SN KV+DFGL R+ D
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 437 VTHVSTAPQG------TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNR 488
T G T PE + T SDV+S+G+VL E++S P +M+
Sbjct: 201 PEAAYTTRGGKIPIRWTS----PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 489 HRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQN 542
I + + G+ R+ ++ +L C Q++
Sbjct: 257 QD--------VIKAVDE-----------GY-------RLPPPMDCPAALYQLMLDCWQKD 290
Query: 543 KELRPSMEEVLAELQR-IKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSLLKNMR 601
+ RP E++++ L + I++ S I + + L +
Sbjct: 291 RNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVW 350
Query: 602 L 602
Sbjct: 351 T 351
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 77/340 (22%), Positives = 134/340 (39%), Gaps = 71/340 (20%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE-----VAVKRLYDNNYRR-VEQFMNEVEILTRL 335
+ + K LG G FGTV+ G E V +K + D + R+ + + + + L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 336 RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H ++V L G C L LV +++ G++ D + R G L + +N ++ A
Sbjct: 73 DHAHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAK 126
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS----------TAP 444
+ YL ++HR++ N+LL S V+VADFG++ L P D + A
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA- 185
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINK 502
E + T +SDV+S+GV + EL++ + P + E+ +
Sbjct: 186 --------LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEV------PDL 229
Query: 503 IQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAEL 556
++K G R+ T V + C ++ +RP+ +E+ E
Sbjct: 230 LEK-----------GE-------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271
Query: 557 QRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDEDSL 596
R+ ++ RE P P P L
Sbjct: 272 TRMARDPPRY-----LVIKRESGPGIAPGPEPHGLTNKKL 306
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 77/320 (24%), Positives = 133/320 (41%), Gaps = 64/320 (20%)
Query: 269 VPIFSYSDLAEATNDFSRE---------KELGDGGFGTVYYGKLKDGRE----VAVKRLY 315
+Y + A F+RE K +G G G V YG+L+ + VA+K L
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 316 DNN-YRRVEQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGD 373
R+ F++E I+ + H N++ L G T + ++V E++ NG++ L
Sbjct: 87 AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFL--- 141
Query: 374 RAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
R G T + + + + YL +HRD+ N+L+DSN KV+DFGLSR+
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 434 PLDVTHVSTAPQG------TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVD 485
D T G T PE + SDV+SFGVV+ E+++ P +
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 486 MNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCL 539
M I+ +++ G+ R+ ++ +L C
Sbjct: 258 MTNRD--------VISSVEE-----------GY-------RLPAPMGCPHALHQLMLDCW 291
Query: 540 QQNKELRPSMEEVLAELQRI 559
+++ RP ++++ L +
Sbjct: 292 HKDRAQRPRFSQIVSVLDAL 311
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 82/350 (23%), Positives = 140/350 (40%), Gaps = 70/350 (20%)
Query: 269 VPIFSYSDLAEATNDFSRE---------KELGDGGFGTVYYGKLKDGRE-----VAVKRL 314
SD +A F+ E K +G G FG VY G LK VA+K L
Sbjct: 22 FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL 81
Query: 315 YDNN-YRRVEQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHG 372
++ F+ E I+ + H N++ L G + + ++++ E++ NG + L
Sbjct: 82 KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFL-- 137
Query: 373 DRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432
R K G + + + A+ + YL + +HRD+ NIL++SN KV+DFGLSR+
Sbjct: 138 -REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
Query: 433 FPLDVTHVSTAPQG-------TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPA 483
D + G T PE + T SDV+SFG+V+ E+++ P
Sbjct: 197 L-EDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
Query: 484 VDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFL 537
+++ H + I GF R+ +++ +L
Sbjct: 252 WELSNHE--------VMKAIND-----------GF-------RLPTPMDCPSAIYQLMMQ 285
Query: 538 CLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPS 587
C QQ + RP ++++ L ++ + D + P S
Sbjct: 286 CWQQERARRPKFADIVSILDKLIRAPDSL---KTLADFDPRVSIRLPSTS 332
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-39
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 43/287 (14%)
Query: 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLV 341
F + LG G GT+ Y + D R+VAVKR+ + ++ EV++L H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
F CT + Q + E A T+ + + K + + +T S LA+LH+
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 402 SDIIHRDVKTNNILL-----DSNFCVKVADFGLSRLFPLDV--THVSTAPQGTPGYVDPE 454
+I+HRD+K +NIL+ ++DFGL + + + GT G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 455 -----YHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCA 507
+ T D++S G V +IS S P + + I + C+
Sbjct: 197 MLSEDCKENP--TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LLGACS 246
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
D L D + EL + + + RPS + VL
Sbjct: 247 LDCLHPEK---HEDVIAR-------ELIEKMIAMDPQKRPSAKHVLK 283
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 69/301 (22%), Positives = 111/301 (36%), Gaps = 64/301 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE----VAVKRL-YDNNYRRVEQFMNEVEILTRLR 336
D + LG+G FG VY G + + VAVK D E+FM+E I+ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H ++V L G + ++ E G + L L + +++ A
Sbjct: 72 HPHIVKLIGIIEE---EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKA 125
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS---------TAPQG 446
+AYL + + +HRD+ NIL+ S CVK+ DFGLSR + + + +
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS--- 182
Query: 447 TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQ 504
PE + T SDV+ F V + E++S P + I ++
Sbjct: 183 ------PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLE 228
Query: 505 KCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
K G R+ + L C + RP E++ L
Sbjct: 229 K-----------GD-------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
Query: 559 I 559
+
Sbjct: 271 V 271
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 71/308 (23%), Positives = 118/308 (38%), Gaps = 57/308 (18%)
Query: 286 REKELGDGGFGTVYYGKLKDGR---EVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNL 340
+KELG G FGTV G + + VAVK L + + ++ + E ++ +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 341 VSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
V + G C + + +LV E G + L ++ + + + + + + YL
Sbjct: 81 VRMIGICEA---ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYL 133
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TPGYVDP 453
S+ +HRD+ N+LL + K++DFGLS+ D + G P
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----P 189
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
E Y+ + KSDV+SFGV++ E S P M E+ ++K
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEV------TAMLEK------ 235
Query: 512 IDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSK 565
G RM + +L LC + E RP V L+
Sbjct: 236 -----GE-------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283
Query: 566 FEIHEEKQ 573
H
Sbjct: 284 EGHHHHHH 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 27/306 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR-VEQFMNEVEILTRLRHKN 339
+ + LG G V+ G+ K G A+K + ++ R V+ M E E+L +L HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 340 LVSLFGC-TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V LF ++ +L+ EF G++ L + + L + + + + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 399 LHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
L + I+HR++K NI+ D K+ DFG +R D VS GT Y+ P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185
Query: 455 YHQCYQLTD--------KSDVYSFGVVLIELIS-SMPAVDMNRHRHEINL--------AN 497
++ L D++S GV + S+P R + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557
AI+ +QK + S + + + + L+ ++E ++ AE
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 558 RIKSGK 563
I
Sbjct: 306 DILHRM 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNN---YRRVEQFMNEVEILTRLRH 337
DF + LG G FG VY + K +A+K L+ Q EVEI + LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
N++ L+G + + L+ E+ GTV +L K E A+A
Sbjct: 69 PNILRLYGYFHDATR---VYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANA 121
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
L+Y H+ +IHRD+K N+LL S +K+ADFG S P GT Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYLPPEM 178
Query: 455 -YHQCYQLTDKSDVYSFGVVLIELI 478
+ + +K D++S GV+ E +
Sbjct: 179 IEGRMH--DEKVDLWSLGVLCYEFL 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 35/323 (10%), Positives = 77/323 (23%), Gaps = 52/323 (16%)
Query: 267 FGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLY---DNNYRRV 322
S L++ + L G V+ + + + A+K +N+ +
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106
Query: 323 EQFMNEVEILTRLRHKNLVSLF-------------------------GCTSRYSQGLLLV 357
E+ RL ++ G LL+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 358 YEFVA--NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415
+ + L G + + A L + ++H +N+
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 416 LDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVV 473
+ + + + D V A Y E+ T + + G+
Sbjct: 227 IMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 474 LIELISSMP--AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSV 531
+ + + + +L + AF + V
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG-------------SCTPLPDFV 329
Query: 532 AELAFLCLQQNKELRPSMEEVLA 554
L L ++ R E +
Sbjct: 330 KTLIGRFLNFDRRRRLLPLEAME 352
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 64/301 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE----VAVKRLYDN-NYRRVEQFMNEVEILTRLR 336
+ +G+G FG V+ G VA+K + + E+F+ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H ++V L G T + ++ E G + L + + L + A + ++A
Sbjct: 75 HPHIVKLIGVITE---NPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTA 128
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS---------TAPQG 446
LAYL + +HRD+ N+L+ SN CVK+ DFGLSR + + A
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA--- 185
Query: 447 TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQ 504
PE + T SDV+ FGV + E++ P + + I +I+
Sbjct: 186 ------PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIE 231
Query: 505 KCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
G R+ ++ L C + RP E+ A+L
Sbjct: 232 N-----------GE-------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273
Query: 559 I 559
I
Sbjct: 274 I 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 59/289 (20%), Positives = 105/289 (36%), Gaps = 41/289 (14%)
Query: 275 SDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF-MNEVEIL 332
+ E + + + +G G FG V+ K + G + AVK++ R+E F + E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVAC 104
Query: 333 TRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
L +V L+G R + + E + G++ + + G L + +
Sbjct: 105 AGLSSPRIVPLYGA-VREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQA 159
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAP----QGT 447
L YLH I+H DVK +N+LL S+ + DFG + D S GT
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKC 506
++ PE K D++S +++ +++ P R KI
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCLKIAS- 270
Query: 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFL--CLQQNKELRPSMEEVL 553
+P E + + L++ R S E+
Sbjct: 271 ------EPPPIREIPPSC-----APLTAQAIQEGLRKEPVHRASAMELR 308
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDN---NYRRVEQFMNEVEILTRLRH 337
+DF + LG G FG VY + K +A+K L+ + Q E+EI + LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
N++ ++ + + L+ EF G + +L KHG E A A
Sbjct: 74 PNILRMYNYFHDRKR---IYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADA 126
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
L Y H +IHRD+K N+L+ +K+ADFG S P GT Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEM 183
Query: 455 -YHQCYQLTDKSDVYSFGVVLIELI 478
+ + +K D++ GV+ E +
Sbjct: 184 IEGKTH--DEKVDLWCAGVLCYEFL 206
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 65/277 (23%), Positives = 102/277 (36%), Gaps = 35/277 (12%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVK--RLYDNNYRRVEQFMNEVEILTRL-RHK 338
F R LG G +G V+ + K DGR AVK + + + EV ++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
V L L L E ++ A L +T ALA+
Sbjct: 118 CCVRLEQAWEEGGI-LYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ- 457
LH+ ++H DVK NI L K+ DFGL L +G P Y+ PE Q
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQEGDPRYMAPELLQG 230
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
Y +DV+S G+ ++E+ +M ++ F +
Sbjct: 231 SY--GTAADVFSLGLTILEVACNMELPHGGEGWQQL------RQGYLPPEFTAGL----- 277
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
S E + + + L+ + +LR + E +LA
Sbjct: 278 --SSE--------LRSVLVMMLEPDPKLRATAEALLA 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 70/346 (20%), Positives = 131/346 (37%), Gaps = 69/346 (19%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGRE-----VAVKRLYDNNYRRVEQ-FMNEVEILTRL 335
+F + K LG G FGTVY G E VA+K L + + + ++E ++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 336 RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+ ++ L G C + + L+ + + G + D + R + +N ++ A
Sbjct: 75 DNPHVCRLLGICLT---STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAK 128
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS----------TAP 444
+ YL ++HRD+ N+L+ + VK+ DFGL++L + A
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA- 187
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINK 502
E T +SDV+S+GV + EL++ S P + EI +
Sbjct: 188 --------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI------SSI 231
Query: 503 IQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCLQQNKELRPSMEEVLAEL 556
++K G R+ T V + C + + RP E++ E
Sbjct: 232 LEK-----------GE-------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
Query: 557 QRIKSGKSKFEIHEEKQDDREGI-KCTQPPPSPPYCDEDSLLKNMR 601
++ + + D+R + T DE+ + +
Sbjct: 274 SKMA--RDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 317
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 78/314 (24%), Positives = 135/314 (42%), Gaps = 37/314 (11%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ LG GG V+ + L+D R+VAVK L + +F E + L H +V+
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 343 LF--GCTSRYSQGLL-LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
++ G + L +V E+V T+ D +H G +T + + + AL +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 132
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPEYHQ 457
H + IIHRDVK NI++ + VKV DFG++R V+ GT Y+ PE +
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 458 CYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
+ +SDVYS G VL E+++ P + ++ +A ++ ++ I P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVS-VAYQHVR----EDPIPP-- 239
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKSGKSKFEIHEEKQDD 575
+ ++ + + L +N E R + E+ A+L R+ +G+ +
Sbjct: 240 ----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAE 295
Query: 576 REGIKCTQPPPSPP 589
R T S
Sbjct: 296 R-----TSLLSSAA 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 287 EKELGDGGFGTVYYGKLKDGRE----VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLV 341
++ +G G FG VY+G+ D + A+K L ++VE F+ E ++ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+L G ++ ++ +G + + + T ++ ++ A + YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLAE 142
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQG------TPGYVDPE 454
+HRD+ N +LD +F VKVADFGL+R + + V T E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LE 198
Query: 455 --YHQCYQLTDKSDVYSFGVVLIELIS 479
+ T KSDV+SFGV+L EL++
Sbjct: 199 SLQTYRF--TTKSDVWSFGVLLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 275 SDLAEATNDFSRE---------KELGDGGFGTVYYGKLKDGRE----VAVKRLYDN-NYR 320
+L +A + +G G FG VY+G L D AVK L +
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 321 RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLL 380
V QF+ E I+ H N++SL G R L+V ++ +G + + + +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---P 125
Query: 381 TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTH 439
T + ++ A + YL + +HRD+ N +LD F VKVADFGL+R ++ +
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 440 VSTAPQG------TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
V E Q + T KSDV+SFGV+L EL++
Sbjct: 186 VHNKTGAKLPVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 58/310 (18%), Positives = 108/310 (34%), Gaps = 76/310 (24%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGR--------EVAVKRLYDNNYRRVEQFMNEVEILT 333
D + LG G F ++ G ++ EV +K L + E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 334 RLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
+L HK+LV +G C +LV EFV G++ L + + ++ +A +
Sbjct: 68 KLSHKHLVLNYGVCVC--GDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQL 122
Query: 393 ASALAYLHASDIIHRDVKTNNILLDS--------NFCVKVADFGLSRLFPLDVTHVSTAP 444
A+A+ +L + +IH +V NILL +K++D G+S
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV----------- 171
Query: 445 QGTPGYVDP---------EYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEI 493
+ E + +D +SFG L E+ S P ++ R
Sbjct: 172 LPKDILQERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKPLSALDSQR--- 226
Query: 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRM----TTSVAELAFLCLQQNKELRPSM 549
+ + ++ +A L C+ + RPS
Sbjct: 227 -----KLQFYED-----------RH-------QLPAPKAAELANLINNCMDYEPDHRPSF 263
Query: 550 EEVLAELQRI 559
++ +L +
Sbjct: 264 RAIIRDLNSL 273
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 27/219 (12%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE----VAVKRLYDNNY--RRVEQFMNEVEIL 332
+ + LG G FG+V +LK VAVK L + +E+F+ E +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 333 TRLRHKNLVSLFG-CT----SRYSQGLLLVYEFVANGTVADQLHGDRAKH--GLLTWPIR 385
H ++ L G +++ F+ +G + L R L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
+ ++ A + YL + + IHRD+ N +L + V VADFGLSR + Q
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQ 195
Query: 446 GTPGYV-----DPEYHQCYQLTDKSDVYSFGVVLIELIS 479
G + E T SDV++FGV + E+++
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 70/302 (23%), Positives = 132/302 (43%), Gaps = 39/302 (12%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+LG GG TVY + +VA+K + +++F EV ++L H+N+VS
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 343 LFGCTSRYSQG-----LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+ LV E++ T+++ + HG L+ +N + +
Sbjct: 76 M------IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIK 125
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP-QGTPGYVDPEYH 456
+ H I+HRD+K NIL+DSN +K+ DFG+++ + + T GT Y PE
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQA 184
Query: 457 QCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ + +D+YS G+VL E++ P E ++ +AI IQ D + +
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP------FNGETAVS-IAIKHIQ----DSVPNV- 232
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKSGKSKFEIHEEKQD 574
+ + K + S++ + +++K R +++E+ +L + E E
Sbjct: 233 ----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDK 288
Query: 575 DR 576
+
Sbjct: 289 MK 290
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 54/309 (17%), Positives = 107/309 (34%), Gaps = 53/309 (17%)
Query: 281 TNDFSREKELGDGGFGTVYYG-KLKDGREVAVKR--LYDNNYRRVEQFMNEVEILTRL-R 336
T +F +++G G FG+V+ K DG A+KR + + EV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H ++V F + +L+ E+ G++AD + + ++ ++ L
Sbjct: 70 HSHVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 397 AYLHASDIIHRDVKTNNILLDSN-------------------FCVKVADFGLSRLFPLDV 437
Y+H+ ++H D+K +NI + K+ D G
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 438 THVSTAPQGTPGYVDPE-YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA 496
G ++ E + Y K+D+++ + ++ + P HEI
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG 243
Query: 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
L +I + E + L + + + E RPS ++ +
Sbjct: 244 RLP--RIPQVLSQEFTE--------------------LLKVMIHPDPERRPSAMALV-KH 280
Query: 557 QRIKSGKSK 565
+ S K
Sbjct: 281 SVLLSASRK 289
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 275 SDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDN---NYRRVEQFMNEVE 330
+ + E DF LG G F VY + + G EVA+K + V++ NEV+
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 331 ILTRLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI 388
I +L+H +++ L+ S Y + LV E NG + L + + +
Sbjct: 64 IHCQLKHPSILELYNYFEDSNY---VYLVLEMCHNGEMNRYLK---NRVKPFSENEARHF 117
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
+ + + YLH+ I+HRD+ +N+LL N +K+ADFGL+ + T GTP
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTP 176
Query: 449 GYVDPE--YHQCYQLTDKSDVYSFGVVLIELI 478
Y+ PE + +SDV+S G + L+
Sbjct: 177 NYISPEIATRSAH--GLESDVWSLGCMFYTLL 206
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-36
Identities = 38/247 (15%), Positives = 64/247 (25%), Gaps = 37/247 (14%)
Query: 268 GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLY---DNNYRRVE 323
G P S+L E R LG + G V Y ++
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 324 QFMNEVEILTRLR-------------------------HKNLVSLFGCTSRYSQGLLLVY 358
Q EV L LR K ++ +
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 359 EFVANG---TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415
T + L + H L R+ + ++ LA LH ++H ++ +I+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 416 LDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ-----LTDKSDVYSF 470
LD V + F P Q +T D ++
Sbjct: 244 LDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303
Query: 471 GVVLIEL 477
G+ + +
Sbjct: 304 GLAIYWI 310
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-35
Identities = 60/293 (20%), Positives = 103/293 (35%), Gaps = 62/293 (21%)
Query: 202 EVHRVCWECRWRGGQCQNDSKGNFQCAETRECNDCHKKRGYCHIDDKGNFQCENERTDLE 261
E R CW C G+ +++KG A C C + L
Sbjct: 32 ESKRFCWNCGRPVGRSDSETKG----ASEGWCPYCGSPYSF--------------LPQLN 73
Query: 262 TGTVYFGVPIFSYSDLAEATNDFSR---EKELGDGGFGTVYYGK---LKDGREVAVKRL- 314
G + G + + + GG G +Y + +GR V +K L
Sbjct: 74 PGDIVAG-----------------QYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLV 115
Query: 315 YDNNYRRVEQFMNEVEILTRLRHKNLVSL--FGCTSRYSQGLL--LVYEFVANGTVADQL 370
+ + M E + L + H ++V + F + + +V E+V ++
Sbjct: 116 HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK 175
Query: 371 HGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430
L + +E AL+YLH+ +++ D+K NI+L +K+ D G
Sbjct: 176 GQK------LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAV 228
Query: 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMP 482
+ GTPG+ PE T +D+Y+ G L L +P
Sbjct: 229 SR----INSFGYLY-GTPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 287 EKELGDGGFGTVYYGKLKDGRE----VAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNL 340
K LG+G FG+V G LK VAVK + +N R +E+F++E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 341 VSLFG-CT---SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR--MNIAIETAS 394
+ L G C S+ +++ F+ G + L R + G P++ + ++ A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV--- 451
+ YL + +HRD+ N +L + V VADFGLS+ + QG +
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMPVK 214
Query: 452 --DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
E + Y T KSDV++FGV + E+ +
Sbjct: 215 WIAIESLADRVY--TSKSDVWAFGVTMWEIAT 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 275 SDLAEATNDFSRE---------KELGDGGFGTVYYGKLKDGRE----VAVKRLYDN-NYR 320
+L +A + +G G FG VY+G L D AVK L +
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132
Query: 321 RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLL 380
V QF+ E I+ H N++SL G R L+V ++ +G + + + +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---P 189
Query: 381 TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTH 439
T + ++ A + +L + +HRD+ N +LD F VKVADFGL+R ++ +
Sbjct: 190 TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 440 VSTAPQG------TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
V E Q + T KSDV+SFGV+L EL++
Sbjct: 250 VHNKTGAKLPVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 74/313 (23%), Positives = 127/313 (40%), Gaps = 80/313 (25%)
Query: 287 EKELGDGGFGTVYYGKLKDGRE------VAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
++ELG+G FG V+ + + VAVK L D + F E E+LT L+H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 341 VSLFGCTSRYSQGLLLVYEFVANG------------TVADQLHGDRAKHGLLTWPIRMNI 388
V +G L++V+E++ +G + R G L ++I
Sbjct: 80 VKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
A + AS + YL + +HRD+ T N L+ +N VK+ DFG+SR DV G
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 194
Query: 449 GYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLA 499
+ PE ++ + T +SDV+SFGV+L E+ + P +
Sbjct: 195 TMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFTYGKQPWFQL------------- 239
Query: 500 INKIQKCAFDELIDPCLGFESDEEV-------KRM------TTSVAELAFLCLQQNKELR 546
S+ EV + + V ++ C Q+ + R
Sbjct: 240 --------------------SNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279
Query: 547 PSMEEVLAELQRI 559
+++E+ L +
Sbjct: 280 LNIKEIYKILHAL 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
++ LG G +G VY G+ L + +A+K + + + R + E+ + L+HKN
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW--PIRMNIAIETASALA 397
+V G S + + E V G+++ L R+K G L + L
Sbjct: 81 IVQYLGSFSENGF-IKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 398 YLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-- 454
YLH + I+HRD+K +N+L+++ + +K++DFG S+ T GT Y+ PE
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEII 195
Query: 455 --YHQCYQLTDKSDVYSFGVVLIELISSMP 482
+ Y +D++S G +IE+ + P
Sbjct: 196 DKGPRGY--GKAADIWSLGCTIIEMATGKP 223
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 63/282 (22%), Positives = 106/282 (37%), Gaps = 44/282 (15%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHK 338
+ R + LG GGF + A K + + + E+ E+ I L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 339 NLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
++V G + + + +V E ++ + + LT P +
Sbjct: 102 HVVGFHGFFEDNDF---VFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGC 154
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-- 454
YLH + +IHRD+K N+ L+ + VK+ DFGL+ D GTP Y+ PE
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVL 213
Query: 455 ---YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
H + DV+S G ++ L+ P + L +I+K +
Sbjct: 214 SKKGHSF-----EVDVWSIGCIMYTLLVGKPPFE------TSCLKET-YLRIKKNEYSI- 260
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
P K + A L LQ + RP++ E+L
Sbjct: 261 --P----------KHINPVAASLIQKMLQTDPTARPTINELL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 38/279 (13%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHK 338
+ R + LG GGF + A K + + + E+ E+ I L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 339 NLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
++V G + + + +V E ++ + + LT P +
Sbjct: 76 HVVGFHGFFEDNDF---VFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGC 128
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-- 454
YLH + +IHRD+K N+ L+ + VK+ DFGL+ D GTP Y+ PE
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVL 187
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
+ + + + DV+S G ++ L+ P + L +I+K + P
Sbjct: 188 SKKGH--SFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET-YLRIKKNEYSI---P 235
Query: 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
K + A L LQ + RP++ E+L
Sbjct: 236 ----------KHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 77/339 (22%), Positives = 130/339 (38%), Gaps = 88/339 (25%)
Query: 272 FSYSDLAEATNDFSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRLYDNNYR 320
FS + + R ELG+G FG V+ + + VAVK L + +
Sbjct: 30 FSDACVHH----IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES 85
Query: 321 RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG-----------TVADQ 369
+ F E E+LT L+H+++V FG + + LL+V+E++ +G
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 370 LHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL 429
G+ G L + +A + A+ + YL +HRD+ T N L+ VK+ DFG+
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
Query: 430 SRLFPLDVTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS--S 480
SR D+ G + PE ++ + T +SDV+SFGVVL E+ +
Sbjct: 205 SR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFTYGK 258
Query: 481 MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEV-------KRM------ 527
P + S+ E + +
Sbjct: 259 QPWYQL---------------------------------SNTEAIDCITQGRELERPRAC 285
Query: 528 TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKF 566
V + C Q+ + R S+++V A LQ + +
Sbjct: 286 PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY 324
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 58/306 (18%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNL 340
N EK LG G GTV + GR VAVKR+ + + E+++LT H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA------- 393
+ + C+ + L + E N + D + + +++
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLV----ESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 394 SALAYLHASDIIHRDVKTNNILLDS-------------NFCVKVADFGLSRLFPLDVTHV 440
S +A+LH+ IIHRD+K NIL+ + N + ++DFGL + +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 441 STA---PQGTPGYVDPE-------YHQCYQLTDKSDVYSFGVVLIELISS--MPAVDMNR 488
T P GT G+ PE +LT D++S G V ++S P D
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 489 HRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS 548
I ++++++ LI + +M + + RP+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDL-----ISQM-----------IDHDPLKRPT 289
Query: 549 MEEVLA 554
+VL
Sbjct: 290 AMKVLR 295
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 286 REKELGDGGFGTVYYGKLKDGRE---VAVKRLYDNNYRRVEQ-FMNEVEILTRLRHKNLV 341
+ ELG G FG+V G + ++ VA+K L + + M E +I+ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 342 SLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L G C + + L+LV E G + L K + + + + + YL
Sbjct: 400 RLIGVCQA---EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG------TPGYVDPE 454
+ +HR++ N+LL + K++DFGLS+ D ++ + G PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PE 509
Query: 455 YHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMN 487
+ + +SDV+S+GV + E +S P M
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLY-----DNNYRRVEQFMNEVEILTRLRHKNL 340
+ +G GG G VY + R VA+K + D +R + E RL+ ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFR--TRMQREARTAGRLQEPHV 96
Query: 341 VSLFGCTSRYSQG-----LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
V + + G L + + +A L + G L P + I + SA
Sbjct: 97 VPI------HDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSA 146
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LFPLDVTHVSTAPQGTPGYVDPE 454
L HA+ HRDVK NIL+ ++ + DFG++ +T + GT Y+ PE
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPE 205
Query: 455 YHQCYQLTDKSDVYSFGVVLIELI 478
T ++D+Y+ VL E +
Sbjct: 206 RFSESHATYRADIYALTCVLYECL 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 39/255 (15%), Positives = 70/255 (27%), Gaps = 48/255 (18%)
Query: 268 GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVK-------------- 312
G P S+L E R LG + G V
Sbjct: 59 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 313 --RLYDNNYRRVEQFMNEVEILTRLR------------HKNLVSLFGCTSRYS-QGLLLV 357
+ R + N+ + LR K ++ + +
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 358 YEFVA--NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNIL 415
Y + T + L + H L R+ + ++ LA LH ++H ++ +I+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238
Query: 416 LDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL-----------TDK 464
LD V + F V + G+ PE T
Sbjct: 239 LDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 465 SDVYSFGVVLIELIS 479
D ++ G+V+ +
Sbjct: 294 FDAWALGLVIYWIWC 308
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 77/359 (21%), Positives = 130/359 (36%), Gaps = 78/359 (21%)
Query: 270 PIFSYSDLAEATND---FSRE-----KELGDGGFGTVYYGKLKDGR------EVAVKRLY 315
P + ++ + +D R+ + LG G FG VY G++ +VAVK L
Sbjct: 10 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 316 DN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDR 374
+ + + F+ E I+++ H+N+V G + + S ++ E +A G + L R
Sbjct: 70 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETR 128
Query: 375 AKHG---LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD---SNFCVKVADFG 428
+ L +++A + A YL + IHRD+ N LL K+ DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 429 LSRLFPLDVTHVSTAPQGTPGYV-----DPEYHQCYQLTDKSDVYSFGVVLIELIS--SM 481
++R D+ S +G + PE T K+D +SFGV+L E+ S M
Sbjct: 189 MAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 482 PAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM------TTSVAELA 535
P + + + RM V +
Sbjct: 245 PYPSKSNQE--------VLEFV------------------TSGGRMDPPKNCPGPVYRIM 278
Query: 536 FLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPPPSPPYCDED 594
C Q E RP+ +L ++ D + I P P +E+
Sbjct: 279 TQCWQHQPEDRPNFAIILERIEYC-------------TQDPDVINTALPIEYGPLVEEE 324
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 71/320 (22%), Positives = 120/320 (37%), Gaps = 67/320 (20%)
Query: 269 VPIFSYSDLAEATNDFSRE---------KELGDGGFGTVYYGKLKDGRE----VAVKRLY 315
I D + E + +G+G FG V+ G VA+K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 316 DN-NYRRVEQFMNEVEILTRLRHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGD 373
+ + E+F+ E + + H ++V L G T + ++ E G + L
Sbjct: 428 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFL--- 481
Query: 374 RAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
+ + L + A + ++ALAYL + +HRD+ N+L+ SN CVK+ DFGLSR
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY- 540
Query: 434 PLDVTHVSTAPQG------TPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVD 485
++ + A +G PE + T SDV+ FGV + E++ P
Sbjct: 541 -MEDSTYYKASKGKLPIKWMA----PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 486 MNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM------TTSVAELAFLCL 539
+ + I +I+ G R+ ++ L C
Sbjct: 596 VKNND--------VIGRIEN-----------GE-------RLPMPPNCPPTLYSLMTKCW 629
Query: 540 QQNKELRPSMEEVLAELQRI 559
+ RP E+ A+L I
Sbjct: 630 AYDPSRRPRFTELKAQLSTI 649
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 63/309 (20%), Positives = 123/309 (39%), Gaps = 55/309 (17%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLY-----------------DNNYRRVEQ 324
ND+ + L G F + + KD + A+K+ + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 325 FMNEVEILTRLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTW 382
F NE++I+T ++++ ++ G + ++YE++ N ++ T
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDE---VYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 383 PIRMNIAI----ETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
I + + ++ +Y+H +I HRDVK +NIL+D N VK++DFG S
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 438 THVSTAPQGTPGYVDPE-------YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHR 490
S +GT ++ PE Y+ K D++S G+ L + ++
Sbjct: 207 IKGS---RGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVPFS----- 253
Query: 491 HEINLANLAINKIQKCAF------DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKE 544
+I+L L N I+ + + P +S ++ + L L++N
Sbjct: 254 LKISLVEL-FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 545 LRPSMEEVL 553
R + E+ L
Sbjct: 313 ERITSEDAL 321
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 287 EKELGDGGFGTVYYGKLKDGRE------VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKN 339
+ELG+ FG VY G L VA+K L D E+F +E + RL+H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANG------------TVADQLHGDRAKHGLLTWPIRMN 387
+V L G ++ Q L +++ + ++G + DR L P ++
Sbjct: 74 VVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
+ + A+ + YL + ++H+D+ T N+L+ VK++D GL R +V
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLG 188
Query: 448 PGYV-----DPEYHQCYQLTDKSDVYSFGVVLIELIS 479
+ PE + + SD++S+GVVL E+ S
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 266 YFGVPIFSYSDLAEATNDFSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRL 314
YF D E +RE +ELG G FG VY G K + VA+K +
Sbjct: 8 YFSAADVYVPDEWE----VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 315 YDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGD 373
+ + R +F+NE ++ ++V L G S+ Q L++ E + G + L
Sbjct: 64 NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSL 122
Query: 374 RAKHGLLTWPIR------MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427
R + +A E A +AYL+A+ +HRD+ N ++ +F VK+ DF
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 428 GLSRLFPLDVTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
G++R D+ +G G + PE + T SDV+SFGVVL E+ +
Sbjct: 183 GMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIAT 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKD------GREVAVKRLYDN-NYRRVEQFMNEVEI 331
F R+ K LG G FG V R VAVK L + + M+E++I
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 332 LTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANG------------TVADQLHGDRAKHG 378
L + H N+V+L G ++ L+++ EF G V ++ +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 379 LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438
LT + + + A + +L + IHRD+ NILL VK+ DFGL+R D+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199
Query: 439 HVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
+ + PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 79/371 (21%), Positives = 133/371 (35%), Gaps = 79/371 (21%)
Query: 260 LETGTVYFGV-PIFSYSDLAEATND---FSRE-----KELGDGGFGTVYYGKLKDGR--- 307
L T T+ P + ++ + +D R+ + LG G FG VY G++
Sbjct: 40 LRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 99
Query: 308 ---EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN 363
+VAVK L + + + F+ E I+++ H+N+V G + + S ++ E +A
Sbjct: 100 SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILLELMAG 158
Query: 364 GTVADQLHGDRAKHG---LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD--- 417
G + L R + L +++A + A YL + IHRD+ N LL
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218
Query: 418 SNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV-----DPEYHQCYQLTDKSDVYSFGV 472
K+ DFG++R D+ +G + PE T K+D +SFGV
Sbjct: 219 PGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274
Query: 473 VLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM--- 527
+L E+ S MP + + + RM
Sbjct: 275 LLWEIFSLGYMPYPSKSNQE--------VLEFV------------------TSGGRMDPP 308
Query: 528 ---TTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQP 584
V + C Q E RP+ +L ++ D + I P
Sbjct: 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC-------------TQDPDVINTALP 355
Query: 585 PPSPPYCDEDS 595
P +E+
Sbjct: 356 IEYGPLVEEEE 366
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-33
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL--YDNNYRRVEQFMNEVEILTRLRH 337
+ + R K+LG G +G V + K E A+K + + + + EV +L L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 338 KNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
N++ L+ + + LV E G + D++ I + S
Sbjct: 96 PNIMKLYDF---FEDKRNYYLVMECYKGGELFDEI----IHRMKFNEVDAAVIIKQVLSG 148
Query: 396 LAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
+ YLH +I+HRD+K N+LL+S + +K+ DFGLS +F GT Y+
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIA 206
Query: 453 PE-YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
PE + Y +K DV+S GV+L L++ P + EI + K++K +
Sbjct: 207 PEVLRKKY--DEKCDVWSIGVILFILLAGYPPF-GGQTDQEI------LRKVEKGKYT-- 255
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F+S E K ++ +L LQ + + R S ++ L
Sbjct: 256 ------FDS-PEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRLYDN-NYRRVEQFMNEVEI 331
F R+ K LG+G FG V + VAVK L +N + + ++E +
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 332 LTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG--------------------TVADQLH 371
L ++ H +++ L+G S+ LLL+ E+ G +
Sbjct: 80 LKQVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 372 GDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
D LT ++ A + + + YL ++HRD+ NIL+ +K++DFGLSR
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 432 LFPLDVTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
DV + + + G + E + Y T +SDV+SFGV+L E+++
Sbjct: 199 ----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVT 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 82/308 (26%), Positives = 131/308 (42%), Gaps = 41/308 (13%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ ELGDG FG VY K + G A K + + +E ++ E+EIL H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
L G + L ++ EF G V + LT P + + AL +LH+
Sbjct: 81 LLGAYYHDGK-LWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
IIHRD+K N+L+ +++ADFG + + + GTP ++ PE C
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMC 191
Query: 459 YQLTD-----KSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFDELI 512
+ D K+D++S G+ LIE+ P ++N R + KI K L+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDPPTLL 243
Query: 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRIKSGKSKFE-IH 569
P + + + + L +N E RPS ++L + I S K+ E +
Sbjct: 244 TP----------SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVA 293
Query: 570 EEKQDDRE 577
E K + E
Sbjct: 294 EAKAEVME 301
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 35/279 (12%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
++R +++G G GTVY + G+EVA++++ + E +NE+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V+ + L +V E++A G++ D + + + E AL +L
Sbjct: 79 IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPEY 455
H++ +IHRD+K++NILL + VK+ DFG ++ T V GTP ++ PE
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEV 187
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
K D++S G++ IE+I P ++ N R A+ I EL +P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNGTPELQNP 239
Query: 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
++++ + CL+ + E R S +E+L
Sbjct: 240 ----------EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 4e-33
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 18/224 (8%)
Query: 279 EATNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLY-DNNYRRVEQFMNEVEILTRLR 336
+ + ++ LG GGFG V +D G +VA+K+ + + + E++ E++I+ +L
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 337 HKNLVSLF-----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
H N+VS + LL E+ G + L+ L + +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSD 129
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSN---FCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
+SAL YLH + IIHRD+K NI+L K+ D G ++ + T GT
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTL 187
Query: 449 GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRH 489
Y+ PE + Y T D +SFG + E I+ P + +
Sbjct: 188 QYLAPELLEQKKY--TVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 59/230 (25%), Positives = 110/230 (47%), Gaps = 41/230 (17%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE--------VAVKRLYDN-NYRRVEQFMNEV 329
F R+ K LG+G FG V + + VAVK L D+ + + ++E+
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 330 EILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANG------------TVADQLHGDRAK 376
E++ + +HKN+++L G ++ L ++ E+ + G + +R
Sbjct: 92 EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 377 HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
+T+ ++ + A + YL + IHRD+ N+L+ N +K+ADFGL+R D
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 206
Query: 437 VTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
+ ++ + T G + PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-33
Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 37/283 (13%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL---YDNNYRRVEQFMNEVEILTRLR 336
++ + ++ LG G FG V K K G+E AVK + E + EV++L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 337 HKNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H N++ L+ + LV E G + D++ + I + S
Sbjct: 85 HPNIMKLYEF---FEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 137
Query: 395 ALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
+ Y+H + I+HRD+K N+LL+S + +++ DFGLS F GT Y+
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYI 195
Query: 452 DPE-YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
PE H Y +K DV+S GV+L L+S P + + ++I + K++K +
Sbjct: 196 APEVLHGTY--DEKCDVWSTGVILYILLSGCPPFN-GANEYDI------LKKVEKGKYT- 245
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
FE + K+++ S +L L +R S + L
Sbjct: 246 -------FEL-PQWKKVSESAKDLIRKMLTYVPSMRISARDAL 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKN 339
+D+ ++ +G G V +VA+KR+ + +++ + E++ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-MNIAI---ETASA 395
+VS + + L LV + ++ G+V D + AK + + IA E
Sbjct: 75 IVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS-RLFPLDVTHVSTAPQ---GTPGYV 451
L YLH + IHRDVK NILL + V++ADFG+S L + + GTP ++
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 452 DPE-YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL----AINKIQKC 506
PE Q K+D++SFG+ IEL + + +
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAA-----------PYHKYPPMKVLMLTLQN 242
Query: 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
L + E +K+ S ++ LCLQ++ E RP+ E+L
Sbjct: 243 DPPSLETGV---QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNL 340
F++ +++G G FG V+ G + + VA+K + + +E E+ +L++ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+G + ++ L ++ E++ G+ D L + G L I E L YLH
Sbjct: 83 TKYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLH 136
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
+ IHRD+K N+LL + VK+ADFG L+ T V GTP ++ PE
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVI 191
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMP 482
+ K+D++S G+ IEL P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 61/238 (25%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRLYDN-NYRRVEQFMNEVEI 331
F R K LG G FG V + VAVK L + E M+E++I
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 332 LTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANG----------TVADQLHGDRAKHGLL 380
++ L +H+N+V+L G + +L++ E+ G V + +
Sbjct: 103 MSHLGQHENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 381 TWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440
+ ++ + + A +A+L + + IHRDV N+LL + K+ DFGL+R D+
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DI--- 214
Query: 441 STAPQGTPGYVDPEY-------------------HQCYQLTDKSDVYSFGVVLIELIS 479
D Y Y T +SDV+S+G++L E+ S
Sbjct: 215 ---------MNDSNYIVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 65/276 (23%), Positives = 124/276 (44%), Gaps = 35/276 (12%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
++G+G G V + GR+VAVK + +R E NEV I+ +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
++ + L ++ EF+ G + D + L + ALAYLHA
Sbjct: 107 MYKSYLVGEE-LWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
+IHRD+K+++ILL + VK++DFG +S+ P + V GTP ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISR 215
Query: 459 YQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+ D++S G+++IE++ P + + A+ +++ +L +
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLKNS--- 264
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+++ + + L ++ + R + +E+L
Sbjct: 265 -------HKVSPVLRDFLERMLVRDPQERATAQELL 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 52/292 (17%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLY-DNNYRRVEQFMNEVEILTRLRHK 338
+ F +++LG G FG V+ + + G E +K + D + +EQ E+E+L L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 339 NLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
N++ +F + +V E G + +++ +A+ L+ + + +AL
Sbjct: 81 NIIKIFEVFEDYHN---MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 397 AYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
AY H+ ++H+D+K NIL + +K+ DFGL+ LF D + A GT Y+ P
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAP 195
Query: 454 E-YHQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
E + + T K D++S GVV+ L +P + E+ K +
Sbjct: 196 EVFKRDV--TFKCDIWSAGVVMYFLLTGCLPFTGTS--LEEV------QQKATYKEPN-- 243
Query: 512 IDPCLGFESD-----EE----VKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
+ + + +K+M L ++ E RPS +VL
Sbjct: 244 ------YAVECRPLTPQAVDLLKQM-----------LTKDPERRPSAAQVLH 278
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-------------YDNNYRRVEQFM 326
+ + ++LG G +G V K K E A+K + N + E+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 327 NEVEILTRLRHKNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI 384
NE+ +L L H N++ LF + + LV EF G + +Q+
Sbjct: 95 NEISLLKSLDHPNIIKLFDV---FEDKKYFYLVTEFYEGGELFEQI----INRHKFDECD 147
Query: 385 RMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVS 441
NI + S + YLH +I+HRD+K NILL++ +K+ DFGLS F D
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 442 TAPQGTPGYVDPE-YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500
GT Y+ PE + Y +K DV+S GV++ L+ P ++ +I I
Sbjct: 208 RL--GTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFG-GQNDQDI------I 256
Query: 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
K++K + F+ + K ++ EL L L + R + EE L
Sbjct: 257 KKVEKGKYY--------FDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 80/324 (24%), Positives = 139/324 (42%), Gaps = 59/324 (18%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHK 338
F + +G+G +G VY G+ +K G+ A+K + D E+ E+ +L + H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHR 81
Query: 339 NLVSLFGC-----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN---IAI 390
N+ + +G L LV EF G+V D + + + IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--------TLKEEWIAY 133
Query: 391 ---ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-- 445
E L++LH +IHRD+K N+LL N VK+ DFG+S T +
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRRN 187
Query: 446 ---GTPGYVDPEYHQCYQLTD-----KSDVYSFGVVLIELISSM-PAVDMNRHRHEINLA 496
GTP ++ PE C + D KSD++S G+ IE+ P DM+ R
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241
Query: 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556
A+ I + +P +S + K+ + + CL +N RP+ E+++ +
Sbjct: 242 --ALFLIPR-------NPAPRLKSKKWSKKFQSFIE----SCLVKNHSQRPATEQLM-KH 287
Query: 557 QRIKSGKSKFEIHEEKQDDREGIK 580
I+ ++ ++ + +D + K
Sbjct: 288 PFIRDQPNERQVRIQLKDHIDRTK 311
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 43/235 (18%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRLYDN-NYRRVEQFMNEVEI 331
F R K LG G FG V + VAVK L + + E M+E+++
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 332 LTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH------------- 377
L+ L H N+V+L G + L++ E+ G + + L R
Sbjct: 80 LSYLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 378 -GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
L ++ + + A +A+L + + IHRD+ NILL K+ DFGL+R D
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR----D 194
Query: 437 VTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS--SMP 482
+ + S + PE ++ Y T +SDV+S+G+ L EL S S P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 46/319 (14%), Positives = 101/319 (31%), Gaps = 46/319 (14%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNNYRRVEQFMNEVEILTR 334
+ LG+G F VY D ++ +K N +E L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQL-HGDRAKHGLLTWPIRMNIAIETA 393
+ + + G +LV E + GT+ + + ++ + ++ A+
Sbjct: 124 SMQHMFMKFYSAHL-FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 394 SALAYLHASDIIHRDVKTNNILL-----------DSNFCVKVADFGLS---RLFPLDVTH 439
+ +H +IIH D+K +N +L D + + + D G S +LFP
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 440 VSTAPQGTPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497
+ T G+ E ++ + + D + + ++ + E
Sbjct: 243 TAKC--ETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYM-KVKNEGGECKPEG 297
Query: 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE-- 555
L ++E L L LR +++V +
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHH---------------LPSLDLLRQKLKKVFQQHY 342
Query: 556 LQRIKSGKSKFEIHEEKQD 574
+I++ +++ + +
Sbjct: 343 TNKIRALRNRLIVLLLECK 361
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 59/230 (25%), Positives = 110/230 (47%), Gaps = 41/230 (17%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE--------VAVKRLYDN-NYRRVEQFMNEV 329
F R+ K LG+G FG V + + VAVK L D+ + + ++E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 330 EILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANG------------TVADQLHGDRAK 376
E++ + +HKN+++L G ++ L ++ E+ + G + +R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 377 HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
+T+ ++ + A + YL + IHRD+ N+L+ N +K+ADFGL+R D
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 252
Query: 437 VTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
+ ++ + T G + PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKD--------GREVAVKRLYDN-NYRRVEQFMNEV 329
R+ K LG+G FG V + +VAVK L + + + ++E+
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 330 EILTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANG------------TVADQLHGDRAK 376
E++ + +HKN+++L G ++ L ++ E+ + G + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 377 HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
L+ ++ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R D
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----D 240
Query: 437 VTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
+ H+ + T G + PE + + Y T +SDV+SFGV+L E+ +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 60/253 (23%), Positives = 106/253 (41%), Gaps = 48/253 (18%)
Query: 266 YFGVPIFSYSDLAEATNDFSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRL 314
Y +P+ L ++ R +++G+G FG V+ + VAVK L
Sbjct: 28 YQRMPLLLNPKLLS--LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 85
Query: 315 YDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANG--------- 364
+ + F E ++ + N+V L G + + + L++E++A G
Sbjct: 86 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSM 144
Query: 365 -----------TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNN 413
++ + L+ ++ IA + A+ +AYL +HRD+ T N
Sbjct: 145 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204
Query: 414 ILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSD 466
L+ N VK+ADFGLSR ++ + PE ++ Y T +SD
Sbjct: 205 CLVGENMVVKIADFGLSR----NIYSADYYKADGNDAIPIRWMPPESIFYNRY--TTESD 258
Query: 467 VYSFGVVLIELIS 479
V+++GVVL E+ S
Sbjct: 259 VWAYGVVLWEIFS 271
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 287 EKELGDGGFGTVYYGKLKDGRE---VAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLV 341
+ +G+G FG V ++K A+KR+ + + F E+E+L +L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH------------GLLTWPIRMNIA 389
+L G L L E+ +G + D L R L+ ++ A
Sbjct: 90 NLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG--- 446
+ A + YL IHRD+ NIL+ N+ K+ADFGLSR G
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 204
Query: 447 ---TPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
E + Y T SDV+S+GV+L E++S
Sbjct: 205 VRWMA----IESLNYSVY--TTNSDVWSYGVLLWEIVS 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-32
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 38/283 (13%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRH 337
++ LG G FG V K + +E AVK + + + + EVE+L +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 338 KNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
N++ LF S +V E G + D++ K + I + S
Sbjct: 81 PNIMKLFEI---LEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSG 133
Query: 396 LAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
+ Y+H +I+HRD+K NILL+S + +K+ DFGLS F + GT Y+
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIA 191
Query: 453 PE-YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
PE Y +K DV+S GV+L L+S + P N ++I + +++ +
Sbjct: 192 PEVLRGTY--DEKCDVWSAGVILYILLSGTPPFYGKN--EYDI------LKRVETGKYA- 240
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F+ + + ++ +L L + LR + + L
Sbjct: 241 -------FDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
E +G G +G V K A K++ V++F E+EI+ L H N++ L+
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 346 C--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
+ + LV E G + +++ + I + SA+AY H +
Sbjct: 74 TFEDNTD---IYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 404 IIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-YHQCY 459
+ HRD+K N L + + +K+ DFGL+ F + GTP YV P+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGLY 184
Query: 460 QLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+ D +S GV++ + L P E+ + KI++ F F
Sbjct: 185 --GPECDEWSAGVMMYVLLCGYPPFSA--PTDSEV------MLKIREGTFT--------F 226
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
++ ++ L L ++ + R + + L
Sbjct: 227 PE-KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 53/322 (16%), Positives = 92/322 (28%), Gaps = 45/322 (13%)
Query: 271 IFSYSDLAEATNDFSREKELGDG--GFGTVYYGK-LKDGREVAVKR--LYDNNYRRVEQF 325
+ S+ + +G G TV + G V V+R L + V
Sbjct: 17 MSSFLPEGG---CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL 73
Query: 326 MNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR 385
E+ + H N+V ++ L +V F+A G+ D + +
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLIC--THFMDGMNELAI 130
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
I AL Y+H +HR VK ++IL+ + V ++ +
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 446 ------GTPGYVDPEYHQCYQL--TDKSDVYSFGVVLIELISSMP--------------- 482
++ PE Q KSD+YS G+ EL +
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 483 -----------AVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSV 531
+ + + S + +
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 532 AELAFLCLQQNKELRPSMEEVL 553
CLQ+N + RPS +L
Sbjct: 311 HHFVEQCLQRNPDARPSASTLL 332
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 46/235 (19%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKDGRE------VAVKRLYDN-NYRRVEQFMNEVEI 331
F RE K LG G FG V + VAVK L + + E M+E+++
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 332 LTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANG-------------------TVADQLH 371
+T+L H+N+V+L G + S + L++E+ G +
Sbjct: 102 MTQLGSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 372 GDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
+ +LT+ + A + A + +L +HRD+ N+L+ VK+ DFGL+R
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 432 LFPLDVTHVSTAPQGTPGYV-----DPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
D+ S + PE + Y T KSDV+S+G++L E+ S
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFS 269
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 78/278 (28%), Positives = 123/278 (44%), Gaps = 45/278 (16%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK-----RLYDNNYRRVEQFMNEVEILTRLRHKNL 340
K +G G F V + + GREVA+K +L + +++ + EV I+ L H N+
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRIMKILNHPNI 76
Query: 341 VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
V LF T + L L+ E+ + G V D L HG + + + SA+ Y
Sbjct: 77 VKLFEVIETEKT---LYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQY 129
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YH 456
H I+HRD+K N+LLD++ +K+ADFG S F + + G P Y PE
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPELFQG 187
Query: 457 QCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ Y + DV+S GV+L L+S S+P NL L ++ + + P
Sbjct: 188 KKYDGP-EVDVWSLGVILYTLVSGSLPFDGQ-------NLKEL-RERVLRGKYRI---P- 234
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
M+T L L N R ++E+++
Sbjct: 235 ---------FYMSTDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
F ++LG+G +G+VY + G+ VA+K++ +++ + E+ I+ + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+G + + L +V E+ G+V+D + R ++ LT I T L YLH
Sbjct: 89 YYGSYFKNTD-LWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 403 DIIHRDVKTNNILLDSNFCVKVADFG----LSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
IHRD+K NILL++ K+ADFG L+ T + GTP ++ PE Q
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQE 199
Query: 459 YQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+D++S G+ IE+ P D++ R AI I P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AIFMIPTNPPPTFRKP--- 248
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ + + + CL ++ E R + ++L
Sbjct: 249 -------ELWSDNFTDFVKQCLVKSPEQRATATQLL 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 73/369 (19%), Positives = 132/369 (35%), Gaps = 67/369 (18%)
Query: 224 NFQCAETRECNDCHKKRGYCHIDDK--------GNFQCENERTDLETG-TVYFGVP---I 271
RE K +I+D + +R L + + +
Sbjct: 58 KKHFRIFREVGP--KNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNNNSEIALSLSRNKV 115
Query: 272 FSYSDLAEA-----TNDFSRE----KELGDGGFGTVYYGKLKD-GREVAVKRL------- 314
F + DL E K LG G G V + ++VA++ +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 315 -YDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLLLVYEFVANGTVADQLHG 372
E+EIL +L H ++ + + ++ +V E + G + D++
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNF---FDAEDYYIVLELMEGGELFDKV-- 230
Query: 373 DRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGL 429
+ L + A+ YLH + IIHRD+K N+LL S + +K+ DFG
Sbjct: 231 --VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 430 SRLFPLDVTHVSTAPQGTPGYVDPE-----YHQCYQLTDKSDVYSFGVVLIELISSMPAV 484
S++ + + + T GTP Y+ PE Y D +S GV+L +S P
Sbjct: 289 SKILG-ETSLMRTL-CGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILFICLSGYPPF 344
Query: 485 DMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKE 544
+R + + ++I ++ F + ++ +L L + +
Sbjct: 345 SEHRTQVSL------KDQITSGKYN--------FIPEVW-AEVSEKALDLVKKLLVVDPK 389
Query: 545 LRPSMEEVL 553
R + EE L
Sbjct: 390 ARFTTEEAL 398
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 58/287 (20%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVSLF 344
LG G FG V K + +E AVK + + + + EVE+L +L H N++ LF
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 345 GCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
S +V E G + D++ K + I + S + Y+H
Sbjct: 88 EI---LEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 403 DIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-YHQC 458
+I+HRD+K NILL+S + +K+ DFGLS F + GT Y+ PE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRGT 198
Query: 459 YQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
Y +K DV+S GV+L I L + P N ++I + +++ +
Sbjct: 199 Y--DEKCDVWSAGVILYILLSGTPPFYGKN--EYDI------LKRVETGKYA-------- 240
Query: 518 FESD------EE----VKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F+ ++ +++M L + LR + + L
Sbjct: 241 FDLPQWRTISDDAKDLIRKM-----------LTFHPSLRITATQCLE 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 64/284 (22%), Positives = 111/284 (39%), Gaps = 44/284 (15%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRL--------YDNNYRRVEQFMNEVEILTRLRHK 338
K LG G G V + ++VA+K + E+EIL +L H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 339 NLVSLFGCTSRY-SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
++ + + ++ +V E + G + D++ + L + A+
Sbjct: 76 CIIKIKNF---FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQ 128
Query: 398 YLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
YLH + IIHRD+K N+LL S + +K+ DFG S++ T + GTP Y+ PE
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 186
Query: 455 -----YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
Y D +S GV+L +S P +R + + ++I ++
Sbjct: 187 VLVSVGTAGY--NRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGKYN 238
Query: 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F E ++ +L L + + R + EE L
Sbjct: 239 --------FIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
DF K LG+G F TV + RE A+K L + + V E ++++RL H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAIETAS 394
V L+ L + NG + + K G R A E S
Sbjct: 90 PFFVKLYFTFQDDEK---LYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTA-EIVS 141
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ-GTPGYVDP 453
AL YLH IIHRD+K NILL+ + +++ DFG +++ + GT YV P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 454 EYHQCYQLTDK-----SDVYSFGVVLIELISSMP 482
E LT+K SD+++ G ++ +L++ +P
Sbjct: 202 EL-----LTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/326 (20%), Positives = 113/326 (34%), Gaps = 74/326 (22%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVK-----RLYDNNYRRVEQFMNEVEILTR 334
+ + +G G +G V A+K ++ N + VE+ EV ++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 335 LRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQL--HGDRAKHGLLTWPIRMNIAI 390
L H N+ L+ +Y + LV E G + D+L D + ++ I
Sbjct: 85 LHHPNIARLYEVYEDEQY---ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 391 ETA----------------------------------SALAYLHASDIIHRDVKTNNILL 416
SAL YLH I HRD+K N L
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 417 DS--NFCVKVADFGLSRLFPL---DVTHVSTAPQGTPGYVDPE----YHQCYQLTDKSDV 467
+ +F +K+ DFGLS+ F + T GTP +V PE ++ Y K D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY--GPKCDA 259
Query: 468 YSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRM 527
+S GV+L L+ + + I+++ FE+ +
Sbjct: 260 WSAGVLLHLLLMGAVPFP-GVNDADT------ISQVLNKKLC--------FENPNY-NVL 303
Query: 528 TTSVAELAFLCLQQNKELRPSMEEVL 553
+ +L L +N + R L
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 68/280 (24%), Positives = 110/280 (39%), Gaps = 33/280 (11%)
Query: 285 SREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVS 342
++K LG+G F K + AVK + R E+ L H N+V
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVK 70
Query: 343 LFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L + LV E + G + +++ K + I + SA++++H
Sbjct: 71 LHEV---FHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMH 123
Query: 401 ASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--Y 455
++HRD+K N+L + N +K+ DFG +RL P D + T P T Y PE
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLN 182
Query: 456 HQCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
Y D+S D++S GV+L ++S + A + KI+K F
Sbjct: 183 QNGY---DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS----- 234
Query: 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
FE E K ++ +L L + R M +
Sbjct: 235 ---FEG-EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 43/221 (19%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVK--------------------------RLYDNNYR 320
E+G G +G V D A+K
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 321 RVEQFMNEVEILTRLRHKNLVSLF---GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
+EQ E+ IL +L H N+V L + L +V+E V G V +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH--LYMVFELVNQGPVME-----VPTL 131
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
L+ + + YLH IIHRD+K +N+L+ + +K+ADFG+S F
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 438 THVSTAPQGTPGYVDPE----YHQCYQLTDKSDVYSFGVVL 474
+S GTP ++ PE + + DV++ GV L
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTL 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 60/284 (21%), Positives = 117/284 (41%), Gaps = 39/284 (13%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
+ + +ELG G FG V+ K GR K + NE+ I+ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 340 LVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
L++L ++L+ EF++ G + D++ A+ ++ +N + L
Sbjct: 110 LINLHDAFEDKYE---MVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLK 163
Query: 398 YLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
++H I+H D+K NI+ ++ VK+ DFGL+ + + T + PE
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEI 221
Query: 456 HQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
+ +D+++ GV+ L+S P + E + +++C ++
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLET------LQNVKRCDWE----- 268
Query: 515 CLGFESDEEVKRMTTSVAELA--FL--CLQQNKELRPSMEEVLA 554
F+ D +SV+ A F+ LQ+ R ++ + L
Sbjct: 269 ---FDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKN 339
FS +E+G G FG VY+ + +++ VA+K++ + + + + EV L +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+ GC R LV E+ G+ +D L L + LAYL
Sbjct: 116 TIQYRGCYLREHT-AWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ ++IHRDVK NILL VK+ DFG + + + V GTP ++ PE
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 460 QLTD---KSDVYSFGVVLIELISSMP 482
K DV+S G+ IEL P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKP 251
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 43/284 (15%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
S+ + LG G FG V+ + G ++A K + + E+ NE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 342 SLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDR--AKHGLLTWPIRMNIAIETASALA 397
L+ + ++LV E+V G +L DR + LT + + +
Sbjct: 150 QLYDAFESKND---IVLVMEYVDGG----ELF-DRIIDESYNLTELDTILFMKQICEGIR 201
Query: 398 YLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
++H I+H D+K NIL + +K+ DFGL+R + GTP ++ PE
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEV 259
Query: 456 HQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
++ +D++S GV+ + L P + N E +N I C +D
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAET------LNNILACRWD----- 306
Query: 515 CLGFESDEEVKRMTTSVAELA--FL--CLQQNKELRPSMEEVLA 554
E +E ++E A F+ L + K R S E L
Sbjct: 307 ---LEDEE-----FQDISEEAKEFISKLLIKEKSWRISASEALK 342
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
+ LG G F V+ K + G+ A+K + + R NE+ +L +++H+N+V+L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 346 CTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD 403
Y + LV + V+ G + D++ + G+ T + + SA+ YLH +
Sbjct: 74 I---YESTTHYYLVMQLVSGGELFDRI----LERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 404 IIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
I+HRD+K N+L + N + + DFGLS++ + + GTPGYV PE
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPGYVAPEVLAQKP 183
Query: 461 LTDKSDVYSFGVVL 474
+ D +S GV+
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 67/292 (22%), Positives = 107/292 (36%), Gaps = 72/292 (24%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK---------RLYDNNYRRVEQFMNEVEILTRLR 336
LG GGFG+VY G + D VA+K N RV EV +L ++
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM---EVVLLKKVS 104
Query: 337 HK--NLVSLFGCTSRYSQGLLLVYEFVAN-GTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
++ L R +L+ E + D + + G L + + +
Sbjct: 105 SGFSGVIRLLDWFER-PDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVL 159
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFC-VKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
A+ + H ++HRD+K NIL+D N +K+ DFG L V GT Y
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSP 216
Query: 453 PEY--HQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE+ + Y + V+S G++L +++ +P
Sbjct: 217 PEWIRYHRYHGR-SAAVWSLGILLYDMVCGDIP--------------------------- 248
Query: 510 ELIDPCLGFESDEEVKR--------MTTSVAELAFLCLQQNKELRPSMEEVL 553
FE DEE+ R +++ L CL RP+ EE+
Sbjct: 249 --------FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 19/200 (9%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVK-----RLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ +G G F V ++ G++ AVK + + E E I L+H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 342 SLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
L + L +V+EF+ + ++ + + + + + AL Y
Sbjct: 90 ELLETYSSDGM---LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 400 HASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-- 454
H ++IIHRDVK + +LL S + VK+ FG++ GTP ++ PE
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVV 205
Query: 455 YHQCYQLTDKSDVYSFGVVL 474
+ Y DV+ GV+L
Sbjct: 206 KREPY--GKPVDVWGCGVIL 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/249 (21%), Positives = 92/249 (36%), Gaps = 38/249 (15%)
Query: 318 NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
+ ++ ++ + KN V S L + + + D R
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVG-QLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSL 158
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR------ 431
+ ++I I+ A A+ +LH+ ++HRD+K +NI + VKV DFGL
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 432 -----LFPLDVTHVSTAPQGTPGYVDPE--YHQCYQLTDKSDVYSFGVVLIELISSMPAV 484
L P+ T GT Y+ PE + Y + K D++S G++L EL+ S
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY--SHKVDIFSLGLILFELLYSFST- 275
Query: 485 DMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKE 544
M R R I ++ F L + +E + L +
Sbjct: 276 QMERVR--------IITDVRNLKFPLLFTQ----KYPQE--------HMMVQDMLSPSPT 315
Query: 545 LRPSMEEVL 553
RP +++
Sbjct: 316 ERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 2/67 (2%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKN 339
DF + +G GGFG V+ K K D A+KR+ N E+ M EV+ L +L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 340 LVSLFGC 346
+V F
Sbjct: 66 IVRYFNA 72
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 281 TNDFSRE----KELGDGGFGTVYYGKLKD-GREVAVKRLYDNNY--RRVEQFMNEVEILT 333
+ FS +ELG G F V K G E A K + R ++ E I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 334 RLRHKNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
+L+H N+V L LV++ V G + + + + + +
Sbjct: 61 KLQHPNIVRLHDS---IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQ 113
Query: 392 TASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
++AY H++ I+HR++K N+LL S VK+ADFGL+ A GTP
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTP 171
Query: 449 GYVDPE--YHQCYQLTDKSDVYSFGVVL 474
GY+ PE Y + D+++ GV+L
Sbjct: 172 GYLSPEVLKKDPY--SKPVDIWACGVIL 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 51/236 (21%), Positives = 88/236 (37%), Gaps = 29/236 (12%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK----RLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
LG+G +G V + AVK + E+++L RLRHKN++
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 342 SLF----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
L + + +V E+ G ++ D + L
Sbjct: 70 QLVDVLYNEEKQK---MYMVMEYCVCGM--QEML-DSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL--DVTHVSTAPQGTPGYVDPEY 455
YLH+ I+H+D+K N+LL + +K++ G++ T+ QG+P + PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEI 182
Query: 456 HQCYQLTD--KSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAF 508
K D++S GV L + + P N+ L I K ++
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-------EGDNIYKL-FENIGKGSY 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK---RLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
LG G FG V G+ G +VAVK R + V + E++ L RH +++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 343 LFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+ T +V E+V+ G + D + KHG + + + SA+ Y H
Sbjct: 76 LYQVISTPTD---FFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YHQC 458
++HRD+K N+LLD++ K+ADFGLS + + T+ G+P Y PE +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVISGRL 186
Query: 459 YQLTDKSDVYSFGVVL 474
Y + D++S GV+L
Sbjct: 187 YA-GPEVDIWSCGVIL 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 53/283 (18%), Positives = 116/283 (40%), Gaps = 37/283 (13%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
+ + +ELG G FG V+ + G A K + + E E++ ++ LRH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 340 LVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
LV+L ++++YEF++ G + +++ +H ++ + + L
Sbjct: 216 LVNLHDAFEDDNE---MVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 398 YLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
++H ++ +H D+K NI+ + + +K+ DFGL+ D GT + PE
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEV 327
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ + +D++S GV+ L+S + + E + ++ C ++
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDET------LRNVKSCDWN------ 374
Query: 516 LGFESDEEVKRMTTSVAELA--FL--CLQQNKELRPSMEEVLA 554
+ + ++E F+ L + R ++ + L
Sbjct: 375 --MDDSA-----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-YDNNYRRVEQFMNEVEILTRL-RHK 338
D E+G G +G+V K G+ +AVKR+ + + +Q + +++++ R
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V +G R + E ++ + ++ I I + T AL +
Sbjct: 82 YIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 399 LHASD-IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
L + IIHRD+K +NILLD + +K+ DFG+S L + T G Y+ PE
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ--LVDSIAKTRDAGCRPYMAPERID 198
Query: 458 CYQLTD----KSDVYSFGVVLIEL 477
+SDV+S G+ L EL
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYEL 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVK---------RLYDNNYRRVEQFMNEVEILTRL-R 336
+ LG G V K +E AVK + E + EV+IL ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 337 HKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
H N++ L T+ + LV++ + G + D L + L+ I
Sbjct: 83 HPNIIQLKDTYETNTF---FFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLE 135
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
+ LH +I+HRD+K NILLD + +K+ DFG S D GTP Y+ PE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPE 193
Query: 455 --------YHQCYQLTDKSDVYSFGVVL 474
H Y + D++S GV++
Sbjct: 194 IIECSMNDNHPGY--GKEVDMWSTGVIM 219
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 66/300 (22%), Positives = 118/300 (39%), Gaps = 37/300 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLY-DNNYRRVEQFMNEVEILTRLRHKN 339
+DF + ELG G G V+ K G +A K ++ + Q + E+++L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 340 LVSLFGCTSRYSQG-LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V +G + YS G + + E + G++ L K G + I ++I L Y
Sbjct: 93 IVGFYG--AFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTY 146
Query: 399 LHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
L I+HRDVK +NIL++S +K+ DFG+S L + ++ GT Y+ PE Q
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSF-VGTRSYMSPERLQ 203
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+ +SD++S G+ L+E+ + + + + P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 518 FESDEEVKRMTTSVAELAFL------------------------CLQQNKELRPSMEEVL 553
R ++ EL CL +N R +++++
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 69/303 (22%), Positives = 108/303 (35%), Gaps = 60/303 (19%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLF 344
E LG+G V +E AVK + + EVE+L + + H+N++ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 345 GC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
LV+E + G++ +H K + + ASAL +LH
Sbjct: 78 EFFEEEDR---FYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK 130
Query: 403 DIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLDVTHVSTAPQ------GTPGYVDP 453
I HRD+K NIL + VK+ DF L L+ + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 454 E-------YHQCYQLTDKS-DVYSFGVVLIELISSMP--------AVDMNRHRHEINLAN 497
E Y DK D++S GV+L L+S P +R N
Sbjct: 191 EVVEAFSEEASIY---DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 498 LAINKIQKCAFDELIDPCLGFESD------EEVKRMTTSVAELAFLCLQQNKELRPSMEE 551
+ IQ+ ++ F K +L L ++ + R S +
Sbjct: 248 MLFESIQEGKYE--------FPDKDWAHISCAAK-------DLISKLLVRDAKQRLSAAQ 292
Query: 552 VLA 554
VL
Sbjct: 293 VLQ 295
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 80/297 (26%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK---------RLYDNNYRRVEQFMNEVEILTRLR 336
LG GGFGTV+ G L D +VA+K ++ EV +L ++
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVG 92
Query: 337 ----HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGD----RAKHGLLTWPIRMNI 388
H ++ L +G +LV E D + G L
Sbjct: 93 AGGGHPGVIRLLDWFET-QEGFMLVLERPLPA-------QDLFDYITEKGPLGEGPSRCF 144
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
+ +A+ + H+ ++HRD+K NIL+D C K+ DFG L + GT
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGT 201
Query: 448 PGYVDPEY--HQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQ 504
Y PE+ Y + V+S G++L +++ +P
Sbjct: 202 RVYSPPEWISRHQYHAL-PATVWSLGILLYDMVCGDIP---------------------- 238
Query: 505 KCAFDELIDPCLGFESDEEVKR--------MTTSVAELAFLCLQQNKELRPSMEEVL 553
FE D+E+ ++ L CL RPS+EE+L
Sbjct: 239 -------------FERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-YDNNYRRVEQFMNEVEILTRL-RHK 338
+D ELG G +G V + G+ +AVKR+ N + ++ + +++I R
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
V+ +G R + + E + + ++ K + I IA+ AL +
Sbjct: 67 FTVTFYGALFREGD-VWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 399 LHASD-IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--- 454
LH+ +IHRDVK +N+L+++ VK+ DFG+S L G Y+ PE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPERIN 182
Query: 455 -YHQCYQLTDKSDVYSFGVVLIEL 477
+ KSD++S G+ +IEL
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 44/279 (15%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
ELG G VY K K + A+K L + E+ +L RL H N++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 347 TSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
+ + LV E V G + D++ + G + + + A+AYLH + I
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 405 IHRDVKTNNILL---DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+HRD+K N+L + +K+ADFGLS++ V + GTPGY PE +
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGCAY 227
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
+ D++S G++ L+ R + +I C + F S
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFM------FRRILNCEYY--------FISP 273
Query: 522 ------EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
K + + + + R + + L
Sbjct: 274 WWDEVSLNAKDLVRK-------LIVLDPKKRLTTFQALQ 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 58/290 (20%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVK--------RLYDNNYRRVEQFMNEVEILT 333
+S LG G FG V+ + +EV VK ++ + E+ IL+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 334 RLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGD----RAKHGLLTWPIRMN 387
R+ H N++ + + LV E +G D +H L P+
Sbjct: 85 RVEHANIIKVLDIFENQGF---FQLVMEKHGSG-------LDLFAFIDRHPRLDEPLASY 134
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
I + SA+ YL DIIHRD+K NI++ +F +K+ DFG + T GT
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFC-GT 192
Query: 448 PGYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQ 504
Y PE Y+ + +++S GV L L+ P + + +
Sbjct: 193 IEYCAPEVLMGNPYR-GPELEMWSLGVTLYTLVFEENPFCE--------------LEETV 237
Query: 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
+ A + E V + LQ E R ++E+++
Sbjct: 238 EAAIH--PPYLVSKELMSLVSGL-----------LQPVPERRTTLEKLVT 274
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 50/286 (17%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLF 344
++ LG G G V + G++ A+K LYD+ + EV+ + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 345 GC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ LL++ E + G + ++ T I + +A+ +LH+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 402 SDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YH 456
+I HRDVK N+L + + +K+ DFG ++ + + T P TP YV PE
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAPEVLGP 203
Query: 457 QCYQLTDKS-DVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
+ Y DKS D++S GV++ I L P + +I+ +
Sbjct: 204 EKY---DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----KRRIRLGQYG----- 251
Query: 515 CLGFESD------EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F + E+ K +L L L+ + R ++ + +
Sbjct: 252 ---FPNPEWSEVSEDAK-------QLIRLLLKTDPTERLTITQFMN 287
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 277 LAEATNDFSRE----KELGDGGFGTVYYGKLKD-GREVAVKRLYDNNY--RRVEQFMNEV 329
+ A+ FS +ELG G F V K G E A K + R ++ E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 330 EILTRLRHKNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
I +L+H N+V L LV++ V G + + + + +
Sbjct: 80 RICRKLQHPNIVRLHDS---IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASH 132
Query: 388 IAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAP 444
+ ++AY H++ I+HR++K N+LL S VK+ADFGL+ A
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 191
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVL 474
GTPGY+ PE + + D+++ GV+L
Sbjct: 192 -GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 22/201 (10%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVK------RLYDNNYRRVEQFMNEVEILTRLRHKN 339
+ELG G F V + K G+E A K E+ EV IL +RH N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 340 LVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+++L ++L+ E V+ G + D L A+ LT + +
Sbjct: 70 IITLHDIFENKTD---VVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVH 122
Query: 398 YLHASDIIHRDVKTNNILLDS----NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
YLH+ I H D+K NI+L N +K+ DFG++ + GTP +V P
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAP 180
Query: 454 EYHQCYQLTDKSDVYSFGVVL 474
E L ++D++S GV+
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 69/306 (22%), Positives = 117/306 (38%), Gaps = 55/306 (17%)
Query: 268 GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKD-GREVAVK------RLYDNNYR 320
G+ F + + + +ELG G F V + K G E A K
Sbjct: 1 GMEPFKQQKV---EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 321 RVEQFMNEVEILTRLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHG 378
E+ EV IL ++ H N+++L ++L+ E V+ G + D L A+
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRTD---VVLILELVSGGELFDFL----AQKE 110
Query: 379 LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS----NFCVKVADFGLSRLFP 434
L+ + + + YLH I H D+K NI+L +K+ DFGL+
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI- 169
Query: 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRH 491
+ GTP +V PE L ++D++S GV+ L+S +
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQ 224
Query: 492 EINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELA--FL--CLQQNKELRP 547
E + I ++D F+ + + +ELA F+ L + R
Sbjct: 225 ET------LANITSVSYD--------FDEEF-----FSHTSELAKDFIRKLLVKETRKRL 265
Query: 548 SMEEVL 553
+++E L
Sbjct: 266 TIQEAL 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 31/207 (14%)
Query: 288 KELGDGGFGTVYYGKLKD-GREVAVKRL--------YDNNYRRVEQFMNEVEILTRLR-H 337
+G G V + G E AVK + + E E IL ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
++++L +S + + LV++ + G + D L + L+ +I A
Sbjct: 160 PHIITLIDSYESSSF---MFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEA 212
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
+++LHA++I+HRD+K NILLD N ++++DFG S + GTPGY+ PE
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEI 270
Query: 455 -------YHQCYQLTDKSDVYSFGVVL 474
H Y + D+++ GV+L
Sbjct: 271 LKCSMDETHPGY--GKEVDLWACGVIL 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 56/293 (19%), Positives = 110/293 (37%), Gaps = 58/293 (19%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
+ ++LG G FG V+ + K + E+ IL RH+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 340 LVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDR--AKHGLLTWPIRMNIAIETASA 395
++ L + + L++++EF++ + +R L ++ + A
Sbjct: 63 ILHLHES---FESMEELVMIFEFISGL----DIF-ERINTSAFELNEREIVSYVHQVCEA 114
Query: 396 LAYLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLF-PLDVTHVSTAPQGTPGYVD 452
L +LH+ +I H D++ NI+ + + +K+ +FG +R P D + P Y
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYA 171
Query: 453 PEYHQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
PE HQ ++ +D++S G ++ + L P + +I I I +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQI------IENIMNAEYT-- 221
Query: 512 IDPCLGFESD------EE----VKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F+ + E V R+ L + ++ R + E L
Sbjct: 222 ------FDEEAFKEISIEAMDFVDRL-----------LVKERKSRMTASEALQ 257
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 38/285 (13%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR--VEQFMNEVEILTRLRH 337
T ++ +ELG G F V G+E A + ++ E I L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 338 KNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
N+V L L+++ V G + + + + + + A
Sbjct: 70 PNIVRLHDS---ISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCIQQILEA 122
Query: 396 LAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
+ + H ++HR++K N+LL S VK+ADFGL+ + GTPGY+
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLS 181
Query: 453 PE--YHQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509
PE Y D+++ GV+L I L+ P D ++HR +I+ A+D
Sbjct: 182 PEVLRKDPY--GKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQQIKAGAYD 231
Query: 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F S E +T +L L N R + E L
Sbjct: 232 --------FPS-PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 64/297 (21%), Positives = 114/297 (38%), Gaps = 60/297 (20%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRL------YDNNYRRVEQFMNEVEILT 333
+ + +ELG G F V + K G + A K + E EV IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 334 RLRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
++H N+++L ++L+ E VA G + D L A+ LT +
Sbjct: 70 EIQHPNVITLHEVYENKTD---VILILELVAGGELFDFL----AEKESLTEEEATEFLKQ 122
Query: 392 TASALAYLHASDIIHRDVKTNNILLDS----NFCVKVADFGLSRLFPLDVTHVSTAPQGT 447
+ + YLH+ I H D+K NI+L +K+ DFGL+ + GT
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GT 180
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKC 506
P +V PE L ++D++S GV+ I L + P + + E + +
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQET------LANVSAV 232
Query: 507 AFDELIDPCLGFESD------EE----VKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
++ FE + ++R+ L ++ + R ++++ L
Sbjct: 233 NYE--------FEDEYFSNTSALAKDFIRRL-----------LVKDPKKRMTIQDSL 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 41/213 (19%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK-----RLYDNNYRRVEQFMNEVEILTRLRHKNL 340
+ LG+G +G V VAVK R D E E+ I L H+N+
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC----PENIKKEICINKMLNHENV 67
Query: 341 VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA----- 393
V +G L E+ + G + D++ M A
Sbjct: 68 VKFYGHRREGNI---QYLFLEYCSGGELFDRI----EPDI------GMPE--PDAQRFFH 112
Query: 394 ---SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT--HVSTAPQGTP 448
+ + YLH I HRD+K N+LLD +K++DFGL+ +F + ++ GT
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTL 171
Query: 449 GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
YV PE + + + DV+S G+VL +++
Sbjct: 172 PYVAPELLKRREFH-AEPVDVWSCGIVLTAMLA 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 55/293 (18%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHK 338
T+ + ++++G G + K E AVK + + E+EIL R +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHP 76
Query: 339 NLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
N+++L Y + + +V E + G + D++ + + + +
Sbjct: 77 NIITLKDV---YDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTV 129
Query: 397 AYLHASDIIHRDVKTNNILLDSN----FCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
YLHA ++HRD+K +NIL +++ DFG ++ + + T P T +V
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVA 188
Query: 453 PE--YHQCYQLTDKS-DVYSFGVVLIELISSMP--AVDMNRHRHEINLANLAINKIQKCA 507
PE Q Y D + D++S GV+L +++ A + EI + +I
Sbjct: 189 PEVLERQGY---DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI------LARIGSGK 239
Query: 508 FDELIDPCLGFESD------EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F + K +L L + R + VL
Sbjct: 240 FS--------LSGGYWNSVSDTAK-------DLVSKMLHVDPHQRLTAALVLR 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 51/304 (16%)
Query: 268 GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKD-GREVAVK------RLYDNNYR 320
G+ F + + + +ELG G F V + K G E A K
Sbjct: 1 GMETFKQQKV---EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 321 RVEQFMNEVEILTRLRHKNLVSLFGCTSRY--SQGLLLVYEFVANGTVADQLHGDRAKHG 378
E+ EV IL ++ H N+++L Y ++L+ E V+ G + D L A+
Sbjct: 58 CREEIEREVSILRQVLHPNIITLHDV---YENRTDVVLILELVSGGELFDFL----AQKE 110
Query: 379 LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS----NFCVKVADFGLSRLFP 434
L+ + + + YLH I H D+K NI+L +K+ DFGL+
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI- 169
Query: 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEI 493
+ GTP +V PE L ++D++S GV+ I L + P + + E
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQET 226
Query: 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELA--FL--CLQQNKELRPSM 549
+ I ++D F+ + + +ELA F+ L + R ++
Sbjct: 227 ------LANITAVSYD--------FDEEF-----FSQTSELAKDFIRKLLVKETRKRLTI 267
Query: 550 EEVL 553
+E L
Sbjct: 268 QEAL 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-YDNNYRRVEQFMNEVEILTRL-RHK 338
ND E+G G G V+ + + G +AVK++ N ++ + +++++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V FG + + + E + GT A++L + G + I + + AL Y
Sbjct: 85 YIVQCFGTFITNTD-VFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKALYY 139
Query: 399 LHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
L +IHRDVK +NILLD +K+ DFG+S L G Y+ PE
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR--LVDDKAKDRSAGCAAYMAPERID 197
Query: 458 CYQLTD-----KSDVYSFGVVLIEL 477
T ++DV+S G+ L+EL
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVEL 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 30/215 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN--EVEILTRLRHK 338
+ + ++G+G +G V+ + +D G+ VA+K+ ++ V + + E+ +L +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
NLV+L R + L LV+E+ + TV +L DR + G+ ++ +I +T A+ +
Sbjct: 63 NLVNLLEVFRRKRR-LHLVFEYC-DHTVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNF 117
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDV-TH-VST----APQ---GT 447
H + IHRDVK NIL+ + +K+ DFG +RL P D V+T +P+ G
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
Y P DV++ G V EL+S +P
Sbjct: 178 TQYGPP-----------VDVWAIGCVFAELLSGVP 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 68/287 (23%), Positives = 109/287 (37%), Gaps = 53/287 (18%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLF 344
+ LG G G V K + A+K L D + EVE+ R + ++V +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 121
Query: 345 GC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ LL+V E + G + ++ T I A+ YLH+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 402 SDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YH 456
+I HRDVK N+L S N +K+ DFG ++ + T P TP YV PE
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP 237
Query: 457 QCYQLTDKS-DVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDELI 512
+ Y DKS D++S GV++ L+ P + + +I+ ++
Sbjct: 238 EKY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KTRIRMGQYE--- 285
Query: 513 DPCLGFESDE------EVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F + E EVK L L+ R ++ E +
Sbjct: 286 -----FPNPEWSEVSEEVK-------MLIRNLLKTEPTQRMTITEFM 320
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 41/213 (19%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK-----RLYDNNYRRVEQFMNEVEILTRLRHKNL 340
+ LG+G +G V VAVK R D E E+ I L H+N+
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC----PENIKKEICINKMLNHENV 67
Query: 341 VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA----- 393
V +G L E+ + G + D++ M A
Sbjct: 68 VKFYGHRREGNI---QYLFLEYCSGGELFDRI----EPDI------GMPE--PDAQRFFH 112
Query: 394 ---SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT--HVSTAPQGTP 448
+ + YLH I HRD+K N+LLD +K++DFGL+ +F + ++ GT
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTL 171
Query: 449 GYVDPE--YHQCYQLTDKSDVYSFGVVLIELIS 479
YV PE + + + DV+S G+VL +++
Sbjct: 172 PYVAPELLKRREFH-AEPVDVWSCGIVLTAMLA 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 34/279 (12%), Positives = 84/279 (30%), Gaps = 59/279 (21%)
Query: 287 EKELGDGGFGTVYYGKLKD---GREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKNL 340
G + D R+VA+ + +++ ++ L+R+ +
Sbjct: 36 LIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-MNIAIETASALAYL 399
+ G L+V E++ G++ + P+ + A+A
Sbjct: 94 ARVLD-VVHTRAGGLVVAEWIRGGSLQEVADT-----SPS--PVGAIRAMQSLAAAADAA 145
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H + + + + + + V +A T P P
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------TMPDANP----------- 181
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
+ D+ G L L+ + + R + A + I+P
Sbjct: 182 ----QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-------GQPIEP----- 225
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
+ + + ++ +A +Q + +R + +L +Q+
Sbjct: 226 -ADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQ 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK---RLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ LG+G FG V K ++VA+K R + E+ L LRH +++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 343 LFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+ T +++V E+ G + D + + +T + A+ Y H
Sbjct: 74 LYDVITTPTD---IVMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YHQC 458
I+HRD+K N+LLD N VK+ADFGLS + + T+ G+P Y PE +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAAPEVINGKL 183
Query: 459 YQLTDKSDVYSFGVVL 474
Y + DV+S G+VL
Sbjct: 184 YA-GPEVDVWSCGIVL 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK---RLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
LG G FG V GK G +VAVK R + V + E++ L RH +++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 343 LFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
L+ T + +V E+V+ G + D + K+G L + + S + Y H
Sbjct: 81 LYQVISTPSD---IFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--YHQC 458
++HRD+K N+LLD++ K+ADFGLS + + T+ G+P Y PE +
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVISGRL 191
Query: 459 YQLTDKSDVYSFGVVL 474
Y + D++S GV+L
Sbjct: 192 YA-GPEVDIWSSGVIL 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 33/221 (14%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
+DF K +G G F V K+K +V A+K + + + V F E ++L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANG-------TVADQLHGDRAKHGLLTWPIRMNI 388
+ + L Y L LV E+ G +++ + A R +
Sbjct: 121 RWITQLHFAFQDENY---LYLVMEYYVGGDLLTLLSKFGERIPAEMA---------RFYL 168
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTP 448
A E A+ +H +HRD+K +NILLD +++ADFG D T S GTP
Sbjct: 169 A-EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 449 GYVDPEYHQCYQLTDKSDVY-------SFGVVLIELISSMP 482
Y+ PE Q + Y + GV E+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 67/286 (23%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 286 REKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR-----VEQFMNEVEILTRLRH-K 338
KELG G F V K G+E A K L RR + ++E+ +L +
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFL---KKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 339 NLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
+++L + ++L+ E+ A G + + A+ ++ + + + +
Sbjct: 90 RVINLHEVYENTSE---IILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGV 144
Query: 397 AYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
YLH ++I+H D+K NILL +K+ DFG+SR GTP Y+ P
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAP 202
Query: 454 EYHQCYQLTDKSDVYSFGVVL-IELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512
E +T +D+++ G++ + L + P V + E I + D
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--NQET------YLNISQVNVD--- 251
Query: 513 DPCLGFESDEEVKRMTTSVAELA--FL--CLQQNKELRPSMEEVLA 554
+ + +SV++LA F+ L +N E RP+ E L+
Sbjct: 252 -----YSEET-----FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 32/202 (15%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVK-----RLYDNNYRRVEQFMNEVEILTRLRHKNL 340
K++G G FG + VAVK D N +R E+ LRH N+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR------EIINHRSLRHPNI 78
Query: 341 VSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
V T + L ++ E+ + G + +++ G + + S ++Y
Sbjct: 79 VRFKEVILTPTH---LAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 399 LHASDIIHRDVKTNNILLDSNFC--VKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE-- 454
H+ I HRD+K N LLD + +K+ DFG S+ L ST GTP Y+ PE
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVL 189
Query: 455 YHQCYQLTD--KSDVYSFGVVL 474
Q Y D +DV+S GV L
Sbjct: 190 LRQEY---DGKIADVWSCGVTL 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
DF K +G G FG V KLK+ +V A+K L + F E ++L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
K + +L L LV ++ G + L + + L R +A E A
Sbjct: 134 KWITTLHYAFQDDNN---LYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLA-EMVIA 187
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
+ +H +HRD+K +NIL+D N +++ADFG D T S+ GTP Y+ PE
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 456 HQCYQLTDKS-----DVYSFGVVLIELISSMP 482
Q + D +S GV + E++
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN--EVEILTRLRHK 338
+ +G+G +G V + KD GR VA+K+ +++ ++ + + E+++L +LRH+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
NLV+L + + LV+EFV + T+ D L + +GL ++ + + + +
Sbjct: 85 NLVNLLEVCKKKKR-WYLVFEFV-DHTILDDL--ELFPNGLDYQVVQ-KYLFQIINGIGF 139
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDV-TH-VST----APQ---GT 447
H+ +IIHRD+K NIL+ + VK+ DFG +R P +V V+T AP+ G
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
Y DV++ G ++ E+ P
Sbjct: 200 VKYGKA-----------VDVWAIGCLVTEMFMGEP 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNN---YRRVEQFMNEVEILTRLRH 337
+ F + +G G FG V + D +++ A+K + V E++I+ L H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIETAS 394
LV+L+ + +V + + G + L ++ +++ I E
Sbjct: 75 PFLVNLWYSFQDEED---MFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFIC-ELVM 126
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
AL YL IIHRD+K +NILLD + V + DF ++ + P + + A GT Y+ PE
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPE 184
Query: 455 --YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ + D +S GV EL+
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 47/223 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQF--------MNEVEILT 333
+ + +++G+G +G VY K GR VA+KR+ R++ + E+ +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLK 74
Query: 334 RLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQ-LHG--DRAKHGLLTWPIRMNIAI 390
L H N+VSL L LV+EF+ ++ L D K GL I+
Sbjct: 75 ELHHPNIVSLIDVIHSERC-LTLVFEFM------EKDLKKVLDENKTGLQDSQIK-IYLY 126
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST---- 442
+ +A+ H I+HRD+K N+L++S+ +K+ADFGL+R F + V TH V T
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 443 APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP G+ Y + D++S G + E+I+ P
Sbjct: 187 APDVLMGSKKY-----------STSVDIWSIGCIFAEMITGKP 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
D+ K +G G FG V + K R+V A+K L + F E +I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+V LF RY L +V E++ G + + + + + R A E A
Sbjct: 129 PWVVQLFYAFQDDRY---LYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTA-EVVLA 180
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
L +H+ IHRDVK +N+LLD + +K+ADFG + GTP Y+ PE
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 455 -----YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
Y + D +S GV L E++
Sbjct: 241 LKSQGGDGYY---GRECDWWSVGVFLYEMLVGDT 271
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
+ F + LG GGFG V+ ++K ++ A K+L ++ + M E +IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+ +VSL T L LV + G + ++ + P + + S
Sbjct: 245 RFIVSLAYAFETK---TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
L +LH +II+RD+K N+LLD + V+++D GL+ T GTPG++ PE
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPEL 360
Query: 455 -YHQCYQLTDKS-DVYSFGVVLIELISSMP---AVDMNRHRHEI 493
+ Y D S D ++ GV L E+I++ A E+
Sbjct: 361 LLGEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDN---NYRRVEQFMNEVEILTRLRH 337
+ F R K LG G FG V K K+ G A+K L +++E +NE IL +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
LV L + L +V E+VA G + L + G + P A +
Sbjct: 101 PFLVKLEFSFKDNSN---LYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLT 153
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE- 454
YLH+ D+I+RD+K N+L+D ++V DFG ++ T GTP + PE
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWTLC---GTPEALAPEI 209
Query: 455 -YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ Y +K+ D ++ GV++ E+ + P
Sbjct: 210 ILSKGY---NKAVDWWALGVLIYEMAAGYP 236
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 47/223 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQF--------MNEVEILT 333
+ +++G+G +G VY + G A+K++ R+E+ + E+ IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI------RLEKEDEGIPSTTIREISILK 55
Query: 334 RLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQ-LHG--DRAKHGLLTWPIRMNIAI 390
L+H N+V L+ + L+LV+E + DQ L D + GL + + + +
Sbjct: 56 ELKHSNIVKLYDVIHT-KKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAK-SFLL 107
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST---- 442
+ + +AY H ++HRD+K N+L++ +K+ADFGL+R F + V TH + T
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 443 APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP G+ Y + D++S G + E+++ P
Sbjct: 168 APDVLMGSKKY-----------STTIDIWSVGCIFAEMVNGTP 199
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDN---NYRRVEQFMNEVEILTRLRH 337
NDFS + +G GGFG VY + D G+ A+K L + +NE +L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 338 KN---LVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
+ +V + T L + + + G + L +HG+ + A E
Sbjct: 249 GDCPFIVCMSYAFHTP---DKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEI 301
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD 452
L ++H +++RD+K NILLD + V+++D GL+ F H S GT GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 453 PEYHQCYQLTDKS-DVYSFGVVLIELISSMP 482
PE Q D S D +S G +L +L+
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 276 DLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMN-----EV 329
D+ + + LG+G F TVY + + VA+K++ + + +N E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 330 EILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGD-----RAKHGLLTWPI 384
++L L H N++ L S + LV++F + D + +LT
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSN-ISLVFDF---------METDLEVIIKDNSLVLTPSH 113
Query: 385 RMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
+ T L YLH I+HRD+K NN+LLD N +K+ADFGL++ F
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 4e-22
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNN---YRRVEQFMNEVEILTRLRH 337
DF + LG G FG V+ + + A+K L ++VE +E +L+ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 338 KNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAIETAS 394
++ ++G ++ + ++ +++ G + L K P+ + A E
Sbjct: 66 PFIIRMWGTFQDAQQ---IFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAA-EVCL 117
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
AL YLH+ DII+RD+K NILLD N +K+ DFG ++ P DVT+ GTP Y+ PE
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLC---GTPDYIAPE 173
Query: 455 --YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ Y +KS D +SFG+++ E+++
Sbjct: 174 VVSTKPY---NKSIDWWSFGILIYEMLAGYT 201
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 24/178 (13%)
Query: 280 ATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQF----MNEVEILT 333
AT+ + E+G G +GTVY + G VA+K + N + EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 334 RLR---HKNLVSLF----GCTSRYSQGLLLVYEFVANGTVADQ-LHG--DRAKHGLLTWP 383
RL H N+V L + + LV+E V DQ L D+A L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLDKAPPPGLPAE 120
Query: 384 IRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDVTH 439
++ + L +LHA+ I+HRD+K NIL+ S VK+ADFGL+R++ + +T
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 48/221 (21%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF--------MNEVEIL 332
+ + +++G+G +GTV+ K + VA+KR+ R++ + E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLL 55
Query: 333 TRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQ-LHG--DRAKHGLLTWPIRMNIA 389
L+HKN+V L + L LV+EF DQ L D L ++ +
Sbjct: 56 KELKHKNIVRLHDVLHSDKK-LTLVFEFC------DQDLKKYFDSCNGDLDPEIVK-SFL 107
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST--- 442
+ L + H+ +++HRD+K N+L++ N +K+A+FGL+R F + V + V T
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 443 -APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
P G Y + D++S G + EL +
Sbjct: 168 RPPDVLFGAKLY-----------STSIDMWSAGCIFAELAN 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 40/224 (17%)
Query: 280 ATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQ-------FMNEVEI 331
+++ F + ++LG+G + TVY G G VA+K + +++ + E+ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISL 56
Query: 332 LTRLRHKNLVSLFGCTSRYSQGLLLVYEFVAN--GTVADQLHGDRAKHGLLTWPIRMNIA 389
+ L+H+N+V L+ ++ L LV+EF+ N D GL ++
Sbjct: 57 MKELKHENIVRLYDVIHTENK-LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQ 114
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST--- 442
+ LA+ H + I+HRD+K N+L++ +K+ DFGL+R F + V + V T
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 443 -APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP G+ Y + D++S G +L E+I+ P
Sbjct: 175 RAPDVLMGSRTY-----------STSIDIWSCGCILAEMITGKP 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 284 FSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN-EVEILTRLRHKNLV 341
++ K +G+G FG VY KL D G VA+K++ + ++F N E++I+ +L H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 110
Query: 342 SLFGC-----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
L + L LV ++V TV L + +L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCV-KVADFGLSRLFPLD---VTHVST----APQ--- 445
AY+H+ I HRD+K N+LLD + V K+ DFG ++ V+++ + AP+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 229
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
G Y T DV+S G VL EL+ P
Sbjct: 230 GATDY-----------TSSIDVWSAGCVLAELLLGQP 255
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 18/222 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
N F + + LG GGFG V +++ ++ A K+L ++ +NE +IL ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+ +VSL L LV + G + ++ + A E L
Sbjct: 244 RFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLE 300
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE--Y 455
LH I++RD+K NILLD + ++++D GL+ P T GT GY+ PE
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVK 358
Query: 456 HQCYQLTDKS-DVYSFGVVLIELISSMP---AVDMNRHRHEI 493
++ Y S D ++ G +L E+I+ R E+
Sbjct: 359 NERY---TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 34/181 (18%)
Query: 282 NDFSREKELGDGGFGTVYYGK--LKDGREVAVKRLYDNNYRRVEQFMN--------EVEI 331
+ E+G+G +G V+ + GR VA+KR+ RV+ EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAV 64
Query: 332 LTRLR---HKNLVSLF----GCTSRYSQGLLLVYEFVANGTVADQ-LHG--DRAKHGLLT 381
L L H N+V LF + L LV+E V DQ L D+ +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVP 118
Query: 382 WPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF--PLDVTH 439
++ + L +LH+ ++HRD+K NIL+ S+ +K+ADFGL+R++ + +T
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178
Query: 440 V 440
V
Sbjct: 179 V 179
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 40/224 (17%)
Query: 279 EATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMN-EVEILTRLRH 337
+ ++ K +G+G FG V+ KL + EVA+K++ + ++F N E++I+ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKH 91
Query: 338 KNLVSLFGCTSRYSQG-------LLLVYEFVANGTVADQL-HGDRAKHGLLTWPIRMNIA 389
N+V L YS G L LV E+V TV H + K + I+
Sbjct: 92 PNVVDLKAFF--YSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIK-LYM 147
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSR-LFPLD--VTHVST--- 442
+ +LAY+H+ I HRD+K N+LLD +K+ DFG ++ L + V+++ +
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYY 207
Query: 443 -APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
AP+ G Y T D++S G V+ EL+ P
Sbjct: 208 RAPELIFGATNY-----------TTNIDIWSTGCVMAELMQGQP 240
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 51/225 (22%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQ-------FMNEVEILT 333
+ + +LG+G + TVY GK K VA+K + R+E + EV +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLK 55
Query: 334 RLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH-----GLLTWPIRMNI 388
L+H N+V+L L LV+E+ L D ++ ++
Sbjct: 56 DLKHANIVTLHDIIHTEKS-LTLVFEY---------LDKDLKQYLDDCGNIINMHNVKLF 105
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV---TH-VST-- 442
+ LAY H ++HRD+K N+L++ +K+ADFGL+R + + V T
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 443 --APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
P G+ Y + + D++ G + E+ + P
Sbjct: 166 YRPPDILLGSTDY-----------STQIDMWGVGCIFYEMATGRP 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 62/218 (28%), Positives = 91/218 (41%), Gaps = 36/218 (16%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNEVEILTRL 335
NDF K LG G FG V + K A+K L + V + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNT 62
Query: 336 RHKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNI-AIE 391
RH L +L R L V E+ G + L + + T R E
Sbjct: 63 RHPFLTALKYAFQTHDR----LCFVMEYANGGELFFHLS----RERVFTEE-RARFYGAE 113
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPG 449
SAL YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPE 170
Query: 450 YVDPEYHQCYQLTDKS-----DVYSFGVVLIELISSMP 482
Y+ PE L D D + GVV+ E++
Sbjct: 171 YLAPEV-----LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 50/227 (22%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF--------MNEVEIL 332
+ + R +LG+G +G VY VA+KR+ R+E + EV +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLL 87
Query: 333 TRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQ-LHGDRAKHGLLTWPIRMNIAIE 391
L+H+N++ L + L L++E+ + L K+ ++ + + +
Sbjct: 88 KELQHRNIIELKSVIHHNHR-LHLIFEYA------ENDLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNF-----CVKVADFGLSRLFPLDV---TH-VST 442
+ + + H+ +HRD+K N+LL + +K+ DFGL+R F + + TH + T
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 443 ----APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
P+ G+ Y + D++S + E++ P
Sbjct: 201 LWYRPPEILLGSRHY-----------STSVDIWSIACIWAEMLMKTP 236
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 46/178 (25%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQF--------MNEVEIL 332
+ + + ++G G FG V+ + K G++VA+K++ +E + E++IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV------LMENEKEGFPITALREIKIL 70
Query: 333 TRLRHKNLVSLFG-CTSRYSQG------LLLVYEFVANGTVADQLHGDRAKHGLLTWPIR 385
L+H+N+V+L C ++ S + LV++F + D A GLL+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EH---DLA--GLLS---N 116
Query: 386 MNIAIETA----------SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433
+ + + + L Y+H + I+HRD+K N+L+ + +K+ADFGL+R F
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 55/288 (19%), Positives = 96/288 (33%), Gaps = 76/288 (26%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLF 344
+ LG G G V K + A+K L D + EVE+ R + ++V +
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 77
Query: 345 GC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ LL+V E + G + ++ T I A+ YLH+
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 402 SDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
+I HRDVK N+L S N +K+ DFG A + T D
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------AKETTGEKYDKS---- 178
Query: 459 YQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
D++S GV++ L+ P + + +I+ ++
Sbjct: 179 ------CDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KTRIRMGQYE------ 220
Query: 516 LGFESDE----------EVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
F + E ++ + L+ R ++ E +
Sbjct: 221 --FPNPEWSEVSEEVKMLIRNL-----------LKTEPTQRMTITEFM 255
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 290 LGDGGFGTVYYGKLKD---GREVAVKRLYDNNYRRVEQF----MNEVEILTRLRHKNLVS 342
+G G +G VY K KD ++ A+K++ E+ +L L+H N++S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGISMSACREIALLRELKHPNVIS 82
Query: 343 LFG-CTSRYSQGLLLVYEFVAN--GTVADQLHGDRAKHGLLTWPIRM--NIAIETASALA 397
L S + + L++++ + + +A + P M ++ + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 398 YLHASDIIHRDVKTNNILLDSNF----CVKVADFGLSRLF 433
YLHA+ ++HRD+K NIL+ VK+AD G +RLF
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 59/217 (27%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNEVEILTRL 335
N+F K LG G FG V K K A+K L + V + E +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNS 205
Query: 336 RHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
RH L +L T L V E+ G + L + + + E
Sbjct: 206 RHPFLTALKYSFQTHDR---LCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIV 258
Query: 394 SALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGY 450
SAL YLH+ ++++RD+K N++LD + +K+ DFGL + + +T GTP Y
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEY 315
Query: 451 VDPEYHQCYQLTDKS-----DVYSFGVVLIELISSMP 482
+ PE L D D + GVV+ E++
Sbjct: 316 LAPEV-----LEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 282 NDFSREKELGDGGFGTVY---YGKLKDGREV-AVKRL----YDNNYRRVEQFMNEVEILT 333
F + LG GG+G V+ + ++ A+K L N + E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 334 RLRHKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIA 389
++H +V L + L L+ E+++ G + QL + G+ +A
Sbjct: 77 EVKHPFIVDLIYAFQTGGK----LYLILEYLSGGELFMQLE----REGIFMEDTACFYLA 128
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GT 447
E + AL +LH II+RD+K NI+L+ VK+ DFGL + + + GT
Sbjct: 129 -EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGT 184
Query: 448 PGYVDPE--YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
Y+ PE + +++ D +S G ++ ++++ P
Sbjct: 185 IEYMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAP 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL---YDNNYRRVEQFMNEVEILTR-LR 336
+DF K +G G FG V + K AVK L + + M+E +L + ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 337 HKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIET 392
H LV L + L V +++ G + L + P R A E
Sbjct: 98 HPFLVGLHFSFQTADK----LYFVLDYINGGELFYHLQ----RERCFLEPRARFYAA-EI 148
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGY 450
ASAL YLH+ +I++RD+K NILLDS + + DFGL + ++ H ST GTP Y
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEY 205
Query: 451 VDPE--YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ PE + Q Y D++ D + G VL E++ +P
Sbjct: 206 LAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLP 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 72/322 (22%), Positives = 123/322 (38%), Gaps = 71/322 (22%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYD--NN-------YRRVEQFMNE 328
+ K +G G G V R VA+K+L N YR E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-------E 74
Query: 329 VEILTRLRHKNLVSLF-----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP 383
+ ++ + HKN++ L + Q + +V E + A+ L
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQ----------V 119
Query: 384 IRMNIAIETAS--------ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435
I+M + E S + +LH++ IIHRD+K +NI++ S+ +K+ DFGL+R
Sbjct: 120 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177
Query: 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL 495
+ + T T Y PE + D++S G ++ E+I H + N
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237
Query: 496 --------ANLAINKIQ--------------KCAFDELIDPCLGFESDEEVKRMTTSVA- 532
+ K+Q +F++L P + F +D E ++ S A
Sbjct: 238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF-PDVLFPADSEHNKLKASQAR 296
Query: 533 ELAFLCLQQNKELRPSMEEVLA 554
+L L + R S++E L
Sbjct: 297 DLLSKMLVIDASKRISVDEALQ 318
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLY----------DNNYRRVEQFMNEVEI 331
+F K LG G +G V+ + G + +LY + E E ++
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDT--GKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 332 LTRLRHKN-LVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRM 386
L +R LV+L ++ L L+ +++ G + L ++ T +++
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETK----LHLILDYINGGELFTHL----SQRERFTEHEVQI 163
Query: 387 NIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG 446
+ E AL +LH II+RD+K NILLDSN V + DFGLS+ F D T + G
Sbjct: 164 YVG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 447 TPGYVDPE----YHQCYQLTDKS-DVYSFGVVLIELISSMP---AVDMNRHRHEI 493
T Y+ P+ + DK+ D +S GV++ EL++ + EI
Sbjct: 223 TIEYMAPDIVRGGDSGH---DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNEVEILTR- 334
DF K LG G FG V+ + K + A+K L ++ VE M E +L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLA 74
Query: 335 LRHKNLVSLFGC--TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
H L +F T L V E++ G + + A E
Sbjct: 75 WEHPFLTHMFCTFQTKEN---LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEI 127
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGY 450
L +LH+ I++RD+K +NILLD + +K+ADFG+ + ++ + GTP Y
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDY 184
Query: 451 VDPEYHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ PE Q + S D +SFGV+L E++
Sbjct: 185 IAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNEVEILTR- 334
++F + LG G FG V ++K+ ++ AVK L ++ VE M E IL+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLA 80
Query: 335 LRHKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
H L LF C R L V EFV G + + K A E
Sbjct: 81 RNHPFLTQLFCCFQTPDR----LFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAE 132
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPG 449
SAL +LH II+RD+K +N+LLD K+ADFG+ + + + T GTP
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPD 189
Query: 450 YVDPE--YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
Y+ PE Y + D ++ GV+L E++
Sbjct: 190 YIAPEILQEMLY---GPAVDWWAMGVLLYEMLCGHA 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 40/220 (18%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQ--FMN---------EVEILTRLR 336
+ + G +G V G +G VA+KR+++ + E+ +L
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 337 HKNLVSLFGC----TSRYSQGLLLVYEFVANGTVADQLHGD-RAKHGLLTWPIRMNIAIE 391
H N++ L L LV E + D L + +++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TD-LAQVIHDQRIVISPQHIQYFMYH 142
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
L LH + ++HRD+ NILL N + + DF L+R + T YV
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-------EDTADANKT-HYV 194
Query: 452 D------PE---YHQCYQLTDKSDVYSFGVVLIELISSMP 482
PE + + T D++S G V+ E+ +
Sbjct: 195 THRWYRAPELVMQFKGF--TKLVDMWSAGCVMAEMFNRKA 232
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNEVEILTR- 334
DF+ LG G FG V + K E+ AVK L ++ VE M E +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALP 77
Query: 335 LRHKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
+ L L C R L V E+V G + + + G P + A E
Sbjct: 78 GKPPFLTQLHSCFQTMDR----LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAE 129
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPG 449
A L +L + II+RD+K +N++LDS +K+ADFG+ + ++ T GTP
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPD 186
Query: 450 YVDPEYHQCYQLTDKS-DVYSFGVVLIELISSMP 482
Y+ PE YQ KS D ++FGV+L E+++
Sbjct: 187 YIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL---YDNNYRRVEQFMNEVEILTR-LR 336
DF + +G G + V +LK + A+K + N+ ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 337 HKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI-RMNIAIET 392
H LV L C SR L V E+V G + + + L R A E
Sbjct: 69 HPFLVGLHSCFQTESR----LFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSA-EI 119
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGY 450
+ AL YLH II+RD+K +N+LLDS +K+ D+G+ + + T GTP Y
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNY 176
Query: 451 VDPE--YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ PE + Y S D ++ GV++ E+++
Sbjct: 177 IAPEILRGEDY---GFSVDWWALGVLMFEMMAGRS 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 282 NDFSREKELGDGGFGTVY---YGKLKDGREV-AVKRLYDNN--YRRVEQFMNEVEILTRL 335
+ F K LG G FG V+ D R++ A+K L R + E +IL +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 336 RHKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIE 391
H +V L + L L+ +F+ G + +L K + T ++ +A E
Sbjct: 84 NHPFIVKLHYAFQTEGK----LYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLA-E 134
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPG 449
A AL +LH+ II+RD+K NILLD +K+ DFGLS+ + H A GT
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVE 191
Query: 450 YVDPE--YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
Y+ PE + + +S D +SFGV++ E+++
Sbjct: 192 YMAPEVVNRRGH---TQSADWWSFGVLMFEMLTGTL 224
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREV-AVKRL---YDNNYRRVEQFMNEVEILTR-LR 336
DF + +G G + V +LK + A++ + N+ ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 337 HKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP-IRMNIAIET 392
H LV L C SR L V E+V G + + + L R A E
Sbjct: 112 HPFLVGLHSCFQTESR----LFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSA-EI 162
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGY 450
+ AL YLH II+RD+K +N+LLDS +K+ D+G+ + + T GTP Y
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNY 219
Query: 451 VDPE--YHQCYQLTDKS-DVYSFGVVLIELISSMP 482
+ PE + Y S D ++ GV++ E+++
Sbjct: 220 IAPEILRGEDY---GFSVDWWALGVLMFEMMAGRS 251
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 48/248 (19%), Positives = 85/248 (34%), Gaps = 59/248 (23%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN-EVEILTRLRHK 338
+ +S K LG G FG V + G+ A+K++ + ++ N E++I+ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKVLDHV 60
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-----MNIAIE-- 391
N++ L + + + H +N+ +E
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 392 -----------------------------TASALAYLHASDIIHRDVKTNNILLDSNFCV 422
A+ ++H+ I HRD+K N+L++S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 423 -KVADFGLSRLFPLDVTHVSTAPQGTPGYV------DPE-YHQCYQLTDKSDVYSFGVVL 474
K+ DFG ++ V+ Y+ PE + T D++S G V
Sbjct: 181 LKLCDFGSAKKLIPSEPSVA--------YICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 475 IELISSMP 482
ELI P
Sbjct: 233 GELILGKP 240
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 1e-17
Identities = 86/439 (19%), Positives = 145/439 (33%), Gaps = 44/439 (10%)
Query: 55 ECGLMVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSITVEDQVFQNHLNQRSCESFKNFS 114
C + V C VP ++ +++ R
Sbjct: 135 TCMMNVHKRCVMNVP--------------SLCGTDHTERRGRIYIQAHIDREVLIVVVRD 180
Query: 115 LPSSASLSFYVKSKLLSLFRCTDKLDNKFTSFNSTCNSSSFIYYNHPDDDLPSILPPNCS 174
+ + S + ++ T SS +N +
Sbjct: 181 AKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRR 240
Query: 175 LIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCWECRWRGGQCQNDSKGNFQCAETRECN 234
L + S + F + S+ E+ + + ++ + N
Sbjct: 241 LSVEIWDWDLTSRNDF--MGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEG 298
Query: 235 DCHKKRGYCHIDDKGNFQCENERTDLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGG 294
+ ++ + + E+T DF+ LG G
Sbjct: 299 NEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMK-----LTDFNFLMVLGKGS 353
Query: 295 FGTVYYGKLKDGREV-AVKRL-----YDNNYRRVEQFMNEVEILTR-LRHKNLVSLFGC- 346
FG V + K E+ AVK L ++ VE M E +L + L L C
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQLHSCF 411
Query: 347 --TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDI 404
R L V E+V G + + + G P + A E A L +L + I
Sbjct: 412 QTMDR----LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 405 IHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDK 464
I+RD+K +N++LDS +K+ADFG+ + D T GTP Y+ PE YQ K
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA-YQPYGK 521
Query: 465 S-DVYSFGVVLIELISSMP 482
S D ++FGV+L E+++
Sbjct: 522 SVDWWAFGVLLYEMLAGQA 540
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 36/230 (15%)
Query: 259 DLETGTVYFGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDN 317
D E+ V +G +D+ ++LG G + V+ + + +V VK L
Sbjct: 24 DYESHVVEWGNQ-----------DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 72
Query: 318 NYRRVEQFMNEVEILTRLR-HKNLVSLFGC-TSRYSQGLLLVYEFVANG---TVADQLHG 372
+++++ E++IL LR N+++L S+ LV+E V N + L
Sbjct: 73 KKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD 129
Query: 373 DRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC-VKVADFGLSR 431
+ + E AL Y H+ I+HRDVK +N+++D +++ D+GL+
Sbjct: 130 YDIRFYMY----------EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
Query: 432 LF-PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVYSFGVVLIELIS 479
+ P +V A + + PE YQ+ D S D++S G +L +I
Sbjct: 180 FYHPGQEYNVRVA---SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 61/238 (25%)
Query: 279 EATNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMN----EVEILT 333
+ + F E+ G G FGTV GK K G VA+K++ + +F N ++ L
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 334 RLRHKNLVSL---FGCTSRYSQG---LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMN 387
L H N+V L F + L +V E+V T+ H R
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTL----------HRCCRNYYRRQ 123
Query: 388 IAIE----------TASALAYLHAS--DIIHRDVKTNNILLDSNFCV-KVADFGLSRLFP 434
+A ++ LH ++ HRD+K +N+L++ K+ DFG ++
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 435 LDVTHVST-------APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
+V+ AP+ G Y T D++S G + E++ P
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGEP 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRL 335
E + +G G +G+V + G +VA+K+L + ++ E+ +L +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 336 RHKNLVSLF-----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI 390
+H+N++ L + R LV F+ D L + + +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQ--KIMGLKFSEEKIQYLVY 133
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-VST----APQ 445
+ L Y+H++ ++HRD+K N+ ++ + +K+ DFGL+R ++T V T AP+
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPE 193
Query: 446 ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
Y D++S G ++ E+++
Sbjct: 194 VILSWMHY-----------NQTVDIWSVGCIMAEMLTGKT 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 69/320 (21%), Positives = 119/320 (37%), Gaps = 67/320 (20%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYD--NN-------YRRVEQFMNE 328
+ K +G G G V R VA+K+L N YR E
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 111
Query: 329 VEILTRLRHKNLVSLF-----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP 383
+ ++ + HKN++SL T Q + LV E + A+ L + L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LC--QVIQMELDHE 164
Query: 384 IRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443
+ + + +LH++ IIHRD+K +NI++ S+ +K+ DFGL+R + + T
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT- 221
Query: 444 PQGTPGYVD------PEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL-- 495
YV PE + D++S G ++ E++ + + N
Sbjct: 222 -----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 496 ------ANLAINKIQ--------------KCAFDELIDPCLGFESDEEVKRMTTSVA-EL 534
+ K+Q F +L P F +D E ++ S A +L
Sbjct: 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF-PDSLFPADSEHNKLKASQARDL 335
Query: 535 AFLCLQQNKELRPSMEEVLA 554
L + R S+++ L
Sbjct: 336 LSKMLVIDPAKRISVDDALQ 355
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 44/210 (20%), Positives = 75/210 (35%), Gaps = 47/210 (22%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYD--NN-------YRRVEQFMNE 328
+++ + +G G +G VY + VA+K++ + R E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-------E 75
Query: 329 VEILTRLRHKNLVSLFGC----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI 384
+ IL RL+ ++ L+ L +V E +D L
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKK----------LF 120
Query: 385 RMNIAIETA----------SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LF 433
+ I + ++H S IIHRD+K N LL+ + VKV DFGL+R +
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTD 463
T++ + + QLT
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 33/233 (14%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYD--NNYRRVEQFMNEVEILTRL 335
E + + +G G +G V + G +VA+K+LY + ++ E+ +L +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 336 RHKNLVSLF-----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI 390
RH+N++ L T LV F+ D L KH L +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LG-KLMKHEKLGEDRIQFLVY 135
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVST----APQ 445
+ L Y+HA+ IIHRD+K N+ ++ + +K+ DFGL+R ++T +V T AP+
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPE 195
Query: 446 ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL 495
Y T D++S G ++ E+I+ + H ++
Sbjct: 196 VILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 41/200 (20%), Positives = 68/200 (34%), Gaps = 46/200 (23%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMN---------E 328
+ + + +G G +G V + R VA+K++ F + E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILRE 102
Query: 329 VEILTRLRHKNLVSLF----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPI 384
+ IL RL H ++V + L +V E D K
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI---------ADSDFKKL------F 147
Query: 385 RMNIAIETA----------SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434
R + + + Y+H++ I+HRD+K N L++ + VKV DFGL+R
Sbjct: 148 RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 435 LDVTHVSTAPQGTPGYVDPE 454
S P
Sbjct: 208 YPENGNSQLPISPREDDMNL 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 61/251 (24%), Positives = 103/251 (41%), Gaps = 58/251 (23%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL--YDNN------YRRVEQFMNEV 329
++DF + LG+G +G V G VA+K++ +D R E+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EI 60
Query: 330 EILTRLRHKNLVSLFGC----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR 385
+IL +H+N++++F + + ++ E + D LH I
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TD-LHR----------VIS 105
Query: 386 MNIAIE---------TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436
+ + T A+ LH S++IHRD+K +N+L++SN +KV DFGL+R+
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 437 VTHVSTAPQGTP---GYVD------PE---YHQCYQLTDKSDVYSFGVVLIELISSMPAV 484
S +V PE Y + DV+S G +L EL P
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRRPIF 223
Query: 485 DMNRHRHEINL 495
+RH++ L
Sbjct: 224 PGRDYRHQLLL 234
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 48/248 (19%), Positives = 96/248 (38%), Gaps = 50/248 (20%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNN------YRRVEQFMNEVE 330
+ + + K LG GG G V+ + VA+K++ + R E++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-------EIK 60
Query: 331 ILTRLRHKNLVSLF-------------GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
I+ RL H N+V +F + + +V E++ D L + +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LA-NVLEQ 114
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC-VKVADFGLSRLFPLD 436
G L + L Y+H+++++HRD+K N+ +++ +K+ DFGL+R+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-- 172
Query: 437 VTHVSTAPQGTPGYVD------PE---YHQCYQLTDKSDVYSFGVVLIELISSMPAVDMN 487
H S + + P Y T D+++ G + E+++
Sbjct: 173 -PHYSHKGHLS-EGLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGKTLFAGA 228
Query: 488 RHRHEINL 495
++ L
Sbjct: 229 HELEQMQL 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 43/197 (21%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVKRLYD--NN-------YRRVEQFMNEVEILTRLR- 336
K+LG G +G V+ + G VAVK+++D N +R E+ ILT L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-------EIMILTELSG 67
Query: 337 HKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE---- 391
H+N+V+L + + + LV++++ D LH IR NI
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYME----TD-LHA----------VIRANILEPVHKQ 112
Query: 392 -----TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQG 446
+ YLH+ ++HRD+K +NILL++ VKVADFGLSR F + P
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 447 TPGYVDPEYHQCYQLTD 463
+ LTD
Sbjct: 173 INENTENFDDDQPILTD 189
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 47/240 (19%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNN------YRRVEQFMNE 328
E + +G G +G+V K G VAVK+L + + YR E
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-------E 78
Query: 329 VEILTRLRHKNLVSLF-----GCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP 383
+ +L ++H+N++ L + + LV + AD L+ + K LT
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LN-NIVKCQKLTDD 132
Query: 384 IRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVST 442
+ + L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R ++T +V+T
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 443 ----APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL 495
AP+ Y D++S G ++ EL++ H ++ L
Sbjct: 193 RWYRAPEIMLNWMHY-----------NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 44/187 (23%), Positives = 68/187 (36%), Gaps = 14/187 (7%)
Query: 300 YGKLKD--GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357
+G L + Y R Q + V + + L S+ S S G +
Sbjct: 111 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170
Query: 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD 417
+ LT + + + A + +L + IHRD+ NILL
Sbjct: 171 KSLSDVEEEEAPEDLYK---DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 227
Query: 418 SNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVD-----PEYHQCYQLTDKSDVYSFGV 472
VK+ DFGL+R D+ + + PE T +SDV+SFGV
Sbjct: 228 EKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
Query: 473 VLIELIS 479
+L E+ S
Sbjct: 284 LLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 21/161 (13%)
Query: 284 FSRE-----KELGDGGFGTVYYGKLKD------GREVAVKRLYDN-NYRRVEQFMNEVEI 331
F R+ K LG G FG V R VAVK L + + M+E++I
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 332 LTRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAI 390
L + H N+V+L G ++ L+++ EF G ++ L R +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR--------NEFVPYKT 130
Query: 391 ETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
+ A I D+K + S+ + F +
Sbjct: 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 53/224 (23%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL--YDNN------YRRVEQFMNEV 329
+ ++ +G+G +G V + VA+K++ +++ R E+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-------EI 76
Query: 330 EILTRLRHKNLVSLFGC----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR 385
+IL R RH+N++ + T + + +V + + D L+ K L+
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TD-LY-KLLKTQHLSNDHI 130
Query: 386 MNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
+ L Y+H+++++HRD+K +N+LL++ +K+ DFGL+R+ D H
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---TGF 187
Query: 446 GTPGYVD------PEYHQCYQLTDKS-DVYSFGVVLIELISSMP 482
T YV PE + KS D++S G +L E++S+ P
Sbjct: 188 LT-EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 35/218 (16%), Positives = 72/218 (33%), Gaps = 28/218 (12%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLF 344
+G GGFG +Y + V E++ R + +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 345 GCTSR---------YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR-------MNI 388
T + + GL + D+ D K + + + +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK--IYEANAKRFSRKTVLQL 157
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV--ADFGLSRLFPLDVTHV------ 440
++ L Y+H + +H D+K +N+LL+ +V D+GL+ + + H
Sbjct: 158 SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217
Query: 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELI 478
GT + + H + + D+ G +I+ +
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN---LVS 342
+++G G FG +Y G + G EVA+K + Q E +I ++ +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIR 71
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
G Y+ ++V E + G + L + + +A + S + Y+H+
Sbjct: 72 WCGAEGDYN---VMVMELL--GPSLEDLF--NFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 403 DIIHRDVKTNNILL---DSNFCVKVADFGLSRLF--PLDVTHV----STAPQGTPGYVDP 453
+ IHRDVK +N L+ V + DFGL++ + H+ + GT Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELI 478
H + + + D+ S G VL+
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFN 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 42/217 (19%), Positives = 80/217 (36%), Gaps = 29/217 (13%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFG 345
K++G GGFG +Y + A + + +E++ R+ K+ + +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 346 CTSRYSQ-GLLLVYEFVANGTVADQLHGDRA---------------KHGLLTWPIRMNIA 389
+ G+ L Y G + R ++G + +
Sbjct: 101 ERKQLDYLGIPLFYGS---GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 390 IETASALAYLHASDIIHRDVKTNNILLDSNFCVKV--ADFGLSRLFPLDVTHV------S 441
I L Y+H ++ +H D+K N+LL +V AD+GLS + + H
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELI 478
GT + + H+ L+ +SDV G ++ +
Sbjct: 218 KGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 2e-11
Identities = 35/196 (17%), Positives = 62/196 (31%), Gaps = 43/196 (21%)
Query: 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR--------RVEQFMNEVEI 331
T R +++G+G FG V+ VA+K + E+ + E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 332 LTRL---------RHKNLVSLFG---CTSRYSQGLLLVYE----------FVANGTVADQ 369
L R + + L Y LL ++ + DQ
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 370 LHG-----------DRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLD 417
L ++ + L + +I + ++LA AS HRD+ N+LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 418 SNFCVKVADFGLSRLF 433
K+ +
Sbjct: 197 KTSLKKLHYTLNGKSS 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 46/214 (21%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR---------- 336
++LG G F TV+ K + + VA+K + + E +E+++L R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 337 -HKNLVSL---FGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
+++ L F +++V+E V + + + +H + I+ +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIK--KYEHRGIPLIYVKQISKQL 140
Query: 393 ASALAYLHAS-DIIHRDVKTNNILLD------SNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
L Y+H IIH D+K N+L++ + +K+AD G + H + + Q
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSIQ 197
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479
T Y PE +D++S ++ ELI+
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 40/208 (19%), Positives = 84/208 (40%), Gaps = 26/208 (12%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN---LVS 342
+ +G+G FG ++ G L + ++VA+K + Q +E L V
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
FG ++ +LV + + G + L + A + + + +H
Sbjct: 73 YFGQEGLHN---VLVIDLL--GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 403 DIIHRDVKTNNILL------DSNFCVKVADFGLSRLF--PLDVTHV----STAPQGTPGY 450
+++RD+K +N L+ ++N + V DFG+ + + P+ H+ GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANM-IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 451 VDPEYHQCYQLTDKSDVYSFGVVLIELI 478
+ H + + + D+ + G V + +
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFL 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN---LVS 342
K++G G FG + GK L VA+K + R Q E +L + V
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
FG +Y+ +V E + G + L + + IAI+ S + Y+H+
Sbjct: 72 YFGPCGKYN---AMVLELL--GPSLEDLF--DLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 403 DIIHRDVKTNNILL-----DSNFCVKVADFGLSRLF--PLDVTHV----STAPQGTPGYV 451
++I+RDVK N L+ + + + DF L++ + P H+ + GT Y+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELI 478
H + + + D+ + G + + +
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFL 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 46/206 (22%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS--- 342
+++G G FG +Y G ++ EVA+K + Q + E +I L+ +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVR 69
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
FG Y+ +LV + + G + L L+ + +A + + + ++H+
Sbjct: 70 WFGVEGDYN---VLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 403 DIIHRDVKTNNILL----DSNFCVKVADFGLSRLF--PLDVTHV----STAPQGTPGYVD 452
+HRD+K +N L+ +N V + DFGL++ + H+ + GT Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELI 478
H + + + D+ S G VL+ +
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFL 207
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 55/212 (25%), Positives = 80/212 (37%), Gaps = 38/212 (17%)
Query: 290 LGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHK------NL 340
+G G FG V K + VA+K R N R Q E+ IL LR + N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 341 VSLFGCTSRYSQGLLLV--------YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
+ + + + + + YE + G +R A
Sbjct: 162 IHMLENFT-FRNHICMTFELLSMNLYELIKKNKF----------QGFSLPLVRK-FAHSI 209
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFC--VKVADFGLSRLFPLDVTHVSTAPQGTPGY 450
L LH + IIH D+K NILL +KV DFG S + V T Q + Y
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ-SRFY 265
Query: 451 VDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
PE + D++S G +L EL++ P
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 39/222 (17%), Positives = 80/222 (36%), Gaps = 36/222 (16%)
Query: 287 EKELGDGGFGTVYYGK---------LKDGREVAVK------RLYD--NNYRRVEQFMNEV 329
+ G +Y ++ ++K RL++ N ++R + + +V
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL-QV 105
Query: 330 EILTRLRHKNLV---SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRM 386
+L L+ + G + LV + G KH L R
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVL---SERS 160
Query: 387 --NIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV--ADFGLSRLFPLDVTHVST 442
+A AL +LH ++ +H +V NI +D +V A +G + + HV+
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 443 APQ------GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELI 478
G ++ + H+ + +SD+ S G +++ +
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 49/217 (22%), Positives = 76/217 (35%), Gaps = 42/217 (19%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRH------K 338
+G G FG V + VA+K + N + Q EV +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 339 NLVSLFGCTSRYSQGLLLV--------YEFV-ANGTVADQLHGDRAKHGLLTWPIRMNIA 389
+V L + L LV Y+ + G+ R A
Sbjct: 117 YIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTN-----------FRGVSLNLTRK-FA 163
Query: 390 IETASALAYLHASD--IIHRDVKTNNILL--DSNFCVKVADFGLSRLFPLDVTHVSTAPQ 445
+ +AL +L + IIH D+K NILL +K+ DFG S + Q
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQ--LGQRIYQYIQ 220
Query: 446 GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMP 482
+ Y PE D++S G +L+E+ + P
Sbjct: 221 -SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 47/254 (18%), Positives = 81/254 (31%), Gaps = 70/254 (27%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR--------HK 338
++LG G F TV+ ++ + VA+K + + E ++E+ +L +R +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 339 NLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
+V L + + +V+E V + + ++ + L P I +
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQG 158
Query: 396 LAYLHAS-DIIHRDVKTNNILL-------------------------------------- 416
L YLH IIH D+K NILL
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 417 -----------DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 465
VK+AD G + T T Y E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPA 274
Query: 466 DVYSFGVVLIELIS 479
D++S + EL +
Sbjct: 275 DIWSTACMAFELAT 288
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 55/240 (22%), Positives = 82/240 (34%), Gaps = 78/240 (32%)
Query: 288 KELGDGGFGTVYYGK-LKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRH-----KN 339
+++GDG FG V + + + + AVK R N + E +IL ++++ N
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 340 LVSLFGC----------TSRYSQGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNI 388
+V G L YE + N +G I+
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSL---YEIITRNN-----------YNGFHIEDIK-LY 142
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFC-------------------------VK 423
IE AL YL + H D+K NILLD + +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 424 VADFGLSRLFPLDVTHVSTAPQGTPGYVDPE------YHQCYQLTDKSDVYSFGVVLIEL 477
+ DFG F + + T Y PE + SD++SFG VL EL
Sbjct: 203 LIDFG-CATF--KSDYHGSIIN-TRQYRAPEVILNLGWDV------SSDMWSFGCVLAEL 252
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 49/239 (20%), Positives = 80/239 (33%), Gaps = 84/239 (35%)
Query: 290 LGDGGFGTVY--YGKLKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHK------N 339
LG+G FG V + +VA+K R N + E E+ +L +++ K
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 340 LVSLFGC----------TSRYSQGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNI 388
V + + +EF+ N +R ++
Sbjct: 84 CVLMSDWFNFHGHMCIAFELLGKNT---FEFLKENN-----------FQPYPLPHVR-HM 128
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFC-------------------VKVADFGL 429
A + AL +LH + + H D+K NIL ++ ++VADFG
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 187
Query: 430 SRLFPLDVTHVST--------APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
S F D H +T P+ + Q DV+S G +L E
Sbjct: 188 SATF--DHEHHTTIVATRHYRPPEVILELG------WAQ------PCDVWSIGCILFEY 232
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 54/239 (22%), Positives = 79/239 (33%), Gaps = 84/239 (35%)
Query: 290 LGDGGFGTVY--YGKLKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHK------N 339
LG+G FG V GR VAVK + N R E +E+++L L
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 340 LVSLFGC----------TSRYSQGLLLVYEFV-ANGTVADQLHGDRAKHGLLTWPIRMNI 388
V + Y+F+ NG IR +
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGLST---YDFIKENG-----------FLPFRLDHIR-KM 123
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFC-------------------VKVADFGL 429
A + ++ +LH++ + H D+K NIL + +KV DFG
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG- 182
Query: 430 SRLFPLDVTHVST--------APQ---GTPGYVDPEYHQCYQLTDKSDVYSFGVVLIEL 477
S + D H ST AP+ + Q DV+S G +LIE
Sbjct: 183 SATY--DDEHHSTLVSTRHYRAPEVILALG------WSQ------PCDVWSIGCILIEY 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 70/468 (14%), Positives = 131/468 (27%), Gaps = 116/468 (24%)
Query: 218 QNDSKGNFQCAETREC-NDCHKKRGYCHIDDKGNFQCENERTDL---------ETGTVYF 267
++ NF C + ++ K HI + T E F
Sbjct: 26 EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD---AVSGTLRLFWTLLSKQEEMVQKF 82
Query: 268 --GVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQF 325
V +Y L R+ + + +L + +V K N R++ +
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE-QRDRLYNDNQVFAKY----NVSRLQPY 137
Query: 326 MNEVEILTRLRHKNLVSLF---GC--------TSRYSQGLLLVYEF------VANGTVAD 368
+ + L LR V + G S + +F + N +
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL-SYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 369 -----------QLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-----IIHRDVKTN 412
Q+ + + I++ I A L + ++ +V+
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256
Query: 413 NILLDSNF-C--------VKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE----YHQCY 459
N C +V DF L TH+S + E +
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDF----LSAATTTHISLDHH-SMTLTPDEVKSLLLKYL 311
Query: 460 QLTDKS------DVYSFGVVLI-ELISSMPA-------VDMNRHRH--EINLANLAINKI 503
+ + +I E I A V+ ++ E +L L +
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 504 QKCAFDEL-IDPCLGFESD-----------------EEVKRMTTSVAELAFLCLQQNKEL 545
+K FD L + F +V + + + + L +Q KE
Sbjct: 372 RKM-FDRLSV-----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS-LVEKQPKES 424
Query: 546 RPSMEEVLAELQRIKSGKSKFEIHEEKQDDREGIKCTQPP-PSPPYCD 592
S+ + EL+ ++++ +H D K PPY D
Sbjct: 425 TISIPSIYLELK--VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 9e-04
Identities = 72/506 (14%), Positives = 143/506 (28%), Gaps = 135/506 (26%)
Query: 56 CG--LMVVDNCNKPVPRIRLGKAGPFYNILNIAQDVSITVEDQVFQNHLNQRSCESFKNF 113
G + +D C + ++ F+ LN+ S ++ Q L Q
Sbjct: 161 SGKTWVALDVCLSYKVQCKMD-FKIFW--LNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 114 SLPSSASLSFY-VKSKLLSLF------RCTDKLDN-----KFTSFNSTC-------NSSS 154
S+ L + ++++L L C L N + +FN +C
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 155 FIYYNHPDDDLPSILPPNCSLIQLPVNKT-RKSGDLF-NML-TSVFSLQVEVHRVCWECR 211
D L + + SL + T + L L L EV
Sbjct: 278 T-------DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL------- 323
Query: 212 WRGGQCQNDSKGN-FQC----AETRECNDCHKKRGYCHIDDKGNFQCENERTDLETGTVY 266
N + R+ G D+ + C+ T +E+
Sbjct: 324 ----------TTNPRRLSIIAESIRD--------GLATWDNWKHVNCDKLTTIIES---- 361
Query: 267 FGVPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKL---KDGREVAVKRL----YDNNY 319
S + L A ++ + + +L + L +D
Sbjct: 362 ------SLNVLEPA--EYRK------------MFDRLSVFPPSAHIPTILLSLIWFDVIK 401
Query: 320 RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY-EFVANGTVADQLH------- 371
V +N+ L +LV S S + +Y E LH
Sbjct: 402 SDVMVVVNK------LHKYSLVEKQPKESTIS--IPSIYLELKVKLENEYALHRSIVDHY 453
Query: 372 -GDRA--KHGLLTWPIRMNIAIETASALAYLHASDI--IHRDVKTNNILLDSNFC-VKVA 425
+ L+ + S + + H +I R + LD F K+
Sbjct: 454 NIPKTFDSDDLIPPYLDQYF----YSHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 426 DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVD 485
+ + + ++++ Y + D Y ++ ++ +P ++
Sbjct: 509 HDSTAWNASGSILNT---------LQQLKFYKPY-ICDNDPKYE--RLVNAILDFLPKIE 556
Query: 486 MNRHRHE-INLANLAINKIQKCAFDE 510
N + +L +A+ + F+E
Sbjct: 557 ENLICSKYTDLLRIALMAEDEAIFEE 582
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 625 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.64 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.44 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.45 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.76 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-55 Score=449.15 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=204.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++++.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+++|++|+|||||++++++.+ .+.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEE
Confidence 468999999999999999999986 7999999998644 34556789999999999999999999997665 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||++||+|.++|... +...+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999999632 34568999999999999999999999999999999999999999999999999998753221
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......||+.|||||++.+..|+.++|||||||++|||++|++||...... .....+....+..+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~~~~~------ 245 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-------NLVLKIISGSFPPV------ 245 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCCC------
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCCCCCC------
Confidence 1223456999999999999999999999999999999999999999764321 12222333322211
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...++.++.+||.+||++||++|||++|+++|
T Consensus 246 ------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 ------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01245678899999999999999999999987
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=448.52 Aligned_cols=261 Identities=29% Similarity=0.423 Sum_probs=208.8
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|.+.++||+|+||+||+|+++ +++.||||++...+....++|.+|+++|++++|||||+++|++.+ .+.++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence 46788899999999999999864 478899999988777778899999999999999999999997765 56789
Q ss_pred EEEEeccCCChHHHhccCcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 356 LVYEFVANGTVADQLHGDRA-----------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
|||||+++|+|.++++.... ..+.++|.+++.|+.||++||+|||+++||||||||+||||+.++.+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 99999999999999975332 2356999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHH
Q 047969 425 ADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 425 ~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||....... ....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~ 272 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDC 272 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HHHH
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 99999987643322 22344679999999999999999999999999999999999 999997543221 1222
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
+..+..... ...++.++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 273 i~~g~~~~~------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGRELER------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTCCCCC------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCCCC------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222211110 012456788999999999999999999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=445.42 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=213.4
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|.+.++||+|+||+||+|++. +++.||||++........++|.+|+++|++++|||||+++|++.+ .+.++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEE
Confidence 57888999999999999999864 477899999987777777899999999999999999999997765 56789
Q ss_pred EEEEeccCCChHHHhccCc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 356 LVYEFVANGTVADQLHGDR---------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
|||||+++|+|.++|+... .....++|.+++.|+.||++||+|||+++||||||||+||||+.++.+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 9999999999999997532 2345799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhh
Q 047969 427 FGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 427 Fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .....+.
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~~i~ 244 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIECIT 244 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHH
Confidence 9999865433222 2233468999999999999999999999999999999998 99999754321 1222233
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.+..... ...++.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 245 ~~~~~~~------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRVLQR------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221111 01245678899999999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=446.36 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=210.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.. .+.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeC
Confidence 56999999999999999999987 799999999976555555678999999999999999999997665 6789999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
++||+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 999999999852 359999999999999999999999999999999999999999999999999998764332 22
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....+||+.|||||++.+..|+.++|||||||++|||++|++||....... ....+.......+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~~--------- 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPRL--------- 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSSCCCC---------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCCC---------
Confidence 355689999999999999899999999999999999999999997543211 1122222111110
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.....++.++.+||.+||+.||++|||++|+++|-.
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 011245668899999999999999999999998743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=432.10 Aligned_cols=261 Identities=30% Similarity=0.477 Sum_probs=205.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+++++.++||+|+||+||+|++++ .||||+++.. +....+.|.+|+++|++++|||||+++|++.+ +.++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEE
Confidence 3578889999999999999998753 5999998533 44567889999999999999999999997654 4579999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc-
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV- 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~- 437 (625)
||++||+|.++|+. ....+++..++.|+.||++||+|||+++||||||||+||||++++.+||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999963 34569999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
........||+.|||||++.+ ..|+.++|||||||+||||++|+.||....... .....+..... .+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~----~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA----SP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----CC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----CC
Confidence 222345689999999999864 358999999999999999999999997543221 11111111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.+. .....++.++.+|+.+||+.||++||||.||+++|+.++..
T Consensus 258 ~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 258 DLS----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CST----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred Ccc----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111 01113456788999999999999999999999999988753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=435.62 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=209.7
Q ss_pred cCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
+++++.++||+|+||+||+|++. +++.||||++... .....++|.+|+.+|++++|||||+++|++.. .+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEE
Confidence 45677889999999999999863 4678999998654 23345789999999999999999999997765 5678
Q ss_pred EEEEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeE
Q 047969 355 LLVYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCV 422 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~ 422 (625)
+|||||+++|+|.++|.... .....+++..++.|+.||++||+|||+++||||||||+||||++++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 99999999999999996432 123569999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHH
Q 047969 423 KVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAI 500 (625)
Q Consensus 423 kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 500 (625)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||....... ..
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------~~ 257 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VV 257 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------HH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 9999999987543322 22345679999999999999999999999999999999998 899997543221 12
Q ss_pred HHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
..+..+..... ...++..+.+|+.+||+.||++||||+||+++|+.+.
T Consensus 258 ~~i~~~~~~~~------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 EMIRNRQVLPC------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCCCCCC------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22222221111 0124557889999999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=424.03 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=200.6
Q ss_pred CccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceEEEEE
Q 047969 285 SREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGLLLVY 358 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~ 358 (625)
++.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++++|||||++++++.. ....++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999987 7899999998643 34456789999999999999999999997643 235689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECC-CCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDS-NFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~-~~~~kl~DFgla~~~~~ 435 (625)
||++||+|.+++. +.+.+++..+..++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999996 3457999999999999999999999998 999999999999984 79999999999986432
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.......||+.|||||++.+ .|+.++|||||||++|||++|++||...... ......+.........
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~--- 251 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF--- 251 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG---
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCC---
Confidence 22345679999999999875 6999999999999999999999999643321 1122222222111111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....++++.+||.+||+.||++|||++|+++|-
T Consensus 252 --------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 252 --------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp --------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred --------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 112345788999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=436.79 Aligned_cols=255 Identities=20% Similarity=0.226 Sum_probs=206.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.+.|++.++||+|+||+||+|+++ +|+.||||++..... +.+|+.+|++++|||||++++++.. .+.++||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEe
Confidence 356888899999999999999987 799999999965422 2479999999999999999997665 677999999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccccccCCCcc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~~~~~~~ 438 (625)
|++||+|.+++. +.+.+++..+..++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.......
T Consensus 131 y~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 131 LLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999996 345699999999999999999999999999999999999999988 699999999987653322
Q ss_pred c----cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 439 H----VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 439 ~----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
. .....+||+.|||||++.+..|+.++|||||||++|||++|++||........ ... +...... +.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~----i~~~~~~-~~-- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK----IASEPPP-IR-- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH----HHHSCCG-GG--
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH----HHcCCCC-ch--
Confidence 1 12335799999999999999999999999999999999999999976543221 111 1111110 00
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.....++..+.+||.+||++||++|||+.|++++|......
T Consensus 277 -------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 -------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 00113456788999999999999999999999999876653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=436.06 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=209.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++++.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 57999999999999999999986 79999999996542 2345779999999999999999999996655 6789999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||++||+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp ECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999996 34579999999999999999999999999999999999999999999999999999765433
Q ss_pred c-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 T-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. ......+||+.|||||++.+..|+.++|||||||++|||++|++||...+.. .....+....+.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~~~------- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLEYD------- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC-------
Confidence 2 2335678999999999999999999999999999999999999999754321 122223322211
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.. ..++.++.+||.+||++||++|||++|++.+
T Consensus 253 -~p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 -FP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -CC-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -CC-----cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 00 1245678899999999999999999997544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=445.26 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=210.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+.|+++++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.. .+.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEeC
Confidence 57999999999999999999987 799999999976555556778999999999999999999997765 6789999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
|+||+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999999842 359999999999999999999999999999999999999999999999999998764332 22
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....+||+.|||||++.+..|+.++|||||||++|||++|++||....... ....+.......+ .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~~-----~--- 368 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPRL-----K--- 368 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCC-----S---
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCCC-----c---
Confidence 355679999999999999999999999999999999999999997543211 1122222211111 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....++.++.+||.+||+.||++|||+.|+++|-
T Consensus 369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 0123456888999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=421.13 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=192.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.. .+.++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEE
Confidence 368999999999999999999976 79999999986542 2335678999999999999999999997655 678999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+ +|+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 91 vmEy~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 91 VIEYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEeCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99999 679999985 4457999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.......||+.|||||++.+..+ +.++||||+||++|+|++|+.||...... .....+......
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~~~~~i~~~~~~------ 230 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------VLFKNISNGVYT------ 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC------
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC------
Confidence 22345679999999999988776 57999999999999999999999754321 122222222211
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+ . ..++.++.+|+.+||+.||++|||++|+++|-
T Consensus 231 ~--p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 231 L--P-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp C--C-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred C--C-----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 0 0 12456788999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=436.35 Aligned_cols=270 Identities=25% Similarity=0.345 Sum_probs=217.5
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcC------CcEEEEEEecccc-HHHHHHHHHHHHHHHhcCC-CCeeeeeee
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNN-YRRVEQFMNEVEILTRLRH-KNLVSLFGC 346 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~~~ 346 (625)
+.+....++|++.+.||+|+||+||+|++.. ++.||||++.... ....+.|.+|+++|++++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3344456789999999999999999998652 3679999996543 3456789999999999965 899999998
Q ss_pred eeeccceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 047969 347 TSRYSQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNI 414 (625)
Q Consensus 347 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NI 414 (625)
+...+..++||||||++|+|.++|+.... ....+++..++.++.||++||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 77666778999999999999999975432 134589999999999999999999999999999999999
Q ss_pred EECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccc
Q 047969 415 LLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHE 492 (625)
Q Consensus 415 ll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~ 492 (625)
||++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876443322 2344568999999999999999999999999999999998 999997543221
Q ss_pred cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 493 INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.....+..+..... . ..++.++.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 296 -----~~~~~i~~g~~~~~-----p-------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 -----EFCRRLKEGTRMRA-----P-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -----HHHHHHHHTCCCCC-----C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCCCC-----C-------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 12222222211110 0 12345788999999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=426.17 Aligned_cols=268 Identities=24% Similarity=0.319 Sum_probs=202.0
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc---ceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---QGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~ 358 (625)
.+|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.... ..++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688889999999999999998 5899999998654322 223445667777899999999999776543 2579999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS--------DIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
||+++|+|.++++. ..++++.+++++.|+++||+|||++ +||||||||+||||+.++.+||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999953 3589999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCcccc---ccCCCCCCCccCccccccC------CCCCchhhhhHHHHHHHHHhCCCCCcccccccccc-------
Q 047969 431 RLFPLDVTHV---STAPQGTPGYVDPEYHQCY------QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN------- 494 (625)
Q Consensus 431 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~------- 494 (625)
+......... .....||+.|||||++.+. .++.++|||||||+||||+||.+|+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 8764433221 2345799999999998653 46779999999999999999998876443221110
Q ss_pred -hhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 495 -LANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 495 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
........+.. ...++.+. ........+..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 236 ~~~~~~~~~~~~----~~~rp~~p--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCE----QKLRPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCC--GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhc----ccCCCCCC--ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 01111111111 11122111 1111123456788999999999999999999999999988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=425.70 Aligned_cols=248 Identities=27% Similarity=0.334 Sum_probs=197.5
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|++++.||+|+||+||+|+.. +++.||||++.+.. .....++.+|+++|++++|||||++++++.. .+.++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence 57999999999999999999863 47889999986432 1223468899999999999999999997665 67899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
|||||++||+|.+++. +.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999996 445799999999999999999999999999999999999999999999999999986533
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.. .......||+.|||||++.+..|+.++|||||||++|||++|++||...+... ....+.+....
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~------ 244 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKLG------ 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCCC------
Confidence 22 22345679999999999999999999999999999999999999997643221 12222222211
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~ 555 (625)
.. ..++.++.+||.+||++||++||| ++|+++|
T Consensus 245 --~p-----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 245 --MP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CC-----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CC-----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 00 124567889999999999999998 4677765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=416.21 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=192.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ------ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 352 (625)
.++|++++.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+++|++++|||||++++++...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999986 7999999998643 33456789999999999999999999997654332
Q ss_pred -----eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 353 -----GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 353 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
.++|||||+++|+|.+++.... ......+..++.++.||++||+|||++||+||||||+||||+.++.+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 3799999999999999996432 2233567788999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccc-----------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchh
Q 047969 428 GLSRLFPLDVTH-----------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA 496 (625)
Q Consensus 428 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~ 496 (625)
|+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||..... .
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~------~ 233 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME------R 233 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH------H
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH------H
Confidence 999876433211 1133579999999999999999999999999999999996 6643211 0
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......+.... ..+.....++.+.+||.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLTDVRNLK------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHTTC------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCC------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111122111 123334455677889999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=419.50 Aligned_cols=267 Identities=19% Similarity=0.306 Sum_probs=206.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-----ccce
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-----YSQG 353 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 353 (625)
++|++++.||+|+||+||+|+++ +|+.||||++... .....+.+++|+++|++++|||||++++++.. ..+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 58999999999999999999986 7999999999643 33456778999999999999999999996543 2367
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
+||||||++ |+|.+++. +.+.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 57999885 4457999999999999999999999999999999999999999999999999999876
Q ss_pred CCCc---cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 434 PLDV---THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 434 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
.... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+...... .+..........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~---~I~~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ---LIMMVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH---HHHHHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhcCCCChH
Confidence 4321 2223457899999999998765 56899999999999999999999997654332211 111111000000
Q ss_pred cc--------------cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 EL--------------IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 ~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+ ..+............++.++.+||.+||+.||++|||++|+++|-
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 00 000000111111223466888999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=405.23 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=199.3
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
...++|++.++||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|+.+ +|||||++++++.. .+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCE
Confidence 45678999999999999999999864 46789999986553 235678999999998 69999999996665 678
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRL 432 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~ 432 (625)
++|||||++||+|.+++. .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999983 38999999999999999999999999999999999999876 8999999999986
Q ss_pred cCCCcc---------------------------ccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCC
Q 047969 433 FPLDVT---------------------------HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAV 484 (625)
Q Consensus 433 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~ 484 (625)
...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 532211 112345799999999998765 5899999999999999999999999
Q ss_pred cccccccc-cchhHHHHHH-----hhhcccccc-cCCcCC----------------------------CCChHHHHHHHH
Q 047969 485 DMNRHRHE-INLANLAINK-----IQKCAFDEL-IDPCLG----------------------------FESDEEVKRMTT 529 (625)
Q Consensus 485 ~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~-~~~~~~----------------------------~~~~~~~~~~~~ 529 (625)
.......+ +......... ......... ...... ....+....+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 54432211 1000000000 000000000 000000 000011123456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 530 SVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 530 ~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
++.+|+.+||+.||++|||++|+++|-
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 788999999999999999999999873
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=422.40 Aligned_cols=254 Identities=20% Similarity=0.370 Sum_probs=212.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++++.||+|+||.||+|+++ +|+.||||++........+.+.+|+++|+.++|||||++++++.. ...++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence 478999999999999999999987 799999999977766677889999999999999999999996655 678999999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC--CeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN--FCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~--~~~kl~DFgla~~~~~~~ 437 (625)
|++||+|.++|.. +.+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 235 ~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 235 FMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred ecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999853 34569999999999999999999999999999999999999854 899999999999764332
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......||+.|||||++.+..|+.++|||||||++|||++|++||....... ....+....+.
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~-------- 374 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN-------- 374 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC--------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCC--------
Confidence 2234579999999999999999999999999999999999999997654321 12222222111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
........++.++.+||.+||+.||++|||+.|+++|-
T Consensus 375 -~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 375 -MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp -CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 01112234566888999999999999999999999973
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=389.47 Aligned_cols=287 Identities=39% Similarity=0.607 Sum_probs=236.0
Q ss_pred cChHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc
Q 047969 272 FSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS 351 (625)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 351 (625)
+.+.++...+++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.++++++||||+++++++.. .
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-R 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-T
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 344455667899999999999999999999988899999999877666667889999999999999999999997655 5
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
+..++||||+++|+|.+++.........+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 67899999999999999997554444569999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 432 LFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 432 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............+.........+..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 6543222 222344589999999999888899999999999999999999999987665555555554444444444444
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.+++.+..... ...+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 268 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 268 IVDPNLADKIR---PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSCTTCSC---HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcChhhccccC---HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 44443322222 34667889999999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=415.90 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=201.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHH---HHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQF---MNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++++.||+|+||.||+|+.+ +|+.||||++.+... .....+ .+++.+++.++|||||++++++.. ...
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCE
Confidence 478999999999999999999987 799999999864321 112223 344667777899999999996655 678
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
+||||||++||+|.++|. +.+.+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 267 lylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999996 4457999999999999999999999999999999999999999999999999999876
Q ss_pred CCCccccccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... ....+||+.|||||++. +..|+.++|+|||||++|||++|++||......... .....+......
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~----~i~~~i~~~~~~--- 412 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAVE--- 412 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH----HHHHHHHHCCCC---
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhhcCCCCC---
Confidence 4322 34568999999999986 457999999999999999999999999754432211 111222211111
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L 556 (625)
. ...++.++.+||.+||++||++|++ ++|+++|-
T Consensus 413 -----~-----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 413 -----L-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp -----C-----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred -----C-----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 0 0124568899999999999999998 78888773
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=385.49 Aligned_cols=288 Identities=39% Similarity=0.603 Sum_probs=233.2
Q ss_pred ccccChHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeee
Q 047969 269 VPIFSYSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCT 347 (625)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~ 347 (625)
...+++.++....++|++.+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4568889999999999999999999999999999888999999998654322 223688999999999999999999976
Q ss_pred eeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCCEEECCCCeEEE
Q 047969 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS---DIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 348 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~ivHrDikp~NIll~~~~~~kl 424 (625)
.. ....++||||+++|+|.+++.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||
T Consensus 97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CC-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ec-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 65 5667999999999999999986655566799999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccc--ccccchhHHHHHH
Q 047969 425 ADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRH--RHEINLANLAINK 502 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~--~~~~~~~~~~~~~ 502 (625)
+|||+++..............||+.|+|||++.+..++.++||||||+++|+|++|+.||+.... ........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999987755444444556799999999999888899999999999999999999999964321 1222233333332
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
........+.+..+.... ....+..+.+++.+||+.+|++|||+.||+++|+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 333333333333322222 2345678999999999999999999999999998644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=371.07 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=208.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||+||+|++. +++.||||++........+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEE
Confidence 468999999999999999999965 789999999876555556778999999999999999999997665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999853 2589999999999999999999999999999999999999999999999999987643322
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..+.......+.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~~~~~~~------- 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-------YLIATNGTPELQ------- 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHHCSCCCS-------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCCCC-------
Confidence 234457999999999999889999999999999999999999999754322111 111111111100
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ...++..+.+++.+||+.||++|||+.|++++-.
T Consensus 238 ~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 238 N---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp C---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred C---ccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 0 1234567889999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=369.20 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=212.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEE
Confidence 368999999999999999999986 689999999977777778899999999999999999999997765 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999963 2456999999999999999999999999999999999999999999999999999876432221
Q ss_pred c-------------ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 440 V-------------STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 440 ~-------------~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
. .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.............. ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc-
Confidence 1 1145799999999999998999999999999999999999999865432211110000 000000
Q ss_pred ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 507 AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.. . ..++..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 243 ~~----~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 YC----P-----------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp TC----C-----------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC----C-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 0 1123467889999999999999999999999998874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=366.87 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=208.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence 368999999999999999999976 7899999998432 34556789999999999999999999996654 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 v~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999996 3346999999999999999999999999999999999999999999999999999876443
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.. .....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~~~~----- 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SVPNV----- 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CCCCH-----
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cCCCc-----
Confidence 3333344579999999999998889999999999999999999999997543211 11111111 11100
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhchhcCC
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKSGK 563 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~i~~~~ 563 (625)
.......++..+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus 233 ---~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 ---TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ---HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ---chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0001123456788999999999999998 9999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=361.91 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=212.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeC
Confidence 58999999999999999999998899999999875532 33678999999999999999999996655 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++++|.+++.. ....+++..++.++.|+++||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999953 345689999999999999999999999999999999999999999999999999987654433333
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+...... ..+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~------ 229 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL--YKP------ 229 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC--CCC------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCccC--CCC------
Confidence 45567889999999988889999999999999999999 999997543221 11111111100 000
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...+..+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus 230 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 ----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11245788899999999999999999999999988753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=372.50 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=207.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
..++|++.+.||+|+||.||+|++. +|+.||||++... +....+.+.+|+++|+.++||||+++++++.. .+..++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEE
Confidence 3568999999999999999999985 8999999998654 34556788999999999999999999997655 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999985 3356999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCCccCccccccCCCC-CchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLT-DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. ......||+.|+|||++.+..+. .++||||||+++|+|++|+.||...... .....+......
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~------ 232 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRGKYR------ 232 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC------
Confidence 2 23456799999999999887765 7899999999999999999999764321 111222222111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+. ..++..+.+++.+||+.||++|||++|++++-.
T Consensus 233 ~p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 233 IP-------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp CC-------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred CC-------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 00 013457888999999999999999999998743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=367.84 Aligned_cols=270 Identities=25% Similarity=0.400 Sum_probs=217.4
Q ss_pred ecCccccChHHHHHHhcC----------CCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHh
Q 047969 266 YFGVPIFSYSDLAEATND----------FSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTR 334 (625)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~----------~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 334 (625)
++..+.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98 (321)
T ss_dssp ------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred eecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence 345567888888888765 777889999999999999987 799999999976655566789999999999
Q ss_pred cCCCCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 047969 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNI 414 (625)
Q Consensus 335 l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NI 414 (625)
++||||+++++++.. ....++||||+++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 99 l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 99 YQHFNVVEMYKSYLV-GEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172 (321)
T ss_dssp CCCTTBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCCCcceEEEEEEE-CCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 999999999997665 567899999999999999984 23589999999999999999999999999999999999
Q ss_pred EECCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccc
Q 047969 415 LLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN 494 (625)
Q Consensus 415 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~ 494 (625)
|++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--- 248 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--- 248 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred EECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 999999999999999987643322 2244579999999999988889999999999999999999999997543211
Q ss_pred hhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 495 LANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
....+.......+ . ....++..+.+++.+||+.||++|||+.|++++-.-.
T Consensus 249 ----~~~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 249 ----AMKRLRDSPPPKL-----K-----NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp ----HHHHHHHSSCCCC-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred ----HHHHHhcCCCCCc-----C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 1111221111110 0 0113455788999999999999999999999976543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=371.28 Aligned_cols=273 Identities=26% Similarity=0.346 Sum_probs=209.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc---ceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---QGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~lv 357 (625)
.++|++.+.||+|+||+||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++.... ..+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999886 89999999865533 3455677999999999999999999766532 347999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCcccCCCCCCEEECCCCeEEEccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS----------DIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
|||+++|+|.+++.. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999953 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCccc-cccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--
Q 047969 428 GLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA-- 499 (625)
Q Consensus 428 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~-- 499 (625)
|+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 2234579999999999876 34567889999999999999999999765443222222110
Q ss_pred ---HHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 500 ---INKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 500 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...+..........+.+. ........+.++.+|+.+||+.||++|||+.|+++.|+.+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLR--DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCC--GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCcc--ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000000111111 0001113455789999999999999999999999999988753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=360.56 Aligned_cols=258 Identities=26% Similarity=0.493 Sum_probs=212.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|+.+++..||||++..... ..+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEc
Confidence 468999999999999999999998888999999865432 34678999999999999999999996654 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999999963 23358999999999999999999999999999999999999999999999999998765444333
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||+...... ....+...... ..+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~----- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHRL--YRP----- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCC--CCC-----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCCC--CCC-----
Confidence 444567888999999988889999999999999999999 999997543221 11111111100 000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...+..+.+++.+||+.+|++|||+.+++++|+.++..
T Consensus 228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 -----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 01244788899999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.61 Aligned_cols=284 Identities=34% Similarity=0.577 Sum_probs=225.2
Q ss_pred ccccChHHHHHHhcCCCcc------ceecccCcEEEEEEEEcCCcEEEEEEeccc----cHHHHHHHHHHHHHHHhcCCC
Q 047969 269 VPIFSYSDLAEATNDFSRE------KELGDGGFGTVYYGKLKDGREVAVKRLYDN----NYRRVEQFMNEVEILTRLRHK 338 (625)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~ 338 (625)
...|++.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4668999999999999887 8999999999999987 5889999998543 233467799999999999999
Q ss_pred CeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 339 niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
||+++++++.. ....++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 91 ~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 91 NLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE 168 (307)
T ss_dssp TBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CeEEEEEEEec-CCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC
Confidence 99999996655 567899999999999999986432 3456999999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH
Q 047969 419 NFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~ 497 (625)
++.+||+|||+++........ ......||+.|+|||++.+ .++.++||||||+++|+|++|.+||.............
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999875432222 2234579999999998875 48899999999999999999999998654432221111
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.... .....+...++..+... ....+..+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 248 ~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIE-DEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHH-TTSCCHHHHSCSSCSCC----CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhh-hhhhhhhhhcccccccc----chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111 11112222333322222 23456788999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=362.02 Aligned_cols=261 Identities=31% Similarity=0.491 Sum_probs=202.6
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
...++|++.+.||+|+||+||+|+. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCceEE
Confidence 3457899999999999999999987 5889999998654 34556789999999999999999999996655 566899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999996422 1124899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...+..... ..
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~----~~ 258 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-------VAAVGFKCK----RL 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHHSCC----CC
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCC----CC
Confidence 221 222345799999999999988899999999999999999999999975432211 111110000 00
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.+ ...++..+.+||.+||+.+|++|||+.++++.|+.+..
T Consensus 259 ~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 259 EI-------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CC-------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 01244578899999999999999999999999998875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.15 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=210.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 468999999999999999999863 3557999998654 344567899999999999 89999999997655
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
.+.+++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 5678999999999999999975321 2345899999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----- 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999999999865433221 2233467889999999988889999999999999999999 999997543221
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+........ ...++..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 314 --~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 --LFKLLKEGHRMDK------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --HHHHHHTTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111100 01234578899999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=369.88 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=208.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-----HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-----RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.. .+..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence 357999999999999999999976 789999999854321 135778999999999999999999997665 6778
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe---EEEccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC---VKVADFGLSR 431 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~---~kl~DFgla~ 431 (625)
++||||+++++|.+++.........+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888654444556899999999999999999999999999999999999986554 9999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .....+......
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~~-- 250 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKYK-- 250 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCCC--
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCCC--
Confidence 764332 223445799999999999988899999999999999999999999975321 111222221111
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
........++.++.+||.+||+.||++|||+.|++++-
T Consensus 251 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 251 -------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp -------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 11222334567889999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=361.16 Aligned_cols=267 Identities=25% Similarity=0.390 Sum_probs=208.4
Q ss_pred hcCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 354 (625)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36899999999999999999984 2688999999987777777889999999999999999999996643 23458
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999643 2358999999999999999999999999999999999999999999999999998764
Q ss_pred CCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc---------ccchhHHHHHHh
Q 047969 435 LDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH---------EINLANLAINKI 503 (625)
Q Consensus 435 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~---------~~~~~~~~~~~~ 503 (625)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..|+....... ...........+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 33221 1233457788999999998889999999999999999999999886432110 000000111111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...... . ....++.++.+++.+||+.+|++|||++|+++.|+.+...
T Consensus 246 ~~~~~~-------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 246 KNNGRL-------P-----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HTTCCC-------C-----CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hccCcC-------C-----CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111000 0 0113456788999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=361.84 Aligned_cols=258 Identities=24% Similarity=0.437 Sum_probs=208.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||+||+|++.+++.||||++..... ..+++.+|++++++++||||+++++++.. ....++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEec
Confidence 468999999999999999999999888999999975532 33678999999999999999999996654 6678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999999642 3459999999999999999999999999999999999999999999999999998765433333
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+...... ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~-----~~~-- 243 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRL-----YRP-- 243 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCC-----CCC--
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhcccCC-----CCC--
Confidence 344567889999999988889999999999999999998 999997543221 11111111100 000
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...+..+.+++.+||+.+|++|||+++++++|+.+...
T Consensus 244 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 01234788899999999999999999999999988653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.88 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=208.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccE
Confidence 367899999999999999999975 3456999999654 44556789999999999999999999997654 66789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999953 335699999999999999999999999999999999999999999999999999987644
Q ss_pred Ccccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 436 DVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 436 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.......
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~~-- 274 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYRLP-- 274 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCCC--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCCCC--
Confidence 32221 223456788999999988889999999999999999999 999996543221 111111111000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
. ...++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 275 ---~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 275 ---A-------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---C-------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0 0123457889999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.84 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=209.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR------RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++...... ..+.+.+|+.+|++++||||+++++++.. ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCE
Confidence 468999999999999999999987 7899999998654321 34678999999999999999999997655 677
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC----eEEEccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGL 429 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~----~~kl~DFgl 429 (625)
.++||||++||+|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 899999999999999995 345699999999999999999999999999999999999998876 799999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
++..... .......||+.|+|||++.+..++.++||||||+++|+|++|.+||....... ....+......
T Consensus 166 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~ 236 (361)
T 2yab_A 166 AHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVSYD 236 (361)
T ss_dssp CEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC
T ss_pred ceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCCC
Confidence 9876432 22344579999999999998889999999999999999999999997543211 11222221110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
........++..+.+||.+||..||++|||+.|+++|-
T Consensus 237 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 237 ---------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp ---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred ---------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 11233345667889999999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=368.63 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=203.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence 468999999999999999999987 789999999854432 334668899999999999999999996655 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999985 344699999999999999999999999999999999999999999999999999986542222
Q ss_pred -ccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 439 -HVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 439 -~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... .. .......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~-----~~~~~~~-------- 226 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS-----DWKEKKT-------- 226 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH-----HHHTTCT--------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH-----HHhcccc--------
Confidence 22345679999999999987665 77899999999999999999999754432111 11 1010000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.......++..+.+|+.+||+.||++|||+.|++++-.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 227 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ---cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 00011234567889999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=372.69 Aligned_cols=271 Identities=25% Similarity=0.348 Sum_probs=215.6
Q ss_pred ChHHHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeee
Q 047969 273 SYSDLAEATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLF 344 (625)
Q Consensus 273 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~ 344 (625)
...++....++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34455556789999999999999999999742 4678999999654 334567899999999999 799999999
Q ss_pred eeeeeccceEEEEEEeccCCChHHHhccCccc------------------------------------------------
Q 047969 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAK------------------------------------------------ 376 (625)
Q Consensus 345 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------ 376 (625)
+++.......++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 98777666689999999999999999754321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc-ccc
Q 047969 377 --------------HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-HVS 441 (625)
Q Consensus 377 --------------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~-~~~ 441 (625)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 12289999999999999999999999999999999999999999999999999986543222 223
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....||+.|+|||++.+..++.++||||||+++|+|++ |..||....... .....+........ .
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~-----~--- 318 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-----P--- 318 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC-----C---
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC-----C---
Confidence 44568899999999988889999999999999999998 999997543221 11111111111110 0
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
..++.++.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 319 ----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 319 ----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1134578899999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.71 Aligned_cols=250 Identities=27% Similarity=0.350 Sum_probs=206.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++++.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.. ...+++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEE
Confidence 468999999999999999999987 79999999986542 2345678899999999999999999996655 667899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999985 3456899999999999999999999999999999999999999999999999999864322
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+......
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~------- 223 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIR------- 223 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-------
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC-------
Confidence 2 2234457999999999999889999999999999999999999999754321 111122111110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
.. ..++.++.++|.+||+.||++|| +++|+++|-
T Consensus 224 -~p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 -FP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp -CC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -CC-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 00 12455788999999999999999 899999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=362.58 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=203.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++++.||+|+||+||+|++.+|+.||||++..... ...+.+.+|++++++++||||+++++++.. ....++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEE
Confidence 478999999999999999999998899999999864422 234678899999999999999999996654 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99985 78787753 334599999999999999999999999999999999999999999999999999987643222
Q ss_pred ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc------
Q 047969 439 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL------ 511 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 511 (625)
......||+.|+|||++.+ ..++.++||||||+++|+|++|++||...........................
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 2234568999999999876 56899999999999999999999999765443322111111100000000000
Q ss_pred cC---CcCC-CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 ID---PCLG-FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~---~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.. .... .........++.++.+|+.+||+.||++|||++|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0000 01111222345678899999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.17 Aligned_cols=276 Identities=21% Similarity=0.269 Sum_probs=212.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-ceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-QGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv 357 (625)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 368999999999999999999987 58999999986543 234577889999999999999999999765433 367999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE----CCCCeEEEccccccccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLF 433 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll----~~~~~~kl~DFgla~~~ 433 (625)
|||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999997533 23349999999999999999999999999999999999999 88889999999999876
Q ss_pred CCCccccccCCCCCCCccCccccc--------cCCCCCchhhhhHHHHHHHHHhCCCCCccccccccc-chhHHHHHHhh
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQ--------CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI-NLANLAINKIQ 504 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~ 504 (625)
..... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... ...........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 43322 23456999999999875 467899999999999999999999999754332211 11111111111
Q ss_pred hcccccccC---------CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 505 KCAFDELID---------PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 505 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
......+.. ..+. ........++..+.+++.+||+.||++|||++|++++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111111000 0000 001123467778999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=363.63 Aligned_cols=263 Identities=16% Similarity=0.191 Sum_probs=209.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+++++++ +||||+++++++.. ....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEE
Confidence 368999999999999999999975 789999999864432 24588999999999 99999999996665 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe-----EEEccccccccc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC-----VKVADFGLSRLF 433 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~-----~kl~DFgla~~~ 433 (625)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 99999999632 457999999999999999999999999999999999999999887 999999999876
Q ss_pred CCCcccc------ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 434 PLDVTHV------STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 434 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 4332211 2346799999999999998899999999999999999999999976543222111111111100000
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
. .......+ ++.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus 241 ~------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 I------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp H------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 00111234 7889999999999999999999999998876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=368.25 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=203.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+|+.++|||||++++++.. ....++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEE
Confidence 368999999999999999999977 68899999986442 2235678899999999999999999996665 667899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+.||+|.+++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 93 v~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999996 3456999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.......||+.|+|||++.. ..++.++||||||+++|+|++|+.||.......... ....+......
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~~~~~~~~~~~---- 238 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----IVHTFETTVVT---- 238 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH----HHHHHHHCCCC----
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH----HHHHHhhcccC----
Confidence 22345679999999999863 458999999999999999999999997543322111 11111111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-MEEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~ell~~ 555 (625)
.. ..++..+.+||.+||+.||++||+ +++++++
T Consensus 239 ----~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 239 ----YP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----CC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----CC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 00 123457889999999999999998 7777654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=357.60 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=202.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHh--cCCCCeeeeeeeeee---ccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTR--LRHKNLVSLFGCTSR---YSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~---~~~~~~ 355 (625)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998654 33456677777777 799999999996543 234589
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH--------ASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
+||||+++|+|.+++. ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999994 346899999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCcccc---ccCCCCCCCccCccccccC------CCCCchhhhhHHHHHHHHHhC----------CCCCcccc
Q 047969 428 GLSRLFPLDVTHV---STAPQGTPGYVDPEYHQCY------QLTDKSDVYSFGVVLIELISS----------MPAVDMNR 488 (625)
Q Consensus 428 gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslG~il~elltG----------~~p~~~~~ 488 (625)
|+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998654332221 2334799999999998765 455799999999999999999 77775433
Q ss_pred cccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 489 HRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
..... .... ........ ..+ ...........+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 238 ~~~~~-~~~~-~~~~~~~~----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPS-FEDM-RKVVCVDQ----QRP--NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCC-HHHH-HHHHTTSC----CCC--CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcc-hhhh-hHHHhccC----CCC--CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22111 1111 11111000 011 0111111234567899999999999999999999999999876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=363.26 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=207.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR------RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+|++++||||+++++++.. ...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCE
Confidence 457999999999999999999987 6899999998654221 35778999999999999999999997655 677
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC----eEEEccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGL 429 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~----~~kl~DFgl 429 (625)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 899999999999999995 345699999999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.....
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~- 234 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY- 234 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHTCC-
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHHhcCC-
Confidence 98764322 2234569999999999988889999999999999999999999996543211 1111111110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.........++..+.+|+.+||+.||++|||+.|++++-
T Consensus 235 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 235 --------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred --------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 011222334566888999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=361.15 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=209.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEE
Confidence 478999999999999999999987 68899999986543 345678899999999999999999997665 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC--CCeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~--~~~~kl~DFgla~~~~~~~ 437 (625)
|+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999953 3346999999999999999999999999999999999999987 7899999999998764332
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
. .....||+.|+|||++.+..++.++||||||+++|+|++|.+||....... ....+......
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-------- 221 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT-------- 221 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--------
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCC--------
Confidence 2 233468999999999988888999999999999999999999997543221 11222221111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
........++.++.+++.+||+.||++|||+.|++++-.
T Consensus 222 -~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 222 -FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 112333456778999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=367.52 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=207.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
..++|++.+.||+|+||.||+|+++ +|+.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence 3568999999999999999999986 7899999998643 34456788999999999999999999996655 667899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC---CeEEEccccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN---FCVKVADFGLSRLF 433 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~---~~~kl~DFgla~~~ 433 (625)
||||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999985 34568999999999999999999999999999999999999865 45999999999876
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...... .....+.......
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~~--- 249 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYDY--- 249 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC---
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCC---
Confidence 4322 223457999999999999888999999999999999999999999654321 1112222221110
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.......++.++.+||.+||+.||++|||+.|++++-
T Consensus 250 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 250 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp ------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred ------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0111223456888999999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=382.45 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=212.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..++|++.+.||+|+||.||+|+++++..||||++.... ...+.|++|+++|++++|||||++++++. .+..+||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEe
Confidence 457899999999999999999999888999999997543 34678999999999999999999999765 456899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 263 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred ecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999999642 2235889999999999999999999999999999999999999999999999999876443322
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||++....++.++||||||+++|||++ |+.||....... ....+....... .
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~--~----- 406 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMP--R----- 406 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTCCCC--C-----
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--C-----
Confidence 2334457889999999988889999999999999999999 999997543211 111121111000 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+||.+||+.||++|||+++|++.|+.+...
T Consensus 407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 012455788999999999999999999999999988653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=375.18 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=206.9
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
...++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEE
Confidence 34578999999999999999999876 78999999986543 3445678999999999999999999996655 67789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC---CCCeEEEcccccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD---SNFCVKVADFGLSRL 432 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~---~~~~~kl~DFgla~~ 432 (625)
+||||++||+|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 87 lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 87 LIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999999986 345699999999999999999999999999999999999998 568899999999987
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|.+||...... .....+....... .
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~-~ 233 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAYDF-P 233 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCC-C
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCCCC-C
Confidence 64332 2224467999999999999888999999999999999999999999654321 1122222222110 0
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+....++.++.+||.+||+.||++|||+.|++++-
T Consensus 234 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 234 --------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp --------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred --------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 011123456788999999999999999999999873
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=366.79 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=201.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 354 (625)
..++|++++.||+|+||.||+|+++ +|+.||||++.+.. ....+.+.+|..+++.+ +||||+++++++.. ...+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEE
Confidence 3578999999999999999999987 68999999986542 23456788999999998 69999999996655 6779
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||++||+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999996 33569999999999999999999999999999999999999999999999999998543
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.. ........||+.|+|||++.+..++.++||||||+++|||++|++||....... ....+......
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~----- 242 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVV----- 242 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-----
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 22 222345679999999999988889999999999999999999999997553221 12222221110
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSM------EEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~ell~~L 556 (625)
.. ..++..+.+++.+||+.||++||++ +|+++|-
T Consensus 243 ---~p-----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 243 ---YP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp ---CC-----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred ---CC-----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 00 1134578889999999999999998 7787763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.02 Aligned_cols=260 Identities=25% Similarity=0.308 Sum_probs=208.0
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS 351 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 351 (625)
++....++|++.+.||+|+||.||+|+++ +++.||+|++.+... ...+.+.+|+.+++.++|||||++++++.. .
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-D 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-C
Confidence 34445689999999999999999999987 688999999865321 123457899999999999999999996665 6
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
..++|||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 779999999999999999852 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCC----CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
..............||+.|+|||++.+.. ++.++||||||+++|||++|++||....... ....+....
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~ 289 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHK 289 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-------HHHHHHhcc
Confidence 76544433345678999999999987654 7889999999999999999999997543221 111111110
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHh
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAELQ 557 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~L~ 557 (625)
.. +.-+ . ...++.++.+||.+||+.+|.+ ||+++|+++|-.
T Consensus 290 ~~-~~~p-----~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 290 NS-LTFP-----D---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HH-CCCC-----T---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred cc-ccCC-----C---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 00 0000 0 0123557889999999999988 999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=359.37 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=202.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-----
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ----- 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 352 (625)
..++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3568999999999999999999987 89999999986432 3356789999999999999999999997654321
Q ss_pred ---------------------------------------------------eEEEEEEeccCCChHHHhccCcccCCCCC
Q 047969 353 ---------------------------------------------------GLLLVYEFVANGTVADQLHGDRAKHGLLT 381 (625)
Q Consensus 353 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~ 381 (625)
..++||||+++++|.+++.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 3799999999999999997533 233467
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc-----------ccccCCCCCCCc
Q 047969 382 WPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT-----------HVSTAPQGTPGY 450 (625)
Q Consensus 382 ~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~-----------~~~~~~~gt~~y 450 (625)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 778999999999999999999999999999999999999999999999987654321 122345699999
Q ss_pred cCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHH
Q 047969 451 VDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTS 530 (625)
Q Consensus 451 ~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (625)
+|||++.+..++.++||||||+++|+|++|..|+.... .....+... .........+..
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~------------~~~~~~~~~~~~ 301 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNL------------KFPLLFTQKYPQ 301 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTT------------CCCHHHHHHCHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhcc------------CCCcccccCChh
Confidence 99999998899999999999999999999877653210 111111111 112334455667
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 531 VAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 531 l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+.+++.+||+.||++|||+.|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 8899999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.84 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=198.3
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|+++ ++..||||++... .....+.|.+|+.++++++||||+++++++.. ....++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEE
Confidence 58999999999999999999875 5678999998654 34456789999999999999999999997655 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999963 3346999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccc--cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 437 VTHVS--TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 437 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+.......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~~~~--- 270 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGYRLP--- 270 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTEECC---
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---
Confidence 22211 22345788999999998889999999999999999998 999996543211 111111111000
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
. . ..++..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 271 ~--~-------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 271 P--P-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp C--C-------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred C--C-------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 0 123457889999999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.28 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=202.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++++.||+|+||.||+|+.+ +++.||||++.+.. ....+.+.+|..+++++ +|||||++++++.. ...++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence 468999999999999999999987 68899999986542 23345678999999887 89999999996655 67799
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||++||+|..++. +.+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999986 335699999999999999999999999999999999999999999999999999985322
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc--ccchhHHHHHHhhhcccccccC
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH--EINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
. ........||+.|+|||++.+..++.++||||||+++|||++|++||....... ...........+......
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 280 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 280 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----
Confidence 2 222345679999999999999999999999999999999999999996432211 111112222222222111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSM------EEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~ell~~ 555 (625)
.. ..++.++.+||.+||+.||++||++ .|+++|
T Consensus 281 ----~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 ----IP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----CC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----CC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 00 1245578899999999999999985 666665
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.85 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=200.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 352 (625)
.++|++++.||+|+||+||+|++. +++.||||++... .....+++.+|+.+|+.++|||||++++++... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999876 7899999998653 445567889999999999999999999976532 24
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.++|||||++++ |.+.+. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 679999999865 666653 1389999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc------
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC------ 506 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------ 506 (625)
.... .......||+.|+|||++.+..++.++||||||+++|||++|++||........... ....+...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~---i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---VIEQLGTPCPEFMK 288 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCSCCHHHHT
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCHHHHH
Confidence 5432 223456799999999999998999999999999999999999999976543221111 11100000
Q ss_pred -------------------ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 -------------------AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 -------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+.......+........+..+.++.+|+.+||+.||++|||++|+++|-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 00000000001111223344577899999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=376.95 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=209.3
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR---RVEQFMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
.++....++|++.++||+|+||+||+|+++ +++.||||++.+.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 145 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD- 145 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 344455689999999999999999999987 5789999998653221 22348899999999999999999996665
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
...++|||||++||+|.+++.. ..+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 6779999999999999999963 2456999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
+..............||+.|+|||++. ...++.++||||||+++|||++|++||........ ...+......
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~ 299 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKER 299 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHH
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhcccc
Confidence 876544444445568999999999986 45689999999999999999999999975432211 1111111011
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKEL--RPSMEEVLAEL 556 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ell~~L 556 (625)
..+... ...++.++.+||.+||..+|++ ||+++|+++|-
T Consensus 300 ~~~p~~------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 300 FQFPTQ------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CCCCSS------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred ccCCcc------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 111110 0123557889999999988888 99999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=354.41 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=197.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+|+||.||+|++.. +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccE
Confidence 4689999999999999999998752 457999998653 3445678999999999999999999999764 35679
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999963 334689999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
..........+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i~~~~~~~~--- 238 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERLPM--- 238 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCCCC---
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHHHcCCCCCC---
Confidence 33333334457889999999988889999999999999999996 9999975443211 111111111110
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...++..+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 239 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 239 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01235578899999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=351.57 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=211.1
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeC
Confidence 358999999999999999999998889999999975532 33678999999999999999999996655 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 999999999963 33568999999999999999999999999999999999999999999999999998764433333
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+....... .+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~~~--~~----- 227 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRLY--KP----- 227 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCCC--CC-----
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCcCC--CC-----
Confidence 344567889999999988889999999999999999999 899997543211 111222111000 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+..+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0134578889999999999999999999999998875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=355.67 Aligned_cols=266 Identities=22% Similarity=0.357 Sum_probs=201.1
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEE
Confidence 58999999999999999999998899999999864432 224678899999999999999999997655 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++ +|.+++.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 9986 89888853 335689999999999999999999999999999999999999999999999999987543221
Q ss_pred cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---cccc----
Q 047969 440 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA---FDEL---- 511 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 511 (625)
......||+.|+|||++.+ ..++.++||||||+++|+|++|++||......... ........... ....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhccc
Confidence 1234468999999999865 45899999999999999999999999764422211 11111110000 0000
Q ss_pred -cCCcCC----CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 512 -IDPCLG----FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 512 -~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.++... .........++.++.+|+.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000000 000111123456788999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.43 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=197.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--------------------------HHHHHHHHHHHHHH
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--------------------------RRVEQFMNEVEILT 333 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 333 (625)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999976 788999999865421 12356889999999
Q ss_pred hcCCCCeeeeeeeeee-ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 047969 334 RLRHKNLVSLFGCTSR-YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTN 412 (625)
Q Consensus 334 ~l~h~niv~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~ 412 (625)
+++||||+++++++.. .....++||||+++++|.+++ ....+++..++.++.||++||+|||++||+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999999999997654 356789999999999988765 3346999999999999999999999999999999999
Q ss_pred CEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccCC---CCCchhhhhHHHHHHHHHhCCCCCccccc
Q 047969 413 NILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ---LTDKSDVYSFGVVLIELISSMPAVDMNRH 489 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwslG~il~elltG~~p~~~~~~ 489 (625)
|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987643322 223457999999999987654 37789999999999999999999965432
Q ss_pred ccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 490 RHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. .....+....... + . ...++..+.+++.+||+.||++|||+.|+++|
T Consensus 246 ~-------~~~~~~~~~~~~~---~-----~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 M-------CLHSKIKSQALEF---P-----D---QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H-------HHHHHHHHCCCCC---C-----S---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H-------HHHHHHhcccCCC---C-----C---ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 1111222111110 0 0 01234578899999999999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.92 Aligned_cols=263 Identities=15% Similarity=0.211 Sum_probs=210.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++.+ +|+|++++++++.. ....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEE
Confidence 468999999999999999999975 78999999986443 234578899999999 79999999996654 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe-----EEEccccccccc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC-----VKVADFGLSRLF 433 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~-----~kl~DFgla~~~ 433 (625)
||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 9999999963 2345999999999999999999999999999999999999987776 999999999876
Q ss_pred CCCccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 434 PLDVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 434 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 12445799999999999988899999999999999999999999976543222211111111111111
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
. ......++..+.+++.+||+.+|++||++++|++.|+.+...
T Consensus 242 ~------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 L------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp H------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 111123456889999999999999999999999999988753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=360.91 Aligned_cols=268 Identities=28% Similarity=0.384 Sum_probs=212.1
Q ss_pred cCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~ 355 (625)
++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 3688999999987777777889999999999999999999996653 456689
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999642 23589999999999999999999999999999999999999999999999999987654
Q ss_pred Cccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc--------ccchhHHHHHHhhh
Q 047969 436 DVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH--------EINLANLAINKIQK 505 (625)
Q Consensus 436 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~~ 505 (625)
.... ......||..|+|||++.+..++.++||||||+++|+|++|..||....... ...........+..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3322 2234568899999999988889999999999999999999999986433210 00011111111111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
..... . ...++..+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 260 ~~~~~---------~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 260 GQRLP---------A---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp TCCCC---------C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ccCCC---------C---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11000 0 11245678899999999999999999999999998876443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.82 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=204.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+|+||.||+|+++ +++.||||++.+. .....+.+.+|+.+++++ +||||+++++++.. ...++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEE
Confidence 368999999999999999999987 6889999998654 334567788999999998 89999999996655 67799
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++|+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999985 334699999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccc--cchhHHHHHHhhhcccccccC
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE--INLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.. .......||+.|+|||++.+..++.++||||||+++|||++|++||........ ..........+......
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 237 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 237 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----
Confidence 21 223456799999999999988999999999999999999999999965322111 01111122222221110
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSM------EEVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~ell~~ 555 (625)
.. ..++..+.++|.+||+.||++||++ .++++|
T Consensus 238 ----~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 ----IP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ----CC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ----CC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00 1245578899999999999999995 677665
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=361.63 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=185.1
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEEEEeccCC
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLVYEFVANG 364 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g 364 (625)
.+.||+|+||.||+|+++ +++.||||++... ....+.+|+.+++.+. ||||+++++++.. ....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence 378999999999999986 7899999998654 3456778999999997 9999999997655 67789999999999
Q ss_pred ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---eEEEcccccccccCCCccccc
Q 047969 365 TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF---CVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 365 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~---~~kl~DFgla~~~~~~~~~~~ 441 (625)
+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ...
T Consensus 92 ~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 92 ELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp BHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 9999996 345699999999999999999999999999999999999997665 89999999998654332 223
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCCh
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (625)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+....+. ...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---------~~~ 237 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---------FEG 237 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---------CCS
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---------CCc
Confidence 44568999999999998899999999999999999999999997654332222222333333332211 122
Q ss_pred HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 522 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+....++.++.+|+.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 34456678899999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.25 Aligned_cols=263 Identities=26% Similarity=0.376 Sum_probs=211.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-CC
Confidence 4578999999999999999999975 3478999998654 34456789999999999999999999997655 56
Q ss_pred eEEEEEEeccCCChHHHhccCccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAK--------------------HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTN 412 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~ 412 (625)
..++||||+++|+|.+++...... ...+++..++.++.||++||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 789999999999999999753211 257999999999999999999999999999999999
Q ss_pred CEEECCCCeEEEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccc
Q 047969 413 NILLDSNFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHR 490 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~ 490 (625)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999986543221 12234568899999999988889999999999999999999 99999654321
Q ss_pred cccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 491 HEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.....+......... ..++..+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus 284 -------~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 -------EVIYYVRDGNILACP------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp -------HHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred -------HHHHHHhCCCcCCCC------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 111222222111100 12345788999999999999999999999999988753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=374.13 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=208.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.|.+|+++|++++||||+++++++.. .+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEEE
Confidence 468999999999999999999987 7899999998654 23445678999999999999999999997654 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999963 334589999999999999999999999999999999999999999999999999986533222
Q ss_pred ccc-cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 439 HVS-TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 439 ~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
... ....+++.|+|||++....++.++||||||+++|||++ |..||....... ....+.......
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~------ 335 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLP------ 335 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCCC------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence 111 12235678999999988889999999999999999998 999997543211 111111111000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. ...++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 336 -~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 -C-----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp -C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0 01234578899999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.72 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=212.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|++.+.||+|+||.||+|+.. .++.||||++... .....+.+.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence 468999999999999999999863 2357999998654 344567899999999999 89999999997655
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 5678999999999999999975331 1246999999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~------ 300 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 300 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999987643322 22234567889999999998889999999999999999999 99999754321
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
.....+........ . ..++.++.+++.+||+.+|++|||++|++++|+.+....
T Consensus 301 -~~~~~~~~~~~~~~-----~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 -ELFKLLKEGHRMDK-----P-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -HHHHHHHTTCCCCC-----C-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -HHHHHHHcCCCCCC-----C-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11122222111110 0 123457889999999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=363.48 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=202.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence 468999999999999999999975 789999999864322 123578899999999999999999997665 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+ +|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99999 678988885 3346999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||+......... .+....
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~~~ 224 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNSCV 224 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCSSC
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHcCC
Confidence 22345579999999999987765 689999999999999999999997543221110 000000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
... ...++..+.+|+.+||+.||++|||++|++++-.
T Consensus 225 ~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 225 YVM-----PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CCC-----CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred CCC-----cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 000 0124557889999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=361.98 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=201.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcE----EEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGRE----VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.++|++.+.||+|+||+||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STV 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--SSE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCe
Confidence 357999999999999999999965 4443 688877543 23445789999999999999999999997765 347
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 899999999999999963 34569999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 435 LDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 435 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .. ..+.......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~~~-- 239 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP-- 239 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCC--
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcCCCCC--
Confidence 433222 233457889999999998899999999999999999999 999997644321 11 1111111000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
. ....+..+.+++.+||+.+|++||++.+++++|+.+...
T Consensus 240 -----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 -----Q-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----C-----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----C-----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0 011344788899999999999999999999999988754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=368.75 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=208.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++..........+.+|+.+|++++||||+++++++.. ....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEE
Confidence 468999999999999999999987 789999999977666666789999999999999999999996655 677899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC--CCeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~--~~~~kl~DFgla~~~~~~~ 437 (625)
|+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999853 3346899999999999999999999999999999999999974 5789999999998764332
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
. .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+...... .+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~~~~~~--~~---- 270 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE--FD---- 270 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC--CC----
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CC----
Confidence 2 223468999999999998889999999999999999999999997543211 11112211111 00
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
......++.++.+||.+||+.||++|||+.|++++-
T Consensus 271 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 271 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 001123456788999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.11 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=208.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.. ...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCC
Confidence 368999999999999999999843 4678999998643 34455678999999999999999999997655 566
Q ss_pred EEEEEEeccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---eEEEccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF---CVKVADF 427 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~---~~kl~DF 427 (625)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 7999999999999999975332 224699999999999999999999999999999999999999554 5999999
Q ss_pred ccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||....... ....+..
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i~~ 301 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTS 301 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHT
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc
Confidence 99975422111 11233457899999999988889999999999999999998 999997543221 1112221
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...... ...++..+.+|+.+||+.+|++|||+.+++++|+.+...
T Consensus 302 ~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 302 GGRMDP------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCC------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111100 012345688999999999999999999999999988753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=352.29 Aligned_cols=265 Identities=19% Similarity=0.251 Sum_probs=209.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|++.+.||+|+||.||+|++. +++.||||++.... ..+.+.+|+.+++.++|++++..++.+.......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4579999999999999999999975 78999999865432 22457889999999999998888886766678889999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~~~ 435 (625)
||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 9999999863 23469999999999999999999999999999999999999 7889999999999987654
Q ss_pred Cccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 436 DVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 436 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence 3321 123457999999999999888999999999999999999999999765443332222222211111110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
......++..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 240 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 240 -----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 011123456889999999999999999999999999988754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=363.64 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=202.8
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcE----EEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGRE----VAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|++.+.||+|+||+||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccE
Confidence 58999999999999999999975 4443 7888774332 223356788999999999999999999664 35689
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+.+|+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999642 34689999999999999999999999999999999999999999999999999997654
Q ss_pred Cccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLAQ-- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCCC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCCC--
Confidence 3322 2244568889999999998889999999999999999999 999997643221 1111111111000
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
+ ..++..+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus 239 ~----------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 P----------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C----------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C----------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 01233577899999999999999999999999988654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=350.90 Aligned_cols=265 Identities=19% Similarity=0.246 Sum_probs=212.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|++. +++.||||++..... .+.+.+|+.+++.++|++++..+..+.......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 478999999999999999999974 799999999865432 24688999999999999888777766666778899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEcccccccccCCC
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~~~~ 436 (625)
|+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 8999999953 23469999999999999999999999999999999999999 48889999999999876543
Q ss_pred ccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 437 VTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 437 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 321 123457999999999999888999999999999999999999999865433222222222211111110
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
......++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 240 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 ----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0111234567899999999999999999999999999886543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=358.71 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=211.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CCc
Confidence 468999999999999999999862 4578999998654 34556789999999999999999999996655 567
Q ss_pred EEEEEEeccCCChHHHhccCcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 047969 354 LLLVYEFVANGTVADQLHGDRA--------------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNN 413 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~N 413 (625)
.++||||+++++|.+++..... ....+++..++.++.||++||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 8999999999999999975332 12348999999999999999999999999999999999
Q ss_pred EEECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCccccccc
Q 047969 414 ILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRH 491 (625)
Q Consensus 414 Ill~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~ 491 (625)
||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876433222 2234567889999999988889999999999999999999 999997554321
Q ss_pred ccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 492 EINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. ...+........ ...++..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 261 ~-------~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 261 L-------FNLLKTGHRMER------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp H-------HHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-------HHHhhcCCcCCC------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 111111111100 01235578899999999999999999999999998765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=363.34 Aligned_cols=269 Identities=14% Similarity=0.224 Sum_probs=205.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC------CcEEEEEEeccccHHH-----------HHHHHHHHHHHHhcCCCCeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDNNYRR-----------VEQFMNEVEILTRLRHKNLVSL 343 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~ 343 (625)
.++|++.+.||+|+||.||+|++.. ++.||||++....... ...+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998764 4789999986554211 1224456677788899999999
Q ss_pred eeeeeec---cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC--C
Q 047969 344 FGCTSRY---SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD--S 418 (625)
Q Consensus 344 ~~~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~--~ 418 (625)
++++... ....+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+||||+ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9976543 24579999999 9999999963 335699999999999999999999999999999999999999 8
Q ss_pred CCeEEEcccccccccCCCcccc------ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccc
Q 047969 419 NFCVKVADFGLSRLFPLDVTHV------STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE 492 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~ 492 (625)
++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 8999999999998764322211 1234599999999999988899999999999999999999999985432211
Q ss_pred cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 493 INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
. ....... .......+++.++.. ..++.++.+++..||+.+|++||++.+|++.|+.+...
T Consensus 270 ~--~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 270 Y--VRDSKIR-YRENIASLMDKCFPA------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp H--HHHHHHH-HHHCHHHHHHHHSCT------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H--HHHHHHH-hhhhHHHHHHHhccc------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 1 1111111 111122222221110 12356788999999999999999999999999887653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=374.92 Aligned_cols=254 Identities=25% Similarity=0.455 Sum_probs=208.7
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|++. |+.||||++.... ..+.|.+|+++|++++||||+++++++.......+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 468999999999999999999985 7899999997653 4567999999999999999999999877656678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp CTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 9999999999642 2334799999999999999999999999999999999999999999999999999854321
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||........ ...+..+.... .
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~~~-------~- 407 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYKMD-------A- 407 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTCCCC-------C-
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCCC-------C-
Confidence 122357889999999998899999999999999999998 9999975432211 11122111000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 408 ----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 ----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 012456788999999999999999999999999988754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=372.40 Aligned_cols=262 Identities=23% Similarity=0.258 Sum_probs=207.6
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
.++....++|++.+.||+|+||.||+|+.+ +|+.||||++.+... ...+.+.+|..++..++||||+++++++..
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD- 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-
Confidence 344445689999999999999999999986 799999999865322 223458899999999999999999996655
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
.+.++|||||++||+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 6779999999999999999963 2346999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccc-------cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQ-------CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
+..............||+.|+|||++. ...++.++||||||+++|||++|++||....... ....+
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i 282 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------TYGKI 282 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------HHHHH
Confidence 876544433344568999999999986 3568999999999999999999999997543221 11111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELR---PSMEEVLAEL 556 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~ell~~L 556 (625)
..... .+.-+ .....++.++.+||.+||. +|++| |+++|+++|-
T Consensus 283 ~~~~~-~~~~p-------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 283 VHYKE-HLSLP-------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HTHHH-HCCCC-----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred Hhccc-CcCCC-------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 11000 00000 0112345688999999999 99998 6999998873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.80 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=205.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.+... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEE
Confidence 468999999999999999999987 799999999865422 235678899999999999999999996654 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||+|.+++. +...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999996 3456899999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+......
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~------- 221 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAELR------- 221 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCCC-------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence 234579999999999998899999999999999999999999996543211 11222221110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
.. ..++.++.+++.+||+.||++|| +++++++|-
T Consensus 222 -~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 222 -FP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp -CC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -CC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 00 12345788999999999999999 899998874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.96 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=195.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEE
Confidence 468999999999999999999987 789999999865432 23568899999999999999999997665 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe--EEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC--VKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~--~kl~DFgla~~~~~~~ 437 (625)
|+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 999999999985 3346999999999999999999999999999999999999987765 999999999753222
Q ss_pred cccccCCCCCCCccCccccccCCCCCc-hhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDK-SDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||......... ......+......
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~------- 240 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY---RKTIQRILSVKYS------- 240 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH---HHHHHHHHTTCCC-------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH---HHHHHHHhcCCCC-------
Confidence 22234569999999999988777665 89999999999999999999764432221 1111111111110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
... ...++..+.+||.+||+.||++|||+.|+++|-.-
T Consensus 241 -~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 241 -IPD---DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp -CCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred -CCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 000 00234578899999999999999999999998544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=349.69 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=205.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+|+||.||+|++.+ +..||||++... .....+.+.+|+.++++++||||+++++++.. +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCE
Confidence 4689999999999999999998652 346999998654 34556789999999999999999999997654 4568
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999963 345689999999999999999999999999999999999999999999999999987654
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
..........+++.|+|||++.+..++.++||||||+++|+|++ |+.||........ . ..+........
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~----~~~~~~~~~~~--- 235 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I----GVLEKGDRLPK--- 235 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H----HHHHHTCCCCC---
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H----HHHhcCCCCCC---
Confidence 33333344567889999999988889999999999999999998 9999975433221 1 11111110000
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. ..++..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 236 --~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 --P-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0 1134578899999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=363.70 Aligned_cols=272 Identities=19% Similarity=0.215 Sum_probs=204.9
Q ss_pred hcCCCccceeccc--CcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDG--GFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++.+.||+| +||.||+|++. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.. .+..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEE
Confidence 4689999999999 99999999987 79999999986442 4456778899999999999999999997765 66789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999999643 234599999999999999999999999999999999999999999999999999865421
Q ss_pred Cc------cccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH-HHHHhhh-
Q 047969 436 DV------THVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL-AINKIQK- 505 (625)
Q Consensus 436 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~- 505 (625)
.. ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.............. ....+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 111233478999999999977 5799999999999999999999999975433221110000 0000000
Q ss_pred -----c-------------ccccccC---C---cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 506 -----C-------------AFDELID---P---CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 506 -----~-------------~~~~~~~---~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ....... + ............++..+.+||.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000000 0 00000111233456789999999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=365.51 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=203.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
...++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|..+++.+ +||||+++++++.. ...
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KEN 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCE
Confidence 45689999999999999999999987 68999999986542 22356678899999987 89999999996655 677
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
+++||||++||+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999996 3346899999999999999999999999999999999999999999999999999864
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... .......||+.|+|||++.+..++.++||||||+++|||++|++||....... ....+.....
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~----- 235 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP----- 235 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCC-----
Confidence 3221 22345679999999999998889999999999999999999999997543211 1122222111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSME-EVLAE 555 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~ 555 (625)
... ..++.++.++|.+||+.||++||++. ++++|
T Consensus 236 -~~p-------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 236 -FYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -CCC-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -CCC-------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 000 12345788999999999999999997 66654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=377.22 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=205.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..++|++.+.||+|+||.||+|++.++..||||++..... ..+.|.+|+++|++++||||+++++++.. +..+||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEeh
Confidence 3468999999999999999999998888899999875432 34679999999999999999999997654 56799999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 99999999999632 2345899999999999999999999999999999999999999999999999999876433322
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||++....++.++||||||+++|||++ |+.||....... ....+....... .
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~-------~ 402 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMP-------C 402 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-------C
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-------C
Confidence 2334457889999999988889999999999999999999 999997543211 112222111000 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.++|.+||+.+|++|||+++|++.|+.+...
T Consensus 403 -----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 403 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 012455788999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=382.85 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=213.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|+++ +++.||||++.... ...+.|.+|+.+|++++|||||++++++.. ....+||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEEE
Confidence 467899999999999999999987 48899999986553 345789999999999999999999997665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 99999999999642 2345899999999999999999999999999999999999999999999999999876544333
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||++....++.++||||||+++|||++ |..||....... . ...+...... ..
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~-------~~ 440 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKDYRM-------ER 440 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCCC-------CC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC-------CC
Confidence 3344557889999999988889999999999999999999 999997544221 1 1111111000 00
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
...++..+.+||.+||+.+|++|||+.+|++.|+.+....
T Consensus 441 -----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 441 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred -----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 0123457889999999999999999999999999886543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.71 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=208.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 368999999999999999999975 799999999877666777889999999999999999999997652 2346899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++.........+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999999999765445677999999999999999999999999999999999999999999999999998764321
Q ss_pred cccc--------ccCCCCCCCccCccccccCC---CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 437 VTHV--------STAPQGTPGYVDPEYHQCYQ---LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 437 ~~~~--------~~~~~gt~~y~aPE~~~~~~---~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
.... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......... .... +..
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~----~~~ 262 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALA----VQN 262 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHH----HHC
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHH----hhc
Confidence 1110 11234799999999987543 688999999999999999999999643211111 1100 000
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
... .+ . ...++..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 263 -~~~---~~-----~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 -QLS---IP-----Q---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -C-----CC-----C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -cCC---CC-----c---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00 0 01234578899999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=350.83 Aligned_cols=263 Identities=25% Similarity=0.437 Sum_probs=202.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecc---ccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYD---NNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++.. ......+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEE
Confidence 468999999999999999999975 799999999864 234556789999999999999999999997665 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999999754445667999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... . ......+....+.....
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~-~~~~~~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L-YSLCKKIEQCDYPPLPS--- 260 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----H-HHHHHHHHTTCSCCCCT---
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----H-HHHHHHhhcccCCCCcc---
Confidence 21 123346899999999998888999999999999999999999999643211 1 11112222222211110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
..++.++.+++.+||+.||++|||+.+++++|+.+..
T Consensus 261 --------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 261 --------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1234578899999999999999999999999998875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.33 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=200.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|++.+.||+|+||+||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEE
Confidence 58999999999999999999987 6899999998643 23345778899999999999999999997665 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++ ++.+.+.. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp ECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred ecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 99986 55555532 34569999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccCCCCCCCccCccccccCC-CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---ccccc--
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA---FDELI-- 512 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 512 (625)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|..|+........ ............. .....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccc
Confidence 2234457899999999987665 89999999999999999987777532221111 1111111111000 00000
Q ss_pred -C--Cc----CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 513 -D--PC----LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 513 -~--~~----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+ +. ...........++..+.+|+.+||+.||++|||++|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 0 00 00000111123556788999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=352.32 Aligned_cols=270 Identities=23% Similarity=0.358 Sum_probs=202.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEE
Confidence 468999999999999999999987 68999999885442 3345678899999999999999999997665 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 81 FEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999998875 34568999999999999999999999999999999999999999999999999998754322
Q ss_pred cccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh--------hh-cc
Q 047969 438 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI--------QK-CA 507 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~-~~ 507 (625)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|++||................... .. ..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2234568999999999875 568999999999999999999999997654332221111110000 00 00
Q ss_pred ccc--ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 508 FDE--LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 508 ~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+.. +.++............++..+.+|+.+||+.||++|||++|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 000 0000000001111234566788999999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=346.17 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=208.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.. ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEE
Confidence 4568999999999999999999987 577899999876655567789999999999999999999996654 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~~~ 435 (625)
||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 86 ELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp ECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred eccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999885 33468999999999999999999999999999999999999 7889999999999987643
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||....... ....+......
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 225 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFT------ 225 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC------
Confidence 32 22445699999999998764 8999999999999999999999997543211 11122221111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
........++..+.+++.+||+.||++|||+.+++++-
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 226 ---FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp ---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ---CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11222234567889999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=344.77 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=193.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH----HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY----RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. ++.||||++..... ...+.+.+|+++++.++||||+++++++.. .+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEE
Confidence 368999999999999999999985 89999999864422 235678999999999999999999997665 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCCCEEECC--------CCeEEEc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD---IIHRDVKTNNILLDS--------NFCVKVA 425 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---ivHrDikp~NIll~~--------~~~~kl~ 425 (625)
||||+++++|.+++. ...+++..++.++.|+++||+|||++| |+||||||+|||++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999984 346899999999999999999999999 899999999999986 7789999
Q ss_pred ccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 426 DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 426 DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ..+..
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VA-YGVAM 228 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HH-HHHHT
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-Hhhhc
Confidence 999998654322 224468999999999988889999999999999999999999997543211 11 11111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
..... .. ...++..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 229 ~~~~~----~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKLAL----PI-------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCCCC----CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCC----CC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11000 00 012345788999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=352.24 Aligned_cols=269 Identities=28% Similarity=0.309 Sum_probs=200.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-----HHHHHHHHHHHHHHhc---CCCCeeeeeeeeeec
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-----RRVEQFMNEVEILTRL---RHKNLVSLFGCTSRY 350 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~ 350 (625)
..++|++.+.||+|+||+||+|++. +++.||||++..... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3579999999999999999999975 789999999863321 1123456777777666 499999999976653
Q ss_pred cc----eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 351 SQ----GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 351 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 32 4799999997 5999998643 223499999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 427 FGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 427 Fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|++||......... ......+...
T Consensus 164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~ 238 (308)
T 3g33_A 164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLP 238 (308)
T ss_dssp CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence 999986543222 23456899999999998888999999999999999999999999765432211 1111111110
Q ss_pred cccccc----------CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 AFDELI----------DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 ~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....+. ..............++..+.+|+.+||+.||++|||+.|+++|-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 000000 00000001112224566888999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.23 Aligned_cols=268 Identities=26% Similarity=0.370 Sum_probs=195.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeee-ccce
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSR-YSQG 353 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~ 353 (625)
...++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+.+++++. ||||+++++++.. ....
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35679999999999999999999976 7899999998543 3455677889999999997 9999999997654 3346
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
+++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 589888852 46899999999999999999999999999999999999999999999999999865
Q ss_pred CCC--------------------ccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccc
Q 047969 434 PLD--------------------VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE 492 (625)
Q Consensus 434 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~ 492 (625)
... .........||+.|+|||++.+ ..++.++||||||+++|||++|++||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 0111234579999999999876 5789999999999999999999999976543222
Q ss_pred cchhHHHHHHhhhcccccc---cC-----------------CcCCCCChHHHH----------HHHHHHHHHHHHhcccC
Q 047969 493 INLANLAINKIQKCAFDEL---ID-----------------PCLGFESDEEVK----------RMTTSVAELAFLCLQQN 542 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~---~~-----------------~~~~~~~~~~~~----------~~~~~l~~li~~cl~~~ 542 (625)
... ....+.......+ .. ............ ..+.++.+|+.+||+.|
T Consensus 240 ~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 240 LER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 111 1111100000000 00 000000001000 23557889999999999
Q ss_pred CCCCCCHHHHHHH
Q 047969 543 KELRPSMEEVLAE 555 (625)
Q Consensus 543 P~~RPs~~ell~~ 555 (625)
|++|||++|+++|
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999988
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=350.28 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=210.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEec
Confidence 46899999999999999999999888899999986543 235678999999999999999999996653 457999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999999632 22358999999999999999999999999999999999999999999999999998765443333
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+....... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~~-- 232 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYRMV-----RP-- 232 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-----CC--
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcccCCC-----Cc--
Confidence 344567889999999988889999999999999999999 999997543211 111111111000 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
..++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 233 -----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 233 -----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1234578899999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.70 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=201.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH----H---HHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR----R---VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|++. +++.||||++...... . .+.+.+|+.++++++||||+++++++.. ..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN-PP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT-TT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC-CC
Confidence 368999999999999999999986 7899999998543221 1 2678999999999999999999996644 22
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECCCCe-----EEEc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDSNFC-----VKVA 425 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~~~~-----~kl~ 425 (625)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999998853 3456999999999999999999999999 999999999999988776 9999
Q ss_pred ccccccccCCCccccccCCCCCCCccCccccc--cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 426 DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ--CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 426 DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
|||+++.... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||......... . ...+
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~----~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-F----INMI 242 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-H----HHHH
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-H----HHHH
Confidence 9999975432 233457999999999983 456788999999999999999999999754432111 1 1111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
........ .. ..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus 243 ~~~~~~~~----~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLRPT----IP-------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCCCC----CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCCCC----CC-------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111110 00 12355788999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.17 Aligned_cols=264 Identities=26% Similarity=0.328 Sum_probs=204.8
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-----NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR 349 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 349 (625)
++....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45677889999999999999999999976 7889999998643 23456789999999999999999999997655
Q ss_pred ccceEEEEEEeccCCChHHHhccCccc------------------------------------CCCCCHHHHHHHHHHHH
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAK------------------------------------HGLLTWPIRMNIAIETA 393 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~ 393 (625)
.+..++||||+++|+|.+++...... ...+++..++.++.||+
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 67789999999999999998521111 12246778899999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCC--eEEEcccccccccCCCcc---ccccCCCCCCCccCcccccc--CCCCCchh
Q 047969 394 SALAYLHASDIIHRDVKTNNILLDSNF--CVKVADFGLSRLFPLDVT---HVSTAPQGTPGYVDPEYHQC--YQLTDKSD 466 (625)
Q Consensus 394 ~~L~yLH~~~ivHrDikp~NIll~~~~--~~kl~DFgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~~sD 466 (625)
.||+|||++||+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999998776 899999999986532211 12244579999999999865 57899999
Q ss_pred hhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCC
Q 047969 467 VYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELR 546 (625)
Q Consensus 467 vwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 546 (625)
|||||+++|+|++|+.||....... ....+...... . ..+....++..+.+||.+||+.+|++|
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~--------~-~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDAD-------TISQVLNKKLC--------F-ENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------T-TSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcccc--------c-CCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999997543221 11111111100 0 011112345688899999999999999
Q ss_pred CCHHHHHHHH
Q 047969 547 PSMEEVLAEL 556 (625)
Q Consensus 547 Ps~~ell~~L 556 (625)
|++.+++++-
T Consensus 323 ps~~~~l~hp 332 (345)
T 3hko_A 323 FDAMRALQHP 332 (345)
T ss_dssp CCHHHHHHSH
T ss_pred CCHHHHhcCh
Confidence 9999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=348.53 Aligned_cols=260 Identities=29% Similarity=0.479 Sum_probs=196.8
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.++||+|+||+||+|+.. ..||||++... .....+.+.+|+.++++++||||++++++.. ....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEEE
Confidence 468999999999999999999864 35999998543 3455678999999999999999999999543 45679999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc-
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV- 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~- 437 (625)
||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999953 34569999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .....+...........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCTTS
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcchhh
Confidence 12223456999999999886 5568889999999999999999999997543221 11122222111111100
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 250 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 --------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011234578899999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=356.48 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=195.7
Q ss_pred hcCCCccceecccCcEEEEEEEE----cCCcEEEEEEecccc----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL----KDGREVAVKRLYDNN----YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+|++++||||+++++++.. .+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CC
Confidence 46899999999999999999987 478999999986542 2344667899999999999999999996655 67
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 7899999999999999985 334689999999999999999999999999999999999999999999999999975
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+......
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~~--- 239 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-------TIDKILKCKLN--- 239 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC---
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC---
Confidence 43222 22234579999999999988889999999999999999999999997543221 11222221110
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHh
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAELQ 557 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L~ 557 (625)
.. ..++..+.+++.+||+.||++|| ++.|+++|-.
T Consensus 240 -----~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 240 -----LP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -----CC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -----CC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 00 12345788999999999999999 7889988743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=351.27 Aligned_cols=264 Identities=24% Similarity=0.383 Sum_probs=206.2
Q ss_pred cCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 354 (625)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++... ....
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4689999999999999999984 368899999986442 23457789999999999999999999976653 2568
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999999999953 33569999999999999999999999999999999999999999999999999998765
Q ss_pred CCcc--ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccc--------cccchhHHHHHHhh
Q 047969 435 LDVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHR--------HEINLANLAINKIQ 504 (625)
Q Consensus 435 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~ 504 (625)
.... .......||..|+|||++.+..++.++||||||+++|+|++|..|+...... ............+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 4332 2234456889999999998888999999999999999999999987432110 00001111111111
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
...... ....++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 258 ~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKRLP------------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCCCC------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCC------------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111000 00124567889999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.68 Aligned_cols=270 Identities=23% Similarity=0.387 Sum_probs=191.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++++.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence 468999999999999999999976 689999999865432 234678899999999999999999996655 66789999
Q ss_pred EeccCCChHHHhccCcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 359 EFVANGTVADQLHGDRA--KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||++ ++|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 599998864321 2245899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---cccccc-
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---CAFDEL- 511 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 511 (625)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|++||.......... ........ ..+...
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK---LIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCTTTCGGGG
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChhHhhhhh
Confidence 22 2234568999999999876 468999999999999999999999997654322111 11111100 000000
Q ss_pred ----cCCcCC----CCChHHH-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 512 ----IDPCLG----FESDEEV-----KRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 512 ----~~~~~~----~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..+... ....... ..++.++.+|+.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 000000 0000000 12456788999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.85 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=196.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcC-C---cEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce-
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD-G---REVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG- 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 353 (625)
.++|++.+.||+|+||.||+|++.. + ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999998763 3 27999998654 334567899999999999999999999976553221
Q ss_pred ----EEEEEEeccCCChHHHhccCcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 354 ----LLLVYEFVANGTVADQLHGDRA--KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 354 ----~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 3899999999999999864332 2235899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+..
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~ 254 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------YNYLIG 254 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHT
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-------HHHHhc
Confidence 999875433221 1233457889999999988889999999999999999999 9999975443211 111111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
...... ...++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 255 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 255 GNRLKQ------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TCCCCC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCC------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 110000 0123457889999999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=355.18 Aligned_cols=260 Identities=30% Similarity=0.441 Sum_probs=213.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEE
Confidence 4578999999999999999999987 58899999986553 345789999999999999999999996654 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 999999999999642 335689999999999999999999999999999999999999999999999999987654443
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+....... .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~~~~~~~-----~- 233 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDYRME-----R- 233 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTTCCCC-----C-
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhccCCCC-----C-
Confidence 33344457889999999988889999999999999999999 9999975432211 11111110000 0
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 234 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 012345788999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=352.55 Aligned_cols=246 Identities=25% Similarity=0.325 Sum_probs=195.9
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.++||+|+||+||+|++. +|+.||||++... .......+..|+..+.++ +||||+++++++.. ....++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEE
Confidence 68999999999999999999987 7999999998543 233444556666666665 89999999997665 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999 6689888853 3456999999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.......||+.|+|||++.+ .++.++||||||+++|||++|..++..... ...+....
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~---------- 268 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY---------- 268 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC----------
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC----------
Confidence 22344569999999999876 789999999999999999999766543211 11111111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
........++.++.+++.+||+.||++|||+.|++++-
T Consensus 269 -~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 269 -LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 11223334567899999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=355.08 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=201.5
Q ss_pred hcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSRE-KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+++++++ +||||+++++++.. .+..++|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEE
Confidence 3578884 78999999999999965 7899999999766555567889999999995 79999999997665 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe---EEEcccccccccC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC---VKVADFGLSRLFP 434 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~---~kl~DFgla~~~~ 434 (625)
|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999963 346899999999999999999999999999999999999998776 9999999997653
Q ss_pred CCcc------ccccCCCCCCCccCcccccc-----CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccc--------h
Q 047969 435 LDVT------HVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN--------L 495 (625)
Q Consensus 435 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~--------~ 495 (625)
.... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11123469999999999864 458899999999999999999999997543221000 0
Q ss_pred hHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 496 ANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.......+...... ........++..+.+|+.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~i~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQEGKYE---------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHCCCC---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHhccCcc---------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 11111222221110 11222334567889999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.35 Aligned_cols=271 Identities=25% Similarity=0.351 Sum_probs=214.9
Q ss_pred ChHHHHHHhcCCCccceecccCcEEEEEEEE------cCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeee
Q 047969 273 SYSDLAEATNDFSREKELGDGGFGTVYYGKL------KDGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLF 344 (625)
Q Consensus 273 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~ 344 (625)
....+....++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444568999999999999999999984 25688999998654 334557789999999999 799999999
Q ss_pred eeeeeccceEEEEEEeccCCChHHHhccCccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 047969 345 GCTSRYSQGLLLVYEFVANGTVADQLHGDRAK------------HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTN 412 (625)
Q Consensus 345 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~ 412 (625)
+++.......++||||+++++|.+++...... ...+++..++.++.||++||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 98776566689999999999999999753321 223899999999999999999999999999999999
Q ss_pred CEEECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccc
Q 047969 413 NILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHR 490 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~ 490 (625)
|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999999999999999999865433222 1233457889999999988889999999999999999998 99999754322
Q ss_pred cccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 491 HEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. .....+........ . ..++..+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 258 ~------~~~~~~~~~~~~~~-----~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 258 E------EFCRRLKEGTRMRA-----P-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp H------HHHHHHHHTCCCCC-----C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHHhccCccCCC-----C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11111111111110 0 0134578889999999999999999999999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.59 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=198.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.+.||+|+||.||+|+.. ++.||||++.... ..+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcC
Confidence 57899999999999999999985 7899999986543 45779999999999999999999996553 368999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcccCCCCCCEEECCCCe-EEEcccccccccCCCc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA---SDIIHRDVKTNNILLDSNFC-VKVADFGLSRLFPLDV 437 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~ivHrDikp~NIll~~~~~-~kl~DFgla~~~~~~~ 437 (625)
++++|.+++.... ....+++..++.++.||++||+|||+ +||+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999996432 22357899999999999999999999 89999999999999988876 799999999754322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... . .....+........
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~-~~~~~~~~~~~~~~------ 225 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----F-RIMWAVHNGTRPPL------ 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----H-HHHHHHHTTCCCCC------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----H-HHHHHHhcCCCCCc------
Confidence 223458999999999998899999999999999999999999997533211 0 01111111111111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus 226 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 226 ------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp ------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred ------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 012345788999999999999999999999999988754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=355.83 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=198.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc---e
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ---G 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 353 (625)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999975 7899999998654 33455778999999999999999999996654322 3
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+++++|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 599999999999999996 3346999999999999999999999999999999999999999999999999999865
Q ss_pred CCCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~--- 237 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI--- 237 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC---
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC---
Confidence 433222 1233568999999999998889999999999999999999999997543211 11111111100
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHhchh
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL-AELQRIK 560 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell-~~L~~i~ 560 (625)
........++..+.+++.+||+.||++||++.+++ +.|..+.
T Consensus 238 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00111123566888999999999999999665554 5555443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=349.74 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=206.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
..+|++.+.||+|+||+||+|++.+ ...||+|.+... .....+.+.+|+.++++++||||+++++++.......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3578899999999999999998652 235899998653 44556789999999999999999999997666667789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999963 345689999999999999999999999999999999999999999999999999987643
Q ss_pred Cccc---cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 436 DVTH---VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 436 ~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||....... ... .+......
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~----~~~~~~~~-- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRRL-- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH----HHHTTCCC--
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhcCCCC--
Confidence 3221 1233467889999999988889999999999999999999 667775443221 111 11111100
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
..+ ..++..+.+++.+||+.+|++|||++|+++.|+.+...
T Consensus 252 ~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 LQP----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCC----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 11345788999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.73 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=205.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++++.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.. ...+++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEE
Confidence 468999999999999999999987 789999999865422 245678899999999999999999996655 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999996 3346999999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....||+.|+|||++.+..++.++||||||+++|+|++|++||...... .....+......
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~------- 256 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVR------- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCCCC-------
Confidence 23456899999999999888999999999999999999999999754321 112222222111
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L 556 (625)
.. ..++..+.++|.+||+.||++||+ ++++++|-
T Consensus 257 -~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 257 -FP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -CC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -CC-----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 00 123557889999999999999998 88888764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=345.53 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=206.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---------
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR--------- 349 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 349 (625)
..++|++.+.||+|+||.||+|++. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4568999999999999999999987 79999999986554 346789999999999999999996543
Q ss_pred ------ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEE
Q 047969 350 ------YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVK 423 (625)
Q Consensus 350 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~k 423 (625)
.....++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 234579999999999999999643 335699999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 424 VADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 424 l~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+.... .....+
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~ 231 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFTDL 231 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHHHH
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHHHh
Confidence 99999998764332 2234568999999999988889999999999999999999998874211 111112
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCC
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~ 564 (625)
....... .++..+.+++.+||+.||++|||+.|++++|+.++....
T Consensus 232 ~~~~~~~---------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 232 RDGIISD---------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HTTCCCT---------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hcccccc---------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 2211111 133467889999999999999999999999998876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=371.82 Aligned_cols=264 Identities=19% Similarity=0.246 Sum_probs=208.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.++||+|+||.||+|++. +++.||||++..... .+++.+|+++++.++|++.+..+..+.......+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999975 789999998754432 24578999999999886555555545555777899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEcccccccccCCC
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~~~~ 436 (625)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 8999999963 24469999999999999999999999999999999999999 68899999999999876543
Q ss_pred cccc------ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 437 VTHV------STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 437 ~~~~------~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
.... .....||+.|+|||++.+..++.++||||||++||||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-- 237 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-- 237 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH--
Confidence 3211 22567999999999999989999999999999999999999999765433222222222111111111
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
......++.++.+|+.+||+.+|++||++.+|++.|+.+...
T Consensus 238 ----------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 238 ----------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111234466889999999999999999999999999887553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.74 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=191.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEE
Confidence 4578999999999999999999987 68899999986543 34668899999999999999999997655 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~~~~~ 435 (625)
||+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999985 3456899999999999999999999999999999999999975 88999999999986533
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .....+....... ..
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~~-~~-- 272 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYYF-IS-- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCCC-CT--
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCcc-CC--
Confidence 2 12234568999999999998889999999999999999999999996543221 1122222221110 00
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+....++..+.+|+.+||+.||++|||+.|++++-
T Consensus 273 ------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 273 ------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp ------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred ------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11123456788999999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=362.10 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=204.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 354 (625)
..++|++++.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|..+++.+ +||||+++++++.. .+.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEE
Confidence 3578999999999999999999987 57899999986542 23456788999999988 79999999996655 6789
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||++||+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999996 33469999999999999999999999999999999999999999999999999998643
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.. ........||+.|+|||++.+..++.++||||||+++|||++|++||...... .....+......
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~----- 239 (353)
T 2i0e_A 173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNVA----- 239 (353)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-----
T ss_pred cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhCCCC-----
Confidence 22 12234567999999999999889999999999999999999999999754321 112222221111
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~L 556 (625)
.. ..++.++.+||.+||+.||++||+ ++++++|-
T Consensus 240 ---~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 240 ---YP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp ---CC-----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred ---CC-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 00 124567889999999999999995 57777763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=350.60 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=200.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEE
Confidence 468999999999999999999976 78999999986543 2345788999999999999999999997654 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~~~ 435 (625)
||+++|+|.+++.........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999999997655556779999999999999999999999999999999999999 4568899999999986543
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|+.||....... ...........
T Consensus 180 ~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~------ 243 (285)
T 3is5_A 180 DE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQKATYKEPN------ 243 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred cc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHhhhccCCcc------
Confidence 22 224456899999999886 468899999999999999999999997543211 11111111000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... ....++..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 244 YAV----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccc----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 001134577889999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.05 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=198.8
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+++|++++||||+++++++.. .+..+|||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCc
Confidence 568999999999999976 789999999987766677889999999999999999999997665 667899999999999
Q ss_pred hHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE--CCCCeEEEcccccccccCCCccccccC
Q 047969 366 VADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL--DSNFCVKVADFGLSRLFPLDVTHVSTA 443 (625)
Q Consensus 366 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll--~~~~~~kl~DFgla~~~~~~~~~~~~~ 443 (625)
|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||+ +.++.+||+|||+++...... ....
T Consensus 173 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 247 (373)
T 2x4f_A 173 LFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV 247 (373)
T ss_dssp EHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence 9998853 23458999999999999999999999999999999999999 677899999999998764332 2234
Q ss_pred CCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHH
Q 047969 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEE 523 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (625)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+....... ....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~~---------~~~~ 311 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------TLNNILACRWDL---------EDEE 311 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCCS---------CSGG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCCC---------Chhh
Confidence 569999999999988889999999999999999999999997543221 111221111100 0111
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 524 VKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 524 ~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...++.++.+||.+||+.||++|||+.|++++-
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 223456889999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=351.59 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=210.2
Q ss_pred hcCCCccceecccCcEEEEEEEE------cCCcEEEEEEecccc-HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL------KDGREVAVKRLYDNN-YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.. .+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-CC
Confidence 46899999999999999999985 256789999986543 34567899999999999 99999999997655 56
Q ss_pred eEEEEEEeccCCChHHHhccCcc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
..++||||+++|+|.+++..... ....+++..++.++.||++||.|||++||+||||||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 78999999999999999975321 1235899999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---- 256 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH----
Confidence 9999999999998765433221 233457889999999988889999999999999999998 9999975432211
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+... ...... ..++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 257 --~~~~~~~~-~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 --FYKMIKEG-FRMLSP-----------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp --HHHHHHHT-CCCCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHhccC-CCCCCc-----------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11111111 110000 1234578899999999999999999999999998765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=372.52 Aligned_cols=271 Identities=23% Similarity=0.300 Sum_probs=188.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec----cce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY----SQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~ 353 (625)
.++|++.+.||+|+||+||+|++. +++.||||++... .....+++.+|+++|++++|||||++++++... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999876 7899999998543 345567899999999999999999999976432 256
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
+++||||+. ++|.+++. ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 132 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999984 68988885 3456999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcc--------------------------ccccCCCCCCCccCcccc-ccCCCCCchhhhhHHHHHHHHHh-------
Q 047969 434 PLDVT--------------------------HVSTAPQGTPGYVDPEYH-QCYQLTDKSDVYSFGVVLIELIS------- 479 (625)
Q Consensus 434 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwslG~il~ellt------- 479 (625)
..... .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 42211 112345789999999976 55679999999999999999998
Q ss_pred ----CCCCCccccccc---------c--------cchhHHHHHHhhhccc-----------c---cccCCcCCCCChHHH
Q 047969 480 ----SMPAVDMNRHRH---------E--------INLANLAINKIQKCAF-----------D---ELIDPCLGFESDEEV 524 (625)
Q Consensus 480 ----G~~p~~~~~~~~---------~--------~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~~ 524 (625)
|+++|....... . ......+...+..... . ...............
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 566664432100 0 0000000000000000 0 000000000111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 525 KRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 525 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...+.++.+||.+||+.||++|||++|+++|-
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 23356788999999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.35 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=199.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeE
Confidence 34579999999999999999999986 7889999998654 23345778999999999999999999997665 6678
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++++|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999996 33468999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
...........|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+... ....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~~~~--- 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQA-IPRP--- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSC-CCCG---
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccC-CCCc---
Confidence 43333334557999999999998888999999999999999999999999754321 111111111 1000
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhchhcC
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKSG 562 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~i~~~ 562 (625)
......++..+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 255 ------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 ------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 001113445788899999999999999 999999999877543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.87 Aligned_cols=267 Identities=18% Similarity=0.234 Sum_probs=199.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeccccHH-----------HHHHHHHHHHHHHhcCCCCeeeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNNYR-----------RVEQFMNEVEILTRLRHKNLVSLFG 345 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 345 (625)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ..+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999976 5778999998654321 1134678899999999999999999
Q ss_pred eeeec---cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC--
Q 047969 346 CTSRY---SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-- 420 (625)
Q Consensus 346 ~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-- 420 (625)
++... ....++||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 66542 56789999999 9999999963 23699999999999999999999999999999999999998877
Q ss_pred eEEEcccccccccCCCccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccc
Q 047969 421 CVKVADFGLSRLFPLDVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN 494 (625)
Q Consensus 421 ~~kl~DFgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~ 494 (625)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA- 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence 9999999999876432211 113457999999999999888999999999999999999999999643221110
Q ss_pred hhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 495 LANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.......... .+...+..... ...++.++.+++.+||+.+|++|||+++|++.|+.+.-
T Consensus 270 -~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 -VQTAKTNLLD-ELPQSVLKWAP------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHH-TTTHHHHHHSC------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHhhcc-cccHHHHhhcc------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111 01100000000 00345588999999999999999999999999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.04 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=207.2
Q ss_pred cCC-CccceecccCcEEEEEEEEc-----CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cce
Q 047969 282 NDF-SREKELGDGGFGTVYYGKLK-----DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQG 353 (625)
Q Consensus 282 ~~~-~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~ 353 (625)
++| ++++.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 99999999999999988643 68899999996543 34567899999999999999999999977654 456
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 8999999999999999953 24899999999999999999999999999999999999999999999999999876
Q ss_pred CCCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc----ccchhH----HHHHHh
Q 047969 434 PLDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH----EINLAN----LAINKI 503 (625)
Q Consensus 434 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~----~~~~~~----~~~~~~ 503 (625)
...... ......+|..|+|||++.+..++.++||||||+++|+|++|..||....... ...... .....+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 543221 2234568889999999988889999999999999999999999986432110 000000 001111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...... .. ...++..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 265 ~~~~~~---------~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ERGERL---------PR---PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HTTCCC---------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCC---------CC---CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111000 00 11245678899999999999999999999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=353.05 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=207.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR------RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.. ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCE
Confidence 468999999999999999999987 6899999998654221 35778999999999999999999996655 677
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC----eEEEccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGL 429 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~----~~kl~DFgl 429 (625)
.++||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 899999999999999996 345689999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.....
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~- 235 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVSY- 235 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC-
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc-
Confidence 98764322 2234569999999999998889999999999999999999999996543211 1111111110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.........++..+.+++.+||+.||++|||+.|++++-
T Consensus 236 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 236 --------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp --------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred --------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 011222334566789999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.54 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=202.0
Q ss_pred HHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc--CCCCeeeeeeeeeecc---ce
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL--RHKNLVSLFGCTSRYS---QG 353 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~---~~ 353 (625)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++..+ +||||+++++++.... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34579999999999999999999986 8999999986443 23445566666554 8999999999766532 56
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCCEEECCCCeEEEc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS--------DIIHRDVKTNNILLDSNFCVKVA 425 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~ivHrDikp~NIll~~~~~~kl~ 425 (625)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 8999999999999999952 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCcccc---ccCCCCCCCccCccccccCCCCCc------hhhhhHHHHHHHHHhC----------CCCCcc
Q 047969 426 DFGLSRLFPLDVTHV---STAPQGTPGYVDPEYHQCYQLTDK------SDVYSFGVVLIELISS----------MPAVDM 486 (625)
Q Consensus 426 DFgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------sDvwslG~il~elltG----------~~p~~~ 486 (625)
|||+++......... .....||+.|+|||++.+.....+ +||||||+++|||++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998664332221 134579999999999987666655 9999999999999999 555543
Q ss_pred cccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 487 NRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
....... .......+.... ..+. .........++..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 265 ~~~~~~~--~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPS--YEDMREIVCIKK----LRPS--FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCC--HHHHHHHHTTSC----CCCC--CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCc--hhhhHHHHhhhc----cCcc--ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 2221111 111111111110 1111 1111112256778999999999999999999999999999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=346.96 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=201.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CC-------cEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DG-------REVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||+||+|+.. ++ +.||+|++........+.+.+|+.++++++||||+++++++.. .+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CC
Confidence 368999999999999999999866 33 5799999977666677889999999999999999999997665 56
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe--------EEE
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC--------VKV 424 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~--------~kl 424 (625)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 679999999999999999642 234899999999999999999999999999999999999988877 999
Q ss_pred cccccccccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHHHHHH
Q 047969 425 ADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++| .+|+....... .....
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFY 231 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHHHh
Confidence 999998754322 12236889999999877 6789999999999999999995 55554322111 00000
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
........ ..+..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 232 ~~~~~~~~---------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQLPA---------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCCCC---------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCCCC---------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000000 012357789999999999999999999999998875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.21 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=206.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEE
Confidence 478999999999999999999976 6899999998543 34456778999999999999999999997654 6678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe---EEEcccccccccC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC---VKVADFGLSRLFP 434 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~---~kl~DFgla~~~~ 434 (625)
|||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++....
T Consensus 84 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999998885 3356899999999999999999999999999999999999976655 9999999998654
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+....... .
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~-~-- 227 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-P-- 227 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-C--
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC-C--
Confidence 322 2234569999999999998889999999999999999999999996543211 111112111110 0
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
......++.++.+++.+||+.||++|||+.|++++-.
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 228 ------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp ------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred ------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 0011234557889999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=366.07 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=196.9
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--------HHHHHHHHHHHHHHhcCCCCeeeeeeeeee
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--------RRVEQFMNEVEILTRLRHKNLVSLFGCTSR 349 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 349 (625)
...++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999976 689999999864321 12235789999999999999999999764
Q ss_pred ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC---CeEEEcc
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN---FCVKVAD 426 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~---~~~kl~D 426 (625)
.+..++||||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence 345799999999999999885 44569999999999999999999999999999999999999754 4599999
Q ss_pred cccccccCCCccccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 427 FGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 427 Fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|++||........ ... .+
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~----~i 357 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----QI 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----HH
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----HH
Confidence 9999875432 22344579999999998853 5678899999999999999999999975433221 111 11
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...... ...+....++..+.+|+.+||+.||++|||+.|+++|-
T Consensus 358 ~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 358 TSGKYN---------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HTTCCC---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcCCCC---------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 111110 11223344567889999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=355.82 Aligned_cols=261 Identities=24% Similarity=0.386 Sum_probs=209.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc--------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 478999999999999999999863 4678999998654 344567899999999999 89999999997655
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
.+..++||||+++|+|.+++..... ....+++..++.++.||++||+|||++||+||||||+|||++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 5678999999999999999975332 1235899999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 267 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 267 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-----
Confidence 999999999999876433221 2234467889999999988889999999999999999999 999997543211
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+........ . ..++..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 268 --~~~~~~~~~~~~~-----~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 --LFKLLKEGHRMDK-----P-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp --HHHHHHHTCCCCC-----C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHhcCCCCCC-----C-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111221111110 0 1234578889999999999999999999999998865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=381.38 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=211.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
..++|++.++||+|+||.||+|++.++..||||++..... ..+.|++|+++|++++||||+++++++.. +..+||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeee
Confidence 3568999999999999999999998888899999975532 34679999999999999999999997654 56899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++|+|.+++... ....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 99999999999632 2345899999999999999999999999999999999999999999999999999876433222
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......++..|+|||++....++.++||||||++||||++ |+.||....... ....+....... .
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~-------~ 485 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMP-------C 485 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCCCC-------C
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-------C
Confidence 2234457889999999988889999999999999999999 999997543211 112222211000 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+||.+||+.||++|||+++|++.|+.+...
T Consensus 486 -----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 486 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 012345788999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=356.97 Aligned_cols=264 Identities=26% Similarity=0.347 Sum_probs=206.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-S 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-C
Confidence 3578999999999999999999862 4568999998654 233457789999999999 89999999997665 5
Q ss_pred ceEEEEEEeccCCChHHHhccCccc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAK-------------------HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTN 412 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~ 412 (625)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 6789999999999999999753211 134899999999999999999999999999999999
Q ss_pred CEEECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccc
Q 047969 413 NILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHR 490 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~ 490 (625)
|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999999999865433221 1233457889999999988889999999999999999998 99999754322
Q ss_pred cccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 491 HEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.. ....+....... .. ..++..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 282 ~~------~~~~~~~~~~~~-----~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 AN------FYKLIQNGFKMD-----QP-------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HH------HHHHHHTTCCCC-----CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HH------HHHHHhcCCCCC-----CC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 111111111000 00 12345788899999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=345.81 Aligned_cols=249 Identities=31% Similarity=0.463 Sum_probs=201.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEE
Confidence 578999999999999999999877 678999999854422 224678899999999999999999997655 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999985 3346899999999999999999999999999999999999999999999999998654322
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+...... .
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~ 226 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFT------F 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC------C
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCCCC------C
Confidence 2234568999999999998889999999999999999999999997543211 11111111110 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ..++..+.+|+.+||+.+|++|||++|++++-.
T Consensus 227 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 227 P-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp C-------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred C-------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 0 113457788999999999999999999999854
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=345.53 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=209.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeee-eccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTS-RYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++. ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999987 7899999998643 3445678999999999999999999999654 34567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCCEEECCCCeEEEccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-----IIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
||||+++++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999765445566999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.......+
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRI 236 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhcccccC
Confidence 7543221 112335899999999998888999999999999999999999999754321 11222222222111
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
. ..++.++.+++.+||+.+|++|||+.|+++++...
T Consensus 237 ~------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 237 P------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp C------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred C------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 0 12345788999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.70 Aligned_cols=279 Identities=21% Similarity=0.262 Sum_probs=213.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-ceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-QGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv 357 (625)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ...++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 368999999999999999999987 58999999986543 234577889999999999999999999765533 367999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE----CCCCeEEEccccccccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL----DSNFCVKVADFGLSRLF 433 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll----~~~~~~kl~DFgla~~~ 433 (625)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999996432 23349999999999999999999999999999999999999 88889999999999876
Q ss_pred CCCccccccCCCCCCCccCcccccc--------CCCCCchhhhhHHHHHHHHHhCCCCCccccccccc-chhHHHHHHhh
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQC--------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI-NLANLAINKIQ 504 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~-~~~~~~~~~~~ 504 (625)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ...........
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 4332 2234569999999998864 45778999999999999999999999754322111 11111111111
Q ss_pred hcccccccC---------CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 505 KCAFDELID---------PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 505 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
......+.. ..+. ........++..+.+++.+||+.||++||+++++++.++.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 111100000 0000 001112456778899999999999999999999999999887653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.31 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=204.2
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-----CCCeeeeeeeeeecc
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-----HKNLVSLFGCTSRYS 351 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~ 351 (625)
....++|++.++||+|+||+||+|++. +++.||||++... ....+.+..|+.+++.++ ||||+++++++.. .
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-~ 108 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-Y 108 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-T
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-C
Confidence 344679999999999999999999985 7899999998643 344567788999999997 9999999997665 5
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-------------
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS------------- 418 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~------------- 418 (625)
...++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred CeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 6789999999 89999999643 2345899999999999999999999999999999999999975
Q ss_pred ------------CCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcc
Q 047969 419 ------------NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDM 486 (625)
Q Consensus 419 ------------~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~ 486 (625)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999864322 2345789999999999998999999999999999999999999976
Q ss_pred cccccccchhHHHHH--------HhhhcccccccC-C----cCCC--CChHHH-----------HHHHHHHHHHHHHhcc
Q 047969 487 NRHRHEINLANLAIN--------KIQKCAFDELID-P----CLGF--ESDEEV-----------KRMTTSVAELAFLCLQ 540 (625)
Q Consensus 487 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~----~~~~--~~~~~~-----------~~~~~~l~~li~~cl~ 540 (625)
............... ...........+ . .... ...... ......+.+|+.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 543221111111000 000000000000 0 0000 000000 0112567899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 047969 541 QNKELRPSMEEVLAE 555 (625)
Q Consensus 541 ~~P~~RPs~~ell~~ 555 (625)
.||++|||+.|++++
T Consensus 342 ~dP~~Rpta~elL~h 356 (360)
T 3llt_A 342 IDPTLRPSPAELLKH 356 (360)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=339.99 Aligned_cols=254 Identities=18% Similarity=0.353 Sum_probs=204.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv 357 (625)
.++|++.+.||+|+||.||+|+++ ++.||||++... .....+.+.+|+.++++++||||+++++++... ....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 368999999999999999999985 899999998654 345567899999999999999999999976553 3567999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|.|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999642 2335899999999999999999999999 99999999999999999999999888754221
Q ss_pred CccccccCCCCCCCccCccccccCCCCC---chhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTD---KSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
....||+.|+|||++.+..++. ++||||||+++|+|++|+.||....... ......... ..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~--- 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG-LR--- 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC-CC---
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC-CC---
Confidence 2345899999999987655444 7999999999999999999997543211 111111111 10
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
+... ..++..+.+++.+||+.||++|||++++++.|+.+++
T Consensus 230 -~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 -PTIP-------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1010 1235578899999999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=374.47 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=195.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.+++.++||||+++++++.. .+.++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEE
Confidence 468999999999999999999976 7899999998653 23345678899999999999999999997665 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++....
T Consensus 226 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999985 33569999999999999999999998 9999999999999999999999999999986432
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+......
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~------ 367 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEIR------ 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCCC------
Confidence 22 22345679999999999998899999999999999999999999996543211 11111111110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
+ . ..++.++.+||.+||+.||++|| +++|+++|-
T Consensus 368 ~--p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 368 F--P-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp C--C-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred C--C-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 0 0 12345788999999999999999 999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.31 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=196.6
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCC--CCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRH--KNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.+|++++| +||+++++++.. ....+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEE
Confidence 3579999999999999999999988999999998543 34556789999999999986 999999996665 678899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||| +.+++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 87 v~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEC-CCSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEe-CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999 56789999996 345699999999999999999999999999999999999997 678999999999876433
Q ss_pred ccc-cccCCCCCCCccCcccccc-----------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh
Q 047969 437 VTH-VSTAPQGTPGYVDPEYHQC-----------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 437 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .... ..+.
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~-~~~~ 234 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL-HAII 234 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH-HHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHH-HHHh
Confidence 222 2234579999999999864 56888999999999999999999999643221 1111 1111
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
..... ..... ..+..+.+|+.+||+.||++|||+.|++++..-
T Consensus 235 ~~~~~----~~~~~-------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 235 DPNHE----IEFPD-------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp CTTSC----CCCCC-------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCcc----cCCcc-------cCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 11000 00000 112467889999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.63 Aligned_cols=252 Identities=29% Similarity=0.419 Sum_probs=202.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+.|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEE
Confidence 56999999999999999999975 7899999998643 23445778999999999999999999997765 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+. |+|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 99997 578887742 345699999999999999999999999999999999999999999999999999986532
Q ss_pred cccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.....||+.|+|||++. ...++.++||||||+++|||++|++||....... .. ..+..........
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~-~~~~~~~~~~~~~- 275 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL-YHIAQNESPALQS- 275 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHSCCCCCCC-
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HH-HHHHhcCCCCCCC-
Confidence 23456999999999884 4578999999999999999999999996543211 11 1111111111100
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
..++..+.+|+.+||+.+|++|||+++++++..-...
T Consensus 276 ----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 276 ----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ----------CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 1234578889999999999999999999988665443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=356.90 Aligned_cols=270 Identities=21% Similarity=0.318 Sum_probs=197.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|++.+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.. .+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEec
Confidence 58999999999999999999987 7899999998644322 12245689999999999999999997655 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++ +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 81 YLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 9974 88888853 34469999999999999999999999999999999999999999999999999998653322 2
Q ss_pred cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC-----
Q 047969 440 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID----- 513 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 513 (625)
......||+.|+|||++.+ ..++.++||||||+++|+|++|++||.......................+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2234568999999999876 5689999999999999999999999976543221111111100000000000000
Q ss_pred ----CcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 ----PCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ----~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+.. ..........++..+.+|+.+||+.||++|||++|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 000 00001112235667889999999999999999999999743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.37 Aligned_cols=258 Identities=24% Similarity=0.289 Sum_probs=195.7
Q ss_pred hcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHH-hcCCCCeeeeeeeeee---ccceE
Q 047969 281 TNDFSRE-KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILT-RLRHKNLVSLFGCTSR---YSQGL 354 (625)
Q Consensus 281 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~---~~~~~ 354 (625)
.++|.+. +.||+|+||+||+|+++ +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4577776 68999999999999987 7899999998643 34668888874 4589999999996643 24568
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSR 431 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~ 431 (625)
+|||||++||+|.+++... ....+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999999642 2346999999999999999999999999999999999999987 7899999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ....+....+. +
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~-~ 286 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYE-F 286 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCC-C
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCccc-C
Confidence 65422 222455789999999999888999999999999999999999999976543221111 11111111111 0
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
. ......++.++.+||.+||+.||++|||+.|++++-.-.
T Consensus 287 ~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 287 P--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp C--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred C--------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 0 001123456788999999999999999999999986543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.46 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=208.1
Q ss_pred cCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREK-ELGDGGFGTVYYGKLK---DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|.+.+ .||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++. .+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEE
Confidence 4666766 9999999999999854 5788999999764 3455678999999999999999999999763 456899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.. ....+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999953 3456999999999999999999999999999999999999999999999999999876433
Q ss_pred cccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 437 VTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 437 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+........
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~~~-- 234 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC-- 234 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCC--
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcCCC--
Confidence 3221 233457899999999988889999999999999999998 999997543211 1111221111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. ..++..+.+++.+||+.+|++||++.+++++|+.+..
T Consensus 235 ---~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 235 ---P-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---C-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---C-------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 1245578899999999999999999999999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.22 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=207.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.. ...+++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEE
Confidence 467999999999999999999986 799999999865422 234668899999999999999999996655 678999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998642 2335999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. ......||+.|+|||++.+..++.++||||||+++|||++|++||......... ......+..... . .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~-~-----~ 408 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPE-E-----Y 408 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCC-C-----C
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcccc-c-----C
Confidence 2 223457999999999999888999999999999999999999999765432111 111111111110 0 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAEL 556 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L 556 (625)
. ..++.++.+||.+||+.||++|| +++|+++|-
T Consensus 409 p-------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 409 S-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred C-------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 0 12456788999999999999999 789998873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=361.63 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=198.7
Q ss_pred CCCccceecccCcEEEEEEEEc--CC--cEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK--DG--REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.|++.+.||+|+||.||+|+.. ++ ..||||.+... .....+.|.+|+.++++++||||+++++++....+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5777889999999999999864 22 36899988543 3456688999999999999999999999766656678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999963 34468999999999999999999999999999999999999999999999999998653322
Q ss_pred cc---cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 438 TH---VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 438 ~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||....... ... .+...... ..
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~----~~~~~~~~--~~ 317 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRRL--LQ 317 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH----HHHTTCCC--CC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH----HHHcCCCC--CC
Confidence 11 1233457889999999998899999999999999999999 788886543322 111 11111100 00
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
+ ..++..+.+++.+||+.+|++|||+.|++++|+.+....
T Consensus 318 p----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 318 P----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp C----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 123457889999999999999999999999999987644
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=359.30 Aligned_cols=265 Identities=15% Similarity=0.214 Sum_probs=206.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcC---------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeee---------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD---------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS--------- 342 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 342 (625)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999763 788999998654 35789999999999999987
Q ss_pred ------eeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 047969 343 ------LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL 416 (625)
Q Consensus 343 ------~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll 416 (625)
+++++.......++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 4555555467889999999 99999999743 23569999999999999999999999999999999999999
Q ss_pred CCCC--eEEEcccccccccCCCccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccc
Q 047969 417 DSNF--CVKVADFGLSRLFPLDVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNR 488 (625)
Q Consensus 417 ~~~~--~~kl~DFgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~ 488 (625)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999876432211 1133479999999999998889999999999999999999999997653
Q ss_pred cccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 489 HRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
..... .. .....+ ......+...... ...++..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 273 ~~~~~-~~-~~~~~~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 273 PNTED-IM-KQKQKF-VDKPGPFVGPCGH------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TCHHH-HH-HHHHHH-HHSCCCEECTTSC------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCHHH-HH-HHHHhc-cCChhhhhhhccc------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 21111 11 111111 1111111111100 012345788999999999999999999999999988754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=359.49 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=197.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-----c
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-----Q 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 352 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+++|+.++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999986 7999999998543 3345677899999999999999999999765432 3
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 7899999853 4589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH--------HHh
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI--------NKI 503 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~--------~~~ 503 (625)
.... .....+|+.|+|||++.+ ..++.++||||||+++|||++|++||................ ..+
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5322 234578999999999876 679999999999999999999999997654322111110000 000
Q ss_pred hhcccccc---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 504 QKCAFDEL---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 504 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
........ +...............+..+.+|+.+||+.||++|||+.|+++|-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 00000000 000000000111123456788999999999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=358.82 Aligned_cols=257 Identities=26% Similarity=0.319 Sum_probs=203.5
Q ss_pred hcCCCccceecccCcEEEEEEEE----cCCcEEEEEEecccc----HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL----KDGREVAVKRLYDNN----YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++|+++ +||||+++++++.. .
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-E 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-T
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-C
Confidence 36899999999999999999997 368999999986432 12345677899999999 69999999996655 5
Q ss_pred ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
...+|||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 678999999999999999963 3468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
..............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... ......+.....
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~- 283 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP- 283 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HHHHHHHhccCC-
Confidence 764433333344579999999999875 35789999999999999999999999754332211 111111111110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHhc
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAELQR 558 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L~~ 558 (625)
. .. ..++..+.+||.+||+.||++|| +++|++++..-
T Consensus 284 ~-----~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 284 P-----YP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp C-----CC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred C-----CC-------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 0 00 12345788899999999999999 99999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=370.29 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=207.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+++ +|+.||||++.+... ...+.+.+|+.+|++++||||+++++++.. ...+++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEE
Confidence 368999999999999999999986 799999999865432 234678899999999999999999996655 677999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||+|.+++.........+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999999755444567999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.. ......||+.|+|||++.+..++.++||||||+++|||++|++||........ .......+......
T Consensus 343 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~~~~------- 411 (543)
T 3c4z_A 343 QT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQAVT------- 411 (543)
T ss_dssp CC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHCCCC-------
T ss_pred Cc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhcccC-------
Confidence 22 22345799999999999988999999999999999999999999976532211 11112222221110
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSM-----EEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~~ 555 (625)
.. ..++..+.+||.+||+.||++||++ +++++|
T Consensus 412 -~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 -YP-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -CC-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -CC-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 00 1245678899999999999999965 667665
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.39 Aligned_cols=271 Identities=22% Similarity=0.287 Sum_probs=199.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----ce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----QG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 353 (625)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+++.+|+++|++++||||+++++++.... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 6889999998653 3445678999999999999999999999765533 56
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999986 59999985 3456999999999999999999999999999999999999999999999999999876
Q ss_pred CCCccc---------------------cccCCCCCCCccCcccc-ccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc
Q 047969 434 PLDVTH---------------------VSTAPQGTPGYVDPEYH-QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH 491 (625)
Q Consensus 434 ~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~ 491 (625)
...... ......||+.|+|||++ ....++.++|||||||++|||++|..|+.......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 432211 12456799999999986 55679999999999999999998554443211000
Q ss_pred c-------------------------cchhHHHHHHhhhccc-----------ccc---cCCcCCCCChHHHHHHHHHHH
Q 047969 492 E-------------------------INLANLAINKIQKCAF-----------DEL---IDPCLGFESDEEVKRMTTSVA 532 (625)
Q Consensus 492 ~-------------------------~~~~~~~~~~~~~~~~-----------~~~---~~~~~~~~~~~~~~~~~~~l~ 532 (625)
. ..........+..... ... ...............++.++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 0 0000000000000000 000 000001111112234567889
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 047969 533 ELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 533 ~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+|+.+||+.||++|||++|+++|-
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp 363 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHP 363 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCG
T ss_pred HHHHHHhcCCcccCCCHHHHhcCh
Confidence 999999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=356.44 Aligned_cols=269 Identities=20% Similarity=0.292 Sum_probs=195.5
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
....++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEE
Confidence 345679999999999999999999876 789999999865432 234567899999999999999999997665 6778
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE-----CCCCeEEEccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL-----DSNFCVKVADFGL 429 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll-----~~~~~~kl~DFgl 429 (625)
++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 109 ~lv~e~~~~-~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEEECCSE-EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEEecCCC-CHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999999985 9999985 34469999999999999999999999999999999999999 4556699999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc--
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC-- 506 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 506 (625)
++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|.+||......... ..........
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL---FKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCT
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH---HHHHHHhCCCch
Confidence 987643222 22345689999999998764 4899999999999999999999999765432211 1111111000
Q ss_pred -cc------ccccCC--cCCCCCh--HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 -AF------DELIDP--CLGFESD--EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 -~~------~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.. ..+... ....... .....++.++.+|+.+||+.||++|||++|+++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 000000 0000000 01112456888999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.06 Aligned_cols=266 Identities=25% Similarity=0.390 Sum_probs=209.7
Q ss_pred hcCCCccceecccCcEEEEEEEE-----cCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-cceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-----KDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-SQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 354 (625)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35799999999999999999984 36889999999877666778899999999999999999999966543 3467
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++++|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 999999999999999963 23458999999999999999999999999999999999999999999999999998765
Q ss_pred CCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccc--------c-cchhHHHHHHh
Q 047969 435 LDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH--------E-INLANLAINKI 503 (625)
Q Consensus 435 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~--------~-~~~~~~~~~~~ 503 (625)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..|+....... . ..........+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 43321 1233457888999999988888999999999999999999999886431100 0 00000011111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...... .. ...++.++.++|.+||+.+|++|||+.|+++.|+.++.
T Consensus 277 ~~~~~~-------~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNNGRL-------PR-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTTCCC-------CC-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCC-------CC-----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111000 00 01245578899999999999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=354.11 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=200.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcE----EEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGRE----VAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.++|++.+.||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STV 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--SSE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--CCc
Confidence 368999999999999999999975 4543 577776433 23456789999999999999999999997765 347
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 899999999999999963 34569999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 435 LDVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 435 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~~~~~- 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERLPQ- 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCCCC-
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCCCC-
Confidence 332221 233457889999999998899999999999999999999 9999976543221 111111110000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 241 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 241 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 012344788899999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.43 Aligned_cols=267 Identities=25% Similarity=0.398 Sum_probs=212.5
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeee
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCT 347 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 347 (625)
+++....++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344445678999999999999999999864 3678999998654 334556789999999999999999999966
Q ss_pred eeccceEEEEEEeccCCChHHHhccCcc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe
Q 047969 348 SRYSQGLLLVYEFVANGTVADQLHGDRA------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC 421 (625)
Q Consensus 348 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~ 421 (625)
.. ....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 98 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 98 SQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp CS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred cc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 55 5678999999999999999864321 1245799999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHH
Q 047969 422 VKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLA 499 (625)
Q Consensus 422 ~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 499 (625)
+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~ 249 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------V 249 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------H
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------H
Confidence 999999999865332211 1233457889999999988889999999999999999999 899996543211 1
Q ss_pred HHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 500 INKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+........ ...++..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 250 ~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGGLLDK------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCCcCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 112222111110 01234578899999999999999999999999988755
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.74 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=201.5
Q ss_pred cCCCccceecccCcEEEEEEEEcC-----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD-----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|++.+.||+|+||.||+|++.. +..||||++... .......+.+|+.++++++||||+++++++.. .+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcE
Confidence 578888999999999999998652 235999998654 33455678999999999999999999996654 56789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999963 345699999999999999999999999999999999999999999999999999987643
Q ss_pred Ccccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 436 DVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 436 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+.......
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~~~-- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRLP-- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCCC--
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCcCC--
Confidence 32211 122346789999999988889999999999999999999 99999654321 1111222111000
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
. ...++..+.+++.+||+.+|++||++.+++++|+.+...
T Consensus 271 -----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 -----T-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -----C-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----C-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 012345788999999999999999999999999988754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=358.14 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=203.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 357 (625)
..++|++.+.||+|+||.||+|+++ +|+.||||++..... ...+|++++.++ +||||+++++++.. ....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEE
Confidence 3568999999999999999999987 689999999865432 245788888888 79999999996654 6788999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC----CeEEEccccccccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN----FCVKVADFGLSRLF 433 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~----~~~kl~DFgla~~~ 433 (625)
|||++||+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 95 TELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp ECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999986 34569999999999999999999999999999999999998433 35999999999876
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||....... .......+....+.. .
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~~-~- 243 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFSL-S- 243 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCCC-C-
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCccc-C-
Confidence 43322 2344578999999999988778999999999999999999999997532211 112222233222211 0
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 558 (625)
......++.++.+|+.+||+.||++|||+.++++|-.-
T Consensus 244 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 244 -------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp -------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred -------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 00112345678899999999999999999999987554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=346.08 Aligned_cols=254 Identities=26% Similarity=0.467 Sum_probs=201.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++||||+++++++.......++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 468999999999999999999885 8899999986543 4567899999999999999999999766656678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999999999632 1223889999999999999999999999999999999999999999999999999754322
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+....... .
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-----~--- 235 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMD-----A--- 235 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCCC-----C---
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCC-----C---
Confidence 123357889999999988889999999999999999998 999997543221 111111111000 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 012355788999999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.43 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=206.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcE--EEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGRE--VAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|+.. +++. ||||++... .....+.+.+|+++++++ +||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEE
Confidence 58999999999999999999876 5664 499988643 233456789999999999 89999999997655 567899
Q ss_pred EEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 357 VYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
||||+++++|.+++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 999999999999997543 23357999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHh
Q 047969 425 ADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
+|||+++.... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+
T Consensus 184 ~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~ 254 (327)
T 1fvr_A 184 ADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKL 254 (327)
T ss_dssp CCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHG
T ss_pred cccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHHHh
Confidence 99999974321 112233457889999999988888999999999999999998 999996543211 11222
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCCCc
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSK 565 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~~~ 565 (625)
....... .. ..++..+.+++.+||+.+|++|||+.+++++|+.+......
T Consensus 255 ~~~~~~~-----~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 255 PQGYRLE-----KP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp GGTCCCC-----CC-------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred hcCCCCC-----CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 2111000 00 12345788999999999999999999999999998775543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=368.30 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=205.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence 368999999999999999999987 799999999865422 235678999999999999999999997655 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 94 VMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999995 3456999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||+..... .....+....+.. +
T Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~---p- 236 (476)
T 2y94_A 170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDGIFYT---P- 236 (476)
T ss_dssp --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTTCCCC---C-
T ss_pred --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCcCC---C-
Confidence 22345579999999999987765 67999999999999999999999754321 1122222221110 0
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..++.++.+|+.+||+.||++|||++|++++-
T Consensus 237 ---------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 237 ---------QYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp ---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred ---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 11345788999999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.79 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=200.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc----CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ- 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 352 (625)
..++|++.+.||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3568999999999999999999865 3457999998643 34556789999999999999999999997655332
Q ss_pred ---eEEEEEEeccCCChHHHhccCc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 353 ---GLLLVYEFVANGTVADQLHGDR--AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 353 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
..++||||+++++|.+++.... .....+++..++.++.||++||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999999999999985432 23456999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||........ . ..+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~----~~~~~ 264 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---Y----DYLLH 264 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHHT
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---H----HHHHc
Confidence 999865433221 1233457889999999988889999999999999999999 8999975433211 1 11111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...... ...++..+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 265 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 GHRLKQ------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TCCCCC------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111100 01234578899999999999999999999999998865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.18 Aligned_cols=272 Identities=23% Similarity=0.298 Sum_probs=199.7
Q ss_pred HHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHH-----HHHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 277 LAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYR-----RVEQFMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 277 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
+....++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH- 83 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-
Confidence 3445679999999999999999999976 6899999998643221 12467899999999999999999997655
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
....++||||+++ +|.+++.. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred CCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 5678999999986 88888853 3346889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
+...... .......||+.|+|||++.+. .++.++||||||+++|+|++|.+||........ ..............
T Consensus 160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEE 235 (346)
T ss_dssp STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChh
Confidence 8764322 223445789999999998654 588999999999999999999999976543211 11111111111000
Q ss_pred cccCC-----cC------CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 510 ELIDP-----CL------GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 510 ~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+.+. .. ..........++.++.+||.+||+.||++|||+.|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00000 00 00001112344568899999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.85 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=184.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
..++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEE
Confidence 3568999999999999999999975 799999999864422 224678999999999999999999997655 67789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+++++|.+++.. ....+++..++.++.||++||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999863 335689999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..+....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~-------- 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLAD-------- 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSC--------
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhcc--------
Confidence 222 123356899999999998888999999999999999999999999754322111 0100000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
... ...++.++.+++.+||+.||++|||+.+++++-
T Consensus 229 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 229 YEM-----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CCC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred cCC-----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 000 012345788999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=343.47 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=204.6
Q ss_pred CCCccceecccCcEEEEEEEEc-CC---cEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DG---REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.|+..+.||+|+||+||+|++. ++ ..||+|++... .....+.+.+|+.++++++||||+++++++.......++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999864 22 37999998653 3455678999999999999999999999777655556899
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+.+++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999963 34568999999999999999999999999999999999999999999999999998654322
Q ss_pred c---ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 438 T---HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 438 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
. .......+++.|+|||.+.+..++.++||||||+++|+|++| .+|+....... .. ..+........
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~----~~~~~~~~~~~-- 249 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LT----HFLAQGRRLPQ-- 249 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HH----HHHHTTCCCCC--
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HH----HHhhcCCCCCC--
Confidence 1 122345688999999999998999999999999999999995 55554332211 11 11111110000
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++..+.+++.+||+.+|++|||++++++.|+.+...
T Consensus 250 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 250 ----------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 012345788999999999999999999999999988754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.28 Aligned_cols=270 Identities=24% Similarity=0.383 Sum_probs=203.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEE
Confidence 468999999999999999999987 6899999998543 23345678899999999999999999997665 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 FEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999988864 34469999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH--------Hhhh-cc
Q 047969 438 THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN--------KIQK-CA 507 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~-~~ 507 (625)
.......||+.|+|||++.+. .++.++||||||+++|+|++|++||................. .... ..
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 222345689999999998765 689999999999999999999999976543222111110000 0000 00
Q ss_pred cccccCCcCCC--CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 508 FDELIDPCLGF--ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 508 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+.....+.... ........++..+.+|+.+||+.||++|||+.|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 01111111111 11112234567899999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.40 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=205.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc----ceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS----QGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 354 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999976 7889999998643 3345578899999999999999999999765432 468
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+.+ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~~-~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccCc-CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999999975 89998842 359999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccc--ccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc-
Q 047969 435 LDVTHV--STAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE- 510 (625)
Q Consensus 435 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 510 (625)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|++||..........................
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 332221 234579999999998654 4589999999999999999999999976543322211111000000000000
Q ss_pred -------c---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 511 -------L---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 511 -------~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ...............++..+.+|+.+||+.||++|||+.|++++-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0 0000000111112234567899999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=341.27 Aligned_cols=250 Identities=19% Similarity=0.332 Sum_probs=202.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 355 (625)
..++|++.+.||+|+||+||+|+.. +++.||||++... .......+.+|+.++..+ +||||+++++++.. .+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEE
Confidence 3578999999999999999999987 7999999998653 234456788999999999 99999999997665 66789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC----------------
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN---------------- 419 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~---------------- 419 (625)
+||||+++++|.+++.........+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999997554445679999999999999999999999999999999999999844
Q ss_pred ---CeEEEcccccccccCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccch
Q 047969 420 ---FCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL 495 (625)
Q Consensus 420 ---~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~ 495 (625)
..+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+++.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------ 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------
Confidence 47999999999875432 233589999999998765 566899999999999999999987643211
Q ss_pred hHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 496 ANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...+.......+. ..++..+.+++.+||+.||++|||+.|++++-.
T Consensus 237 ----~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 237 ----WHEIRQGRLPRIP------------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp ----HHHHHTTCCCCCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred ----HHHHHcCCCCCCC------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 1112222211110 123457889999999999999999999998743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.22 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=206.7
Q ss_pred cChHHHHHHhcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcC-CCCeeeeeee
Q 047969 272 FSYSDLAEATNDFSRE-KELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLR-HKNLVSLFGC 346 (625)
Q Consensus 272 ~~~~~~~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 346 (625)
..+.......++|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344455666788887 88999999999999987 68999999986532 223567899999999995 6999999997
Q ss_pred eeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEE
Q 047969 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVK 423 (625)
Q Consensus 347 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~k 423 (625)
+.. ....++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+|
T Consensus 98 ~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YEN-TSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EEC-SSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEe-CCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence 654 67789999999999999998532 3356999999999999999999999999999999999999987 78999
Q ss_pred EcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 424 VADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 424 l~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i 245 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------TYLNI 245 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHH
Confidence 99999998764322 2234569999999999998899999999999999999999999997543221 11111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....... ..+....++..+.+++.+||+.||++|||+++++++-.
T Consensus 246 ~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 246 SQVNVDY---------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHTCCCC---------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred Hhccccc---------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 1111100 01111234557889999999999999999999998743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.08 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=196.5
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcC--CCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLR--HKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~lv 357 (625)
.+|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.+|++++ ||||+++++++.. ...++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEE
Confidence 469999999999999999999888999999998543 3456678999999999996 5999999996655 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 568899999963 34689999999999999999999999999999999999995 5899999999998764332
Q ss_pred cc-cccCCCCCCCccCcccccc-----------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh
Q 047969 438 TH-VSTAPQGTPGYVDPEYHQC-----------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 438 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|++||...... ... ...+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~-~~~~~~ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK-LHAIID 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHH-HHHHHC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHH-HHHHhC
Confidence 22 2244579999999999865 36888999999999999999999999643221 111 111111
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.... ...... .+..+.+||.+||+.||++|||+.|++++..
T Consensus 283 ~~~~----~~~~~~-------~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 283 PNHE----IEFPDI-------PEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp TTSC----CCCCCC-------SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccc----CCCCcc-------chHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 1100 000000 1346788999999999999999999998854
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.42 Aligned_cols=257 Identities=27% Similarity=0.378 Sum_probs=191.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeee-------eccc
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTS-------RYSQ 352 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-------~~~~ 352 (625)
.+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 58999999999999999999976 78999999987777777788999999999996 999999999763 3345
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEECCCCeEEEcccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
..++||||+. |+|.+++.... ..+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5899999996 68988885422 3456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCcccc-----------ccCCCCCCCccCcccc---ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchh
Q 047969 431 RLFPLDVTHV-----------STAPQGTPGYVDPEYH---QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA 496 (625)
Q Consensus 431 ~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~ 496 (625)
+......... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---- 261 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI---- 261 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh----
Confidence 8764322111 1134589999999998 556788999999999999999999999964322110
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
....... +. . ...+..+.+|+.+||+.||++|||+.|++++|+.+...
T Consensus 262 -------~~~~~~~---~~-~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 -------VNGKYSI---PP-H-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------CCC---CT-T-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------hcCcccC---Cc-c-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000 00 0 01123577899999999999999999999999988653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.45 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=190.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHH-HHhcCCCCeeeeeeeeeeccceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEI-LTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
.++|++++.||+|+||.||+|+.+ +++.||||++.+.. ....+.+.+|..+ ++.++||||+++++++.. .+.++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEE
Confidence 468999999999999999999987 68899999986543 2334556777776 577899999999996655 67899
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||++||+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999986 334689999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.. .......||+.|+|||++.+..++.++|+||||+++|||++|.+||....... ....+......
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~------ 257 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPLQ------ 257 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSCCC------
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcccC------
Confidence 21 22344579999999999998899999999999999999999999997543211 11222221110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 551 (625)
.. ..++..+.+||.+||+.||++||++.+
T Consensus 258 --~~-----~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 --LK-----PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CC-----SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --CC-----CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 00 123457889999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=353.77 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=197.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-----c
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-----Q 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 352 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999976 7899999998643 3445677899999999999999999999765433 3
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 68999999975 7888774 2489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh---------
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI--------- 503 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~--------- 503 (625)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ......+
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHC-CCCCCHHHHT
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHHH
Confidence 5322 1223457899999999999888999999999999999999999999765432111 0000000
Q ss_pred ---------hhc-------ccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 504 ---------QKC-------AFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 504 ---------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
... .+.............+.....+..+.+|+.+||+.||++|||++|++++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000 000000000001112233455778999999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=341.85 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=205.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH------HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY------RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTD 82 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCe
Confidence 357999999999999999999987 789999999864421 135778999999999999999999997665 567
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC----eEEEccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGL 429 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~----~~kl~DFgl 429 (625)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 899999999999999995 334689999999999999999999999999999999999998877 899999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
+....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~- 228 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNY- 228 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhccc-
Confidence 98754322 2234568999999999988889999999999999999999999997543211 1111111110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhchh
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRIK 560 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~--L~~i~ 560 (625)
.........++..+.+++.+||+.||++|||+.+++++ ++.++
T Consensus 229 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 --------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 01122233456678899999999999999999999986 44444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.95 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=208.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CC-----cEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeecc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DG-----REVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYS 351 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 351 (625)
..++|++.+.||+|+||.||+|+.. ++ +.||+|++... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-G 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-C
Confidence 4578999999999999999999975 23 47999998654 334567899999999999 89999999997655 5
Q ss_pred ceEEEEEEeccCCChHHHhccCcc----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe
Q 047969 352 QGLLLVYEFVANGTVADQLHGDRA----------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC 421 (625)
Q Consensus 352 ~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~ 421 (625)
...++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 678999999999999999864321 1346899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHH
Q 047969 422 VKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLA 499 (625)
Q Consensus 422 ~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 499 (625)
+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------ 276 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------ 276 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH------
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH------
Confidence 999999999865332221 1233457889999999988889999999999999999998 99999754322111
Q ss_pred HHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 500 INKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+... .... .+ ...+..+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 277 ~~~~~~~-~~~~-~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 YKLVKDG-YQMA-QP----------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHT-CCCC-CC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcC-CCCC-CC----------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1111111 0000 00 0123478889999999999999999999999988764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=355.89 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=204.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEE
Confidence 368999999999999999999987 7899999998654 34456789999999999999999999997665 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||+++++|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred ECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 99999999999963 34689999999999999999999996 999999999999999999999999999975421
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH--------------------
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN-------------------- 497 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~-------------------- 497 (625)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 12234578999999999998889999999999999999999999997543221100000
Q ss_pred ---------------HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 498 ---------------LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 498 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.....+....... . ....++.++.+|+.+||+.||++|||++|+++|-.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPK--------L---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCC--------C---CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCC--------C---CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000000000000 0 00123557889999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.06 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=201.8
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--------HHHHHHHHHHHHHHhcCCCCeeeeeeeeee
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--------RRVEQFMNEVEILTRLRHKNLVSLFGCTSR 349 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 349 (625)
...++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34578999999999999999999976 788999999865421 133457789999999999999999997655
Q ss_pred ccceEEEEEEeccCC-ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccc
Q 047969 350 YSQGLLLVYEFVANG-TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFG 428 (625)
Q Consensus 350 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFg 428 (625)
.+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred -CCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 67789999999776 9999985 34569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
+++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~-- 238 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------E-- 238 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------T--
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------h--
Confidence 9987643322 233568999999999987776 789999999999999999999996422110 0
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..... . ..++.++.+|+.+||+.||++|||+.+++++-.
T Consensus 239 --~~~~~--~-------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 239 --AAIHP--P-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp --TCCCC--S-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred --hccCC--C-------cccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00000 0 013457889999999999999999999999744
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.13 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=205.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEE
Confidence 3468999999999999999999987 7899999998543 23445778999999999999999999997665 6678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 84 LEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999885 33468999999999999999999999999999999999999999999999999998653222
Q ss_pred c-ccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 438 T-HVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 438 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... . ..+..... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-----~~~~~~~~--~~--- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKT--YL--- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-H-----HHHHTTCT--TS---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHhhhccc--cc---
Confidence 1 12244578999999999987665 67899999999999999999999764432111 1 11111000 00
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.....++..+.+++.+||+.||++|||+.|++++-
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 00123456788999999999999999999998863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.14 Aligned_cols=273 Identities=22% Similarity=0.331 Sum_probs=203.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRY------- 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 350 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999985 789999999854322 2245678999999999999999999976553
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
.+..++||||+++ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999986 77777643 3345999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCcc---ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 431 RLFPLDVT---HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 431 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
+....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||......................
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 87643221 22244578999999998875 458999999999999999999999998654332221111111111111
Q ss_pred cccccc-----CC--cCCCCC---hHHHH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 507 AFDELI-----DP--CLGFES---DEEVK--RMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 507 ~~~~~~-----~~--~~~~~~---~~~~~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.+.... +. ...... ..... ..+..+.+|+.+||+.||++|||++|++++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 111000 00 000000 01111 12456889999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=347.27 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=203.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEE
Confidence 3468999999999999999999986 799999999976654455678899999999999999999996655 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~~~ 435 (625)
||+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 86 QLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EcCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999985 33468999999999999999999999999999999999999 7889999999999976432
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+...... ...
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~-~~~-- 228 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYYE-FES-- 228 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCCC-CCT--
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC-CCc--
Confidence 2 112235899999999999888999999999999999999999999654321 112222222111 000
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.....++..+.+++.+||+.||++|||+.|++++-.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 229 ------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp ------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 011134567889999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=342.27 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=204.7
Q ss_pred hcCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 281 TNDFSREK-ELGDGGFGTVYYGKLK---DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
.++|++.+ .||+|+||+||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++. .+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence 35788887 9999999999999643 46889999986542 234678999999999999999999999773 4568
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999963 3469999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 435 LDVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 435 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+........
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC 241 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 433221 223456789999999988888999999999999999999 999997543211 1111221111110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 242 ------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 242 ------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01245578899999999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.86 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=207.2
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--------HHHHHHHHHHHHHHHhc-CCCCeeeeee
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--------YRRVEQFMNEVEILTRL-RHKNLVSLFG 345 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~ 345 (625)
......++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999986 79999999985432 12246688999999999 7999999999
Q ss_pred eeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEc
Q 047969 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVA 425 (625)
Q Consensus 346 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~ 425 (625)
++.. ....++||||+++++|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 168 ~~~~-~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 168 SYES-SSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEB-SSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEee-CCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence 6654 677899999999999999986 33469999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccCcccccc------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH
Q 047969 426 DFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA 499 (625)
Q Consensus 426 DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~ 499 (625)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~ 313 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LM 313 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HH
Confidence 999998764322 2244679999999998853 35888999999999999999999999653321 11
Q ss_pred HHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 500 INKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...+...... ...+....++..+.+++.+||+.||++|||+.+++++-
T Consensus 314 ~~~i~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 314 LRMIMEGQYQ---------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHHTCCC---------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHhCCCC---------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 1112111111 11122234456788999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.14 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=187.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 352 (625)
.++|++++.||+|+||.||+|++. +|+.||||++... .....+.+.+|+++|+.++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999876 7899999998543 344567889999999999999999999976432 24
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++|||++ +++|.+++.. ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 579999999 6799888842 4699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc-----
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC----- 506 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 506 (625)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|++|++||.......... .....+...
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELL 254 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence 4322 234578999999999876 678999999999999999999999997654322111 111110000
Q ss_pred ------ccccccC---CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 507 ------AFDELID---PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 507 ------~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....++. ..............+..+.+|+.+||+.||++|||+.|+++|-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0000000 00000111111234567889999999999999999999998743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=340.63 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=200.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~ 355 (625)
..|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. .....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999976 6889999998643 34556789999999999999999999996644 245689
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEEC-CCCeEEEcccccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLD-SNFCVKVADFGLSRL 432 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~-~~~~~kl~DFgla~~ 432 (625)
+||||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999995 3356899999999999999999999999 99999999999997 789999999999976
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... .....+.........
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASF 251 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGG
T ss_pred cccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCCcccc
Confidence 4332 2234568999999998874 58999999999999999999999996533211 111222211111101
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
....+..+.+++.+||+.||++|||+.+++++-
T Consensus 252 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 252 -----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp -----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 111234688999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=352.93 Aligned_cols=274 Identities=21% Similarity=0.292 Sum_probs=202.4
Q ss_pred hHHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc-----------cHHHHHHHHHHHHHHHhcCCCCeee
Q 047969 274 YSDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN-----------NYRRVEQFMNEVEILTRLRHKNLVS 342 (625)
Q Consensus 274 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~ 342 (625)
..++....++|++.+.||+|+||.||+|+..+|+.||||++... +....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998542 1223478999999999999999999
Q ss_pred eeeeeeec----cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 343 LFGCTSRY----SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 343 ~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
+++++... ....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC
Confidence 99976432 336899999998 588888753 3446999999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH
Q 047969 419 NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~ 497 (625)
++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--- 244 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN--- 244 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---
T ss_pred CCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 9999999999997543222 2234568999999998876 678999999999999999999999997654222111
Q ss_pred HHHHHhhhcc-----------cccccCCcC----CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 498 LAINKIQKCA-----------FDELIDPCL----GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 498 ~~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.......... ......... ...........+..+.+|+.+||+.||++|||+.|++++-
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 1111000000 000000000 0111112223456788999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.77 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=205.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-------------HHHHHHHHHHHHHHhcCCCCeeeeee
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-------------RRVEQFMNEVEILTRLRHKNLVSLFG 345 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 345 (625)
..++|++.++||+|+||+||+|+.+ +++.||||++..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4679999999999999999999987 688999999865421 23467899999999999999999999
Q ss_pred eeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---eE
Q 047969 346 CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF---CV 422 (625)
Q Consensus 346 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~---~~ 422 (625)
++.. ....++||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~-~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFED-KKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEC-SSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEc-CCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 7655 677899999999999999885 335699999999999999999999999999999999999998776 69
Q ss_pred EEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH
Q 047969 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 423 kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
||+|||+++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|.+||....... ....
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKK 258 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 999999998764332 2344579999999999874 68999999999999999999999997643221 2222
Q ss_pred hhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 503 IQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+...... ........++.++.+|+.+||+.||++|||+.|++++-.
T Consensus 259 i~~~~~~---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 259 VEKGKYY---------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHCCCC---------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHcCCCC---------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 2222111 122334456778999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.58 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=206.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence 468999999999999999999987 6889999998643 33456788999999999999999999997665 667899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999885 3356899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... +
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~------~ 260 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEYS------I 260 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC------C
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCCCC------C
Confidence 2 22344569999999999988889999999999999999999999997543211 11111111110 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ..++..+.+++.+||+.||++|||+.|++++-.
T Consensus 261 ~-------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 261 P-------KHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 023446788999999999999999999998643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.14 Aligned_cols=269 Identities=24% Similarity=0.319 Sum_probs=197.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHH--HHhcCCCCeeeeeeeee----eccceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEI--LTRLRHKNLVSLFGCTS----RYSQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~----~~~~~~ 354 (625)
.++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ ++.++||||+++++.+. ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 689999999865432 334444444 45589999999997432 223457
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccCCCCCCEEECCCCeEEEc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS---------DIIHRDVKTNNILLDSNFCVKVA 425 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~ivHrDikp~NIll~~~~~~kl~ 425 (625)
++||||+++|+|.+++.. ...++..++.++.||++||+|||++ ||+||||||+||||+.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 899999999999999953 2358999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCcc-------ccccCCCCCCCccCcccccc-------CCCCCchhhhhHHHHHHHHHhCCCCCccccccc
Q 047969 426 DFGLSRLFPLDVT-------HVSTAPQGTPGYVDPEYHQC-------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRH 491 (625)
Q Consensus 426 DFgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~ 491 (625)
|||+++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 11234569999999999876 356678999999999999999976654322211
Q ss_pred ccchhH-----------HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 492 EINLAN-----------LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 492 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
...... .....+... ...+.+.... ......+..+.+||.+||+.||++|||++|+++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSRE----KQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTS----CCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhccc----ccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 111000 000000000 0011111000 011235667999999999999999999999999999987
Q ss_pred cCC
Q 047969 561 SGK 563 (625)
Q Consensus 561 ~~~ 563 (625)
...
T Consensus 318 ~~~ 320 (336)
T 3g2f_A 318 MIW 320 (336)
T ss_dssp HCC
T ss_pred HHH
Confidence 643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=342.89 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=208.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEE
Confidence 457999999999999999999876 78999999986442 3446789999999999999999999997665 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 100 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp ECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 9999999999984 34689999999999999999999999999999999999999999999999999987543321
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.......+ .
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-----~- 240 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNPPTL-----E- 240 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCC-----C-
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCCCCC-----c-
Confidence 2244578999999999998889999999999999999999999997543211 1111111111111 0
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
..++..+.+++.+||+.+|++|||+.+++++..-...
T Consensus 241 ------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 241 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ------cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 1234568889999999999999999999998665443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.58 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=206.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEE
Confidence 468999999999999999999987 6889999998543 33456788999999999999999999997655 667899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++. ....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999885 3346899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...... +
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~ 234 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEYS------I 234 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCC------C
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccCC------C
Confidence 2 22344568999999999988889999999999999999999999997543211 11111111110 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ..++..+.+++.+||+.||++|||+++++++-.
T Consensus 235 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 235 P-------KHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred c-------cccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0 123457888999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.68 Aligned_cols=267 Identities=22% Similarity=0.265 Sum_probs=200.4
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-------
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY------- 350 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 350 (625)
...++|++.+.||+|+||+||+|++. +|+.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45679999999999999999999975 799999999865432 234799999999999999999976432
Q ss_pred ------------------------------cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH
Q 047969 351 ------------------------------SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400 (625)
Q Consensus 351 ------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH 400 (625)
....++||||+++ +|.+.+.........+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2347899999984 888877654445678999999999999999999999
Q ss_pred hCCCcccCCCCCCEEEC-CCCeEEEcccccccccCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHH
Q 047969 401 ASDIIHRDVKTNNILLD-SNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELI 478 (625)
Q Consensus 401 ~~~ivHrDikp~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~ell 478 (625)
++||+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 99999999999999997 68999999999998764332 22445689999999988764 5899999999999999999
Q ss_pred hCCCCCcccccccccchhHHHHHHhhh----------cccccccCCcCCCCChH--HHHHHHHHHHHHHHHhcccCCCCC
Q 047969 479 SSMPAVDMNRHRHEINLANLAINKIQK----------CAFDELIDPCLGFESDE--EVKRMTTSVAELAFLCLQQNKELR 546 (625)
Q Consensus 479 tG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~R 546 (625)
+|++||........... ....+.. ..+....-+........ ....++.++.+|+.+||+.||++|
T Consensus 237 ~g~~pf~~~~~~~~~~~---i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVR---IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HSSCSSCCSSHHHHHHH---HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred hCCCCCCCCChHHHHHH---HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999976543221111 1110000 00000000111111100 011245678899999999999999
Q ss_pred CCHHHHHHH
Q 047969 547 PSMEEVLAE 555 (625)
Q Consensus 547 Ps~~ell~~ 555 (625)
||+.|+++|
T Consensus 314 ~t~~e~l~h 322 (383)
T 3eb0_A 314 INPYEAMAH 322 (383)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=359.68 Aligned_cols=268 Identities=25% Similarity=0.281 Sum_probs=198.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~ 355 (625)
.+|++.+.||+|+||.||+|++. +|+.||||++..... .+.+|+++|++++|||||++++++... ...++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 47899999999999999999986 689999999865421 234799999999999999999866432 22367
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccccccC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFP 434 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~~~ 434 (625)
+||||+++ +|.+.+.........+++..++.++.||++||+|||++||+||||||+||||+.+ +.+||+|||+++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999986 6666664433455679999999999999999999999999999999999999954 678999999998754
Q ss_pred CCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH-----HHhh--hc
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI-----NKIQ--KC 506 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~--~~ 506 (625)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|++||........+....... ..+. ..
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 3322 2345789999999998764 78999999999999999999999997654322111111000 0000 00
Q ss_pred ccccccCCcCCCCChHH--HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 AFDELIDPCLGFESDEE--VKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+.++.-+.+....... ...++.++.+||.+||+.||++|||+.|+++|-
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 11111111111111110 012356889999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=340.84 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=189.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-H-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-Y-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... . ...+.+.++...++.++||||+++++++.. .+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEE
Confidence 468999999999999999999985 78999999986542 2 233444556666888899999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
|||+++ +|.+++.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 999975 88888765444567899999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccCCCCCCCccCcccc----ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 437 VTHVSTAPQGTPGYVDPEYH----QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.. .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... ...............
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPSPQLP 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCCCCCC
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCCCCcc
Confidence 22 2334699999999996 45578899999999999999999999996432211 111111111111100
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...++..+.+++.+||+.+|++|||+.|++++-
T Consensus 236 -----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 236 -----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp -----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred -----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 012355788999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.00 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=204.3
Q ss_pred hcCCCccceecccCcEEEEEEEE------cCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL------KDGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.. ...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCC
Confidence 46899999999999999999983 25778999998643 34456778999999999999999999996665 566
Q ss_pred EEEEEEeccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADF 427 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DF 427 (625)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 7999999999999999975432 1245899999999999999999999999999999999999984 456999999
Q ss_pred ccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+..
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~ 260 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTS 260 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHT
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHHHhc
Confidence 99975432221 11233457899999999988889999999999999999998 999997543211 1111221
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...... . ..++..+.+++.+||+.+|++||++.+++++|+.+...
T Consensus 261 ~~~~~~-----~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 GGRMDP-----P-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TCCCCC-----C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCC-----C-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111100 0 12345788899999999999999999999999988653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.20 Aligned_cols=267 Identities=21% Similarity=0.330 Sum_probs=197.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee----------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---------- 349 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 349 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++...+....+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999987 589999999987777777889999999999999999999986532
Q ss_pred ---ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCeEEEc
Q 047969 350 ---YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVA 425 (625)
Q Consensus 350 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-~~~~~kl~ 425 (625)
.....++||||++ |+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 2356899999998 59999984 34689999999999999999999999999999999999997 56799999
Q ss_pred ccccccccCCCccc--cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHH
Q 047969 426 DFGLSRLFPLDVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINK 502 (625)
Q Consensus 426 DFgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 502 (625)
|||+++........ ......+|..|+|||++.+ ..++.++||||||+++|+|++|+.||......... ......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHh
Confidence 99999875432111 1223457899999998765 67899999999999999999999999765432111 111110
Q ss_pred hhh----------cccccccCCcC---CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 503 IQK----------CAFDELIDPCL---GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 503 ~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
... ........... ..........++.++.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 000 00000000000 0000111123567899999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=367.38 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=206.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEE
Confidence 468999999999999999999987 79999999985432 2346778999999999999999999997665 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE---CCCCeEEEccccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLF 433 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---~~~~~~kl~DFgla~~~ 433 (625)
||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999986 34569999999999999999999999999999999999999 56789999999999876
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|.+||....... ....+.......
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~--- 246 (484)
T 3nyv_A 180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTF--- 246 (484)
T ss_dssp CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC---
T ss_pred ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC---
Confidence 43322 233469999999999876 68999999999999999999999997643221 122222221110
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..+....++..+.+||.+||+.+|++|||+.|+++|-.
T Consensus 247 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 247 ------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 01122345668899999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.97 Aligned_cols=269 Identities=24% Similarity=0.340 Sum_probs=207.7
Q ss_pred HHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHh--cCCCCeeeeeeeeeecc---c
Q 047969 278 AEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTR--LRHKNLVSLFGCTSRYS---Q 352 (625)
Q Consensus 278 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~---~ 352 (625)
....++|++.+.||+|+||.||+|+. +|+.||||++... ..+.+.+|+++++. ++||||+++++++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567999999999999999999998 4899999998644 33567889999988 78999999999766543 2
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCCCEEECCCCeEEE
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH--------ASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~ivHrDikp~NIll~~~~~~kl 424 (625)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred eeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 68999999999999999953 35899999999999999999999 889999999999999999999999
Q ss_pred cccccccccCCCccc---cccCCCCCCCccCccccccC------CCCCchhhhhHHHHHHHHHhC----------CCCCc
Q 047969 425 ADFGLSRLFPLDVTH---VSTAPQGTPGYVDPEYHQCY------QLTDKSDVYSFGVVLIELISS----------MPAVD 485 (625)
Q Consensus 425 ~DFgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwslG~il~elltG----------~~p~~ 485 (625)
+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999999876443322 22445799999999998765 233689999999999999999 66765
Q ss_pred ccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 486 MNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
....... .. ......+.... ..+.+. ........+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 269 ~~~~~~~-~~-~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPSDP-SV-EEMRKVVCEQK----LRPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCSSC-CH-HHHHHHHTTSC----CCCCCC--GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcCcc-cH-HHHHHHHHHHH----hCCCCc--ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 4322111 11 11111111111 111111 00011245668899999999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=340.06 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=204.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEE
Confidence 468999999999999999999987 678899999864322 224678899999999999999999997655 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999863 346899999999999999999999999999999999999999999999999999765322
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.....
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~-------- 229 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVDL-------- 229 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhcccc--------
Confidence 1234568999999999998889999999999999999999999997543211 1111111111
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
... ..++..+.+++.+||+.+|++|||+.+++++-.
T Consensus 230 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 230 KFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred CCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 000 123457889999999999999999999998743
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.87 Aligned_cols=254 Identities=17% Similarity=0.208 Sum_probs=203.3
Q ss_pred HhcCCCccceecccCcEEEEEEE------EcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC---CCCeeeeeeeeeec
Q 047969 280 ATNDFSREKELGDGGFGTVYYGK------LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR---HKNLVSLFGCTSRY 350 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 350 (625)
..++|++.+.||+|+||+||+|. ..+++.||||++.... ...+.+|+++++.++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~- 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF- 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence 34689999999999999999994 3478899999997654 345778888888887 9999999996655
Q ss_pred cceEEEEEEeccCCChHHHhccCcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-----------
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA-KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS----------- 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~----------- 418 (625)
.+..+|||||+++|+|.+++..... ....+++..++.|+.||+.||+|||++||+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 5678999999999999999964322 3456999999999999999999999999999999999999998
Q ss_pred CCeEEEcccccccccCCC-ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH
Q 047969 419 NFCVKVADFGLSRLFPLD-VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN 497 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~ 497 (625)
++.+||+|||+|+..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 899999999999764321 222335567999999999999888999999999999999999999998643321100
Q ss_pred HHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhchhc
Q 047969 498 LAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELR-PSMEEVLAELQRIKS 561 (625)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~ell~~L~~i~~ 561 (625)
....+.... ....+.+++..||+.+|.+| |+++++.+.|+.+..
T Consensus 295 --------------~~~~~~~~~------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 --------------PEGLFRRLP------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --------------ECSCCTTCS------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------echhccccC------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 001011111 13466789999999999999 689999988887654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=346.87 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=199.2
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--------HHHHHHHHHHHHHHhcCCCCeeeeeeeeeec
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--------RRVEQFMNEVEILTRLRHKNLVSLFGCTSRY 350 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 350 (625)
..++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 4568999999999999999999976 688999999864321 223458899999999999999999997654
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe---EEEccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC---VKVADF 427 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~---~kl~DF 427 (625)
+..++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 87 -~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 87 -EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -SSEEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -CceEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 34799999999999999985 3456999999999999999999999999999999999999987654 999999
Q ss_pred ccccccCCCccccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh
Q 047969 428 GLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 428 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
|+++...... ......||+.|+|||++. ...++.++||||||+++|+|++|..||........ .... +.
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~----~~ 233 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----IT 233 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH----HH
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH----HH
Confidence 9998754321 112345899999999873 45688999999999999999999999975443221 1111 11
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..... ........++..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYN---------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCC---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccc---------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11110 1112223456688999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=366.54 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=204.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.. ....++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEE
Confidence 3568999999999999999999987 78999999985432 2245678999999999999999999997655 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC---CCCeEEEccccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD---SNFCVKVADFGLSRLF 433 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~---~~~~~kl~DFgla~~~ 433 (625)
||||+.+|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 99 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 99 VGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999999885 334699999999999999999999999999999999999995 4568999999999865
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|.+||....... ....+.......
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~--- 241 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF--- 241 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCS---
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC---
Confidence 4322 2344579999999999876 58999999999999999999999997543211 122222221110
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
..+....++..+.+||.+||+.+|++|||+.|++++-.
T Consensus 242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 01112345668899999999999999999999999843
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.83 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=200.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeec-cceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRY-SQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv 357 (625)
.++|++.+.||+|+||+||+|++. +++.||||++.... .+.+.+|+.++++++ ||||+++++++... ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 368999999999999999999875 78999999986543 356889999999997 99999999976542 4568999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccccccCCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSRLFPLD 436 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~~~~~ 436 (625)
|||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999884 288999999999999999999999999999999999999776 8999999999875433
Q ss_pred ccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc----
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL---- 511 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 511 (625)
. ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......... ..............+.
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHT
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHhcCCchhhhHHHHh
Confidence 2 2344578999999999876 56899999999999999999999999543221111 0000000000000000
Q ss_pred -----------cCCcCC-----CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 512 -----------IDPCLG-----FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 512 -----------~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...... .........++.++.+||.+||+.||++|||++|+++|-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 000000 000011122567889999999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=367.67 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=201.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
..++|++++.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+.+++.++|||||++++++.. ....++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence 3468999999999999999999987 78899999986542 2235678999999999999999999997665 677899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEccccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLF 433 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~~~ 433 (625)
||||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 114 v~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 114 VMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999999885 3346899999999999999999999999999999999999976 455999999999876
Q ss_pred CCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|.+||...... .....+.......
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~--- 256 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYTF--- 256 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC---
T ss_pred CCCc--cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCC---
Confidence 4332 2344579999999998864 6899999999999999999999999764322 1122222221110
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..+....++..+.+||.+||+.+|++|||+.|+++|-
T Consensus 257 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 257 ------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp ------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred ------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 0111223556788999999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.74 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=200.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH----HHHHHHHHHHHHHHhcCCCCeeeeeeeee-eccce
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY----RRVEQFMNEVEILTRLRHKNLVSLFGCTS-RYSQG 353 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~ 353 (625)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++. .....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4579999999999999999999976 788999999865422 34577899999999999999999999764 33557
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||++++ |.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 89999999876 77776532 3456999999999999999999999999999999999999999999999999999875
Q ss_pred CCCc-cccccCCCCCCCccCccccccCC--CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 434 PLDV-THVSTAPQGTPGYVDPEYHQCYQ--LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 434 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
.... ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... .....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~- 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGSYA- 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCC-
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCCCC-
Confidence 4322 12224456999999999987643 477999999999999999999999754321 111222222111
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+. ..++..+.+++.+||+.||++|||+.|++++-.
T Consensus 232 -----~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 232 -----IP-------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp -----CC-------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred -----CC-------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 00 013457788999999999999999999998744
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.26 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=195.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEE
Confidence 368999999999999999999987 799999999865422 235678999999999999999999996655 667899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999963 346899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. ......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...... .....+......
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------ 229 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVFY------ 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC------
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCccc------
Confidence 2 2234568999999999987655 67999999999999999999999754321 111222221110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
+. ..++..+.+++.+||+.||++|||+.+++++-
T Consensus 230 ~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 230 IP-------EYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred Cc-------hhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 00 11345788899999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=363.96 Aligned_cols=245 Identities=16% Similarity=0.153 Sum_probs=189.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHH---HHHHhcCCCCeeeee-------ee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEV---EILTRLRHKNLVSLF-------GC 346 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~ 346 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ ++|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999964 7999999998632 334567889999 555566899999998 43
Q ss_pred eeeccc----------------eEEEEEEeccCCChHHHhccCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 047969 347 TSRYSQ----------------GLLLVYEFVANGTVADQLHGDRA---KHGLLTWPIRMNIAIETASALAYLHASDIIHR 407 (625)
Q Consensus 347 ~~~~~~----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 407 (625)
+...+. ..+|||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 332211 378999999 6799999964221 11224458888999999999999999999999
Q ss_pred CCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccC-----------CCCCchhhhhHHHHHHH
Q 047969 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-----------QLTDKSDVYSFGVVLIE 476 (625)
Q Consensus 408 Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwslG~il~e 476 (625)
||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986322 2234567 999999999877 79999999999999999
Q ss_pred HHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 477 LISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 477 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
|++|+.||.......... .+... . ..++..+.+||.+||+.||++|||+.|++++
T Consensus 306 lltg~~Pf~~~~~~~~~~---------------~~~~~-~--------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 306 IWCADLPITKDAALGGSE---------------WIFRS-C--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHSSCCC------CCSG---------------GGGSS-C--------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHCCCCCcccccccchh---------------hhhhh-c--------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999996543222110 00000 0 1234578899999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.94 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=201.0
Q ss_pred CCCccc-eecccCcEEEEEEEEc---CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 283 DFSREK-ELGDGGFGTVYYGKLK---DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 283 ~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++.+.+ .||+|+||.||+|.++ ++..||||++.... ....+.|.+|+++|++++|||||++++++.. +..+||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEE
Confidence 334444 7999999999999864 46679999996542 3356789999999999999999999997654 458999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999963 34569999999999999999999999999999999999999999999999999998764332
Q ss_pred ccc--ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THV--STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+..+.....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~--- 560 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC--- 560 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCCC---
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC---
Confidence 221 122346789999999988899999999999999999998 999997543321 1122222111100
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...++.++.+||.+||+.+|++||++.+|++.|+.+..
T Consensus 561 ---------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 561 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01245678899999999999999999999999988653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=341.84 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=199.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEE
Confidence 468999999999999999999987 689999999876655667889999999999999999999997665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 9999999998853 3356999999999999999999999999999999999999999999999999997643211 11
Q ss_pred cccCCCCCCCccCcccc-----ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 440 VSTAPQGTPGYVDPEYH-----QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
......||+.|+|||++ ....++.++||||||+++|+|++|..||....... ....+..........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~- 244 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSDPPTLLT- 244 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCCSS-
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHHHHhccCCcccCC-
Confidence 12334689999999987 35678899999999999999999999997543211 111111111111100
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...++..+.+++.+||+.||++|||+.+++++-
T Consensus 245 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 245 ---------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp ---------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ---------ccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 112355788999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.36 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=200.9
Q ss_pred hHHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec-
Q 047969 274 YSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY- 350 (625)
Q Consensus 274 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 350 (625)
..++....++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344455789999999999999999999985 78999999986543 2346788999999999 799999999976553
Q ss_pred ----cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 351 ----SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 351 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 45789999999999999999643 234689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH
Q 047969 427 FGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501 (625)
Q Consensus 427 Fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 501 (625)
||++....... .......||+.|+|||++. +..++.++||||||+++|+|++|..||....... ...
T Consensus 173 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~ 244 (326)
T 2x7f_A 173 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALF 244 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHH
T ss_pred CcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHH
Confidence 99998654321 1223456899999999986 4568999999999999999999999996543211 111
Q ss_pred HhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+.......... ..++..+.++|.+||..||++||++.+++++-
T Consensus 245 ~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 245 LIPRNPAPRLKS-----------KKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHHSCCCCCSC-----------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred HhhcCccccCCc-----------cccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 111111111111 12345788999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.91 Aligned_cols=255 Identities=21% Similarity=0.343 Sum_probs=199.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
++|.....||+|+||.||+|++. +++.||||++........+.+.+|+.+++.++||||+++++++.. ....++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEe
Confidence 35566679999999999999975 788999999977666667889999999999999999999997665 5678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEcccccccccCCCccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgla~~~~~~~~~ 439 (625)
+++++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...... .
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 99999999996432 2335678999999999999999999999999999999999987 8999999999998754322 1
Q ss_pred cccCCCCCCCccCccccccC--CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCY--QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......||+.|+|||++.+. .++.++||||||+++|+|++|+.||........ ......... ..+.+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-----~~~~~~ 248 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGMFK-----VHPEIP 248 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHHHC-----CCCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhcccc-----cccccc
Confidence 22345689999999998654 378899999999999999999999964332111 000000000 001111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..++.++.+++.+||+.||++|||+.+++++-
T Consensus 249 -------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 249 -------ESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp -------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred -------ccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 12345788899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=340.63 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=197.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc--CCc--EEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK--DGR--EVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||+||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PP 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--CC
Confidence 368999999999999999999864 333 6899988643 23456789999999999999999999997665 33
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.++||||+++++|.+++.. ....+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 7899999999999999963 2345899999999999999999999999999999999999999999999999999876
Q ss_pred CCCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 434 PLDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 434 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
...... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERL 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-------HHHHHHccCCCC
Confidence 543322 1233457889999999988888999999999999999999 999997543211 111111111000
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.. ...++..+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus 245 ------~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 ------PR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ------CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ------CC-----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00 012455788999999999999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=377.17 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=204.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 354 (625)
..++|++++.||+|+||.||+|+++ +++.||||++.+.. ....+.+.+|..+|..+ +||+|+++++++.. .+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence 4578999999999999999999987 68899999986532 23356788999999988 79999999996654 6778
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
+|||||++||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 418 ~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999996 33469999999999999999999999999999999999999999999999999998643
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
... .......||+.|+|||++.+..++.++||||||+++|||++|++||...... .....+.....
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~------ 559 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNV------ 559 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHSSCC------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhCCC------
Confidence 222 2234567999999999999889999999999999999999999999764321 11222222111
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSM-----EEVLAE 555 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~~ 555 (625)
... ..++.++.+||.+||+.||++||++ +||++|
T Consensus 560 --~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 --AYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --CCC-----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --CCC-----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111 1345688899999999999999997 677665
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=374.78 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=198.1
Q ss_pred ceecccCcEEEEEEEEc---CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK---DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
++||+|+||.||+|.+. .++.||||++.... ....+.+.+|+++|++++|||||++++++.. +..+|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence 47999999999999653 46789999986542 2346789999999999999999999997653 45789999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc--c
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH--V 440 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~--~ 440 (625)
+|+|.+++. ....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++........ .
T Consensus 453 ~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999995 3456999999999999999999999999999999999999999999999999999876543321 1
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+........
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~-------- 593 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC-------- 593 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC--------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC--------
Confidence 233457889999999998899999999999999999998 999997543221 1122222111110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
...++.++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0124567889999999999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.00 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=204.7
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---------HHHHHHHHHHHHHHHhcC-CCCeeeeeeee
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---------YRRVEQFMNEVEILTRLR-HKNLVSLFGCT 347 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 347 (625)
...++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34579999999999999999999987 68999999985432 233567889999999996 99999999966
Q ss_pred eeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 348 SRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 348 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
.. ....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ET-NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EC-SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cc-CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 54 6778999999999999999963 346899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccCccccc------cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH
Q 047969 428 GLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ------CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501 (625)
Q Consensus 428 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 501 (625)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...... ....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLR 239 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------HHHH
Confidence 9998754322 223456899999999875 346889999999999999999999999654321 1111
Q ss_pred HhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.+....... ..+....++..+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 240 MIMSGNYQF---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHHTCCCC---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHhcCCccc---------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 222211110 0011123456788999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.48 Aligned_cols=200 Identities=24% Similarity=0.307 Sum_probs=171.8
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc------CCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL------RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 353 (625)
..+|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+++++.+ +|+||+++++++.. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCe
Confidence 468999999999999999999876 6889999998654 34456778899988887 57799999996665 577
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe--EEEccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC--VKVADFGLSR 431 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~--~kl~DFgla~ 431 (625)
.++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 899999996 5899988643 2345899999999999999999999999999999999999999887 9999999997
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRH 489 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~ 489 (625)
..... .....||+.|+|||++.+..++.++||||||+++|||++|.+||.....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 64322 2345789999999999988999999999999999999999999976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.21 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=197.0
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-----eEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ-----GLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~~l 356 (625)
.+|++.+.||+|+||+||+|++..+..||+|++..... ...+|+++|+.++||||+++++++..... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 57999999999999999999998777799998865432 12379999999999999999997654222 3789
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCeEEEcccccccccCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-~~~~~kl~DFgla~~~~~ 435 (625)
||||++++.+ ..+.........+++..++.++.||++||+|||++||+||||||+||||+ .++.+||+|||+++....
T Consensus 116 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 116 VLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9999987544 33332223456799999999999999999999999999999999999999 799999999999987643
Q ss_pred CccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH--------HHhhhc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI--------NKIQKC 506 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 506 (625)
... .....||+.|+|||++.+. .++.++||||||+++|||++|++||................ ..+..
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~- 271 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP- 271 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG-
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh-
Confidence 322 2345689999999998664 58999999999999999999999997654322211111100 00000
Q ss_pred ccccccCCcCCCCChHH--HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 AFDELIDPCLGFESDEE--VKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+....-+......... ...++.++.+|+.+||+.||++|||+.|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000001001000 11245688999999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=346.14 Aligned_cols=277 Identities=21% Similarity=0.262 Sum_probs=194.4
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ- 352 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 352 (625)
.......++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677899999999999999999999986 78999999985542 233456788899999999999999997654222
Q ss_pred -----eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCCCEEECC-CCeEEE
Q 047969 353 -----GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH--ASDIIHRDVKTNNILLDS-NFCVKV 424 (625)
Q Consensus 353 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~ivHrDikp~NIll~~-~~~~kl 424 (625)
..++||||+++ +|.+.+.........+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 27899999986 555544433335567899999999999999999999 999999999999999996 899999
Q ss_pred cccccccccCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHH---
Q 047969 425 ADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI--- 500 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~--- 500 (625)
+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|++||................
T Consensus 174 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 174 CDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999998764332 22345689999999998654 48999999999999999999999997654322111111000
Q ss_pred -----HHhhhccc-ccccCCcCCCCChHHH----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 501 -----NKIQKCAF-DELIDPCLGFESDEEV----KRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 501 -----~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..+..... ....+. ......... ...+.++.+|+.+||+.||++|||+.|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNS-KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCC-CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred CHHHHHhcccchhhcccccc-ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 00000000 000000 000000000 01456889999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.05 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=200.7
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEe
Confidence 4578999999999999999999987 68999999986543 34678899999999999999999997665 56789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999999852 345699999999999999999999999999999999999999999999999999987543222
Q ss_pred ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ...+.......+
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~------- 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------IFMIPTNPPPTF------- 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCCCCC-------
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCccc-------
Confidence 22345689999999999888899999999999999999999999975432111 111111111000
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.. ...++..+.+++.+||+.||++|||+.+++++-
T Consensus 246 ~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 246 RK---PELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp SS---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CC---cccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 00 112355788999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=347.82 Aligned_cols=268 Identities=21% Similarity=0.235 Sum_probs=201.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC--------CCCeeeeeeeeee--
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR--------HKNLVSLFGCTSR-- 349 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~-- 349 (625)
.++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+++++.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 368999999999999999999876 6889999998654 345577899999999996 7889999996652
Q ss_pred -ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCC-------
Q 047969 350 -YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNF------- 420 (625)
Q Consensus 350 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~------- 420 (625)
.....++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 355789999999 55666666422 235699999999999999999999999 999999999999999776
Q ss_pred ------------------------------------------eEEEcccccccccCCCccccccCCCCCCCccCcccccc
Q 047969 421 ------------------------------------------CVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458 (625)
Q Consensus 421 ------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 458 (625)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999875322 234578999999999998
Q ss_pred CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH---HHHHHhhh--------cccc-cccCC------cCCCCC
Q 047969 459 YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN---LAINKIQK--------CAFD-ELIDP------CLGFES 520 (625)
Q Consensus 459 ~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~---~~~~~~~~--------~~~~-~~~~~------~~~~~~ 520 (625)
..++.++||||||+++|+|++|+.||............. ........ .... .+... ......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 889999999999999999999999997554322111111 11110000 0000 00000 000000
Q ss_pred h----------HHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 521 D----------EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 521 ~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. ......+..+.+||.+||+.||++|||+.|+++|-
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 0 01134567889999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.65 Aligned_cols=268 Identities=25% Similarity=0.341 Sum_probs=202.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec----cceE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY----SQGL 354 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~ 354 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++... .......+.+|++++++++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999987 7899999998643 334556788999999999999999999965442 2568
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 589998852 468999999999999999999999999999999999999999999999999998764
Q ss_pred CCccc---------cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh
Q 047969 435 LDVTH---------VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 435 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
..... ......||+.|+|||++.. ..++.++||||||+++|+|++|++||........... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhC
Confidence 32211 1123468999999998754 6789999999999999999999999976543221110 000000
Q ss_pred hccccc------------ccC--CcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 505 KCAFDE------------LID--PCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 505 ~~~~~~------------~~~--~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...... ... +.. ..........++..+.+|+.+||+.||++|||+.|++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000000 000 000 00001112245678889999999999999999999998743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=350.77 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=205.0
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHH-----------------HHHHHHHHHHHHhcCCCCeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRR-----------------VEQFMNEVEILTRLRHKNLVSL 343 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~ 343 (625)
.++|++.+.||+|+||.||+|+. +|+.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432211 1789999999999999999999
Q ss_pred eeeeeeccceEEEEEEeccCCChHHH------hccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEE
Q 047969 344 FGCTSRYSQGLLLVYEFVANGTVADQ------LHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILL 416 (625)
Q Consensus 344 ~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll 416 (625)
++++.. .+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 109 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEES-SSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 997665 5678999999999999998 432 125679999999999999999999999 999999999999999
Q ss_pred CCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccC-CCCC-chhhhhHHHHHHHHHhCCCCCcccccccccc
Q 047969 417 DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTD-KSDVYSFGVVLIELISSMPAVDMNRHRHEIN 494 (625)
Q Consensus 417 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDvwslG~il~elltG~~p~~~~~~~~~~~ 494 (625)
+.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence 99999999999999875432 23445789999999999876 5666 9999999999999999999997544311
Q ss_pred hhHHHHHHhhhcccccc------cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 495 LANLAINKIQKCAFDEL------IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 495 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.....+........ ..+............++..+.+|+.+||+.||++|||+.|++++-
T Consensus 260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 260 ---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp ---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred ---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 11122222211100 000000000111234566889999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=345.49 Aligned_cols=266 Identities=27% Similarity=0.410 Sum_probs=187.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN-YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEEE
Confidence 3578999999999999999999865 78999999885432 3345678899999999999999999996665 5678999
Q ss_pred EEeccCCChHHHhccCc----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 358 YEFVANGTVADQLHGDR----AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
|||+++++|.+++.... .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99999999999986321 13456999999999999999999999999999999999999999999999999999865
Q ss_pred CCCcc----ccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 434 PLDVT----HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 434 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... ...+. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ-NDP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHT-SSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhc-cCC
Confidence 43211 11234568999999999865 56899999999999999999999999764432211 11111 110
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...... .........++..+.+++.+||+.||++|||+.+++++-
T Consensus 245 ~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 245 PSLETG---VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred Cccccc---cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000000 000000112345788999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.00 Aligned_cols=266 Identities=18% Similarity=0.267 Sum_probs=198.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-----
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ----- 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 352 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999976 7899999998653 33446788999999999999999999997655332
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 2399999997 58888773 2389999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc--
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD-- 509 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 509 (625)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........................
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 4322 234568999999999876 678999999999999999999999997654322111110000000000000
Q ss_pred ------cc---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 510 ------EL---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 510 ------~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.. +..............++..+.+|+.+||+.||++|||+.|++++-.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 00 0000000111112234678899999999999999999999998743
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.32 Aligned_cols=274 Identities=22% Similarity=0.269 Sum_probs=185.3
Q ss_pred cCCCc-cceecccCcEEEEEEEEc---CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEE
Q 047969 282 NDFSR-EKELGDGGFGTVYYGKLK---DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLL 356 (625)
Q Consensus 282 ~~~~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~l 356 (625)
+.|++ .++||+|+||+||+|+++ +++.||||++..... .+.+.+|+.+|++++||||+++++++.. .....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 457999999999999976 578899999865432 2467899999999999999999997643 4567899
Q ss_pred EEEeccCCChHHHhccCc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE----CCCCeEEEccc
Q 047969 357 VYEFVANGTVADQLHGDR-----AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL----DSNFCVKVADF 427 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll----~~~~~~kl~DF 427 (625)
||||+.+ +|.+++.... .....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9999975 7877775322 122359999999999999999999999999999999999999 67899999999
Q ss_pred ccccccCCCcc--ccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccc------cchhHH
Q 047969 428 GLSRLFPLDVT--HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE------INLANL 498 (625)
Q Consensus 428 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~------~~~~~~ 498 (625)
|+++....... .......||+.|+|||++.+. .++.++||||||+++|+|++|++||........ ......
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987643222 122345799999999998764 589999999999999999999999975432100 000111
Q ss_pred HHHHhhhccccccc----------------CCcCCCCChHH-HH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 499 AINKIQKCAFDELI----------------DPCLGFESDEE-VK----RMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 499 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~-~~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
....+.......+. ........... .. ..+..+.+||.+||+.||++|||++|+++|-.
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 11111000000000 00000000000 00 01457789999999999999999999999855
Q ss_pred c
Q 047969 558 R 558 (625)
Q Consensus 558 ~ 558 (625)
-
T Consensus 337 f 337 (405)
T 3rgf_A 337 F 337 (405)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.90 Aligned_cols=255 Identities=11% Similarity=0.058 Sum_probs=182.1
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhc--CCCCeeeeee-------eee
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRL--RHKNLVSLFG-------CTS 348 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~~~~-------~~~ 348 (625)
.+|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.+ +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45899999999999999999976 78999999997643 24456778886555555 6999888553 221
Q ss_pred ecc----------------ceEEEEEEeccCCChHHHhccCcccCCCCCHHHH------HHHHHHHHHHHHHHHhCCCcc
Q 047969 349 RYS----------------QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIR------MNIAIETASALAYLHASDIIH 406 (625)
Q Consensus 349 ~~~----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~ivH 406 (625)
..+ ...+|||||++ |+|.+++... ...+.+..+ +.++.||++||+|||++||+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 111 34799999999 8999999643 223455555 778899999999999999999
Q ss_pred cCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCC
Q 047969 407 RDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAV 484 (625)
Q Consensus 407 rDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~ 484 (625)
|||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998753221 13346799999999987 67999999999999999999999999
Q ss_pred cccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 485 DMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
............ ............... ....++..+.+||.+||+.||++|||+.+++++
T Consensus 294 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKGSWK--------RPSLRVPGTDSLAFG---SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTTCCC--------BCCTTSCCCCSCCCT---TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCcccccchh--------hhhhhhccccccchh---hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 765322110000 000000000000000 011345678899999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=343.35 Aligned_cols=269 Identities=24% Similarity=0.317 Sum_probs=202.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEc--CCcEEEEEEeccccH--HHHHHHHHHHHHHHhc---CCCCeeeeeeeeee---
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK--DGREVAVKRLYDNNY--RRVEQFMNEVEILTRL---RHKNLVSLFGCTSR--- 349 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~--- 349 (625)
..++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4579999999999999999999983 688999999854321 1223466777777766 89999999996652
Q ss_pred -ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccc
Q 047969 350 -YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFG 428 (625)
Q Consensus 350 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFg 428 (625)
.....++||||+. |+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 3566899999998 5999998643 23458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|++||........ .......+.....
T Consensus 166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 240 (326)
T 1blx_A 166 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGE 240 (326)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCG
T ss_pred ccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCc
Confidence 99865422 223445789999999999888899999999999999999999999976543221 1111111110000
Q ss_pred cccc----------CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 509 DELI----------DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 509 ~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..+. ..............++..+.+|+.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0000 00000000111123456788999999999999999999999763
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.97 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=193.9
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec--------
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-------- 350 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 350 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999976 7999999998654 44567899999999999999999999966432
Q ss_pred ----cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 351 ----SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 351 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
....++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4568999999999999999964 233578899999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc-------------cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccc
Q 047969 427 FGLSRLFPLDV-------------THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHE 492 (625)
Q Consensus 427 Fgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~ 492 (625)
||+++...... ........||+.|+|||++.+. .++.++||||||+++|+|++ ||......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-- 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-- 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence 99998654221 1112345689999999998754 68999999999999999998 44321110
Q ss_pred cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 493 INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
......+...... ..+.. ....+..+.+++.+||+.||++|||+.+++++-
T Consensus 235 ----~~~~~~~~~~~~~--~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 235 ----VNILKKLRSVSIE--FPPDF-------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp ----HHHHHHHHSTTCC--CCTTC-------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred ----HHHHHhccccccc--cCccc-------cccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 1111111111100 00101 112344678899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=369.77 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=205.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEcC----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
..++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.+|++++||||+++++++. .+..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCce
Confidence 34689999999999999999998752 457999998653 3445578999999999999999999999764 3557
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999999963 33468999999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
...........+|+.|+|||++.+..++.++||||||+++|||++ |.+||....... ....+........
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~~-- 613 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM-- 613 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTCCCCC--
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCCCCC--
Confidence 433333334557889999999988889999999999999999997 999997543221 1112222111110
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. ..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 614 ---~-------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 614 ---P-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---C-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0 1234578899999999999999999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=340.66 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=201.5
Q ss_pred hcCCCccceecccCcEEEEEEEE-c-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC------eeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKL-K-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN------LVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||.||+|.. . +++.||||++... ....+.+.+|+++++.++|++ ++++++++.. .+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CC
Confidence 36899999999999999999987 3 6889999998654 345577889999999997654 8999996655 56
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC--------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-------------- 418 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-------------- 418 (625)
..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 889999999 88999998642 2236899999999999999999999999999999999999987
Q ss_pred -----CCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccccc
Q 047969 419 -----NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI 493 (625)
Q Consensus 419 -----~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~ 493 (625)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999864322 23456899999999999888999999999999999999999999765432211
Q ss_pred chhHHHHHHhhhcccc-----cc-cCCcCCCCCh-H-----------------HHHHHHHHHHHHHHHhcccCCCCCCCH
Q 047969 494 NLANLAINKIQKCAFD-----EL-IDPCLGFESD-E-----------------EVKRMTTSVAELAFLCLQQNKELRPSM 549 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~-~-----------------~~~~~~~~l~~li~~cl~~~P~~RPs~ 549 (625)
................ .. .......... . .....+..+.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1111111000000000 00 0000000000 0 001345688999999999999999999
Q ss_pred HHHHHH
Q 047969 550 EEVLAE 555 (625)
Q Consensus 550 ~ell~~ 555 (625)
.|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.24 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=202.9
Q ss_pred HHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 279 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEE
Confidence 34578999999999999999999987 78999999985432 2345778999999999999999999997655 66789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC---CeEEEcccccccc
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN---FCVKVADFGLSRL 432 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~---~~~kl~DFgla~~ 432 (625)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999998852 3468999999999999999999999999999999999999754 4799999999986
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+.......
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-- 241 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF-- 241 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC--
T ss_pred ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC--
Confidence 543221 122347889999998876 48999999999999999999999997543211 112222221110
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..+....++.++.+++.+||+.+|++|||+.|++++-
T Consensus 242 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 242 -------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp -------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 0011123456788999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.59 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=180.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHH-HHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVE-ILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|+||.||+|+.. +|+.||||++... ......++.+|+. +++.++||||+++++++.. .+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEE
Confidence 368999999999999999999986 7899999998654 2334455666666 6777899999999997665 5678999
Q ss_pred EEeccCCChHHHhccCc-ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 358 YEFVANGTVADQLHGDR-AKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 999986 7777765321 1245799999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccccCCCCCCCccCcccc----ccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYH----QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
.. ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ....+.......+
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~ 250 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVKGDPPQL 250 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhcCCCCCC
Confidence 22 12334689999999998 455689999999999999999999999975321100 0000111111100
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.. .....++..+.+|+.+||+.||++|||+.+++++-.
T Consensus 251 -----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 251 -----SN---SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp -----CC---CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -----CC---cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 00 000123457889999999999999999999998743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.10 Aligned_cols=263 Identities=18% Similarity=0.282 Sum_probs=197.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc-----
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ----- 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 352 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999976 7899999998643 33446778999999999999999999997655332
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 3599999997 58877763 2489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc---cc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC---AF 508 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 508 (625)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ......... ..
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHCBCCHHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence 4322 234568999999998876 678999999999999999999999997654321111 111000000 00
Q ss_pred cc--------c---cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 509 DE--------L---IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 509 ~~--------~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.. . +..............++..+.+|+.+||+.||++|||+.+++++-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 00 0 0000000001111234568899999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.84 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=195.6
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcC--CCCeeeeeeeeeeccceEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLR--HKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~ 355 (625)
..++|++.+.||+|+||.||+|+..+++.||||++... .....+.+.+|++++++++ |+||+++++++.. ....+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEEE
Confidence 45689999999999999999999988999999998543 3456678999999999997 5999999996655 56789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||| +.+++|.+++. ....+++..++.++.||++||.|||++||+||||||+|||+++ +.+||+|||+++....
T Consensus 105 lv~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 105 MVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEC-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEe-cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 9999 56789999996 3346899999999999999999999999999999999999964 8999999999987643
Q ss_pred Cccc-cccCCCCCCCccCcccccc-----------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh
Q 047969 436 DVTH-VSTAPQGTPGYVDPEYHQC-----------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 436 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ... ..+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~-~~~ 252 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL-HAI 252 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHH-HHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHH-HHH
Confidence 3222 1234568999999999865 467889999999999999999999996432211 111 111
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...... ..... ..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 253 ~~~~~~----~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 253 IDPNHE----IEFPD-------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HCTTSC----CCCCC-------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred Hhcccc----cCCcc-------cchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 111000 00000 11346788999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.39 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=200.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-----------CCCeeeeeeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-----------HKNLVSLFGCTS 348 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 348 (625)
.++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999975 7899999998654 344567889999999886 899999999765
Q ss_pred ecc---ceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEEC------C
Q 047969 349 RYS---QGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLD------S 418 (625)
Q Consensus 349 ~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~------~ 418 (625)
... ...++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+||||+ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 422 3689999999 88999998643 234589999999999999999999998 999999999999994 4
Q ss_pred CCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhH-
Q 047969 419 NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLAN- 497 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~- 497 (625)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 558999999999865322 234568999999999998889999999999999999999999997544221111111
Q ss_pred --HHHHHhhhc--------c-----c--ccccCC--cCCCCChH--------HHHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047969 498 --LAINKIQKC--------A-----F--DELIDP--CLGFESDE--------EVKRMTTSVAELAFLCLQQNKELRPSME 550 (625)
Q Consensus 498 --~~~~~~~~~--------~-----~--~~~~~~--~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~ 550 (625)
.....+... . + ...... ........ .....+.++.+||.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 111100000 0 0 000000 00000000 0135677899999999999999999999
Q ss_pred HHHHHHh
Q 047969 551 EVLAELQ 557 (625)
Q Consensus 551 ell~~L~ 557 (625)
|++++-.
T Consensus 330 ell~hp~ 336 (373)
T 1q8y_A 330 GLVNHPW 336 (373)
T ss_dssp HHHTCGG
T ss_pred HHhhChh
Confidence 9998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.65 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=175.6
Q ss_pred HhcCCCccc-eecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceE
Q 047969 280 ATNDFSREK-ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGL 354 (625)
Q Consensus 280 ~~~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~ 354 (625)
..++|++.+ .||+|+||+||+|+++ +|+.||||++.... .. ..+....++.++||||+++++++.. .....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356899955 6999999999999987 79999999986542 11 1223344667799999999996644 23458
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSR 431 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~ 431 (625)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999999642 2346999999999999999999999999999999999999976 4569999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....+...... .
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~-~ 252 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQYG-F 252 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C-C
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccccc-c
Confidence 65322 2234568999999999988888999999999999999999999996543221100 000001000000 0
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
.......++..+.+|+.+||+.||++|||+.|++++-.
T Consensus 253 --------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 253 --------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp --------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred --------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00111234567889999999999999999999999754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=339.62 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=198.1
Q ss_pred HhcCCCccceecccCcEEEEEEEEcCCcEEEEEEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
..++|++.+.||+|+||.||+|+... .||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCceEEE
Confidence 35789999999999999999999863 49999885432 2234567889999999999999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999963 334689999999999999999999999999999999999998 6799999999987643211
Q ss_pred ----cccccCCCCCCCccCcccccc---------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh
Q 047969 438 ----THVSTAPQGTPGYVDPEYHQC---------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 438 ----~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
........|++.|+|||++.. ..++.++||||||+++|+|++|+.||....... ....+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHhc
Confidence 111233458999999998864 347889999999999999999999997543211 111222
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
.......... .++.++.+++.+||+.+|++|||+.+++++|+.+....
T Consensus 257 ~~~~~~~~~~-----------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMKPNLSQI-----------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCCCCCCCS-----------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCCCCcC-----------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 2211111110 12346788999999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.60 Aligned_cols=267 Identities=20% Similarity=0.289 Sum_probs=198.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CC-cEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC------eeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DG-REVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN------LVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 352 (625)
.++|++.+.||+|+||+||+|+.. ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++.. ..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CC
Confidence 368999999999999999999976 44 68999998654 345577889999999997765 8888886554 56
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE----------------
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILL---------------- 416 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll---------------- 416 (625)
..+|||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 789999999 56777766532 23469999999999999999999999999999999999999
Q ss_pred ---CCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccccccc
Q 047969 417 ---DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI 493 (625)
Q Consensus 417 ---~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~ 493 (625)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999864322 23457899999999999889999999999999999999999999765432211
Q ss_pred chhHHHHHHhhhccccc------ccCCcCCCCCh-HH-----------------HHHHHHHHHHHHHHhcccCCCCCCCH
Q 047969 494 NLANLAINKIQKCAFDE------LIDPCLGFESD-EE-----------------VKRMTTSVAELAFLCLQQNKELRPSM 549 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~~-----------------~~~~~~~l~~li~~cl~~~P~~RPs~ 549 (625)
.........+....... ........... .. ....+..+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 11111110000000000 00000000000 00 01235578899999999999999999
Q ss_pred HHHHHHH
Q 047969 550 EEVLAEL 556 (625)
Q Consensus 550 ~ell~~L 556 (625)
.|++++-
T Consensus 329 ~e~l~hp 335 (355)
T 2eu9_A 329 AEALLHP 335 (355)
T ss_dssp HHHTTSG
T ss_pred HHHhcCh
Confidence 9999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.83 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=186.4
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+.|.+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++.. ....+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEec
Confidence 3455678899999999987776789999999986542 35678999999987 89999999996554 6778999999
Q ss_pred ccCCChHHHhccCcccCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-------------CeEEE
Q 047969 361 VANGTVADQLHGDRAKHGL---LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-------------FCVKV 424 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-------------~~~kl 424 (625)
+. |+|.+++......... .++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5999999643322111 1334567899999999999999999999999999999754 48999
Q ss_pred cccccccccCCCccc---cccCCCCCCCccCcccccc-------CCCCCchhhhhHHHHHHHHHh-CCCCCccccccccc
Q 047969 425 ADFGLSRLFPLDVTH---VSTAPQGTPGYVDPEYHQC-------YQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEI 493 (625)
Q Consensus 425 ~DFgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~ 493 (625)
+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |..||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999876543222 1234579999999999865 568999999999999999998 999996432211
Q ss_pred chhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. .+....... +..... ....++.++.++|.+||+.||++|||+.++++|-
T Consensus 248 ---~----~i~~~~~~~---~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 248 ---S----NIIRGIFSL---DEMKCL---HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp ---H----HHHHTCCCC---CCCTTC---CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ---H----HHhcCCCCc---cccccc---ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1 111111100 000000 1134667899999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=338.90 Aligned_cols=201 Identities=24% Similarity=0.299 Sum_probs=170.3
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCC-----eeeeeeeeeeccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKN-----LVSLFGCTSRYSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n-----iv~~~~~~~~~~~ 352 (625)
..++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+++++.++ |++ |+++++++.. ..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-TT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-CC
Confidence 3579999999999999999999977 6889999998654 344567888999999885 553 8999986655 57
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCCCEEEC--CCCeEEEcccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH--ASDIIHRDVKTNNILLD--SNFCVKVADFG 428 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~ivHrDikp~NIll~--~~~~~kl~DFg 428 (625)
..+|||||+. ++|.+++... ....+++..+..++.||+.||.||| +.||+||||||+||||+ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 7899999996 4999998643 2245899999999999999999999 46999999999999994 57889999999
Q ss_pred cccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCccccc
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRH 489 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~ 489 (625)
+++..... .....||+.|+|||++.+..++.++||||||+++|||++|++||.....
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99875322 2345789999999999988999999999999999999999999986543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.35 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=192.2
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH------HHHHHHHHHHHHHHhc----CCCCeeeee
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY------RRVEQFMNEVEILTRL----RHKNLVSLF 344 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~ 344 (625)
+.....++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455689999999999999999999875 789999999865432 1233466899999999 899999999
Q ss_pred eeeeeccceEEEEEEe-ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCeE
Q 047969 345 GCTSRYSQGLLLVYEF-VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-SNFCV 422 (625)
Q Consensus 345 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-~~~~~ 422 (625)
+++.. .+..++|||+ +.+++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+
T Consensus 105 ~~~~~-~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFET-QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred EEEec-CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence 96655 5668999999 789999999963 34689999999999999999999999999999999999999 88999
Q ss_pred EEcccccccccCCCccccccCCCCCCCccCccccccCCCC-CchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH
Q 047969 423 KVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLT-DKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501 (625)
Q Consensus 423 kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 501 (625)
||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------ 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ 244 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------
Confidence 999999998764322 2345689999999998766654 489999999999999999999964211
Q ss_pred HhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 502 KIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
+...... +. ..++..+.++|.+||+.+|++|||+.|++++-.
T Consensus 245 -~~~~~~~------~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 245 -ILEAELH------FP-------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp -HHHTCCC------CC-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred -HhhhccC------Cc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0010000 00 123457888999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=337.71 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=197.8
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH------HHHHHHHHHHHHHHhcC--CCCeeeeeeeeeec
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY------RRVEQFMNEVEILTRLR--HKNLVSLFGCTSRY 350 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 350 (625)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 4578999999999999999999875 789999999865422 12245678999999996 5999999996665
Q ss_pred cceEEEEEEeccC-CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCeEEEcccc
Q 047969 351 SQGLLLVYEFVAN-GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD-SNFCVKVADFG 428 (625)
Q Consensus 351 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~-~~~~~kl~DFg 428 (625)
.+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 5678999999986 899999863 35689999999999999999999999999999999999999 78999999999
Q ss_pred cccccCCCccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 429 LSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 429 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... +....
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~ 259 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ 259 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhccc
Confidence 99876432 2234568999999999876665 6789999999999999999999964311 00100
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
. ... ..++.++.+++.+||+.||++|||++|++++-
T Consensus 260 ~--~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 260 V--FFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp C--CCS-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c--ccc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 000 02345788999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.22 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=180.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-H-HHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-R-RVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
.++|++.+.||+|+||.||+|++. +|+.||||++..... . ..+.+.++..+++.++||||+++++++.. ....++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEE
Confidence 468999999999999999999986 789999999865422 2 23344555667888899999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
|||+ ++.+..++. .....+++..++.++.||++||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 455555543 2345699999999999999999999996 9999999999999999999999999999765432
Q ss_pred ccccccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
. ......||+.|+|||++. ...++.++||||||+++|+|++|+.||....... .....+.......+
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------EVLTKVLQEEPPLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHHSCCCCC
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------HHHHHHhccCCCCC
Confidence 2 223456899999999984 4568899999999999999999999997532211 11111111111110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.. ...++..+.+++.+||+.||++||++.+++++-
T Consensus 251 ~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 251 PG----------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp CS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred Cc----------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 00 002345788899999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.77 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=185.2
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.+|++.+.||+|+||+||.....+++.||||++..... +.+.+|+++|+++ +|||||++++++.. ....+|||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEEC
Confidence 46888999999999997766566899999999865432 2356899999999 79999999996654 6778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-----CCeEEEcccccccccCC
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-----NFCVKVADFGLSRLFPL 435 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-----~~~~kl~DFgla~~~~~ 435 (625)
+. |+|.+++.... ..+.+..++.++.||+.||+|||++||+||||||+||||+. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 96 59999986432 23455566789999999999999999999999999999953 34688999999987643
Q ss_pred Ccc--ccccCCCCCCCccCccccc---cCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 436 DVT--HVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 436 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
... .......||+.|+|||++. ...++.++||||||+++|||++ |..||....... ....+......
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~ 248 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSLD 248 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCCCT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCCcc
Confidence 322 1224467999999999987 4567889999999999999999 999995432111 00011110000
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.. . .....+..+.+||.+||+.||++|||+.++++|
T Consensus 249 -~~----~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 249 -CL----H-----PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -TS----C-----TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc----C-----ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00 0 011334567889999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.41 Aligned_cols=232 Identities=13% Similarity=0.079 Sum_probs=184.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEEE
Confidence 68999999999999999999987 58999999986542 3456789999999999999999999997665 5678999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||++|++|.+++.. + .....+..++.||+.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999842 2 3556788999999999999999999999999999999999999998543
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
|++| ++.++||||||+++|+|++|+.||........+.... ...... .
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------~~~~~~-~ 222 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------RDTAGQ-P 222 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------BCTTSC-B
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------HHhccC-C
Confidence 3332 6889999999999999999999998654322110000 000000 0
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.........++..+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00011122456688999999999999999 999999999988754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=354.78 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=195.1
Q ss_pred cCCCccceecccCcEEEEEEEEc--CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce----E
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK--DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG----L 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~ 354 (625)
++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+.++++++||||+++++++...... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999986 6899999998643 345567789999999999999999999977653332 6
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
+|||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999887642 58999999999999999999999999999999999999885 89999999998754
Q ss_pred CCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 435 LDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 435 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.. ....||+.|+|||++.+. ++.++||||||+++|+|++|.+|+....... .
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-~--------------------- 284 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-L--------------------- 284 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-C---------------------
T ss_pred cC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-c---------------------
Confidence 32 345699999999998764 4889999999999999999998886421110 0
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhchh
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIK 560 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~i~ 560 (625)
.........+..+.+||.+||+.||++|| +++++.+.|..+.
T Consensus 285 ----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00112223456788999999999999999 5777777776654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.90 Aligned_cols=277 Identities=23% Similarity=0.282 Sum_probs=202.0
Q ss_pred HhcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-----ccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-----YSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 352 (625)
..++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999975 6899999998653 44556789999999999999999999996433 245
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCe---EEEccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC---VKVADFGL 429 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~---~kl~DFgl 429 (625)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 6799999999999999997432 2346899999999999999999999999999999999999987664 99999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccch--hHHHHHHhhhcc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL--ANLAINKIQKCA 507 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~--~~~~~~~~~~~~ 507 (625)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........... .......+ .
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~---~ 245 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI---V 245 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C---C
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh---h
Confidence 98764322 22445799999999999988999999999999999999999999965321110000 00000000 0
Q ss_pred cccccCCcCCC-----CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHH-----HHHHhchhcC
Q 047969 508 FDELIDPCLGF-----ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEV-----LAELQRIKSG 562 (625)
Q Consensus 508 ~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~el-----l~~L~~i~~~ 562 (625)
........... ........++..+.+++.+||..||++|||+.++ .+.+..+...
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000000000 0011122356788999999999999999999884 4555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.93 Aligned_cols=235 Identities=23% Similarity=0.253 Sum_probs=182.8
Q ss_pred hcCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHH-HhcCCCCeeeeeeeeee---ccceE
Q 047969 281 TNDFSRE-KELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEIL-TRLRHKNLVSLFGCTSR---YSQGL 354 (625)
Q Consensus 281 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~---~~~~~ 354 (625)
.++|.+. +.||+|+||.||+|+.. +++.||||++... ..+.+|+.++ +.++||||+++++++.. .....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4678887 77999999999999985 7899999998643 3466888888 56689999999996643 24568
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSR 431 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~ 431 (625)
++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999999642 2346999999999999999999999999999999999999998 7899999999987
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
... +..++.++||||||+++|+|++|+.||......... ......
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~- 213 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR- 213 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS-
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH-
Confidence 532 134678999999999999999999999654321100 000000
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
...............++.++.+++.+||+.||++|||+.|++++-.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0000011122233456778999999999999999999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.18 Aligned_cols=245 Identities=18% Similarity=0.158 Sum_probs=183.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCC-CCee--------------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRH-KNLV-------------- 341 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv-------------- 341 (625)
...|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+++.++| .|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345788899999999999999966 79999999986332 2335779999999999987 2211
Q ss_pred -eeee------eeee----ccceEEEEEEeccCCChHHHhccC---cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 047969 342 -SLFG------CTSR----YSQGLLLVYEFVANGTVADQLHGD---RAKHGLLTWPIRMNIAIETASALAYLHASDIIHR 407 (625)
Q Consensus 342 -~~~~------~~~~----~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 407 (625)
.+.+ +... .....+++|+++ +++|.+++... ......+++..++.++.||++||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111 0011 012356777765 67999888421 1234458888999999999999999999999999
Q ss_pred CCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCcccc----------ccCCCCCchhhhhHHHHHHHH
Q 047969 408 DVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH----------QCYQLTDKSDVYSFGVVLIEL 477 (625)
Q Consensus 408 Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDvwslG~il~el 477 (625)
||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||+++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999864322 344567 999999998 555688899999999999999
Q ss_pred HhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 478 ISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 478 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
++|+.||.......... ....... .++..+.+||.+||+.||++||++.+++++
T Consensus 311 ltg~~Pf~~~~~~~~~~---------------~~~~~~~---------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSE---------------WIFRSCK---------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHSSCCCCTTGGGSCSG---------------GGGSSCC---------CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHCCCCCCCcchhhhHH---------------HHHhhcc---------cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999997554322111 1111000 234578899999999999999999988765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=324.78 Aligned_cols=245 Identities=20% Similarity=0.207 Sum_probs=188.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhcC---------CCCeeee
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNN--------YRRVEQFMNEVEILTRLR---------HKNLVSL 343 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~ 343 (625)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+|+.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 68999999986542 223477889999999986 7777776
Q ss_pred eeeee-----------------e------------ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHH
Q 047969 344 FGCTS-----------------R------------YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394 (625)
Q Consensus 344 ~~~~~-----------------~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 394 (625)
.++.. . .....+|||||+++|++.+.+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 66422 1 1567899999999997766663 245899999999999999
Q ss_pred HHHHHH-hCCCcccCCCCCCEEECCCC--------------------eEEEcccccccccCCCccccccCCCCCCCccCc
Q 047969 395 ALAYLH-ASDIIHRDVKTNNILLDSNF--------------------CVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453 (625)
Q Consensus 395 ~L~yLH-~~~ivHrDikp~NIll~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aP 453 (625)
||+||| ++||+||||||+||||+.++ .+||+|||+|+..... ...||+.|+||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999999 99999999999999999887 9999999999875422 23689999999
Q ss_pred cccccCCCCCchhhhhHHHH-HHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHH
Q 047969 454 EYHQCYQLTDKSDVYSFGVV-LIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVA 532 (625)
Q Consensus 454 E~~~~~~~s~~sDvwslG~i-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 532 (625)
|++.+.. +.++||||++.+ .++++.|..||..... .......+..... ............++.++.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQMT------FKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHTCC------CSSCCCSHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhhhc------cCcccchhhhhhcCHHHH
Confidence 9998765 889999998777 7778889999843110 0011111111000 001122345567889999
Q ss_pred HHHHHhcccCCCCCCCHHHHH-HH
Q 047969 533 ELAFLCLQQNKELRPSMEEVL-AE 555 (625)
Q Consensus 533 ~li~~cl~~~P~~RPs~~ell-~~ 555 (625)
+||.+||+.| |++|++ +|
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-31 Score=291.75 Aligned_cols=185 Identities=18% Similarity=0.103 Sum_probs=129.2
Q ss_pred eecccCcEEEEEEEE-cCCcEEEEEEeccc----------cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEE
Q 047969 289 ELGDGGFGTVYYGKL-KDGREVAVKRLYDN----------NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 289 ~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l 356 (625)
.++.|++|.+..++. ..|+.+|+|++... .....++|.+|+++|+++ .|+||+++++++.+ ++..||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence 467788887777653 36899999998543 223457799999999999 79999999996554 778999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++|++|.++|. ..+.+++. +|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999996 44567764 48899999999999999999999999999999999999999999876433
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA 483 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p 483 (625)
.. ......||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22 2234569999999999976 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=260.21 Aligned_cols=184 Identities=17% Similarity=0.216 Sum_probs=140.6
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNN--------YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
...+.||+|+||.||+|+. .++.+++|+..... ....+++.+|+++|++++||||+++..+... ....+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEE
Confidence 4456899999999999954 57889999864321 1124568999999999999999944432333 445699
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++|++|.+++.. +..++.||++||+|||++||+||||||+|||++. .+||+|||+++.....
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999999953 4579999999999999999999999999999998 9999999999986543
Q ss_pred cccc------ccCCCCCCCccCcccccc--CCCCCchhhhhHHHHHHHHHhCCCCC
Q 047969 437 VTHV------STAPQGTPGYVDPEYHQC--YQLTDKSDVYSFGVVLIELISSMPAV 484 (625)
Q Consensus 437 ~~~~------~~~~~gt~~y~aPE~~~~--~~~s~~sDvwslG~il~elltG~~p~ 484 (625)
.... .....||+.|||||++.. ..|+..+|+|+..+-.++.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 124568999999999976 56788899999999888888766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=219.74 Aligned_cols=151 Identities=16% Similarity=0.100 Sum_probs=121.2
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH------------------HHHHHHHHHHHHHHhcCC
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY------------------RRVEQFMNEVEILTRLRH 337 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 337 (625)
.+......|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444566777899999999999999997799999999854321 13567899999999999
Q ss_pred CCeeeeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 047969 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD 417 (625)
Q Consensus 338 ~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~ 417 (625)
| +++++++.. +..++||||++|++|.+ +.. .....++.||+.||.|||++||+||||||+|||++
T Consensus 163 -~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW--EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec--cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE
Confidence 4 566664433 45699999999999988 421 12446999999999999999999999999999999
Q ss_pred CCCeEEEcccccccccCCCccccccCCCCCCCccCccccc
Q 047969 418 SNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457 (625)
Q Consensus 418 ~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 457 (625)
++.+||+|||+|+. +..++|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999973 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=186.25 Aligned_cols=136 Identities=18% Similarity=0.190 Sum_probs=106.5
Q ss_pred CCccceecccCcEEEEEEEE-cCCcE--EEEEEeccccH------------------------HHHHHHHHHHHHHHhcC
Q 047969 284 FSREKELGDGGFGTVYYGKL-KDGRE--VAVKRLYDNNY------------------------RRVEQFMNEVEILTRLR 336 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~ 336 (625)
|++.+.||+|+||.||+|.. .+|+. ||||++..... .....+.+|+.+|+++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999998 68999 99998643311 11236789999999998
Q ss_pred CCCe--eeeeeeeeeccceEEEEEEeccC-C----ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccC
Q 047969 337 HKNL--VSLFGCTSRYSQGLLLVYEFVAN-G----TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH-ASDIIHRD 408 (625)
Q Consensus 337 h~ni--v~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ivHrD 408 (625)
|+++ ..++.+ ...+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.||+|||
T Consensus 129 ~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred hCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 8764 334431 245899999943 3 67666531 234467789999999999999 99999999
Q ss_pred CCCCCEEECCCCeEEEccccccccc
Q 047969 409 VKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 409 ikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-19 Score=183.34 Aligned_cols=135 Identities=14% Similarity=0.149 Sum_probs=100.0
Q ss_pred CCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH--------------HHHH--------HHHHHHHHHHhcCCCCe
Q 047969 283 DFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--------------RRVE--------QFMNEVEILTRLRHKNL 340 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~ni 340 (625)
-|++.++||.|+||.||+|...+|+.||||+++.... .... ...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4999999999999999999999999999998642100 0001 12356777777755443
Q ss_pred e--eeeeeeeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 341 V--SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 341 v--~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
. ..++ . ...+|||||++|++|.++.. . +....++.||+.+|.+||+.|||||||||.||||++
T Consensus 176 ~vp~p~~---~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIA---Q--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEE---E--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCeeee---c--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 2 2222 1 12379999999988765432 1 234568899999999999999999999999999987
Q ss_pred CC----------eEEEcccccccc
Q 047969 419 NF----------CVKVADFGLSRL 432 (625)
Q Consensus 419 ~~----------~~kl~DFgla~~ 432 (625)
++ .+.|+||+.+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 489999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.4e-13 Score=130.99 Aligned_cols=145 Identities=12% Similarity=0.071 Sum_probs=113.0
Q ss_pred HHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceE
Q 047969 276 DLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 276 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 354 (625)
.+.....+|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.+++++... .+..
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~ 85 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCce
Confidence 34556678999899999999999999864 7899999986432122345889999999995 6677788885554 5667
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA--------------------------------- 401 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--------------------------------- 401 (625)
++||||++|.+|.+.+. +......++.+++++|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 99999999999887642 112234688999999999998
Q ss_pred --------------------------CCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 402 --------------------------SDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 402 --------------------------~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
..++|+|++|.|||++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876666799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.4e-11 Score=122.00 Aligned_cols=136 Identities=15% Similarity=0.126 Sum_probs=98.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC--eeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN--LVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~ 358 (625)
..++.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++... .+..++||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~ 94 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLL 94 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEE
Confidence 4456654333455569999998777888999987543 2245778999999996545 4457774443 45679999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD----------------------------------- 403 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~----------------------------------- 403 (625)
||++|.+|. ... .. ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999998874 211 11 1256777888888888643
Q ss_pred -----------------------CcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 404 -----------------------IIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 404 -----------------------ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
++|+|++|.|||+++++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.6e-10 Score=117.73 Aligned_cols=141 Identities=17% Similarity=0.226 Sum_probs=104.1
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEec--ccc-HHHHHHHHHHHHHHHhcC--CCCeeeeeeeeeecc--ceEEEE
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLY--DNN-YRRVEQFMNEVEILTRLR--HKNLVSLFGCTSRYS--QGLLLV 357 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~--~~~~lv 357 (625)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+.+++.+..... +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999999875 4678888765 322 122356788999999997 455777777554321 346899
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA------------------------------------ 401 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~------------------------------------ 401 (625)
|||++|..+.+.. ...++......++.++++.|..||+
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999997764321 1236788888999999999999997
Q ss_pred ----------------------CCCcccCCCCCCEEECCCCe--EEEcccccccc
Q 047969 402 ----------------------SDIIHRDVKTNNILLDSNFC--VKVADFGLSRL 432 (625)
Q Consensus 402 ----------------------~~ivHrDikp~NIll~~~~~--~kl~DFgla~~ 432 (625)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987653 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-09 Score=110.08 Aligned_cols=184 Identities=20% Similarity=0.189 Sum_probs=120.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCC--eeeeeeeeeecc--ceEEEEEEec
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKN--LVSLFGCTSRYS--QGLLLVYEFV 361 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~--~~~~lv~e~~ 361 (625)
++.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +.+++....... ...++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4579999999999864 45889986432 34567889999999884 332 334443222211 1348899999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA---------------------------------------- 401 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---------------------------------------- 401 (625)
+|.+|.+... ..++..++..++.++++.|..||+
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865432 136777888889999999988886
Q ss_pred ------------------CCCcccCCCCCCEEECC--CCeEEEcccccccccCCCccccccCCCCCCCccCcccc----c
Q 047969 402 ------------------SDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH----Q 457 (625)
Q Consensus 402 ------------------~~ivHrDikp~NIll~~--~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~ 457 (625)
..++|+|++|.||+++. +..+.|+||+.+......... ....... .-..|+.. .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~-~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDD-EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTT-TSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhc-cccCHHHHHHHHH
Confidence 13699999999999998 566889999998753221100 0000000 00223221 1
Q ss_pred cCC----------CCCchhhhhHHHHHHHHHhCCCCC
Q 047969 458 CYQ----------LTDKSDVYSFGVVLIELISSMPAV 484 (625)
Q Consensus 458 ~~~----------~s~~sDvwslG~il~elltG~~p~ 484 (625)
.+. .....+.|+++.++|.+.+|.+++
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 112368999999999999998766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=3.3e-07 Score=92.94 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=93.7
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC---CeeeeeeeeeeccceEEEEEEeccC
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK---NLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
.+.++.|....||+. |+.+++|+.. .......+.+|+++|+.+.+. .+.+++.+.....+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 457888999999988 5678888853 233456788999999999752 2445555443334456899999999
Q ss_pred CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 047969 364 GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS----------------------------------------- 402 (625)
Q Consensus 364 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------------------------------------- 402 (625)
.++..... ..++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88866321 1234555555566666666666542
Q ss_pred -------------------CCcccCCCCCCEEECC---CCe-EEEcccccccc
Q 047969 403 -------------------DIIHRDVKTNNILLDS---NFC-VKVADFGLSRL 432 (625)
Q Consensus 403 -------------------~ivHrDikp~NIll~~---~~~-~kl~DFgla~~ 432 (625)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.1e-06 Score=82.95 Aligned_cols=139 Identities=19% Similarity=0.144 Sum_probs=94.7
Q ss_pred hcCCCccceecccCcE-EEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccceEEEE
Q 047969 281 TNDFSREKELGDGGFG-TVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv 357 (625)
...|+. +.+..|..| .||+.... ++..+++|+-... ....+.+|+.+|+.+. +-.+.+++++... .+..++|
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lv 98 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLL 98 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEE
Confidence 334443 345556555 68988765 5677999986433 3456788999999885 3345666665444 4667999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS----------------------------------- 402 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------------------------------- 402 (625)
||+++|.++.+..... ......+..+++..|..||+.
T Consensus 99 me~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp EECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 9999998877654311 112234555666666666642
Q ss_pred -----------------------CCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 403 -----------------------DIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 403 -----------------------~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=1.4e-06 Score=90.21 Aligned_cols=81 Identities=5% Similarity=-0.013 Sum_probs=53.4
Q ss_pred ccee-cccCcEEEEEEEEc-------CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcC-C--CCeeeeeeeeeecc-
Q 047969 287 EKEL-GDGGFGTVYYGKLK-------DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLR-H--KNLVSLFGCTSRYS- 351 (625)
Q Consensus 287 ~~~L-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~- 351 (625)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+|+.+. + ..+.+++.+.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999988764 26789999764322 001245678888888884 2 34666776443321
Q ss_pred -ceEEEEEEeccCCChH
Q 047969 352 -QGLLLVYEFVANGTVA 367 (625)
Q Consensus 352 -~~~~lv~e~~~~gsL~ 367 (625)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3458999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.5e-05 Score=81.58 Aligned_cols=140 Identities=18% Similarity=0.215 Sum_probs=79.1
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC--CCCeeeeee-----eeeeccceEEEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR--HKNLVSLFG-----CTSRYSQGLLLVYE 359 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~-----~~~~~~~~~~lv~e 359 (625)
.+.|+.|..+.||+....+| .+++|+.... . +.+..|+.+++.|. .-.+.+++. .+....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987655 5899988652 2 23344555555553 112333332 11122456789999
Q ss_pred eccCCChH--------------HHhccCcccC----------CCCCHHHH------------------------------
Q 047969 360 FVANGTVA--------------DQLHGDRAKH----------GLLTWPIR------------------------------ 385 (625)
Q Consensus 360 ~~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~------------------------------ 385 (625)
|++|..+. ..+|...... ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122111100 01122211
Q ss_pred -HHHHHHHHHHHHHHHh-------------CCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 386 -MNIAIETASALAYLHA-------------SDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 386 -~~i~~qi~~~L~yLH~-------------~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
..+..++..++.+|+. ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666652 479999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=6.9e-06 Score=86.38 Aligned_cols=75 Identities=17% Similarity=0.184 Sum_probs=49.1
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeccccH-------HHHHHHHHHHHHHHhcCC--CC-eeeeeeeeeeccceEE
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-------RRVEQFMNEVEILTRLRH--KN-LVSLFGCTSRYSQGLL 355 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~~ 355 (625)
.+.||.|..+.||++... +++.++||....... ...+++..|+++|+.+.. +. +.+++.+ . ....+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d--~~~~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEMAV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTTTE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c--CCccE
Confidence 568999999999999754 578899997643211 123456789999988742 33 3455542 2 23358
Q ss_pred EEEEeccCC
Q 047969 356 LVYEFVANG 364 (625)
Q Consensus 356 lv~e~~~~g 364 (625)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.99 E-value=2.5e-05 Score=78.13 Aligned_cols=79 Identities=23% Similarity=0.194 Sum_probs=57.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC---CCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH---KNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~lv~ 358 (625)
......+.+|.|..+.||+.+..||+.|++|+...........|..|++.|+.|.- ..+.+++++. .-++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEEE
Confidence 34556778999999999999999999999998654433333457889999998842 2344555421 127899
Q ss_pred EeccCCC
Q 047969 359 EFVANGT 365 (625)
Q Consensus 359 e~~~~gs 365 (625)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00065 Score=68.76 Aligned_cols=157 Identities=13% Similarity=0.166 Sum_probs=88.4
Q ss_pred cChHHHHHHhcCCCc-----cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC--eeeee
Q 047969 272 FSYSDLAEATNDFSR-----EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN--LVSLF 344 (625)
Q Consensus 272 ~~~~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~ 344 (625)
++.+++.....+|.+ .+.|+.|....+|+....+| .+++|+.... ...+.+..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 555667777666765 34567788899999987655 6889987542 12234566888887774222 33333
Q ss_pred ee-----eeeccceEEEEEEeccCCChHH--------------HhccCccc--C---CCCC---HHHHHH----------
Q 047969 345 GC-----TSRYSQGLLLVYEFVANGTVAD--------------QLHGDRAK--H---GLLT---WPIRMN---------- 387 (625)
Q Consensus 345 ~~-----~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~--~---~~l~---~~~~~~---------- 387 (625)
.. .....+..+++|+|++|..+.. .+|..... . .... |...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1112345689999999864311 12211000 0 0011 221100
Q ss_pred --HHHHHHHHHHHHHh-------CCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 388 --IAIETASALAYLHA-------SDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 388 --i~~qi~~~L~yLH~-------~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
+...+.+.++.+++ .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01123445555553 369999999999999987666899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0002 Score=71.92 Aligned_cols=74 Identities=9% Similarity=0.075 Sum_probs=45.4
Q ss_pred CCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEEEEec-
Q 047969 284 FSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLVYEFV- 361 (625)
Q Consensus 284 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~- 361 (625)
+.-++.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .++++.. ...-++|+||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecC
Confidence 344678999999999998 55888887543211 1123468888877743233 3455422 22237899999
Q ss_pred cCCCh
Q 047969 362 ANGTV 366 (625)
Q Consensus 362 ~~gsL 366 (625)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00089 Score=67.51 Aligned_cols=76 Identities=17% Similarity=0.179 Sum_probs=57.2
Q ss_pred ccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC---CCCeeeeeeeeeeccceEEEEEEecc
Q 047969 286 REKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR---HKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
..+.|+.|....+|+... +++.+++|+.... ....+..|++.|+.|. ...+.+++.+... .+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEecc
Confidence 356799999999999886 4778889986543 3466888999998884 3567777774433 456799999999
Q ss_pred CCCh
Q 047969 363 NGTV 366 (625)
Q Consensus 363 ~gsL 366 (625)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00082 Score=68.20 Aligned_cols=159 Identities=14% Similarity=0.105 Sum_probs=89.8
Q ss_pred cccChHHHHHHhcCCCc-----cceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCC--Ceee
Q 047969 270 PIFSYSDLAEATNDFSR-----EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHK--NLVS 342 (625)
Q Consensus 270 ~~~~~~~~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~ 342 (625)
...+.+.+....+.|.+ .+.|+ |....||+....+|+.+++|+..... ...+.+..|..+++.+... .+++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 33455556555555532 34577 88889999887778789999875331 1234566788888887422 2344
Q ss_pred eeee----eeeccceEEEEEEeccCCChH-----H---------HhccCcc-----cCCCCCHHHH--------------
Q 047969 343 LFGC----TSRYSQGLLLVYEFVANGTVA-----D---------QLHGDRA-----KHGLLTWPIR-------------- 385 (625)
Q Consensus 343 ~~~~----~~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~~~-----~~~~l~~~~~-------------- 385 (625)
++.. .....+..+++||+++|..+. . .+|.... ....+++...
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4432 011134567899999885432 1 1111000 0111222111
Q ss_pred --------HHHHHHHHHHHHHH----HhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 386 --------MNIAIETASALAYL----HASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 386 --------~~i~~qi~~~L~yL----H~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
...+.+++..++-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11112222222222 123589999999999999 4 899999988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00014 Score=76.96 Aligned_cols=80 Identities=15% Similarity=0.113 Sum_probs=46.7
Q ss_pred HhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccCCCCCCCccCccccccC---CCCCchhhhhHHHHHHH
Q 047969 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY---QLTDKSDVYSFGVVLIE 476 (625)
Q Consensus 400 H~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwslG~il~e 476 (625)
+...++|+|++|.|||++.++ ++|+||+.+...............-...|.+|+..... ......++......+|+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 355799999999999998876 99999998875321100000000001235555544311 11123455677777887
Q ss_pred HHhC
Q 047969 477 LISS 480 (625)
Q Consensus 477 lltG 480 (625)
.+.+
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0014 Score=61.33 Aligned_cols=97 Identities=13% Similarity=0.132 Sum_probs=65.8
Q ss_pred ChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccccC
Q 047969 365 TVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTA 443 (625)
Q Consensus 365 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 443 (625)
+|.+.|. ..+.+|+++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 7888885 466789999999999999999888732 1222333557899999999988764 1111
Q ss_pred CCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh
Q 047969 444 PQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS 479 (625)
Q Consensus 444 ~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt 479 (625)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888663 345678899999999999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00069 Score=69.04 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=72.7
Q ss_pred cceecccCcEE-EEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC--CCeeeeeeeeeeccceEEEEEEeccC
Q 047969 287 EKELGDGGFGT-VYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH--KNLVSLFGCTSRYSQGLLLVYEFVAN 363 (625)
Q Consensus 287 ~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~ 363 (625)
.+.|+.|+... +|+....+|+.+++|....... +.+..|+.+++.+.. -.+.+++.+. . ... +++||++.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d-~-~~g-~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE-H-ARG-LLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE-T-TTT-EEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec-C-CCC-EEEEeeCCC
Confidence 34566665554 6677654477788876533211 234457777776642 2345566532 2 222 789999977
Q ss_pred CChHHHhccCcc---------------------c-CCCCCHHHHH-------H-------------HHHHHHHHHHHH--
Q 047969 364 GTVADQLHGDRA---------------------K-HGLLTWPIRM-------N-------------IAIETASALAYL-- 399 (625)
Q Consensus 364 gsL~~~l~~~~~---------------------~-~~~l~~~~~~-------~-------------i~~qi~~~L~yL-- 399 (625)
..+.+++..... . ...++..... . ....+...+..|
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 666544421100 0 0112211110 0 001112223333
Q ss_pred ----HhCCCcccCCCCCCEEECCC----CeEEEcccccccc
Q 047969 400 ----HASDIIHRDVKTNNILLDSN----FCVKVADFGLSRL 432 (625)
Q Consensus 400 ----H~~~ivHrDikp~NIll~~~----~~~kl~DFgla~~ 432 (625)
+...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 22369999999999999874 6899999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00051 Score=72.77 Aligned_cols=73 Identities=16% Similarity=0.295 Sum_probs=49.5
Q ss_pred cceecccCcEEEEEEEEcC--------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKD--------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv 357 (625)
++.|+.|....||+....+ ++.+++|+...... .+.+.+|+.+++.+...++ .++++.+. + .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~---~--g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS---G--GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET---T--EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC---C--CEE
Confidence 4678888899999998753 57899998743211 1455689999998853344 45665332 2 389
Q ss_pred EEeccCCCh
Q 047969 358 YEFVANGTV 366 (625)
Q Consensus 358 ~e~~~~gsL 366 (625)
|||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00056 Score=70.85 Aligned_cols=74 Identities=12% Similarity=0.124 Sum_probs=44.4
Q ss_pred cceecccCcEEEEEEEEcC---------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEE
Q 047969 287 EKELGDGGFGTVYYGKLKD---------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLL 356 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~l 356 (625)
.+.|+.|....+|+....+ ++.+++|+..... ........|.++++.+...++ .++++.. . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF---N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec---C--CcE
Confidence 4568888889999998754 2688899864432 111123578888888853343 3555422 1 268
Q ss_pred EEEeccCCCh
Q 047969 357 VYEFVANGTV 366 (625)
Q Consensus 357 v~e~~~~gsL 366 (625)
||||++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.001 Score=69.06 Aligned_cols=140 Identities=18% Similarity=0.234 Sum_probs=81.1
Q ss_pred cceecccCcEEEEEEEEc--------CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEE
Q 047969 287 EKELGDGGFGTVYYGKLK--------DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv 357 (625)
++.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.|...++ .++++.+.. .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----ccE
Confidence 356777888899998864 2578999985332 1234556789999988853222 455553322 289
Q ss_pred EEeccCCChHH-----------------HhccCccc-CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 047969 358 YEFVANGTVAD-----------------QLHGDRAK-HGLL--TWPIRMNIAIETAS-------------------ALAY 398 (625)
Q Consensus 358 ~e~~~~gsL~~-----------------~l~~~~~~-~~~l--~~~~~~~i~~qi~~-------------------~L~y 398 (625)
|||++|.+|.. .||..... .... -+.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999865431 11111111 1112 23455555444322 2333
Q ss_pred HH----hC----CCcccCCCCCCEEECCC----CeEEEcccccccc
Q 047969 399 LH----AS----DIIHRDVKTNNILLDSN----FCVKVADFGLSRL 432 (625)
Q Consensus 399 LH----~~----~ivHrDikp~NIll~~~----~~~kl~DFgla~~ 432 (625)
|. .. .++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 22 58999999999999876 7899999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0044 Score=65.90 Aligned_cols=74 Identities=12% Similarity=0.020 Sum_probs=47.5
Q ss_pred cceecccCcEEEEEEEEcC-CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEEEEeccCC
Q 047969 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLVYEFVANG 364 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~g 364 (625)
++.|+.|-...+|+....+ ++.+++|+......... ...+|..+++.|...++ .++++.+ . + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~-~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF-T--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE-T--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe-C--C--eEEEEeeCCc
Confidence 4678888899999998864 47888997643221111 12579999999975555 4566543 2 2 3599999875
Q ss_pred Ch
Q 047969 365 TV 366 (625)
Q Consensus 365 sL 366 (625)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0078 Score=61.41 Aligned_cols=30 Identities=20% Similarity=0.406 Sum_probs=27.2
Q ss_pred CCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 403 DIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 403 ~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 699999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.61 E-value=0.025 Score=59.41 Aligned_cols=74 Identities=9% Similarity=0.099 Sum_probs=47.7
Q ss_pred cceecccCcEEEEEEEEcC--------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKD--------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv 357 (625)
++.|..|-...+|+....+ ++.+++|+...... ..-...+|.++++.+...++ .++++. .. + ++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~-~~--~--~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIAD-FP--E--GRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEE-ET--T--EEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEE-cC--C--CEE
Confidence 4567778888999998753 57899998643321 11123578888888853333 344442 21 2 789
Q ss_pred EEeccCCCh
Q 047969 358 YEFVANGTV 366 (625)
Q Consensus 358 ~e~~~~gsL 366 (625)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.45 E-value=0.12 Score=53.68 Aligned_cols=29 Identities=31% Similarity=0.448 Sum_probs=24.9
Q ss_pred CcccCCCCCCEEE------CCCCeEEEcccccccc
Q 047969 404 IIHRDVKTNNILL------DSNFCVKVADFGLSRL 432 (625)
Q Consensus 404 ivHrDikp~NIll------~~~~~~kl~DFgla~~ 432 (625)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.76 E-value=0.14 Score=54.43 Aligned_cols=60 Identities=7% Similarity=0.062 Sum_probs=17.4
Q ss_pred CccceecccCcEEEEEEEEcC-CcEEEE------EEecccc--HHHHHHHHHHHHHHHhcCCCCeeeeeeee
Q 047969 285 SREKELGDGGFGTVYYGKLKD-GREVAV------KRLYDNN--YRRVEQFMNEVEILTRLRHKNLVSLFGCT 347 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 347 (625)
.+.+.|| ||.||+|.+.. ..+||| |...... ......|.+|..+++.++|||+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 3456676 99999998763 357888 7664432 23345688999999999999999998854
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 625 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 5e-72
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 23/283 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ + +G G FGTVY GK V + + ++++ F NEV +L + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
G ++ + L +V ++ ++ LH K ++IA +TA + YLHA
Sbjct: 68 LFMGYST--APQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHA 122
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP-LDVTHVSTAPQGTPGYVDPEYHQCYQ 460
IIHRD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 461 ---LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+ +SDVY+FG+VL EL++ IN + I + + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
+ L CL++ ++ RP ++LA ++ +
Sbjct: 237 NCPKA--------MKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-67
Identities = 69/278 (24%), Positives = 124/278 (44%), Gaps = 23/278 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ LG G FG V+ G +VAVK L + F+ E ++ +L+H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ + + + ++ E++ NG++ D L LT +++A + A +A++
Sbjct: 72 RLYAVVT--QEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE 127
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+ IHRD++ NIL+ K+ADFGL+RL + + + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
T KSDV+SFG++L E+++ E+ I +++ D C
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNC-----P 236
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
EE+ +L LC ++ E RP+ + + + L+
Sbjct: 237 EELY-------QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-66
Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 27/280 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ + +G G FG V G + G +VAVK + N + F+ E ++T+LRH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L G GL +V E++A G++ D L +L + +++ A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
++ +HRD+ N+L+ + KV+DFGL++ + + PE + +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKF 177
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
+ KSDV+SFG++L E+ S ++ + +++K + D C
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGC------ 225
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
+V E+ C + +RPS ++ +L+ IK+
Sbjct: 226 ------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 9e-66
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 23/278 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
E +LG G FG V+ G VA+K L E F+ E +++ +LRH+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+ S + + +V E+++ G++ D L G+ K+ P +++A + AS +AY+
Sbjct: 76 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVER 131
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+ +HRD++ NIL+ N KVADFGL+RL + + + PE +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
T KSDV+SFG++L EL + E+ ++++++ C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPEC------ 239
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
S+ +L C ++ E RP+ E + A L+
Sbjct: 240 ------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 77/282 (27%), Positives = 133/282 (47%), Gaps = 24/282 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
++ + +E+G G FG V+ G + +VA+K + + E F+ E E++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+G + LV+EF+ +G ++D L + GL + + ++ +AYL
Sbjct: 64 QLYGV-CLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+ +IHRD+ N L+ N +KV+DFG++R D ST + + PE +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
+ KSDV+SFGV++ E+ S NR E+ + I L P
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKP------- 224
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI-KSG 562
+ +T V ++ C ++ E RP+ +L +L I +SG
Sbjct: 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 8e-65
Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 23/278 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
D + KELG G FG V YGK + +VA+K + ++F+ E +++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L+G ++ + + ++ E++ANG + + L + + + A+ YL +
Sbjct: 63 QLYGVCTK-QRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
+HRD+ N L++ VKV+DFGLSR D S + + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 462 TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESD 521
+ KSD+++FGV++ E+ S E I + L P
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRP------- 223
Query: 522 EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
+ V + + C + + RP+ + +L+ + +
Sbjct: 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-62
Identities = 70/304 (23%), Positives = 135/304 (44%), Gaps = 37/304 (12%)
Query: 287 EKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGC 346
++ +G G FG V+ GK + G EVAVK + R E+ LRH+N++
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 347 TSRYSQG---LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS- 402
++ + L LV ++ +G++ D L+ +T + +A+ TAS LA+LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEI 120
Query: 403 -------DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ---GTPGYVD 452
I HRD+K+ NIL+ N +AD GL+ + AP GT Y+
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 453 PEY------HQCYQLTDKSDVYSFGVVLIELISSMP----AVDMNRHRHEINLANLAINK 502
PE + ++ ++D+Y+ G+V E+ D +++ ++ ++ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 503 IQKCAFDELIDPCL--GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
++K ++ + P + ++S E ++ M A++ C N R + + L ++
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 561 SGKS 564
+
Sbjct: 297 QQEG 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-62
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 29/280 (10%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKN 339
D+ +G G +G + K DG+ + K L + + ++EV +L L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+V + R + L +V E+ G +A + + L + + + AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 399 LH-----ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
H ++HRD+K N+ LD VK+ DFGL+R+ D T + A GTP Y+ P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSP 183
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
E +KSD++S G +L EL + MP + KI++ F +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIPY 236
Query: 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
SDE + E+ L RPS+EE+L
Sbjct: 237 RY----SDE--------LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (521), Expect = 1e-61
Identities = 75/308 (24%), Positives = 135/308 (43%), Gaps = 44/308 (14%)
Query: 272 FSYSDLAEATNDFSRE---------KELGDGGFGTVYYGKLK----DGREVAVKRLYDNN 318
F++ D EA +F++E + +G G FG V G LK VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 319 YRR-VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKH 377
+ F++E I+ + H N++ L G ++ S ++++ EF+ NG++ R
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMIITEFMENGSL---DSFLRQND 122
Query: 378 GLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437
G T + + A+ + YL + +HRD+ NIL++SN KV+DFGLSR D
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 438 THV----STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRH 491
+ + + + PE Q + T SDV+S+G+V+ E++S P DM
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--- 239
Query: 492 EINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551
++I+ +++ +L C Q+++ RP +
Sbjct: 240 -----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 552 VLAELQRI 559
++ L ++
Sbjct: 283 IVNTLDKM 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (518), Expect = 2e-61
Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 23/279 (8%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
D + + +LG G +G VY G K VAVK L + VE+F+ E ++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V L G +R ++ EF+ G + D L ++ + + +A + +SA+ YL
Sbjct: 76 VQLLGVCTREPP-FYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 401 ASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQ 460
+ IHRD+ N L+ N VKVADFGLSRL D + + PE +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 461 LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520
+ KSDV++FGV+L E+ + + ++ EL++ E
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELLEKDYRMER 237
Query: 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
E V EL C Q N RPS E+ + +
Sbjct: 238 PEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-60
Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 37/317 (11%)
Query: 280 ATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLY-DNNYRRVEQFMNEVEILTRLRH 337
+DF + ELG G G V+ K G +A K ++ + Q + E+++L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+V +G + + E + G++ L K G + I ++I L
Sbjct: 64 PYIVGFYGA-FYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLT 118
Query: 398 YLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
YL I+HRDVK +NIL++S +K+ DFG+S ++ + GT Y+ PE
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERL 175
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
Q + +SD++S G+ L+E+ + + + + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 517 GFESDEEVKRMTTSVAELAFL------------------------CLQQNKELRPSMEEV 552
S R ++ EL CL +N R ++++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 553 LAE--LQRIKSGKSKFE 567
+ ++R + + F
Sbjct: 296 MVHAFIKRSDAEEVDFA 312
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 8e-60
Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 28/280 (10%)
Query: 281 TNDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
+ + ELGDG FG VY + K+ A K + + +E +M E++IL H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V L Y L ++ EF A G V + LT + +T AL YL
Sbjct: 71 IVKLLDA-FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYL 126
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H + IIHRD+K NIL + +K+ADFG+S + + GTP ++ PE C
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCE 185
Query: 460 QLTD-----KSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
D K+DV+S G+ LIE+ P HE+N + + KI K L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRV-LLKIAKSEPPTLAQP 238
Query: 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
R +++ + CL++N + R + ++L
Sbjct: 239 ----------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-59
Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 31/280 (11%)
Query: 287 EKELGDGGFGTVYYGKLKD---GREVAVKRLYD--NNYRRVEQFMNEVEILTRLRHKNLV 341
+KELG G FGTV G + + VAVK L + N+ ++ + E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ G + +LV E G + L ++ + + + + + + YL
Sbjct: 72 RMIGICEA--ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGYVDPEYHQCY 459
S+ +HRD+ N+LL + K++DFGLS+ D + + PE Y
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519
+ + KSDV+SFGV++ E S E+ ++K C
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGC---- 235
Query: 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
E + +L LC + E RP V L+
Sbjct: 236 PRE--------MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 3e-59
Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 47/306 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRL-YDNNYRRVEQFMNEVEILTR 334
N+ +++G+G FG V+ + VAVK L + + F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGL--------------- 379
+ N+V L G + + L++E++A G + + L
Sbjct: 73 FDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 380 -----LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR-LF 433
L+ ++ IA + A+ +AYL +HRD+ T N L+ N VK+ADFGLSR ++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 434 PLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEI 493
D ++ PE + T +SDV+++GVVL E+ S E+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 494 NLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
I ++ + C + L LC + RPS +
Sbjct: 252 ------IYYVRDGNILACPENC------------PLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 554 AELQRI 559
LQR+
Sbjct: 294 RILQRM 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-59
Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 34/276 (12%)
Query: 287 EKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHKNLVSL 343
+ E+G G F TVY G + EVA L D + ++F E E+L L+H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 344 FGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+ T + + ++LV E + +GT+ L + ++ + + + L +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 401 A--SDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
IIHRD+K +NI + VK+ D GL+ L + A GTP ++ PE ++
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+ + DVY+FG+ ++E+ +S ++ +I ++ D
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPASFDKVA- 238
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
EVK E+ C++QNK+ R S++++L
Sbjct: 239 ---IPEVK-------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-58
Identities = 71/286 (24%), Positives = 132/286 (46%), Gaps = 30/286 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDG-----REVAVKRLY-DNNYRRVEQFMNEVEILTRL 335
+ +R+K +G G FG VY G LK VA+K L ++ F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 336 RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
H N++ L G S+ + ++++ E++ NG + L K G + + + A+
Sbjct: 67 SHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAG 122
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD--VTHVSTAPQGTPGYVDP 453
+ YL + +HRD+ NIL++SN KV+DFGLSR+ D T+ ++ + + P
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
E + T SDV+SFG+V+ E+++ HE+ + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAIN 227
Query: 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
+ + +++ +L C QQ + RP ++++ L ++
Sbjct: 228 DGFRLPTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-58
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 34/289 (11%)
Query: 280 ATNDFS-REKELGDGGFGTVYYGKLK---DGREVAVKRLYDNNYRR-VEQFMNEVEILTR 334
++ + ELG G FG+V G + +VA+K L + E+ M E +I+ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
L + +V L G ++ L+LV E G + L G K + + + +
Sbjct: 66 LDNPYIVRLIGVCQ--AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSM 120
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH--VSTAPQGTPGYVD 452
+ YL + +HRD+ N+LL + K++DFGLS+ D ++ +A + +
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
PE + + +SDV+S+GV + E +S P M + I++ E
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME 232
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
C E + L C E RP V ++
Sbjct: 233 CPPEC----PPE--------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-58
Identities = 78/276 (28%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR---VEQFMNEVEILTRLRH 337
DF + LG G FG VY + K +A+K L+ + Q EVEI + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
N++ L+G + + L+ E+ GTV +L K E A+AL+
Sbjct: 66 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALS 120
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
Y H+ +IHRD+K N+LL S +K+ADFG S P GT Y+ PE +
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIE 177
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+K D++S GV+ E + P + N ++ +I + E P
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRV---EFTFP--- 224
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+T +L L+ N RP + EVL
Sbjct: 225 -------DFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-58
Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 29/283 (10%)
Query: 287 EKELGDGGFGTVYYGKLKD----GREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKNLV 341
+ +G G FG VY+G L D AVK L + V QF+ E I+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
SL G R L+V ++ +G + + + + T + ++ A + +L +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP---LDVTHVSTAPQGTPGYVDPEYHQC 458
+HRD+ N +LD F VKVADFGL+R D H T + ++ E Q
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 459 YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+ T KSDV+SFGV+L EL++ + + +I + + L+ P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQG--RRLLQP---- 256
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561
+ + E+ C E+RPS E+++ + I S
Sbjct: 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 1e-57
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 38/305 (12%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHKN 339
FS +E+G G FG VY+ + +++ VA+K++ + + + + EV L +LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+ GC LV E+ L + LAYL
Sbjct: 77 TIQYRGC-YLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ ++IHRDVK NILL VK+ DFG + + + V GTP ++ PE
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 186
Query: 460 ---QLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
Q K DV+S G+ IEL P +MN A+ I + L
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPALQSGH 238
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKSKFEIHEEKQDD 575
E + CLQ+ + RP+ E +L + + + + I + Q
Sbjct: 239 W----SEYFR-------NFVDSCLQKIPQDRPTSEVLL-KHRFVLRERPPTVIMDLIQRT 286
Query: 576 REGIK 580
++ ++
Sbjct: 287 KDAVR 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 62/276 (22%), Positives = 111/276 (40%), Gaps = 26/276 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHKN 339
D+ + LG+G +G V + VAVK + E E+ I L H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V +G R L E+ + G + D++ + P + + + YL
Sbjct: 65 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV-THVSTAPQGTPGYVDPEYHQC 458
H I HRD+K N+LLD +K++DFGL+ +F + + GT YV PE +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 459 YQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
+ + DV+S G+VL +++ D + + K +K +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKKTYLNPW------ 229
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
K++ ++ L L +N R ++ ++
Sbjct: 230 -------KKIDSAPLALLHKILVENPSARITIPDIK 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 1e-56
Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN 339
++R +++G G GTVY + G+EVA++++ + E +NE+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V+ L +V E++A G++ D + + + E AL +L
Sbjct: 79 IVNYLDS-YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H++ +IHRD+K++NILL + VK+ DFG + + ST GTP ++ PE
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 191
Query: 460 QLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
K D++S G++ IE+I P ++ N R A+ I EL +P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNGTPELQNP---- 239
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
++++ + CL + E R S +E+L
Sbjct: 240 ------EKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 6e-56
Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 38/302 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDG---REVAVKRLYDNNYRR-VEQFMNEVEILTRL-R 336
ND + +G+G FG V ++K + A+KR+ + + F E+E+L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHG------------DRAKHGLLTWPI 384
H N+++L G + L L E+ +G + D L + L+
Sbjct: 70 HPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 385 RMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAP 444
++ A + A + YL IHRD+ NIL+ N+ K+ADFGLSR + V
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 187
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504
++ E T SDV+S+GV+L E++S E+ K+
Sbjct: 188 -LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLP 240
Query: 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGKS 564
+ E C DE V +L C ++ RPS ++L L R+ +
Sbjct: 241 QGYRLEKPLNC----DDE--------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 565 KF 566
+
Sbjct: 289 TY 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-56
Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 28/283 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDNNYRRV-EQFMNEVEILTRLR 336
+ +G+G FG V+ G VA+K + V E+F+ E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H ++V L G + + ++ E G + L + L + A + ++AL
Sbjct: 67 HPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTAL 121
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
AYL + +HRD+ N+L+ SN CVK+ DFGLSR + ++ + ++ PE
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
+ T SDV+ FGV + E++ +++ I +I+ + C
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNC- 234
Query: 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
+ L C + RP E+ A+L I
Sbjct: 235 ----PPTLY-------SLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-56
Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 31/288 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK----DGREVAVKRL---YDNNYRRVEQFMNEVEILTR 334
D ++LGDG FG V G+ VAVK L + ++ F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
L H+NL+ L+G + + +V E G++ D+L G A++ A
Sbjct: 68 LDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAE 122
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH--VSTAPQGTPGYVD 452
+ YL + IHRD+ N+LL + VK+ DFGL R P + H + + +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 453 PEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512
PE + + SD + FGV L E+ + + + +I ++KI K
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERLPR 236
Query: 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
+ + C E RP+ + L +
Sbjct: 237 PE-----------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-55
Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 41/301 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLY-DNNYRRVEQFMNEVEILTR 334
N S K LG G FG V VAVK L + E M+E+++L+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 335 L-RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAK--------------HGL 379
L H N+V+L G L++ E+ G + + L R
Sbjct: 83 LGNHMNIVNLLGA-CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 380 LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439
L ++ + + A +A+L + + IHRD+ NILL K+ DFGL+R D +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 440 -VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL 498
V + ++ PE T +SDV+S+G+ L EL S +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256
Query: 499 AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
F ++I S E + ++ C + RP+ ++++ +++
Sbjct: 257 ---------FYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 559 I 559
Sbjct: 305 Q 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-54
Identities = 70/306 (22%), Positives = 118/306 (38%), Gaps = 50/306 (16%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD------GREVAVKRLYDN-NYRRVEQFMNEVEILTR 334
+ K LG G FG V +VAVK L + + E M+E++++T+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 335 L-RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAK----------------- 376
L H+N+V+L G S + L++E+ G + + L R K
Sbjct: 97 LGSHENIVNLLGA-CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 377 --HGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434
+LT+ + A + A + +L +HRD+ N+L+ VK+ DFGL+R
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 435 LDVTHVS-TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS--SMPAVDMNRHRH 491
D +V + ++ PE T KSDV+S+G++L E+ S P +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 274
Query: 492 EINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551
F +LI + T + + C + RPS
Sbjct: 275 ---------------NFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 552 VLAELQ 557
+ + L
Sbjct: 317 LTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 7e-54
Identities = 58/285 (20%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-----GREVAVKRLYD-NNYRRVEQFMNEVEILTRLR 336
+F + K LG G FGTVY G VA+K L + + + ++ ++E ++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
+ ++ L G + + L+ + + G + D + + +N ++ A +
Sbjct: 70 NPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGM 124
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF-PLDVTHVSTAPQGTPGYVDPEY 455
YL ++HRD+ N+L+ + VK+ DFGL++L + + + + ++ E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
T +SDV+S+GV + EL++ EI + ++K C
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPIC 238
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560
T V + C + + RP E++ E ++
Sbjct: 239 ------------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-53
Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 36/307 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLY-DNNYRRVEQFMNEVEILTR 334
+ +ELG G FG VY G K VA+K + + R +F+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 335 LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDR------AKHGLLTWPIRMNI 388
++V L G S Q L++ E + G + L R + + +
Sbjct: 80 FNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 389 AIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP-LDVTHVSTAPQGT 447
A E A +AYL+A+ +HRD+ N ++ +F VK+ DFG++R D
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 448 PGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507
++ PE + T SDV+SFGVVL E+ + ++ + + +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGG 252
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS---GKS 564
+ D C D + EL +C Q N ++RPS E+++ ++ +
Sbjct: 253 LLDKPDNC----PDM--------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
Query: 565 KFEIHEE 571
F EE
Sbjct: 301 SFYYSEE 307
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 179 bits (456), Expect = 1e-52
Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 30/292 (10%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLR 336
++ + + LG GG V+ + L+ R+VAVK L + +F E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 337 HKNLVSLFGC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
H +V+++ + +V E+V T+ D +H G +T + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV--STAPQGTPGYV 451
AL + H + IIHRDVK NI++ + VKV DFG++R V + A GT Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
PE + + +SDVYS G VL E+++ P + ++ + I A E
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEG 240
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKSG 562
+ + + L +N E R + E+ A+L R+ +G
Sbjct: 241 LSA---------------DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (457), Expect = 7e-52
Identities = 52/276 (18%), Positives = 113/276 (40%), Gaps = 25/276 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
+ + +ELG G FG V+ G A K + + E E++ ++ LRH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
V+L ++++YEF++ G + +++ +H ++ + + L ++H
Sbjct: 86 VNLHDA-FEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 401 ASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
++ +H D+K NI+ + + +K+ DFGL+ + T GT + PE +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 199
Query: 459 YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+ +D++S GV+ L+S + + E + ++ C ++
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDET------LRNVKSCDWN--------- 243
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
D ++ + L + R ++ + L
Sbjct: 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 69/299 (23%), Positives = 112/299 (37%), Gaps = 38/299 (12%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK------DGREVAVKRL-YDNNYRRVEQFMNEVEILTR 334
+ K LG G FG V R VAVK L + M+E++IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 335 -LRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDR------------AKHGLLT 381
H N+V+L G ++ L+++ EF G ++ L R LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 382 WPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV- 440
+ + + A + +L + IHRD+ NILL VK+ DFGL+R D +V
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAI 500
+ ++ PE T +SDV+SFGV+L E+ S + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFC 247
Query: 501 NKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
++++ D T + + C RP+ E++ L +
Sbjct: 248 RRLKEGTRMRAPDYT------------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRHK 338
DF K LG+G F TV + L RE A+K L + +V E ++++RL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
V L+ + + L + NG + + K G E SAL Y
Sbjct: 69 FFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEY 123
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF-PLDVTHVSTAPQGTPGYVDPEYHQ 457
LH IIHRD+K NILL+ + +++ DFG +++ P + + GT YV PE
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 458 CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517
SD+++ G ++ +L++ +P + + I KI K +D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLI------FQKIIKLEYDFP------ 230
Query: 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
++ +L L + R EE+
Sbjct: 231 -------EKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-48
Identities = 65/301 (21%), Positives = 125/301 (41%), Gaps = 42/301 (13%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK--------DGREVAVKRLY-DNNYRRVEQFMNEVEIL 332
+ K LG+G FG V + +VAVK L D + + ++E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 333 TRL-RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRA------------KHGL 379
+ +HKN+++L G ++ L ++ E+ + G + + L R
Sbjct: 73 KMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 380 LTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439
L+ ++ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 440 VST-APQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL 498
T + ++ PE T +SDV+SFGV+L E+ + + E+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL----- 246
Query: 499 AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQR 558
+++ + C T + + C RP+ ++++ +L R
Sbjct: 247 -FKLLKEGHRMDKPSNC------------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 559 I 559
I
Sbjct: 294 I 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 2e-48
Identities = 53/276 (19%), Positives = 111/276 (40%), Gaps = 25/276 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
+ + +ELG G FG V+ GR K + NE+ I+ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
++L ++L+ EF++ G + D++ A+ ++ +N + L ++H
Sbjct: 89 INLHDA-FEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 401 ASDIIHRDVKTNNILLDSNFC--VKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
I+H D+K NI+ ++ VK+ DFGL+ D T T + PE
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202
Query: 459 YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+ +D+++ GV+ L+S + ++ + +++C ++
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLET----LQNVKRCDWE--------- 246
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
++ ++ + LQ+ R ++ + L
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 51/279 (18%), Positives = 107/279 (38%), Gaps = 26/279 (9%)
Query: 279 EATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH 337
E + ++LG G FG V+ + K + E+ IL RH
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARH 60
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+N++ L + L++++EF++ + +++ L ++ + AL
Sbjct: 61 RNILHLHES-FESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQ 116
Query: 398 YLHASDIIHRDVKTNNILLDS--NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
+LH+ +I H D++ NI+ + + +K+ +FG +R P Y PE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEV 174
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
HQ ++ +D++S G ++ L+S + ++ I I +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT------ 221
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
+E K ++ + L + ++ R + E L
Sbjct: 222 ---FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 2e-47
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 40/289 (13%)
Query: 283 DFSREKELGDGGFGTVYYGK-LKDGREVAVKRL---------YDNNYRRVEQFMNEVEIL 332
++ ++ LG G V +E AVK + + E + EV+IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 333 TRLR-HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
++ H N++ L + LV++ + G + D L + L+ I
Sbjct: 64 RKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRA 118
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
+ LH +I+HRD+K NILLD + +K+ DFG S D GTP Y+
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYL 176
Query: 452 DPEYHQCYQL------TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK 505
PE +C + D++S GV++ L++ P HR ++ + + I
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLM----LRMIMS 229
Query: 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
+ E + +V +L L + R + EE LA
Sbjct: 230 GNYQ---------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-46
Identities = 51/288 (17%), Positives = 98/288 (34%), Gaps = 28/288 (9%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL 340
N + +++G G FG +Y G + G EVA+K Q E +I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 341 VSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLH 400
+ ++V E + + + +A + S + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSL----EDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 401 ASDIIHRDVKTNNIL---LDSNFCVKVADFGLSRLFPLDVTHV------STAPQGTPGYV 451
+ + IHRDVK +N L V + DFGL++ + TH + GT Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
H + + + D+ S G VL+ + + K ++ + ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-------RQKYERISEKKM 233
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
P + K + A C + +P + + +
Sbjct: 234 STPI-----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 5e-46
Identities = 62/279 (22%), Positives = 117/279 (41%), Gaps = 28/279 (10%)
Query: 281 TNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLRHK 338
+ + LG G F V + + + VA+K + + NE+ +L +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V+L L L+ + V+ G + D++ + G T + + A+ Y
Sbjct: 68 NIVALDDI-YESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKY 122
Query: 399 LHASDIIHRDVKTNNILL---DSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
LH I+HRD+K N+L D + + ++DFGLS++ D V + GTPGYV PE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEV 180
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515
+ D +S GV+ L+ P + + ++ +I K ++
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKL------FEQILKAEYE------ 227
Query: 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
++ S + ++++ E R + E+ L
Sbjct: 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 22/301 (7%)
Query: 280 ATNDFSREKELGDGGFGTVYYGKLK--DGREVAVKRLYDNNYRR--VEQFMNEVEILTRL 335
A + E+G+G +G V+ + GR VA+KR+ + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 336 ---RHKNLVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
H N+V LF CT + + + + D+ + ++ +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
L +LH+ ++HRD+K NIL+ S+ +K+ADFGL+R++ + S T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYR 182
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAF 508
PE D++S G + E+ P +I +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 509 DELIDPCLGFESDEEVKRMTTSVAELA--FL--CLQQNKELRPSMEEVLA-----ELQRI 559
L +S + +++ T + EL L CL N R S L+ +L+R
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302
Query: 560 K 560
K
Sbjct: 303 K 303
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-44
Identities = 71/289 (24%), Positives = 110/289 (38%), Gaps = 24/289 (8%)
Query: 283 DFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLV 341
++ K +G+G FG VY KL D G VA+K++ + E++I+ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 342 SLFGC-----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
L + L LV ++V H RAK L + +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSL 135
Query: 397 AYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP-E 454
AY+H+ I HRD+K N+LLD + +K+ DFG ++ +VS Y P
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPEL 193
Query: 455 YHQCYQLTDKSDVYSFGVVLIELISSMP-------AVDMNRHRHEINLANLAINKIQKCA 507
T DV+S G VL EL+ P + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFL--CLQQNKELRPSMEEVLA 554
+ E P + +V R T +A L+ R + E A
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 7e-44
Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 16/284 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKN 339
+ +++G+G +G VY + G A+K RL + + E+ IL L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V L+ + L+LV+E + G L + ++ + +AY
Sbjct: 62 IVKLYDVI-HTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H ++HRD+K N+L++ +K+ADFGL+R F + V +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 460 QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL---------ANLAINKIQKCAFDE 510
+ + D++S G + E+++ P ++ + N + +D
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
+ +K + S +L L+ + R + ++ L
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 29/275 (10%)
Query: 287 EKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLF 344
+ LG G G V + + A+K L + + EVE+ R + ++V +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71
Query: 345 GC---TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
+ LL+V E + G + ++ T I A+ YLH+
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 402 SDIIHRDVKTNNILLDSNFC---VKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
+I HRDVK N+L S +K+ DFG ++ + + TP YV PE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGP 187
Query: 459 YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518
+ D++S GV++ L+ P H + ++ +I+ ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYE--------- 235
Query: 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553
+ E ++ V L L+ R ++ E +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (397), Expect = 3e-43
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 33/282 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGKLKD-GREVAVKRLYDNNYRR---VEQFMNEVEILTRLR- 336
NDFS + +G GGFG VY + D G+ A+K L + +NE +L+ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 337 --HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETAS 394
+V + L + + + G + L +HG+ + A E
Sbjct: 64 GDCPFIVCMSYA-FHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIIL 118
Query: 395 ALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPE 454
L ++H +++RD+K NILLD + V+++D GL+ F H S GT GY+ PE
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 175
Query: 455 YHQCYQLTD-KSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513
Q D +D +S G +L +L+ ++ + + + + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------DRMTLTMAVEL 228
Query: 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555
P + + L LQ++ R A+
Sbjct: 229 P----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-43
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 16/284 (5%)
Query: 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVK--RLYDNNYRRVEQFMNEVEILTRLRHKN 339
+F + +++G+G +G VY + K G VA+K RL + E+ +L L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 340 LVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYL 399
+V L L LV+EF+ + D + + P+ + + LA+
Sbjct: 63 IVKLLDVI-HTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 400 HASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCY 459
H+ ++HRD+K N+L+++ +K+ADFGL+R F + V + C
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 460 QLTDKSDVYSFGVVLIELISS---MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516
+ D++S G + E+++ P I +++ + D
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 517 GFES------DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F + V + L L + R S + LA
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 59/296 (19%), Positives = 119/296 (40%), Gaps = 26/296 (8%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL-YDNNYRRVEQFMNEVEILTRLR 336
+ ++ +G+G +G V + VA+K++ + ++ + E++IL R R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 337 HKNLVSLFGC----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
H+N++ + T + + LV + K L+ +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLM------GADLYKLLKTQHLSNDHICYFLYQI 118
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ--GTPGY 450
L Y+H+++++HRD+K +N+LL++ +K+ DFGL+R+ D H + T Y
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 451 VDPEYHQCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHEINL-----------ANL 498
PE + KS D++S G +L E++S+ P + ++N
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 499 AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
I ++ + + + + +L L N R +E+ LA
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-43
Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 21/282 (7%)
Query: 288 KELGDGGFGTVYYGKLK-DGREVAVKRL-----YDNNYRRVEQFMNEVEILTRLRHKNLV 341
LG+G F TVY + K + VA+K++ + + E+++L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 342 SLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA 401
L + + LV++F+ D + +LT + T L YLH
Sbjct: 64 GLLDAF-GHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 402 SDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL 461
I+HRD+K NN+LLD N +K+ADFGL++ F T T Y PE ++
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 462 TD-KSDVYSFGVVLIELISSMPAVDMNRHRHEINL--------ANLAINKIQKCAFDELI 512
D+++ G +L EL+ +P + + ++ +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
G + +L N R + + L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (388), Expect = 7e-43
Identities = 39/288 (13%), Positives = 89/288 (30%), Gaps = 30/288 (10%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ + +G+G FG ++ G L + ++VA+K Q +E L +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS 402
+ +LV + + + A + + + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 403 DIIHRDVKTNNILLDSNF-----CVKVADFGLSRLFPLDVTHVSTAPQ------GTPGYV 451
+++RD+K +N L+ + V DFG+ + + VT + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 452 DPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
H + + + D+ + G V + + + A K ++ +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLR-------GSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559
P E + + P + + ++
Sbjct: 234 STP-----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-42
Identities = 65/301 (21%), Positives = 113/301 (37%), Gaps = 46/301 (15%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLY------DNNYRRVEQFMNEVEILTR 334
+ + LG GGFG+VY G + D VA+K + + EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 335 LR--HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIET 392
+ ++ L R +L+ E + G L + + +
Sbjct: 64 VSSGFSGVIRLLDWFER-PDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQV 119
Query: 393 ASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDVTHVSTAPQGTPGYV 451
A+ + H ++HRD+K NIL+D N +K+ DFG L V T GT Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYS 176
Query: 452 DPEYHQCYQLTDKS-DVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510
PE+ + ++ +S V+S G++L +++ + H EI +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFR--------- 224
Query: 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRIKSGKSKFEI 568
+R+++ L CL RP+ EE+ +Q + + EI
Sbjct: 225 --------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
Query: 569 H 569
H
Sbjct: 271 H 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 61/299 (20%), Positives = 121/299 (40%), Gaps = 30/299 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRR--VEQFMNEVEILTRLRHK 338
+ + + ++G G FG V+ + K G++VA+K++ N + + E++IL L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 339 NLVSLFGC-------TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIE 391
N+V+L +R + LV++F + + T +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125
Query: 392 TASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQ---GTP 448
+ L Y+H + I+HRD+K N+L+ + +K+ADFGL+R F L T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 449 GYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507
Y PE + D++ G ++ E+ + P + N +H++ L + I
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 508 FDELIDPCL----------GFESDEEVKRMTTSVAELAFL--CLQQNKELRPSMEEVLA 554
+ + + L + + +K L + L + R ++ L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-41
Identities = 67/256 (26%), Positives = 105/256 (41%), Gaps = 17/256 (6%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL---YDNNYRRVEQFMNEVEILTR-LR 336
DF K LG G FG V+ + K + A+K L VE M E +L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 337 HKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASAL 396
H L +F + + L V E++ G + + A E L
Sbjct: 62 HPFLTHMFCT-FQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGL 116
Query: 397 AYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYH 456
+LH+ I++RD+K +NILLD + +K+ADFG+ + L +T GTP Y+ PE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 175
Query: 457 QCYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDELID 513
+ D +SFGV+L E++ D H I + N + + +L+
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235
Query: 514 PCLGFESDEEVKRMTT 529
E + KR+
Sbjct: 236 KLFVREPE---KRLGV 248
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 8e-41
Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 16/260 (6%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRH 337
DF + LG G FG V+ + + +GR A+K L ++VE +E +L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
++ ++G + +Q + ++ +++ G + L K P+ A E AL
Sbjct: 64 PFIIRMWGT-FQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALE 118
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
YLH+ DII+RD+K NILLD N +K+ DFG ++ P V+ GTP Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVS 174
Query: 458 CYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
D +SFG+++ E+++ + + +I A L +L+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234
Query: 515 CLGFESDEEVKRMTTSVAEL 534
+ + + + + ++
Sbjct: 235 LITRDLSQRLGNLQNGTEDV 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 39/296 (13%)
Query: 271 IFSYSDLAEATNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL------YDNNYRRVE 323
+F ++ + + +ELG G F V + K G + A K + E
Sbjct: 2 VFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 324 QFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWP 383
EV IL ++H N+++L ++L+ E VA G +L A+ LT
Sbjct: 59 DIEREVSILKEIQHPNVITLHEV-YENKTDVILILELVAGG----ELFDFLAEKESLTEE 113
Query: 384 IRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFC----VKVADFGLSRLFPLDVTH 439
+ + + YLH+ I H D+K NI+L +K+ DFGL+ +D +
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGN 171
Query: 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANL 498
GTP +V PE L ++D++S GV+ L+S + P + +
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------- 223
Query: 499 AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
+ + ++ DE + + L ++ + R ++++ L
Sbjct: 224 TLANVSAVNYE---------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 18/286 (6%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLY--DNNYRRVEQFMNEVEILTRLRHK 338
+ + +++G+G +GTV+ K + VA+KR+ D++ + E+ +L L+HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 339 NLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
N+V L + L LV+EF D + +G L I + + L +
Sbjct: 62 NIVRLHDVL-HSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 399 LHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQC 458
H+ +++HRD+K N+L++ N +K+A+FGL+R F + V S
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 459 YQLTDKSDVYSFGVVLIELISS----MPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
+ D++S G + EL ++ P D++ I + Q + +L D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 515 CLGFESD------EEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
V ++ + +L L+ N R S EE L
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-39
Identities = 66/260 (25%), Positives = 102/260 (39%), Gaps = 13/260 (5%)
Query: 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRL---YDNNYRRVEQFMNEVEILTRLRH 337
NDF K LG G FG V + K GR A+K L V + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
L +L + L V E+ G + L + + T E SAL
Sbjct: 65 PFLTALKYAF-QTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALE 119
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
YLH+ D+++RD+K N++LD + +K+ DFGL + D GTP Y+ PE +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178
Query: 458 CYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
D + GVV+ E++ D R I + + + L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 515 CLGFESDEEVKRMTTSVAEL 534
L + + + + E+
Sbjct: 239 LLKKDPKQRLGGGPSDAKEV 258
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 5e-38
Identities = 57/260 (21%), Positives = 98/260 (37%), Gaps = 16/260 (6%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRH 337
+ F R K LG G FG V K + G A+K L +++E +NE IL +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
LV L S V ++ + G + P A +
Sbjct: 101 PFLVKLEFSFKDNSN-----LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
YLH+ D+I+RD+K N+L+D ++V DFG ++ + GTP + PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIIL 211
Query: 458 CYQLTDKSDVYSFGVVLIELISSMP---AVDMNRHRHEINLANLAINKIQKCAFDELIDP 514
D ++ GV++ E+ + P A + +I + +L+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 515 CLGFESDEEVKRMTTSVAEL 534
L + + + V ++
Sbjct: 272 LLQVDLTKRFGNLKNGVNDI 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 56/290 (19%), Positives = 107/290 (36%), Gaps = 18/290 (6%)
Query: 279 EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLY--DNNYRRVEQFMNEVEILTRL 335
E + + +G G +G V + G +VA+K+LY + ++ E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 336 RHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASA 395
RH+N++ L + L +F G KH L + +
Sbjct: 75 RHENVIGLLDV-FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 396 LAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEY 455
L Y+HA+ IIHRD+K N+ ++ + +K+ DFGL+R + ++
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVI 190
Query: 456 HQCYQLTDKSDVYSFGVVLIELISSMP--------AVDMNRHRHEINLANLAINKIQKCA 507
+ T D++S G ++ E+I+ + + ++Q
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 508 FDELIDPCLGFESDEEVKRMTTSVAELAFL---CLQQNKELRPSMEEVLA 554
+ E + +T + L L + E R + E LA
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 3e-35
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 35/296 (11%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKN 339
+D+ ++LG G + V+ + + +V VK L + ++ E++IL LR N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91
Query: 340 LVSLFG-CTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAY 398
+++L S+ LV+E V N LT E AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDY 144
Query: 399 LHASDIIHRDVKTNNILLDS-NFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQ 457
H+ I+HRDVK +N+++D + +++ D+GL+ + + + + PE
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202
Query: 458 CYQLTD-KSDVYSFGVVLIELISSMP-------AVDMNRHRHEINLANLAINKIQKCAFD 509
YQ+ D D++S G +L +I D ++ + I K +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 510 -----------ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLA 554
F E ++ + L+ + + R + E +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 65/284 (22%), Positives = 105/284 (36%), Gaps = 30/284 (10%)
Query: 282 NDFSREKELGDGGFGTVYYGKL----KDGREVAVKRL----YDNNYRRVEQFMNEVEILT 333
+F K LG G +G V+ + G+ A+K L + E E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 334 RLRHKNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
+R + + L L+ +++ G + L + T E
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIV 139
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
AL +LH II+RD+K NILLDSN V + DFGLS+ F D T + GT Y+ P
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 454 EYHQC--YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511
+ + D +S GV++ EL++ E N +I K
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT---VDGEKNSQAEISRRILKSEP--- 253
Query: 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555
+ M+ +L L ++ + R A+
Sbjct: 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 54/307 (17%), Positives = 107/307 (34%), Gaps = 30/307 (9%)
Query: 270 PIFSYSDLA----EATNDFSREKELGDGGFGTVYYGK-LKDGREVAVKRL--YDNNYRRV 322
P F +L E + +G G +G+V K G VAVK+L +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 323 EQFMNEVEILTRLRHKNLVSLFGC----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHG 378
++ E+ +L ++H+N++ L S + + + + K
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-----DLNNIVKCQ 116
Query: 379 LLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438
LT + + L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---D 173
Query: 439 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINL--- 495
++ D++S G ++ EL++ H ++ L
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 496 --------ANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP 547
I+ + + + +L L + + R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 548 SMEEVLA 554
+ + LA
Sbjct: 294 TAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 66/337 (19%), Positives = 121/337 (35%), Gaps = 50/337 (14%)
Query: 282 NDFSREKELGDGGFGTVYYGK-LKDGREVAVKRLY--DNNYRRVEQFMNEVEILTRLRHK 338
+ K +G G G V R VA+K+L N ++ E+ ++ + HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 339 NLVSLFGC-----TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETA 393
N++SL T Q + LV E + + L + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANL-------CQVIQMELDHERMSYLLYQML 129
Query: 394 SALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDP 453
+ +LH++ IIHRD+K +NI++ S+ +K+ DFGL+R + + T T Y P
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 187
Query: 454 EYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEIN------------------- 494
E + D++S G ++ E++ + + N
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 495 -LANLAINKIQKCA--FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEE 551
+ N N+ + F +L L E K + +L L + R S+++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 552 VL-----------AELQRIKSGKSKFEIHEEKQDDRE 577
L AE++ ++ E + E
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 9e-27
Identities = 50/318 (15%), Positives = 103/318 (32%), Gaps = 52/318 (16%)
Query: 284 FSREKELGDGGFGTVYYGK-LKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVS 342
+ ++LG G F TV+ K + + VA+K + + E +E+++L R+ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 343 LFGCTSRYSQGLLLVYEFVANGTVADQLHG-----------DRAKHGLLTWPIRMNIAIE 391
+ + LL + V + + +H + I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 392 TASALAYLHASD-IIHRDVKTNNILLDSNFC------VKVADFGLSRLFPLDVTHVSTAP 444
L Y+H IIH D+K N+L++ +K+AD G + + T+
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---- 189
Query: 445 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS------------------------- 479
T Y PE +D++S ++ ELI+
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 480 ---SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAF 536
+P+ + ++ N + E + K +++
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 537 LCLQQNKELRPSMEEVLA 554
LQ + R ++
Sbjct: 310 PMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 3e-22
Identities = 26/154 (16%), Positives = 52/154 (33%), Gaps = 19/154 (12%)
Query: 288 KELGDGGFGTVYYGKLKDGREVAVK--RLYDNNYRRV--------EQFMNEVEILTRLRH 337
K +G+G V+ + E VK ++ ++++V F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 338 KNLVSLFGCTSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALA 397
+ L L G + VY + N + + + + P + +A
Sbjct: 66 RALQKLQGL------AVPKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 398 YLHASDIIHRDVKTNNILLDSNFCVKVADFGLSR 431
+ I+H D+ N+L+ + + DF S
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 625 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.85 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=423.03 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=208.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
++|+++++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.. .+.++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEe
Confidence 57999999999999999999976 799999999876555556789999999999999999999997665 6678999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 999999998742 359999999999999999999999999999999999999999999999999998764332 22
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||....... ......... ...+.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~-~~~~~-------- 237 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPELQ-------- 237 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-SCCCS--------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-CCCCC--------
Confidence 345679999999999999899999999999999999999999996543221 111111111 11110
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++.++.+||.+||+.||++|||++|+++|
T Consensus 238 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 --NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 012346688999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=419.29 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=200.3
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|++.. .+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEec
Confidence 5789999999999999999999988999999987543 334679999999999999999999997765 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++|+|.+++.. ....+++..++.++.||++||+|||+++|+||||||+||||+.++.+||+|||+++..........
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999999863 345689999999999999999999999999999999999999999999999999987654444434
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....||+.|+|||++.+..++.++||||||+++|||++ |.+|+...... .....+..+... ..+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-------~~~~~i~~~~~~--~~p------ 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRL--YKP------ 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-------HHHHHHHHTCCC--CCC------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHhcCCC--CCc------
Confidence 45679999999999999899999999999999999999 56666543221 111222221111 011
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+.++.+|+.+||+.||++||||+||+++|+++.+
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1124578899999999999999999999999998864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=421.52 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=203.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.. .+..+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEE
Confidence 358999999999999999999986 799999999865432 344678999999999999999999997765 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++. ..+.+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 Ey~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999999985 345699999999999999999999999999999999999999999999999999987643322
Q ss_pred -ccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 439 -HVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 439 -~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.......||+.|||||++.+..+ +.++|||||||++|||++|++||......... . ..+.....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~-----~~~~~~~~-------- 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKT-------- 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H-----HHHHTTCT--------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H-----HHHhcCCC--------
Confidence 22345689999999999987776 57899999999999999999999754432111 0 01111000
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......++.++.+|+.+||+.||++|||++|+++|
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000112345678899999999999999999999876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=418.53 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=201.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-ccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-YSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~l 356 (625)
.++|++++.||+|+||+||+|+++ +|+.||||++... +....+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999986 7899999998654 34456779999999999999999999997654 3456899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCCEEECCCCeEEEccccccc
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD-----IIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
||||+++|+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999999765556678999999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
...... .......||+.|||||++.+..++.++||||||+++|||++|++||...... .....+.......+
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~~~~~ 234 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRI 234 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCCC
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 764332 2234567999999999999889999999999999999999999999754321 12223333322211
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ..+++++.+|+.+||+.||++|||+.|+++|
T Consensus 235 ~------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 P------------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp C------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C------------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 1245678899999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=417.28 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=204.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|++.+.||+|+||+||+|+++ ..||||++... +....+.|.+|+.+|++++|||||++++++.. ..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEE
Confidence 468999999999999999999865 36999998543 34567889999999999999999999996543 4679999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+++|+|.+++.. ....+++..++.++.||++||+|||+++||||||||+||||+.++.+||+|||+|+.......
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999963 335699999999999999999999999999999999999999999999999999987643322
Q ss_pred -ccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 439 -HVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 439 -~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.......||+.|||||++.+ ..++.++|||||||++|||++|+.||........+ ...+.........
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~~~p~~-- 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYLSPDL-- 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTSCCCCG--
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCCCCcc--
Confidence 22345679999999999864 35789999999999999999999999754332211 1111111111000
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
......+++++.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus 232 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 232 ------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 001112455788999999999999999999999999988753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=415.39 Aligned_cols=247 Identities=32% Similarity=0.474 Sum_probs=206.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||+||+|+++ +++.||||++.+... ...+.+.+|+++|++++|||||++++++.+ .+.++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence 57999999999999999999986 789999999864322 235678999999999999999999997665 6779999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+++|+|.+++. +.+.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 mEy~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EeecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999999996 3456999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+..+. +.
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~------~p 224 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFT------FP 224 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCC------CC
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC------CC
Confidence 2234579999999999999899999999999999999999999997543221 12222222111 00
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..++.++.+|+.+||+.||++|||++|+++|-
T Consensus 225 -------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 225 -------DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred -------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 12456788999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=416.30 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=209.5
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.++||+|+||+||+|++++++.||||++.... ...+.|.+|+++|++++|||||++++++.+ +..+|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEe
Confidence 46889999999999999999999888999999996543 345679999999999999999999997644 457999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++|+|.+++... ....+++..++.|+.||++||.|||+++|+||||||+||||+.++.+||+|||+|+.........
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999999988643 23358999999999999999999999999999999999999999999999999999876544444
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....||+.|+|||++.+..++.++||||||+++|||++| .+|+...... .....+....... ..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-------~~~~~i~~~~~~~-----~p-- 232 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERGYRMV-----RP-- 232 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----CC--
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCCC-----Cc--
Confidence 4556799999999999888899999999999999999995 5555433211 1112222211100 00
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
..++.++.+|+.+||+.||++||||+||++.|+.+-
T Consensus 233 -----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 233 -----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 124457889999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-52 Score=418.87 Aligned_cols=261 Identities=30% Similarity=0.423 Sum_probs=212.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... ...++|.+|+++|++++|||||++++++.. .+..+||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-CCeeEEEee
Confidence 468999999999999999999987 68899999986543 345789999999999999999999997665 567899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+++|+|.+++... ....+++..++.|+.||++||+|||++||+||||||+||||+.++.+||+|||+|+........
T Consensus 94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 99999999998642 3457999999999999999999999999999999999999999999999999999976554444
Q ss_pred cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 440 VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
......|++.|+|||++.+..++.++||||||+++|||++|..|+....... .....+....... .
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~~~~-----~--- 237 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRME-----R--- 237 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCCC-----C---
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcCCCCC-----C---
Confidence 4444568999999999998899999999999999999999665543222111 1111122111110 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcCC
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSGK 563 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~~ 563 (625)
...++.++.+|+.+||+.||++|||++||++.|+.+.+..
T Consensus 238 ----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 238 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 0124557889999999999999999999999998876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=408.17 Aligned_cols=254 Identities=25% Similarity=0.462 Sum_probs=212.6
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
++|++.++||+|+||+||+|++++++.||||++..... ..++|++|+.++++++|||||+++|++.+ .+.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEcc
Confidence 68999999999999999999999889999999976543 34679999999999999999999997765 56789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccccc
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHVS 441 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 441 (625)
++|+|.+++.. ....+++..+++++.||++||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999999753 344689999999999999999999999999999999999999999999999999987655444444
Q ss_pred cCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCCC
Q 047969 442 TAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFES 520 (625)
Q Consensus 442 ~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (625)
....||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+...... ..+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~--~~p------ 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRL--YRP------ 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCC--CCC------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCC--CCc------
Confidence 55679999999999998899999999999999999998 899997554221 12222222111 011
Q ss_pred hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 521 DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 521 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...+.++.+||.+||+.||++|||+++++++|..|
T Consensus 224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12345788999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=419.33 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=198.0
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc---EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR---EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||+||+|+++ +++ .||||++... .....+.|.+|+++|++++|||||+++|++.. .+..+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEE
Confidence 45667889999999999999976 332 5899988553 44556789999999999999999999997655 567899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++.. ..+.+++..++.++.||++||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999998863 3456999999999999999999999999999999999999999999999999999876543
Q ss_pred cccc----ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 437 VTHV----STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 437 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
.... .....||+.|||||++.+..++.++|||||||++|||++ |++||....... ....+......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~-- 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYRL-- 252 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC--
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--
Confidence 2221 122458999999999998899999999999999999998 899996543221 11222221110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.. ...++.++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 253 -----~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 -----PP-----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----CC-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CC-----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 00 012455788999999999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=416.08 Aligned_cols=252 Identities=29% Similarity=0.397 Sum_probs=207.6
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
+.|++++.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.. .+.++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEec
Confidence 47899999999999999999986 789999999977666667889999999999999999999997665 6778999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++|+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 91 ~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp CTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999999998753 34569999999999999999999999999999999999999999999999999997643221 12
Q ss_pred ccCCCCCCCccCccccc-----cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 441 STAPQGTPGYVDPEYHQ-----CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+.......+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~~~i~~~~~~~~~--- 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPTLA--- 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHHSCCCCCS---
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCCCC---
Confidence 24567999999999874 44688999999999999999999999976543221 1122222111110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
....++.++.+||.+||+.||++|||++|+++|
T Consensus 237 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 -------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112356688999999999999999999999886
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=404.09 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=199.1
Q ss_pred CccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee---ccceEEEEE
Q 047969 285 SREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR---YSQGLLLVY 358 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~ 358 (625)
+..++||+|+||+||+|+++ +++.||+|++... .....+.|.+|+++|++++|||||++++++.. ....++|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999987 6889999998543 34556789999999999999999999997643 245689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCEEEC-CCCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASD--IIHRDVKTNNILLD-SNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDikp~NIll~-~~~~~kl~DFgla~~~~~ 435 (625)
||+++|+|.+++. +...+++..++.++.||++||+|||+++ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999996 3456999999999999999999999998 99999999999996 578999999999986432
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||....... .....+.......
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~----- 232 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA----- 232 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG-----
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCc-----
Confidence 2 2234679999999999875 59999999999999999999999996433211 1222222221111
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......++++.+||.+||+.||++|||++|+++|
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111234578899999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=422.30 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=204.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|+++++||+|+||+||+|++. +|+.||+|++... .....+++.+|+.+|++++|||||++++++.. ...++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 468999999999999999999986 7899999998654 33445788999999999999999999997765 66799999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS-DIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
||++||+|.+++. +.+.+++..+..++.||++||.|||++ ||+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp ECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 9999999999996 345699999999999999999999975 999999999999999999999999999986532
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH-HHHHhhhc----------
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL-AINKIQKC---------- 506 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~---------- 506 (625)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. ........
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 223456899999999999999999999999999999999999999975442211000000 00000000
Q ss_pred ccccccCCcCCCCChHHH-------------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 AFDELIDPCLGFESDEEV-------------KRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
......+........... ..++.++.+|+.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000000000000000 1135678899999999999999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-50 Score=418.68 Aligned_cols=253 Identities=20% Similarity=0.373 Sum_probs=211.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.. .+.++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 568999999999999999999986 799999999987776777889999999999999999999997665 678999999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC--CCCeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD--SNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~--~~~~~kl~DFgla~~~~~~~ 437 (625)
|++||+|.+++.. ..+.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+......
T Consensus 104 ~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999853 345699999999999999999999999999999999999995 46889999999998764332
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......||+.|||||++.+..++.++|||||||++|+|++|+.||....... ....+......
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~-------- 243 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN-------- 243 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--------
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------
Confidence 2234579999999999999899999999999999999999999997543221 11222221111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
........++.++.+||.+||+.||++|||++|+++|
T Consensus 244 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 -MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011122456688999999999999999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=403.98 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=207.3
Q ss_pred cCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREK-ELGDGGFGTVYYGKLK---DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|.+.+ +||+|+||+||+|.++ ++..||||++... .....++|.+|+++|++++|||||+++|++.. +.++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEE
Confidence 4566666 4999999999999764 3557999998654 44557889999999999999999999997653 45899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999999853 3456999999999999999999999999999999999999999999999999999976543
Q ss_pred ccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 437 VTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 437 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+..+.....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~-- 233 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC-- 233 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCC--
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC--
Confidence 322 2234568999999999988899999999999999999998 999997543211 1122222221111
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
...++.++.+||.+||+.+|++|||+.+|++.|+.+.
T Consensus 234 ----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 234 ----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0124567889999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=414.13 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=205.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+.++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEE
Confidence 57999999999999999999986 79999999986432 2345678999999999999999999996655 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||++||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp ECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999885 44579999999999999999999999999999999999999999999999999999765433
Q ss_pred cc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 438 TH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 438 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .....+....+. +
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~~------~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKIIKLEYD------F 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCCC------C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHHcCCCC------C
Confidence 22 234567999999999999999999999999999999999999999754321 112222222211 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ..++.++.+||.+||+.||++|||++|++++..
T Consensus 230 p-------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 230 P-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp C-------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred C-------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 0 124567889999999999999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-50 Score=408.14 Aligned_cols=247 Identities=29% Similarity=0.408 Sum_probs=202.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
+.|+.+++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+..+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence 35999999999999999999976 78899999986542 3445779999999999999999999997665 6779999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+.+|+|..++. ..+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 99999999877664 345799999999999999999999999999999999999999999999999999986432
Q ss_pred cccccCCCCCCCccCcccccc---CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDP 514 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (625)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... ....+.......+..
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~~- 236 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPALQS- 236 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCCSC-
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCCCCC-
Confidence 234579999999999864 358999999999999999999999996543211 111222222111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 515 CLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 515 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
..++.++.+||.+||+.||++|||++|+++|-
T Consensus 237 ----------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 237 ----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ----------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 12355788999999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-51 Score=415.27 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=191.7
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY-RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
.+.|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.. .+.++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 467999999999999999999987 789999999865432 234568899999999999999999996655 67799999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC---CCCeEEEcccccccccCC
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD---SNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~---~~~~~kl~DFgla~~~~~ 435 (625)
||++||+|.+++. ..+.+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 87 E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 87 QLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred eccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999996 345799999999999999999999999999999999999994 578999999999986532
Q ss_pred CccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
. .......||+.|||||++.+..++.++|||||||++|||++|++||....... ....+.......
T Consensus 163 ~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~~----- 228 (307)
T d1a06a_ 163 G--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYEF----- 228 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCCC-----
T ss_pred C--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCCC-----
Confidence 2 22344679999999999999899999999999999999999999997543211 112222221110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..+....++.++.+|+.+||+.||++|||++|+++|
T Consensus 229 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 ----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001112355678999999999999999999999997
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-50 Score=416.58 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=210.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++++.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.. ...++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 458999999999999999999976 799999999977666666788999999999999999999997665 678899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC--CCCeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLD--SNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~--~~~~~kl~DFgla~~~~~~~ 437 (625)
|++||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+......
T Consensus 107 ~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999988752 345699999999999999999999999999999999999998 67899999999998765432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......||+.|+|||++.+..++.++|||||||++|+|++|++||....... ....+.......
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~~------- 247 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEF------- 247 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCCC-------
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC-------
Confidence 2234568999999999999999999999999999999999999997543221 122222222110
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.......++.++.+||.+||+.||++|||++|+++|
T Consensus 248 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 --DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112345678899999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=400.39 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=198.9
Q ss_pred ceecccCcEEEEEEEEc---CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEecc
Q 047969 288 KELGDGGFGTVYYGKLK---DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFVA 362 (625)
Q Consensus 288 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 362 (625)
++||+|+||+||+|.++ .++.||||++... +....++|.+|+++|++++|||||++++++.. +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence 57999999999999865 3568999998543 23345789999999999999999999997643 45789999999
Q ss_pred CCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc--
Q 047969 363 NGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV-- 440 (625)
Q Consensus 363 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~-- 440 (625)
+|+|.+++. ....+++..++.++.||++||+|||+++|+||||||+||||+.++.+||+|||+++.........
T Consensus 91 ~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 91 LGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999986 44569999999999999999999999999999999999999999999999999998765433322
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....||+.|+|||++.+..++.++||||||+++|||++ |++||...... .....+..+.....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-------- 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGC-------- 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC--------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCCCC--------
Confidence 234579999999999988889999999999999999998 89999754321 11222222211110
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
...++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus 232 ----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 012456788999999999999999999999888754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=404.76 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=199.5
Q ss_pred cCCCccceecccCcEEEEEEEEcCC-----cEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDG-----REVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
+.|++.+.||+|+||+||+|.++.+ ..||||++... .....++|++|+++|++++|||||+++|++.. ....+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CCceE
Confidence 5688899999999999999987632 36999998643 34455679999999999999999999997665 56789
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
+||||+.++++.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988753 445699999999999999999999999999999999999999999999999999987643
Q ss_pred Cccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCC-CcccccccccchhHHHHHHhhhccccccc
Q 047969 436 DVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA-VDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 436 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..| +...... .....+..+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------~~~~~i~~~~~~~-- 233 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRLP-- 233 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCCC--
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-------HHHHHHhccCCCC--
Confidence 3222 22335689999999999999999999999999999999996544 4332211 1112222211110
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.. ..++..+.+||.+||+.+|++||||.||+++|+.+.+.
T Consensus 234 ---~~-------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 ---TP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---CC-------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---Cc-------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 00 12345788999999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=401.22 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=208.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH------HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY------RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+... ...+.+.+|+.+|++++|||||++++++.. ...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence 368999999999999999999986 799999999854321 235789999999999999999999997665 678
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC----eEEEccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF----CVKVADFGL 429 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~----~~kl~DFgl 429 (625)
++|||||+++|+|.+++. ..+.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999996 334699999999999999999999999999999999999998776 599999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFD 509 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (625)
|+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+......
T Consensus 164 a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~ 234 (293)
T d1jksa_ 164 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE 234 (293)
T ss_dssp CEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC
T ss_pred hhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCCC
Confidence 9876433 22345679999999999998899999999999999999999999997543221 11222221110
Q ss_pred cccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 510 ELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
........++..+.+||.+||+.||++|||++|+++|
T Consensus 235 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 ---------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123334566788999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=400.16 Aligned_cols=257 Identities=29% Similarity=0.467 Sum_probs=202.3
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|++++++.||||++..... ..+.|.+|+.+|++++|||||++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEe
Confidence 368999999999999999999999888999999865533 34779999999999999999999997643 457999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++|+|..++... ..+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.........
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999999988643 33469999999999999999999999999999999999999999999999999998765444333
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCC-CcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPA-VDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....||+.|+|||++....++.++||||||+++|||++|..| +...... .....+........ .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-------~~~~~i~~~~~~~~-~------ 236 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMPC-P------ 236 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC-C------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCCCC-C------
Confidence 4456799999999999999999999999999999999996544 4432211 11122222111110 0
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
..++.++.++|.+||+.||++|||+++|+++|+....
T Consensus 237 -----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 237 -----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1234578899999999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=408.41 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=202.8
Q ss_pred cCCCccceecccCcEEEEEEEEcC-C-----cEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccce
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD-G-----REVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 353 (625)
++|++.+.||+|+||+||+|++.. + ..||||++... .......+.+|+.+|+++ +|||||++++++.. .+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-CCe
Confidence 689999999999999999998652 2 36999998543 333456789999999998 89999999997665 567
Q ss_pred EEEEEEeccCCChHHHhccCcc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 047969 354 LLLVYEFVANGTVADQLHGDRA-------------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNI 414 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NI 414 (625)
++|||||+++|+|.++|+..+. ....+++..++.++.||++||+|||+++||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 8999999999999999975331 124589999999999999999999999999999999999
Q ss_pred EECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccc
Q 047969 415 LLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHE 492 (625)
Q Consensus 415 ll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~ 492 (625)
|++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||++ |++||........
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999875433322 2234568999999999998899999999999999999997 8999975433221
Q ss_pred cchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047969 493 INLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQ 557 (625)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 557 (625)
. ...+......+ . ...+++++.+||.+||+.||++|||++||+++|.
T Consensus 276 ~------~~~~~~~~~~~-----~-------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 276 F------YKLIQNGFKMD-----Q-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H------HHHHHTTCCCC-----C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H------HHHHhcCCCCC-----C-------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 11111111000 0 0123557889999999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=408.70 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=208.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++++.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+ .+.+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-cccccc
Confidence 468999999999999999999986 79999999986542 2345778999999999999999999996665 678999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999986 4456899999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......||+.|+|||++.+..|+.++|||||||++|||++|++||...+... ....+....+.
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~~------- 223 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIR------- 223 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCCC-------
Confidence 2 22345679999999999999999999999999999999999999997654321 12222222111
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~ 555 (625)
. +..++.++.+||.+||++||++|++ ++|+++|
T Consensus 224 -~-----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 -F-----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -C-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -C-----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 0 0124567889999999999999995 8888886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-49 Score=397.71 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=205.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc---ce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---QG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~ 353 (625)
.++|++.+.||+|+||+||+|++. +|+.||||++... +....+.|.+|+++|++++|||||++++++.... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999976 7999999998643 3445678999999999999999999999765432 34
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.+|||||++|++|.+++. ..+.+++.+++.++.||++||+|||++||+||||||+|||++.++..+|+|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 799999999999999885 4456999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcc--ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 434 PLDVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 434 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... .......||+.|+|||++.+..++.++||||||+++|||++|++||...... ......+.......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP- 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCC-
Confidence 43222 2234567999999999999889999999999999999999999999754321 11112222111110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhchhc
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-SMEEVLAELQRIKS 561 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~i~~ 561 (625)
......++.++.++|.+||+.||++|| |++++++.|.++++
T Consensus 235 ---------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 235 ---------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ---------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ---------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 001113456888999999999999998 89999999988764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=394.75 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=198.7
Q ss_pred cCCCccceecccCcEEEEEEEEcC----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKD----GREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||.||+|++.. +..||||++... .....+.|.+|+.+|++++|||||++++++. .+.+++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEEE
Confidence 689999999999999999998752 356899988543 3445678999999999999999999999764 356899
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999998753 4456899999999999999999999999999999999999999999999999999876544
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCc
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPC 515 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (625)
.........||+.|+|||++.+..++.++||||||+++|||++ |.+||....... ....+..+.....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~~~---- 230 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM---- 230 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCCC----
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC----
Confidence 4444455678999999999998899999999999999999998 899997654322 1112222211110
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 516 LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 516 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...++.++.+||.+||+.||++|||++||+++|+.+.+
T Consensus 231 --------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 231 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11245678899999999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=393.41 Aligned_cols=253 Identities=26% Similarity=0.470 Sum_probs=201.2
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEe
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEF 360 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 360 (625)
.++|++.+.||+|+||.||+|+++ |+.||||++.... ..+.|.+|++++++++|||||+++|++.+..+.++|||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 457889999999999999999985 7899999996543 4467999999999999999999999776655668999999
Q ss_pred ccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcccc
Q 047969 361 VANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTHV 440 (625)
Q Consensus 361 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 440 (625)
+++|+|.+++... ....+++..+++|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999999642 2235899999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccCCcCCCC
Q 047969 441 STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGFE 519 (625)
Q Consensus 441 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (625)
.....+|..|+|||++.+..++.++||||||+++|||++ |++||....... ....+..+...++
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~~~~~-------- 221 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDA-------- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCCCC--------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC--------
Confidence 233457899999999988899999999999999999998 788886543221 1122222111111
Q ss_pred ChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 520 SDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 520 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+++++.+|+.+||+.||++||||.+++++|+.++.
T Consensus 222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 01234578899999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=400.95 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|+.++.++ +|+|||.+++++.....
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 468999999999999999999864 3468999998653 334556788888888887 68999999997777677
Q ss_pred eEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF 420 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~ 420 (625)
.+++||||+++|+|.+++..... ....+++..++.++.||++||+|||+++|+||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 78999999999999999975432 234589999999999999999999999999999999999999999
Q ss_pred eEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHH
Q 047969 421 CVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANL 498 (625)
Q Consensus 421 ~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~ 498 (625)
.+||+|||+|+........ ......||+.|+|||++.+..++.++||||||+++|||++| .+||....... .
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------~ 245 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------E 245 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------H
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------H
Confidence 9999999999876433322 23456799999999999999999999999999999999986 56776443221 1
Q ss_pred HHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 499 AINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
....+..+...... ..+++++.+++.+||+.||++|||++|++++|+.+.+
T Consensus 246 ~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 FCRRLKEGTRMRAP------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCC------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11222222111110 1234578899999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-49 Score=401.90 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=206.1
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 356 (625)
.++|++++.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.. .+.+++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeee
Confidence 367999999999999999999986 79999999986432 2345778999999999999999999997665 678999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||++||+|..++. ....+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999999885 4556899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
.....||+.|||||++.+..++.++|||||||++|+|++|+.||...... .....+...... ..
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~~--~p--- 221 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAELR--FP--- 221 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCCCC--CC---
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHHHHcCCCC--CC---
Confidence 23467999999999999989999999999999999999999999754321 112222222111 00
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
..++.++.+++.+||+.||++|+ |++++++|
T Consensus 222 --------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 --------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12345788999999999999996 89999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=400.84 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=203.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc----EEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR----EVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 355 (625)
++|++++.||+|+||+||+|++. +|+ .||+|++... .....++|.+|+++|++++|||||+++|++.+ +..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCee
Confidence 47999999999999999999875 444 5899988543 33456789999999999999999999997765 4568
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
++||++.+|+|.+++.. ....+++..++.++.||++||+|||+++|+||||||+||||+.++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999998853 455799999999999999999999999999999999999999999999999999997654
Q ss_pred Ccccc-ccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccccC
Q 047969 436 DVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDELID 513 (625)
Q Consensus 436 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (625)
..... .....||+.|+|||++.+..++.++||||||+++|||+| |.+||+...... .. ..+..+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i~~~~~~~--- 233 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP--- 233 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHHHHTCCCC---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC---
Confidence 33322 234568999999999998899999999999999999998 899997543321 11 1111111100
Q ss_pred CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 514 PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 514 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.. ..++..+.+|+.+||+.||++|||+.|++++|..+..
T Consensus 234 ----~p-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 ----QP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CC-----cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 00 1234578899999999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-49 Score=398.86 Aligned_cols=261 Identities=26% Similarity=0.368 Sum_probs=209.5
Q ss_pred HhcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccc
Q 047969 280 ATNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 280 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 352 (625)
..++|++++.||+|+||+||+|+.+ +++.||||++... .....++|.+|+++|++++||||+++++++.. ..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-CC
Confidence 3578999999999999999999864 3578999998654 33446789999999999999999999997665 56
Q ss_pred eEEEEEEeccCCChHHHhccCc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 047969 353 GLLLVYEFVANGTVADQLHGDR--------------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTN 412 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~ 412 (625)
..++||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 7899999999999999986422 12235899999999999999999999999999999999
Q ss_pred CEEECCCCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCC-CCCcccccc
Q 047969 413 NILLDSNFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHR 490 (625)
Q Consensus 413 NIll~~~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~-~p~~~~~~~ 490 (625)
||||+.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++||||||+++|||++|. +||......
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999999865433222 224467899999999999999999999999999999999985 677654322
Q ss_pred cccchhHHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 491 HEINLANLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
. ....+.++..... ...++.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 250 e-------~~~~v~~~~~~~~------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 E-------VIYYVRDGNILAC------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp H-------HHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H-------HHHHHHcCCCCCC------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 1222333322111 0123457889999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-48 Score=390.63 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=205.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---------HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeec
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---------YRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRY 350 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 350 (625)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 68999999999999999999986 78999999985432 123456889999999997 9999999997665
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
++.++|||||+++|+|.+++. ..+.+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 778999999999999999996 3456999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCCCCCccCcccccc------CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhh
Q 047969 431 RLFPLDVTHVSTAPQGTPGYVDPEYHQC------YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQ 504 (625)
Q Consensus 431 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 504 (625)
+...... ......||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ....+.
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~ 228 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM 228 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHH
Confidence 8764322 2345679999999998753 346889999999999999999999997653211 112222
Q ss_pred hcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 505 KCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...... ..+....+++++.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~---------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNYQF---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCCCC---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCCCC---------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 221110 011122456789999999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=396.01 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=208.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++++.||+|+||+||+|+++ +|+.||||++..... ....+.+|+++|++++|||||++++++.. .+.++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence 578999999999999999999987 788999999976543 34568899999999999999999997665 678999999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC--CeEEEcccccccccCCCc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN--FCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~--~~~kl~DFgla~~~~~~~ 437 (625)
|++||+|.+++.. ....+++.+++.++.||++||+|||++||+||||||+|||++.+ ..+||+|||+++......
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999953 33469999999999999999999999999999999999999854 589999999998754322
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
......+|+.|+|||.+.+..++.++|||||||++|+|++|..||....... ....+......
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~-------- 221 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT-------- 221 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--------
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------
Confidence 2234468999999999998899999999999999999999999997654321 12222221111
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
........++.++.+||.+||+.||++|||++|+++|
T Consensus 222 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 -FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123334567789999999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=396.77 Aligned_cols=254 Identities=25% Similarity=0.283 Sum_probs=202.3
Q ss_pred hcCCCccc-eecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeee---ccceE
Q 047969 281 TNDFSREK-ELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSR---YSQGL 354 (625)
Q Consensus 281 ~~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---~~~~~ 354 (625)
.++|++++ .||+|+||+||+|++. +++.||||++... +.+.+|+.++.++ +|||||++++++.. ....+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46899875 5999999999999975 7899999998643 3467899987655 89999999997643 24668
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEccccccc
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSR 431 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~ 431 (625)
+|||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 9999999999999999632 2346999999999999999999999999999999999999975 5679999999998
Q ss_pred ccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 432 LFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 432 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|++||......... ......+...
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~----- 232 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMG----- 232 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC-----
T ss_pred eccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcC-----
Confidence 764432 234567999999999999989999999999999999999999999765432111 0111111110
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... ........++.++.+||.+||+.||++|||+.|+++|
T Consensus 233 ---~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 ---QYE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SSS-CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCC-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011 1123345678899999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-48 Score=403.37 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=205.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 357 (625)
++|++++.||+|+||.||+|+++ +|+.||||++.+.. ....+.+++|+++|+.++|||||++++++.. ....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccc
Confidence 68999999999999999999986 79999999986432 2345778999999999999999999996655 6778999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~ 437 (625)
|||+.+|+|.+++. +.+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999985 3456999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCC
Q 047969 438 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLG 517 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (625)
.....||+.|||||++.+..++.++|||||||++|||++|++||...... .....+.......
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~~~------- 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVRF------- 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCC-------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-------HHHHHHhcCCCCC-------
Confidence 23457999999999999999999999999999999999999999754321 1222222221110
Q ss_pred CCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 518 FESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 518 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
...++.++.+||.+||+.||++|+ |++++++|
T Consensus 258 ------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 ------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 012456788999999999999994 89999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=389.25 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=196.8
Q ss_pred cCCCccceecccCcEEEEEEEEc--CC--cEEEEEEeccc---cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK--DG--REVAVKRLYDN---NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGL 354 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 354 (625)
++|++.+.||+|+||.||+|++. ++ ..||||++... .....++|.+|+.+|++++|||||+++|++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cch
Confidence 57999999999999999999864 23 36899988643 23446789999999999999999999997754 457
Q ss_pred EEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccC
Q 047969 355 LLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFP 434 (625)
Q Consensus 355 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~ 434 (625)
++||||+++|++.+++.. ..+.+++..++.++.||++||.|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 899999999999998863 33469999999999999999999999999999999999999999999999999999764
Q ss_pred CCccc--cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchhHHHHHHhhhcccccc
Q 047969 435 LDVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLANLAINKIQKCAFDEL 511 (625)
Q Consensus 435 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (625)
..... ......|+..|+|||++.+..++.++||||||+++|||++ |++||....... ....+.+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-------~~~~i~~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERL- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSCCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-------HHHHHHhCCCCC-
Confidence 43322 2234568899999999999899999999999999999998 899997543221 112222211100
Q ss_pred cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhch
Q 047969 512 IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRI 559 (625)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i 559 (625)
+ ....++..+.+++.+||+.||++||||.||++.|.+.
T Consensus 235 --~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --P--------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C--------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 0113445788999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=392.93 Aligned_cols=261 Identities=24% Similarity=0.301 Sum_probs=197.1
Q ss_pred ccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHH-----HHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 286 REKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRR-----VEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 286 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.+++||+|+||+||+|+++ +|+.||||++....... .+.+.+|+.+|++++|||||++++++.. .+.++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhh
Confidence 4678999999999999976 79999999986443221 2468899999999999999999997665 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
|+.++++..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999987776663 445689999999999999999999999999999999999999999999999999987543322
Q ss_pred cccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccC-----
Q 047969 440 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELID----- 513 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 513 (625)
......||+.|+|||++.. ..++.++|||||||++|||++|++||......... ....+.+.......+.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSST
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccc
Confidence 2234579999999998864 45799999999999999999999999765432211 11111111100000000
Q ss_pred --CcC----CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 --PCL----GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 --~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
... ..........++.++.+|+.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 000111122446688999999999999999999999886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=392.23 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=204.3
Q ss_pred cceecccCcEEEEEEEEcCC----cEEEEEEecc-ccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEEec
Q 047969 287 EKELGDGGFGTVYYGKLKDG----REVAVKRLYD-NNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYEFV 361 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 361 (625)
.++||+|+||+||+|++.++ ..||||++.. .+....++|.+|+++|++++|||||+++|++.......++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 2589999864 355667889999999999999999999998777667789999999
Q ss_pred cCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc--
Q 047969 362 ANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH-- 439 (625)
Q Consensus 362 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~-- 439 (625)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999863 4446788999999999999999999999999999999999999999999999999876443222
Q ss_pred -cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcCCC
Q 047969 440 -VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCLGF 518 (625)
Q Consensus 440 -~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (625)
......||+.|+|||.+....++.++||||||+++|||++|..||.......+ ... .+..+... ..+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~----~i~~g~~~--~~p---- 256 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITV----YLLQGRRL--LQP---- 256 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCC--CCC----
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcCCCC--CCc----
Confidence 12335689999999999988999999999999999999997777654322111 111 11111111 011
Q ss_pred CChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 519 ESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 519 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
...++++.+||.+||+.||++||||+||+++|+.+...
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12345788999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-48 Score=402.19 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=199.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH---HHHHHHH---HHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY---RRVEQFM---NEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++++.||+|+||.||+|++. +|+.||||++.+... .....+. +|+++++.++|||||++++++.. .+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDK 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCE
Confidence 468999999999999999999987 799999999854321 1122333 44677777789999999996655 677
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
++|||||++||+|.+++. +...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999996 3456899999999999999999999999999999999999999999999999999876
Q ss_pred CCCccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccccc
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELI 512 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (625)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ...........
T Consensus 158 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~~~~---- 226 (364)
T d1omwa3 158 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAV---- 226 (364)
T ss_dssp SSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSSSCCC----
T ss_pred CCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcccCCC----
Confidence 432 2344579999999999864 56899999999999999999999999765432211 11111111110
Q ss_pred CCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047969 513 DPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPS-----MEEVLAE 555 (625)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ell~~ 555 (625)
.. ...++.++.+||.+||+.||++||| ++|+++|
T Consensus 227 ----~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ----EL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----CC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----CC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 0124567889999999999999999 7899887
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=389.52 Aligned_cols=269 Identities=22% Similarity=0.364 Sum_probs=201.4
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|+++++||+|+||+||+|++. +|+.||||++..... ...+++.+|+++|++++|||||++++++.. ...+++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence 68999999999999999999975 799999999854432 235678999999999999999999997765 67899999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
||+.++.+. ++.. .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 81 e~~~~~~~~-~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 81 EFLHQDLKK-FMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp ECCSEEHHH-HHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred eecCCchhh-hhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 999765444 4422 234569999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccCCCCCCCccCccccccCC-CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccc---cC-
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDEL---ID- 513 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 513 (625)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+................+...... .+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2234457999999999876654 578999999999999999999999765432211111000000000000000 00
Q ss_pred -Cc----CCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 514 -PC----LGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 514 -~~----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.. ...........++.++.+|+.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0001111222445688999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=397.07 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=203.5
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEecccc---HHHHHHHHHHHHHHH-hcCCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNN---YRRVEQFMNEVEILT-RLRHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|..++. .++|||||++++++.. ++.++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeE
Confidence 68999999999999999999987 78999999996432 223456777777765 6899999999996665 677999
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~ 436 (625)
||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999996 3456899999999999999999999999999999999999999999999999999865433
Q ss_pred ccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcccccccCCcC
Q 047969 437 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDELIDPCL 516 (625)
Q Consensus 437 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (625)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~------~ 222 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF------Y 222 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------C
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC------C
Confidence 2 22345679999999999999999999999999999999999999997543221 22222222111 0
Q ss_pred CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 047969 517 GFESDEEVKRMTTSVAELAFLCLQQNKELRPSME-EVLAE 555 (625)
Q Consensus 517 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~ 555 (625)
. +.++.++.+||.+||+.||++|||+. ++++|
T Consensus 223 p-------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 223 P-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp C-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred C-------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 0 12456788999999999999999995 77665
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=394.55 Aligned_cols=259 Identities=29% Similarity=0.423 Sum_probs=204.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCc--EEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccceEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGR--EVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQGLLL 356 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l 356 (625)
++|++.++||+|+||+||+|+++ +|. .||||++... .....+.|.+|+++|+++ +|||||++++++.. .+.++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEE
Confidence 68999999999999999999976 444 4788887543 334556799999999999 79999999997765 677899
Q ss_pred EEEeccCCChHHHhccCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEE
Q 047969 357 VYEFVANGTVADQLHGDR------------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKV 424 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl 424 (625)
||||+++|+|.++++... .....+++..++.++.||++||.|||+++|+||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 999999999999996431 23467999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCC-CCCcccccccccchhHHHHHHh
Q 047969 425 ADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSM-PAVDMNRHRHEINLANLAINKI 503 (625)
Q Consensus 425 ~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 503 (625)
+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|. +||...... .....+
T Consensus 169 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-------~~~~~i 239 (309)
T d1fvra_ 169 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKL 239 (309)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHG
T ss_pred ccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-------HHHHHH
Confidence 9999998643222 223446899999999999889999999999999999999965 567543211 112222
Q ss_pred hhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 504 QKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
.++.... . ...+++++.+||.+||+.||++||||+||+++|+++.+.
T Consensus 240 ~~~~~~~-----~-------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 240 PQGYRLE-----K-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGTCCCC-----C-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcCCCC-----C-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2221111 0 112456888999999999999999999999999988753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=393.34 Aligned_cols=273 Identities=23% Similarity=0.332 Sum_probs=201.4
Q ss_pred hcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc---ceEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---QGLLLV 357 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~lv 357 (625)
.++|.+.+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+++++|||||++++++.... ..+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35788889999999999999997 589999999865432 2222334555666789999999999776533 257999
Q ss_pred EEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccCCCCCCEEECCCCeEEEccccc
Q 047969 358 YEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA--------SDIIHRDVKTNNILLDSNFCVKVADFGL 429 (625)
Q Consensus 358 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--------~~ivHrDikp~NIll~~~~~~kl~DFgl 429 (625)
|||+++|+|.++++. ..+++..++.++.|++.||+|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999963 258999999999999999999996 5999999999999999999999999999
Q ss_pred ccccCCCccc---cccCCCCCCCccCccccccCC------CCCchhhhhHHHHHHHHHhCCCCCcccccccccchh----
Q 047969 430 SRLFPLDVTH---VSTAPQGTPGYVDPEYHQCYQ------LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLA---- 496 (625)
Q Consensus 430 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~---- 496 (625)
++........ ......||+.|+|||++.+.. ++.++||||||++||||++|.+|+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876543322 223467999999999986542 567899999999999999999887543322111000
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhcC
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKSG 562 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~~ 562 (625)
......+.........++.+. ...........+.+++.+||+.||++|||+.||+++|+++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCC--GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCC--cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 001111111111111111111 1111223455788999999999999999999999999988753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=384.96 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=205.9
Q ss_pred hcCCCccceecccCcEEEEEEEEcC--------CcEEEEEEecccc-HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeec
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLKD--------GREVAVKRLYDNN-YRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRY 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 350 (625)
.++|++.+.||+|+||.||+|+... +..||||++.... .....++.+|+..+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 3689999999999999999998642 2479999986543 34567889999999998 79999999997765
Q ss_pred cceEEEEEEeccCCChHHHhccCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRA------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
....++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+++||||||||+|||++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 5678999999999999999964431 2356999999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~------ 244 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 244 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH------
Confidence 999999999999876433222 2344678999999999998999999999999999999998 78888654322
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
.....+..+..... . ..+++++.+||.+||+.||++|||+.||++.|+++..
T Consensus 245 -~~~~~i~~~~~~~~-----p-------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKLLKEGHRMDK-----P-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHTTCCCCC-----C-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCC-----C-------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11222222211110 0 1235578899999999999999999999999988753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=386.94 Aligned_cols=262 Identities=26% Similarity=0.371 Sum_probs=209.2
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeeeccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRL-RHKNLVSLFGCTSRYSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 352 (625)
.++|++.++||+|+||.||+|++. +++.||||++... .......|++|+.+++++ +|||||++++++.. ..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-CC
Confidence 468999999999999999999852 4568999999654 344566799999999999 69999999997665 56
Q ss_pred eEEEEEEeccCCChHHHhccCcc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 047969 353 GLLLVYEFVANGTVADQLHGDRA--------------KHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS 418 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~ 418 (625)
..+|||||+++|+|.+++..... ....+++..+..++.||++||+|||+++||||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 68999999999999999965321 2346999999999999999999999999999999999999999
Q ss_pred CCeEEEcccccccccCCCcc-ccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHh-CCCCCcccccccccchh
Q 047969 419 NFCVKVADFGLSRLFPLDVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELIS-SMPAVDMNRHRHEINLA 496 (625)
Q Consensus 419 ~~~~kl~DFgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~ellt-G~~p~~~~~~~~~~~~~ 496 (625)
++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |.+|+........+
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~--- 257 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH---
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH---
Confidence 99999999999997654332 22344678999999999998899999999999999999998 66666544322111
Q ss_pred HHHHHHhhhcccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 497 NLAINKIQKCAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
...+... ..... . ...+..+.+||.+||+.||++||||+||+++|+++..
T Consensus 258 ---~~~i~~~-~~~~~----~-------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 258 ---YKMIKEG-FRMLS----P-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ---HHHHHHT-CCCCC----C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHhcC-CCCCC----c-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111111 11000 0 1234578899999999999999999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-47 Score=384.87 Aligned_cols=265 Identities=21% Similarity=0.319 Sum_probs=201.9
Q ss_pred cCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY--RRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
++|+++++||+|+||+||+|++++|+.||||++..... ...+++.+|+.+|++++|||||++++++.. .+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEE
Confidence 68999999999999999999999999999999865432 235789999999999999999999996665 667899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCccc
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVTH 439 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 439 (625)
++.++.+..+.. ..+.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 81 HLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred eehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 998877766653 446799999999999999999999999999999999999999999999999999987643322
Q ss_pred cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc---cccc----
Q 047969 440 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA---FDEL---- 511 (625)
Q Consensus 440 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 511 (625)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......... .......... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGST
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCChhhccchhhhh
Confidence 22344689999999988654 57899999999999999999999997544322111 1111110000 0000
Q ss_pred -----cCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 -----IDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...............++..+.+|+.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000111111223345678899999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=386.87 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=200.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-C-CcEEEEEEeccccH--HHHHHHHHHHHHHHhc---CCCCeeeeeeeeee----
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-D-GREVAVKRLYDNNY--RRVEQFMNEVEILTRL---RHKNLVSLFGCTSR---- 349 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 349 (625)
.++|+++++||+|+||+||+|++. + ++.||||++..... .....+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 479999999999999999999974 4 66799999854321 1223456777777666 79999999996642
Q ss_pred ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccc
Q 047969 350 YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGL 429 (625)
Q Consensus 350 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgl 429 (625)
.....+++|||++++.+..... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 3356899999999887765543 2445689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---c
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---C 506 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 506 (625)
++.... ........||+.|+|||++.+..++.++||||+||++|||++|++||.......... ........ .
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGEE 237 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCGG
T ss_pred hhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCchh
Confidence 986432 233356679999999999999999999999999999999999999997654322111 11111100 0
Q ss_pred cccc-------ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 AFDE-------LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+.. ................++..+.+|+.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000001111122345678899999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=384.77 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=209.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK------DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 353 (625)
.++|++.++||+|+||+||+|.++ +++.||||++... .......|.+|+.++++++|||||++++++.. ...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCc
Confidence 368899999999999999999864 3578999999654 34455679999999999999999999997655 567
Q ss_pred EEEEEEeccCCChHHHhccCc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccc
Q 047969 354 LLLVYEFVANGTVADQLHGDR------AKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADF 427 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DF 427 (625)
.++||||+++|+|.+++.... .....+++..+..++.|+++||.|||+++|+||||||+||||+.++++||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 899999999999999986432 12235799999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccc-cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhC-CCCCcccccccccchhHHHHHHhhh
Q 047969 428 GLSRLFPLDVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISS-MPAVDMNRHRHEINLANLAINKIQK 505 (625)
Q Consensus 428 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~ 505 (625)
|+|+........ ......||+.|+|||.+.+..++.++||||||+++|||++| .+||....... ....+.+
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~i~~ 250 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVME 250 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHHT
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHh
Confidence 999876433222 22445689999999999998999999999999999999998 47775433221 1122222
Q ss_pred cccccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 506 CAFDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
+...... ..++..+.++|.+||+.+|++|||+++|+++|++..+
T Consensus 251 ~~~~~~p------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGLLDKP------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCc------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2211110 1234578899999999999999999999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=383.85 Aligned_cols=241 Identities=24% Similarity=0.382 Sum_probs=195.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccH------HHHHHHHHHHHHHHhcC--CCCeeeeeeeeeecc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNY------RRVEQFMNEVEILTRLR--HKNLVSLFGCTSRYS 351 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 351 (625)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.. .
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-P 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-S
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-C
Confidence 368999999999999999999976 789999999864321 12234678999999997 8999999996655 6
Q ss_pred ceEEEEEEeccC-CChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCeEEEccccc
Q 047969 352 QGLLLVYEFVAN-GTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-NFCVKVADFGL 429 (625)
Q Consensus 352 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-~~~~kl~DFgl 429 (625)
+..++||||+.+ +++.+++. ....+++..++.++.||++||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 778999999976 57777774 3456999999999999999999999999999999999999985 57999999999
Q ss_pred ccccCCCccccccCCCCCCCccCccccccCCC-CCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc
Q 047969 430 SRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF 508 (625)
Q Consensus 430 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (625)
|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... +.....
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~~ 221 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQV 221 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCC
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhccc
Confidence 9865332 2345679999999999987665 5678999999999999999999964311 111110
Q ss_pred ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ..+ .++.++.+||.+||+.||++|||++|+++|
T Consensus 222 ~--~~~-----------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 F--FRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--CSS-----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C--CCC-----------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 111 235678899999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-45 Score=373.72 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=202.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVYE 359 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 359 (625)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .+++.+|+++++.++|+|+|..++.+.......++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999976 789999998765432 24578899999999988877776656666778899999
Q ss_pred eccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC---CCeEEEcccccccccCCC
Q 047969 360 FVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS---NFCVKVADFGLSRLFPLD 436 (625)
Q Consensus 360 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~---~~~~kl~DFgla~~~~~~ 436 (625)
|+. ++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.+...
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 995 566665532 4456999999999999999999999999999999999999864 557999999999976543
Q ss_pred ccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 437 VTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 437 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence 221 12345799999999999998999999999999999999999999976543332222211111111100
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchh
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIK 560 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~ 560 (625)
.......++.++.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 237 ---------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 ---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ---------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ---------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 01112235568899999999999999999999988887754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=383.23 Aligned_cols=270 Identities=20% Similarity=0.273 Sum_probs=199.3
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc---ceEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS---QGLL 355 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~ 355 (625)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++++|+.+|++++||||+++++++.... ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999875 8999999998644 3445678999999999999999999999764422 1234
Q ss_pred EEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCC
Q 047969 356 LVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPL 435 (625)
Q Consensus 356 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~ 435 (625)
++++++.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55566779999999852 3589999999999999999999999999999999999999999999999999987643
Q ss_pred Cccc--cccCCCCCCCccCccccc-cCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc-----
Q 047969 436 DVTH--VSTAPQGTPGYVDPEYHQ-CYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA----- 507 (625)
Q Consensus 436 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 507 (625)
.... ......||+.|+|||++. ...++.++||||+|+++|+|++|++||.......................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3222 234467999999999884 45678999999999999999999999976543221111110000000000
Q ss_pred ------cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 ------FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
...................++.++.+|+.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000111111222345678899999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=376.30 Aligned_cols=272 Identities=21% Similarity=0.310 Sum_probs=199.5
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-------
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY------- 350 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 350 (625)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|+.+|++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999976 8999999998543 223356788999999999999999999865332
Q ss_pred cceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccc
Q 047969 351 SQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLS 430 (625)
Q Consensus 351 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla 430 (625)
...+++||||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence 345899999998877665543 4456899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccc---cccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhc
Q 047969 431 RLFPLDVTH---VSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKC 506 (625)
Q Consensus 431 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 506 (625)
+........ ......||+.|+|||++.+. .++.++||||||+++|||++|++||......................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 876533221 22335699999999998654 68999999999999999999999997544322211111111000000
Q ss_pred cccccc--------CCcCCCCC--hHH--HHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 507 AFDELI--------DPCLGFES--DEE--VKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 507 ~~~~~~--------~~~~~~~~--~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
...... ........ .+. ....+..+.+||.+||+.||++|||++|+++|=
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 000000 00000000 011 112245678899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=382.16 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=195.9
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeecc-----c
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYS-----Q 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 352 (625)
.++|+++++||+|+||+||+|+++ +|+.||||++... +....+.+.+|+++|++++|||||++++++...+ .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999976 7999999998643 3345678899999999999999999999765432 2
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.++|||||+ +.+|..++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 579999999 567777763 34699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHh----hhc-
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKI----QKC- 506 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~- 506 (625)
.... .+...||+.|+|||++.+. .++.++||||+||++|+|++|++||................... ...
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5432 2456799999999988654 57899999999999999999999997654322111111000000 000
Q ss_pred c------cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 507 A------FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 507 ~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
. ...................+++++.+||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000001111112345578899999999999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=379.69 Aligned_cols=270 Identities=24% Similarity=0.278 Sum_probs=198.3
Q ss_pred CCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec-----cceEEE
Q 047969 283 DFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY-----SQGLLL 356 (625)
Q Consensus 283 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~l 356 (625)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++|||||++++++... ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999986 799999999965532 234799999999999999999976432 234789
Q ss_pred EEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC-eEEEcccccccccCC
Q 047969 357 VYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNF-CVKVADFGLSRLFPL 435 (625)
Q Consensus 357 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~-~~kl~DFgla~~~~~ 435 (625)
||||++++.+..+. ........+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 97 v~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99999876444433 2223556799999999999999999999999999999999999999775 899999999987643
Q ss_pred CccccccCCCCCCCccCcccccc-CCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHH--------HHHhhhc
Q 047969 436 DVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLA--------INKIQKC 506 (625)
Q Consensus 436 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 506 (625)
.. ......||..|+|||.+.+ ..++.++||||+||++|||++|++||............... .......
T Consensus 176 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 176 GE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred Cc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 32 2344579999999998764 57899999999999999999999999765432211111000 0000000
Q ss_pred ccccccCCcCCCCC--hHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhchh
Q 047969 507 AFDELIDPCLGFES--DEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE--LQRIK 560 (625)
Q Consensus 507 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~--L~~i~ 560 (625)
.....-+...... .......++++.+|+.+||+.||++|||++|+++| ++.+.
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 -YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred -hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000000000 00011345678899999999999999999999987 44444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-44 Score=364.29 Aligned_cols=262 Identities=15% Similarity=0.213 Sum_probs=206.4
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeeeccceEEEEE
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH-KNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~ 358 (625)
.++|+++++||+|+||+||+|++. +|+.||||++.... ..+.+.+|+++++.++| +|++.++++... ....++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEE
Confidence 368999999999999999999976 78999999875442 22457789999999975 899999986554 67789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-----CCeEEEccccccccc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDS-----NFCVKVADFGLSRLF 433 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~-----~~~~kl~DFgla~~~ 433 (625)
||+ +++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 81 e~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 998 6799988853 3446999999999999999999999999999999999999964 578999999999976
Q ss_pred CCCccc------cccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhcc
Q 047969 434 PLDVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCA 507 (625)
Q Consensus 434 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 507 (625)
...... ......||+.|||||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 433221 12345799999999999998999999999999999999999999976543332222111111111111
Q ss_pred cccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhchhc
Q 047969 508 FDELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAELQRIKS 561 (625)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~i~~ 561 (625)
. .+..+.++.++.+++..|++.+|++||+++.+.+.|+.+..
T Consensus 237 ~------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 L------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp H------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred h------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1 11112345678899999999999999999999998887643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=364.40 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=204.2
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeeccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRYSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 358 (625)
++|+++++||+|+||+||+|++. +++.||||++... .....+++.+|+.+|+.++|||||++++++.. ....++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence 68999999999999999999976 7899999998543 23456789999999999999999999996665 66789999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccccCCCcc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLFPLDVT 438 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~~~~~~ 438 (625)
|++.+++|..++. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus 81 ~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 81 EFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp ECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999999888775 455789999999999999999999999999999999999999999999999999987643322
Q ss_pred ccccCCCCCCCccCccccccCC-CCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhh---ccccc---c
Q 047969 439 HVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQK---CAFDE---L 511 (625)
Q Consensus 439 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~ 511 (625)
......+++.|+|||++.... ++.++|||||||++|||++|+.||.......+. .......... ..... .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhhc
Confidence 223456788999999887654 689999999999999999999887433221111 1111111000 00000 0
Q ss_pred cC------CcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 512 ID------PCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 512 ~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
.+ .............++..+.+|+.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000011111223455678899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=372.11 Aligned_cols=267 Identities=22% Similarity=0.249 Sum_probs=196.0
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeee-----ccc
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSR-----YSQ 352 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 352 (625)
.++|+++++||+|+||+||+|++. +|+.||||++... +....+++.+|+.+|++++|||||++++++.. ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999987 7999999998643 34556778999999999999999999997643 236
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.+++||||+.++.+. .+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 789999999776554 332 2489999999999999999999999999999999999999999999999999886
Q ss_pred cCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH--------------
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL-------------- 498 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~-------------- 498 (625)
.... .......+|+.|+|||++.+..++.++||||+||++++|++|++||..............
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5432 223455789999999999998999999999999999999999999975432111100000
Q ss_pred -HHHHhhhccc-------ccccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047969 499 -AINKIQKCAF-------DELIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAEL 556 (625)
Q Consensus 499 -~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 556 (625)
.......... ...................+.++.+|+.+||+.||++|||++|+++|=
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000000000 000111111122234456788899999999999999999999999883
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=370.11 Aligned_cols=253 Identities=26% Similarity=0.329 Sum_probs=202.0
Q ss_pred cCCCccceecccCcEEEEEEEEc----CCcEEEEEEecccc----HHHHHHHHHHHHHHHhcCC-CCeeeeeeeeeeccc
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK----DGREVAVKRLYDNN----YRRVEQFMNEVEILTRLRH-KNLVSLFGCTSRYSQ 352 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 352 (625)
++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++| |||+++++++.. ..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CC
Confidence 67999999999999999999863 47899999985431 2234668899999999976 899999996655 66
Q ss_pred eEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 353 GLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 353 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
..++||||+.+|+|.+++. ..+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 7899999999999999986 344578999999999999999999999999999999999999999999999999987
Q ss_pred cCCCccccccCCCCCCCccCccccccC--CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccccc
Q 047969 433 FPLDVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAFDE 510 (625)
Q Consensus 433 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (625)
+............|++.|+|||.+.+. .++.++|||||||+||+|++|+.||......... .............
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~~- 254 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEPP- 254 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCCC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCCC-
Confidence 655444444556799999999988653 4788999999999999999999999765433222 1111111111110
Q ss_pred ccCCcCCCCChHHHHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047969 511 LIDPCLGFESDEEVKRMTTSVAELAFLCLQQNKELRP-----SMEEVLAE 555 (625)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~ 555 (625)
. ...++.++.+|+.+||+.||++|| |++|+++|
T Consensus 255 -----~-------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 -----Y-------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----C-------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----C-------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 012456888999999999999999 48898876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-44 Score=369.16 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=199.3
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeee-ccceEEEEE
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSR-YSQGLLLVY 358 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~~~lv~ 358 (625)
++|+++++||+|+||+||+|++. +|+.||||++.... .+++.+|+.+|++++ ||||+++++++.. ....+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999986 78999999986543 356889999999995 9999999997653 345689999
Q ss_pred EeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC-CeEEEcccccccccCCCc
Q 047969 359 EFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSN-FCVKVADFGLSRLFPLDV 437 (625)
Q Consensus 359 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~-~~~kl~DFgla~~~~~~~ 437 (625)
||+.+++|..+. +.+++..+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999986654 248999999999999999999999999999999999999865 479999999998764332
Q ss_pred cccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHH-HH------HHhhhcc--
Q 047969 438 THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANL-AI------NKIQKCA-- 507 (625)
Q Consensus 438 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~-~~------~~~~~~~-- 507 (625)
......+|+.|+|||.+.+. .++.++||||+|+++++|++|+.||.............. .. .......
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23456789999999988664 579999999999999999999999975443221110000 00 0000000
Q ss_pred ----cccccCCcCC-----CCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 508 ----FDELIDPCLG-----FESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 508 ----~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
+......... .........++.++.+||.+||+.||++|||++|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 00111123356678999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=371.68 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=197.6
Q ss_pred hcCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhcCCCCeeeeeeeeeec----cce
Q 047969 281 TNDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDN--NYRRVEQFMNEVEILTRLRHKNLVSLFGCTSRY----SQG 353 (625)
Q Consensus 281 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~ 353 (625)
.++|+++++||+|+||+||+|++. +|+.||||++... +....+++.+|+++|++++|||||++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999976 7999999998644 344567789999999999999999999966421 233
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEccccccccc
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVADFGLSRLF 433 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~DFgla~~~ 433 (625)
.+++|+++.+|+|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 466778888999999984 245999999999999999999999999999999999999999999999999999754
Q ss_pred CCCccccccCCCCCCCccCccccccC-CCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHHHhhhccc----
Q 047969 434 PLDVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAINKIQKCAF---- 508 (625)
Q Consensus 434 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 508 (625)
. .......||+.|+|||.+.+. .++.++||||||+++|+|++|++||......... ............
T Consensus 172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAELLK 244 (348)
T ss_dssp T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHT
T ss_pred C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChHHhh
Confidence 2 223455789999999987654 4688999999999999999999999765432111 111111000000
Q ss_pred -------ccccC--CcC-CCCChHHHHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047969 509 -------DELID--PCL-GFESDEEVKRMTTSVAELAFLCLQQNKELRPSMEEVLAE 555 (625)
Q Consensus 509 -------~~~~~--~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 555 (625)
..... ... ..........++.++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 000 001111122356678899999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-38 Score=331.71 Aligned_cols=268 Identities=21% Similarity=0.253 Sum_probs=191.7
Q ss_pred cCCCccceecccCcEEEEEEEEc-CCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-----------CCCeeeeeeeeee
Q 047969 282 NDFSREKELGDGGFGTVYYGKLK-DGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-----------HKNLVSLFGCTSR 349 (625)
Q Consensus 282 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 349 (625)
++|+++++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+++++.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 36999999999999999999986 79999999997553 34567889999998886 4789999886543
Q ss_pred -ccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCC------e
Q 047969 350 -YSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHA-SDIIHRDVKTNNILLDSNF------C 421 (625)
Q Consensus 350 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDikp~NIll~~~~------~ 421 (625)
.....+++|+++..+........ ......+++..+..++.||+.||+|||+ .||+||||||+||||+.++ .
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 33456777777665543333221 2345578999999999999999999998 8999999999999997654 4
Q ss_pred EEEcccccccccCCCccccccCCCCCCCccCccccccCCCCCchhhhhHHHHHHHHHhCCCCCcccccccccchhHHHHH
Q 047969 422 VKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSMPAVDMNRHRHEINLANLAIN 501 (625)
Q Consensus 422 ~kl~DFgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwslG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 501 (625)
+|++|||.+..... ......||+.|+|||++....++.++||||+|+++++|++|+.||.................
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999986432 22445799999999999988999999999999999999999999975443222211111111
Q ss_pred Hhh---h-------------ccccc--ccC--CcCCCCChH--------HHHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047969 502 KIQ---K-------------CAFDE--LID--PCLGFESDE--------EVKRMTTSVAELAFLCLQQNKELRPSMEEVL 553 (625)
Q Consensus 502 ~~~---~-------------~~~~~--~~~--~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~ell 553 (625)
.+. . ..+.. ... ......... .....+.++.+|+.+||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 0 00000 000 000000111 1135677899999999999999999999999
Q ss_pred HH
Q 047969 554 AE 555 (625)
Q Consensus 554 ~~ 555 (625)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 87
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=6.1e-25 Score=206.63 Aligned_cols=165 Identities=14% Similarity=0.105 Sum_probs=120.8
Q ss_pred CccceecccCcEEEEEEEEcCCcEEEEEEeccccH------------------HHHHHHHHHHHHHHhcCCCCeeeeeee
Q 047969 285 SREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNY------------------RRVEQFMNEVEILTRLRHKNLVSLFGC 346 (625)
Q Consensus 285 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 346 (625)
.+.++||+|+||+||+|++.+|+.||||++..... .....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999998999999998642210 112345678999999999999988863
Q ss_pred eeeccceEEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCeEEEcc
Q 047969 347 TSRYSQGLLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHASDIIHRDVKTNNILLDSNFCVKVAD 426 (625)
Q Consensus 347 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDikp~NIll~~~~~~kl~D 426 (625)
.. .+++|||+++..+.+ ++...+..++.|++++|.|||++||+||||||+|||++++ .++|+|
T Consensus 83 ~~-----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG-----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET-----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred cC-----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 21 279999998865432 3344556799999999999999999999999999999865 589999
Q ss_pred cccccccCCCccccccCCCCCCCccCcc--c---cccCCCCCchhhhhHHHHHH
Q 047969 427 FGLSRLFPLDVTHVSTAPQGTPGYVDPE--Y---HQCYQLTDKSDVYSFGVVLI 475 (625)
Q Consensus 427 Fgla~~~~~~~~~~~~~~~gt~~y~aPE--~---~~~~~~s~~sDvwslG~il~ 475 (625)
||+|........ ..|.... . +-...|+.++|+||+.--++
T Consensus 146 FG~a~~~~~~~~---------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGW---------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTH---------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCc---------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 999976432211 1121111 0 11245788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=9.2e-08 Score=92.16 Aligned_cols=147 Identities=12% Similarity=0.080 Sum_probs=98.7
Q ss_pred HHHHHHhcCCCccceecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeeeccce
Q 047969 275 SDLAEATNDFSREKELGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLR-HKNLVSLFGCTSRYSQG 353 (625)
Q Consensus 275 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 353 (625)
.++.+..+.|+..+..+-++.+.||+... +++.++||+...........+.+|+.+++.+. +--+.+++.+.. ..+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-cCCc
Confidence 46777788898877655555678998865 56677888875544333445678988888774 333555665333 3566
Q ss_pred EEEEEEeccCCChHHHhccCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 047969 354 LLLVYEFVANGTVADQLHGDRAKHGLLTWPIRMNIAIETASALAYLHAS------------------------------- 402 (625)
Q Consensus 354 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------------------------------- 402 (625)
.++||++++|.++.+..... .....++.++++.|..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 79999999998876554211 01122344445555555531
Q ss_pred ----------------------------CCcccCCCCCCEEECCCCeEEEcccccccc
Q 047969 403 ----------------------------DIIHRDVKTNNILLDSNFCVKVADFGLSRL 432 (625)
Q Consensus 403 ----------------------------~ivHrDikp~NIll~~~~~~kl~DFgla~~ 432 (625)
.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 258999999999999877677999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=2.8e-05 Score=73.70 Aligned_cols=74 Identities=12% Similarity=0.065 Sum_probs=50.6
Q ss_pred eecccCc-EEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCC--CCeeeeeeeeeeccceEEEEEEeccCCC
Q 047969 289 ELGDGGF-GTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRH--KNLVSLFGCTSRYSQGLLLVYEFVANGT 365 (625)
Q Consensus 289 ~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~gs 365 (625)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+.. ..+..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~-~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecc-cccceEEEEEeeeccc
Confidence 4555553 689999888888899998654432 345678888887743 33555666433 3566799999998865
Q ss_pred h
Q 047969 366 V 366 (625)
Q Consensus 366 L 366 (625)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=3.9e-05 Score=77.93 Aligned_cols=76 Identities=18% Similarity=0.167 Sum_probs=47.8
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEeccc-------cHHHHHHHHHHHHHHHhcC-C--CCeeeeeeeeeeccceEE
Q 047969 287 EKELGDGGFGTVYYGKLK-DGREVAVKRLYDN-------NYRRVEQFMNEVEILTRLR-H--KNLVSLFGCTSRYSQGLL 355 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 355 (625)
.+.||.|....||+.... +++.++||.-... -....++...|++.|+.+. + ..+.+++.+ .. ...+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~--~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT--EMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET--TTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cC--CCCE
Confidence 457999999999999865 4778999964221 0112344556888887773 2 345556653 22 3347
Q ss_pred EEEEeccCCC
Q 047969 356 LVYEFVANGT 365 (625)
Q Consensus 356 lv~e~~~~gs 365 (625)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.00042 Score=68.05 Aligned_cols=69 Identities=16% Similarity=0.115 Sum_probs=45.5
Q ss_pred cEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe--eeeee----eeeeccceEEEEEEeccCC
Q 047969 295 FGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL--VSLFG----CTSRYSQGLLLVYEFVANG 364 (625)
Q Consensus 295 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~----~~~~~~~~~~lv~e~~~~g 364 (625)
--.||+++..+|+.+++|+.... ....+++..|...+..|...++ +..+. .........+.+++++.|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 46899999999999999987554 2234667788888888853222 22111 1122345578899998774
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.89 E-value=0.0027 Score=61.56 Aligned_cols=157 Identities=10% Similarity=0.061 Sum_probs=83.2
Q ss_pred cChHHHHHHhcCCCccce-----ecccCcEEEEEEEEcCCcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCC-----ee
Q 047969 272 FSYSDLAEATNDFSREKE-----LGDGGFGTVYYGKLKDGREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKN-----LV 341 (625)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~-----LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv 341 (625)
.+-+++.....+|.+.+. |..|---+.|+.+..+|+ +++|+..... ..+.+..|+++|..|...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 456788888888877443 345666889999887655 8999875431 2234455677777764322 11
Q ss_pred eeee--eeeeccceEEEEEEeccCCChHH--------------HhccC----c-ccCCCCC------------------H
Q 047969 342 SLFG--CTSRYSQGLLLVYEFVANGTVAD--------------QLHGD----R-AKHGLLT------------------W 382 (625)
Q Consensus 342 ~~~~--~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~-~~~~~l~------------------~ 382 (625)
...+ ...........++.++.+..... .++.. . ....... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1111 11112334566677766532211 11100 0 0000000 0
Q ss_pred HHHHHHHHHHHHHHHHHHh----CCCcccCCCCCCEEECCCCeEEEccccccc
Q 047969 383 PIRMNIAIETASALAYLHA----SDIIHRDVKTNNILLDSNFCVKVADFGLSR 431 (625)
Q Consensus 383 ~~~~~i~~qi~~~L~yLH~----~~ivHrDikp~NIll~~~~~~kl~DFgla~ 431 (625)
......+..+...+...+. .|+||+|+.++||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222223333333332 279999999999999998877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.85 E-value=0.0013 Score=66.33 Aligned_cols=73 Identities=16% Similarity=0.297 Sum_probs=48.8
Q ss_pred cceecccCcEEEEEEEEcC--------CcEEEEEEeccccHHHHHHHHHHHHHHHhcCCCCe-eeeeeeeeeccceEEEE
Q 047969 287 EKELGDGGFGTVYYGKLKD--------GREVAVKRLYDNNYRRVEQFMNEVEILTRLRHKNL-VSLFGCTSRYSQGLLLV 357 (625)
Q Consensus 287 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv 357 (625)
++.|+.|-.-.+|++...+ .+.|.+++.... ... ....+|..+++.+.-.++ .++++++.. .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE-SHLVAESVIFTLLSERHLGPKLYGIFSG-----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ceE
Confidence 4678889999999998754 345777765422 222 345679999998853344 466664332 689
Q ss_pred EEeccCCCh
Q 047969 358 YEFVANGTV 366 (625)
Q Consensus 358 ~e~~~~gsL 366 (625)
|||++|.++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|